<SEC-DOCUMENT>0000784199-23-000088.txt : 20230505
<SEC-HEADER>0000784199-23-000088.hdr.sgml : 20230505
<ACCEPTANCE-DATETIME>20230505145625
ACCESSION NUMBER:		0000784199-23-000088
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		72
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230505
DATE AS OF CHANGE:		20230505

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ARTIVION, INC.
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		23893246

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CRYOLIFE INC
		DATE OF NAME CHANGE:	19940526
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>aort-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:b72a0741-f899-4d87-a80c-f9fdcb4bb4b4,g:8ab7fb08-5903-4a38-b428-03d2f07a3992,d:5fc3aab1863a48b289e7fc6726692d73--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:aort="http://www.cryolife.com/20230331" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>aort-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV8yLTEtMS0xLTU0OTkz_e1c6021e-bd51-469b-9f90-57f9717b5b2d">0000784199</ix:nonNumeric><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV8zLTEtMS0xLTU0OTkz_cad3afa7-714b-4aa9-8846-5ce7deb21874">12-31</ix:nonNumeric><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV80LTEtMS0xLTU0OTkz_0f19baec-a1c7-4049-bb37-524c2d1bc9f7">2023</ix:nonNumeric><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV81LTEtMS0xLTU0OTkz_b035c50c-d137-4f97-948b-7fb550a92dd6">Q1</ix:nonNumeric><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV82LTEtMS0xLTU0OTkz_ff09f6e2-d9b8-4e92-8e51-2e50ef553040">false</ix:nonNumeric><ix:nonNumeric contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_2e5b36fd-c488-467a-a7e5-80e362ee1e08">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_c3cbd70e-0a04-4d24-ab66-5fb27dcd22e3">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ica3af079dd144cbfa68005cf48df464f_D20210602-20210602" name="aort:DebtInstrumentExtensionPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181OC9mcmFnOjAxMjNlMjNkYmNkYzRjNTVhZjgyOTBjMjU5MTAxZWU2L3RhYmxlOmNmNDk5NDRlZWMyMjQwMGRiYjJlNDQ5MmYwNGYxMWIxL3RhYmxlcmFuZ2U6Y2Y0OTk0NGVlYzIyNDAwZGJiMmU0NDkyZjA0ZjExYjFfMi0xLTEtMS01NDk5Mw_071e48f5-8e91-4854-9d7b-dd43e689db4c">2.5</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="id7abca8345f249998cb27b9c944935cc_D20200618-20200618" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181OC9mcmFnOjAxMjNlMjNkYmNkYzRjNTVhZjgyOTBjMjU5MTAxZWU2L3RhYmxlOmNmNDk5NDRlZWMyMjQwMGRiYjJlNDQ5MmYwNGYxMWIxL3RhYmxlcmFuZ2U6Y2Y0OTk0NGVlYzIyNDAwZGJiMmU0NDkyZjA0ZjExYjFfMy0xLTEtMS01NDk5Mw_df6675bd-2a85-450c-a4c9-c9a4e28a79cc">0.0426203</ix:nonFraction></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="aort-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7835c64896c44c22ac5cc78e13028978_I20230428"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1ae3a909430949bd90a175d270eb249f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i979c20305ec145afbd438a672f317ec1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5cf4550d1e64e08a695b28c0c89be0e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1c72bde95b6478d85567313998b4435_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id34f77b2e87c4767bbb2e6a239ed82d3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i684ce4d481204a1aad79ec17a22ca9cc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8906191b80d94b2cb337250ebd00ffe4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d4870864b08435ba93e18e414576db4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia20c6db1b736414388dabc9465f16d8e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i314c30b8aff54268bfed28a9c6beccd1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7766a77cc4e4f6c80f140d23c8e7323_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie07dff7c65f54941b40235f8253ee52f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7529137f6374134ba29f2ac0fc74e1a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1f0e19f9d2846e8836488a6f5034a54_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0611add9d054ed19bdf0000b33535f2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i371e868a09e8420ca81b51ae2ded7735_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80ee1b53042f49daa8481c6a55b7f28d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba4345bc04bc4fd0b009820cbf10edda_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a9f88cb8b244d1f8d88193d41aee37f_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice4c3a2465c545898bd620a0413d3832_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib03cb376e30e462b9363c3c0bf7170c4_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id19300d854664ca394ffabc2a495b2e5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccd5df30d43d4a12952dc6138272e270_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8256b73459843e0aaf032088b5f7f90_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i572ac13fae7e4dafbdaa8efdf37bea7f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id42a947477504a9f9a4328bba9370244_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib659527ecee343bc87c222d16f27cd19_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i898f1ad5afdf4d8f9d86cd812ca5514c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf6b10a5a1ad4e50a4bc84b969e56728_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99a5bc1a71c34a1b9e0b212e75b8f3c8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ffb145f12444931806dfef0dd45ec75_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e538adb023b42dba22d620e4792eb34_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9897803022524b6b83398955223e2444_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16e5777fa0694cc18917f184d3087f01_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6b549ee865943d6855f63e539a42cc5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia60a357239894830b1528f32f19aaf03_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icef1a873474b47e7b3ee0e7be4ef40b8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb10dd17357d43dfb35870e5456e7882_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53c72e2891b643879b972b1f3ceb58fe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if63692cacc3a445dacf59c9a1047dd06_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if66fb22ae36440dab8fe8254cd95ffb1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a5e9956c83a49c0b5cac54ad6a7f263_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4bd3bfffc6a2457bba90e050e14c2e58_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib98547abf55f42c59aefaa0f6d22fe1b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71edbd22e4cf42339603deb7cbeac930_I20200902"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i77a16d00eb08404da8ae5de65c51f748_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f174cecb39e48b9af65991c55af673a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie59b048c0d4b4b56a468429d5b300520_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08c0ea5c117b4dfeb0384a9e1247a5b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26fcb04471584b5ea9d699972f9aa939_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03f86365100d412b8f424f38d54c35d2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i330d4af7abf24d219bcf5d1880f8fc1e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c6dba73291e448e8f57ab1bc8a6db08_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79506f115b764903b5b77aff6438f481_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie93b31b47b134081a15dded0e238e7c8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idfdcdca476ee4794a47f75b9b0908a9f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4136c9e254424e49b35b6472a39e43cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a48d6cb9ff746b094b85d9a721d7be5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dd274f665ea4e7683e9b456604be8cf_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c38d20648d74b51a72771f63edb7c84_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31c830db6dc5484fad7ab16e160c2aff_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if024f14950384826b773eb09bb2b089c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a2765316f314fceb7d349c3f5a72808_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4c9d1fe9fed440d85fc4a9e9e993bd5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f8ed83f3d44b89bdc1f649e920bcad_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52d7e0b1e38944d8b119d3830e7326b9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf585199079741d2ad24baa4508e7b79_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i225c6055e6e34ecc8ff6267a3e5c52cb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e7ccf2f59bf4c329c1dd9a597525246_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a6a965e9f9b4929b0346378e7446b64_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3329eed5890493eaa1e7419306565e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id934e39711ff42389941ee999e64276a_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i261990d377b24cd39e6196259557695b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34a04e6aff414a2493a8ecbef5858fb2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcb5f46ffb5a46dba6a079186a59afa2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78d3a75cb5e242e999b5d7a86b03fb8c_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3b14dd7eb30490fab897cf536448da7_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f4a2ffeb0704db5bbaba540ed9732b7_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1555b8edf0a442659291ed6e92593f09_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc88d943c8ff4e8d852e826c95138da2_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i65f995e36b114f65a815c61bd66eb185_I20171201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f57c4f591b04b389e472914c7195492_I20171201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4c41e2ba6794170b867018c3fdc30de_I20171201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia34bdcd0d6c84be4827773cf070dbfa6_I20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideecae1179894ead84a8360473c0cd9d_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia668b5ef64df4c60b5d51cbb5b636f5d_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45eb9ce0dbf4431780b0e06047ccab97_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c108b384b6c4ed9a50513917888bcb4_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied0df1c4e0394f72aa46bda78244dc54_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e0b9fb023d14f00a03ee59906304080_D20210601-20210601"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieed7b0b097e2498496903c8c4c67c075_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bfa2fe6123047d79b18fc3d9809b3a6_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fd78494bf304f19b2f857c42b606fbc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i662e0658aa8247cd94c867b2227ab80a_D20221219-20221219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-19</xbrli:startDate><xbrli:endDate>2022-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id234474f9a60494f90af8c621f315f96_D20221219-20221219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-19</xbrli:startDate><xbrli:endDate>2022-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19a8334307424620aa3c250d4ca58b1b_D20221219-20221219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-12-19</xbrli:startDate><xbrli:endDate>2022-12-19</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i782ff58a89804bf0b00b3bdac6676855_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3124cad286644aab11fa66ae00f4ef1_I20200618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7abca8345f249998cb27b9c944935cc_D20200618-20200618"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-18</xbrli:startDate><xbrli:endDate>2020-06-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb16f084b93484db1e521afa59177ff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb07d4b1080c4319a548201e2649918b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1abb3e2cea84ab7abd42b17a5446166_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8df2957838504948bdf1f9a293198c26_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdbd0ff6519a49e0a3512380762dc454_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55c6d9dae4af45268902f43249c1803c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i936177e90cbd4e0b9837af78bc6af1ad_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>aort:day</xbrli:measure></xbrli:unit><xbrli:context id="i245d6adca68f4145ad5ff6862bb500d7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIiMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceAfterJuly52023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34b6700b45d349109d8e1e8318e1f9d0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i330928a666a2457b8aec74cf41920829_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d1d1110dd9c4c4ea0509148da8595ea_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65a4c670870a4d9f8805dd18a1e03eff_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ee531be8b494d88bc9356fd017a9774_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6292b6052bc40909d1a2f96522bdb4f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cadf7c14ba34a48bad3de79cb43a15f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17368e8c263742ae9eac5e48717b6911_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica3af079dd144cbfa68005cf48df464f_D20210602-20210602"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-02</xbrli:startDate><xbrli:endDate>2021-06-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6765ee8c4e514375bf2377f15526dbbc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e02717d99e84bc08078c02ad4f2d3ab_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82de625935f54b34bbb5e4589a1fc149_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf63598993c849b9a81d477b9517fc7c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9af7b4096844040ad375baefedff835_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8a7f94f926946f1b329419bb02b1cf7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9490fb1e6a364e808b33e4f022177191_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide1a4c016001405a9f9e00487555dcea_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3cbd678f84346a6bd714e53648d0ce7_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockUnitsAndPreferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e96a5da80644389a43614a81619129f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockUnitsAndPreferredStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib35623233c83476c8ae2823d953479ac_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie87171075e7c46b3a5e2f515abfa3038_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46dae3eb2d6d4db5b3282cd30f4eb3b9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39bfa788f29c453e8e82fca1bd97483c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1fbc6109379459ab9d95037d44ee0bc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20695d53f4ce4fe6a0127135b2d1f023_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>aort:segment</xbrli:measure></xbrli:unit><xbrli:context id="i24d764c46d944801885c59dde6cec14b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb6dc10bc7ed4b5492b4ae7557ed2a02_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i350257931547498a908d5663ff901b70_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaade080667b34ceaa2d4b4d14761568d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d27f99bdef34490ab29648e4ece9919_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e3f19c886f3413fb86666f3e6eb9394_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88ac222b2f944d15bd71802bc159841a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc9e6e0e71d487eaa136ec7431e6ce6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfa08b9642074e35bc71304309d137aa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0b90e8de9b7458c9afe003e4bad474a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2d424b22c484323a8479a4346ad4545_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4337b65585504d8bbb937a66cdd29f5b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf3dcedf29fb4d59856021f6832683f4_I20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie06473170a934a1f8ba18b66bd8feeb5_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tranche"><xbrli:measure>aort:tranche</xbrli:measure></xbrli:unit><xbrli:context id="i2b7e03d58c2d4458be09a447fde2288f_D20190911-20190911"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-11</xbrli:startDate><xbrli:endDate>2019-09-11</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6093549b9fc14acc8ec2494386cd4ca5_D20200901-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ed7688ddb8243768813e25604041962_D20230416-20230416"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000784199</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-16</xbrli:startDate><xbrli:endDate>2023-04-16</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5fc3aab1863a48b289e7fc6726692d73_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">UNITED STATES</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:110%">FORM <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ1_b65f0aea-69b6-45fa-93b4-c062b5bedba6">10-Q</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ2_4cb6f8ca-b8b5-44c9-a16e-c5fb979f2f28">x</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">For the quarterly period ended <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8xMDk5NTExNjI5OTYz_816c4c52-6978-4976-9069-f2e401ac399a">March&#160;31, 2023</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">OR</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ3_939f2a8a-638a-4968-8a69-3931c5dc0fc0">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">For the transition period from ________________ to ________________</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Commission file number: <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQw_fab1693c-5d43-4840-a215-691365ac46ff">1-13165</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:110%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQx_4ce310d1-1a6e-4d4d-80b0-a8e560f12e82">ARTIVION, INC.</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:110%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18wLTAtMS0xLTU0OTkz_d5bd344e-46d1-40ff-8fb4-eb356bbc0a11">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18wLTItMS0xLTU0OTkz_e4188672-ef05-4c3c-adbb-7c996369e6cc">59-2417093</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(State or other jurisdiction of <br/>incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(I.R.S. Employer<br/>Identification No.)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18zLTAtMS0xLTU0OTkzL3RleHRyZWdpb246NmViMTNkNDg3NDMwNDk2Mjg2NzNmZjliOTljYjJhYTZfNA_31db9412-6bb3-430e-9ae0-b61bc7e8d04b">1655 Roberts Boulevard, NW</ix:nonNumeric>, <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18zLTAtMS0xLTU0OTkzL3RleHRyZWdpb246NmViMTNkNDg3NDMwNDk2Mjg2NzNmZjliOTljYjJhYTZfOA_0d057aab-fc61-4a34-9b47-adc499891e9d">Kennesaw</ix:nonNumeric>, <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18zLTAtMS0xLTU0OTkzL3RleHRyZWdpb246NmViMTNkNDg3NDMwNDk2Mjg2NzNmZjliOTljYjJhYTZfMTI_c9134897-77dd-4887-9305-3caf6c0b8cb1">Georgia</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18zLTItMS0xLTU0OTkz_ba40943e-3ff5-4eda-a4ae-de7a4fcb3c63">30144</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Zip Code)</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:110%">(<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQy_01879642-0e4d-426a-99dd-ddacb6f81efd">770</ix:nonNumeric>) <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ4_3db44940-28a3-4738-9ed9-c817d38c35e9">419-3355</ix:nonNumeric> </span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:31.676%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.813%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.211%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NmYxZDliYTFhZjIyNDI0M2IzMjRhODcwMzMxODlhMGYvdGFibGVyYW5nZTo2ZjFkOWJhMWFmMjI0MjQzYjMyNGE4NzAzMzE4OWEwZl8xLTAtMS0xLTU0OTkz_1963ec39-d913-43bd-b34f-551525fb92d6">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NmYxZDliYTFhZjIyNDI0M2IzMjRhODcwMzMxODlhMGYvdGFibGVyYW5nZTo2ZjFkOWJhMWFmMjI0MjQzYjMyNGE4NzAzMzE4OWEwZl8xLTEtMS0xLTU0OTkz_053d7063-364e-4f58-8f2d-f7341b4e311b">AORT</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 2.38pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NmYxZDliYTFhZjIyNDI0M2IzMjRhODcwMzMxODlhMGYvdGFibGVyYW5nZTo2ZjFkOWJhMWFmMjI0MjQzYjMyNGE4NzAzMzE4OWEwZl8xLTItMS0xLTU0OTkz_d7f60acf-c8a1-4771-8077-cdfc99fc062a">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ5_21864cc1-557c-442c-b1fb-eb1330e79e52">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">o</span></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTUx_c0e13f3a-0342-4d00-acee-151419ebad31">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">o</span></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:3.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.931%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NDBkMTg2MjI3ZTk2NDc2ZDliYThlMGNiODg2OGM0NGUvdGFibGVyYW5nZTo0MGQxODYyMjdlOTY0NzZkOWJhOGUwY2I4ODY4YzQ0ZV8wLTEtMS0xLTU0OTkzL3RleHRyZWdpb246MmUyOGJhYTk3Mjk3NDAwZWFhNGY4MTU4Y2YwYjkzNWFfNA_9dfd1e87-67a0-4aaa-8a2c-5a24bc3f4130">Large Accelerated Filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%">x</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accelerated Filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%">o</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-accelerated Filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%">o</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Smaller Reporting Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NDBkMTg2MjI3ZTk2NDc2ZDliYThlMGNiODg2OGM0NGUvdGFibGVyYW5nZTo0MGQxODYyMjdlOTY0NzZkOWJhOGUwY2I4ODY4YzQ0ZV8xLTQtMS0xLTU0OTkz_aed7032f-fde5-4bd3-bd28-d90430a5b286">o</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Emerging Growth Company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NDBkMTg2MjI3ZTk2NDc2ZDliYThlMGNiODg2OGM0NGUvdGFibGVyYW5nZTo0MGQxODYyMjdlOTY0NzZkOWJhOGUwY2I4ODY4YzQ0ZV8yLTQtMS0xLTU0OTkz_feb0091e-89cd-4b36-a5eb-06701105ab1c">o</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"> </span></div></td></tr></table></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">o</span></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%"> No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:110%"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ0_90167882-14b9-4a08-8924-d8f0d48ad0c7">x</ix:nonNumeric></span></div><div style="margin-top:4pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:110%">Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding at April&#160;28, 2023</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock, $0.01 par value</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7835c64896c44c22ac5cc78e13028978_I20230428" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6ODVhN2M1ODc2ZDFkNDBkNTg5MmY3NzdlODA0MTk5OTIvdGFibGVyYW5nZTo4NWE3YzU4NzZkMWQ0MGQ1ODkyZjc3N2U4MDQxOTk5Ml8xLTItMS0xLTU0OTkz_1ffc6311-2208-4fbb-ac94-7a7b73aa0bd6">40,875,444</ix:nonFraction></span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_7"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.961%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_10">Part I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_13">Item 1. Financial Statements.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_13">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_16">Condensed Consolidated Statements of Operations and Comprehensive Loss</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_16">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_19">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_19">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_22">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_22">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_25">Condensed Consolidated Statements of Shareholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_25">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_28">Notes to Condensed Consolidated Financial Statements </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_28">7</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_79">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_79">22</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_133">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_133">33</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_136">Item 4. Controls and Procedures.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_136">34</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_139">Part II - OTHER INFORMATION</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_139">36</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_142">Item 1. Legal Proceedings.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_142">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_145">Item 1A. Risk Factors.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_145">36</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_148">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_148">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_151">Item 3. Defaults Upon Senior Securities.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_151">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_154">Item 4. Mine Safety Disclosures.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_154">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_157">Item 5. Other Information.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_157">51</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_160">Item 6. Exhibits.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_160">52</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_163">Signatures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i5fc3aab1863a48b289e7fc6726692d73_163">53</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I &#8211; FINANCIAL INFORMATION</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_13"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations and Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands, Except Per Share Data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:71.889%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.104%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae3a909430949bd90a175d270eb249f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMy0xLTEtMS01NDk5Mw_184c1d76-8ee1-44c1-8698-b612a4a0da6a">62,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979c20305ec145afbd438a672f317ec1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMy0zLTEtMS01NDk5Mw_adbf9203-2489-4a1c-9338-6e7db6abd4b6">57,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5cf4550d1e64e08a695b28c0c89be0e_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNC0xLTEtMS01NDk5Mw_c9e2171f-3e89-4195-abf5-f99d70ff4912">20,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c72bde95b6478d85567313998b4435_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNC0zLTEtMS01NDk5Mw_e0e3f455-59e0-4d4e-bd73-95a3017872c7">19,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNS0xLTEtMS01NDk5Mw_cfe55018-018f-4756-b93f-a9971137cc9c">83,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNS0zLTEtMS01NDk5Mw_4f87c967-a16e-46dc-bd0e-935f7b5d7c00">77,213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost of products and preservation services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ae3a909430949bd90a175d270eb249f_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfOC0xLTEtMS01NDk5Mw_1ebca0c2-e1c7-4214-951c-0c17858eaa36">19,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i979c20305ec145afbd438a672f317ec1_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfOC0zLTEtMS01NDk5Mw_56c89e94-f65d-4e90-bdb8-b64ba2ee1aa3">17,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preservation services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5cf4550d1e64e08a695b28c0c89be0e_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfOS0xLTEtMS01NDk5Mw_a500463a-c82d-4bc0-ab2e-6c25fcebe5a4">9,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1c72bde95b6478d85567313998b4435_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfOS0zLTEtMS01NDk5Mw_0b3a6c8f-4df6-4391-9116-9e1f732273c2">9,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total cost of products and preservation services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTAtMS0xLTEtNTQ5OTM_14bb03c4-19c2-4c14-8030-1f1f0f648d4b">29,502</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTAtMy0xLTEtNTQ5OTM_9446488b-93f8-41ae-b759-31f971ea114d">26,494</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTItMS0xLTEtNTQ5OTM_70b06b60-b242-4b41-b6dc-a0f23534c6e6">53,727</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTItMy0xLTEtNTQ5OTM_dd63dc9f-b2ec-416e-8544-d2083ef39370">50,719</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General, administrative, and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTUtMS0xLTEtNTQ5OTM_367eeb52-1c63-4247-895b-36bad5902c32">50,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTUtMy0xLTEtNTQ5OTM_14c6ac6f-3590-4bf6-913c-c005b5e28922">38,955</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTYtMS0xLTEtNTQ5OTM_407d123a-085d-4acc-9fdd-dd433bc4c786">7,223</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTYtMy0xLTEtNTQ5OTM_927d3701-8dfb-4cbf-a21a-b204b78e0785">10,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTctMS0xLTEtNTQ5OTM_7a6559a2-42dc-4648-bb4e-c3e16e44dc59">57,588</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTctMy0xLTEtNTQ5OTM_85954b8c-4b29-4b49-996e-0f170ba35a7e">49,083</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating (loss) income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTktMS0xLTEtNTQ5OTM_0504444d-b9d5-4dd7-9bfc-c64a40bdf7d9">3,861</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTktMy0xLTEtNTQ5OTM_e11424b3-ca0f-48f0-a81e-9cd38e9ff83a">1,636</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjEtMS0xLTEtNTQ5OTM_338efd1f-325d-484f-9887-a02f8b8c685d">6,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjEtMy0xLTEtNTQ5OTM_4f3f189d-68bb-4d09-9e01-29a138e3016e">3,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjItMS0xLTEtNTQ5OTM_da19086b-5a3c-471b-9883-4a3905c6ed0f">75</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjItMy0xLTEtNTQ5OTM_69a99a6b-1375-4699-beee-da0c5aff472d">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjMtMS0xLTEtNTQ5OTM_65168206-4493-439c-bf9c-64c60f2c1a92">963</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjMtMy0xLTEtNTQ5OTM_6fc4a77d-0772-4a7e-b15f-c68ed060387f">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjUtMS0xLTEtNTQ5OTM_f6b4cb9d-6e6f-4a49-a9bb-3d04647c8036">8,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjUtMy0xLTEtNTQ5OTM_7d3ffeb7-dce7-4bd1-9034-948bb4bf0eb4">2,429</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjYtMS0xLTEtNTQ5OTM_d2ac711e-2728-4c11-9571-4ea61b0f8364">4,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjYtMy0xLTEtNTQ5OTM_fa03f4d0-be62-4c41-96cf-3bc165406303">960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjgtMS0xLTEtNTQ5OTM_40060c90-1151-458e-b526-eddece2daa58">13,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjgtMy0xLTEtNTQ5OTM_301fd401-d117-4b65-a51c-f6eb3891d7c9">3,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzEtMS0xLTEtNTQ5OTM_37271a5a-9d8b-4d3b-a72b-755110195c96">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzEtMy0xLTEtNTQ5OTM_4b4bf364-0058-4508-b731-a87276d59d8d">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzItMS0xLTEtNTQ5OTM_24c178e9-e71f-4a35-a12e-656a6a1a1b5b">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzItMy0xLTEtNTQ5OTM_f1991c21-11ee-4ab5-af0b-ac75a8e1ab4b">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzUtMS0xLTEtNTQ5OTM_33178973-4f69-42c0-bc84-2299adcea1b3">40,432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzUtMy0xLTEtNTQ5OTM_3afd25f4-4e8b-42bf-b6c3-d7821634d9b6">39,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzYtMS0xLTEtNTQ5OTM_34a9f06a-4efa-481d-a10b-609a6d934c86">40,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzYtMy0xLTEtNTQ5OTM_cad59af5-ce3c-4692-835b-3ad4a554adf0">39,850</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzgtMS0xLTEtNTQ5OTM_20ab3e06-6c7b-4c89-9170-22437425c997">13,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzgtMy0xLTEtNTQ5OTM_b7113e76-efc7-430a-969e-a36055f0dbb1">3,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNDAtMS0xLTEtNTQ5OTM_94170091-ec26-4fa3-87d0-4399695069a5">3,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNDAtMy0xLTEtNTQ5OTM_66a112ef-b743-442f-92dd-a04cd81ca3d6">3,775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNDEtMS0xLTEtNTQ5OTM_90d87f2e-ab36-46f9-b909-408c3d00474b">9,916</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNDEtMy0xLTEtNTQ5OTM_0792ad44-2268-46d3-acda-1cdbe332ad02">7,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_19"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:71.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.405%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(Unaudited) </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNC0xLTEtMS01NDk5Mw_e05d1842-6cd9-4077-ba5a-905a2fc7ab53">30,773</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNC0zLTEtMS01NDk5Mw_80acd703-d884-489e-bcbd-07aa46d1afae">39,351</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trade receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNS0xLTEtMS01NDk5Mw_ff337c29-13c2-49fc-bbda-551c40fafffd">62,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNS0zLTEtMS01NDk5Mw_080ed72b-39a5-49d7-932a-6a927d63a373">61,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNi0xLTEtMS01NDk5Mw_7e055cf9-3b55-4cd8-9909-024332172413">3,952</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OtherReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNi0zLTEtMS01NDk5Mw_89258b18-d366-4794-a5d5-9231cbd6cbdf">7,764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventories, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNy0xLTEtMS01NDk5Mw_2808aa23-1fb5-4c69-a19c-0ece6fb204ff">76,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNy0zLTEtMS01NDk5Mw_67b22c83-22f3-4500-8029-b061e7397a1b">74,478</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred preservation costs, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="aort:DeferredPreservationCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfOC0xLTEtMS01NDk5Mw_6768f1a5-a96c-4527-b46d-9da0ed192808">47,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="aort:DeferredPreservationCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfOC0zLTEtMS01NDk5Mw_c9ed2780-5eca-4fe1-a5c6-d1916f6196c6">46,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfOS0xLTEtMS01NDk5Mw_6d0c6de3-f1d0-42c7-b9ea-1c59dc0beb64">19,508</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfOS0zLTEtMS01NDk5Mw_378fbb7d-44a5-4195-ace5-bf0723b9070d">17,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTAtMS0xLTEtNTQ5OTM_0abdab53-c1fe-4edc-9273-b45cd42060a5">240,681</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTAtMy0xLTEtNTQ5OTM_a9b23c62-93ad-4e11-bf11-80a54eda018a">247,334</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTItMS0xLTEtNTQ5OTM_82a7da54-9eb0-4668-8276-cd95221f548a">245,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTItMy0xLTEtNTQ5OTM_8c732447-319b-41a5-aaa7-4494bf2cdedf">243,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Acquired technology, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTMtMS0xLTEtNTQ5OTM_6d671b5d-375f-4a9a-9d17-502d73000211">149,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTMtMy0xLTEtNTQ5OTM_30dee6ce-5aa9-443b-91fe-63e9ef6bbdb8">151,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTQtMS0xLTEtNTQ5OTM_3b06fe67-5e54-4386-965c-ebd88b3c7ed8">41,473</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTQtMy0xLTEtNTQ5OTM_9fc58420-4038-4f44-8c3c-51a3cd827e49">41,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTUtMS0xLTEtNTQ5OTM_dcefdef1-1f5a-405d-96c9-eb73703010ec">38,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTUtMy0xLTEtNTQ5OTM_618a9eb5-ec92-4aa6-8623-c2c15de7cf56">38,674</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other intangibles, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OtherIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTYtMS0xLTEtNTQ5OTM_565e55f7-3fc2-4f98-b8f1-09ab6fecd005">30,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OtherIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTYtMy0xLTEtNTQ5OTM_bbb004bc-4cc6-480a-86b1-63855c4131bd">31,384</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTctMS0xLTEtNTQ5OTM_df25f0b2-65d6-43d8-9927-23c507d9fbe9">2,373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTctMy0xLTEtNTQ5OTM_fa233739-6480-4cf2-b4a3-3e4482dcc30f">1,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTgtMS0xLTEtNTQ5OTM_66e537dc-7d41-42f5-bc31-cd8eeafb4842">7,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTgtMy0xLTEtNTQ5OTM_cb885ab3-0f78-4c41-bd7d-37d418513a28">7,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTktMS0xLTEtNTQ5OTM_d58693ba-7d0a-48f7-8b56-f35128854951">757,073</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTktMy0xLTEtNTQ5OTM_710a79a6-607f-4454-a8e3-9d4e2eb7e467">762,798</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES AND SHAREHOLDERS' EQUITY</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjMtMS0xLTEtNTQ5OTM_95dd3fb2-1a46-45d1-939a-c231874ea843">9,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjMtMy0xLTEtNTQ5OTM_beac3a4b-e925-46b1-bd5c-0baa2396958c">12,004</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjQtMS0xLTEtNjI3NzA_7ba0591f-e925-4c3b-84f0-d2d3979ba1a7">9,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjQtMy0xLTEtNjI3NzA_134a65bf-29d4-4d13-a1b0-d39394d17821">12,374</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjQtMS0xLTEtNTQ5OTM_07b39162-c4ef-4aa1-ae07-973b9c303bb9">9,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjQtMy0xLTEtNTQ5OTM_f4a7b208-98c7-4e09-834d-1b3dd94de328">13,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Taxes payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjYtMS0xLTEtNTQ5OTM_bb9bb857-c6bb-4367-ad22-a2d7480787b0">6,911</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:TaxesPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjYtMy0xLTEtNTQ5OTM_126c6a38-1d79-4de2-9ccb-5f6793d2e9be">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current maturities of operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjctMS0xLTEtNjI3Nzg_f6b62a15-1025-4d15-8150-e2f3636e35d0">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjctMy0xLTEtNjI3Nzg_fc259758-cb40-4b04-8413-1a66baf8d764">3,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued procurement fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="aort:AccruedProcurementFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjctMS0xLTEtNTQ5OTM_e5ad15a0-eb71-4d9e-b593-fade769236d6">2,155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="aort:AccruedProcurementFees" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjctMy0xLTEtNTQ5OTM_f4f12bdd-1841-4ba8-b268-4de59a0ae8b2">2,111</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjktMS0xLTEtNjI3ODY_71e8c484-451b-47fd-9329-83488f042a0e">1,620</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjktMy0xLTEtNjI3ODY_10e70bf6-3ff0-4e7e-bbd7-61a3ad57e77f">1,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzAtMS0xLTEtNTQ5OTM_6ee5a45e-7c43-49c6-b430-172313ddf405">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzAtMy0xLTEtNTQ5OTM_ee70d79e-350f-4d2f-a419-f4f8e125a813">1,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzEtMS0xLTEtNTQ5OTM_a1a9dd8b-e224-430a-bb2e-789ee53a183a">43,961</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzEtMy0xLTEtNTQ5OTM_365dd1e6-93b6-44bd-a283-4d634b41fcf7">49,675</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzMtMS0xLTEtNTQ5OTM_20287866-abe0-47fb-8cda-fa633545a41c">306,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzMtMy0xLTEtNTQ5OTM_f90613b4-b0ba-43b7-9e5a-ef1380e31693">306,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Contingent consideration </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzQtMS0xLTEtNTQ5OTM_1b1f5428-273d-4b08-be4f-d51a97240670">45,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzQtMy0xLTEtNTQ5OTM_3abc23fd-54df-4e91-bc29-70a2100ace9a">40,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current maturities of operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzUtMS0xLTEtNTQ5OTM_8264f4b5-a901-4647-8b6c-c8a4c83b986c">40,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzUtMy0xLTEtNTQ5OTM_dbbf3ec5-bef2-4bcd-a62f-ece5f83fe1b9">41,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzctMS0xLTEtNjI3OTQ_ff6ad13a-f2f1-4312-9080-96b4b237432e">23,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzctMy0xLTEtNjI3OTQ_d458843b-14bc-4dd0-bd62-5987e8847bcf">24,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred compensation liability</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzgtMS0xLTEtNjI3OTQ_ef7eed1d-055c-45ea-98ef-8fa26fcb92c5">6,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzgtMy0xLTEtNjI3OTQ_2192ef2c-cda7-4b6a-83c3-3d344600354f">5,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-current finance lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzYtMS0xLTEtNTQ5OTM_53cb82f3-3d6c-4e08-aeb8-55d105685e98">3,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzYtMy0xLTEtNTQ5OTM_05711ce4-39ba-4c3c-a340-2784c7d1e7ec">3,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzktMS0xLTEtNTQ5OTM_2250708b-c7d1-44ea-a31c-62fa3e2b33ff">7,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzktMy0xLTEtNTQ5OTM_48b9ee41-2589-4f5d-9406-140f2c6a3d06">7,027</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDAtMS0xLTEtNTQ5OTM_bd66891e-03fb-4d41-b591-09a795ef58bf">477,156</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDAtMy0xLTEtNTQ5OTM_6091f4f3-f759-4495-a190-d7fe8aea26c5">478,469</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:11pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDItMS0xLTEtNTQ5OTM_35b4a6be-f050-4a56-81ee-d9716d050684"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDItMy0xLTEtNTQ5OTM_530a4911-8438-4f89-b6b3-dfd409be1cad"></ix:nonFraction></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shareholders' equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDUtMS0xLTEtNTQ5OTM_7f99a4e8-9255-4880-b37d-31576794bf50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDUtMy0xLTEtNTQ5OTM_10626597-ded4-4c15-a312-af70b780888c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock (<ix:nonFraction unitRef="shares" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3OTA3_2061118f-540d-473a-a1bc-5016043a3f39"><ix:nonFraction unitRef="shares" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3OTA3_c1864409-b4f8-49ab-951f-957349a8673b">75,000</ix:nonFraction></ix:nonFraction> shares authorized, <ix:nonFraction unitRef="shares" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3ODg5_342bb3a7-a21f-4167-92cf-59cb546917eb"><ix:nonFraction unitRef="shares" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3ODg5_c7e8d518-ebd8-40e9-88dc-137ef6628015">42,366</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3ODk4_03041999-7c65-4044-9277-203998058722"><ix:nonFraction unitRef="shares" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3ODk4_3915feb0-d07c-432a-8c01-8e99b77af709">41,830</ix:nonFraction></ix:nonFraction> shares issued and outstanding in 2023 and 2022, respectively)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMS0xLTEtNTQ5OTM_e85592d1-8a78-4627-80ca-5b1e073a3e5a">424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMy0xLTEtNTQ5OTM_422d2d4d-83fa-492e-b6e1-1cb8570e9f04">418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDctMS0xLTEtNTQ5OTM_a61c2200-b098-4231-a15a-0db36cd23544">342,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDctMy0xLTEtNTQ5OTM_be6282e8-480c-4574-9221-7f63f00831af">337,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Retained deficit </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDgtMS0xLTEtNTQ5OTM_76dbba2b-1b25-4b72-9479-0e1bba42a8d4">30,749</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDgtMy0xLTEtNTQ5OTM_e329dbeb-9955-46f2-8d1d-4ac050ef4141">17,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDktMS0xLTEtNTQ5OTM_7225a011-26eb-40ce-99ce-cf91432427ae">17,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDktMy0xLTEtNTQ5OTM_1dfe56d2-1773-4f27-81be-f3f8140cd063">21,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury stock, at cost, <ix:nonFraction unitRef="shares" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTAtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjpmMjg0NmY3MzBmOGQ0MTUxYTc5Y2FjZDEwMzY4YzgyMF8xMDk5NTExNjI3ODY2_51e3cf54-5066-40e4-9081-9d5770795a1b"><ix:nonFraction unitRef="shares" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="INF" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTAtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjpmMjg0NmY3MzBmOGQ0MTUxYTc5Y2FjZDEwMzY4YzgyMF8xMDk5NTExNjI3ODY2_e5025e94-8881-4a02-8349-707161e44731">1,487</ix:nonFraction></ix:nonFraction> shares as of March 31, 2023 and December 31, 2022</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTAtMS0xLTEtNTQ5OTM_09447901-4edc-42ef-8170-73bf1575d63c">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTAtMy0xLTEtNTQ5OTM_31b09dbb-39c0-4d0b-be00-cc3d7b097f90">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total shareholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTEtMS0xLTEtNTQ5OTM_174205b7-3892-4087-8f89-5a8cf77344e1">279,917</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTEtMy0xLTEtNTQ5OTM_0f40ff60-1375-4d37-8f8d-bfde5685b82f">284,329</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total liabilities and shareholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTMtMS0xLTEtNTQ5OTM_b7511d95-93d7-4cec-be59-4c2fe2e228c3">757,073</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTMtMy0xLTEtNTQ5OTM_00d0b6aa-a629-4aef-a3ca-19d31b9d6997">762,798</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_22"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMy0xLTEtMS01NDk5Mw_9b3f296b-61ed-4a8b-a4bc-4bd0c39c8a6d">13,532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMy0zLTEtMS01NDk5Mw_d6f995d7-8e1a-4af4-88b0-3c3aa6f5c785">3,389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash from operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNi0xLTEtMS01NDk5Mw_96c03291-b28d-43b8-aeb2-c8ead5adcfab">5,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNi0zLTEtMS01NDk5Mw_70234e54-dbcb-4112-9966-c41950dc17f8">5,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNy0xLTEtMS02MTE0Mg_9cb2d1ab-55a0-4636-816c-12e2467b5071">4,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNy0zLTEtMS02MTE0Mg_6184d400-420e-4c9b-a6c3-9206bf83d3ea">1,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNy0xLTEtMS01NDk5Mw_aef2f1cf-50cb-485b-9893-1bf4cbee1fc5">3,341</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNy0zLTEtMS01NDk5Mw_1d86fc36-ec0a-43ab-8cd3-cc2e265d9873">3,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash lease expense </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="aort:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfOC0xLTEtMS01NDk5Mw_be1983fe-a123-42b8-9c1d-5effe31a3fdb">1,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="aort:NoncashLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfOC0zLTEtMS01NDk5Mw_b379b326-71a0-4d54-b0b3-0f55d5828d27">1,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-down of inventories and deferred preservation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="aort:WriteDownOfDeferredPreservationCostsAndInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTAtMS0xLTEtNjExNTI_fec216b2-4d20-4f60-85fd-187b139355c2">1,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="aort:WriteDownOfDeferredPreservationCostsAndInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTAtMy0xLTEtNjExNTI_0d4f6183-8200-495b-8f92-c39f208888f2">989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfOS0xLTEtMS01NDk5Mw_90d7cd2c-fb31-4f0e-9724-8c70fcd289ab">2,167</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfOS0zLTEtMS01NDk5Mw_fab7fb12-6a57-4ae2-9f39-24278f729f13">2,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:OtherNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTQtMS0xLTEtNTQ5OTM_945da9ef-7065-46af-9bc7-ea2005ea3cf0">754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:OtherNoncashExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTQtMy0xLTEtNTQ5OTM_b0de9cca-57ce-4408-a9a6-f50ecfb28d5b">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTUtMS0xLTEtNjExNzI_918c1b24-6491-4fdb-b3c7-8780dd0a1847">3,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTUtMy0xLTEtNjExNzI_5ae9bdd5-f7b7-4247-a6cf-6819854ac00a">1,710</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTYtMS0xLTEtNTQ5OTM_f25a604d-16fc-4385-ab7d-58231bc556de">2,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTYtMy0xLTEtNTQ5OTM_008320bd-a117-4a50-8b34-4448792b6557">1,494</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories and deferred preservation costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTctMS0xLTEtNjExODQ_d3be2189-1a0f-480e-9139-d0f4ba53c874">3,222</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTctMy0xLTEtNjExODQ_a73bcb5e-31f7-49ad-9b6f-6d51231eb6c3">1,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable, accrued expenses, and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTctMS0xLTEtNTQ5OTM_5f677919-c585-403e-8845-c3e7905662a4">6,313</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTctMy0xLTEtNTQ5OTM_3c8e25f4-c15f-4cbe-ac81-ce1a03d98c0c">3,320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjAtMS0xLTEtNTQ5OTM_d2aa810e-0837-4158-a300-cc081b5a5714">6,154</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjAtMy0xLTEtNTQ5OTM_958128df-a26b-45c3-bb54-bdc6ee1c7efa">598</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjQtMS0xLTEtNTQ5OTM_0e1d765e-a55f-40a9-abfa-4485f2c32a9b">2,238</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjQtMy0xLTEtNTQ5OTM_82486aab-1c36-4d56-b990-c68f0d6f2766">2,239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjYtMS0xLTEtNTQ5OTM_ada6f73c-470b-4559-86c0-aa6b4aaaaa4b">605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjYtMy0xLTEtNTQ5OTM_c0ece91e-5a3d-4197-934f-14d26a4c912f">469</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjctMS0xLTEtNTQ5OTM_1ebe97cb-6181-4e2a-8753-3d0c0ebd6b8c">2,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjctMy0xLTEtNTQ5OTM_45068e70-0ad8-4e49-ac6a-b37bfb2100bc">2,708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options and issuance of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzAtMS0xLTEtNTQ5OTM_bf4b244c-9438-407f-9de7-00c1803c2be7">2,581</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzAtMy0xLTEtNTQ5OTM_b5df2166-3b18-4c65-80d4-8bcdeae4aa78">2,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and repurchase of stock to cover tax withholdings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzEtMS0xLTEtNTQ5OTM_41831257-e05f-4f24-913c-4bb3078eddbb">590</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzEtMy0xLTEtNTQ5OTM_2f452591-ade8-4bd8-95eb-4f75164b8993">1,730</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of term loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzItMS0xLTEtNTQ5OTM_b3f124ec-0ec0-4a65-9550-242cf1bce55e">690</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzItMy0xLTEtNTQ5OTM_f72ced52-95f6-4c29-bd95-ba7c5a8f854b">694</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzQtMS0xLTEtNTQ5OTM_aaa94be0-b945-4a26-ae2a-11055d6ee707">130</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzQtMy0xLTEtNTQ5OTM_1f4f4330-a891-43e3-9b7c-6aa25095caed">129</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash flows provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzUtMS0xLTEtNTQ5OTM_15c23126-e69a-4d9b-8131-aecf24a589db">1,171</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzUtMy0xLTEtNTQ5OTM_be717cf6-a7ee-46bb-acea-e314631698a7">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzctMS0xLTEtNTQ5OTM_b53ed860-5545-49f6-b17d-b4217b3a4d7d">752</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzctMy0xLTEtNTQ5OTM_b3e3fc7d-f00a-40f2-a341-0a7dc0f04231">61</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Decrease in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzgtMS0xLTEtNTQ5OTM_76ba0001-3db2-476e-9428-a2b4a70ac7aa">8,578</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzgtMy0xLTEtNTQ5OTM_11156bbc-3767-44a6-b8eb-5222800e4952">3,602</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNDAtMS0xLTEtNTQ5OTM_d610b3a4-82c5-4299-bef6-6c363280b2b6">39,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34f77b2e87c4767bbb2e6a239ed82d3_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNDAtMy0xLTEtNTQ5OTM_f614572d-bb02-47c7-b4f6-2254da35f4c6">55,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNDEtMS0xLTEtNTQ5OTM_673fa443-5463-4fc4-b8d3-c2c0ebd50f73">30,773</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684ce4d481204a1aad79ec17a22ca9cc_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNDEtMy0xLTEtNTQ5OTM_af75b3ce-e604-492f-acbb-041916dfd5a8">51,408</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying Notes to Condensed Consolidated Financial Statements </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">In Thousands</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="margin-top:4pt"><span><br/></span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.000%"><tr><td style="width:1.0%"></td><td style="width:37.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.093%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated <br/>Other<br/>Comprehensive <br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders'<br/>Equity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8906191b80d94b2cb337250ebd00ffe4_I20221231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0xLTEtMS01NDk5Mw_a1ab71f1-661b-4047-8ed7-2c34ee38c69e">41,830</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8906191b80d94b2cb337250ebd00ffe4_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0zLTEtMS01NDk5Mw_f6f319ed-4ab2-44f9-8359-4282d31ae2ee">418</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0d4870864b08435ba93e18e414576db4_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi01LTEtMS01NDk5Mw_74f0aced-dc92-431a-ba3f-cbfc58274ba2">337,385</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia20c6db1b736414388dabc9465f16d8e_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi03LTEtMS01NDk5Mw_aa3d8d78-4f18-47da-8e1c-1a67ef6010ce">17,217</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i314c30b8aff54268bfed28a9c6beccd1_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi05LTEtMS01NDk5Mw_94ef9c16-e1f8-4b5d-bd56-ec3066aa8260">21,609</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie7766a77cc4e4f6c80f140d23c8e7323_I20221231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0xMS0xLTEtNTQ5OTM_7bb39f27-8b77-48a5-afdf-7020cfa731c4">1,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie7766a77cc4e4f6c80f140d23c8e7323_I20221231" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0xMy0xLTEtNTQ5OTM_6dff7ebd-388d-4543-a7e7-7b4ccf124f2e">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0xNS0xLTEtNTQ5OTM_efcd615a-66f7-4f47-b101-2cbafdb5cb82">284,329</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie07dff7c65f54941b40235f8253ee52f_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMy03LTEtMS01NDk5Mw_d7fe8154-9d97-4c75-9983-d571a21e9494">13,532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMy0xNS0xLTEtNTQ5OTM_467889da-5a86-43b0-8c49-2f65ff69d519">13,532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id7529137f6374134ba29f2ac0fc74e1a_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNC05LTEtMS01NDk5Mw_b0885c15-0c85-4e3f-a5d1-3950a0e09a5d">3,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNC0xNS0xLTEtNTQ5OTM_41e74777-0c0c-421f-8944-92aa52746e7a">3,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNS0xLTEtMS01NDk5Mw_015cd668-196a-4725-8c7a-9651063e5211">326</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNS0zLTEtMS01NDk5Mw_9a4e6a43-ee59-4b9f-ad69-e2a876af9b49">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNS01LTEtMS01NDk5Mw_c14b65e3-c3ec-46b7-9951-c328875a30e4">3,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNS0xNS0xLTEtNTQ5OTM_da55e18c-4797-4597-be6e-6aebdf2f2cc7">3,513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNi0xLTEtMS01NDk5Mw_b4a2004f-cf4d-45ca-a5e5-59cac891f793">196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNi0zLTEtMS01NDk5Mw_0812dda2-c8b6-46b2-a8a8-3ad96b918fa3">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNi01LTEtMS01NDk5Mw_c8c9c78f-fe95-41d2-a75d-404e165b8a7e">2,004</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNi0xNS0xLTEtNTQ5OTM_dc20f3ff-6216-47ee-afb7-d72091db3a2a">2,006</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNy0xLTEtMS01NDk5Mw_c8059fc2-c15c-44ed-bee4-a1baca93d261">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNy0zLTEtMS01NDk5Mw_d5d7d972-8e72-4e2b-a12d-22045ee03f78">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNy01LTEtMS01NDk5Mw_e2c05d92-4a16-4b24-97c4-aa2a7fc90cd5">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNy0xNS0xLTEtNTQ5OTM_c2022d1c-d727-449d-84a2-d4011d8930a9">575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and repurchase of stock to cover tax withholdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOC0xLTEtMS01NDk5Mw_ef0ba993-0d78-483c-a7de-4fbcb1411892">42</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOC0zLTEtMS01NDk5Mw_53f3fe78-372d-4d31-a4aa-8f6d70171c5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOC01LTEtMS01NDk5Mw_d9f161e4-8133-49db-bff2-b99edf687e13">590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOC0xNS0xLTEtNTQ5OTM_ee468370-6d75-449d-9176-70d06de2651c">590</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia1f0e19f9d2846e8836488a6f5034a54_I20230331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0xLTEtMS01NDk5Mw_c54bed82-c020-4ea3-b408-3756e0587368">42,366</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f0e19f9d2846e8836488a6f5034a54_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0zLTEtMS01NDk5Mw_e9c1a872-e3ac-43b1-8be6-7595fa6f366d">424</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0611add9d054ed19bdf0000b33535f2_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS01LTEtMS01NDk5Mw_04fcdd6d-1d04-49d2-964b-3fe0f21d5ed5">342,883</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i371e868a09e8420ca81b51ae2ded7735_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS03LTEtMS01NDk5Mw_e38dcffb-cf7e-4a1b-854f-34caee3fd793">30,749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i80ee1b53042f49daa8481c6a55b7f28d_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS05LTEtMS01NDk5Mw_26b13643-6eeb-4bce-9849-b4cd98fd7f74">17,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iba4345bc04bc4fd0b009820cbf10edda_I20230331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0xMS0xLTEtNTQ5OTM_9e60e6a7-9b06-4fdb-aab7-6d9d64ec85d8">1,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba4345bc04bc4fd0b009820cbf10edda_I20230331" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0xMy0xLTEtNTQ5OTM_e8615e6e-237f-4959-9896-5c6e333d5e17">14,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0xNS0xLTEtNTQ5OTM_b32142a5-756d-4320-8cf3-d3c5bc553032">279,917</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:4pt"><span><br/></span></div><div style="margin-top:4pt;text-align:center"><span><br/></span></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.000%"><tr><td style="width:1.0%"></td><td style="width:37.171%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.093%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.878%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.634%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.248%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.224%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings (Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Shareholders'<br/>Equity</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6a9f88cb8b244d1f8d88193d41aee37f_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0xLTEtMS01NDk5Mw_64bfc69a-ba31-49bf-a592-cc7906f3e5af">41,397</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a9f88cb8b244d1f8d88193d41aee37f_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0zLTEtMS01NDk5Mw_bca1e45e-5214-4601-a763-c232fc12ebcc">414</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice4c3a2465c545898bd620a0413d3832_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi01LTEtMS01NDk5Mw_8073311b-feb8-46ad-b0b8-88cdc4df52d8">322,874</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib03cb376e30e462b9363c3c0bf7170c4_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi03LTEtMS01NDk5Mw_93c44098-b20c-41e0-80fc-6491536c10bf">1,975</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id19300d854664ca394ffabc2a495b2e5_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi05LTEtMS01NDk5Mw_0c53873f-7f1a-480d-9635-ca6454f7a7c9">9,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="iccd5df30d43d4a12952dc6138272e270_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0xMS0xLTEtNTQ5OTM_cd7669f4-7a77-49dd-b8bb-e890646ba381">1,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iccd5df30d43d4a12952dc6138272e270_I20211231" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0xMy0xLTEtNTQ5OTM_edab00e3-27dd-41e9-b34c-34c60c7e5b4c">14,648</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id34f77b2e87c4767bbb2e6a239ed82d3_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0xNS0xLTEtNTQ5OTM_9cacaa47-c1a0-441a-be1c-9ed8c82affd7">300,728</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8256b73459843e0aaf032088b5f7f90_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMy03LTEtMS01NDk5Mw_968aaff6-c77d-4765-bb11-1c2e955547c5">3,389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMy0xNS0xLTEtNTQ5OTM_4a1460b5-6ead-45d0-a3e8-c8d9e73e5e58">3,389</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i572ac13fae7e4dafbdaa8efdf37bea7f_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNC05LTEtMS01NDk5Mw_7d4c9b6e-8ffb-47ef-a1cf-2f996b525b9f">3,775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNC0xNS0xLTEtNTQ5OTM_55f752f9-ae83-4e35-9394-3cff813af16c">3,775</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNi0xLTEtMS01NDk5Mw_730f736e-8ecb-4330-9f41-118ea86dfb49">205</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNi0zLTEtMS01NDk5Mw_74028645-7065-41b1-93b5-d9c0dda3f775">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNi01LTEtMS01NDk5Mw_4a402f28-501a-4973-b49b-2cda47b3391a">3,338</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNi0xNS0xLTEtNTQ5OTM_f6cf2a45-edec-4250-a1ef-b68981ce9526">3,340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNy0xLTEtMS01NDk5Mw_c0b6ead0-2427-4d03-9c93-0f0086b7635f">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNy0zLTEtMS01NDk5Mw_a5cdeb91-0c6c-4f24-b3c0-004584c10fa5">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNy01LTEtMS01NDk5Mw_89887166-e599-4667-9f24-7ab7233ff6cc">1,678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNy0xNS0xLTEtNTQ5OTM_3bb5af69-398d-463f-8709-ed4aa3305ff1">1,680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOC0xLTEtMS01NDk5Mw_3a525907-8448-4ad5-8e26-1e881ef922b7">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOC0zLTEtMS01NDk5Mw_ca893b20-d7af-4791-9e32-2fd8bc6c15b5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOC01LTEtMS01NDk5Mw_4488fcd8-1fa2-4485-955a-436e97397767">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOC0xNS0xLTEtNTQ5OTM_3b0f5f30-113b-4679-999b-986801737508">638</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Redemption and repurchase of stock to cover tax withholdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOS0xLTEtMS01NDk5Mw_6421793c-d265-414e-9ccf-f926babf13a1">91</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOS0zLTEtMS01NDk5Mw_e904dd3b-6539-45d6-aee1-3b03c2e47fac">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOS01LTEtMS01NDk5Mw_cf2c954d-4273-452c-b10c-c180ba329521">1,729</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOS0xNS0xLTEtNTQ5OTM_ceb643fb-fbd1-4e51-beb3-b6710d61b414">1,730</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id42a947477504a9f9a4328bba9370244_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMS0xLTEtNTQ5OTM_599df7d8-8923-41ed-b3ab-484b57975131">41,688</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id42a947477504a9f9a4328bba9370244_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMy0xLTEtNTQ5OTM_073f28a5-ba54-461e-9ac0-520a7b8925b7">417</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib659527ecee343bc87c222d16f27cd19_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtNS0xLTEtNTQ5OTM_e471d6c8-9fd5-4f4f-98ac-c7be1b6791c3">326,799</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i898f1ad5afdf4d8f9d86cd812ca5514c_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtNy0xLTEtNTQ5OTM_33a1895f-e77a-4a95-a5e9-5d85157f5fe6">1,414</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf6b10a5a1ad4e50a4bc84b969e56728_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtOS0xLTEtNTQ5OTM_460adc53-bf05-4ac7-be4a-71eab663b39d">13,662</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i99a5bc1a71c34a1b9e0b212e75b8f3c8_I20220331" decimals="-3" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMTEtMS0xLTU0OTkz_c0bac6a1-f4a7-4485-9fc3-f3fb47953c77">1,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99a5bc1a71c34a1b9e0b212e75b8f3c8_I20220331" decimals="-3" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMTMtMS0xLTU0OTkz_d050dd24-ae5a-4865-886d-0072ecc0d8a8">14,648</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684ce4d481204a1aad79ec17a22ca9cc_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMTUtMS0xLTU0OTkz_64fc1439-511e-4923-b301-fb7dfd724f68">297,492</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Artivion, Inc. and Subsidiaries</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_31"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:BasisOfAccounting" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zMS9mcmFnOjM4MmRkMjVhNGZjZjQ3Njk4N2ZmODNiYTg0YzY3NzlkL3RleHRyZWdpb246MzgyZGQyNWE0ZmNmNDc2OTg3ZmY4M2JhODRjNjc3OWRfNDE5Nw_70d32714-b857-45cf-b245-4dcd08ed83af" continuedAt="ica25028960ea4ea080e10f5a49e703ca" escape="true">Basis of Presentation and Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ica25028960ea4ea080e10f5a49e703ca"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of Artivion, Inc. and its subsidiaries (&#8220;Artivion,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Condensed Consolidated Balance Sheet as of December&#160;31, 2022 has been derived from audited financial statements. The accompanying unaudited Condensed Consolidated Financial Statements as of, and for the three months ended, March&#160;31, 2023 and 2022 have been prepared in accordance with (i) accounting principles generally accepted in the United States of America ("US GAAP") for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the US Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, such statements do not include all the information and disclosures that are required by US GAAP for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. These Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included in Artivion&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on February&#160;23, 2023. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our significant accounting policies is included in Note 1 of the &#8220;Notes to Consolidated Financial Statements&#8221; contained in our Form 10-K for the year ended December&#160;31, 2022. Management believes that the consistent application of these policies enables us to provide users of the financial statements with useful and reliable information about our operating results and financial condition. The Condensed Consolidated Financial Statements are prepared in accordance with US GAAP, which require us to make estimates and assumptions. We did not experience any significant changes during the three months ended March&#160;31, 2023 in any of our Significant Accounting Policies from those contained in our Form 10-K for the year ended December&#160;31, 2022.</span></div><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zMS9mcmFnOjM4MmRkMjVhNGZjZjQ3Njk4N2ZmODNiYTg0YzY3NzlkL3RleHRyZWdpb246MzgyZGQyNWE0ZmNmNDc2OTg3ZmY4M2JhODRjNjc3OWRfNDE5OA_62f8409d-09e1-4750-a97a-df40cbc259e7" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020 the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 848&#8221;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. US GAAP requires entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December 31, 2022 and cannot be applied to contract modifications that occur after December 31, 2022.  In January 2021 the FASB issued ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The objective of the new reference rate reform standard is to clarify the scope of Topic 848 and provide explicit guidance to help companies applying optional expedients and exceptions. We adopted ASU 2020-04 and ASU 2021-01 on a prospective basis in fiscal year 2022. The adoption of ASU 2020-04 and ASU 2021-01 did not have a material impact on our financial condition or results of operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_37"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMjk0Mg_788a0a0a-3b65-434f-9ee9-d744efb1ce48" continuedAt="i2c458276ef1c494ab7437dce634438a9" escape="true">Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="i2c458276ef1c494ab7437dce634438a9" continuedAt="icc4155b6345345c38b2df52ad8c04c1f"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMjk0Mw_7183ca8b-d9b8-40f8-8c86-8ff2950bdbb6" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7ffb145f12444931806dfef0dd45ec75_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMi0yLTEtMS01NDk5Mw_e5eb3ff1-1365-439f-bdbf-f6c7ef3910b9">7,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e538adb023b42dba22d620e4792eb34_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMi00LTEtMS01NDk5Mw_17faf652-fb11-4093-a5dd-ebab8ae7d1fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9897803022524b6b83398955223e2444_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMi02LTEtMS01NDk5Mw_eba5a6b0-32c2-41ba-8d04-efae7f0ed7db">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16e5777fa0694cc18917f184d3087f01_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMi04LTEtMS01NDk5Mw_b5dd53b4-37d7-4158-b0b3-4e8af693b66e">7,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b549ee865943d6855f63e539a42cc5_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMy0yLTEtMS01NDk5Mw_59f56131-38b2-45df-bd84-8197f7611744">7,154</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia60a357239894830b1528f32f19aaf03_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMy00LTEtMS01NDk5Mw_be711114-c4b8-4ce4-b3ff-8b67a836a597">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef1a873474b47e7b3ee0e7be4ef40b8_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMy02LTEtMS01NDk5Mw_7adce2b8-be8c-45a0-af39-802dac076345">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMy04LTEtMS01NDk5Mw_ee2903ed-7a1f-4cd4-8c5c-a3a2a4cf9929">7,154</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b549ee865943d6855f63e539a42cc5_I20230331" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNi0yLTEtMS01NDk5Mw_2205e512-5044-4c1a-8acb-acab1aad892d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia60a357239894830b1528f32f19aaf03_I20230331" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNi00LTEtMS01NDk5Mw_29d9dbef-3624-4495-ad19-461c948b068f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icef1a873474b47e7b3ee0e7be4ef40b8_I20230331" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNi02LTEtMS01NDk5Mw_c46cfe97-e72d-4923-b4a4-356cbcd8d5d5">45,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNi04LTEtMS01NDk5Mw_5220c395-b0ed-4b93-85c9-be879611b7ce">45,200</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6b549ee865943d6855f63e539a42cc5_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNy0yLTEtMS01NDk5Mw_bf9cd3a6-13c4-4bda-ae6e-9c33ae159f56">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia60a357239894830b1528f32f19aaf03_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNy00LTEtMS01NDk5Mw_3da101d2-52a1-455f-9e34-5539fc9bedd9">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icef1a873474b47e7b3ee0e7be4ef40b8_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNy02LTEtMS01NDk5Mw_c59993bd-b00c-451a-a13b-1149f9a96989">45,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNy04LTEtMS01NDk5Mw_5c38f2a4-24bf-4ff1-ac7b-8ea812e1b0e0">45,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb10dd17357d43dfb35870e5456e7882_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMi0yLTEtMS01NDk5Mw_9dc3e8b4-7f06-44f2-ac48-ff6aff23ea9f">10,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53c72e2891b643879b972b1f3ceb58fe_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMi00LTEtMS01NDk5Mw_8af14551-44ff-48de-a162-c3553af41f68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63692cacc3a445dacf59c9a1047dd06_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMi02LTEtMS01NDk5Mw_317d603c-9c1b-4527-9a03-fee5aa99496c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if66fb22ae36440dab8fe8254cd95ffb1_I20221231" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMi04LTEtMS01NDk5Mw_db8bb7c4-48c0-48d8-8efc-06366a560685">10,098</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a5e9956c83a49c0b5cac54ad6a7f263_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMy0yLTEtMS01NDk5Mw_af944278-901e-4056-98e6-b6fa2c8381d1">10,098</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd3bfffc6a2457bba90e050e14c2e58_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMy00LTEtMS01NDk5Mw_b254ea70-bb34-4b0e-b782-e169ea4dfc40">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib98547abf55f42c59aefaa0f6d22fe1b_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMy02LTEtMS01NDk5Mw_b483f726-adce-4527-bb03-11f5935f5088">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMy04LTEtMS01NDk5Mw_300baecb-634b-4f95-8c9b-4070d75ad470">10,098</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a5e9956c83a49c0b5cac54ad6a7f263_I20221231" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNi0yLTEtMS01NDk5Mw_b1dd531f-9940-4b7c-a1ea-c46efc71b94a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd3bfffc6a2457bba90e050e14c2e58_I20221231" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNi00LTEtMS01NDk5Mw_0b86de05-8326-4e28-863e-b6fa43920ca9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib98547abf55f42c59aefaa0f6d22fe1b_I20221231" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNi02LTEtMS01NDk5Mw_3015cbf6-6e14-4364-866f-da8aa3b11acf">40,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="aort:ContingentConsiderationNoncurrentFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNi04LTEtMS01NDk5Mw_b7b85af3-5264-43ac-a0eb-38367d150204">40,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5a5e9956c83a49c0b5cac54ad6a7f263_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNy0yLTEtMS01NDk5Mw_f01fd494-b25b-4a6e-8ffc-d84374c993c3">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bd3bfffc6a2457bba90e050e14c2e58_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNy00LTEtMS01NDk5Mw_674bf456-2d9b-4d17-9c2f-51623ae6c086">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib98547abf55f42c59aefaa0f6d22fe1b_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNy02LTEtMS01NDk5Mw_e72a7ea3-1f24-4b7f-a8b7-f6a173e1f92e">40,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNy04LTEtMS01NDk5Mw_272246cc-c32e-46e3-886a-d5be9afeb929">40,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used prices quoted from our investment advisors to determine the Level 1 valuation of our investments in money market funds. The estimated market value of all cash equivalents is equal to cost basis as there were no gross realized gains or losses on cash equivalents for the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;2, 2020 we entered into a Securities Purchase Agreement to acquire <ix:nonFraction unitRef="number" contextRef="i71edbd22e4cf42339603deb7cbeac930_I20200902" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMzQz_3e2f32ae-31d3-43f3-b500-3d14991ca445">100</ix:nonFraction>% of the outstanding equity interests of Ascyrus Medical LLC (&#8220;Ascyrus&#8221;). Ascyrus developed the AMDS, the world&#8217;s first aortic arch remodeling device for use in the treatment of acute Type A aortic dissections. As part of the acquisition, we may be required to pay additional consideration in cash of up to $<ix:nonFraction unitRef="usd" contextRef="i71edbd22e4cf42339603deb7cbeac930_I20200902" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfNjUx_787567e3-beb8-4538-a074-8beca02b9900">100.0</ix:nonFraction> million to the former shareholders of Ascyrus upon the achievement of certain milestones and the sales-based additional earn-out. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration represents the estimated fair value of future potential payments. The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach. We applied a discount rate based on our unsecured credit spread and the term commensurate risk-free rate to the additional consideration to be paid, and then applied a risk-based estimate of the probability of achieving each scenario to calculate the fair value of the contingent consideration. This fair value measurement was based on unobservable inputs, including management estimates and assumptions about the future achievement of milestones and future estimate of revenues, and is, therefore, classified as Level 3 within the fair value hierarchy. We used a discount rate of approximately <ix:nonFraction unitRef="number" contextRef="i77a16d00eb08404da8ae5de65c51f748_I20230331" decimals="2" name="us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMTY2NQ_a26f6199-4260-4d29-be56-7aad7bcae491">13</ix:nonFraction>% and estimated future achievement of milestone dates between 2025 and 2026 to calculate the fair value of contingent consideration as of March&#160;31, 2023. We will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive Loss. Increases or decreases in the fair value of the contingent consideration liability can result from changes in passage of time, discount rates, the timing and amount of our revenue estimates, and the timing and expectation of regulatory approvals.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed an assessment of the fair value of the contingent consideration and recorded an expense of $<ix:nonFraction unitRef="usd" contextRef="i9f174cecb39e48b9af65991c55af673a_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMjQyMQ_0aa5e9c7-bdbe-47fa-9a6a-2331edeba50f">4.8</ix:nonFraction> million and income of $<ix:nonFraction unitRef="usd" contextRef="ie59b048c0d4b4b56a468429d5b300520_D20220101-20220331" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfNTQ5NzU1ODE2ODYx_b02bf80d-c180-409f-bf6b-ef59c2335d4b">1.8</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively, in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive Loss, as a result of this assessment.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="icc4155b6345345c38b2df52ad8c04c1f"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration component of the Ascyrus acquisition was updated using Level 3 inputs. <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMjk0NA_86e60101-2b83-44f0-bd4f-12dbbe825356" continuedAt="i4b11d95beee748369077e01f645b8e81" escape="true">Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):</ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i4b11d95beee748369077e01f645b8e81"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.809%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOjBjYmFlOTMyYjFkYTQwY2E4Y2EzMTRiNzdkOTUxOTFiL3RhYmxlcmFuZ2U6MGNiYWU5MzJiMWRhNDBjYThjYTMxNGI3N2Q5NTE5MWJfMS0xLTEtMS01NDk5Mw_969e11ab-6cd4-4af9-b2e0-777031ac5f77">40,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOjBjYmFlOTMyYjFkYTQwY2E4Y2EzMTRiNzdkOTUxOTFiL3RhYmxlcmFuZ2U6MGNiYWU5MzJiMWRhNDBjYThjYTMxNGI3N2Q5NTE5MWJfMi0xLTEtMS01NDk5Mw_0d70ac4e-9ce2-4c14-a457-3c8ea1511ed1">4,800</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOjBjYmFlOTMyYjFkYTQwY2E4Y2EzMTRiNzdkOTUxOTFiL3RhYmxlcmFuZ2U6MGNiYWU5MzJiMWRhNDBjYThjYTMxNGI3N2Q5NTE5MWJfMy0xLTEtMS01NDk5Mw_19ed0282-635a-43ba-9011-2356a2d14763">45,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of fair value and the assessment of a measurement&#8217;s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Although we believe that the recorded fair values of our financial instruments are appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.</span></div></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_43"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfOTI1_e68971c7-7c08-40b9-8234-613777768634" continuedAt="i2db22a79104d48718b2d9eb36224c2ea" escape="true">Inventories, net and Deferred Preservation Costs  </ix:nonNumeric></span></div><ix:continuation id="i2db22a79104d48718b2d9eb36224c2ea"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfOTI2_5988a47a-efee-4504-b520-0639c9cd20f1" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net at March&#160;31, 2023 and December&#160;31, 2022 were comprised of the following (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:71.088%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.881%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMS0xLTEtMS01NDk5Mw_36f79126-c9ad-4d4c-84fc-c6036eea9754">36,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMS0zLTEtMS01NDk5Mw_d3c75487-8f79-44a8-a190-9c72ebc0d34d">36,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMi0xLTEtMS01NDk5Mw_cbcb9f0f-c474-4075-9792-0de769dcee17">11,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMi0zLTEtMS01NDk5Mw_2822a314-0b5d-4401-9ac9-f83e44eef55f">10,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMy0xLTEtMS01NDk5Mw_57223a97-dfa3-4af9-a965-a10438ddf7ae">28,632</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMy0zLTEtMS01NDk5Mw_78043e03-2b2c-4110-8e1c-daeab1522fe2">27,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories, net </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfNC0xLTEtMS01NDk5Mw_cfcee641-77f4-459b-9a7e-644ef0497143">76,273</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfNC0zLTEtMS01NDk5Mw_7592564c-8219-40de-bf0c-08e4717719f0">74,478</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To facilitate product usage, we maintain consignment inventory of our On-X heart valves at domestic hospital locations and On-X heart valves and aortic stent grafts at international hospital locations. We retain title and control over this consignment inventory until the device is implanted, at which time we invoice the hospital and recognize revenue. As of March&#160;31, 2023 we had $<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-5" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNTA0_7902e7dc-4eb4-48f8-9d9a-ac9eb2c6c0dc">12.7</ix:nonFraction> million in consignment inventory, with approximately <ix:nonFraction unitRef="number" contextRef="i08c0ea5c117b4dfeb0384a9e1247a5b9_I20230331" decimals="2" name="aort:ConsignmentInventoryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNTUy_9d92f83d-c5cf-4d34-bd1f-1ccd30107665">42</ix:nonFraction>% in domestic locations and <ix:nonFraction unitRef="number" contextRef="i26fcb04471584b5ea9d699972f9aa939_I20230331" decimals="2" name="aort:ConsignmentInventoryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNTgx_e678c5cf-2da4-415d-ac95-b0fc89af824d">58</ix:nonFraction>% in international locations. As of December&#160;31, 2022 we had $<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-5" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNjI4_71250245-cc31-4b42-8ba7-1a8e731da4e6">12.7</ix:nonFraction> million in consignment inventory, with approximately <ix:nonFraction unitRef="number" contextRef="i03f86365100d412b8f424f38d54c35d2_I20221231" decimals="2" name="aort:ConsignmentInventoryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNjc2_30cfebcb-ad54-484a-ac6f-01d5e7d7779d">41</ix:nonFraction>% in domestic locations and <ix:nonFraction unitRef="number" contextRef="i330d4af7abf24d219bcf5d1880f8fc1e_I20221231" decimals="2" name="aort:ConsignmentInventoryPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNzA1_58275f9a-83eb-4041-9ae5-848c2f410c4f">59</ix:nonFraction>% in international locations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred preservation costs were $<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-5" name="aort:DeferredPreservationCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNzc1_3ca630a2-9be5-493c-a197-46516dacb7dd">47.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-5" name="aort:DeferredPreservationCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNzgy_694a3c25-99e6-4d37-9a68-9d5f2c86ef16">46.4</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory and deferred preservation costs obsolescence reserves were $<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfODg2_5a29b53c-083c-4b5b-8e5b-a956ddbc64ba">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-5" name="us-gaap:InventoryValuationReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfODkz_da26cc7f-d019-46a4-96c3-8080c6ddb37f">2.2</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_46"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2NA_4c9c77e1-c7ce-45a2-ae53-615996a4c718" continuedAt="i515d0b8a52dd467bb965a17cc5440304" escape="true">Goodwill and Other Intangible Assets  </ix:nonNumeric></span></div><ix:continuation id="i515d0b8a52dd467bb965a17cc5440304" continuedAt="iee934ea2300d4d1493f173f2b7385da1"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite Lived Intangible Assets </span></div><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2NQ_058719f7-9923-4481-9b06-288019125815" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 the carrying values of our indefinite lived intangible assets were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMS0xLTEtMS01NDk5Mw_6f2015c7-c920-4a7b-b3f0-943cbce6fa54">245,648</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMS0zLTEtMS01NDk5Mw_e23cddaf-e6ac-46a5-897a-f6fbbb864e9c">243,631</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">In-process R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i2c6dba73291e448e8f57ab1bc8a6db08_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMi0xLTEtMS01NDk5Mw_803549c0-7850-46ae-9948-7883323402c9">2,120</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i79506f115b764903b5b77aff6438f481_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMi0zLTEtMS01NDk5Mw_2f6541c5-535f-4f3c-9fa5-c56b2fe9053c">2,080</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Procurement contracts and agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ie93b31b47b134081a15dded0e238e7c8_I20230331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMy0xLTEtMS01NDk5Mw_be84f597-8cbb-4a56-a64a-6ae12ff494e8">2,013</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idfdcdca476ee4794a47f75b9b0908a9f_I20221231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMy0zLTEtMS01NDk5Mw_5e4448c5-5af0-4f0f-b865-391f3e4b3374">2,013</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="iee934ea2300d4d1493f173f2b7385da1" continuedAt="i28176a1b46cb44708d92493d8376ad02"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the phases of development of our acquired in-process research and development projects, including the risks associated with further development and the amount and timing of benefits expected to be derived from the completed projects. Incremental costs associated with development are charged to expense as incurred. Capitalized costs are amortized over the estimated useful life of the developed asset once completed. Our in-process research and development projects are reviewed for impairment annually, or more frequently, if events or changes in circumstances indicate that the asset might be impaired. We did not record any impairment of indefinite lived intangible assets during the three months ended March&#160;31, 2023. In-process research and development, procurement contracts and agreements are included in Other intangibles, net on the Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our experience with similar agreements, we believe that our acquired procurement contracts and agreements have indefinite useful lives, as we expect to continue to renew these contracts for the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our goodwill and non-amortizing intangible assets for impairment on an annual basis during the fourth quarter of the year, and, if necessary, during interim periods if factors indicate that an impairment review is warranted. As of March&#160;31, 2023 we concluded that our assessment of current factors did not indicate that goodwill or non-amortizing intangible assets are more likely than not to be impaired. We will continue to evaluate the recoverability of these non-amortizing intangible assets in future periods as necessary.</span></div><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2Ng_701c1361-47c8-4a96-8679-d7050f12d5fa" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 the carrying value of goodwill, all of which is related to our Medical Devices segment, was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Medical Devices Segment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjQzYjIwYmY3OTU3NzRjZWU5ZjkyZGMxMDBkOWZlZGJjL3RhYmxlcmFuZ2U6NDNiMjBiZjc5NTc3NGNlZTlmOTJkYzEwMGQ5ZmVkYmNfMS0xLTEtMS01NDk5Mw_2a3c6549-ca08-4da5-8bd8-6ef91f3b8b64">243,631</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:GoodwillForeignCurrencyTranslationGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjQzYjIwYmY3OTU3NzRjZWU5ZjkyZGMxMDBkOWZlZGJjL3RhYmxlcmFuZ2U6NDNiMjBiZjc5NTc3NGNlZTlmOTJkYzEwMGQ5ZmVkYmNfMi0xLTEtMS01NDk5Mw_344bdc3b-60a4-4c4d-aa73-0de06297ecb7">2,017</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjQzYjIwYmY3OTU3NzRjZWU5ZjkyZGMxMDBkOWZlZGJjL3RhYmxlcmFuZ2U6NDNiMjBiZjc5NTc3NGNlZTlmOTJkYzEwMGQ5ZmVkYmNfMy0xLTEtMS01NDk5Mw_fc7e6999-94dd-41f0-87a4-59270f7cf3fe">245,648</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definite Lived Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definite lived intangible assets balance includes balances related to acquired technology, customer relationships, distribution and manufacturing rights and know-how, patents, and other definite lived intangible assets. <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2Nw_f3f7d13d-c237-4f62-9b4f-5c5cfa69d94c" continuedAt="i3876a4f333dc4b08846de3ddc23743f9" escape="true">As of March&#160;31, 2023 and December&#160;31, 2022 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): </ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="i3876a4f333dc4b08846de3ddc23743f9" continuedAt="i3ca13a64dd664089a382abebc0e7e8af"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4136c9e254424e49b35b6472a39e43cf_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMS0yLTEtMS01NDk5Mw_e457ebb3-65e5-40c9-b43c-293c3679276f">200,312</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4136c9e254424e49b35b6472a39e43cf_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMS00LTEtMS01NDk5Mw_8b1ca841-220c-4b04-9783-47cae8589c9a">50,479</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4136c9e254424e49b35b6472a39e43cf_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMS02LTEtMS01NDk5Mw_438a3bf2-9b5d-44ca-8049-ee3c65b57c54">149,833</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i4a48d6cb9ff746b094b85d9a721d7be5_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMS04LTEtMS01NDk5Mw_cf39e93e-ffc8-40f4-92fc-46a0e1b4f33d">18.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i8dd274f665ea4e7683e9b456604be8cf_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMy0yLTEtMS01NDk5Mw_0504e9a1-49e8-4394-b23d-3be679843c19">31,068</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i8dd274f665ea4e7683e9b456604be8cf_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMy00LTEtMS01NDk5Mw_6ec375a5-1a24-44ef-9a4f-a271736257a7">11,489</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i8dd274f665ea4e7683e9b456604be8cf_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMy02LTEtMS01NDk5Mw_d8d1351c-b165-4cfa-b6e9-dc845db42a29">19,579</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i7c38d20648d74b51a72771f63edb7c84_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMy04LTEtMS01NDk5Mw_b139d60e-18f1-431c-8c6d-fe2317a25cbe">20.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i31c830db6dc5484fad7ab16e160c2aff_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNC0yLTEtMS01NDk5Mw_012365be-bfdb-4330-8fe1-9efb732fee09">9,455</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i31c830db6dc5484fad7ab16e160c2aff_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNC00LTEtMS01NDk5Mw_ed942790-025b-4ff1-bd5f-13ee38a60b88">6,353</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i31c830db6dc5484fad7ab16e160c2aff_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNC02LTEtMS01NDk5Mw_17829230-d042-4a68-9033-b0d0a2079ebf">3,102</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="if024f14950384826b773eb09bb2b089c_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNC04LTEtMS01NDk5Mw_43e7fe08-e4ed-4c04-9270-e99916b5e7c2">5.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i8a2765316f314fceb7d349c3f5a72808_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNS0yLTEtMS01NDk5Mw_e3a24379-70e6-4fd2-aef7-8b8633a0d240">4,286</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i8a2765316f314fceb7d349c3f5a72808_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNS00LTEtMS01NDk5Mw_c8f4c6ca-b641-437e-8a7a-07dc99a5c4d0">3,192</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i8a2765316f314fceb7d349c3f5a72808_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNS02LTEtMS01NDk5Mw_1f82c086-9a2a-4c4e-b0fd-36fd9058e72b">1,094</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="ia4c9d1fe9fed440d85fc4a9e9e993bd5_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNS04LTEtMS01NDk5Mw_be4b428b-a07f-4b9b-bb72-4e5c8e8a8116">17.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i66f8ed83f3d44b89bdc1f649e920bcad_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNi0yLTEtMS01NDk5Mw_5b263d49-3cd7-4e5a-b8af-58a41f2e73ee">5,822</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i66f8ed83f3d44b89bdc1f649e920bcad_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNi00LTEtMS01NDk5Mw_0fdf294e-75ae-4a31-9e64-d1b37924b1b3">2,923</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i66f8ed83f3d44b89bdc1f649e920bcad_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNi02LTEtMS01NDk5Mw_e934de77-7ebe-47e8-88c8-9da63d6c3e15">2,899</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i52d7e0b1e38944d8b119d3830e7326b9_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNi04LTEtMS01NDk5Mw_63e35c8f-d37b-4497-804d-e0b7246e072c">4.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idf585199079741d2ad24baa4508e7b79_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNy0yLTEtMS01NDk5Mw_903d109a-8b44-4f3e-99bf-d8b9118fa6eb">50,631</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idf585199079741d2ad24baa4508e7b79_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNy00LTEtMS01NDk5Mw_113e9718-c8a9-42a2-a850-6ed312575ac9">23,957</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idf585199079741d2ad24baa4508e7b79_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNy02LTEtMS01NDk5Mw_58f45cb6-7ac4-4632-9572-ce701c067345">26,674</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="i225c6055e6e34ecc8ff6267a3e5c52cb_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNy04LTEtMS01NDk5Mw_aa5fa6a1-57ee-4e04-ba79-ed9d50d3def6">10.2</ix:nonNumeric></span></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="i28176a1b46cb44708d92493d8376ad02"><div style="margin-top:12pt"><ix:continuation id="i3ca13a64dd664089a382abebc0e7e8af"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:44.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3e7ccf2f59bf4c329c1dd9a597525246_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMS0yLTEtMS01NDk5Mw_a0f801ec-1dc9-4776-9915-69d01468c83d">198,420</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3e7ccf2f59bf4c329c1dd9a597525246_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMS00LTEtMS01NDk5Mw_427f6261-526b-437f-8b72-f05488a85f72">47,157</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3e7ccf2f59bf4c329c1dd9a597525246_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMS02LTEtMS01NDk5Mw_cd9421e4-18a8-41d3-b67a-a16be232667d">151,263</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i1a6a965e9f9b4929b0346378e7446b64_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMS04LTEtMS01NDk5Mw_22ab8af6-0df4-4074-ac1a-355c88e0e547">18.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ic3329eed5890493eaa1e7419306565e2_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMy0yLTEtMS01NDk5Mw_6d1c9a96-952e-437b-af52-88f9337fed42">31,030</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ic3329eed5890493eaa1e7419306565e2_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMy00LTEtMS01NDk5Mw_f4ab6133-c883-41d5-aee7-cacbd99917e1">11,100</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ic3329eed5890493eaa1e7419306565e2_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMy02LTEtMS01NDk5Mw_cfb22385-5b76-45f4-8908-3ec084163c6e">19,930</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="id934e39711ff42389941ee999e64276a_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMy04LTEtMS01NDk5Mw_fe596c2f-823c-49ca-815f-f4218288bee4">20.5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i261990d377b24cd39e6196259557695b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNC0yLTEtMS01NDk5Mw_713e08f0-c508-4d75-a951-103c631a6f73">9,274</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i261990d377b24cd39e6196259557695b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNC00LTEtMS01NDk5Mw_943611f6-cd46-4e77-ae7f-0188a0125501">5,796</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i261990d377b24cd39e6196259557695b_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNC02LTEtMS01NDk5Mw_332e9d36-e166-43ee-9872-01d6bdcc3f77">3,478</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i34a04e6aff414a2493a8ecbef5858fb2_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNC04LTEtMS01NDk5Mw_0b51a31d-456b-4cb1-9d45-5a327406cfdf">5.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idcb5f46ffb5a46dba6a079186a59afa2_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNS0yLTEtMS01NDk5Mw_50b08f2f-1eb6-40e2-bfba-287ba2aab9e4">4,246</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idcb5f46ffb5a46dba6a079186a59afa2_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNS00LTEtMS01NDk5Mw_a08765ca-2a6a-4c3a-8f3d-f60d030bb088">3,180</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idcb5f46ffb5a46dba6a079186a59afa2_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNS02LTEtMS01NDk5Mw_a569e87a-406f-419e-8c12-9e556b112e44">1,066</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i78d3a75cb5e242e999b5d7a86b03fb8c_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNS04LTEtMS01NDk5Mw_549cea5e-4ab7-431e-821d-feb7c26858c4">17.0</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ie3b14dd7eb30490fab897cf536448da7_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNi0yLTEtMS01NDk5Mw_a31cba17-8098-4d10-8187-b7e4ebc67814">5,360</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ie3b14dd7eb30490fab897cf536448da7_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNi00LTEtMS01NDk5Mw_46dce217-e892-4bd4-af0b-54ba610069b2">2,543</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ie3b14dd7eb30490fab897cf536448da7_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNi02LTEtMS01NDk5Mw_61cb165e-8eba-4e55-aa5d-a83d41904943">2,817</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i9f4a2ffeb0704db5bbaba540ed9732b7_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNi04LTEtMS01NDk5Mw_1592ffb7-a584-46c6-8906-e7a43ed8c7cf">4.4</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1555b8edf0a442659291ed6e92593f09_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNy0yLTEtMS01NDk5Mw_f152e861-9107-4591-8be7-4b02b6636239">49,910</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1555b8edf0a442659291ed6e92593f09_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNy00LTEtMS01NDk5Mw_c5dccbaf-c9cb-4ee0-8b93-0ac55357fed4">22,619</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1555b8edf0a442659291ed6e92593f09_I20221231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNy02LTEtMS01NDk5Mw_a5caa0e6-2de7-4d26-9ba6-873716ef8de6">27,291</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonNumeric contextRef="idc88d943c8ff4e8d852e826c95138da2_D20220101-20221231" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNy04LTEtMS01NDk5Mw_1c360761-e200-462b-ac06-fb2d5526aa3d">10.3</ix:nonNumeric></span></td></tr></table></ix:continuation></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization Expense </span></div><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2OA_4e5b14f4-c1a6-42e9-a5fa-a1b81f8c345b" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive Loss (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:71.807%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.142%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.143%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmNkNTE4ZTNiODAyYzQxZDc4NTIyZmE0NjRmNTI0Yzc4L3RhYmxlcmFuZ2U6Y2Q1MThlM2I4MDJjNDFkNzg1MjJmYTQ2NGY1MjRjNzhfMi0xLTEtMS01NDk5Mw_8300bfd1-19ce-48f3-b3f2-5980cf2cbcb2">3,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmNkNTE4ZTNiODAyYzQxZDc4NTIyZmE0NjRmNTI0Yzc4L3RhYmxlcmFuZ2U6Y2Q1MThlM2I4MDJjNDFkNzg1MjJmYTQ2NGY1MjRjNzhfMi0zLTEtMS01NDk5Mw_463fd0dd-a33b-4cfc-a24a-86a65716fd77">4,084</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2OQ_90dc86da-f788-4d1a-93cf-e23681e8a22f" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 scheduled amortization of intangible assets for the next five years is as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.839%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.960%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder<br/>of 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS0xLTEtMS01NDk5Mw_9c22d8b5-3ffb-4ed8-a602-7604216f2427">11,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS0zLTEtMS01NDk5Mw_2983d964-7f6f-4a7d-afde-c505a346bdf4">14,802</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS01LTEtMS01NDk5Mw_3b833477-d273-4147-812b-7cafb7867def">12,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS03LTEtMS01NDk5Mw_d7ddf1ad-f921-44f8-a323-3b9ab921b142">12,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS05LTEtMS01NDk5Mw_ba7a6e0c-d352-4fe6-afc2-7a4f9f0bc9b2">12,504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS0xMS0xLTEtNTQ5OTM_a3be039b-04df-471b-8699-cff04b0666fb">12,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="aort:FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS0xMy0xLTEtNTQ5OTM_992da824-9248-4cb1-ae18-1cbdc981fff8">76,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_49"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTU3NQ_8bfc6564-4b9a-4887-9f5e-7bdc150d1163" continuedAt="ibe198d4cc162431d9bdf092c057f738f" escape="true">Income Taxes </ix:nonNumeric></span></div><ix:continuation id="ibe198d4cc162431d9bdf092c057f738f"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was an expense of <ix:nonFraction unitRef="number" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfODE_c138e332-c08f-41ab-a7ae-bb22e40d33ff">52</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="2" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfNTQ5NzU1ODE1NDg4_efee29c4-988b-4552-b20f-331664008647">40</ix:nonFraction>% for the three months ended March&#160;31, 2023 and 2022, respectively. Our income tax rate for the three months ended March&#160;31, 2023 and 2022 was primarily impacted by changes in our valuation allowance against our net deferred tax assets, non-deductible executive compensation, the foreign derived intangible income deduction, the research and development tax credit, changes in our uncertain tax position liabilities, and tax shortfalls on stock compensation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate deferred tax assets primarily as a result of finance and operating leases, net operating losses, excess interest carryforward, accrued compensation, and stock compensation. Our deferred tax liabilities are primarily comprised of intangible assets acquired in previous years, finance and operating leases, and unrealized gains and losses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintained a net deferred tax liability of $<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-5" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTMzNQ_73dcc0b6-64ee-4fb0-b67c-d24251a569c0">21.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-5" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTM0Mg_5b929c40-1cd3-4a58-8384-7e8a86bfb7c9">23.2</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. Our valuation allowance against our deferred tax assets was $<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTQzNg_d2476be5-4e24-4876-9957-f63c7ad9bfda">19.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTQ0Mw_b6f0b9c7-d196-4bb3-a368-72011052e162">17.9</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively, primarily related to net operating loss carryforwards and disallowed excess interest carryforwards.</span></div></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_52"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYyMg_548aff42-6532-4a9b-a251-b311bd7a0ab0" continuedAt="ib87d2c330fab43faa61a7811ec3d79c3" escape="true">Leases </ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib87d2c330fab43faa61a7811ec3d79c3" continuedAt="ic2a31b5297684b52b92a25f2e5cf0ce9">We have operating and finance lease obligations resulting from the lease of land and buildings that comprise our corporate headquarters and various manufacturing facilities; leases related to additional manufacturing, office, and warehouse space; leases on company vehicles; and leases on a variety of office and other equipment.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="ic2a31b5297684b52b92a25f2e5cf0ce9" continuedAt="i2241f43f23384d13adc7e80e126c9fba"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="aort:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxNw_dc4cefaf-b263-47fd-9480-58c1886a8288" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to leases included in the Condensed Consolidated Balance Sheets was as follows (in thousands, except lease term and discount rate):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating leases:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMS0xLTEtMS01NDk5Mw_7b6b2c4f-acf6-42e4-8e2c-5db5ef6b475f">56,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMS0zLTEtMS01NDk5Mw_695bf432-c80c-4c0f-a9ea-9a45c18716dc">56,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMi0xLTEtMS01NDk5Mw_77965f69-b00b-46d6-9c9f-d2d0c966e39f">15,137</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMi0zLTEtMS01NDk5Mw_9d0118b1-e7c9-4a54-8d08-ebf30b48fbce">14,202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating lease right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMy0xLTEtMS01NDk5Mw_5b94509c-b4f4-419c-b7b3-de3c4d89cb4a">41,473</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMy0zLTEtMS01NDk5Mw_ddc09698-c38b-4baf-beba-53917c5e166d">41,859</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNS0xLTEtMS01NDk5Mw_abf3f993-7ed7-470e-8611-ffb0cff25d53">3,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNS0zLTEtMS01NDk5Mw_3cf6ef69-a379-4fbd-912f-d684ed73eb3b">3,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of operating leases </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNi0xLTEtMS01NDk5Mw_aad84070-d64a-4de4-9704-341c2ab48945">40,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNi0zLTEtMS01NDk5Mw_562ebd9a-7cb8-4524-a655-63cb8e238bb8">41,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNy0xLTEtMS01NDk5Mw_6e833334-7fe1-4350-b3fa-bc27b9943b60">44,172</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNy0zLTEtMS01NDk5Mw_616e2c51-36da-4b34-9760-9c6e373a11c4">44,565</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Property and equipment, at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTAtMS0xLTEtNTQ5OTM_c48b856c-d7c7-4eec-a47b-7507719b4181">6,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTAtMy0xLTEtNTQ5OTM_0bcf181e-89d8-433b-b1c8-006b0b8dec1d">6,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTEtMS0xLTEtNTQ5OTM_94499bbe-c61e-4d14-b343-0598e7e735b1">2,679</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTEtMy0xLTEtNTQ5OTM_60903011-8f15-4b28-ab53-d5f03283855a">2,498</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTItMS0xLTEtNTQ5OTM_a08104f6-fe6e-419b-b6d0-56f29cd36bc6">3,854</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTItMy0xLTEtNTQ5OTM_76cf0d19-e382-456c-bd0c-1cbb0dff5616">3,910</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTQtMS0xLTEtNTQ5OTM_87aee7c2-ae91-4a8d-8233-0c4f1362bc5b">526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTQtMy0xLTEtNTQ5OTM_1d34443d-d448-4c0e-92a3-16e6139f3f13">513</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTUtMS0xLTEtNTQ5OTM_1b1512d5-a2f7-4c11-b06e-521cba9bb96e">3,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTUtMy0xLTEtNTQ5OTM_f7406479-a928-41f8-b152-e70f595913e8">3,644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTYtMS0xLTEtNTQ5OTM_6009117e-a1d9-4568-b874-532861d4ff6b">4,108</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTYtMy0xLTEtNTQ5OTM_08dbd30b-e168-431a-9823-1e2f7c1bb14d">4,157</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTktMS0xLTEtNTQ5OTM_ec88a3ae-8f18-40a2-b993-d7182c7c4082">11.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTktMy0xLTEtNTQ5OTM_8d3f1e63-17d7-4906-a5de-c324cb723d24">11.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjAtMS0xLTEtNTQ5OTM_f509441f-18a2-467f-b21a-dbff2a19be46">7.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjAtMy0xLTEtNTQ5OTM_1df7c112-1359-49dc-beff-1039e1128f48">7.8</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjMtMS0xLTEtNTQ5OTM_bc534e98-9361-48dd-a4e6-23bfc3907909">5.8</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjMtMy0xLTEtNTQ5OTM_8f1bf321-414e-414b-9c6e-2cef46cf1f01">5.9</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjQtMS0xLTEtNTQ5OTM_ac29d664-6706-4c71-8cdf-70aef43f1877">2.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjQtMy0xLTEtNTQ5OTM_f08d61ed-83cc-410f-af10-e6abf792d9f8">2.1</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current maturities of finance leases are included as a component of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_2e5b36fd-c488-467a-a7e5-80e362ee1e08"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_c3cbd70e-0a04-4d24-ab66-5fb27dcd22e3">Other current liabilities</span></span> on our Condensed Consolidated Balance Sheets. <ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOQ_9b7e55df-5ac2-44a8-9639-19d24806a577" continuedAt="ieb6d7a5505024f8caed4655f8c85fa09" escape="true">A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows (in thousands): </ix:nonNumeric></span></div><div style="margin-top:12pt"><ix:continuation id="ieb6d7a5505024f8caed4655f8c85fa09" continuedAt="id5d613a04b424a80ae2049fbded6178c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:71.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.101%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.558%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.104%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Amortization of property and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfMi0xLTEtMS01NDk5Mw_2f1653cb-ba66-4fca-8f51-da0f5ccd4f32">131</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfMi0zLTEtMS01NDk5Mw_be9ff0ca-b4f9-4d15-a375-cf6b6165c31a">137</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Interest expense on finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfMy0xLTEtMS01NDk5Mw_1c3ef568-4c5e-4b97-89ee-2ab012227c3e">21</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfMy0zLTEtMS01NDk5Mw_11a356b2-5e44-40e6-ad7f-fa0ab1e865aa">25</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="aort:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNC0xLTEtMS01NDk5Mw_6d95a218-fc11-4de0-ab6e-5bab67dbde08">152</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="aort:FinanceLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNC0zLTEtMS01NDk5Mw_71af75b5-b3a4-4931-a45f-8e0923884093">162</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNS0xLTEtMS01NDk5Mw_49684180-2ab9-4958-89fe-cd01e09a6447">1,802</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNS0zLTEtMS01NDk5Mw_5323ef3a-c0ea-4951-ad48-d4963384178d">1,920</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNi0xLTEtMS01NDk5Mw_da3e5bf3-b013-47b9-a26a-e7f7de3402ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNi0zLTEtMS01NDk5Mw_79f163a7-0538-47d5-a00e-f75645f6c503">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total lease expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNy0xLTEtMS01NDk5Mw_aca15001-292d-4360-bca6-95f2cd50ac70">1,954</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNy0zLTEtMS01NDk5Mw_d933db98-f669-49fe-8610-3914aaf08e41">1,990</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="i2241f43f23384d13adc7e80e126c9fba"><ix:continuation id="id5d613a04b424a80ae2049fbded6178c"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfMi0xLTEtMS01NDk5Mw_3534bf5a-ef52-4345-8dfa-b21fadb0718c">1,796</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfMi0zLTEtMS01NDk5Mw_61798fe1-02ad-4d90-846c-5812c5dccfe8">1,525</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfMy0xLTEtMS01NDk5Mw_04f4f9a3-ef7f-46cb-9d4f-d4c3daf81b84">132</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfMy0zLTEtMS01NDk5Mw_27c02276-1f20-4bf3-a6e6-281c85c61e4a">130</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfNC0xLTEtMS01NDk5Mw_e36a8a00-c10f-4423-95c4-428ec3c94c84">21</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfNC0zLTEtMS01NDk5Mw_8237461b-75b2-494f-991a-f1c72d05522d">24</ix:nonFraction></span></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYyMQ_00ed2207-213a-4d0f-8e04-537b7b292ecf" escape="true"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYyMQ_284b8fdc-d90b-4456-9f51-a078881d24a9" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments and sublease rental income are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMS0xLTEtMS01NDk5Mw_a385393a-f5f7-46a7-9aac-f2cb9839151f">442</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMS0zLTEtMS01NDk5Mw_3f5fd458-72f2-450e-8be1-289d86eabba5">4,246</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMi0xLTEtMS01NDk5Mw_ebf358e2-a3e1-4534-b29a-246490c6a037">606</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMi0zLTEtMS01NDk5Mw_25178329-3294-4ff7-be6e-841e2820c30a">5,819</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMy0xLTEtMS01NDk5Mw_38c4c783-4896-4b07-b5be-6ff9c76dca74">585</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMy0zLTEtMS01NDk5Mw_3b62e269-516d-4610-9638-471c5c3f5b33">5,620</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNC0xLTEtMS01NDk5Mw_fbad910d-c5e5-42ac-bcb7-7eb1068ca99f">566</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNC0zLTEtMS01NDk5Mw_9654d5ac-3519-4101-81cd-954f6fb1fcbb">5,008</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNS0xLTEtMS01NDk5Mw_dca55fc1-04bf-43df-bae3-7d648269cb2e">561</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNS0zLTEtMS01NDk5Mw_9e844b72-19f0-46b8-a5eb-0b67f4f7090c">4,867</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="aort:FinanceLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNi0xLTEtMS01NDk5Mw_b2119f8d-2eda-4d7e-a706-ab4d7443cd60">1,670</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="aort:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNi0zLTEtMS01NDk5Mw_5ecda146-bfdd-471a-b0b4-e922c1d6153a">37,103</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNy0xLTEtMS01NDk5Mw_ae27440f-7d0d-451e-971f-1f656adc3d5d">4,430</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNy0zLTEtMS01NDk5Mw_053733ed-8a67-47c4-abf5-4b4f7854b0e4">62,663</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfOC0xLTEtMS01NDk5Mw_8081551d-389d-4e02-9ff8-9208b527fdc4">322</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfOC0zLTEtMS01NDk5Mw_4e5cf3a6-085c-4ff0-963e-45bbb0f110dd">18,491</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Present value of net minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfOS0xLTEtMS01NDk5Mw_3ac550c8-8a8c-4ca6-8051-ff5e167ebc09">4,108</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfOS0zLTEtMS01NDk5Mw_171ed910-43da-43d2-9c21-2a65055aa124">44,172</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMTAtMS0xLTEtNTQ5OTM_d789f3f9-32a4-4388-b7c5-2014419df757">526</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMTAtMy0xLTEtNTQ5OTM_6f7eed70-6c56-4a4d-b8d4-e86e4a630f62">3,398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Lease liabilities, less current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMTEtMS0xLTEtNTQ5OTM_7c2decc5-39f7-4bef-b6bd-3438afacdee9">3,582</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMTEtMy0xLTEtNTQ5OTM_312934fe-8287-42f1-b4d0-2d822cc235d7">40,774</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_55"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfODIyMw_982f9c74-7086-4beb-88b3-c7b4e484f1e0" continuedAt="idde6c2c1471a4de09e27453c76f99e0b" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="idde6c2c1471a4de09e27453c76f99e0b" continuedAt="i2be64c431398403384613259c4eee63a"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;1, 2017 we entered into a credit and guaranty agreement for a $<ix:nonFraction unitRef="usd" contextRef="i65f995e36b114f65a815c61bd66eb185_I20171201" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfOTA_284074ec-b029-4c8e-865e-9006755e6f43">255.0</ix:nonFraction> million senior secured credit facility, consisting of a $<ix:nonFraction unitRef="usd" contextRef="i1f57c4f591b04b389e472914c7195492_I20171201" decimals="-5" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTQx_2d8a1c4f-5542-453b-9636-7250a1aaff2e">225.0</ix:nonFraction> million secured term loan facility (the &#8220;Term Loan Facility&#8221;) and a $<ix:nonFraction unitRef="usd" contextRef="ic4c41e2ba6794170b867018c3fdc30de_I20171201" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjA0_343f2990-c8db-4f11-8783-b9bd3e87d037">30.0</ix:nonFraction> million secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221; and, together with the Term Loan Facility, the &#8220;Credit Agreement&#8221;). We and each of our existing domestic subsidiaries (subject to certain exceptions and exclusions) guarantee the obligations under the Credit Agreement (the &#8220;Guarantors&#8221;). The Credit Agreement is secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of us and the Guarantors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;2, 2021 we entered into an amendment to our Credit Agreement to extend the maturity dates of both our Term Loan and Revolving Credit Facility. As part of the amendment, the maturity dates of both our Term Loan and Revolving Credit Facility were each extended by two and one-half years, until June 1, 2027 and June 1, 2025, respectively, subject to earlier springing maturities triggered if our <ix:nonFraction unitRef="number" contextRef="ia34bdcd0d6c84be4827773cf070dbfa6_I20210602" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTEwMw_479714b0-b7e4-4269-b6b4-7575cd676124">4.25</ix:nonFraction>% Convertible Senior Notes, described below, remain outstanding on April 1, 2025 and December 31, 2024, respectively. With respect to the Term Loan, if the Convertible Senior Notes remain outstanding on April 1, 2025, the Term Loan&#8217;s maturity date will be April 1, 2025, or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) <ix:nonNumeric contextRef="ideecae1179894ead84a8360473c0cd9d_D20210602-20210602" name="aort:DebtInstrumentExtensionCircumstancePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTQ2OA_9e58db05-7d6c-4157-937b-a0bd9b3ee82e">91</ix:nonNumeric> days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2027. In the case of the Revolving Credit Facility, if the Convertible Senior Notes are still outstanding on December 31, 2024, the Revolving Credit Facility&#8217;s maturity date will be either December 31, 2024 or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) <ix:nonNumeric contextRef="ia668b5ef64df4c60b5d51cbb5b636f5d_D20210602-20210602" name="aort:DebtInstrumentExtensionCircumstancePeriod" format="ixt-sec:durday" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTg0NQ_c1b2689f-7768-45ba-a64c-698991411362">182</ix:nonNumeric> days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2025. Under the amendment, the Term Loan Facility bears interest, at our option, at a floating annual rate equal to either the base rate, plus a margin of <ix:nonFraction unitRef="number" contextRef="i45eb9ce0dbf4431780b0e06047ccab97_D20210602-20210602" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjA3Nw_3a19ee73-28f0-46e5-9e9d-cfc407175edb">2.50</ix:nonFraction>%, or LIBOR, plus a margin of <ix:nonFraction unitRef="number" contextRef="i7c108b384b6c4ed9a50513917888bcb4_D20210602-20210602" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjEwOA_87332508-dcb9-4217-8bc7-89aa1a93a431">3.50</ix:nonFraction>%. Prior to the amendment, the optional floating annual rate was equal to either the base rate plus a margin of <ix:nonFraction unitRef="number" contextRef="ied0df1c4e0394f72aa46bda78244dc54_D20210601-20210601" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjIyMQ_d23a981d-4bdd-4fa1-b6e6-3256eee4db12">2.25</ix:nonFraction>%, or LIBOR, plus a margin of <ix:nonFraction unitRef="number" contextRef="i1e0b9fb023d14f00a03ee59906304080_D20210601-20210601" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjI1Mg_b00b135f-d9e3-4ac4-9a19-7f7b68db19f2">3.25</ix:nonFraction>%. We paid debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="ieed7b0b097e2498496903c8c4c67c075_D20210602-20210602" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjI4Nw_e5682639-cd98-4af9-85c7-f2abd9650dcf">2.1</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="ieed7b0b097e2498496903c8c4c67c075_D20210602-20210602" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjMwMA_f4991e5c-9686-424d-bced-9a7a592ac911">1.8</ix:nonFraction> million will be amortized over the life of the Term Loan Facility and included in current and long-term debt on the Condensed Consolidated Balance Sheets. The remaining $<ix:nonFraction unitRef="usd" contextRef="i7bfa2fe6123047d79b18fc3d9809b3a6_D20210602-20210602" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjQ2NA_d9580384-a1f4-43ca-b4f2-0add8cfa0251">361,000</ix:nonFraction> of debt issuance costs and $<ix:nonFraction unitRef="usd" contextRef="i7bfa2fe6123047d79b18fc3d9809b3a6_D20210602-20210602" decimals="-3" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjQ5NA_479ec94a-2685-4d9f-9952-162dc0887857">474,000</ix:nonFraction> of non-cash debt extinguishment costs were recorded in Interest expense on the Condensed Consolidated Statements of Operations and Comprehensive Loss. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="i2be64c431398403384613259c4eee63a" continuedAt="i124757ebe13d4e089e3aedc6eb8a4a9c"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 the Credit Agreement contains certain customary affirmative and negative covenants, including covenants that limit our ability and the ability of our subsidiaries to, among other things, grant liens, incur debt, dispose of assets, make loans and investments, make acquisitions, make certain restricted payments (including cash dividends), merge or consolidate, change business or accounting or reporting practices, in each case subject to customary exceptions for a credit facility of this size and type. Beginning in 2021 if we repay borrowings under our Revolving Credit Facility to <ix:nonFraction unitRef="number" contextRef="i5fd78494bf304f19b2f857c42b606fbc_D20230101-20230331" decimals="INF" name="aort:RevolvingCreditFacilityPercentageRepaidForNoCovenants" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMzMxMA_90705e52-e191-434a-b674-3a8fd4a660b0">25</ix:nonFraction>% or less, no financial maintenance covenants, including the minimum liquidity covenant and the maximum first lien net leverage ratio covenant, are applicable. We are in compliance with our debt covenants as of March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2022 in accordance with adopting ASU 2020-04 and 2021-01, we entered into an amendment to our Credit Agreement to replace the LIBOR based benchmark interest rate with the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) based benchmark interest rate for our Term Loan Facility and our Revolving Credit Facility. Based on historical analysis of the differences between the benchmark rates, SOFR is adjusted to arrive at a Term SOFR rate that serves as the replacement base rate for LIBOR under our amended credit facilities. Under this amendment, at the maturity of our existing LIBOR-based loan on December 30, 2022, the interest rate at the repricing of our Term Loan Facility was calculated as Term SOFR plus a fixed percentage credit spread of <ix:nonFraction unitRef="number" contextRef="i662e0658aa8247cd94c867b2227ab80a_D20221219-20221219" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTA5OTUxMTY0MDI5MA_56c8986f-feb0-4936-8c12-0523ee7d62f8">3.50</ix:nonFraction>%. The loan under the Revolving Credit Facility bears interest at Term SOFR plus a margin of between <ix:nonFraction unitRef="number" contextRef="id234474f9a60494f90af8c621f315f96_D20221219-20221219" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTA5OTUxMTY0MDI5Nw_a8acd739-37c9-40e7-af55-357a5ad5d06a">4.00</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i19a8334307424620aa3c250d4ca58b1b_D20221219-20221219" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTA5OTUxMTY0MDMwNA_3a056c2f-142b-4367-a642-46636af49514">4.25</ix:nonFraction>%, depending on our consolidated leverage ratio. As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023 </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the aggregate interest rate of the Credit Agreement was <ix:nonFraction unitRef="number" contextRef="i782ff58a89804bf0b00b3bdac6676855_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTQ5NzU1ODI1MTMw_928e8d3e-bff9-4ea4-bdb5-5814e8436922">8.66</ix:nonFraction>% per annum.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;18, 2020 we issued $<ix:nonFraction unitRef="usd" contextRef="ia3124cad286644aab11fa66ae00f4ef1_I20200618" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMzU2OA_727087a4-58a7-4820-ae8e-49cb7b02c8d1">100.0</ix:nonFraction> million aggregate principal amount of <ix:nonFraction unitRef="number" contextRef="ia3124cad286644aab11fa66ae00f4ef1_I20200618" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMzYwMQ_7d9a3b09-6686-4cb7-94b6-36299568aa7c">4.25</ix:nonFraction>% Convertible Senior Notes with a maturity date of July&#160;1, 2025 (the &#8220;Convertible Senior Notes&#8221;). The net proceeds from this offering, after deducting initial purchasers&#8217; discounts and costs directly related to this offering, were approximately $<ix:nonFraction unitRef="usd" contextRef="id7abca8345f249998cb27b9c944935cc_D20200618-20200618" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMzgzNw_37a3ae4f-3440-45ad-82c9-c813688670d0">96.5</ix:nonFraction> million. On January 1, 2021 we adopted ASU 2020-06 and adjusted the carrying balance of the Convertible Senior Notes to notional. The Convertible Senior Notes balance was $<ix:nonFraction unitRef="usd" contextRef="i5fb16f084b93484db1e521afa59177ff_I20221231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDAwMw_37b8380f-b555-4be7-8b0b-35ddb5c0d61c"><ix:nonFraction unitRef="usd" contextRef="icb07d4b1080c4319a548201e2649918b_I20230331" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDAwMw_496a4140-c475-4a25-9c30-9169f43d127a">100.0</ix:nonFraction></ix:nonFraction> million recorded in Long-term debt on the Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022. The Convertible Senior Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The initial conversion rate of the Convertible Senior Notes is 42.6203 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $<ix:nonFraction unitRef="usdPerShare" contextRef="ia3124cad286644aab11fa66ae00f4ef1_I20200618" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDM1Nw_2b09bdaa-5bd4-467a-8d18-fd9cbee207c7">23.46</ix:nonFraction> per share, subject to adjustments. We use the if-converted method for assumed conversion of the Convertible Senior Notes for the diluted earnings per share calculation. The fair value and the effective interest rate of the Convertible Senior Notes as of March&#160;31, 2023 was approximately $<ix:nonFraction unitRef="usd" contextRef="ia1abb3e2cea84ab7abd42b17a5446166_I20230331" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDYzNQ_86988564-e4bc-4b04-aada-900c98cedc14">90.7</ix:nonFraction> million and <ix:nonFraction unitRef="number" contextRef="ia1abb3e2cea84ab7abd42b17a5446166_I20230331" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDY0Mg_db3e21f2-9e6b-420d-81cc-8651a84e7889">5.05</ix:nonFraction>%, respectively. The fair value was based on market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest expense recognized on the Convertible Senior Notes includes $<ix:nonFraction unitRef="usd" contextRef="i8df2957838504948bdf1f9a293198c26_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDg2Ng_0eb57724-b33b-4a79-9ecb-b94124ac0d62"><ix:nonFraction unitRef="usd" contextRef="icdbd0ff6519a49e0a3512380762dc454_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDg2Ng_e759f220-4eb4-43d5-9e26-b07a834eaf9f">1.2</ix:nonFraction></ix:nonFraction> million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March&#160;31, 2023 and 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to the aggregate of the contractual coupon interest and the amortization of the debt issuance costs</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest on the Convertible Senior Notes began accruing upon issuance and is payable semi-annually. There were $<ix:nonFraction unitRef="usd" contextRef="ia1abb3e2cea84ab7abd42b17a5446166_I20230331" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTIwNA_7d078b55-09d4-4b78-9ae6-d27eee256e30">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i55c6d9dae4af45268902f43249c1803c_I20221231" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTQ5NzU1ODI4NjI5_48e7ff90-0855-402e-b4f2-df4f0933d04f">1.9</ix:nonFraction> million of unamortized debt issuance costs related to Convertible Senior Notes as of March&#160;31, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Convertible Senior Notes may convert their notes at their option at any time prior to January 1, 2025, but only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least <ix:nonFraction unitRef="day" contextRef="i936177e90cbd4e0b9837af78bc6af1ad_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTY0Nw_52767494-98d2-41e5-9cf8-f6c7481eebe2">20</ix:nonFraction> trading days (whether or not consecutive) during a period of <ix:nonFraction unitRef="day" contextRef="i936177e90cbd4e0b9837af78bc6af1ad_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTcxMQ_01c8c2e6-9634-416f-972a-36d84a1683b7">30</ix:nonFraction> consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="i936177e90cbd4e0b9837af78bc6af1ad_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTg2MA_e507b111-b53c-4d23-8778-2a309f5d0dce">130</ix:nonFraction>% of the conversion price on each applicable trading day; (ii) during the <ix:nonFraction unitRef="day" contextRef="i245d6adca68f4145ad5ff6862bb500d7_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTkzNQ_e748ae53-1673-47d6-9dad-94d77fef04dc">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="day" contextRef="i245d6adca68f4145ad5ff6862bb500d7_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTk2OA_d031105d-c85a-4e67-9f64-703a5cd68c75">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than <ix:nonFraction unitRef="number" contextRef="i245d6adca68f4145ad5ff6862bb500d7_D20230101-20230331" decimals="2" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNjEyMw_a2fdd2cb-80b4-4078-9e4f-41aa923931eb">98</ix:nonFraction>% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (iii) we give a notice of redemption with respect to any or all of the notes, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after January 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="i124757ebe13d4e089e3aedc6eb8a4a9c" continuedAt="ie619383d044e4c71b0aa48dff917dfa0"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot redeem the Convertible Senior Notes before July 5, 2023. We can redeem them on or after July 5, 2023, in whole or in part, at our option, if the last reported sale price per share of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNjk1MQ_5915e003-70a1-478e-826f-54332c6f9336">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="day" contextRef="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNzAwNg_ccfaad2b-ef48-4dd6-8639-a14a574466be">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="day" contextRef="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNzA2Mg_ba84cc8c-a54d-4002-ae01-a822df6c2861">30</ix:nonFraction> consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. We may redeem for cash all or part of the Convertible Senior Notes at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331" decimals="INF" name="aort:DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNzM1Nw_ddf7627b-ace5-48bb-b2f4-7c93156b9e23">100</ix:nonFraction>% of the principal amount of the redeemable Convertible Senior Notes, plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the Convertible Senior Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the Convertible Senior Notes do not contain any financial covenants and do not restrict us from conducting significant restructuring transactions or issuing or repurchasing any of its other securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan Balances</span></div><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfODIyMg_e97213a7-43ec-4eef-9217-86ecbb5613d0" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term and long-term balances of our Term Loan and other long-term borrowings were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:71.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.708%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.104%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Term Loan balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i34b6700b45d349109d8e1e8318e1f9d0_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMS0xLTEtMS01NDk5Mw_1b8cd54d-8cb7-4c2f-bc34-82c869e3e5e1">213,188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i330928a666a2457b8aec74cf41920829_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMS0zLTEtMS01NDk5Mw_dbeaf6bb-cc39-4c95-8c36-bd4ef72fbb9c">213,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Convertible Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4d1d1110dd9c4c4ea0509148da8595ea_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMi0xLTEtMS01NDk5Mw_5bb3ca97-19ca-41d7-bdc3-1e7dd5a5055a">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i65a4c670870a4d9f8805dd18a1e03eff_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMi0zLTEtMS01NDk5Mw_ee9a5170-3403-4045-97c5-096d169aa626">100,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i3ee531be8b494d88bc9356fd017a9774_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMy0wLTEtMS01NDk5My90ZXh0cmVnaW9uOmNlYWY4NzBiODA5ZTRhZmNiNGM0MzY1MzlmOGZhOTU5XzQ_0c5d7d6c-42db-490a-b6bf-4d9ced13ee45">2.45</ix:nonFraction>% Sparkasse Zollernalb (KFW Loan 1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i3ee531be8b494d88bc9356fd017a9774_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMy0xLTEtMS01NDk5Mw_6d7b5cc3-d444-46b2-8c16-68d7c1a922d0">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if6292b6052bc40909d1a2f96522bdb4f_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMy0zLTEtMS01NDk5Mw_78e8cb80-c174-46d6-a6a5-3cdc28084410">296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i9cadf7c14ba34a48bad3de79cb43a15f_I20230331" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNC0wLTEtMS01NDk5My90ZXh0cmVnaW9uOmU5OWUxNDQwNDRlNTRlZjRhNjlhOTlmZTMwNTE5NzNkXzQ_0b983f49-9ec4-4689-a323-bc4683ed41c6">1.40</ix:nonFraction>% Sparkasse Zollernalb (KFW Loan 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i9cadf7c14ba34a48bad3de79cb43a15f_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNC0xLTEtMS01NDk5Mw_a2292bf7-1d0a-43ce-9e5b-cae25e3e55cd">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i17368e8c263742ae9eac5e48717b6911_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNC0zLTEtMS01NDk5Mw_0b219f08-9d22-4f81-b500-97cf3082e3f6">733</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total loan balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNS0xLTEtMS01NDk5Mw_7dbead79-6d63-4f9a-aedb-2fb6362f9ed5">314,109</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNS0zLTEtMS01NDk5Mw_7b31fba1-37aa-497f-be4e-b628ad015b71">314,779</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less unamortized loan origination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNi0xLTEtMS01NDk5Mw_be593a65-dce3-49cc-856f-0ab8f535d46d">6,210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNi0zLTEtMS01NDk5Mw_7f5d145b-4fb3-4325-b87e-60631f846377">6,672</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNy0xLTEtMS01NDk5Mw_4ebcbb19-a88a-4df3-9dec-c5af1407ada3">307,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNy0zLTEtMS01NDk5Mw_56e4e9b0-4305-4329-aec3-b8a04b55bf8d">308,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less short-term loan balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfOC0xLTEtMS01NDk5Mw_22b9e864-63ce-4f2b-aa4a-928d1a5bfce4">1,620</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfOC0zLTEtMS01NDk5Mw_362d4930-8ee7-4967-8644-56868e0e88cf">1,608</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Long-term loan balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfOS0xLTEtMS01NDk5Mw_1cb8f584-2e7d-4dbb-b46a-5f8bd11b655f">306,279</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfOS0zLTEtMS01NDk5Mw_d4b5caab-330b-44d5-a3b1-fb0782b0f388">306,499</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:continuation id="ie619383d044e4c71b0aa48dff917dfa0">Interest expense was $<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfODEwNA_eb273645-adcf-402a-a757-34d3e5872590">6.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-5" name="us-gaap:InterestExpenseDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTQ5NzU1ODI2MjE3_052427eb-411b-4f30-ad2e-0ddf3c18d41b">3.9</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively. Interest expense includes interest on debt and uncertain tax positions in both periods.</ix:continuation> </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_61"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182MS9mcmFnOjE4MDRkM2FkYTc1NjQyYmZiZWE4MTU3ODVjNzY5ZTYxL3RleHRyZWdpb246MTgwNGQzYWRhNzU2NDJiZmJlYTgxNTc4NWM3NjllNjFfMTg5NQ_0cd88ba7-0801-46d0-96b2-0f2b99afd336" continuedAt="i76a27a23feba4753b16c1bf40884151e" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i76a27a23feba4753b16c1bf40884151e"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability Claims</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are made aware of adverse events involving our products and tissues. Future adverse events could ultimately give rise to a lawsuit against us, and liability claims may be asserted against us in the future based on past events that we are not aware of at the present time. We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability claims. Claims-made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect. The amounts recorded in these Condensed Consolidated Financial Statements as of March&#160;31, 2023 and the Consolidated Financial Statements as of December&#160;31, 2022 represent our estimate of the probable losses and anticipated recoveries for incurred but not reported claims related to products sold and services performed prior to the balance sheet date.</span></div></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_64"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RleHRyZWdpb246NWFkOGEzZGQ5OGM5NDI3ZmJiNzU3NDFmZDk0OGNhZjVfMTcxNw_018d5a62-c45b-450a-88cf-96cc9ba1f194" continuedAt="i8fff26fb102841eab08ca9d5aec12746" escape="true">Revenue Recognition</ix:nonNumeric></span></div><ix:continuation id="i8fff26fb102841eab08ca9d5aec12746" continuedAt="i8fe9fb4f05754893a99ee41da7cc169a"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified the following revenues disaggregated by revenue source:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Domestic hospitals &#8211; direct sales of products and preservation services.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International hospitals &#8211; direct sales of products and preservation services.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International distributors &#8211; generally these contracts specify a geographic area that the distributor will service, terms and conditions of the relationship, and purchase targets for the next calendar year.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="i8fe9fb4f05754893a99ee41da7cc169a"><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CardioGenesis cardiac laser console trials and sales &#8211; CardioGenesis cardiac trialed laser consoles are delivered under separate agreements.</span></div><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RleHRyZWdpb246NWFkOGEzZGQ5OGM5NDI3ZmJiNzU3NDFmZDk0OGNhZjVfMTcxOA_b8c0a354-3691-45ac-abc5-7162c5714ded" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022 the sources of revenue were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Domestic hospitals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i6765ee8c4e514375bf2377f15526dbbc_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfMi0xLTEtMS01NDk5Mw_447cd5a6-d38d-41b2-9e4b-27667639e285">40,883</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i5e02717d99e84bc08078c02ad4f2d3ab_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfMi0zLTEtMS01NDk5Mw_3adcb103-c3de-44b3-9445-b82521292679">36,993</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International hospitals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i82de625935f54b34bbb5e4589a1fc149_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfMy0xLTEtMS01NDk5Mw_72d7bece-603d-42d9-8135-af86956921e4">28,957</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="idf63598993c849b9a81d477b9517fc7c_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfMy0zLTEtMS01NDk5Mw_dff3b7ba-bd35-4d31-afaf-754434660059">28,414</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib9af7b4096844040ad375baefedff835_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNC0xLTEtMS01NDk5Mw_17d1e054-f274-4aa2-8ad8-8bf1b85c835e">12,939</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ic8a7f94f926946f1b329419bb02b1cf7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNC0zLTEtMS01NDk5Mw_2b9e817c-a818-4c99-8a8d-d7365a6cbd52">11,064</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">CardioGenesis cardiac laser therapy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i9490fb1e6a364e808b33e4f022177191_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNS0xLTEtMS01NDk5Mw_09aae98d-fba8-43b0-b75e-2bd10c5e4f82">450</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ide1a4c016001405a9f9e00487555dcea_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNS0zLTEtMS01NDk5Mw_7a3c784a-80a1-4d2f-ad19-f41b486a3d1e">742</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total sources of revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNi0xLTEtMS01NDk5Mw_fa6f6d92-a0a5-4969-9877-164d50f4cfd9">83,229</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNi0zLTEtMS01NDk5Mw_03da3780-407f-4df4-8d60-ac1f4cc84b71">77,213</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also see segment disaggregation information in Note 12 below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may generate contract assets during the pre-delivery design and manufacturing stage of E-xtra Design Engineering product order fulfillment. We assess the balance related to any arrangements in process and determine if the enforceable right to payment creates a material contract asset requiring disclosure. No material arrangements in process existed as of March&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also incur contract obligations on general customer purchase orders that have been accepted but unfulfilled. Due to the short duration of time between order acceptance and delivery of the related product or service, we have determined that the balance related to these contract obligations is generally immaterial at any point in time. We monitor the value of orders accepted but unfulfilled at the close of each reporting period to determine if disclosure is appropriate. The value of orders accepted but unfulfilled as of March&#160;31, 2023 and 2022 was not material.</span></div></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_67"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMjk0Ng_7cbbf71e-e598-4f3d-a2d6-95016a69df2a" continuedAt="iff8899df763749e1899dbee12cca9b47" escape="true">Stock Compensation </ix:nonNumeric></span></div><ix:continuation id="iff8899df763749e1899dbee12cca9b47" continuedAt="ied075496acb24c0a86633cf24e1d8e27"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;), and options to purchase shares of our common stock at exercise prices generally equal to the fair value of such stock at the dates of grant. We also maintain a shareholder-approved Employee Stock Purchase Plan (&#8220;ESPP&#8221;) for the benefit of our employees. The ESPP allows eligible employees to purchase common stock on a regular basis at the lower of <ix:nonFraction unitRef="number" contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNjAy_a4ba81a0-fbff-4308-a1c2-353f29b128d9">85</ix:nonFraction>% of the market price at the beginning or end of each offering period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Grants</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compensation Committee of our Board of Directors (the &#8220;Committee&#8221;) authorized awards from approved stock incentive plans of RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed <ix:nonFraction unitRef="shares" contextRef="id3cbd678f84346a6bd714e53648d0ce7_D20230101-20230331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMTA0MQ_865d387b-bd2f-4e63-9ff0-da42bcfd16b2">376,000</ix:nonFraction> shares and had an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="id3cbd678f84346a6bd714e53648d0ce7_D20230101-20230331" decimals="-5" name="aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMTA5Nw_fd79fc90-64da-430b-a3e2-81818af90ce3">5.0</ix:nonFraction> million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 the Committee authorized awards from approved stock incentive plans of  RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled <ix:nonFraction unitRef="shares" contextRef="i1e96a5da80644389a43614a81619129f_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2ODQ2_353eaeba-2aa1-486b-b40d-4e079270bafc">452,000</ix:nonFraction> shares and had an aggregate grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="i1e96a5da80644389a43614a81619129f_D20220101-20220331" decimals="-5" name="aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2ODUw_171f6657-fee6-4917-99bd-7f2289e4ff38">8.3</ix:nonFraction> million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee authorized, from approved stock incentive plans, grants of stock options to purchase a total of <ix:nonFraction unitRef="shares" contextRef="ib35623233c83476c8ae2823d953479ac_D20220101-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2ODU4_814171de-d65b-4bc4-9661-113c647e3f31">314,000</ix:nonFraction> shares to certain company officers during the three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The exercise prices of the options were equal to the closing stock prices on their respective grant dates. The Committee did not authorize any grants of stock options during the three months ended March&#160;31, 2023.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="ied075496acb24c0a86633cf24e1d8e27" continuedAt="if168398641d347c2b267922b337b34d1"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees purchased common stock totaling <ix:nonFraction unitRef="shares" contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMTgyOQ_ffe9145f-9d51-4a3c-9768-86e0e4f43d4e">56,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ie87171075e7c46b3a5e2f515abfa3038_D20220101-20220331" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2OTM1_b5ce9e12-51ae-412e-b5d3-7524686ce8c3">37,000</ix:nonFraction> shares in the three months ended March&#160;31, 2023 and 2022, respectively, through the ESPP. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Compensation Expense </span></div><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMjk0Nw_90d41a13-27d0-44a7-bb2b-802c87129989" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.293%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31, 2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonNumeric contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmY5NTNhNjM2Njg4ZjQxNWY5ZjFkMDA1YWI4ZWVjYjEwL3RhYmxlcmFuZ2U6Zjk1M2E2MzY2ODhmNDE1ZjlmMWQwMDVhYjhlZWNiMTBfMi0zLTEtMS01NDk5Mw_8a441661-235b-4675-b8ba-28a11ce776bb">0.5</ix:nonNumeric> Years</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmY5NTNhNjM2Njg4ZjQxNWY5ZjFkMDA1YWI4ZWVjYjEwL3RhYmxlcmFuZ2U6Zjk1M2E2MzY2ODhmNDE1ZjlmMWQwMDVhYjhlZWNiMTBfMy0zLTEtMS01NDk5Mw_a499ca96-54ca-4ae3-b70c-40fbc145be82">0.66</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="number" contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmY5NTNhNjM2Njg4ZjQxNWY5ZjFkMDA1YWI4ZWVjYjEwL3RhYmxlcmFuZ2U6Zjk1M2E2MzY2ODhmNDE1ZjlmMWQwMDVhYjhlZWNiMTBfNC0zLTEtMS01NDk5Mw_136bf017-ed0b-4a60-82ce-2506b64c7b3a">4.77</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMjk0OA_0cf5a423-e74d-4200-a1fd-679d93f4580e" escape="true"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"></td><td style="width:68.200%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.945%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.407%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.948%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">RSA, RSU, and PSU expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i46dae3eb2d6d4db5b3282cd30f4eb3b9_D20230101-20230331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfMi0xLTEtMS01NDk5Mw_2dc2fa94-9da2-48ec-9dd7-8d7366c22fc4">2,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i39bfa788f29c453e8e82fca1bd97483c_D20220101-20220331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfMi0zLTEtMS01NDk5Mw_68ff03ba-129b-4667-9667-2769788ef868">2,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Stock option and ESPP expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if1fbc6109379459ab9d95037d44ee0bc_D20230101-20230331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfMy0xLTEtMS01NDk5Mw_c2e39d52-4c5c-44d9-9337-33c54369d13f">872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i20695d53f4ce4fe6a0127135b2d1f023_D20220101-20220331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfMy0zLTEtMS01NDk5Mw_b3dfd16b-844e-4cd7-876a-d67707da99ef">572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total stock compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfNC0xLTEtMS01NDk5Mw_cbeae9f5-a50a-4119-a37d-c1a752fa83fc">3,513</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfNC0zLTEtMS01NDk5Mw_48cf8dc3-7524-416f-a3c4-e60823bd3c46">3,340</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if168398641d347c2b267922b337b34d1">Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the ESPP. These amounts were recorded as stock compensation expense and were subject to our normal allocation of expenses to inventory costs and deferred preservation costs. We capitalized $<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMjc4MQ_c054322e-22c6-47fe-9e0b-5507d2a08432">172,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2OTg0_760bded2-317c-4e81-8f7f-6cbb3329b58e">174,000</ix:nonFraction> in the three months ended March 31, 2023 and 2022, respectively, of the stock compensation expense into our inventory costs and deferred preservation costs.</ix:continuation> </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_70"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RleHRyZWdpb246ZTJhMzYxN2RmZGM5NGU2YTk5NjFiNDgzNjU1MzMxODdfMTIxOQ_644db5b3-1cba-4ba1-b1b4-8ecbc00e4d4c" continuedAt="i93fda4beb4dd4d6580fc5f154b0dbd25" escape="true">Loss Per Common Share </ix:nonNumeric></span></div><ix:continuation id="i93fda4beb4dd4d6580fc5f154b0dbd25" continuedAt="i2546ed98a28743e39b8ea153ae0392fa"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RleHRyZWdpb246ZTJhMzYxN2RmZGM5NGU2YTk5NjFiNDgzNjU1MzMxODdfMTIxOA_89bfbd93-fb41-47ae-8f79-bed082b052e7" continuedAt="i1f23f49e27084bc6b4eb2c06993b57f1" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted loss per common share (in thousands, except per share data): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:73.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.116%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic loss per common share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfMi0yLTEtMS01NDk5Mw_fd546f3a-5cdd-4753-885b-ce2fa6796993">13,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfMi00LTEtMS01NDk5Mw_631f15b1-d79c-4537-a3ca-a4a3ba2a382a">3,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfMy0yLTEtMS01NDk5Mw_92c28d72-3093-4f37-9b5e-9a008e4592dd">60</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfMy00LTEtMS01NDk5Mw_c3fd1fe5-3e64-4074-883e-945af7a7e233">18</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net loss allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNC0yLTEtMS01NDk5Mw_4bf629ae-3a54-4d10-9a80-4db12b6fd448">13,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNC00LTEtMS01NDk5Mw_be8639e6-33ff-43ac-9768-be5a3bb5c551">3,371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNi0yLTEtMS01NDk5Mw_c3295be5-ce16-4baf-af30-3bc12ea299c1">40,432</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNi00LTEtMS01NDk5Mw_7e249359-6390-4313-9f8d-3044f9f2274e">39,850</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic loss per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNy0yLTEtMS01NDk5Mw_ccd9dd53-fc49-4f51-a7b0-a1d82055460b">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNy00LTEtMS01NDk5Mw_fdbcc176-8ff0-4507-b073-c13d60a78264">0.08</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="i2546ed98a28743e39b8ea153ae0392fa"><div style="margin-top:12pt"><ix:continuation id="i1f23f49e27084bc6b4eb2c06993b57f1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"></td><td style="width:73.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.076%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted loss per common share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMi0yLTEtMS01NDk5Mw_92d6f28a-aa51-4a5a-a0ce-8295528e31cd">13,532</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMi00LTEtMS01NDk5Mw_d91ff517-3ef8-4b00-b53e-24c1bb9405f6">3,389</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMy0yLTEtMS01NDk5Mw_1a63786d-2dc5-4184-9401-63ddcda86f72">60</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMy00LTEtMS01NDk5Mw_09415b62-6b81-49a9-bed8-242126e50b63">18</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net loss allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfNS0yLTEtMS01NDk5Mw_f9bc5d6f-5ca8-487c-ae65-b272a9af1903">13,472</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfNS00LTEtMS01NDk5Mw_b1e1a009-6eba-40f1-a628-5e52cde88cec">3,371</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfNy0yLTEtMS01NDk5Mw_104ad0f9-e6ed-4381-98c4-721a644fe821">40,432</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfNy00LTEtMS01NDk5Mw_1cdc71cc-3dfd-4e34-a1b5-1beae35a7a62">39,850</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMTAtMi0xLTEtNTQ5OTM_49552be8-d024-479f-81d6-9264f6fceb79">40,432</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="shares" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMTAtNC0xLTEtNTQ5OTM_b7f015f1-42d4-4d13-9ea3-2d175fddd647">39,850</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted loss per common share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMTEtMi0xLTEtNTQ5OTM_7ed2e90d-4df6-48ed-9e85-1437bc726401">0.33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMTEtNC0xLTEtNTQ5OTM_518e44bb-5bd8-4cd5-a499-194abfc4347d">0.08</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares because the inclusion of these stock options would be antidilutive to loss per common share. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022 all stock options and awards were excluded from the calculation of diluted weighted-average common shares outstanding as these would be antidilutive due to the net loss.</span></div></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_73"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfMTM4Mg_c1fe487b-3f1c-4b92-9523-d8af48f538a3" continuedAt="i6744a6c879b141b69532a62101d824f3" escape="true">Segment Information </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i6744a6c879b141b69532a62101d824f3" continuedAt="if70b318a0ed74b179c064ac8907a060d"> </ix:continuation></span></div><ix:continuation id="if70b318a0ed74b179c064ac8907a060d" continuedAt="ib8cfd7e0050f4a22a1f87d08c2f694bb"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonFraction unitRef="segment" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfMjI_f2599b81-cd0d-40b7-b2ce-1ce1f318ba3c">two</ix:nonFraction> reportable segments organized according to our products and services: Medical devices and Preservation services. The Medical Devices segment includes external revenues from product sales of aortic stent grafts, On-X, surgical sealants, and other product revenues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, and E-vita Thoracic 3G. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Surgical sealants include BioGlue Surgical Adhesive products. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are <ix:nonFraction unitRef="usd" contextRef="i24d764c46d944801885c59dde6cec14b_D20230101-20230331" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfODM0_11c47906-682e-4063-b8e4-5135294c7069">no</ix:nonFraction> intersegment revenues. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary measure of segment performance, as viewed by our management, is segment gross margin or net external revenues less cost of products and preservation services. We do not segregate assets by segment, therefore, asset information is excluded from the segment disclosures below. </span></div><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfMTM4Mw_6c0a5dea-cd60-411e-a197-58e2f82dc12f" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMy0xLTEtMS01NDk5Mw_084fe88c-38df-436d-9309-7f19be32d997">62,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="icb6dc10bc7ed4b5492b4ae7557ed2a02_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMy0zLTEtMS01NDk5Mw_ec3d5501-00db-4645-ba30-fe176cb24fc9">57,542</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i350257931547498a908d5663ff901b70_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfNC0xLTEtMS01NDk5Mw_0fcb4917-95be-4065-886a-486b80dc14e1">20,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iaade080667b34ceaa2d4b4d14761568d_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfNC0zLTEtMS01NDk5Mw_67de088e-f3df-46e6-873f-6a80f110892f">19,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfNS0xLTEtMS01NDk5Mw_f409b8a2-e0cb-4a41-8405-55a6f6a38c30">83,229</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfNS0zLTEtMS01NDk5Mw_ecdcf572-7a8f-48bc-ada1-9c5ce01502da">77,213</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Cost of products and preservation services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfOC0xLTEtMS01NDk5Mw_84dc806b-adf1-419c-95e8-6ec3073878d6">19,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="icb6dc10bc7ed4b5492b4ae7557ed2a02_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfOC0zLTEtMS01NDk5Mw_add1f00a-5d83-405b-b5f6-3989c859a260">17,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i350257931547498a908d5663ff901b70_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfOS0xLTEtMS01NDk5Mw_6b98f7eb-4115-46cf-9ec1-199a8887e4b2">9,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iaade080667b34ceaa2d4b4d14761568d_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfOS0zLTEtMS01NDk5Mw_558315d0-b354-4a40-b412-3f42f0e1f8ea">9,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total cost of products and preservation services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTAtMS0xLTEtNTQ5OTM_ec5bf81f-fb77-47b4-8eaa-b851611b2317">29,502</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTAtMy0xLTEtNTQ5OTM_a1f2c88d-332a-4c1c-9038-69f2cbbc650a">26,494</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTMtMS0xLTEtNTQ5OTM_93cb0c75-6178-4d60-bae5-3f7c87fda7ea">42,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="icb6dc10bc7ed4b5492b4ae7557ed2a02_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTMtMy0xLTEtNTQ5OTM_cd80f257-88e9-46bf-be27-8d12641fda20">40,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i350257931547498a908d5663ff901b70_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTQtMS0xLTEtNTQ5OTM_deeb5bae-fea1-48d0-a427-5edb8ab9781a">10,969</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iaade080667b34ceaa2d4b4d14761568d_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTQtMy0xLTEtNTQ5OTM_2c7cb9f7-bc2e-48ff-b901-d2eae5ae8fcc">10,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total gross margin</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTUtMS0xLTEtNTQ5OTM_6c604816-c719-42db-bb99-d9f240d93c96">53,727</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTUtMy0xLTEtNTQ5OTM_39b5b2aa-ecf1-4d0c-bc9e-6d23fdf83cb7">50,719</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><ix:continuation id="ib8cfd7e0050f4a22a1f87d08c2f694bb"><ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfMTM4NA_dc89e6a9-81d0-479b-b777-fd1997b064de" escape="true"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net revenues by product and service (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i0d27f99bdef34490ab29648e4ece9919_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfMy0xLTEtMS01NDk5Mw_1764a314-5998-4768-a7bc-e97494771c62">26,150</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4e3f19c886f3413fb86666f3e6eb9394_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfMy0zLTEtMS01NDk5Mw_d2e2a2fa-2898-499c-bb6d-ddbb2587eee8">25,506</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i88ac222b2f944d15bd71802bc159841a_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNC0xLTEtMS02MzM3MQ_7ee79148-2342-4763-88c7-0230df5f405b">17,656</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4cc9e6e0e71d487eaa136ec7431e6ce6_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNC0zLTEtMS02MzM3MQ_0287030f-272e-4bfa-b17a-f3a31a85d856">14,371</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="icfa08b9642074e35bc71304309d137aa_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNC0xLTEtMS01NDk5Mw_669511b8-5d0e-40d7-bcfc-e8591818c057">16,703</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ib0b90e8de9b7458c9afe003e4bad474a_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNC0zLTEtMS01NDk5Mw_aa372d22-59bc-4c63-a971-a22ddab1289a">15,681</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ie2d424b22c484323a8479a4346ad4545_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNi0xLTEtMS01NDk5Mw_1d11a5e3-248b-4cd6-a585-f3b3b05ae0e1">1,782</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i4337b65585504d8bbb937a66cdd29f5b_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNi0zLTEtMS01NDk5Mw_85385265-1c2b-4899-a364-9793141c2f38">1,984</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i1ae3a909430949bd90a175d270eb249f_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNy0xLTEtMS01NDk5Mw_d412a3bc-fb34-42b9-a898-de8e82cffc34">62,291</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i979c20305ec145afbd438a672f317ec1_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNy0zLTEtMS01NDk5Mw_f7960b5c-9801-4c73-a398-2f7acd8b4610">57,542</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="ic5cf4550d1e64e08a695b28c0c89be0e_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfOS0xLTEtMS01NDk5Mw_d8466d00-69b6-4b7f-9fb8-39699c11abd1">20,938</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="if1c72bde95b6478d85567313998b4435_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfOS0zLTEtMS01NDk5Mw_e54a354e-26b4-4d69-a806-db8f536ba7b3">19,671</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfMTAtMS0xLTEtNTQ5OTM_1d3ef0ae-676f-4624-bfbf-672b30c538ba">83,229</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"><ix:nonFraction unitRef="usd" contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfMTAtMy0xLTEtNTQ5OTM_4ea84304-bd8d-4b77-89e2-21a3b611de07">77,213</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i5fc3aab1863a48b289e7fc6726692d73_549755814441"></div><div style="margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA2NzU_20141316-f12c-4682-adf6-6edc6e305b17" continuedAt="i7b6d3dbf38ad4dae89d4f0bd89eebaf9" escape="true">Subsequent Events </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i7b6d3dbf38ad4dae89d4f0bd89eebaf9" continuedAt="i70ac8327385142349eaf353fef7031c8"> </ix:continuation></span></div><ix:continuation id="i70ac8327385142349eaf353fef7031c8" continuedAt="i93754284511b487080d566551d8ad931"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Endospan Loan</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 11, 2019 Artivion and Endospan Ltd. (&#8220;Endospan&#8221;), an Israeli corporation, entered into a loan agreement (&#8220;Endospan Loan&#8221;), in which Artivion agreed to provide Endospan a secured loan of up to $<ix:nonFraction unitRef="usd" contextRef="icf3dcedf29fb4d59856021f6832683f4_I20190911" decimals="-5" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA2Nzc_f215a4cb-be1a-4651-b223-83e89a24cf2c">15.0</ix:nonFraction>&#160;million to be funded in <ix:nonFraction unitRef="tranche" contextRef="ie06473170a934a1f8ba18b66bd8feeb5_D20190911-20190911" decimals="INF" name="aort:NumberOfTranches" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3NTU_8330375e-34bb-44fe-8f19-76029ed701a1">three</ix:nonFraction> tranches of $<ix:nonFraction unitRef="usd" contextRef="i2b7e03d58c2d4458be09a447fde2288f_D20190911-20190911" decimals="-5" name="aort:ThreeTranchesOfFundingForSecuredLoanPerTranche" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA2OTI_6bfe4580-e6dc-440d-bc7d-b49b345f379e">5.0</ix:nonFraction>&#160;million each. The first tranche of the Endospan Loan was funded upon execution of the agreement in September 2019. In September 2020 we funded the second tranche payment of $<ix:nonFraction unitRef="usd" contextRef="i6093549b9fc14acc8ec2494386cd4ca5_D20200901-20200930" decimals="-5" name="aort:FundedTranchePaymentPerAgreement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3MDY_2ab60e70-4976-48cc-ae8a-8c8d36d0ab0d">5.0</ix:nonFraction>&#160;million upon the certification of the NEXUS IDE from the US Food and Drug Administration (the &#8220;FDA&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2023 Endospan completed an enrollment certification of <ix:nonFraction unitRef="number" contextRef="i0ed7688ddb8243768813e25604041962_D20230416-20230416" decimals="2" name="aort:ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3MjA_2a79f70f-5766-4d98-b3b7-06539996ec3b">50</ix:nonFraction>% of the required number of patients in the primary arm of the FDA approved clinical trial for NEXUS, which, assuming compliance with other requirements under the Endospan Loan, may trigger a third tranche payment of $<ix:nonFraction unitRef="usd" contextRef="i0ed7688ddb8243768813e25604041962_D20230416-20230416" decimals="-5" name="aort:ThirdTranchePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3Mjc_fefbf2a2-7ca6-47c0-9005-6f6543cb3abc">5.0</ix:nonFraction>&#160;million. We expect to fund the $<ix:nonFraction unitRef="usd" contextRef="i0ed7688ddb8243768813e25604041962_D20230416-20230416" decimals="-5" name="aort:ThirdTranchePayment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3NTM_fefbf2a2-7ca6-47c0-9005-6f6543cb3abc">5.0</ix:nonFraction>&#160;million payment during the second quarter of fiscal year 2023. </span></div></ix:continuation><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i93754284511b487080d566551d8ad931">We elected the fair value option for recording the Endospan Loan and are evaluating the fair value impact of the anticipated funding of the third tranche payment.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_76"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Form 10-Q includes &#8220;forward-looking statements&#8221; within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;). Forward-looking statements give our expectations or forecasts of future events as of the date of this Form 10-Q. In some cases, words such as &#8220;could,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;would,&#8221; &#8220;shall,&#8221; &#8220;should,&#8221; &#8220;pro forma,&#8221; &#8220;potential,&#8221; &#8220;pending,&#8221; &#8220;intend,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;plan,&#8221; &#8220;future,&#8221; &#8220;assume,&#8221; and variations of these types of words or other similar expressions identify forward-looking statements. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements, which are made as of the date of this Form 10-Q. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All statements included herein, other than statements of historical facts, that address activities, events, or developments that we expect or anticipate will or may occur in the future, or that reflect our beliefs about the future and/or expectations, are forward-looking statements, including statements about the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that new products, new indications, global expansion, and business development are the four growth areas that will drive our business in the future;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact the COVID-19 pandemic and the war in Ukraine may have on demand for and sales of our products and services, business operations, manufacturing operations, supply chain, cash flow, workforce, clinical and regulatory timelines, and our research and development projects;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The potential impact general global, regional, or national economic downturns and macroeconomic trends, including heightened inflation, interest rate and currency fluctuations, as well as general or localized economic slowdowns or recessions may have on demand for and sales of our products and services, including ordering trends for international distributors based on currency fluctuation against the US dollar, and our business operations, manufacturing operations, supply chain, and workforce;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about the robustness of our global supply chain in light of current global and macroeconomic conditions and about the potential impact of supply chain disruptions, particularly disruptions to single and sole source suppliers and third-party manufacturing partners;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about our R&amp;D and product pipeline, including our beliefs about the timing of our clinical trials and product launches; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs and anticipation regarding the favorable attributes, benefits, and clinical advantages of our products and services, the basis on which our products and services compete, the benefits of our physician education activities, and the advantages of our relationships with organ and tissue procurement organizations and tissue banks; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about the future regulatory status of our medical devices, our compliance with applicable laws and regulations, and our ability to make timely transitions to our Notified Bodies and obtain renewals for our Conformit&#233; Europ&#233;ene Mark product certification impacted by Brexit and the transition to the Medical Device Regulation in Europe, and the impact these transitions, renewals, and related processes may have on our business, including any impact on our customers' ordering patterns and our ability to supply products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs regarding our global expansion efforts, including the international growth opportunity that would be provided by obtaining regulatory approval for BioGlue in China;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs regarding the impact lower INR anticoagulation therapy and transcatheter heart valve replacement may have on the number of patients choosing On-X mechanical heart valves;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about the advantages of our intellectual property and its significance to our segments and our business as a whole, and our beliefs about the present value and potential impairment of our intangible assets and leases;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about our workforce, including our ability to attract and retain talent at all levels, and about our relationship with our workforce, including our works council in Germany and union in Brazil;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about potential information security vulnerabilities, and the associated potential adverse effects on our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The dependencies affecting our ability to realize the anticipated business opportunities, growth prospects, synergies, and other benefits of the agreements with Endospan and Baxter and our acquisition of Ascyrus, and our beliefs about the costs and timelines for certain regulatory approvals and clinical trial milestones related to PerClot and the NEXUS stent graft system in the US and the AMDS globally;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs regarding the fair value of our acquisitions, divestitures, and other business development activities and the estimates and assumptions about the future achievements of milestones and future revenues and cash flows related to those business development activities, including our ability to achieve the milestones in the Baxter Transaction;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about the anticipated benefits from our corporate reincorporation and rebranding and the risks posed by the same;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that revenues for preservation services, particularly revenues for certain high-demand cardiac tissues, can vary from quarter-to-quarter and year-to-year due to a variety of factors including: quantity and type of incoming tissues, yields of tissue through the preservation process, timing of receipt of donor information, staffing levels, timing of the release of tissues to an implantable status, demand for certain tissue types due to the number and type of procedures being performed, and pressures from competing products or services;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs regarding the seasonal nature of the demand for some of our products and services and the reasons for such seasonality, if any, and regarding the impact of consignment inventory on product sales, if any;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that our cash from operations and existing cash and cash equivalents will enable us to meet our current operational liquidity needs for at least the next twelve months, our expectations regarding future cash requirements, and the impact that our cash requirements might have on our cash flows for the next twelve months;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectation regarding the impact on cash flows of undertaking significant business development activities and the potential need to obtain additional debt financing or equity financing;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our belief that we will incur expenses for research and development projects, including for clinical research projects to gain regulatory approvals for products or indications, including On-X, aortic stent grafts, and BioGlue products, and for new products and technologies which will likely require additional investment, research, and new clinical studies or data;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about pending and potential legal or other governmental or regulatory proceedings;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding the timing and impact of clinical research work and regulatory approvals for certain products or indications, including On-X, aortic stent grafts, and BioGlue products, and CryoValve SG pulmonary heart valve if the US Food and Drug Administration reclassifies allograft heart valves as Class III medical devices;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our expectations regarding the impact of, and costs associated with, the conclusion of the PROACT Xa Trial;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs and expectations regarding the utilization of net operating loss carryforwards from our acquisitions of JOTEC, On-X, Hemosphere, Inc., and Cardiogenesis Corporation; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our beliefs about our operating results which may fluctuate significantly on a periodic basis as a result of internal and external factors, including reduced demand for our products, healthcare workforce trends and labor disputes, availability of products, materials, and supplies, strategic actions we take such as acquisitions or divestitures, unanticipated costs and expenses, market reception of our new or improved product offerings, and interest rate and currency fluctuations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Other statements regarding projections of future financial and business performance; anticipated growth and trends in our business and the markets relevant to our business, including as our growth relates to our competitors; the robustness and reliability of our workforce and supply chain; future production capacity and product supply; the availability and benefits of our products in the future; and the expected timing and impact of our strategic initiatives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These and other forward-looking statements reflect the views of management at the time and such statements are originally made based on certain assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions, and expected future developments as well as other factors we believe are appropriate in the circumstances and are subject to a number of risks, uncertainties, estimates, and assumptions. Whether actual results and developments will conform with our expectations and predictions is subject to a number of risks and uncertainties which could cause actual results to differ materially and adversely from our expectations, including, without limitation, in addition to those specified in the text surrounding such statements, the risks described in Part II, Item 1A, &#8220;Risks Factors&#8221; in this Form 10-Q and elsewhere throughout this report, the risks described in our other filings with the Securities and Exchange Commission including the risks described in Part I, Item 1A, &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 and elsewhere throughout that report, and other risks which we may not be able to identify in advance, many of which are beyond our control. Consequently, all of the forward-looking statements made in this Form 10-Q are qualified by these cautionary statements, and there can be no assurance that the actual results or developments anticipated by us will be realized or, even if substantially realized, that they will have the expected consequences to, or effects on, us or our business or operations. We assume no obligation, and expressly disclaim any duty, to update publicly any such forward-looking statements, whether as a result of new information, future events, or otherwise. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I - FINANCIAL INFORMATION </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_82"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Artivion, Inc. (&#8220;Artivion,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;), is a leader in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. We have four major product families: aortic stent grafts, surgical sealants, On-X</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, and E-vita Thoracic 3G products. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Surgical sealants include BioGlue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Surgical Adhesive (&#8220;BioGlue&#8221;) products. In addition to these four major product families, we sell or distribute PhotoFix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> bovine surgical patches and CardioGenesis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> cardiac laser therapy. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported quarterly revenues of $83.2 million for the three months ended March&#160;31, 2023, an 8% increase from the three months ended March&#160;31, 2022. The increase in revenues for the three months ended March 31, 2023 was due to an increase in revenues from On-X products, preservation services, surgical sealants, and aortic stent grafts, partially offset by a decrease in revenues from other products. Constant currency revenues, as defined below, increased 10% for the three months ended March 31, 2023, as compared to the three months ended March&#160;31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the &#8220;Results of Operations&#8221; section below for additional analysis of the three months ended March&#160;31, 2023.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_577"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the corresponding measures under generally accepted accounting principles ("US GAAP"), management uses non-GAAP measures in reviewing and disclosing our financial results. The foreign exchange neutral revenues ("constant currency revenues&#8221;) discussed below are non-GAAP financial measures and are not in accordance with, or an alternative to, measures prepared in accordance with US GAAP. Accordingly, the constant currency information appearing in the following discussion of our results of operations should be read in conjunction with the information provided in "Non-GAAP Measures of Financial Performance" below, which includes a reconciliation of constant currency financial measures to the most directly comparable US GAAP measure. </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_88"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Effects of COVID-19 and Macroeconomic Uncertainties</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has continued to have wide-ranging and unpredictable impacts on global economic conditions, our operations, and our financial results. The effects of the pandemic may continue to adversely impact aspects of our business and the global markets, including our workforce, supply chain, and operations, and the workforce and operations of our customers, suppliers, and business partners. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the global healthcare system continues to recover from challenges resulting from the COVID-19 pandemic, we continue to observe impacts on procedural volumes from staffing shortages due to workforce trends, worker availability, and more recently, shortages related to healthcare labor disputes in some markets. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has also impacted certain aspects of the global supply chain and resulted in supply chain inflation. Although we have yet to experience material effects on our supply chain or operations, we face an increasing risk that upstream disruptions may occur or worsen.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As global economies continue to recover from the COVID-19 downturn, increased opportunities for remote work and competitive labor markets at all levels have resulted in turnover and retention challenges that have impacted our workforce and the workforces of our customers and business partners.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Macroeconomic factors, both originating from the pandemic and otherwise, continue to have an impact on our business and operations. Global geopolitical conditions, including the conflict between Russia and Ukraine, and global economic challenges and inflationary pressures have increased prices, placed pressure on worldwide financial and credit markets, and strained the global supply chain.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which our operations and financial performance will be impacted by the pandemic and macroeconomic uncertainties during fiscal year 2023 and beyond, will depend largely on future developments, including changes in hospital utilization rates and staffing, the resilience of the global supply chain, and macroeconomic trends. The significant uncertainty related to the pandemic and macroeconomic conditions could have a material impact on our financial conditions, profitability, cash flows, and results and operations.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_91"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Accounting Pronouncements</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 of &#8220;Notes to Condensed Consolidated Financial Statements&#8221; identified in Part I, Item I of this form 10-Q for further discussion of new accounting standards that have been adopted. </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_97"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Tables in thousands, except percentages)</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.324%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.932%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues for the<br/>Three Months Ended<br/>March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Percent<br/>Change<br/>From Prior<br/>Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues as a Percentage of<br/>Total Revenues for the<br/>Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26,150</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25,506</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">32%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">33%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,656</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14,371</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">23%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,703</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15,681</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,782</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,984</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">-10%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">62,291</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">57,542</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">8%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">75%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">75%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,938</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,671</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">83,229</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">77,213</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">100%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">100%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues increased 8% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase in revenues for the three months ended March 31, 2023 was due to an increase in revenues from On-X products, preservation services, surgical sealants, and aortic stent grafts, partially offset by a decrease in revenues from other products. Revenues for the three months ended March 31, 2022 were negatively impacted in certain regions by delays or cancellations of some surgical procedures as a result of reduced hospital capacity and staffing and hospital restrictions due to the COVID-19 pandemic and local labor disputes. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles revenues to constant currency revenues for the periods presented:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.086%"></td><td style="width:0.1%"></td></tr><tr style="height:36pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues for the<br/>Three Months Ended<br/>March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Percent Change From Prior Year </span></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US GAAP</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">US GAAP</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exchange rate effect</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant Currency</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Constant Currency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26,150</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25,506</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,238)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24,268</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,656</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14,371</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14,225</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,703</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15,681</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(286)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15,395</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">8%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,782</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,984</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,969</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">-9%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">62,291</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">57,542</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(1,685)</span></td><td colspan="3" style="padding:0 1.25pt 0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">55,857</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">12%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,938</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,671</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,636</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">83,229</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">77,213</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1.25pt 0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(1,720)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1.25pt 0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">75,493</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Constant currency revenues increased 10% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. See "Non-GAAP Measures of Financial Performance" below for further background on our non-GAAP measures. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A detailed discussion of the changes in product revenues and preservation services revenues for the three months ended March 31, 2023 is presented below. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues from products increased 8% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase for the three months ended March 31, 2023 was due to an increase in revenues from On-X products, surgical sealants, and aortic stent grafts, partially offset by a decrease in revenues from other products. Constant currency revenues from products increased 12% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. A discussion of the changes in product revenues for aortic stent grafts, On-X products, surgical sealants, and other product revenues is presented below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Sales of certain products through our direct sales force and distributors across Europe and various other countries are denominated in a variety of currencies including Euros, British Pounds, Polish Zlotys, Swiss Francs, Brazilian Reals, and Canadian Dollars, with a concentration denominated in Euros. Each currency is subject to exchange rate fluctuations. For the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, the US Dollar strengthened in comparison to major currencies, resulting in revenue decreases when these foreign currency denominated transactions were translated into US Dollars. Future changes in these exchange rates could have a material, adverse effect on our revenues denominated in these currencies. Additionally, our sales to many distributors around the world are denominated in US Dollars, and although these sales are not directly impacted by currency exchange rates, we believe that some of our distributors may delay or reduce purchases of products in US Dollars depending on the relative price of these goods in their local currencies.  </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aortic Stent Grafts</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, synthetic vascular grafts, and original equipment manufacturing (&#8220;OEM&#8221;) aortic stent graft products. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, and E-vita Thoracic 3G products. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Aortic stent grafts are used in endovascular and open vascular surgery for the treatment of complex aortic arch, thoracic, and abdominal aortic diseases. Our aortic stent grafts are primarily distributed in international markets. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues from aortic stent grafts increased 3% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. This increase was primarily due to an increase in average sales prices, which increased revenues by 5%, and a change in the mix and an increase in units sold, which increased revenues by 3%, partially offset by the effect of foreign exchange rates, which decreased revenues by 5%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Constant currency revenues from aortic stent grafts increased 8% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase in revenues was partially due to improved conditions from the COVID-19 pandemic for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. Revenues for the three months ended March 31, 2023 increased primarily in Europe, the Middle East, and Africa (collectively, &#8220;EMEA&#8221;).  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The revenue increase in EMEA for the three months ended March 31, 2023 was primarily due to buying patterns in direct (to hospitals) and indirect (through distributor) markets. OEM sales of aortic stent grafts accounted for less than 1% of product revenues for the three months ended March 31, 2023 and 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">On-X</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The On-X products include the On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis (&#8220;AAP&#8221;) for heart valve replacement. On-X product revenues also include revenues from the distribution of CarbonAid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:1.41pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> diffusion catheters and from the sale of Chord-X</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ePTFE sutures for mitral chordal replacement. On-X also generates revenue from pyrolytic carbon coating services for OEM customers. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On-X product revenues increased 23% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. This increase was primarily due to an increase in volume of units sold, which increased revenues by 15%, and an increase in average sales prices, which increased revenues by 9%, partially offset by the effect of foreign exchange rates, which decreased revenues by 1%. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Constant currency On-X product revenues increased 24% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase in revenues for the three months ended March 31, 2023 was due to revenue increases in all geographies, primarily in North America, Asia Pacific ("APAC"), and EMEA. The revenue increases in these markets were partially due to improved conditions from the COVID-19 pandemic for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase in revenues in North America for the three months ended March 31, 2023 was also impacted by customer buying patterns. The increase in revenues in APAC was also impacted by distributor buying patterns. The increase in revenues in EMEA was also impacted by an increase of shipments in direct markets and indirect markets for the three months ended March 31, 2023. On-X OEM sales accounted for less than 1% of product revenues for both the three months ended March 31, 2023 and 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Surgical Sealants </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Surgical sealants include BioGlue products used as an adjunct to standard methods of achieving hemostasis (such as sutures and staples) in adult patients in open surgical repair of large vessels (such as aorta, femoral, and carotid arteries).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from the sales of surgical sealants increased 7% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. This increase was primarily due to an increase in volume of milliliters sold, which increased revenues by 9%, partially offset by the effect of foreign exchange rates, which decreased revenues by 1%, and a decrease in average sales prices in certain regions, which decreased revenues by 1%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Constant currency revenues from sales of surgical sealants increased 8% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase in revenues for the three months ended March 31, 2023 was primarily due to revenue increases in North America and APAC, partially offset by revenue decreases in EMEA. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Revenues from the sales of surgical sealants increased in North America during the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, primarily due to hospitals resuming more normal operations resulting from reduction of the COVID-19 pandemic restrictions. Revenues were negatively impacted during the three months ended March 31, 2022 due to delays and cancellations of some surgical procedures due to hospital staffing challenges as a result of a new COVID-19 variant. APAC revenues increased for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, primarily due to distributor buying patterns. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">During the three months ended March 31, 2023 revenues from the sales of surgical sealants in EMEA were less than during the three months ended March 31, 2022, primarily due to some customers accelerating orders in the second half of fiscal year 2022 in connection with delays in the renewal of our BioGlue CE Mark.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Domestic revenues from surgical sealants accounted for 51% and 48% of total surgical sealant revenues for the three months ended March 31, 2023 and 2022, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues are comprised of PhotoFix and CardioGenesis cardiac laser therapy product revenues.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenues decreased 10% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The decrease in other revenues for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to a decrease in CardioGenesis cardiac laser therapy product revenues, partially offset by an increase in PhotoFix product revenues. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from our CardioGenesis cardiac laser therapy product line historically consisted primarily of sales of handpieces and, in certain periods, the sale of laser consoles. In February 2023 our supplier of handpieces informed us that it was exiting the business and will no longer be supplying handpieces effective immediately because the sole-source manufacturer of tubing used in the handpiece assembly had gone out of business and a new supplier had yet to be identified and qualified. We are evaluating the impact of this disruption on our business and possible avenues for resumption of supply including the evaluation of alternate suppliers and handpiece manufacturers. We do not expect significant revenues from the CardioGenesis cardiac laser therapy product line until we qualify and obtain approval for a new handpiece manufacturing source.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preservation Services</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preservation services include service revenues from processing cardiac and vascular tissues. Our cardiac valves are primarily used in cardiac replacement and reconstruction surgeries, including the Ross procedure, for patients with endocarditis or congenital heart defects. The majority of our vascular preservation services revenues are related to shipments of saphenous veins, which are mainly used in peripheral vascular reconstruction surgeries to avoid limb amputations. Competition with synthetic product alternatives and the availability of tissues for processing are key factors affecting revenue volume that can fluctuate from quarter to quarter. Our cardiac and vascular tissues are primarily distributed in domestic markets. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate modifications to our tissue processing procedures in an effort to improve tissue processing throughput, reduce costs, and maintain quality across our tissue processing business. Preservation services revenues, particularly revenues for certain high-demand cardiac tissues, can vary from quarter-to-quarter and year-to-year due to a variety of factors, including quantity and type of incoming tissues, yields of tissue through the preservation process, timing of receipt of donor information, timing of the release of tissues for implant, demand for certain tissue types due to the number and type of procedures being performed, and pressures from competing products or services. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from tissue processing increased 6% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase in revenues for the three months ended March 31, 2023 was primarily due to a change in the mix of tissues shipped, which increased revenues by 3%, and an increase in average sales prices, which increased revenues by 3%. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in revenues from tissue processing for the three months ended March 31, 2023 was primarily due to an increase in medical procedures that utilize our cardiac tissues. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_100"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Products and Preservation Services</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cost of products</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,533&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products increased 12% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. Cost of products for the three months ended March 31, 2023 and 2022 included costs related to aortic stent grafts, On-X products, surgical sealants, and other products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in cost of products for the three months ended March 31, 2023 was primarily due to an increase in shipments of On-X products and surgical sealants as well as an increase in the cost of aortic stent grafts and On-X products, as compared to the three months ended March 31, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Preservation Services</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Cost of preservation services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,969</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,086</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of preservation services increased 10% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. Cost of preservation services included costs for cardiac and vascular tissue preservation services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The increase in cost of preservation services for the three months ended March 31, 2023 was primarily due to an increase in shipments of cardiac tissues, and, to a lesser extent, due to an increase in processing cost of vascular tissues, as compared to the three months ended March 31, 2022. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Gross Margin</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Gross margin</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53,727</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">50,719</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Gross margin as a percentage of total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">65%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">66%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin increased 6% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, was primarily due to an increase in shipments of surgical sealants, certain aortic stent grafts, and On-X products and an increase in average sales prices of aortic stent grafts and On-X products. The increase in gross margin was partially offset by the effect of foreign exchange rates and an increase in product costs of aortic stent grafts and On-X products.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin as a percentage of total revenues decreased for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022, primarily due to an increase in product costs of certain products sold resulting from inflationary pressures of materials and labor, partially offset by favorable pricing of certain products during the three months ended March 31, 2023.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">27</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_103"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General, Administrative, and Marketing Expenses</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">General, administrative, and marketing expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">50,365</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">38,955</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">General, administrative, and marketing expenses as a percentage of total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">61%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">50%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General, administrative, and marketing expenses increased 29% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. The increase in General, administrative, and marketing expenses for the three months ended March 31, 2023 was primarily due to an increase in business development expense, personnel-related, and marketing costs. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General, administrative, and marketing expenses included $5.0 million of business development expense for the three months ended March 31, 2023, as compared to $1.6 million of income for the three months ended March 31, 2022. We incurred $4.8 million of business development expense during the three months ended March 31, 2023, related to the fair value adjustments for the Ascyrus contingent consideration, as compared to $1.8 million of business development income during the three months ended March 31, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Research and development expenses</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7,223</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,128</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Research and development expenses as a percentage of total revenues</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">13%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses decreased 29% for the three months ended March 31, 2023, as compared to the three months ended March 31, 2022. Research and development spending for the three months ended March 31, 2023 was primarily focused on clinical work to gain regulatory approvals for certain aortic stent grafts, On-X, and PerClot products. </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_109"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense was $6.1 million and $3.9 million for the three months ended March 31, 2023 and 2022, respectively. Interest expense for the three months ended March 31, 2023 and 2022 relates to interest on debt and uncertain tax positions. The increase in interest expense for the three months ended March&#160;31, 2023, as compared to the three months ended March&#160;31, 2022, was primarily due to an increase in the interest rate on our term loan. </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_112"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other (Income) Expense, Net</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (income) expense, net was $1.0 million of income and $133,000 of expense for the three months ended March 31, 2023 and 2022, respectively. Other (income) expense, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net primarily includes the realized and unrealized effects of foreign currency gains and losses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Earnings </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Table in thousands, except per share data) </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Loss before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(8,919)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,429)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Income tax expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,532)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(3,389)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted loss per common share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.33)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.08)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted weighted-average common shares outstanding</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,432</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,850</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We experienced a loss before income taxes for the three months ended March&#160;31, 2023 and 2022. The loss before income taxes for the three months ended March&#160;31, 2023 was impacted by an increase in certain operating expenses to support revenue expansion, an increase in interest expense, and the change in fair value of our financial instruments. The loss before income taxes for the three months ended March&#160;31, 2022 was impacted by an increase in operating expenses to support revenue expansion and an increase in research, development, and clinical expenses. Revenues for the three months ended March&#160;31, 2022 were also unfavorably impacted by delays or cancellations of some surgical procedures as a result of reduced hospital capacity and staffing and hospital restrictions due in part to the COVID-19 pandemic in certain regions. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was an expense of 52% and 40% for the three months ended March&#160;31, 2023 and 2022, respectively. The change in the tax rate for the three months ended March&#160;31, 2023 was primarily due to changes in pre-tax book income, a decrease in the excess tax benefit related to stock compensation, and an increase in the estimated current year valuation allowance, as compared to the three months ended March&#160;31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our income tax rate for the three months ended March&#160;31, 2023 and 2022 was primarily impacted by changes in our valuation allowance against our net deferred tax assets, non-deductible executive compensation, the foreign derived intangible income deduction, the research and development tax credit, changes in our uncertain tax position liabilities, and tax shortfalls on stock compensation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We experienced net loss and diluted loss per common share for the three months ended March&#160;31, 2023 and 2022. Net loss and diluted loss per common share for the three months ended March&#160;31, 2023 was primarily due to loss before income taxes, as discussed above. </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_3298534883931"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Measures of Financial Performance</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">To supplement our Condensed Consolidated Financial Statements presented in accordance with US GAAP, we use constant currency revenues, which is a non-GAAP financial measure.  We define constant currency revenues as revenues minus the exchange rate effect. We define exchange rate effect as the year-over-year impact of foreign currency movements using current period foreign currency rates applied to prior period transactional currency amounts.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are providing non-GAAP financial measures in this report as we believe that these figures are helpful in allowing management and investors to more accurately assess the ongoing nature of our operations and measure our performance more consistently across periods. Management uses constant currency revenues internally to assess the operational performance of the Company, as a component in compensation metrics, and as a basis for strategic planning.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the provided non-GAAP measures are meaningful in addition to the information contained in the US GAAP presentation of financial performance. Investors should consider this non-GAAP information in addition to, and not as a substitute for, financial measures prepared in accordance with US GAAP. In addition, this non-GAAP financial information may not be the same as similar measures presented by other companies. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">29</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of the uncertainty and other impacts of the COVID-19 pandemic and the resulting shifts of timing in some revenue, our historically observable seasonality of revenues has been impacted or obscured in 2022 and 2023 and potentially beyond.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we believe the demand for most of our aortic stent grafts is seasonal, with a decline in demand generally occurring in the third quarter due to the summer holiday season in Europe. We are uncertain whether the demand for AMDS and NEXUS products is seasonal, as these products have not fully penetrated many markets and, therefore, the nature of any seasonal trends may not yet be obvious.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we believe the demand for BioGlue and On-X products is seasonal, with a decline in demand generally occurring in the third quarter followed by stronger demand in the fourth quarter. We believe that this trend may be due to the summer holiday season in Europe and the US.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe the demand for our other products is seasonal.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for our cardiac preservation services has traditionally been seasonal, with peak demand generally occurring in the third quarter. We believe this trend for cardiac preservation services is primarily due to the high number of surgeries scheduled during the summer months for school-aged patients. Based on experience in recent years, we believe that this trend is lessening as we are distributing a higher percentage of our tissues for use in adult populations. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Demand for our vascular preservation services has also traditionally been seasonal, with lowest demand generally occurring in the fourth quarter. We believe this trend for vascular preservation services was primarily due to fewer vascular surgeries being scheduled during the winter holiday months.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_121"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Working Capital</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 net working capital (current assets of $240.7 million less current liabilities of $44.0 million) was $196.7 million, with a current ratio (current assets divided by current liabilities) of 5 to 1, as compared to net working capital of $197.6 million and a current ratio of 5 to 1 at December&#160;31, 2022. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overall Liquidity and Capital Resources</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary cash requirements for the three months ended March 31, 2023 were for general working capital needs, interest and principal payments under our Credit Agreement (defined below), interest payments under our Convertible Senior Notes (defined below), capital expenditures for facilities and equipment, and repurchases of stock to cover tax withholdings. We funded our cash requirements through our existing cash reserves and proceeds from stock option exercises.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash from operations and existing cash and cash equivalents will enable us to meet our current operational liquidity needs for at least the next twelve months. Our future cash requirements are expected to include interest and principal payments under our Credit Agreement and Convertible Senior Notes (described in &#8220;Significant Sources and Uses of Liquidity&#8221; section below), expenditures for clinical trials, research and development expenditures, general working capital needs, capital expenditures, and other corporate purposes and may include cash to fund business development activities including obligations in the agreements related to the Endospan and Ascyrus transactions. These items may have a significant effect on our future cash flows during the next twelve months. Subject to the terms of our Credit Agreement, we may seek additional borrowing capacity or financing, pursuant to our current or any future shelf registration statement, for general corporate purposes or to fund other future cash requirements. If we undertake any further significant business development activity, we may need to finance such activities by obtaining additional debt financing or using a registration statement to sell equity securities. There can be no assurance that we will be able to obtain any additional debt or equity financing at the time needed or that such financing will be available on terms that are favorable or acceptable to us. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Sources and Uses of Liquidity</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2017 we entered into a credit and guaranty agreement for a $255.0 million senior secured credit facility, consisting of a $225.0 million secured term loan facility (the &#8220;Term Loan Facility&#8221;) and a $30.0 million secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221; and, together with the Term Loan Facility, the &#8220;Credit Agreement&#8221;). We and each of our existing domestic subsidiaries (subject to certain exceptions and exclusions) guarantee the obligations under the Credit Agreement (the &#8220;Guarantors&#8221;). The Credit Agreement is secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of us and the Guarantors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 2, 2021 we entered into an amendment to our Credit Agreement to extend the maturity dates of both our Term Loan and Revolving Credit Facility. As part of the amendment, the maturity dates of both our Term Loan and Revolving Credit Facility were each extended by two and one-half years, until June 1, 2027 and June 1, 2025, respectively, subject to earlier springing maturities triggered if our 4.25% Convertible Senior Notes, described below, remain outstanding on April 1, 2025 and December 31, 2024, respectively. With respect to the Term Loan, if the Convertible Senior Notes remain outstanding on April 1, 2025, the Term Loan&#8217;s Maturity Date will be April 1, 2025, or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) 91 days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2027. In the case of the Revolving Credit Facility, if the Convertible Senior Notes are still outstanding on December 31, 2024, the Revolving Credit Facility&#8217;s Maturity Date will be either December 31, 2024 or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) 182 days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2025. Under the amendment, the Term Loan Facility bears interest, at our option, at a floating annual rate equal to either the base rate, plus a margin of 2.50%, or LIBOR, plus a margin of 3.50%. Prior to the amendment, the optional floating annual rate was equal to either the base rate plus a margin of 2.25%, or LIBOR, plus a margin of 3.25%.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2022 in accordance with adopting ASU 2020-04 and 2021-01, we entered into an amendment to our Credit Agreement to replace the LIBOR based benchmark interest rate with the SOFR based benchmark interest rate for our Term Loan Facility and our Revolving Credit Facility. Based on historical analysis of the differences between the benchmark rates, SOFR is adjusted to arrive at a Term SOFR rate that serves as the replacement base rate for LIBOR under our amended credit facilities. Under this amendment, at the maturity of our existing LIBOR-based loan on December 30, 2022, the interest rate at the repricing of our Term Loan Facility was calculated as Term SOFR plus a fixed percentage credit spread of 3.50%. The loan under the Revolving Credit Facility bears interest at Term SOFR plus a margin of between 4.00% and 4.25%, depending on our consolidated leverage ratio. As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023 </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the aggregate interest rate of the Credit Agreement was 8.66% per annum.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 18, 2020 we issued $100.0 million aggregate principal amount of 4.25% Convertible Senior Notes with a maturity date of July 1, 2025 (the &#8220;Convertible Senior Notes&#8221;). The net proceeds from this offering, after deducting initial purchasers&#8217; discounts and costs directly related to this offering, were approximately $96.5 million. On January 1, 2021 we adopted ASU 2020-06 and adjusted the carrying balance of the Convertible Senior Notes to notional. The Convertible Senior Notes balance was $100.0 million recorded in Long-term debt on the Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022. The Convertible Senior Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The initial conversion rate of the Convertible Senior Notes is 42.6203 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $23.46 per share, subject to adjustments. We use the if-converted method for assumed conversion of the Convertible Senior Notes for the diluted earnings per share calculation. The fair value and the effective interest rate of the Convertible Senior Notes as of March&#160;31, 2023 was approximately $90.7 million and 5.05%, respectively. The fair value was based on market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest expense recognized on the Convertible Senior Notes includes $1.2 million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March&#160;31, 2023</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2022 related to the aggregate of the contractual coupon interest and the amortization of the debt issuance costs</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest on the Convertible Senior Notes began accruing upon issuance and is payable semi-annually. There were $1.7 million and $1.9 million of unamortized debt issuance costs related to Convertible Senior Notes as of March&#160;31, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Convertible Senior Notes may convert their notes at their option at any time prior to January 1, 2025 but only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (iii) we give a notice of redemption with respect to any or all of the notes, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after January 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot redeem the Convertible Senior Notes before July 5, 2023. We can redeem them on or after July 5, 2023, in whole or in part, at our option, if the last reported sale price per share of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. We may redeem for cash all or part of the Convertible Senior Notes at a redemption price equal to 100% of the principal amount of the redeemable Convertible Senior Notes, plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the Convertible Senior Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the Convertible Senior Notes do not contain any financial covenants and do not restrict us from conducting significant restructuring transactions or issuing or repurchasing any of its other securities.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 approximately 60% of our cash and cash equivalents were held in foreign jurisdictions.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes cash flows from operating activities, investing activities, and financing activities for the periods indicated (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Cash flows (used in) provided by:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(6,154)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(598)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,708)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(235)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(61)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Decrease in cash and cash equivalents</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(8,578)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(3,602)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Operating Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $6.2 million and $598,000 for the three months ended March 31, 2023 and 2022, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the indirect method to prepare our cash flow statement and, accordingly, the operating cash flows are based on our net income, which is then adjusted to remove non-cash items, items classified as investing and financing cash flows, and changes in operating assets and liabilities from the prior year end. For the three months ended March 31, 2023 these non-cash items primarily included $5.7 million of depreciation and amortization expenses, $4.8 million of fair value adjustments of financial instruments, $3.3 million of non-cash compensation, $2.2 million of deferred income tax changes, and $1.8 million of lease expenses.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our working capital needs, or changes in operating assets and liabilities, also affected cash from operations. For the three months ended March 31, 2023 these included $6.3 million due to timing differences between the recording of accounts payable, accrued expenses, and other liabilities and the payment of cash, $3.2 million due to an increase in inventory balances and deferred preservation costs, and $2.0 million due to an increase in prepaid expenses and other assets, partially offset by the favorable effect of $3.5 million due to the timing differences between recording receivables and the receipt of cash. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Investing Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $2.8 million and $2.7 million for the three months ended March 31, 2023 and 2022, respectively. During the three months ended March 31, 2023 cash used in investing activities primarily included $2.2 million of cash used for capital expenditures. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Flows from Financing Activities</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities was $1.2 million for the three months ended March 31, 2023. Net cash used in financing activities was $235,000 for the three months ended March 31, 2022. The current year cash provided by financing activities was primarily due to $2.6 million of proceeds from the exercise of stock options and issuances of common stock, partially offset by $690,000 for the repayment of debt and $590,000 for repurchases of common stock to cover tax withholdings.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_124"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Scheduled Contractual Obligations and Future Payments</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term debt obligations and interest payments include $314.1 million of scheduled principal payments and $85.9 million in anticipated interest payments related to our Credit Agreement, Convertible Senior Notes, and other governmental loans. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have contingent payment obligations that include up to $100.0 million to be paid to the former shareholders of Ascyrus, upon the achievement of certain milestones. Assuming compliance with other requirements under the Endospan loan agreement, during the second quarter of 2023, we anticipate making a $5.0 million third tranche Endospan loan agreement payment, as Endospan has achieved certain clinical trial milestones. As part of the transaction with Baxter, we may be required to pay up to $7.5 million if certain milestones are met. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating and finance lease obligations result from the lease of land and buildings that comprise our corporate headquarters and our various manufacturing facilities; leases related to additional manufacturing, office, and warehouse space; leases on company vehicles; and leases on a variety of office and other equipment. </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_127"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Capital Expenditures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capital expenditures were $2.2 million for the three months ended March 31, 2023 and 2022. Capital expenditures for the three months ended March 31, 2023 were primarily related to routine purchases of leasehold improvements, manufacturing and tissue processing equipment, computer software needed to support our business, and computer equipment.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_130"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks and Uncertainties </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the &#8220;Risk Factors&#8221; identified in Part II, Item 1A of this Form 10-Q.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_133"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our interest income and interest expense are sensitive to changes in the general level of US interest rates. In this regard, changes in US interest rates affect the interest earned on our cash and cash equivalents of $30.8 million as of March&#160;31, 2023 and interest paid on the outstanding balances, if any, of our variable rate Revolving Credit Facility, Term Loan Facility, and Convertible Senior Notes. A 10% adverse change in interest rates, as compared to the rates experienced by us for the three months ended March 31, 2023, affecting our cash and cash equivalents, Term Loan Facility, Revolving Credit Facility, and Convertible Senior Notes would not have a material effect on our financial position, results of operations, or cash flows. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Rate Risk</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have balances, such as cash, accounts receivable, accounts payable, and accruals that are denominated in foreign currencies. These foreign currency denominated balances are sensitive to changes in exchange rates. In this regard, changes in exchange rates could cause a change in the US Dollar equivalent of cash or funds that we will receive in payment for assets or that we would have to pay to settle liabilities. As a result, we could be required to record these changes as gains or losses on foreign currency translation. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have revenues and expenses that are denominated in foreign currencies. Specifically, a portion of our international revenues from aortic stent grafts, surgical sealants, On-X, and other products are denominated in Euros, British Pounds, Swiss Francs, Polish Zlotys, Canadian Dollars, and Brazilian Reals and a portion of our General, administrative, and marketing expenses are denominated in Euros, British Pounds, Swiss Francs, Polish Zlotys, Canadian Dollars, Brazilian Reals, and Singapore Dollars. These foreign currency transactions are sensitive to changes in exchange rates. In this regard, changes in exchange rates could cause a change in the US Dollar equivalent of net income from transactions conducted in other currencies. As a result, we could recognize a reduction in revenues or an increase in expenses related to a change in exchange rates. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An additional 10% adverse change in exchange rates from the exchange rates in effect on March&#160;31, 2023 affecting our balances denominated in foreign currencies could impact our financial position or cash flows by approximately $7.0 million. An additional 10% adverse change in exchange rates from the weighted-average exchange rates experienced by us for the three months ended March 31, 2023 affecting our revenue and expense transactions denominated in foreign currencies would not have had a material impact on our financial position, profitability, or cash flows. </span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_136"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (&#8220;Disclosure Controls&#8221;) as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act. These Disclosure Controls are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission&#8217;s rules and forms and that such information is accumulated and communicated to management, including to the Chief Executive Officer (&#8220;CEO&#8221;) and Chief Financial Officer (&#8220;CFO&#8221;), as appropriate, to allow timely decisions regarding required disclosures.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our President and CEO and our Executive Vice President of Finance and CFO, does not expect that our Disclosure Controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. The design of any system of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our stated goals under all potential future conditions. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within Artivion have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Our Disclosure Controls have been designed to provide reasonable assurance of achieving their objectives.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management utilizes the criteria set forth in &#8220;Internal Control-Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission to evaluate the effectiveness of our Disclosure Controls over financial reporting. Based upon the most recent Disclosure Controls evaluation conducted by management with the participation of the CEO and CFO, as of March&#160;31, 2023 the CEO and CFO have concluded that our Disclosure Controls were effective at a reasonable assurance level to satisfy their objectives and to ensure that the information required to be disclosed by us in our periodic reports is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding disclosure and is recorded, processed, summarized, and reported within the time periods specified in the US Securities and Exchange Commission&#8217;s rules and forms.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes to Disclosure Controls and Procedures</span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal controls over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the three months ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">35</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_139"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II &#8211; OTHER INFORMATION</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_142"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in legal proceedings concerning matters arising from the conduct of our business activities. We regularly evaluate the status of legal proceedings in which we are involved in order to assess whether a loss is probable or whether there is a reasonable possibility that a loss or additional loss may have been incurred and to determine if accruals are appropriate. We further evaluate each legal proceeding to assess whether an estimate of possible loss or range of loss can be made.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on current knowledge, we do not believe that there are any pending matters that could potentially have a material, adverse effect on our business, financial condition, results of operations, or cash flows. We are, however, engaged in various legal actions in the normal course of business. There can be no assurances in light of the inherent uncertainties involved in any potential legal proceedings, some of which are beyond our control, and an adverse outcome in any legal proceeding could be material to our results of operations or cash flows for any particular reporting period.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_145"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Business</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business involves a variety of risks and uncertainties, known and unknown, including, among others, the risks discussed below. These risks should be carefully considered together with the other information provided in this Quarterly Report on Form 10-Q and in our other filings with the SEC. Our failure to adequately anticipate or address these risks and uncertainties may have a material, adverse impact on our business, reputation, revenues, financial condition, profitability, and cash flows. Additional risks and uncertainties not presently known or knowable to us, or that we currently believe to be immaterial, may also adversely affect our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business and Economic Risks</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19, and similar public health crises, could have a material, adverse impact on us. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in early 2020, businesses, communities, and governments worldwide have taken, and continue to take, a wide range of actions to mitigate the spread and impact of COVID-19, leading to an unprecedented impact on the global economy. We continue to be subject to risks related to the COVID-19 pandemic and its impact on broader macroeconomic trends, and risks that may result from future pandemics, epidemics, or other public health crises. The nature and extent of these risks are uncertain and may vary greatly by region, but COVID-19 and similar public health crises have impacted and can impact:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our workforce. The COVID-19 pandemic impacted workforces worldwide as employers faced worker shortages, increased pressure for remote work opportunities, increased compensation pressure, and an unprecedented war for talent and turnover at all levels as a result.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business operations. The COVID-19 pandemic resulted in constraints on healthcare system capacity, shortages in healthcare staffing, and restrictions on travel and non-critical hospital access, all of which have had and may continue to have an impact on our business operations and sales, particularly through reductions in demand for certain products and services due to reduced procedure volumes. We have also observed downstream financial effects from the pandemic, including an increase in delays or difficulty in collecting outstanding receivables, particularly with governmental payors in regions heavily impacted by COVID-19 and the related macroeconomic fallout. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our manufacturing operations. The COVID-19 pandemic and the related macroeconomic fallout has continued to impact the global supply chain; the impact on workforces, material availability, demand, and costs has reportedly continued or worsened in many cases. Although we have yet to experience any material effects on our supply chain, we have faced increasing costs and face an increasing risk that upstream disruptions may occur. Risks relating to the lingering effects of global supply chain disruptions may continue even after COVID-19&#8217;s risk as a global pandemic has subsided.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our research and development pipeline. The COVID-19 pandemic impacted our R&amp;D pipeline, including by impacting the timelines for our R&amp;D and clinical research projects and the timing of and need for spending. Enrollment and timelines for our clinical trials have been, and might continue to be, impacted as healthcare providers re-prioritize resources, address staffing shortages, and limit access to healthcare facilities. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The extent to which COVID-19, its variants, or any future public health crises impact our operations, and extent to which our operations are impacted by the recovery from COVID-19 and its fallout on broader macroeconomic conditions, will depend largely on future developments that are highly uncertain and unpredictable and may vary greatly by region. This impact and any such adverse developments or prolonged periods of uncertainty could adversely affect our financial performance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to a variety of risks due to our international operations and continued global expansion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our international operations subject us to a number of risks, which may vary significantly from the risks we face in our US operations, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Greater difficulties and costs associated with staffing at all levels, establishing and maintaining internal controls, managing foreign operations and distributor relationships, and selling directly to customers;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Broader exposure to corruption and expanded compliance obligations, including under the Foreign Corrupt Practices Act, the UK Bribery Law, local anti-corruption laws, Office of Foreign Asset Control administered sanction programs, the European Union&#8217;s General Data Protection Regulation, and other emerging corruption and data privacy regulations;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Overlapping and potentially conflicting, or unexpected changes in, international legal and regulatory requirements or reimbursement policies and programs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Longer and more expensive collection cycles in certain countries, particularly those in which our primary customers are government-funded hospitals;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in currency exchange rates, particularly fluctuations in the Euro as compared to the US Dollar and inflationary pressures in Latin America;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential adverse financial impact and negative erosion of our operating profit margin over time due to increasing inflationary pressures, particularly impacting our Latin American business as well as impact felt through our supply chain; our exposure may be increased through our limited ability to raise prices and through global expansion where business occurs with, or pricing is set directly by, government entities, or we are party to long term pricing agreements with governments or local distributors, impacting our ability to pass on rising costs;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential adverse tax consequences of overlapping tax structures or potential changes in domestic and international tax policy, laws, and treaties; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential adverse financial and regulatory consequences resulting from Brexit. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As an example of this risk, via a Ministerial Decree of July 6, 2022, published September 15, 2022, the Italian government stated that the spending ceiling for medical devices at the national and regional levels had been exceeded, requiring medical device companies to pay back overpayments the government claims companies received between 2015 and 2018. Currently, Artivion&#8217;s repayment exposure for this period is estimated at approximately &#8364;400,000, which is subject to change as judicial challenges and negotiations between the Company, industry representatives, and the Italian government are ongoing.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance have been, and may continue to be, impacted by regional and global geopolitical conditions, domestic and foreign trade and monetary policies, and other factors beyond our control. As an example of these risks, Russia&#8217;s military attacks on Ukraine have triggered significant sanctions from the US and foreign governments and retaliatory actions from Russia, resulting in significant banking and trade disruptions. The war has also resulted in significant devastation to the people and infrastructure in the region, significantly impacting trade and transportation which may impact our global supply chain, increase prices, and limit our ability to continue to do business in affected regions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, sanctions and other disruptions in the region have not materially impacted our business or ability to supply products to Russia, Belarus, Ukraine, and the region generally; however, continuation or escalation of the war or increased export controls or additional sanctions imposed on or by Russia, its allies, or related entities could adversely affect our financial performance. Although we do not have any direct operations in Russia or Ukraine, it is difficult to predict the ultimate course of the war and we may face business operations and supply chain disruptions as a result, including disruptions related to shortages of materials, higher costs of materials and freight, freight delays, increased energy costs or energy shortages, travel disruptions, currency fluctuation, and disruptions to banking systems or capital markets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We operate in highly competitive market segments, face competition from large, well-established medical device companies and tissue service providers with greater resources and we may not be able to compete effectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for our products and services is competitive and affected by new product introductions and activities of other industry participants. We face intense competition in virtually all of our product lines. A significant percentage of market revenues from competitive products are generated by Baxter, Ethicon (a Johnson &amp; Johnson Company), Medtronic, plc, Abbott Laboratories, Edwards Lifesciences Corp., C.R. Bard, Inc. (a subsidiary of Becton, Dickinson and Company), Integra Life Sciences Holdings, LifeNet, Corcym, Anteris Technologies, Inc., Aziyo Biologics, Cook Medical, Gore &amp; Associates, Terumo, LeMaitre Vascular, Inc., Maquet, Inc., Pfizer, Inc., and BioCer Entwicklungs-GmbH. Several of our competitors enjoy competitive advantages over us, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Greater financial and other resources for research and development, commercialization, acquisitions, and litigation and to weather the impacts of COVID-19 and increased workforce competition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Greater name recognition as well as more recognizable trademarks for products similar to products that we sell; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">More established record of obtaining and maintaining regulatory product clearances or approvals;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">More established relationships with healthcare providers and payors;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Lower cost of goods sold or preservation costs; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Larger direct sales forces and more established distribution networks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are significantly dependent on our revenues from tissue preservation services and are subject to a variety of risks affecting them.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tissue preservation services are a significant source of our revenues, and as such, we face risks if we are unable to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Source sufficient quantities of some human tissue or address potential excess supply of others. We rely primarily upon the efforts of third parties to educate the public and foster a willingness to donate tissue. Factors beyond our control such as supply, regulatory changes, negative publicity concerning methods of tissue recovery or disease transmission from donated tissue, or public opinion of the donor process as well as our own reputation in the industry can negatively impact the supply of tissue;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Achieve necessary price increases to be able to cost reliably process and supply high-demand tissues;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compete effectively, as we may be unable to capitalize on our clinical advantages or our competitors may have advantages over us in terms of cost structure, pricing, back-office automation, marketing, and sourcing; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Mitigate sufficiently the risk that tissue can become contaminated during processing; that processed tissue cannot be end-sterilized and hence carries an inherent risk of infection or disease transmission or that our quality controls can eliminate that risk.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of these risks, in the fourth quarter of 2020 we became aware that a supplier shipped to us a lot of saline solution that we use in our tissue processing that contained some contamination. The contamination was identified by our routine quality controls. While we were able to mitigate the impact of this contamination through our own efforts and additional testing that was reviewed with the FDA, the contaminated solution impacted a small percentage of the tissue processed with this lot of solution, requiring us to write-off approximately $826,000 in contaminated tissues in the fourth quarter of 2020. The written off and temporarily quarantined tissue impacted our ability to fully meet demand for certain tissues and sizes in the fourth quarter of 2020, the first quarter of 2021, and to a lesser extent the second quarter of 2021. See also, Part I, Item 1A, &#8220;Risk Factors&#8212;Operational Risks&#8212; We are dependent on our specialized workforce.&#8221;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, US and foreign governmental authorities have adopted laws and regulations that restrict tissue preservation services. Any of these laws or regulations could change, including becoming more restrictive, or our interpretation of them could be challenged by governmental authorities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are significantly dependent on our revenues from BioGlue and are subject to a variety of related risks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BioGlue is a significant source of our revenues, and as such, any risk adversely affecting our BioGlue products or business would likely be material to our financial results. We face the following risks related to BioGlue:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Competing effectively with our major and start up competitors, as they may have advantages over us in terms of cost structure, supply chain, pricing, sales force footprint, and brand recognition;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be unable to obtain approval to commercialize BioGlue in certain non-US countries as fast as our competitors do of their products or at all. We also may not be able to capitalize on new BioGlue approvals, including for new indications, in non-US countries; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">BioGlue contains a bovine blood protein. Animal-based products are subject to increased scrutiny from the public and regulators, who may seek to impose additional regulations, regulatory hurdles or product bans in certain countries on such products; BioGlue is a mature product and other companies may use the inventions disclosed in expired BioGlue patents to develop and make competing products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As an example of this risk, our BioGlue CE Mark expired in December 2021. Delays in renewing the CE Mark and challenges securing certain related derogations ultimately impacted the availability of BioGlue in certain European markets and other markets reliant on the CE Mark, impacting our revenue from BioGlue in those markets. See also, Part I, Item 1A, &#8220;Risk Factors&#8212;Industry Risks&#8212; Our products and tissues are highly regulated and subject to significant quality and regulatory risks.&#8221; (further discussing the impact of and risks related to the BioGlue CE Mark).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">We are significantly dependent on our revenues from aortic stent grafts and are subject to a variety of related risks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aortic stent grafts are a significant source of our revenues, and as such, any risk adversely affecting aortic stent grafts would likely be material to our financial results. We face risks related to aortic stent grafts based on our ability to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compete effectively with some of our major competitors, as they may have advantages over us in terms of cost structure, supply chain, pricing, sales force footprint, and brand recognition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Develop innovative, high quality, and in-demand aortic repair products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Respond adequately to enhanced regulatory requirements and enforcement activities, and particularly, our ability to obtain regulatory approvals and renewals globally; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Meet demand for aortic stent grafts as we seek to expand our business globally; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Maintain a productive working relationship with our Works Council in Germany.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are significantly dependent on our revenues from On-X products and are subject to a variety of related risks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On-X products are a significant source of our revenues, and as such, any risk adversely affecting our On-X products or business would likely be material to our financial results. We face risks based on our ability to: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compete effectively with some of our major competitors, as they may have advantages over us in terms of cost structure, supply chain, pricing, sales force footprint, and brand recognition;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Take further market share in the mechanical heart valve market based on the FDA&#8217;s approved lower INR indication for the On-X aortic heart valve or complete the associated FDA mandated post-approval studies;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Address clinical trial data or changes in technology that may reduce the demand for mechanical heart valves, such as data regarding transcatheter aortic valve replacement, or &#8220;TAVR&#8221; devices; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Manage risks associated with less favorable contract terms for On-X products on consignment at hospitals; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Respond adequately to enhanced international regulatory requirements or enforcement activities; </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Continued fluctuation of foreign currencies relative to the US Dollar could materially, adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of our foreign product revenues are denominated in Euros and, as such, are sensitive to changes in exchange rates. In addition, a portion of our dollar-denominated and euro-denominated product sales are made to customers in other countries who must convert local currencies into US Dollars or Euros in order to purchase these products. We also have balances, such as cash, accounts receivable, accounts payable, and accruals that are denominated in foreign currencies. These foreign currency transactions and balances are sensitive to changes in exchange rates. Additionally, as a result of global inflationary pressures, and in some cases, currency crises, it is possible that foreign currency controls, the development of parallel exchange rates, or highly inflationary economies could arise in certain countries. Fluctuations in exchange rates of Euros or other local currencies in relation to the US Dollar could materially reduce our future revenues as compared to the comparable prior periods. Should this occur, it could have a material, adverse impact on our revenues, financial condition, profitability, and cash flows. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our charges resulting from acquisitions, restructurings, and integrations may materially, adversely affect the market value of our common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the completion of acquisitions using the purchase method of accounting. Our financial results could be adversely affected by a number of financial adjustments required by purchase accounting such as:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may incur added amortization expense over the estimated useful lives of some acquired intangible assets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may incur additional depreciation expense as a result of recording purchased tangible assets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be required to incur material charges relating to any impairment of goodwill and intangible assets; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Cost of sales may increase temporarily if acquired inventory is recorded at fair market value;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If acquisition consideration consists of earn-outs, our earnings may be affected by changes in estimates of future contingent consideration; or</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Earnings may be affected by transaction and integration costs, which are expensed immediately.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As an example of this risk, in the fourth quarter of 2021, we fully impaired the value of a</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> securities purchase option agreement with Endospan (&#8220;Endospan Option&#8221;) </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">and fully wrote-down the value of an agreement for a secured loan from Artivion to Endospan (&#8220;Endospan Loan&#8221;), primarily driven by a decrease in forecasted operating results. This impairment, and other potential risks like those mentioned above, may adversely affect the market value of our common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Operational Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are heavily dependent on our suppliers and contract manufacturers to provide quality products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The materials and supplies used in our product manufacturing and tissue processing are subject to regulatory requirements and oversight. If materials or supplies used in our processes fail to meet these requirements or are subject to regulatory enforcement action, they may have to be scrapped, or our products or tissues could be rejected during or after processing, recalled, or rejected by customers. In these cases, we may have to immediately scrap raw or in-process materials, or expense the costs of manufacturing or preservation. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of this risk, in the fourth quarter of 2020 we became aware that a supplier shipped to us a lot of saline solution that we use in our tissue processing that contained some contamination. The contamination was identified by our routine quality controls. While we were able to mitigate the impact of this contamination through our own efforts and additional testing that was reviewed with the FDA, the contaminated solution impacted a small percentage of the tissue processed with this lot of solution, requiring us to write-off those contaminated tissues in the fourth quarter of 2020 and impacting our ability to fully meet demand for certain tissues and sizes in the fourth quarter of 2020, the first quarter of 2021, and to a lesser extent the second quarter of 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if these materials or supplies, or changes to them, do not receive regulatory approval or are recalled, if the related suppliers and/or their facilities are shut down temporarily or permanently, for any reason, or if the related suppliers are otherwise unable or unwilling to supply us, we may not have sufficient materials or supplies to manufacture our products or process tissues. In addition, we rely on contract manufacturers to manufacture some of our products or to provide additional manufacturing capacity for some products. If these contract manufacturers fail to meet our quality standards or other requirements or if they are unable or unwilling to supply the products, we may not be able to meet demand for these products. Our ability to fully recover all possible losses from these suppliers and contract manufacturers may have practical limitations imposed by factors like industry standard contractual terms or the financial resources of the adverse party.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, the COVID-19 pandemic, the war in Ukraine, work force shortages, exchange rates, and inflation continue to impact the global supply chain; their impact on workforces, global mobility, material availability, demand, and shipping and reorder times and reliability has reportedly continued or worsened in many cases. The ongoing war in Ukraine may add to or exacerbate challenges faced by the global supply chain. See Part I, Item 1A, &#8220;Risk Factors &#8211; Business and Economic Risks &#8211; We are subject to a variety of risks due to our international operations and continued global expansion.&#8221; Although we have yet to experience any material effects of this impact on our supply chain or operations, we face an increasing risk that upstream disruptions may occur. Risks relating to the lingering effects of global supply chain disruptions may even continue after COVID-19&#8217;s risk as a global pandemic and the war in Ukraine have subsided.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are dependent on single and sole-source suppliers and single facilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the materials, supplies, and services used in our product manufacturing and tissue processing, as well as some of our products, are sourced from single- or sole-source suppliers. As a result, our ability to negotiate favorable terms with those suppliers may be limited, and if those suppliers experience operational, financial, quality, or regulatory difficulties, or if those suppliers and/or their facilities refuse to supply us or cease operations temporarily or permanently, or if those suppliers take unreasonable business positions, we could be forced to cease product manufacturing or tissue processing until the suppliers resume operations, until alternative suppliers could be identified and qualified, or permanently if the suppliers do not resume operations and no alternative suppliers could be identified and qualified. We could also be forced to purchase alternative materials, supplies, or services with unfavorable terms due to diminished bargaining power. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of these risks, in 2019 we lost our supply of handpieces for cardiac laser therapy resulting from a manufacturing location change at our supplier that ultimately required a PMA supplement and FDA approval before handpiece manufacturing and distribution could resume. Even though the FDA approved the PMA-S, our supplier was unable to fully resume production due to factors outside of our control. Due to these and other supplier issues, we had virtually no supply of handpieces during the first three quarters of 2021. In the fourth quarter of 2021 our supplier was notified that their sole-source manufacturer of tubing used in the handpiece assembly had gone out of business, requiring us to work with our supplier to identify and qualify a new supplier before a disruption in handpiece availability occurred. In February 2023 we were notified by our supplier that, because the sole-source manufacturer had gone out of business, and because a new supplier had yet to be identified and qualified, our supplier would cease to supply handpieces, effective immediately, and be disrupted in 2023 and potentially beyond.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By way of additional non-limiting examples, our BioGlue product has three main product components: bovine protein, a cross linker, and a molded plastic resin delivery device. The bovine protein and cross linker are obtained from a small number of qualified suppliers. The delivery devices are manufactured by a single supplier, using resin supplied by a single supplier. We purchase grafts for our On-X AAP from a single supplier and various other components for our On-X valves come from single-source suppliers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our preservation services business and our ability to supply needed tissues is dependent upon donation of tissues from human donors by donor families. Donated human tissue is procured from deceased human donors by OPOs and tissue banks. We must rely on the OPOs and tissue banks that we work with to educate the public on the need for donation, to foster a willingness to donate tissue, to follow our donor screening and procurement procedures, and to send donated tissue to us. We have active relationships with approximately 60 OPOs and tissue banks throughout the US. As with any vendor, we believe these relationships with our OPOs are critical in the preservation services industry and that the breadth of these existing relationships provides us with a significant advantage over potential new entrants to this market. We also use various raw materials, including medicines and solutions, in our tissue processing. Some of these raw materials are manufactured by single suppliers or by a small group of suppliers. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our aortic stent graft systems consist of two main product components: the stent graft and the delivery system. The stent graft is manufactured from several different raw materials that are manufactured internally or at various external suppliers, including single suppliers. The delivery systems we manufacture are comprised of several different raw materials and subassemblies. Our internal manufacturing processes include injection molding and machining of plastic parts, suturing of stent grafts, processing of Nitinol, and weaving of textiles. Our conventional polyester grafts consist of two main product components: polyester fabric and collagen coating. The polyester fabric is woven from a few different yarns that are supplied by an external supplier. The collagen suspension we manufacture is comprised of a collagenous tissue that is supplied by a single supplier. The conventional ePTFE grafts we manufacture are comprised of various raw materials supplied by several suppliers. For some products the ePTFE grafts are heparin coated. For these products, the heparin suspension we manufacture is comprised of a heparin solution that is also supplied by an external supplier. Our E-ventus BX bridging stent is supplied by an external supplier and our supply agreement expired at the end of 2022 with final deliveries occurring in the first half of 2023. Once exhausted, we will no longer have a supply of E-ventus BX bridging stents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have three internal manufacturing facilities: Austin, Texas for On-X products, Hechingen, Germany for internally manufactured aortic stent grafts, and Kennesaw, Georgia for all other products and services. Certain aortic stent graft assemblies are manufactured for us by a contract manufacturer in Slovakia. The AMDS product is solely manufactured by a supplier in Charlotte, North Carolina, and the NEXUS product is solely manufactured by Endospan in Herzliya, Israel. If one of these suppliers or facilities ceases operations temporarily or permanently, for any reason including a pandemic or climate change related event, our business could be substantially disrupted. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we work diligently to maintain adequate inventories of raw materials, components, supplies, subassemblies, and finished goods, there can be no assurance that we will be able to avoid all disruptions to our global supply chain, or disruptions to our sterilization or distribution networks. Any of these disruptions could have a material, adverse effect on our revenues, reputation, or profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are dependent on our specialized workforce.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and future operating results depend in significant part upon the continued contributions of our specialized workforce, including key personnel, qualified personnel with medical device and tissue processing experience, and senior management with experience in the medical device or tissue processing space, some of whom would be difficult to replace. Our business and future operating results, including production at our manufacturing and tissue processing facilities, also depend in significant part on our ability to attract and retain qualified management, operations, processing, marketing, sales, and support personnel. Our primary facilities are in Kennesaw, Georgia; Austin, Texas; and Hechingen, Germany, where the supply of qualified medical device and tissue processing and other personnel is limited, competition for such personnel is significant, and we cannot ensure that we will be successful in attracting or retaining them. We face risks if we lose any key employees to other employers or due to severe illness, death, or retirement, if any of our key employees fail to perform adequately, or if we are unable to attract and retain skilled employees. This risk was exacerbated by the pandemic and continues to be impacted by changes in macroeconomic conditions. Competition or talent and worker shortages at all levels have impacted supply chains and distribution channels and our ability to attract and retain the specialized workforce necessary for our business and operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We continue to evaluate expansion through acquisitions of, or licenses with, investments in, and distribution arrangements with, other companies or technologies, which may carry significant risks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One of our growth strategies is to pursue select acquisitions, licensing, or distribution rights with companies or technologies that complement our existing products, services, and infrastructure. In connection with one or more of these transactions, we may:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Issue additional equity securities that would dilute our stockholders&#8217; ownership interest;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Use cash we may need in the future to operate our business;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Incur debt, including on terms that could be unfavorable to us or debt we might be unable to repay;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Structure the transaction resulting in unfavorable tax consequences, such as a stock purchase that does not permit a step-up in basis for the assets acquired;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Be unable to realize the anticipated benefits of the transaction; or </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Assume material unknown liabilities associated with the acquired business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not realize all the anticipated benefits of our business development activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our efforts to drive growth by pursuing select acquisition, license, and distribution opportunities that are aligned to our objectives and complement our existing products, services, and infrastructure or to divest non-core product lines, we have completed several transactions in recent years and may pursue similar additional transactions in the future. Examples of these activities include the following: </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On December 1, 2017 we acquired JOTEC AG, a Swiss entity that we converted to JOTEC GmbH and subsequently merged with our Swiss acquisition entity, Jolly Buyer Acquisition GmbH and its subsidiaries;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On September 11, 2019 we entered into various agreements with Endospan, an Israeli medical device manufacturer (the &#8220;Endospan Transaction&#8221;). The Endospan Transaction included an exclusive distribution agreement for NEXUS in Europe, the Endospan Loan, and a security purchase option agreement for Artivion to purchase all the outstanding Endospan securities from Endospan&#8217;s existing security holders upon FDA approval of NEXUS;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On September 2, 2020 we acquired 100% of the outstanding shares of Ascyrus, the developer of AMDS; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">On July 28, 2021 we entered into various agreements with Baxter and SMI related to the sale of our PerClot assets to Baxter and the termination of our existing material agreements with SMI.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to realize the anticipated business opportunities, growth prospects, cost savings, synergies, and other benefits of these transactions depends on a number of factors including our ability to:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Leverage our global infrastructure to sell and cross-market the acquired products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Drive adoption of NEXUS and AMDS in the European and other markets, including our ability to manage the substantial product training, implant support, and proctoring requirements for NEXUS procedures;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Bring acquired products to the US market, including our acquired aortic stent grafts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Harness the aortic stent graft product pipeline and our research and development capabilities;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Obtain regulatory approvals in relevant markets, including our ability to timely obtain FDA PMA for PerClot under the terms of the Baxter Transaction and to obtain or maintain CE Mark product certifications for pipeline and current products; </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Execute on development and clinical trial timelines for acquired products;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Manage global inventories, including our ability to manage inventories for product lines with large numbers of product configurations and manage manufacturing and demand cycles to avoid excess inventory obsolescence due to shelf life expiration, particularly for processed tissues and aortic stent grafts;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Carry, service, and manage significant debt and repayment obligations; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Manage the unforeseen risks and uncertainties related to these transactions, including any related to intellectual property rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our ability to realize the anticipated business opportunities, growth prospects, synergies, and other benefits of the Endospan Transaction depends on a number of additional factors including Endospan&#8217;s ability to: (a) comply with the Endospan Loan and other debt obligations, and avoid an event of default; (b) successfully commercialize NEXUS and NEXUS DUO, raise capital and drive adoption in markets in and outside of Europe; (c) meet demand for NEXUS and NEXUS DUO; (d) meet quality and regulatory requirements for NEXUS and NEXUS DUO; (e) manage any intellectual property risks and uncertainties associated with NEXUS and NEXUS DUO; (f) obtain FDA approval of NEXUS and NEXUS DUO; (g) remain a going concern; and (h) develop NEXUS, NEXUS DUO, and other product improvements to meet competitive threats and physician demand. As an example of this risk, the forecasted operating results related to NEXUS decreased in the fourth quarter of 2021, resulting in an impairment to the carrying value of the Endospan Option, and a full write-down of the value of the Endospan Loan, reflecting decreased expectations with respect to the anticipated benefits of the Endospan Transaction. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of these factors are outside of our control and any one of them could result in increased costs, decreased revenues, and diversion of management&#8217;s time and energy. The benefits of these transactions may not be achieved within the anticipated time frame or at all. Any of these factors could negatively impact our earnings per share, decrease or delay the expected accretive effect of the transaction, and negatively impact the price of our common stock. In addition, if we fail to realize the anticipated benefits of a transaction, we could experience an interruption or loss of momentum in our existing business activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not realize all the anticipated benefits of our corporate rebranding and it may result in unanticipated disruptions to our on-going business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to reflect our evolution to focus on providing innovative technologies to surgeons who treat patients with aortic disease, we changed our name to Artivion, Inc., effective January 18, 2022 (the &#8220;Corporate Rebrand&#8221;). The Corporate Rebrand also involved the adoption of a new ticker symbol on the New York Stock Exchange, &#8220;AORT.&#8221; We may face unanticipated disruptions to our business arising from the Corporate Rebrand, and it may expose us to additional risks, including:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Disruptions or unanticipated delays accessing certain markets or segments due to delays or other issues with regulatory approvals, clinical trials, or other updates arising from or related to the Corporate Rebrand;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Confusion within the marketplace, particularly with multiple points of contact in our downstream product flow involving purchasing and accounts payable departments and end users;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Intellectual property risks associated with the adoption of a new corporate identity and trade dress; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss of brand equity associated with our legacy brands, including our CryoLife and JOTEC brands that will become less prominent over time.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Corporate Rebrand involved significant financial and resource investment and will continue to do so as we complete our global brand transitions over the coming years. The anticipated benefits of the Corporate Rebrand may not be achieved within the anticipated timeframe, without additional near or long-term investment, or at all. Any of these factors could negatively impact our revenues, earnings per share, decrease or delay the expected accretive effect of the Corporate Rebrand, and negatively impact the price of our common stock.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant disruptions of information technology systems or breaches of information security systems could adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely upon a combination of sophisticated information technology systems as well as traditional recordkeeping to operate our business. In the ordinary course of business, we collect, store, and transmit confidential information (including, but not limited to, information about our business, financial information, personnel data, intellectual property, and, in some instances, patient data). Our information technology and information security systems and records are potentially vulnerable to security breaches, service interruptions, data loss, or malicious attacks resulting from inadvertent or intentional actions by our employees, vendors, or other third parties. In addition, due to the COVID-19 pandemic, we have implemented remote work arrangements for some employees, and those employees may use outside technology and systems that are vulnerable to security breaches, service interruptions, data loss or malicious attacks, including by third parties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have invested, and continue to invest, in our information technology and information security systems and employee information security training, there can be no assurance that our efforts will prevent all security breaches, service interruptions, or data losses. We have limited cyber-insurance coverage that may not cover all possible events, and this insurance is subject to deductibles and coverage limitations. Any security breaches, service interruptions, or data losses could adversely affect our business operations or result in the loss of critical or sensitive confidential information or intellectual property, or in financial, legal, business, and reputational harm to us or allow third parties to gain material, inside information that they may use to trade in our securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Industry Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our products and tissues are highly regulated and subject to significant quality and regulatory risks.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The commercialization of medical devices and processing and distribution of human tissues are highly complex and subject to significant global quality and regulatory risks and as such, we face the following risks:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our products and tissues allegedly have caused, and may in the future cause, patient injury, which has exposed, and could in the future expose, us to liability claims that could lead to additional regulatory scrutiny;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our manufacturing and tissue processing operations are subject to regulatory scrutiny, inspections and enforcement actions, and regulatory agencies could require us to change or modify our operations or take other action, such as issuing product recalls or holds;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulatory agencies could reclassify, re-evaluate, or suspend our clearances or approvals, or fail, or decline to, issue or reissue our clearances or approvals that are necessary to sell our products and distribute tissues;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Regulatory and quality requirements are subject to change, which could adversely affect our ability to sell our products or distribute tissues; and </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adverse publicity associated with our products, processed tissues, or our industry could lead to a decreased use of our products or tissues, increased regulatory scrutiny, or product or tissue processing liability claims.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an example of these risks, on May 25, 2017, the European Union adopted new regulations governing medical devices (the MDR), which were fully implemented on May 26, 2021. The MDR places stricter requirements on manufacturers and European Notified Bodies regarding, among other things, product classifications and pre- and post-market clinical studies for product clearances and approvals which could result in product reclassifications or the imposition of other regulatory requirements that could delay, impede, or prevent our ability to commercialize existing, improved, or new products in the European Economic Area and other markets that require CE Marking. Additionally, to the extent the MDR places stricter requirements on manufacturers of custom-made devices, those new requirements could delay, impede, or otherwise impact the availability of our E-xtra Design Engineering products. COVID-19 has impacted the predictability and timelines associated with the MDR transition. Most recently, the European Parliament voted to extend the MDR transition period and amend other related provisions but it is still unclear whether this extension will be able to mitigate the challenges posed by the transition to the MDR.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the implementation of the MDR, Notified Bodies must review any proposed changes to determine if they require evaluation under the MDR or if they can still be evaluated under the currently held Medical Device Directive (&#8220;MDD&#8221;) certifications. Our inability to obtain certifications for changes under the transitional provisions of the MDR&#8217;s Article 120 or successfully submit proposed changes requiring MDR evaluation will delay implementation of those changes which could adversely impact our ability to obtain or renew certifications, clearances, or approvals for our products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as MDD-based CE Marks expire, recertification must be obtained under the MDR. Industry-wide, companies are experiencing delays in obtaining new and updated certifications under the MDR as Notified Bodies struggle to recover from COVID-19, deal with depleted workforces, and handle the volume of work required to transition tens of thousands of currently-marketed devices from the MDD to the MDR. As one such example, our MDD-based CE Mark for Chord-X expired in September 2022, which will impact our ability to supply certain territories once our saleable inventory is depleted. If Notified Bodies continue to struggle to meet demand and timely process submissions and recertifications, we may face additional disruptions associated with the MDR transition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As another example of this risk, our CE-mark for BioGlue expired in December 2021. Due to delays renewing this CE-mark and transitioning BioGlue to a new Notified Body, our ability to supply certain markets with BioGlue was impacted. Although we were able to mitigate most of the impact by obtaining derogations in the majority of relevant territories, we may face similar risks and market disruptions related to the MDR transition which continues to be in a state of change.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, we anticipate additional regulatory impact as a result of Brexit. The UK Medicines and Healthcare Products Regulatory Agency has announced that CE Marking will continue to be recognized in the UK and certificates issued by EU-recognized Notified Bodies will continue to be valid in the UK market until June 30, 2023. Thereafter, all devices marketed in the UK will require UK Conformity Assessed Marks certified by a UK Approved Body (the re-designation of the UK Notified Body).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019 our Notified Body in the UK, LRQA, informed us that it would no longer provide Notified Body services for medical devices effective September 2019. The governing German competent authority, the Regierungspraesidium-Tubingen, granted us an extended grace period until December 31, 2021 to transfer LRQA-issued certifications for BioGlue and PhotoFix to a new Notified Body. Although our BioGlue CE Mark has been successfully transferred to our new Notified Body, DEKRA, we are still in the process of transferring PhotoFix to DEKRA. While progress has been made, failure to timely complete the transfer or any other delays in the MDR transition, may have a material, adverse effect on our ability to supply PhotoFix in affected jurisdictions, have a material, adverse impact on our business, and may also impact our MDSAP certifications. Failure to timely obtain new MDSAP certifications following their expiration may impact our ability to distribute covered products in Australia, Brazil, Canada, and Japan.</span><span style="color:#ee2724;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassification by the FDA of CryoValve SG pulmonary heart valve (&#8220;CryoValve SGPV&#8221;) may make it commercially infeasible to continue processing the CryoValve SGPV.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019 we learned that the FDA is preparing to issue a proposed rule for reclassification of more than minimally manipulated ("MMM") allograft heart valves to Class III medical devices, which could include our CryoValve SGPV. Following a comment period and subsequent publication of any final rule, should the CryoValve SGPV be determined to be MMM, we expect to have approximately thirty months to submit an FDA PMA application, after which the FDA will determine if, and for how long, we may continue to provide these tissues to customers during review of the PMA application. To date, the FDA has not issued such a proposed final rule.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the FDA ultimately classifies our CryoValve SGPV as a Class III medical device, and if there are delays in obtaining the PMA, if we are unsuccessful in obtaining the PMA, or if the costs associated with these activities are significant, we could decide that the requirements for continued processing of the CryoValve SGPV are too onerous, leading us to discontinue distribution of these tissues. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may not be successful in obtaining clinical results or regulatory clearances/approvals for new and existing products and services, and our approved products and services may not achieve market acceptance.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth and profitability depends in part upon our ability to develop, and successfully introduce, new products and services, or expand upon existing indications, clearances, and approvals, requiring that we invest significant time and resources to obtain new regulatory clearances/approvals, including investment into pre- and post-market clinical studies. Although we believe certain products and services in our portfolio or under development may be effective in a particular application, we cannot be certain until we successfully execute on relevant clinical trials, and the results we obtain from pre- and post-market clinical studies may be insufficient for us to obtain or maintain any required regulatory approvals or clearances.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently seeking regulatory approval for BioGlue in China, where the Chinese regulatory body has made additional requests, and expressed several concerns, related to the application. We have obtained an extension of time until February 2024 in which to secure approval for BioGlue in China. If we cannot obtain approval by then, or the costs to do so are prohibitive, we ultimately may be unable to sell BioGlue in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As another example of this risk, we obtained a CE Mark for E-nya in the fourth quarter of 2019 and began limited distribution of E-nya in the second quarter of 2020. In the fourth quarter of 2021 we suspended the limited release to evaluate modifications in response to customer feedback. We ultimately concluded the E-nya device would not achieve our market acceptance targets without additional design changes and ended the limited market release.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a further example of this risk, in September 2022 we halted the PROACT Xa clinical trial based on the recommendation of the trial&#8217;s Data and Safety Monitoring Board (&#8220;DSMB&#8221;) due to insufficient evidence to support non-inferiority of apixaban to warfarin for valve thrombosis and thromboembolism. The DSMB found that continuing the trial was unlikely to achieve the primary endpoint while possibly exposing patients to increased risk. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our trials, studies, and approvals is subject to the risks outlined herein.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot give assurance that regulatory agencies will clear or approve these products and services or indications, or any new products and services or new indications, on a timely basis, if ever, or that the products and services or new indications will adequately meet the requirements of the market or achieve market acceptance. Pre- and post-market clinical studies may also be delayed or halted due to many factors beyond our control.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to successfully complete the development of a product, service, or application, or if we determine for any reason not to complete development or obtain regulatory approval or clearance of any product, service, or application, particularly in instances when we have expended significant capital, this could materially, adversely affect our financial performance. Research and development efforts are time consuming and expensive, and we cannot be certain that these efforts will lead to commercially successful products or services. Halting R&amp;D efforts and clinical trials prematurely may lead to accelerated or unanticipated wind down costs. Even the successful commercialization of a new product or service in the medical industry can be characterized by slow growth and high costs associated with marketing, under-utilized production capacity, and continuing research and development and education costs, among other things. The introduction of new products or services may require significant physician training or years of clinical evidence in order to gain acceptance in the medical community.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Regulatory enforcement activities or private litigation regarding the use of ethylene oxide (&#8220;EtO&#8221;), which is used to sterilize some of our products and components, could have a material, adverse impact on us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of our products, including our On-X products, are sterilized using EtO. Although we have a small-scale EtO facility in Austin, Texas, we rely primarily on large-scale EtO facilities to sterilize our products. In addition, some of our suppliers use, or rely upon third parties to use, EtO to sterilize some of our product components. Concerns about the release of EtO into the environment at unsafe levels have led to increased activism and lobbying as well as various regulatory enforcement activities against EtO facilities, including closures and temporary closures, lawsuits against EtO service providers, and proposals increasing regulations related to EtO. The number of EtO facilities in the US is limited, and any permanent or temporary closures or disruption to their operations for any reason could delay, impede, or prevent our ability to commercialize our products. In addition, any regulatory enforcement activities against us for our use of EtO could result in financial, legal, business, and reputational harm to us. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We may be subject to fines, penalties, and other sanctions if we are deemed to be promoting the use of our products for unapproved, or off-label, uses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business and future growth depend on the continued use of our products for approved uses. Generally, regulators contend that, unless our products are approved or cleared by a regulatory body for alternative uses, we may not make claims about the safety or effectiveness of our products or promote them for such uses. Such limitations present a risk that law enforcement could allege that the nature and scope of our sales, marketing, or support activities, though designed to comply with all regulatory requirements, constitute unlawful promotion of our products for an unapproved use. We also face the risk that such authorities might pursue enforcement based on past activities that we discontinued or changed. Investigations concerning the promotion of unapproved uses and related issues are typically expensive, disruptive, and burdensome and generate negative publicity. If our promotional activities are found to be in violation of the law, we may face significant fines and penalties and may be required to substantially change our sales, promotion, grant, and educational activities. In addition, we or our officers could be excluded from participation in government healthcare programs such as Medicare and Medicaid.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Healthcare policy changes may have a material, adverse effect on us.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to perceived increases in healthcare costs in recent years, there have been, and continue to be, proposals by the governmental authorities, third-party payors, and elected office holders and candidates to impact public health, control healthcare costs and, more generally, to reform the healthcare systems. Additional uncertainty is anticipated as debates about healthcare and public health continue in light of the COVID-19 pandemic which may have an impact on US law relating to the healthcare industry. Many US healthcare laws, such as the Affordable Care Act, are complex, subject to change, and dependent on interpretation and enforcement decisions from government agencies with broad discretion. The application of these laws to us, our customers, or the specific services and relationships we have with our customers is not always clear. Our failure to anticipate accurately any changes to, or the repeal or invalidation of all or part of the Affordable Care Act and similar or future laws and regulations, or our failure to comply with them, could create liability for us, result in adverse publicity and negatively affect our business, results of operations, and financial condition. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the growth of our business, results of operations and financial condition rely, in part, on customers in the healthcare industry that receive substantial revenues from governmental and other third-party payer programs. A reduction or less than expected increase in government funding for these programs or a change in reimbursement or allocation methodologies, or a change in reimbursement related to products designated as &#8220;breakthrough devices&#8221; by the FDA, could negatively affect our customers&#8217; businesses and, in turn, negatively impact our business, results of operations and financial condition. Any changes that lower reimbursement for our products or reduce medical procedure volumes, could adversely affect our business and profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Legal, Quality, and Regulatory Risks</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As a medical device manufacturer and tissue services provider we are exposed to risk of product liability claims and our existing insurance coverage may be insufficient, or we may be unable to obtain insurance in the future, to cover any resulting liability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products and processed tissues allegedly have caused, and may in the future cause, injury or result in other serious complications that may result in product or other liability claims from our customers or their patients. If our products are defectively designed, manufactured, or labeled, or contain inadequate warnings, defective components, or are misused, or are used contrary to our warnings, instructions, and approved indications, we may become subject to costly litigation that can have unpredictable and sometimes extreme outcomes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability and securities, claims, among others, that are reported to the insurance carrier while the policy is in effect. These policies do not include coverage for punitive damages. Although we have insurance for product and tissue processing liabilities, securities, property, and general liabilities, if we are unsuccessful in arranging cost-effective acceptable resolutions of claims, it is possible that our insurance program may not be adequate to cover any or all possible claims or losses, including losses arising out of natural disasters or catastrophic circumstances. Any significant claim could result in an increase in our insurance rates or jeopardize our ability to secure coverage on reasonable terms, if at all.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any securities or product liability/tissue processing claim, even a meritless or unsuccessful one, could be costly to defend, and result in diversion of our management&#8217;s attention from our business, adverse publicity, withdrawal of clinical trial participants, injury to our reputation, or loss of revenue.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are subject to various US and international bribery, anti-kickback, false claims, privacy, transparency, and similar laws, any breach of which could cause a material, adverse effect on our business, financial condition, and profitability.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our relationships with physicians, hospitals, and other healthcare providers are subject to scrutiny under various US and international bribery, anti-kickback, false claims, privacy, transparency, and similar laws, often referred to collectively as &#8220;healthcare compliance laws.&#8221; Healthcare compliance laws are broad, sometimes ambiguous, complex, and subject to change and changing interpretations. The ongoing war in Ukraine and the current and future sanctions imposed on Russia and others as a result may exacerbate these risks. See also Part I, Item 1A, &#8220;Risk Factors &#8211; Business and Economic Risks - We are subject to a variety of risks due to our international operations and continued global expansion.&#8221; Possible sanctions for violation of these healthcare compliance laws include fines, civil and criminal penalties, exclusion from government healthcare programs, and despite our compliance efforts, we face the risk of an enforcement activity or a finding of a violation of these laws.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into consulting and product development agreements with healthcare professionals and healthcare organizations, including some who may order our products or make decisions to use them. We have also adopted the AdvaMed Code of Conduct, the MedTech Europe Code of Ethical Business Practice, and the APACMed Code of Ethical Conduct which govern our relationships with healthcare professionals to bolster our compliance with healthcare compliance laws. While our relationships with healthcare professionals and organizations are structured to comply with such laws and we conduct training sessions on these laws and codes, it is possible that enforcement authorities may view our relationships as prohibited arrangements that must be restructured or for which we would be subject to other significant civil or criminal penalties or debarment. In any event, any enforcement review of or action against us as a result of such review, regardless of outcome, could be costly and time consuming. Additionally, we cannot predict the impact of any changes in or interpretations of these laws, whether these changes will be retroactive or will have effect on a going-forward basis only.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The proliferation of new and expanded data privacy laws, including the General Data Protection Regulation in the European Union, could adversely affect our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An increasing number of federal, state, and foreign data privacy laws and regulations, which can be enforced by private parties or governmental entities, have been or are being promulgated and are constantly evolving. These laws and regulations may include new requirements for companies that receive or process an individual&#8217;s personal data (including employees), which increases our operating costs and requires significant management time and energy. Many of these laws and regulations, including the European Union&#8217;s General Data Protection Regulation (&#8220;GDPR&#8221;) also include significant penalties for noncompliance. Although our personal data practices, policies, and procedures are intended to comply with GDPR and other data privacy laws and regulations, there can be no assurance that regulatory or enforcement authorities will view our arrangements as being in compliance with applicable laws, or that one or more of our employees or agents will not disregard the rules we have established. Any privacy related government enforcement activities may be costly, result in negative publicity, or subject us to significant penalties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Some of our products and technologies are subject to significant intellectual property risks and uncertainty.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We own trade secrets, patents, patent applications, and licenses relating to our technologies and trademarks and goodwill related to our products and services, which we believe provide us with important competitive advantages. We cannot be certain that we will be able to maintain our trade secrets, that our pending patent applications will issue as patents, or that no one will challenge the validity or enforceability of any intellectual property that we adopt, own, or license. Competitors may independently develop our proprietary technologies or design non-infringing alternatives to patented inventions. We do not control the maintenance, prosecution, enforcement, or strategy for in-licensed intellectual property and as such are dependent in part on the owners of these rights to maintain their viability. Their failure to do so could significantly impair our ability to exploit those technologies. Additionally, our technologies, products, or services could infringe intellectual property rights owned by others, or others could infringe our intellectual property rights.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we become involved in intellectual property disputes, the costs could be expensive, and if we were to lose or decide to settle, the amounts or effects of the settlement or award by a tribunal could be costly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risks Relating to Our Indebtedness</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The agreements governing our indebtedness contain restrictions that limit our flexibility in operating our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The agreements governing our indebtedness contain, and any instruments governing future indebtedness of ours may contain, covenants that impose significant operating and financial restrictions on us and certain of our subsidiaries, including (subject in each case to certain exceptions) restrictions or prohibitions on our and certain of our subsidiaries&#8217; ability to, among other things:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Incur or guarantee additional debt or create liens on certain assets;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pay dividends on or make distributions of our share capital, including repurchasing or redeeming capital stock, or make other restricted payments, including restricted junior payments;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enter into agreements that restrict our subsidiaries&#8217; ability to pay dividends to us, repay debt owed to us or our subsidiaries, or make loans or advances to us or our other subsidiaries;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enter into certain transactions with our affiliates including any transaction or merger or consolidation, liquidation, winding-up, or dissolution; convey, sell, lease, exchange, transfer or otherwise dispose of all or any part of our business, assets or property; or sell, assign, or otherwise dispose of any capital stock of any subsidiary;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enter into certain rate swap transactions, basis swaps, credit derivative transactions, and other similar transactions, whether relating to interest rates, commodities, investments, securities, currencies, or any other relevant measure, or transactions of any kind subject to any form of master purchase agreement governed by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, or any other master agreement;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Amend, supplement, waive, or otherwise modify our or our subsidiaries' organizational documents in a manner that would be materially adverse to the interests of the lenders, or change or amend the terms of documentation regarding junior financing in a manner that would be materially adverse to the interests of the lenders;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Make changes to our and our subsidiaries&#8217; fiscal year without notice to the administrative agent;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Enter into agreements which restrict our ability to incur liens;</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Engage in any line of business substantially different from that in which we are currently engaged; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Make certain investments, including strategic acquisitions or joint ventures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our indebtedness could adversely affect our ability to raise additional capital to fund operations and limit our ability to react to changes in the economy or our industry.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current and future levels of indebtedness could adversely affect our ability to raise additional capital, limit our operational flexibility, and hinder our ability to react to changes in the economy or our industry. It may also limit our ability to borrow money, require us to dedicate substantial portions of our cash flow to repayment, and restrict our ability to invest in business opportunities. Because most of our borrowings are at a variable rate of interest, we are exposed to interest rate fluctuations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We have pledged substantially all of our US assets as collateral under our existing Credit Agreement. If we default on the terms of such credit agreements and the holders of our indebtedness accelerate the repayment of such indebtedness, there can be no assurance that we will have sufficient assets to repay our indebtedness.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A failure to comply with the covenants in our existing Credit Agreement could result in an event of default, which, if not cured or waived, could have a material, adverse effect on our business, financial condition, and profitability. In the event of any such default, the holders of our indebtedness:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Will not be required to lend any additional amounts to us; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Could elect to declare all indebtedness outstanding, together with accrued and unpaid interest and fees, to be due and payable and terminate all commitments to extend further credit, if applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to repay those amounts, the holders of our secured indebtedness could proceed against their secured collateral to seek repayment out of proceeds from the sale or liquidation of our assets. If our indebtedness were to be accelerated, there can be no assurance that our assets would be sufficient to repay such indebtedness in full.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Risks Related to Ownership of our Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be negatively impacted as a result of shareholder activism.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, shareholder activists have become involved in the governance, strategic direction, and operations of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies. Such involvement with us may disrupt our business and divert the attention of our management, and any perceived uncertainties as to our future direction resulting from such involvement could result in the loss of business opportunities, be exploited by our competitors, cause concern for our current or potential customers, cause significant fluctuations in stock price, or make it more difficult to attract and retain qualified personnel and business partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our business could be impacted by increased shareholder emphasis on environmental, social, and governance matters or efforts by certain governmental authorities to reduce such emphasis.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investors and other key stakeholders are increasingly focusing on areas of corporate responsibility, and particularly matters related to environmental, social, and governance (&#8220;ESG&#8221;) factors. Institutional investors have expressed expectations with respect to ESG matters that they use to guide their investment strategies and may, in some cases, choose not to invest in us if they believe our ESG policies are lagging or inadequate. Other stakeholders also have expectations regarding ESG factors, such as employees or potential employees who desire to work for a company that reflects their personal values. These areas of focus are continuing to evolve, as are the criteria that investors assess companies&#8217; performance in these areas. Investors are increasingly looking to companies that demonstrate strong ESG and sustainability practices as an indicator of long-term resilience, especially in light of events such as the COVID-19 pandemic. Conversely, certain governmental authorities are challenging investors' reliance on ESG factors as, among other things, inconsistent with certain fiduciary duties. Keeping up with and meeting these expectations, sometimes contradictory, may disrupt our business and divert the attention of our management, and we may be unable to make the investments in ESG programs that our competitors with greater financial resources are able to make or we may be challenged by governmental authorities if we choose to make such investments. Failure to meet the expectations of investors, other stakeholders, or certain governmental authorities in these areas may damage our reputation, impact employee retention, impact the willingness of our customers to do business with us, or otherwise impact our financial results and stock price.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We do not anticipate paying any dividends on our common stock for the foreseeable future.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015 our Board of Directors discontinued dividend payments on our common stock for the foreseeable future. If we do not pay cash dividends, our shareholders may receive a return on their investment in our common stock only through appreciation of shares of our common stock that they own. In addition, restrictions in our credit facility limit our ability to pay future dividends.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provisions of Delaware law and anti-takeover provisions in our organizational documents may discourage or prevent a change of control, even if an acquisition would be beneficial to shareholders, which could affect our share price adversely and prevent attempts by shareholders to remove current management.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective January 1, 2022 we reincorporated in Delaware. Our status as a Delaware corporation and the anti-takeover provisions of the Delaware General Corporation Law may discourage, delay, or prevent a change in control by prohibiting us from engaging in a business combination with an interested stockholder for a period of three years after the person becomes an interested stockholder, even if a change of control would be beneficial to our existing stockholders. In addition, the organizational documents adopted in connection with our reincorporation contain provisions that restrict persons who may call shareholder meetings, allow the issuance of blank-check preferred stock without the vote of shareholders, and allow the Board of Directors to fill vacancies and fix the number of directors. These provisions of Delaware law and our articles of incorporation and bylaws could prevent attempts by shareholders to remove current management, prohibit or delay mergers or other changes of control transactions, and discourage attempts by other companies to acquire us, even if such a transaction would be beneficial to our shareholders. The effects of reincorporation in Delaware are detailed in our 2021 Special Proxy Statement and Notice of Special Meeting filed with the SEC on October 7, 2021.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">50</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_148"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) The following table provides information about purchases by us during the three months ended March&#160;31, 2023 of equity securities that are registered by us pursuant to Section 12 of the Securities Exchange Act of 1934:</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.085%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total Number of<br/>Common Shares<br/>and Common Stock<br/>Units Purchased</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Average Price<br/>Paid per<br/>Common Share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total Number<br/>of Common Shares<br/>Purchased as<br/>Part of Publicly<br/>Announced<br/>Plans or Programs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Dollar Value<br/>of Common Shares<br/>That May Yet Be<br/>Purchased Under the<br/>Plans or Programs</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">01/01/23 - 01/31/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:0 1.97pt 0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;border-top:1pt solid #000;padding:0 1.97pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">02/01/23 - 02/28/23</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,690</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">13.94</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1.97pt 0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1.97pt 0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">03/01/23 - 03/31/23</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,789</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12.97</span></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1.97pt 0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1pt"></td><td colspan="3" style="background-color:#CCEEFF;padding:0 1.97pt 0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 40.13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">42,479</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">13.90</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">&#8212;</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The common shares purchased during the three months ended March&#160;31, 2023 were tendered to us in payment of taxes on stock compensation and were not part of a publicly announced plan or program.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our Credit Agreement, we are prohibited from repurchasing our common stock, except for the repurchase of stock from our employees or directors when tendered in payment of taxes or the exercise price of stock options, upon the satisfaction of certain requirements.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_151"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_154"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i5fc3aab1863a48b289e7fc6726692d73_157"></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">51</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_160"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibit index can be found below.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.051%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.143%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Exhibit</span></div><div style="margin-bottom:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Number</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/784199/000078419922000006/cry-20220101xex3_2.htm">3.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware Certificate of Incorporation, effective January 1, 2022. (Incorporated herein by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K filed January 4, 2022).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/784199/000078419922000014/cry-20220118xex3_1.htm">3.2</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Delaware Certificate of Amendment of Certificate of Incorporation, effective January 18, 2022. (Incorporated herein by reference to Exhibit 3.1 to the Registrant&#8217;s Current Report on Form 8-K filed January 20, 2022).</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/784199/000078419922000014/cry-20220118xex3_2.htm">3.3</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amended and Restated Bylaws of Artivion, Inc., a Delaware Corporation (Incorporated herein by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K filed January 20, 2022).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="aort-20230331xex311.htm">31.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification by J. Patrick Mackin pursuant to section 302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="aort-20230331xex312.htm">31.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification by D. Ashley Lee pursuant to section 302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="aort-20230331xex32.htm">32</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certification Pursuant To 18 USC. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act Of 2002.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Definition Linkbase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File &#8211; formatted as Inline XBRL and contained in Exhibit 101</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Filed herewith.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:8pt">Furnished herewith.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">52</span></div></div></div><div id="i5fc3aab1863a48b289e7fc6726692d73_163"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%;text-decoration:underline" href="#i5fc3aab1863a48b289e7fc6726692d73_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                              SIGNATURES</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.990%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.994%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">ARTIVION, INC.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;text-indent:-9.35pt;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">/s/ J. PATRICK MACKIN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">/s/ D. ASHLEY LEE</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">J. PATRICK MACKIN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">D. ASHLEY LEE</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Chairman, President, and<br/>Chief Executive Officer<br/>(Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Executive Vice President, and<br/>Chief Financial Officer<br/>(Principal Financial and<br/>Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">May&#160;5, 2023</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt dashed #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DATE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">53</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>aort-20230331xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id3e63b963efc4caf81c8313ebf04e8ec_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div></div><div style="margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CERTIFICATIONS</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, James Patrick Mackin, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Artivion, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8209;15(f) and 15d&#8209;15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;5, 2023</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; J. PATRICK MACKIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman, President, and<br>Chief Executive Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>aort-20230331xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i5f2151b5c3104fc7b4b98b0729fd1b69_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div></div><div style="margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, David Ashley Lee, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Artivion, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a&#8209;15(f) and 15d&#8209;15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.24pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:9.67pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; May&#160;5, 2023</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; D. ASHLEY LEE</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, and<br>Chief Financial Officer</font></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>aort-20230331xex32.htm
<DESCRIPTION>EX-32
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if4b83dbcc8b24442a53c4f8aa7eb8763_1"></div><div style="min-height:45pt;width:100%"><div style="margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32</font><font style="font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"></font></div></div><div style="margin-top:12pt;text-align:right"><font><br></font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Quarterly Report of Artivion, Inc. (the &#8220;Company&#8221;) on Form 10-Q for the quarter ending March&#160;31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), each of James Patrick Mackin, the Chairman, President, and Chief Executive Officer of the Company, and David Ashley Lee, the Executive Vice President, and Chief Financial Officer of the Company, hereby certifies, pursuant to and for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, in his capacity as an officer of the Company and to his knowledge&#58;</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.921%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; J. PATRICK MACKIN</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; D. ASHLEY LEE</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">J. PATRICK MACKIN</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">D. ASHLEY LEE</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman, President, and<br>Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President, and<br>Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May&#160;5, 2023</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May&#160;5, 2023</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>aort-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b72a0741-f899-4d87-a80c-f9fdcb4bb4b4,g:8ab7fb08-5903-4a38-b428-03d2f07a3992-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:aort="http://www.cryolife.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.cryolife.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aort-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.cryolife.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
        <link:definition>0000002 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofShareholdersEquity" roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPolicies" roleURI="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies">
        <link:definition>0000007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://www.cryolife.com/role/FinancialInstruments">
        <link:definition>0000008 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesnetandDeferredPreservationCosts" roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts">
        <link:definition>0000009 - Disclosure - Inventories, net and Deferred Preservation Costs</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>0000010 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.cryolife.com/role/IncomeTaxes">
        <link:definition>0000011 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.cryolife.com/role/Leases">
        <link:definition>0000012 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.cryolife.com/role/Debt">
        <link:definition>0000013 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.cryolife.com/role/CommitmentsandContingencies">
        <link:definition>0000014 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.cryolife.com/role/RevenueRecognition">
        <link:definition>0000015 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensation" roleURI="http://www.cryolife.com/role/StockCompensation">
        <link:definition>0000016 - Disclosure - Stock Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossPerCommonShare" roleURI="http://www.cryolife.com/role/LossPerCommonShare">
        <link:definition>0000017 - Disclosure - Loss Per Common Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://www.cryolife.com/role/SegmentInformation">
        <link:definition>0000018 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.cryolife.com/role/SubsequentEvents">
        <link:definition>0000019 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000020 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://www.cryolife.com/role/FinancialInstrumentsTables">
        <link:definition>0000021 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesNetAndDeferredPreservationCostsTables" roleURI="http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables">
        <link:definition>0000022 - Disclosure - Inventories, Net And Deferred Preservation Costs (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>0000023 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.cryolife.com/role/LeasesTables">
        <link:definition>0000024 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.cryolife.com/role/DebtTables">
        <link:definition>0000025 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.cryolife.com/role/RevenueRecognitionTables">
        <link:definition>0000026 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationTables" roleURI="http://www.cryolife.com/role/StockCompensationTables">
        <link:definition>0000027 - Disclosure - Stock Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossPerCommonShareTables" roleURI="http://www.cryolife.com/role/LossPerCommonShareTables">
        <link:definition>0000028 - Disclosure - Loss Per Common Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://www.cryolife.com/role/SegmentInformationTables">
        <link:definition>0000029 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" roleURI="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails">
        <link:definition>0000030 - Disclosure - Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsNarrativeDetails" roleURI="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails">
        <link:definition>0000031 - Disclosure - Financial Instruments (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails" roleURI="http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails">
        <link:definition>0000032 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails">
        <link:definition>0000033 - Disclosure - Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesnetandDeferredPreservationCostsNarrativeDetails" roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails">
        <link:definition>0000034 - Disclosure - Inventories, net and Deferred Preservation Costs (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails">
        <link:definition>0000035 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails">
        <link:definition>0000036 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails">
        <link:definition>0000037 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails">
        <link:definition>0000038 - Disclosure - Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails">
        <link:definition>0000039 - Disclosure - Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.cryolife.com/role/IncomeTaxesDetails">
        <link:definition>0000040 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.cryolife.com/role/LeasesNarrativeDetails">
        <link:definition>0000041 - Disclosure - Leases (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails">
        <link:definition>0000042 - Disclosure - Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSummaryOfLeaseCostsDetails" roleURI="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails">
        <link:definition>0000043 - Disclosure - Leases (Summary Of Lease Costs) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails" roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails">
        <link:definition>0000044 - Disclosure - Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" roleURI="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails">
        <link:definition>0000045 - Disclosure - Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://www.cryolife.com/role/DebtNarrativeDetails">
        <link:definition>0000046 - Disclosure - Debt (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" roleURI="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails">
        <link:definition>0000047 - Disclosure - Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationOfRevenueDetails" roleURI="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails">
        <link:definition>0000048 - Disclosure - Revenue Recognition (Disaggregation Of Revenue) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationNarrativeDetails" roleURI="http://www.cryolife.com/role/StockCompensationNarrativeDetails">
        <link:definition>0000049 - Disclosure - Stock Compensation (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" roleURI="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails">
        <link:definition>0000050 - Disclosure - Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockCompensationSummaryOfTotalStockCompensationExpensesDetails" roleURI="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails">
        <link:definition>0000051 - Disclosure - Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" roleURI="http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails">
        <link:definition>0000052 - Disclosure - Loss Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://www.cryolife.com/role/SegmentInformationNarrativeDetails">
        <link:definition>0000053 - Disclosure - Segment Information (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" roleURI="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails">
        <link:definition>0000054 - Disclosure - Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" roleURI="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails">
        <link:definition>0000055 - Disclosure - Segment Information (Summary Of Net Revenues By Product And Service) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.cryolife.com/role/SubsequentEventsDetails">
        <link:definition>0000056 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="aort_InternationalHospitalsMember" abstract="false" name="InternationalHospitalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_RestrictedStockUnitsAndPreferredStockUnitsMember" abstract="false" name="RestrictedStockUnitsAndPreferredStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" abstract="false" name="IncreaseDecreaseInDeferredPreservationCostsAndInventories" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" abstract="false" name="RevolvingCreditFacilityPercentageRepaidForNoCovenants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aort_InternationalDistributorMember" abstract="false" name="InternationalDistributorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_PreservationServicesMember" abstract="false" name="PreservationServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_FinanceLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" abstract="false" name="IntangibleAssetsOtherThanAcquiredTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_RevolvingCreditFacilityAndTermLoanMember" abstract="false" name="RevolvingCreditFacilityAndTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_DeferredPreservationCosts" abstract="false" name="DeferredPreservationCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" abstract="false" name="StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_ThirdTranchePayment" abstract="false" name="ThirdTranchePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_CardiogenesisMember" abstract="false" name="CardiogenesisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_DebtPeriodDomain" abstract="true" name="DebtPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_NumberOfTranches" abstract="false" name="NumberOfTranches" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aort_OnXMember" abstract="false" name="OnXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_AccruedProcurementFees" abstract="false" name="AccruedProcurementFees" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_FundedTranchePaymentPerAgreement" abstract="false" name="FundedTranchePaymentPerAgreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_ConsignmentInventoryPercentage" abstract="false" name="ConsignmentInventoryPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" abstract="false" name="PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_ContingentConsiderationNoncurrentFairValue" abstract="false" name="ContingentConsiderationNoncurrentFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_DomesticHospitalsMember" abstract="false" name="DomesticHospitalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_AscyrusMedicalLlcMember" abstract="false" name="AscyrusMedicalLlcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" abstract="false" name="DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" abstract="false" name="PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_FinanceLeaseCost" abstract="false" name="FinanceLeaseCost" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" abstract="false" name="RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_DebtInstrumentExtensionCircumstancePeriod" abstract="false" name="DebtInstrumentExtensionCircumstancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aort_DebtInstrumentExtensionPeriod" abstract="false" name="DebtInstrumentExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aort_SurgicalSealantsMember" abstract="false" name="SurgicalSealantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_ThreeTranchesOfFundingForSecuredLoanPerTranche" abstract="false" name="ThreeTranchesOfFundingForSecuredLoanPerTranche" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_GovernmentSponsoredDebtKfwLoan1Member" abstract="false" name="GovernmentSponsoredDebtKfwLoan1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_CircumstanceIiMember" abstract="false" name="CircumstanceIiMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_AorticStentGraftsMember" abstract="false" name="AorticStentGraftsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_CircumstanceAfterJuly52023Member" abstract="false" name="CircumstanceAfterJuly52023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_ProductsMember" abstract="false" name="ProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_DebtPeriodAxis" abstract="true" name="DebtPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="aort_MedicalDevicesMember" abstract="false" name="MedicalDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_OtherProductsMember" abstract="false" name="OtherProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_WriteDownOfDeferredPreservationCostsAndInventories" abstract="false" name="WriteDownOfDeferredPreservationCostsAndInventories" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" abstract="false" name="ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aort_GovernmentSponsoredDebtKfwLoan2Member" abstract="false" name="GovernmentSponsoredDebtKfwLoan2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aort_CircumstanceIMember" abstract="false" name="CircumstanceIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>aort-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b72a0741-f899-4d87-a80c-f9fdcb4bb4b4,g:8ab7fb08-5903-4a38-b428-03d2f07a3992-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f5bc296c-b68e-492d-87b8-f74208dc336d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7b027c8f-ec9d-4986-ba7b-b26b81465469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f5bc296c-b68e-492d-87b8-f74208dc336d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7b027c8f-ec9d-4986-ba7b-b26b81465469" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_04685186-d5c6-4d31-ae61-f13eaa8c6ed0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f5bc296c-b68e-492d-87b8-f74208dc336d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_04685186-d5c6-4d31-ae61-f13eaa8c6ed0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7dc538dc-dd3d-4812-bd50-ea1478c0a0c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4e0acfe5-54dc-48a0-903b-98faa45517ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_7dc538dc-dd3d-4812-bd50-ea1478c0a0c8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4e0acfe5-54dc-48a0-903b-98faa45517ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_97eb0a21-8df3-4bb2-b74e-7d0a59e77252" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_7dc538dc-dd3d-4812-bd50-ea1478c0a0c8" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_97eb0a21-8df3-4bb2-b74e-7d0a59e77252" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_349220d6-1469-435f-a89c-b56cbed2a9a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e42e70f1-e165-4b20-90d2-5e28effe6eca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_349220d6-1469-435f-a89c-b56cbed2a9a9" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_e42e70f1-e165-4b20-90d2-5e28effe6eca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e5f696b1-e9e1-4634-af4f-2df648870833" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_349220d6-1469-435f-a89c-b56cbed2a9a9" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e5f696b1-e9e1-4634-af4f-2df648870833" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_251c9ea2-ee6d-46b6-b289-07998e52ad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_8542aa62-d261-4b5f-804c-fdc0727e3a4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_251c9ea2-ee6d-46b6-b289-07998e52ad6d" xlink:to="loc_us-gaap_GrossProfit_8542aa62-d261-4b5f-804c-fdc0727e3a4c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4e980e17-a476-4266-b4e9-b353bc01dbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_251c9ea2-ee6d-46b6-b289-07998e52ad6d" xlink:to="loc_us-gaap_OperatingExpenses_4e980e17-a476-4266-b4e9-b353bc01dbf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4eb1d00-f678-41e4-91e0-43401290bda8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c6da47d3-00cc-408f-938e-a1b724ff69b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4eb1d00-f678-41e4-91e0-43401290bda8" xlink:to="loc_us-gaap_NetIncomeLoss_c6da47d3-00cc-408f-938e-a1b724ff69b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fe85c984-e876-4364-85da-a0ceea498bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_e4eb1d00-f678-41e4-91e0-43401290bda8" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fe85c984-e876-4364-85da-a0ceea498bec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_93468bf4-7a38-44d6-a1e0-25cf33688d07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_442f5660-7a40-4643-8ae8-5c7122e9e075" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_93468bf4-7a38-44d6-a1e0-25cf33688d07" xlink:to="loc_us-gaap_OperatingIncomeLoss_442f5660-7a40-4643-8ae8-5c7122e9e075" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3413fb0a-3fdb-4e50-adf7-d4012a493f44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_93468bf4-7a38-44d6-a1e0-25cf33688d07" xlink:to="loc_us-gaap_InterestExpense_3413fb0a-3fdb-4e50-adf7-d4012a493f44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_4fa89a8c-b73d-4903-9866-48324c086e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_93468bf4-7a38-44d6-a1e0-25cf33688d07" xlink:to="loc_us-gaap_InvestmentIncomeInterest_4fa89a8c-b73d-4903-9866-48324c086e50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_def79622-e8fa-42a5-9753-ede5238516d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_93468bf4-7a38-44d6-a1e0-25cf33688d07" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_def79622-e8fa-42a5-9753-ede5238516d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fd026d79-8fb3-4678-9407-edeb197b6616" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9424e4ad-c0d3-41c7-9394-a12841d38f2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd026d79-8fb3-4678-9407-edeb197b6616" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9424e4ad-c0d3-41c7-9394-a12841d38f2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ac6d3c03-6e7b-4785-8a13-96c91fef1b64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd026d79-8fb3-4678-9407-edeb197b6616" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ac6d3c03-6e7b-4785-8a13-96c91fef1b64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_e9725769-300d-42f2-853f-22d902cdd06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd026d79-8fb3-4678-9407-edeb197b6616" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_e9725769-300d-42f2-853f-22d902cdd06c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_82d3a6b2-c361-4214-857e-574ed70abbff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd026d79-8fb3-4678-9407-edeb197b6616" xlink:to="loc_us-gaap_InventoryNet_82d3a6b2-c361-4214-857e-574ed70abbff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts_abe82886-0983-4851-b51c-75fcaa421a67" xlink:href="aort-20230331.xsd#aort_DeferredPreservationCosts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd026d79-8fb3-4678-9407-edeb197b6616" xlink:to="loc_aort_DeferredPreservationCosts_abe82886-0983-4851-b51c-75fcaa421a67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bf77fa6c-8ca9-4b3c-a5b3-edabf426ce3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fd026d79-8fb3-4678-9407-edeb197b6616" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bf77fa6c-8ca9-4b3c-a5b3-edabf426ce3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_670cb9f5-99b3-436a-afca-a5cc66e055b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9064d08e-e4f3-4ae5-a49a-b612c51664af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_670cb9f5-99b3-436a-afca-a5cc66e055b8" xlink:to="loc_us-gaap_Liabilities_9064d08e-e4f3-4ae5-a49a-b612c51664af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_bbf08a47-679d-4b86-8b2a-37a28d3f4523" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_670cb9f5-99b3-436a-afca-a5cc66e055b8" xlink:to="loc_us-gaap_StockholdersEquity_bbf08a47-679d-4b86-8b2a-37a28d3f4523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_a9ef93ed-a6fc-4f9a-85f8-b36d4924388a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:to="loc_us-gaap_LiabilitiesCurrent_a9ef93ed-a6fc-4f9a-85f8-b36d4924388a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_55444bd1-13c9-4f57-91ae-e100fa118db8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_55444bd1-13c9-4f57-91ae-e100fa118db8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_30041283-a037-402d-b27e-6ae889dc03ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_30041283-a037-402d-b27e-6ae889dc03ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d56e6b56-9f6b-4646-a23c-20a92726ed29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d56e6b56-9f6b-4646-a23c-20a92726ed29" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5c27f398-9ee4-409d-9d3a-29d049283316" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_5c27f398-9ee4-409d-9d3a-29d049283316" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1be2c5f2-1189-4604-ab45-9584b32480a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_1be2c5f2-1189-4604-ab45-9584b32480a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ddad8ec3-4577-47f2-b57b-631a68cf904e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ddad8ec3-4577-47f2-b57b-631a68cf904e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ff2afa4c-f4d9-4f85-9eda-1b32354fa44c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_056af69b-91bb-407d-9eaf-7a8e17dbcde7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ff2afa4c-f4d9-4f85-9eda-1b32354fa44c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_05d7c3b2-c109-4fd2-a027-652ed2e86a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:to="loc_us-gaap_AssetsCurrent_05d7c3b2-c109-4fd2-a027-652ed2e86a7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0275a851-ad8f-4161-a3cf-f0c5b2d934d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0275a851-ad8f-4161-a3cf-f0c5b2d934d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_6e0f52d8-2181-4ae3-8086-3c64b2f61045" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_6e0f52d8-2181-4ae3-8086-3c64b2f61045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_e2b7e0b3-d190-47f2-b01e-9556bf1d350b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:to="loc_us-gaap_Goodwill_e2b7e0b3-d190-47f2-b01e-9556bf1d350b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ff82063-f7a0-425c-9e55-0371446e0638" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8ff82063-f7a0-425c-9e55-0371446e0638" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_7c7c16be-2334-4b0a-86d1-b64930c357d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_7c7c16be-2334-4b0a-86d1-b64930c357d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_5df49ccd-dff7-45c9-a0c0-7c4596e7100e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_5df49ccd-dff7-45c9-a0c0-7c4596e7100e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_16e1edc0-f8b7-424c-96b2-4a643081c7cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_c063a933-f2f6-426a-bb96-4f75a3f46c2d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_16e1edc0-f8b7-424c-96b2-4a643081c7cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_9f4df588-b59d-4824-b72c-9a20542d84a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:to="loc_us-gaap_AccountsPayableCurrent_9f4df588-b59d-4824-b72c-9a20542d84a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_0454a5a4-5010-4d59-b0d7-de6efc4dc4c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:to="loc_us-gaap_TaxesPayableCurrent_0454a5a4-5010-4d59-b0d7-de6efc4dc4c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fbdffb3d-0193-420f-8adc-ef389e7e2b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_fbdffb3d-0193-420f-8adc-ef389e7e2b5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AccruedProcurementFees_71ff9fa0-c7c1-4a7e-86cf-fb33744475f0" xlink:href="aort-20230331.xsd#aort_AccruedProcurementFees"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:to="loc_aort_AccruedProcurementFees_71ff9fa0-c7c1-4a7e-86cf-fb33744475f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_ca3d3f6e-a129-442c-a35f-d71eac8f78bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_ca3d3f6e-a129-442c-a35f-d71eac8f78bb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_8e24317e-ca91-4134-9c57-d9f662163baa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:to="loc_us-gaap_LongTermDebtCurrent_8e24317e-ca91-4134-9c57-d9f662163baa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_e7ca80a6-d016-485a-bff4-498c7509f23d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_e7ca80a6-d016-485a-bff4-498c7509f23d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_2cfc531e-c21c-441c-a503-c0f4443c2c22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_f40928c7-c80b-43cb-ad7b-a24ce5d63cdd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_2cfc531e-c21c-441c-a503-c0f4443c2c22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9c769571-7cc0-44a6-81d0-6c0b1097f302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_997adcf9-79c2-4bd9-a46e-684e260c78c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c769571-7cc0-44a6-81d0-6c0b1097f302" xlink:to="loc_us-gaap_PreferredStockValue_997adcf9-79c2-4bd9-a46e-684e260c78c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c6e042c7-8a8f-4a9e-85c3-acea87370ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c769571-7cc0-44a6-81d0-6c0b1097f302" xlink:to="loc_us-gaap_CommonStockValue_c6e042c7-8a8f-4a9e-85c3-acea87370ad9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c9dbb6c6-9c17-4e58-b9be-751aefc587e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c769571-7cc0-44a6-81d0-6c0b1097f302" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_c9dbb6c6-9c17-4e58-b9be-751aefc587e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_47132365-7c4a-4c40-9228-7e52c3e1982c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c769571-7cc0-44a6-81d0-6c0b1097f302" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_47132365-7c4a-4c40-9228-7e52c3e1982c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c662abcb-f53c-4780-ac30-b76f1886d2e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c769571-7cc0-44a6-81d0-6c0b1097f302" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c662abcb-f53c-4780-ac30-b76f1886d2e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_f5bcc2a9-c56a-4a52-b5a7-63fe3f8affb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9c769571-7cc0-44a6-81d0-6c0b1097f302" xlink:to="loc_us-gaap_TreasuryStockCommonValue_f5bcc2a9-c56a-4a52-b5a7-63fe3f8affb7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c41272b3-c0d9-43a6-8de4-4566010773bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_NetIncomeLoss_c41272b3-c0d9-43a6-8de4-4566010773bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c7f95328-1267-44cf-9c5a-9b1c11e8d42f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c7f95328-1267-44cf-9c5a-9b1c11e8d42f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_68f5f452-535a-4e98-b275-0b3171f74a6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_ShareBasedCompensation_68f5f452-535a-4e98-b275-0b3171f74a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashLeaseExpense_f8b9160f-77c0-46f4-9922-05b57f4003f6" xlink:href="aort-20230331.xsd#aort_NoncashLeaseExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_aort_NoncashLeaseExpense_f8b9160f-77c0-46f4-9922-05b57f4003f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories_d361054b-3318-4251-b3a9-93fc505b1068" xlink:href="aort-20230331.xsd#aort_WriteDownOfDeferredPreservationCostsAndInventories"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories_d361054b-3318-4251-b3a9-93fc505b1068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_97526c0e-9f17-4fa4-b7da-7d3b43a10696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_97526c0e-9f17-4fa4-b7da-7d3b43a10696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3f29ca67-41a1-4680-88c9-d2fe3bf22fbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_3f29ca67-41a1-4680-88c9-d2fe3bf22fbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense_752eb501-558a-4609-9aaa-22b108dcca13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_OtherNoncashExpense_752eb501-558a-4609-9aaa-22b108dcca13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_6cb70382-7280-4088-8ab2-82bb202fbcbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_6cb70382-7280-4088-8ab2-82bb202fbcbc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_b331ea26-b1d2-4527-b346-d44256c3b8c4" xlink:href="aort-20230331.xsd#aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_b331ea26-b1d2-4527-b346-d44256c3b8c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_41ed54a3-1562-406e-ad1c-78c8d4cb0080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_41ed54a3-1562-406e-ad1c-78c8d4cb0080" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3cf9297d-974f-48d4-acbe-376423a4a698" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d09a51d4-6df1-4db5-a6a7-266091bf9e19" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3cf9297d-974f-48d4-acbe-376423a4a698" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97db3349-94f9-4713-adb2-5fa658a04b6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_7e210052-3999-4651-94b6-50deed9e7bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97db3349-94f9-4713-adb2-5fa658a04b6b" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_7e210052-3999-4651-94b6-50deed9e7bd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_64924688-fcd9-4903-b8ab-05d8dee99c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97db3349-94f9-4713-adb2-5fa658a04b6b" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_64924688-fcd9-4903-b8ab-05d8dee99c34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_8f0a28f9-7322-4e71-9aa3-4c83cd461d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97db3349-94f9-4713-adb2-5fa658a04b6b" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_8f0a28f9-7322-4e71-9aa3-4c83cd461d1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_46f3b5ca-da55-403e-9cd1-df0086dfcb10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97db3349-94f9-4713-adb2-5fa658a04b6b" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_46f3b5ca-da55-403e-9cd1-df0086dfcb10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_45579be5-4af6-4638-a98a-77759039637d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0a7440a5-504e-4d4f-99e0-042c355ebcbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_45579be5-4af6-4638-a98a-77759039637d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0a7440a5-504e-4d4f-99e0-042c355ebcbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94975e9e-6529-43ba-a630-5faa9aac4c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_45579be5-4af6-4638-a98a-77759039637d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_94975e9e-6529-43ba-a630-5faa9aac4c44" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2b4075a7-c08f-4770-84a2-71e481dbb0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_45579be5-4af6-4638-a98a-77759039637d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_2b4075a7-c08f-4770-84a2-71e481dbb0f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_edfed651-55b9-4221-af9f-bd272497d16e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_45579be5-4af6-4638-a98a-77759039637d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_edfed651-55b9-4221-af9f-bd272497d16e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca3565dc-6669-475d-8b30-7940196494b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b2e88fd9-a5cd-472c-8b03-f1ab4b5ba59b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca3565dc-6669-475d-8b30-7940196494b1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b2e88fd9-a5cd-472c-8b03-f1ab4b5ba59b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_36557957-04e0-4c3f-842f-d02c8f7c510b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ca3565dc-6669-475d-8b30-7940196494b1" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_36557957-04e0-4c3f-842f-d02c8f7c510b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_2538ba6d-8e74-42db-89f1-e4e4c187364a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ContingentConsiderationNoncurrentFairValue_369d4bd7-ad3c-4499-a3ef-5b494766e066" xlink:href="aort-20230331.xsd#aort_ContingentConsiderationNoncurrentFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_2538ba6d-8e74-42db-89f1-e4e4c187364a" xlink:to="loc_aort_ContingentConsiderationNoncurrentFairValue_369d4bd7-ad3c-4499-a3ef-5b494766e066" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_47eca9c8-c744-4058-b489-1f7b4d4c6c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d27492da-5cee-4105-89de-18b46c50c893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_47eca9c8-c744-4058-b489-1f7b4d4c6c2b" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_d27492da-5cee-4105-89de-18b46c50c893" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_458e131f-7854-43e2-a379-548fe3a025e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c81b27ad-07a8-4fa3-a6bf-6cd7fd7ea6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_458e131f-7854-43e2-a379-548fe3a025e5" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c81b27ad-07a8-4fa3-a6bf-6cd7fd7ea6c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_273ca2f3-2879-457d-97a0-875088dbe539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_458e131f-7854-43e2-a379-548fe3a025e5" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_273ca2f3-2879-457d-97a0-875088dbe539" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_1e5db1f0-fb8a-4233-9791-851ab498de21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_458e131f-7854-43e2-a379-548fe3a025e5" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_1e5db1f0-fb8a-4233-9791-851ab498de21" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c440133c-0ea6-4354-b25e-c5b769277160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_33d0e0d6-6469-48e6-9d4e-9ac4d91c8d6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c440133c-0ea6-4354-b25e-c5b769277160" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_33d0e0d6-6469-48e6-9d4e-9ac4d91c8d6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a1ad2ab0-0933-4e54-b578-d28c0c668db6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c440133c-0ea6-4354-b25e-c5b769277160" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a1ad2ab0-0933-4e54-b578-d28c0c668db6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_73c6a024-3482-4514-932b-7927e5e86c19" xlink:href="aort-20230331.xsd#aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_76850746-4a0c-4549-a8a7-f5469fd79e79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_73c6a024-3482-4514-932b-7927e5e86c19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_76850746-4a0c-4549-a8a7-f5469fd79e79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_617e04fe-5672-4005-99f8-8c37ef99e411" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_73c6a024-3482-4514-932b-7927e5e86c19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_617e04fe-5672-4005-99f8-8c37ef99e411" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3fe4e561-4484-4cc5-96d6-b8210c3b4944" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_73c6a024-3482-4514-932b-7927e5e86c19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_3fe4e561-4484-4cc5-96d6-b8210c3b4944" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_224263bd-93df-4c06-a78f-7d4347f52b92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_73c6a024-3482-4514-932b-7927e5e86c19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_224263bd-93df-4c06-a78f-7d4347f52b92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_aa6189ae-36ab-410a-9d3d-06a02b66690d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_73c6a024-3482-4514-932b-7927e5e86c19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_aa6189ae-36ab-410a-9d3d-06a02b66690d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8ebf2e85-d47c-4fd2-accc-fb0fab9bde49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_73c6a024-3482-4514-932b-7927e5e86c19" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_8ebf2e85-d47c-4fd2-accc-fb0fab9bde49" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_fc23b4d1-ecf2-4b9b-8434-fbb0c9ea8a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_86cca154-a577-4865-a2e1-5ab71fa6412d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_fc23b4d1-ecf2-4b9b-8434-fbb0c9ea8a3f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_86cca154-a577-4865-a2e1-5ab71fa6412d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ad3555b9-5980-41bb-bc79-b851ac67d89d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_fc23b4d1-ecf2-4b9b-8434-fbb0c9ea8a3f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_ad3555b9-5980-41bb-bc79-b851ac67d89d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a198120a-5bda-450b-8530-36731f9877ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_20ed40d9-6578-4084-8069-ba23ba499e60" xlink:href="aort-20230331.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_a198120a-5bda-450b-8530-36731f9877ce" xlink:to="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_20ed40d9-6578-4084-8069-ba23ba499e60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_3b596d12-7d67-4ad2-b3d2-7ecd11c9edde" xlink:href="aort-20230331.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset_a198120a-5bda-450b-8530-36731f9877ce" xlink:to="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_3b596d12-7d67-4ad2-b3d2-7ecd11c9edde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a0b22cb1-9b09-47ba-8a9b-86093797e99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_75b65ad1-a275-4507-a65c-857971db08c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a0b22cb1-9b09-47ba-8a9b-86093797e99c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_75b65ad1-a275-4507-a65c-857971db08c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_880898d5-02dd-428f-9994-9a61db293747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a0b22cb1-9b09-47ba-8a9b-86093797e99c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_880898d5-02dd-428f-9994-9a61db293747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c980c995-03db-4e4d-b590-78520b79e0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_29682c08-cacd-4513-a529-9a098075a042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c980c995-03db-4e4d-b590-78520b79e0c1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_29682c08-cacd-4513-a529-9a098075a042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_755efe2b-a00d-4968-bed5-d869c5831e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_c980c995-03db-4e4d-b590-78520b79e0c1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_755efe2b-a00d-4968-bed5-d869c5831e8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesSummaryOfLeaseCostsDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseCost_74b710fd-ce19-4f39-a8dc-dfca08d0ceef" xlink:href="aort-20230331.xsd#aort_FinanceLeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_5b2ec7cd-a8ed-467b-b12f-6e499eaef367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FinanceLeaseCost_74b710fd-ce19-4f39-a8dc-dfca08d0ceef" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_5b2ec7cd-a8ed-467b-b12f-6e499eaef367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_f28e2d44-6f29-4313-b75b-9bc476381c85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aort_FinanceLeaseCost_74b710fd-ce19-4f39-a8dc-dfca08d0ceef" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_f28e2d44-6f29-4313-b75b-9bc476381c85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_b93ac740-e418-4e42-8723-92e806512f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_4d315c64-6743-4df6-ae2f-b9e994ad8723" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b93ac740-e418-4e42-8723-92e806512f6f" xlink:to="loc_us-gaap_OperatingLeaseCost_4d315c64-6743-4df6-ae2f-b9e994ad8723" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_21a00d4a-bc97-4d60-b278-c7640f3aca83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b93ac740-e418-4e42-8723-92e806512f6f" xlink:to="loc_us-gaap_SubleaseIncome_21a00d4a-bc97-4d60-b278-c7640f3aca83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseCost_b7d2c7c6-7057-47a0-b85a-63aad2d5c922" xlink:href="aort-20230331.xsd#aort_FinanceLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b93ac740-e418-4e42-8723-92e806512f6f" xlink:to="loc_aort_FinanceLeaseCost_b7d2c7c6-7057-47a0-b85a-63aad2d5c922" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f2c22f8-bd40-43ec-9635-bf3c9882ebf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0f2dd3cc-e23a-44b8-86e7-2ce58938465a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f2c22f8-bd40-43ec-9635-bf3c9882ebf1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0f2dd3cc-e23a-44b8-86e7-2ce58938465a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_dbdbf1b1-b2fd-4b19-a5cd-7b5021409b14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f2c22f8-bd40-43ec-9635-bf3c9882ebf1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_dbdbf1b1-b2fd-4b19-a5cd-7b5021409b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_fe5df0bc-a053-493b-b86c-8ecd3bbdc439" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f2c22f8-bd40-43ec-9635-bf3c9882ebf1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_fe5df0bc-a053-493b-b86c-8ecd3bbdc439" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_61b749f3-c84e-43b6-bf7f-b3a0727d7ffd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f2c22f8-bd40-43ec-9635-bf3c9882ebf1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_61b749f3-c84e-43b6-bf7f-b3a0727d7ffd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b3110686-9237-4d8b-aeed-4b1dcc29cd58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f2c22f8-bd40-43ec-9635-bf3c9882ebf1" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_b3110686-9237-4d8b-aeed-4b1dcc29cd58" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_ce0a835a-6626-46bc-aa4e-c810446d6345" xlink:href="aort-20230331.xsd#aort_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1f2c22f8-bd40-43ec-9635-bf3c9882ebf1" xlink:to="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_ce0a835a-6626-46bc-aa4e-c810446d6345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0594d9c4-2d3b-47fc-a6f9-b78ee27eb945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6e9b4047-dc76-4247-8725-5dda7b2c75e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0594d9c4-2d3b-47fc-a6f9-b78ee27eb945" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_6e9b4047-dc76-4247-8725-5dda7b2c75e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_58c83d63-a7d5-41a7-9f63-b4cc25568cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0594d9c4-2d3b-47fc-a6f9-b78ee27eb945" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_58c83d63-a7d5-41a7-9f63-b4cc25568cdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_12ee7d95-8cdc-491a-b1a5-d9fb3057cf65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0594d9c4-2d3b-47fc-a6f9-b78ee27eb945" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_12ee7d95-8cdc-491a-b1a5-d9fb3057cf65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_47086732-3cc5-4ecc-8b83-6b52debecd99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0594d9c4-2d3b-47fc-a6f9-b78ee27eb945" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_47086732-3cc5-4ecc-8b83-6b52debecd99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_65bd2809-3acd-4c3e-af59-8f7abbfa3348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0594d9c4-2d3b-47fc-a6f9-b78ee27eb945" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_65bd2809-3acd-4c3e-af59-8f7abbfa3348" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_b291c6de-6528-45e3-974c-c94e95a8e86b" xlink:href="aort-20230331.xsd#aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0594d9c4-2d3b-47fc-a6f9-b78ee27eb945" xlink:to="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_b291c6de-6528-45e3-974c-c94e95a8e86b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_960a0bf7-cb88-4bf4-a3cb-dfcb5580a479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_a70a0286-7eb9-47d9-b2c6-f9ac2e6a870e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_960a0bf7-cb88-4bf4-a3cb-dfcb5580a479" xlink:to="loc_us-gaap_LongTermDebtCurrent_a70a0286-7eb9-47d9-b2c6-f9ac2e6a870e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_545e717a-840b-4f92-ae08-bdcab168b43c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_960a0bf7-cb88-4bf4-a3cb-dfcb5580a479" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_545e717a-840b-4f92-ae08-bdcab168b43c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1111030c-3257-419e-bef8-ddcac88789b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d5846499-8fda-4e52-b3c9-3b006e8ba6c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1111030c-3257-419e-bef8-ddcac88789b3" xlink:to="loc_us-gaap_NetIncomeLoss_d5846499-8fda-4e52-b3c9-3b006e8ba6c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_9b0c02f5-b21e-4e9a-a461-a8d00c54f90e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_1111030c-3257-419e-bef8-ddcac88789b3" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_9b0c02f5-b21e-4e9a-a461-a8d00c54f90e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8c8c5efa-24a2-43df-811f-af08e862a28c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_59d80f25-b5e9-4ebe-ad0f-f70cf2592a1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8c8c5efa-24a2-43df-811f-af08e862a28c" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_59d80f25-b5e9-4ebe-ad0f-f70cf2592a1a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_83f96ca3-1e87-4d04-95e4-00150d2238ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8c8c5efa-24a2-43df-811f-af08e862a28c" xlink:to="loc_us-gaap_NetIncomeLoss_83f96ca3-1e87-4d04-95e4-00150d2238ac" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>aort-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b72a0741-f899-4d87-a80c-f9fdcb4bb4b4,g:8ab7fb08-5903-4a38-b428-03d2f07a3992-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended" id="ia418bb7dda8b4fd9a452474662f4f423_CondensedConsolidatedStatementsofOperationsandComprehensiveLoss">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_8b164a1f-b777-4272-a42b-749d235c322c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_RevenuesAbstract_8b164a1f-b777-4272-a42b-749d235c322c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d6fc25c-dcbd-43a5-bec1-6ac3b160ff31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesAbstract_8b164a1f-b777-4272-a42b-749d235c322c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d6fc25c-dcbd-43a5-bec1-6ac3b160ff31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_08dca7b8-0d0c-48f0-be93-ca2f51af358d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_CostOfRevenueAbstract_08dca7b8-0d0c-48f0-be93-ca2f51af358d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7b816eb0-9b5b-44ec-b475-12764951c087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CostOfRevenueAbstract_08dca7b8-0d0c-48f0-be93-ca2f51af358d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7b816eb0-9b5b-44ec-b475-12764951c087" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_630b3c50-99b2-45ce-a6ce-6b44466f116c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_GrossProfit_630b3c50-99b2-45ce-a6ce-6b44466f116c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_61a5f251-e2f1-4ded-9853-bfa013567546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_61a5f251-e2f1-4ded-9853-bfa013567546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bf576a99-90bf-4bf9-82ba-643935db598b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bf576a99-90bf-4bf9-82ba-643935db598b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7b85ab3f-704e-42dc-afcc-03f9b9f379ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:to="loc_us-gaap_OperatingExpenses_7b85ab3f-704e-42dc-afcc-03f9b9f379ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6cbb4898-11ec-45bb-a96b-6b8d0dfcc7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_OperatingIncomeLoss_6cbb4898-11ec-45bb-a96b-6b8d0dfcc7fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8f649705-c553-4ee7-ba71-2792faed0cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_InterestExpense_8f649705-c553-4ee7-ba71-2792faed0cbf" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_4a6afb40-16a8-436e-8f16-b253553b6ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_4a6afb40-16a8-436e-8f16-b253553b6ecb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_91dd02a9-dcb7-4697-89c3-737f0d215865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_91dd02a9-dcb7-4697-89c3-737f0d215865" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a20e7c2c-0578-488a-9dc4-5706abb51042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a20e7c2c-0578-488a-9dc4-5706abb51042" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8ac29955-6da8-4803-82e9-af0e1bd0fbce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8ac29955-6da8-4803-82e9-af0e1bd0fbce" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6eac5271-687c-4953-894d-dd253c5f16e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_NetIncomeLoss_6eac5271-687c-4953-894d-dd253c5f16e6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fc50053d-144a-4b6d-905f-78ca38eeb0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fc50053d-144a-4b6d-905f-78ca38eeb0fd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_96a58170-7764-411d-9fb4-68ad9f841c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fc50053d-144a-4b6d-905f-78ca38eeb0fd" xlink:to="loc_us-gaap_EarningsPerShareBasic_96a58170-7764-411d-9fb4-68ad9f841c93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0a99c740-93de-42d7-8c27-97f02e14b9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fc50053d-144a-4b6d-905f-78ca38eeb0fd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0a99c740-93de-42d7-8c27-97f02e14b9cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a664dd86-a762-48f5-83c3-379a1ac4f172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a664dd86-a762-48f5-83c3-379a1ac4f172" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cef32ee8-9787-4d4f-aafc-846fc065ffdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a664dd86-a762-48f5-83c3-379a1ac4f172" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cef32ee8-9787-4d4f-aafc-846fc065ffdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_43043ddb-69b8-498e-a316-c46c3c10ab8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a664dd86-a762-48f5-83c3-379a1ac4f172" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_43043ddb-69b8-498e-a316-c46c3c10ab8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0587a409-d62c-4373-9078-d50dedd03321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_5656a820-6bbc-4822-85cc-7e69a36f016c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_5656a820-6bbc-4822-85cc-7e69a36f016c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_91259192-4632-4664-9597-b6086bb87bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_5656a820-6bbc-4822-85cc-7e69a36f016c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_91259192-4632-4664-9597-b6086bb87bbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_df562eee-4ae7-4d1a-9203-641631ad3458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_df562eee-4ae7-4d1a-9203-641631ad3458" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cc90635d-efad-4d3a-8627-019383fe1bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_StatementTable_cc90635d-efad-4d3a-8627-019383fe1bc5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d0293795-46be-4219-a4e6-614e7348d5ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_cc90635d-efad-4d3a-8627-019383fe1bc5" xlink:to="loc_srt_ProductOrServiceAxis_d0293795-46be-4219-a4e6-614e7348d5ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d0293795-46be-4219-a4e6-614e7348d5ad_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d0293795-46be-4219-a4e6-614e7348d5ad" xlink:to="loc_srt_ProductsAndServicesDomain_d0293795-46be-4219-a4e6-614e7348d5ad_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eab8891f-53bf-400a-b597-5a4d47f65d0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d0293795-46be-4219-a4e6-614e7348d5ad" xlink:to="loc_srt_ProductsAndServicesDomain_eab8891f-53bf-400a-b597-5a4d47f65d0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember_3b9a9dc0-98c6-42ba-b33f-db1d9967a023" xlink:href="aort-20230331.xsd#aort_ProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_eab8891f-53bf-400a-b597-5a4d47f65d0f" xlink:to="loc_aort_ProductsMember_3b9a9dc0-98c6-42ba-b33f-db1d9967a023" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_fad714a8-452c-4a3c-ad71-8c8ecc45d131" xlink:href="aort-20230331.xsd#aort_PreservationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_eab8891f-53bf-400a-b597-5a4d47f65d0f" xlink:to="loc_aort_PreservationServicesMember_fad714a8-452c-4a3c-ad71-8c8ecc45d131" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended" id="i28d6831159a0482ebab54b1e91d95d9d_CondensedConsolidatedStatementsofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8d9fd956-6ce1-455c-aca7-2ed5264b18d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d9fd956-6ce1-455c-aca7-2ed5264b18d9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5ea36b61-e46f-46da-874a-535ee0a36cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5ea36b61-e46f-46da-874a-535ee0a36cf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4a184b55-7656-48fc-8c7c-3268b2fbc294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockholdersEquity_4a184b55-7656-48fc-8c7c-3268b2fbc294" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_7ca22b1f-cbb5-4fb4-a60f-68e8348ad18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_TreasuryStockCommonShares_7ca22b1f-cbb5-4fb4-a60f-68e8348ad18d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_0c167e0e-fc69-4338-a2e9-87824cffb7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_TreasuryStockCommonValue_0c167e0e-fc69-4338-a2e9-87824cffb7ff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4f5c7976-e21e-4f04-882a-005e1625c314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_NetIncomeLoss_4f5c7976-e21e-4f04-882a-005e1625c314" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_82a58568-c59b-42c1-906e-35bc37e533b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_82a58568-c59b-42c1-906e-35bc37e533b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_45ab28b7-6866-489f-9e4a-7d9e62169f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_45ab28b7-6866-489f-9e4a-7d9e62169f3b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_753fa3aa-fb75-4ea0-870c-cf5ac0f3c44b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_753fa3aa-fb75-4ea0-870c-cf5ac0f3c44b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a87fa4c1-2e35-409b-9bfe-80d66b487a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a87fa4c1-2e35-409b-9bfe-80d66b487a53" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_91d6d4c1-297f-46d8-8096-8dd6e596910e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_91d6d4c1-297f-46d8-8096-8dd6e596910e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_da7a03c0-1649-401e-86f2-7eadf8131858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_da7a03c0-1649-401e-86f2-7eadf8131858" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c2c235f2-e929-4fbf-b32a-1c74c3e14265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c2c235f2-e929-4fbf-b32a-1c74c3e14265" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_3349abd4-c346-4f78-9fc9-81ee3eddc047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_3349abd4-c346-4f78-9fc9-81ee3eddc047" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_b0b7d5fa-e508-41af-badf-da6e5554f7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_b0b7d5fa-e508-41af-badf-da6e5554f7e1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bded435c-1fdb-406c-93c7-f345df2cea52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c0bffc84-a3ee-4649-a431-d833a003371a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_2b8a6d38-0c03-4d91-aa68-c4119926d2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_54c26859-d0b9-434c-9507-f45bce111e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f2607bf1-96af-4b95-b586-c705c87c4620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8d9fd956-6ce1-455c-aca7-2ed5264b18d9" xlink:to="loc_us-gaap_StatementTable_f2607bf1-96af-4b95-b586-c705c87c4620" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_264bf80f-e81b-485a-ba41-d7e199537f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f2607bf1-96af-4b95-b586-c705c87c4620" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_264bf80f-e81b-485a-ba41-d7e199537f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_264bf80f-e81b-485a-ba41-d7e199537f1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_264bf80f-e81b-485a-ba41-d7e199537f1a" xlink:to="loc_us-gaap_EquityComponentDomain_264bf80f-e81b-485a-ba41-d7e199537f1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_264bf80f-e81b-485a-ba41-d7e199537f1a" xlink:to="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_29129159-e164-4f8a-b0f8-f8f882d4f4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_CommonStockMember_29129159-e164-4f8a-b0f8-f8f882d4f4ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ef489590-dda5-4d0f-abc0-c1aaf0b4d9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ef489590-dda5-4d0f-abc0-c1aaf0b4d9fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_40e4c968-56c9-4103-a30d-156cc0103289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_RetainedEarningsMember_40e4c968-56c9-4103-a30d-156cc0103289" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df2763c5-49f8-4bc1-998b-cdf6ae3c7fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df2763c5-49f8-4bc1-998b-cdf6ae3c7fc2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_c5709c74-d79a-4825-ac03-7c1770425f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_TreasuryStockCommonMember_c5709c74-d79a-4825-ac03-7c1770425f6f" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="extended" id="id24a14531095465eacc8fb06bd332800_FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_000a0fe7-96e6-490e-9f6e-d1699864c28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_000a0fe7-96e6-490e-9f6e-d1699864c28f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b4383615-ea74-4757-9552-1904368ee0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b4383615-ea74-4757-9552-1904368ee0eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ContingentConsiderationNoncurrentFairValue_ebc23606-e1ed-4480-bcf6-86bff2c1adba" xlink:href="aort-20230331.xsd#aort_ContingentConsiderationNoncurrentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_aort_ContingentConsiderationNoncurrentFairValue_ebc23606-e1ed-4480-bcf6-86bff2c1adba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_dd218dd5-501c-49e9-96bd-f35abfb4326a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_dd218dd5-501c-49e9-96bd-f35abfb4326a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_df7a82f6-7270-47b3-951b-78bc71cc2192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_df7a82f6-7270-47b3-951b-78bc71cc2192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df7a82f6-7270-47b3-951b-78bc71cc2192_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_df7a82f6-7270-47b3-951b-78bc71cc2192" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_df7a82f6-7270-47b3-951b-78bc71cc2192_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_df7a82f6-7270-47b3-951b-78bc71cc2192" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1643bec1-b892-4eb8-89fa-dd78c6d063a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1643bec1-b892-4eb8-89fa-dd78c6d063a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2dcf036a-d669-41ab-9223-a1e15d31ad1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2dcf036a-d669-41ab-9223-a1e15d31ad1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_acd2428f-8b08-4005-a6b0-2b91948f4f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_acd2428f-8b08-4005-a6b0-2b91948f4f1d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_6cae1a10-27df-4d1c-acff-f12726ffd4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_6cae1a10-27df-4d1c-acff-f12726ffd4fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6cae1a10-27df-4d1c-acff-f12726ffd4fd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6cae1a10-27df-4d1c-acff-f12726ffd4fd" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6cae1a10-27df-4d1c-acff-f12726ffd4fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27306752-6d36-410f-92b9-7799cf540be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6cae1a10-27df-4d1c-acff-f12726ffd4fd" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27306752-6d36-410f-92b9-7799cf540be8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_9133afed-578c-4048-ad9e-ff50ac16f76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27306752-6d36-410f-92b9-7799cf540be8" xlink:to="loc_us-gaap_MoneyMarketFundsMember_9133afed-578c-4048-ad9e-ff50ac16f76f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended" id="ic5966c41e923497795b87f1cc8392d8c_FinancialInstrumentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f28d6cda-ba5d-45ef-a341-15de650fdf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f28d6cda-ba5d-45ef-a341-15de650fdf1b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_fb8189aa-c6f6-4a8a-90a3-8c564c699696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_fb8189aa-c6f6-4a8a-90a3-8c564c699696" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9b21279c-3c50-4110-adf7-a2a9544fbd54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9b21279c-3c50-4110-adf7-a2a9544fbd54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_11bb54df-fefa-412c-ab24-b87456108a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_11bb54df-fefa-412c-ab24-b87456108a3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ba75e46e-bb93-43bf-a563-92f97fec3e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ba75e46e-bb93-43bf-a563-92f97fec3e26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba75e46e-bb93-43bf-a563-92f97fec3e26_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ba75e46e-bb93-43bf-a563-92f97fec3e26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ba75e46e-bb93-43bf-a563-92f97fec3e26_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93359c14-ae4c-45a1-bc3a-7913e53199c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ba75e46e-bb93-43bf-a563-92f97fec3e26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93359c14-ae4c-45a1-bc3a-7913e53199c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AscyrusMedicalLlcMember_fa96d714-3686-4583-a43c-f2bbac201736" xlink:href="aort-20230331.xsd#aort_AscyrusMedicalLlcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93359c14-ae4c-45a1-bc3a-7913e53199c3" xlink:to="loc_aort_AscyrusMedicalLlcMember_fa96d714-3686-4583-a43c-f2bbac201736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7ff75361-1197-4b39-999e-cacaddda89de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7ff75361-1197-4b39-999e-cacaddda89de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_7ff75361-1197-4b39-999e-cacaddda89de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7ff75361-1197-4b39-999e-cacaddda89de" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_7ff75361-1197-4b39-999e-cacaddda89de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_db32b499-3852-4753-b1a8-7210a33f59b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7ff75361-1197-4b39-999e-cacaddda89de" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_db32b499-3852-4753-b1a8-7210a33f59b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_70b6a095-62cf-4363-bc70-dc0609a91c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_db32b499-3852-4753-b1a8-7210a33f59b5" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_70b6a095-62cf-4363-bc70-dc0609a91c00" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#InventoriesnetandDeferredPreservationCostsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails" xlink:type="extended" id="i272f56c3d4a94423bcf7a1d8e480c283_InventoriesnetandDeferredPreservationCostsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_3e24bda5-85b3-4553-9254-1e7468f7ea54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_3e24bda5-85b3-4553-9254-1e7468f7ea54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ConsignmentInventoryPercentage_335a200c-6a74-427f-872b-cf946fd59987" xlink:href="aort-20230331.xsd#aort_ConsignmentInventoryPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_aort_ConsignmentInventoryPercentage_335a200c-6a74-427f-872b-cf946fd59987" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts_03837886-97c7-4f75-917d-8547488160d7" xlink:href="aort-20230331.xsd#aort_DeferredPreservationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_aort_DeferredPreservationCosts_03837886-97c7-4f75-917d-8547488160d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_8ef9a22a-d9af-4973-8711-e0c02af58cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_us-gaap_InventoryValuationReserves_8ef9a22a-d9af-4973-8711-e0c02af58cae" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_231ef3e2-a24b-48fd-8868-0c218571a157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_us-gaap_InventoryCurrentTable_231ef3e2-a24b-48fd-8868-0c218571a157" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a5f3c583-07e7-49b5-b255-ecea5b2627c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_231ef3e2-a24b-48fd-8868-0c218571a157" xlink:to="loc_srt_StatementGeographicalAxis_a5f3c583-07e7-49b5-b255-ecea5b2627c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a5f3c583-07e7-49b5-b255-ecea5b2627c9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_a5f3c583-07e7-49b5-b255-ecea5b2627c9" xlink:to="loc_srt_SegmentGeographicalDomain_a5f3c583-07e7-49b5-b255-ecea5b2627c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_61da4427-45b6-4c4e-8253-7120ef081029" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_a5f3c583-07e7-49b5-b255-ecea5b2627c9" xlink:to="loc_srt_SegmentGeographicalDomain_61da4427-45b6-4c4e-8253-7120ef081029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_16d99bd7-461a-4873-9015-ddcf3d172398" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_61da4427-45b6-4c4e-8253-7120ef081029" xlink:to="loc_country_US_16d99bd7-461a-4873-9015-ddcf3d172398" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_deeb3243-4245-4545-a7e9-7805cb77d278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_61da4427-45b6-4c4e-8253-7120ef081029" xlink:to="loc_us-gaap_NonUsMember_deeb3243-4245-4545-a7e9-7805cb77d278" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended" id="i64d4023f6dd447c9b5e805952e43a4e9_GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41585e46-9927-4ef0-9efb-bbe18580d12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_476fa714-3dd7-4b3c-84c7-a40bbfe2b623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41585e46-9927-4ef0-9efb-bbe18580d12f" xlink:to="loc_us-gaap_Goodwill_476fa714-3dd7-4b3c-84c7-a40bbfe2b623" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ee784364-c624-421d-9476-5aa154ce449d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41585e46-9927-4ef0-9efb-bbe18580d12f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ee784364-c624-421d-9476-5aa154ce449d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_47bf86f0-3e25-4576-b5ce-eefb880c4cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41585e46-9927-4ef0-9efb-bbe18580d12f" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_47bf86f0-3e25-4576-b5ce-eefb880c4cec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a3257a2-27f7-4edf-8c66-7c13c5869761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_47bf86f0-3e25-4576-b5ce-eefb880c4cec" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a3257a2-27f7-4edf-8c66-7c13c5869761" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4a3257a2-27f7-4edf-8c66-7c13c5869761_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a3257a2-27f7-4edf-8c66-7c13c5869761" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4a3257a2-27f7-4edf-8c66-7c13c5869761_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_91897bf3-aa74-4361-a337-6d263e86fa67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a3257a2-27f7-4edf-8c66-7c13c5869761" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_91897bf3-aa74-4361-a337-6d263e86fa67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_b78d62c3-2cbd-4143-9c21-b259675c2b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_91897bf3-aa74-4361-a337-6d263e86fa67" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_b78d62c3-2cbd-4143-9c21-b259675c2b16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_4238d241-472b-4f49-be52-1231964b0472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_91897bf3-aa74-4361-a337-6d263e86fa67" xlink:to="loc_us-gaap_ContractualRightsMember_4238d241-472b-4f49-be52-1231964b0472" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="extended" id="i8fe0e351a8de4867ae3a153c4439f753_GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_847e032c-40fe-4b70-8b71-f8bf950ad5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_847e032c-40fe-4b70-8b71-f8bf950ad5cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3c0f8588-33c8-48a2-b2a7-ecc22a4c8e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3c0f8588-33c8-48a2-b2a7-ecc22a4c8e35" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_64dce7b6-0269-496a-95cd-758bd19fd540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_64dce7b6-0269-496a-95cd-758bd19fd540" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55eda0e4-3c43-42c7-b81b-d01eaaabb544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55eda0e4-3c43-42c7-b81b-d01eaaabb544" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d4f5253e-5d2a-4060-a030-faad52971554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d4f5253e-5d2a-4060-a030-faad52971554" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7d27b6db-d115-4f7e-a684-e5503a7534e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d4f5253e-5d2a-4060-a030-faad52971554" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7d27b6db-d115-4f7e-a684-e5503a7534e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7d27b6db-d115-4f7e-a684-e5503a7534e7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7d27b6db-d115-4f7e-a684-e5503a7534e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7d27b6db-d115-4f7e-a684-e5503a7534e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d563f6a3-2739-4814-9298-b1ea49f8fb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7d27b6db-d115-4f7e-a684-e5503a7534e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d563f6a3-2739-4814-9298-b1ea49f8fb98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_44dfe529-b3e8-446d-bc4b-5d390079ad2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d563f6a3-2739-4814-9298-b1ea49f8fb98" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_44dfe529-b3e8-446d-bc4b-5d390079ad2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:href="aort-20230331.xsd#aort_IntangibleAssetsOtherThanAcquiredTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d563f6a3-2739-4814-9298-b1ea49f8fb98" xlink:to="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember_b0ae2971-9b80-42c9-8119-f2a831033f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:to="loc_us-gaap_CustomerListsMember_b0ae2971-9b80-42c9-8119-f2a831033f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_4999d58d-4800-4e88-8169-97d4b0b0d604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:to="loc_us-gaap_DistributionRightsMember_4999d58d-4800-4e88-8169-97d4b0b0d604" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_0c170eba-d8e7-42ef-bc44-8788dd359e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:to="loc_us-gaap_PatentsMember_0c170eba-d8e7-42ef-bc44-8788dd359e24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_cf4e074c-0ebc-4fed-b2ef-81dc00dcc488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_cf4e074c-0ebc-4fed-b2ef-81dc00dcc488" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/DebtNarrativeDetails" xlink:type="extended" id="i5a16fe1335144fc5bc0fcb984b665674_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d44e7da0-586d-4206-a594-a6ab96b253f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d44e7da0-586d-4206-a594-a6ab96b253f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e8988ecf-b4a5-4eb3-8155-6732b566f0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e8988ecf-b4a5-4eb3-8155-6732b566f0ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionPeriod_b7828b92-b288-472e-be47-3e6ae4686966" xlink:href="aort-20230331.xsd#aort_DebtInstrumentExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_aort_DebtInstrumentExtensionPeriod_b7828b92-b288-472e-be47-3e6ae4686966" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_96f1a066-819f-4521-8f07-469c56fcc04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_96f1a066-819f-4521-8f07-469c56fcc04b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionCircumstancePeriod_0ce29501-e577-42c4-82fc-d7f44c88a3c9" xlink:href="aort-20230331.xsd#aort_DebtInstrumentExtensionCircumstancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_aort_DebtInstrumentExtensionCircumstancePeriod_0ce29501-e577-42c4-82fc-d7f44c88a3c9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b0f08d59-3ccc-4104-a55f-4fee9aab2f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b0f08d59-3ccc-4104-a55f-4fee9aab2f05" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2ce8304b-6cf5-4043-a1c7-6d422098344d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2ce8304b-6cf5-4043-a1c7-6d422098344d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_2544cbf2-ea52-466f-9067-0ddaf7c672cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_2544cbf2-ea52-466f-9067-0ddaf7c672cb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_46ddc7fb-87d6-4f00-b2eb-a34759cad126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_46ddc7fb-87d6-4f00-b2eb-a34759cad126" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_dde4004d-f580-463f-986c-68d6735dc33f" xlink:href="aort-20230331.xsd#aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_dde4004d-f580-463f-986c-68d6735dc33f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9f1ed2bc-ddbc-4f9f-8996-5616d65cf68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9f1ed2bc-ddbc-4f9f-8996-5616d65cf68f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_98ed4b62-31b8-4323-b7c0-362165200974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_98ed4b62-31b8-4323-b7c0-362165200974" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_9a52c8c5-ed05-47d7-acd8-203eaa9e21d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_9a52c8c5-ed05-47d7-acd8-203eaa9e21d2" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_11bac857-10ad-46d5-90fc-1ee1ec5dd060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_LongTermDebt_11bac857-10ad-46d5-90fc-1ee1ec5dd060" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_c4e45f6f-ba84-4217-98dc-2c9e28be43ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_c4e45f6f-ba84-4217-98dc-2c9e28be43ff" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_59b7a786-d991-456a-a63e-eaf1f77e97ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_59b7a786-d991-456a-a63e-eaf1f77e97ae" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d1a877f6-9bb3-488c-ac51-4019f1fe36f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d1a877f6-9bb3-488c-ac51-4019f1fe36f0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_fd5e9ee7-aeb7-4159-8300-85db21386adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_InterestExpenseDebt_fd5e9ee7-aeb7-4159-8300-85db21386adf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_b81bf0db-ceba-41d0-9755-c63f3ef27f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_b81bf0db-ceba-41d0-9755-c63f3ef27f2d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_9ecd1a2a-7e01-4b94-baaf-f71d108878d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_9ecd1a2a-7e01-4b94-baaf-f71d108878d4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e4581129-5642-462f-9d1b-a7bc442d9b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e4581129-5642-462f-9d1b-a7bc442d9b60" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_3e9debf0-6a76-4dbf-9df4-6aee36ced174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_3e9debf0-6a76-4dbf-9df4-6aee36ced174" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_7c92d1fb-efe2-48fe-b4c5-f408a0e7ee84" xlink:href="aort-20230331.xsd#aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_7c92d1fb-efe2-48fe-b4c5-f408a0e7ee84" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1d5ae643-0590-4844-a9bb-8f33163aa7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1d5ae643-0590-4844-a9bb-8f33163aa7a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_1d5ae643-0590-4844-a9bb-8f33163aa7a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1d5ae643-0590-4844-a9bb-8f33163aa7a5" xlink:to="loc_us-gaap_TypeOfAdoptionMember_1d5ae643-0590-4844-a9bb-8f33163aa7a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_625a94df-79e4-4252-a1ff-eafbeea5382d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1d5ae643-0590-4844-a9bb-8f33163aa7a5" xlink:to="loc_us-gaap_TypeOfAdoptionMember_625a94df-79e4-4252-a1ff-eafbeea5382d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_5fa63281-fa13-4f5e-8266-d56c126b180e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_625a94df-79e4-4252-a1ff-eafbeea5382d" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_5fa63281-fa13-4f5e-8266-d56c126b180e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c8201e-e4d0-4be5-9c23-0aaf2002a766" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c8201e-e4d0-4be5-9c23-0aaf2002a766" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1c8201e-e4d0-4be5-9c23-0aaf2002a766_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c8201e-e4d0-4be5-9c23-0aaf2002a766" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_d1c8201e-e4d0-4be5-9c23-0aaf2002a766_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f1364133-71b7-47c9-9b6d-8abb201da925" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c8201e-e4d0-4be5-9c23-0aaf2002a766" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f1364133-71b7-47c9-9b6d-8abb201da925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_74164846-dcdd-48cc-a6ef-b1d9f603a8e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f1364133-71b7-47c9-9b6d-8abb201da925" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_74164846-dcdd-48cc-a6ef-b1d9f603a8e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_393834b5-6066-4316-9565-c4fa2c1338ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_CreditFacilityAxis_393834b5-6066-4316-9565-c4fa2c1338ce" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_393834b5-6066-4316-9565-c4fa2c1338ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_393834b5-6066-4316-9565-c4fa2c1338ce" xlink:to="loc_us-gaap_CreditFacilityDomain_393834b5-6066-4316-9565-c4fa2c1338ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_393834b5-6066-4316-9565-c4fa2c1338ce" xlink:to="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4e001a66-586f-4b3c-b487-01ada3b34739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:to="loc_us-gaap_SecuredDebtMember_4e001a66-586f-4b3c-b487-01ada3b34739" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_79d645bc-b1dd-44c7-a67b-e97105f0cbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:to="loc_us-gaap_LoansPayableMember_79d645bc-b1dd-44c7-a67b-e97105f0cbd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a6734807-e11a-4450-9827-462c54048e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a6734807-e11a-4450-9827-462c54048e41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityAndTermLoanMember_40aa3514-c7e5-45f9-8ae7-42e4168fc336" xlink:href="aort-20230331.xsd#aort_RevolvingCreditFacilityAndTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:to="loc_aort_RevolvingCreditFacilityAndTermLoanMember_40aa3514-c7e5-45f9-8ae7-42e4168fc336" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bf1d7476-77ea-4b2c-b67c-d8548b67dca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_VariableRateAxis_bf1d7476-77ea-4b2c-b67c-d8548b67dca5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_bf1d7476-77ea-4b2c-b67c-d8548b67dca5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_bf1d7476-77ea-4b2c-b67c-d8548b67dca5" xlink:to="loc_us-gaap_VariableRateDomain_bf1d7476-77ea-4b2c-b67c-d8548b67dca5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_bf1d7476-77ea-4b2c-b67c-d8548b67dca5" xlink:to="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_c11ee795-1806-424a-9de5-9acc1eb2eeba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:to="loc_us-gaap_BaseRateMember_c11ee795-1806-424a-9de5-9acc1eb2eeba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d6a9b413-d00b-4c11-b609-d319a9884ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d6a9b413-d00b-4c11-b609-d319a9884ab5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_17432936-2a02-4907-b258-91a35e2a33f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_17432936-2a02-4907-b258-91a35e2a33f8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3dff6a30-ef5e-4804-ad54-a9b076e86c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3dff6a30-ef5e-4804-ad54-a9b076e86c95" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3dff6a30-ef5e-4804-ad54-a9b076e86c95_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3dff6a30-ef5e-4804-ad54-a9b076e86c95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3dff6a30-ef5e-4804-ad54-a9b076e86c95_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0d33c143-2fdf-414f-981a-3b63aae1200a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3dff6a30-ef5e-4804-ad54-a9b076e86c95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0d33c143-2fdf-414f-981a-3b63aae1200a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_9fff956b-a923-4b58-9380-9e1e3bcb5a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0d33c143-2fdf-414f-981a-3b63aae1200a" xlink:to="loc_us-gaap_ConvertibleDebtMember_9fff956b-a923-4b58-9380-9e1e3bcb5a04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e398deeb-edd2-4eff-a5c4-65fe6f046e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_DebtInstrumentAxis_e398deeb-edd2-4eff-a5c4-65fe6f046e89" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e398deeb-edd2-4eff-a5c4-65fe6f046e89_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e398deeb-edd2-4eff-a5c4-65fe6f046e89" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e398deeb-edd2-4eff-a5c4-65fe6f046e89_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2a8a2481-67eb-478b-a936-d7ccc128bc51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e398deeb-edd2-4eff-a5c4-65fe6f046e89" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2a8a2481-67eb-478b-a936-d7ccc128bc51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CreditAgreementMember_788ba425-4c4d-49cc-97ca-f643fb8e84d4" xlink:href="aort-20230331.xsd#aort_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2a8a2481-67eb-478b-a936-d7ccc128bc51" xlink:to="loc_aort_CreditAgreementMember_788ba425-4c4d-49cc-97ca-f643fb8e84d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16ff79c4-8099-4b0a-ba36-f28589138120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_16ff79c4-8099-4b0a-ba36-f28589138120" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_16ff79c4-8099-4b0a-ba36-f28589138120_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16ff79c4-8099-4b0a-ba36-f28589138120" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_16ff79c4-8099-4b0a-ba36-f28589138120_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ab78b737-fd72-4a2b-a092-95a2449ab82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16ff79c4-8099-4b0a-ba36-f28589138120" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ab78b737-fd72-4a2b-a092-95a2449ab82e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_66e8c4ba-82b1-49d2-8606-9a0f154603db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ab78b737-fd72-4a2b-a092-95a2449ab82e" xlink:to="loc_us-gaap_InterestExpenseMember_66e8c4ba-82b1-49d2-8606-9a0f154603db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodAxis_976b4eed-31be-4cd0-9282-7150ead03a38" xlink:href="aort-20230331.xsd#aort_DebtPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_aort_DebtPeriodAxis_976b4eed-31be-4cd0-9282-7150ead03a38" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodDomain_976b4eed-31be-4cd0-9282-7150ead03a38_default" xlink:href="aort-20230331.xsd#aort_DebtPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_aort_DebtPeriodAxis_976b4eed-31be-4cd0-9282-7150ead03a38" xlink:to="loc_aort_DebtPeriodDomain_976b4eed-31be-4cd0-9282-7150ead03a38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:href="aort-20230331.xsd#aort_DebtPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_aort_DebtPeriodAxis_976b4eed-31be-4cd0-9282-7150ead03a38" xlink:to="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIMember_1d971b7e-4204-4a1d-94ba-ab53a67c2ce0" xlink:href="aort-20230331.xsd#aort_CircumstanceIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:to="loc_aort_CircumstanceIMember_1d971b7e-4204-4a1d-94ba-ab53a67c2ce0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIiMember_eb5f328d-d49d-480a-bd08-664689279998" xlink:href="aort-20230331.xsd#aort_CircumstanceIiMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:to="loc_aort_CircumstanceIiMember_eb5f328d-d49d-480a-bd08-664689279998" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceAfterJuly52023Member_0d5a8322-4165-4586-a41c-28d9978593c4" xlink:href="aort-20230331.xsd#aort_CircumstanceAfterJuly52023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:to="loc_aort_CircumstanceAfterJuly52023Member_0d5a8322-4165-4586-a41c-28d9978593c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f40866b7-53c8-4d88-b8c6-1fa519497654" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_srt_RangeAxis_f40866b7-53c8-4d88-b8c6-1fa519497654" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f40866b7-53c8-4d88-b8c6-1fa519497654_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f40866b7-53c8-4d88-b8c6-1fa519497654" xlink:to="loc_srt_RangeMember_f40866b7-53c8-4d88-b8c6-1fa519497654_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c397beec-5379-487f-8519-9871a946842b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f40866b7-53c8-4d88-b8c6-1fa519497654" xlink:to="loc_srt_RangeMember_c397beec-5379-487f-8519-9871a946842b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f353deda-6a8a-4148-956a-e4107eccd567" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c397beec-5379-487f-8519-9871a946842b" xlink:to="loc_srt_MinimumMember_f353deda-6a8a-4148-956a-e4107eccd567" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9be4933c-8ff1-47f5-ae9d-772a26e1b680" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c397beec-5379-487f-8519-9871a946842b" xlink:to="loc_srt_MaximumMember_9be4933c-8ff1-47f5-ae9d-772a26e1b680" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="extended" id="ia96babf4efdf4f21b73f5b16616f7772_DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_71a5bf27-8f59-49a4-a074-e8b6ad8bde88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_71a5bf27-8f59-49a4-a074-e8b6ad8bde88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a0d6508a-27d7-4052-a976-dc3a8967a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a0d6508a-27d7-4052-a976-dc3a8967a02d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9aa41e15-9595-4057-a408-39f2c2ba8e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_LongTermDebt_9aa41e15-9595-4057-a408-39f2c2ba8e64" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0a55af86-70a8-4c73-bdf3-cb61fbb217ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_LongTermDebtCurrent_0a55af86-70a8-4c73-bdf3-cb61fbb217ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cb8a7852-ad66-42f9-92b9-7f2b4c3f8889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cb8a7852-ad66-42f9-92b9-7f2b4c3f8889" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d5f1f3ff-6b9a-458a-826f-351e6890c1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d5f1f3ff-6b9a-458a-826f-351e6890c1cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d679334b-6948-4fa6-9d25-6a1a73bd1560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:to="loc_us-gaap_CreditFacilityAxis_d679334b-6948-4fa6-9d25-6a1a73bd1560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d679334b-6948-4fa6-9d25-6a1a73bd1560_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d679334b-6948-4fa6-9d25-6a1a73bd1560" xlink:to="loc_us-gaap_CreditFacilityDomain_d679334b-6948-4fa6-9d25-6a1a73bd1560_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a58dae09-162c-435e-a15b-67430d0c526f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d679334b-6948-4fa6-9d25-6a1a73bd1560" xlink:to="loc_us-gaap_CreditFacilityDomain_a58dae09-162c-435e-a15b-67430d0c526f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_60678a02-c69d-43d7-bc8d-e402f9442401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a58dae09-162c-435e-a15b-67430d0c526f" xlink:to="loc_us-gaap_LoansPayableMember_60678a02-c69d-43d7-bc8d-e402f9442401" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c924145c-b8e7-4c61-9017-06bde1ea300a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_a58dae09-162c-435e-a15b-67430d0c526f" xlink:to="loc_us-gaap_ConvertibleDebtMember_c924145c-b8e7-4c61-9017-06bde1ea300a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b391d26d-ce9e-400a-87ed-add8c35e3257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b391d26d-ce9e-400a-87ed-add8c35e3257" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan1Member_adf9edb6-1019-47cd-9898-2a4ad18086ef" xlink:href="aort-20230331.xsd#aort_GovernmentSponsoredDebtKfwLoan1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b391d26d-ce9e-400a-87ed-add8c35e3257" xlink:to="loc_aort_GovernmentSponsoredDebtKfwLoan1Member_adf9edb6-1019-47cd-9898-2a4ad18086ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan2Member_5bc296d8-bea8-4bce-8760-43ec137ad0f0" xlink:href="aort-20230331.xsd#aort_GovernmentSponsoredDebtKfwLoan2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b391d26d-ce9e-400a-87ed-add8c35e3257" xlink:to="loc_aort_GovernmentSponsoredDebtKfwLoan2Member_5bc296d8-bea8-4bce-8760-43ec137ad0f0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#RevenueRecognitionDisaggregationOfRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended" id="i75d851ce381648cb9662cf11dd1ac238_RevenueRecognitionDisaggregationOfRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f2a1fe96-8b96-4e64-a697-97fdbf06c407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3fdadfcf-3b1d-4b69-93bd-d2ae2324fb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f2a1fe96-8b96-4e64-a697-97fdbf06c407" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3fdadfcf-3b1d-4b69-93bd-d2ae2324fb26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6d2113d6-f13b-4359-a740-24fdb22a1338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f2a1fe96-8b96-4e64-a697-97fdbf06c407" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6d2113d6-f13b-4359-a740-24fdb22a1338" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6ad67cd8-db2f-4031-b723-dab835cc7faa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6d2113d6-f13b-4359-a740-24fdb22a1338" xlink:to="loc_srt_ProductOrServiceAxis_6ad67cd8-db2f-4031-b723-dab835cc7faa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_6ad67cd8-db2f-4031-b723-dab835cc7faa_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_6ad67cd8-db2f-4031-b723-dab835cc7faa" xlink:to="loc_srt_ProductsAndServicesDomain_6ad67cd8-db2f-4031-b723-dab835cc7faa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_6ad67cd8-db2f-4031-b723-dab835cc7faa" xlink:to="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DomesticHospitalsMember_81769f05-4b85-4978-a941-f04437f51b22" xlink:href="aort-20230331.xsd#aort_DomesticHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:to="loc_aort_DomesticHospitalsMember_81769f05-4b85-4978-a941-f04437f51b22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalHospitalsMember_33cb77c8-62cb-48e4-bed2-4b1782fd2697" xlink:href="aort-20230331.xsd#aort_InternationalHospitalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:to="loc_aort_InternationalHospitalsMember_33cb77c8-62cb-48e4-bed2-4b1782fd2697" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalDistributorMember_6f2fa088-a650-43d6-a350-a7674939f2b5" xlink:href="aort-20230331.xsd#aort_InternationalDistributorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:to="loc_aort_InternationalDistributorMember_6f2fa088-a650-43d6-a350-a7674939f2b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CardiogenesisMember_9f6163a3-5c90-47ad-92ef-4daeb7daa9bc" xlink:href="aort-20230331.xsd#aort_CardiogenesisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:to="loc_aort_CardiogenesisMember_9f6163a3-5c90-47ad-92ef-4daeb7daa9bc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#StockCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/StockCompensationNarrativeDetails" xlink:type="extended" id="i2f43f89882464edf98c0fcb2ba3fe80a_StockCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a286363f-8ccb-4446-9a4b-278e17e125c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a286363f-8ccb-4446-9a4b-278e17e125c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_64017897-0d6c-4585-9723-749827a6d667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_64017897-0d6c-4585-9723-749827a6d667" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_1759a840-7cc0-4012-a63a-5e3b6c20bf94" xlink:href="aort-20230331.xsd#aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_1759a840-7cc0-4012-a63a-5e3b6c20bf94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_079edb8b-ee43-4639-9720-fd4c514b02a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_079edb8b-ee43-4639-9720-fd4c514b02a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a63edfa2-3dd6-4ae1-9cd2-0142485eeb23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a63edfa2-3dd6-4ae1-9cd2-0142485eeb23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_4d8ba9e9-11c1-4f99-8a4f-e0df1a08ce32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_4d8ba9e9-11c1-4f99-8a4f-e0df1a08ce32" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_272c677e-8e61-4b6f-98af-981f6eed8f3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:to="loc_srt_TitleOfIndividualAxis_272c677e-8e61-4b6f-98af-981f6eed8f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_272c677e-8e61-4b6f-98af-981f6eed8f3f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_272c677e-8e61-4b6f-98af-981f6eed8f3f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_272c677e-8e61-4b6f-98af-981f6eed8f3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1f825183-6a29-415a-9aae-f624ea9ca1d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_272c677e-8e61-4b6f-98af-981f6eed8f3f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1f825183-6a29-415a-9aae-f624ea9ca1d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_84165e97-1cdf-41fb-8533-8dc7d09bf866" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1f825183-6a29-415a-9aae-f624ea9ca1d6" xlink:to="loc_srt_OfficerMember_84165e97-1cdf-41fb-8533-8dc7d09bf866" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_07c9137b-654a-4811-b1f7-385c793fc748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:to="loc_us-gaap_AwardTypeAxis_07c9137b-654a-4811-b1f7-385c793fc748" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07c9137b-654a-4811-b1f7-385c793fc748_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_07c9137b-654a-4811-b1f7-385c793fc748" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_07c9137b-654a-4811-b1f7-385c793fc748_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd4077a7-0098-4a93-8c6f-b20ba147f641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_07c9137b-654a-4811-b1f7-385c793fc748" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd4077a7-0098-4a93-8c6f-b20ba147f641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d8741da5-d2b8-4f85-8965-13cabd745104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd4077a7-0098-4a93-8c6f-b20ba147f641" xlink:to="loc_us-gaap_EmployeeStockMember_d8741da5-d2b8-4f85-8965-13cabd745104" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockUnitsAndPreferredStockUnitsMember_233390fa-04de-436c-964b-7808d4b8640e" xlink:href="aort-20230331.xsd#aort_RestrictedStockUnitsAndPreferredStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd4077a7-0098-4a93-8c6f-b20ba147f641" xlink:to="loc_aort_RestrictedStockUnitsAndPreferredStockUnitsMember_233390fa-04de-436c-964b-7808d4b8640e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" xlink:type="extended" id="i09743d4cfc3442e5bf9d0fe7102a03e8_StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7e6ea9b1-f498-4ab8-9c0c-2b4d2f728aff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7e6ea9b1-f498-4ab8-9c0c-2b4d2f728aff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1f6c738a-0ab4-4433-824f-ce9d59a7bddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1f6c738a-0ab4-4433-824f-ce9d59a7bddb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_81426b5e-a4e7-47da-b2a0-712c741fc699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_81426b5e-a4e7-47da-b2a0-712c741fc699" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6389801-a7b8-4145-b9c0-217dbf48250c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6389801-a7b8-4145-b9c0-217dbf48250c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6389801-a7b8-4145-b9c0-217dbf48250c" xlink:to="loc_us-gaap_AwardTypeAxis_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607457c4-d26c-4cc2-b49d-94dfc8bfd45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607457c4-d26c-4cc2-b49d-94dfc8bfd45f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_61daf558-98ae-4f63-aa7f-160dd6e0c036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607457c4-d26c-4cc2-b49d-94dfc8bfd45f" xlink:to="loc_us-gaap_EmployeeStockMember_61daf558-98ae-4f63-aa7f-160dd6e0c036" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#StockCompensationSummaryOfTotalStockCompensationExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails" xlink:type="extended" id="i66c0df0f84964539b44f56594abb4190_StockCompensationSummaryOfTotalStockCompensationExpensesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a9aadd3-411a-4000-abd7-397da39f7eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_63a58ec1-aa98-4eca-891b-98a51d932111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a9aadd3-411a-4000-abd7-397da39f7eb7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_63a58ec1-aa98-4eca-891b-98a51d932111" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de2e7c18-7318-4f68-9421-52ee3da9aaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a9aadd3-411a-4000-abd7-397da39f7eb7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de2e7c18-7318-4f68-9421-52ee3da9aaf9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_87ea562f-2421-48b0-8944-152a96f0b224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de2e7c18-7318-4f68-9421-52ee3da9aaf9" xlink:to="loc_us-gaap_AwardTypeAxis_87ea562f-2421-48b0-8944-152a96f0b224" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ea562f-2421-48b0-8944-152a96f0b224_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_87ea562f-2421-48b0-8944-152a96f0b224" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_87ea562f-2421-48b0-8944-152a96f0b224_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0db5dea-8b94-4c04-a813-10610ad5a546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_87ea562f-2421-48b0-8944-152a96f0b224" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0db5dea-8b94-4c04-a813-10610ad5a546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_0d695ea3-fa34-41f0-a19a-243e71a9902e" xlink:href="aort-20230331.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0db5dea-8b94-4c04-a813-10610ad5a546" xlink:to="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_0d695ea3-fa34-41f0-a19a-243e71a9902e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_6d64d0c0-33ea-4408-82f3-b6821eb4885e" xlink:href="aort-20230331.xsd#aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0db5dea-8b94-4c04-a813-10610ad5a546" xlink:to="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_6d64d0c0-33ea-4408-82f3-b6821eb4885e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" id="i3b1ed550e24e4691a2adc8d5bfc6eb20_SegmentInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9663c426-f665-4b3a-ae37-a68857bfd4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b1fe8f16-9075-418e-bce1-82f583c30e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9663c426-f665-4b3a-ae37-a68857bfd4c9" xlink:to="loc_us-gaap_NumberOfReportableSegments_b1fe8f16-9075-418e-bce1-82f583c30e82" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b0f6c8d8-6024-4fd3-95c5-acc8cc8dfd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9663c426-f665-4b3a-ae37-a68857bfd4c9" xlink:to="loc_us-gaap_Revenues_b0f6c8d8-6024-4fd3-95c5-acc8cc8dfd3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81e59873-c219-4ef1-a972-6a6e66eff1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9663c426-f665-4b3a-ae37-a68857bfd4c9" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81e59873-c219-4ef1-a972-6a6e66eff1bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8185348e-c5cb-454f-bfcb-5e856118029d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81e59873-c219-4ef1-a972-6a6e66eff1bb" xlink:to="loc_srt_ConsolidationItemsAxis_8185348e-c5cb-454f-bfcb-5e856118029d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_8185348e-c5cb-454f-bfcb-5e856118029d_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_8185348e-c5cb-454f-bfcb-5e856118029d" xlink:to="loc_srt_ConsolidationItemsDomain_8185348e-c5cb-454f-bfcb-5e856118029d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_868130fe-e1ec-4737-9b86-58122c27d23c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_8185348e-c5cb-454f-bfcb-5e856118029d" xlink:to="loc_srt_ConsolidationItemsDomain_868130fe-e1ec-4737-9b86-58122c27d23c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e26a61c0-eff9-497f-a9a1-692483f314a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_868130fe-e1ec-4737-9b86-58122c27d23c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e26a61c0-eff9-497f-a9a1-692483f314a4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" xlink:type="extended" id="i472cadd2fe964484aab05d685354e273_SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83835836-e34d-4162-9e53-0ebc05404e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83835836-e34d-4162-9e53-0ebc05404e49" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9ff468e6-8107-47c9-b03b-aeb8e7015d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9ff468e6-8107-47c9-b03b-aeb8e7015d8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_6bac5bd3-0bc3-4bd9-8138-8619080e04df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:to="loc_us-gaap_GrossProfit_6bac5bd3-0bc3-4bd9-8138-8619080e04df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d6a6072a-cbef-4334-a93a-b9f95a4f1c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d6a6072a-cbef-4334-a93a-b9f95a4f1c58" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_583820f4-bbb4-4221-86a5-f7a603813f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d6a6072a-cbef-4334-a93a-b9f95a4f1c58" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_583820f4-bbb4-4221-86a5-f7a603813f32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_583820f4-bbb4-4221-86a5-f7a603813f32_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_583820f4-bbb4-4221-86a5-f7a603813f32" xlink:to="loc_us-gaap_SegmentDomain_583820f4-bbb4-4221-86a5-f7a603813f32_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3c4d3ffb-1b6a-4494-8466-0780c454359c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_583820f4-bbb4-4221-86a5-f7a603813f32" xlink:to="loc_us-gaap_SegmentDomain_3c4d3ffb-1b6a-4494-8466-0780c454359c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_MedicalDevicesMember_fe576c63-4ffd-421b-89e2-d772d533fd8e" xlink:href="aort-20230331.xsd#aort_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3c4d3ffb-1b6a-4494-8466-0780c454359c" xlink:to="loc_aort_MedicalDevicesMember_fe576c63-4ffd-421b-89e2-d772d533fd8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_9251e69c-e2e7-4021-be89-4b18ade540bb" xlink:href="aort-20230331.xsd#aort_PreservationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_3c4d3ffb-1b6a-4494-8466-0780c454359c" xlink:to="loc_aort_PreservationServicesMember_9251e69c-e2e7-4021-be89-4b18ade540bb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" xlink:type="extended" id="i5f7563724361468a8e1583d2858035ba_SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_d6caf7f7-6dfc-40cf-b87d-7d4a4b4e78d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c829865-dce7-405d-ace6-5894a36e148f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ProductInformationLineItems_d6caf7f7-6dfc-40cf-b87d-7d4a4b4e78d4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c829865-dce7-405d-ace6-5894a36e148f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_7c3f3d27-c175-469a-9613-9d1d748c7bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ProductInformationLineItems_d6caf7f7-6dfc-40cf-b87d-7d4a4b4e78d4" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_7c3f3d27-c175-469a-9613-9d1d748c7bc2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_7c3f3d27-c175-469a-9613-9d1d748c7bc2" xlink:to="loc_srt_ProductOrServiceAxis_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd" xlink:to="loc_srt_ProductsAndServicesDomain_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2f04077d-a7aa-4d48-bf8e-e8f0be0e024c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd" xlink:to="loc_srt_ProductsAndServicesDomain_2f04077d-a7aa-4d48-bf8e-e8f0be0e024c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:href="aort-20230331.xsd#aort_ProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2f04077d-a7aa-4d48-bf8e-e8f0be0e024c" xlink:to="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AorticStentGraftsMember_b233aae7-96e5-4db8-8007-c3efe326988c" xlink:href="aort-20230331.xsd#aort_AorticStentGraftsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:to="loc_aort_AorticStentGraftsMember_b233aae7-96e5-4db8-8007-c3efe326988c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OnXMember_f43031e0-e8f1-4fa7-9215-850beb80f120" xlink:href="aort-20230331.xsd#aort_OnXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:to="loc_aort_OnXMember_f43031e0-e8f1-4fa7-9215-850beb80f120" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_SurgicalSealantsMember_469eceb0-d312-4497-b3e4-b06adb5b7a64" xlink:href="aort-20230331.xsd#aort_SurgicalSealantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:to="loc_aort_SurgicalSealantsMember_469eceb0-d312-4497-b3e4-b06adb5b7a64" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OtherProductsMember_0ae285a5-6341-46f4-8913-fdccf2a59821" xlink:href="aort-20230331.xsd#aort_OtherProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:to="loc_aort_OtherProductsMember_0ae285a5-6341-46f4-8913-fdccf2a59821" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_d0c18d69-9ac2-48ae-ac95-e8c3f96eb7b8" xlink:href="aort-20230331.xsd#aort_PreservationServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2f04077d-a7aa-4d48-bf8e-e8f0be0e024c" xlink:to="loc_aort_PreservationServicesMember_d0c18d69-9ac2-48ae-ac95-e8c3f96eb7b8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.cryolife.com/role/SubsequentEventsDetails" xlink:type="extended" id="idc64da46bfba41868b5d2e95c1338b66_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_8028a0cf-f5bc-452a-b7a6-eae668734d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_8028a0cf-f5bc-452a-b7a6-eae668734d76" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NumberOfTranches_a688ec74-9fb0-4dbc-a31c-1aa5887c4097" xlink:href="aort-20230331.xsd#aort_NumberOfTranches"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_NumberOfTranches_a688ec74-9fb0-4dbc-a31c-1aa5887c4097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche_af52ef04-8336-4f82-ad7e-38311a5d9e31" xlink:href="aort-20230331.xsd#aort_ThreeTranchesOfFundingForSecuredLoanPerTranche"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche_af52ef04-8336-4f82-ad7e-38311a5d9e31" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FundedTranchePaymentPerAgreement_6ae29838-5d72-4dfa-bbb3-8f620e00e752" xlink:href="aort-20230331.xsd#aort_FundedTranchePaymentPerAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_FundedTranchePaymentPerAgreement_6ae29838-5d72-4dfa-bbb3-8f620e00e752" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients_b19a594a-d527-4c35-ab97-a27148ef09d3" xlink:href="aort-20230331.xsd#aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients_b19a594a-d527-4c35-ab97-a27148ef09d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThirdTranchePayment_84faf1bd-dfa0-4afd-94b8-3742c0b4ab48" xlink:href="aort-20230331.xsd#aort_ThirdTranchePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_ThirdTranchePayment_84faf1bd-dfa0-4afd-94b8-3742c0b4ab48" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8432df2a-68b0-4926-992b-0ef6055fa65f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8432df2a-68b0-4926-992b-0ef6055fa65f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_8432df2a-68b0-4926-992b-0ef6055fa65f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8432df2a-68b0-4926-992b-0ef6055fa65f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_8432df2a-68b0-4926-992b-0ef6055fa65f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5e14faab-733c-42cf-95d9-7c63ccc1ef69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8432df2a-68b0-4926-992b-0ef6055fa65f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5e14faab-733c-42cf-95d9-7c63ccc1ef69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b91c8968-d80f-488f-98b8-131d3665ff03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5e14faab-733c-42cf-95d9-7c63ccc1ef69" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b91c8968-d80f-488f-98b8-131d3665ff03" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17fcc989-3e76-4779-a3dd-4b2ccfc77cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17fcc989-3e76-4779-a3dd-4b2ccfc77cac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_17fcc989-3e76-4779-a3dd-4b2ccfc77cac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17fcc989-3e76-4779-a3dd-4b2ccfc77cac" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_17fcc989-3e76-4779-a3dd-4b2ccfc77cac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a89ba6bc-78d4-4d5f-b77c-544e42d5e79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17fcc989-3e76-4779-a3dd-4b2ccfc77cac" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a89ba6bc-78d4-4d5f-b77c-544e42d5e79d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c00f0b9b-8321-4e2d-9060-2818dbdc6846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a89ba6bc-78d4-4d5f-b77c-544e42d5e79d" xlink:to="loc_us-gaap_SecuredDebtMember_c00f0b9b-8321-4e2d-9060-2818dbdc6846" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1139fb09-4e0f-459a-9929-f2f2bd05862e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1139fb09-4e0f-459a-9929-f2f2bd05862e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1139fb09-4e0f-459a-9929-f2f2bd05862e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1139fb09-4e0f-459a-9929-f2f2bd05862e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1139fb09-4e0f-459a-9929-f2f2bd05862e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_968985bb-089f-4a5c-8fc8-f5bfaa647b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1139fb09-4e0f-459a-9929-f2f2bd05862e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_968985bb-089f-4a5c-8fc8-f5bfaa647b9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5044c31c-3073-4b72-8881-cf0bfd619631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_968985bb-089f-4a5c-8fc8-f5bfaa647b9b" xlink:to="loc_us-gaap_SubsequentEventMember_5044c31c-3073-4b72-8881-cf0bfd619631" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>aort-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b72a0741-f899-4d87-a80c-f9fdcb4bb4b4,g:8ab7fb08-5903-4a38-b428-03d2f07a3992-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_aort_ContingentConsiderationNoncurrentFairValue_d9e46b27-7baa-477b-9824-e467914e954b_negatedLabel_en-US" xlink:label="lab_aort_ContingentConsiderationNoncurrentFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_aort_ContingentConsiderationNoncurrentFairValue_label_en-US" xlink:label="lab_aort_ContingentConsiderationNoncurrentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent, Fair Value</link:label>
    <link:label id="lab_aort_ContingentConsiderationNoncurrentFairValue_documentation_en-US" xlink:label="lab_aort_ContingentConsiderationNoncurrentFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration, Noncurrent, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ContingentConsiderationNoncurrentFairValue" xlink:href="aort-20230331.xsd#aort_ContingentConsiderationNoncurrentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ContingentConsiderationNoncurrentFairValue" xlink:to="lab_aort_ContingentConsiderationNoncurrentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_63342a19-7939-4aec-ab58-679c988b2add_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan provided</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_c79a727e-dcd2-4c52-a6aa-130769575709_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Senior Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OnXMember_feda2f06-68e1-4f3b-b17e-2623ebd78baa_terseLabel_en-US" xlink:label="lab_aort_OnXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">On-X</link:label>
    <link:label id="lab_aort_OnXMember_label_en-US" xlink:label="lab_aort_OnXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">On X [Member]</link:label>
    <link:label id="lab_aort_OnXMember_documentation_en-US" xlink:label="lab_aort_OnXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">On-X [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OnXMember" xlink:href="aort-20230331.xsd#aort_OnXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OnXMember" xlink:to="lab_aort_OnXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d2c66304-bf35-43aa-8307-e301cd4462c6_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_1b0e872f-774e-4fea-ba9c-472195805b0a_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_56dd192f-90bd-4bb2-9dbb-ad12b6d1c4c4_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_a6808a60-4528-48a9-b59e-89707caafd98_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_03c7527f-7d5e-4771-8c01-03a84719a9c2_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_dc5b675c-e49b-4526-aa6c-13e90ed67d58_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_96b0806c-1748-4911-b27b-9118b05ed678_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_d38b429a-408b-4584-aa22-a535f12bbc60_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_84f6589f-78e4-4a6c-8225-4a19cda15143_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_3f95b548-1a45-4a6c-9995-2099b33b707c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_330d54e8-5f04-4e9a-ba67-803bff726b1c_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_e881a1c1-09ef-4103-9b73-d8b0aaf939f7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtPeriodDomain_249a0654-d69f-4a70-8cf8-69deb89d5f45_terseLabel_en-US" xlink:label="lab_aort_DebtPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Domain]</link:label>
    <link:label id="lab_aort_DebtPeriodDomain_label_en-US" xlink:label="lab_aort_DebtPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Domain]</link:label>
    <link:label id="lab_aort_DebtPeriodDomain_documentation_en-US" xlink:label="lab_aort_DebtPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodDomain" xlink:href="aort-20230331.xsd#aort_DebtPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtPeriodDomain" xlink:to="lab_aort_DebtPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_36ff8efa-2864-447b-a28f-48fa1bfa5e24_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_a1ea9b39-e26c-4be0-90c5-0656a4379c19_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_b5d77b21-46af-42b2-a946-c919c76a0f2a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_e6252f19-2c5d-4994-b1ea-50e53e6e317c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_f4ede8ef-6167-4b2a-9417-26deebe27c44_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_38ca9285-5e1b-4fc0-853f-cf22cb875086_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years): Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_MedicalDevicesMember_d941ffb9-f92c-4fcf-a735-3ba9f8b8960d_terseLabel_en-US" xlink:label="lab_aort_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical devices</link:label>
    <link:label id="lab_aort_MedicalDevicesMember_label_en-US" xlink:label="lab_aort_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices [Member]</link:label>
    <link:label id="lab_aort_MedicalDevicesMember_documentation_en-US" xlink:label="lab_aort_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_MedicalDevicesMember" xlink:href="aort-20230331.xsd#aort_MedicalDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_MedicalDevicesMember" xlink:to="lab_aort_MedicalDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_a147f864-e25e-4d1a-bbd2-10bbce2a6ec5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3b752d12-b117-40ea-8800-96153ba277a2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_d586b697-fdd6-418a-be66-193843a90bb9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_280d9fe1-f525-46ac-b0b6-fa558ebdbd66_terseLabel_en-US" xlink:label="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles:</link:label>
    <link:label id="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_label_en-US" xlink:label="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Other Than Acquired Technology [Member]</link:label>
    <link:label id="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_documentation_en-US" xlink:label="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Other Than Acquired Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:href="aort-20230331.xsd#aort_IntangibleAssetsOtherThanAcquiredTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:to="lab_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_c23982e7-b696-48b2-8f13-f3dae1590f8a_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process R&amp;D</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c0fdd6c5-c41d-48a1-9045-02c9a44d10aa_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_1a5d1400-c37e-4149-b6a3-0430f8523d3e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a665546b-a0a8-49b2-bc9b-09869e26bb5a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_b2c7ba6d-634f-418d-9c98-9d68bf2389c3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected stock price volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ConsignmentInventoryPercentage_33af74be-5e38-48dc-b138-338597dade4c_terseLabel_en-US" xlink:label="lab_aort_ConsignmentInventoryPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consignment inventory percentage</link:label>
    <link:label id="lab_aort_ConsignmentInventoryPercentage_label_en-US" xlink:label="lab_aort_ConsignmentInventoryPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consignment Inventory Percentage</link:label>
    <link:label id="lab_aort_ConsignmentInventoryPercentage_documentation_en-US" xlink:label="lab_aort_ConsignmentInventoryPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consignment inventory percentage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ConsignmentInventoryPercentage" xlink:href="aort-20230331.xsd#aort_ConsignmentInventoryPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ConsignmentInventoryPercentage" xlink:to="lab_aort_ConsignmentInventoryPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtInstrumentExtensionCircumstancePeriod_4d061c47-0a22-4a03-a52e-1a3f34738258_terseLabel_en-US" xlink:label="lab_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension circumstance period</link:label>
    <link:label id="lab_aort_DebtInstrumentExtensionCircumstancePeriod_label_en-US" xlink:label="lab_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension circumstance period</link:label>
    <link:label id="lab_aort_DebtInstrumentExtensionCircumstancePeriod_documentation_en-US" xlink:label="lab_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension circumstance period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:href="aort-20230331.xsd#aort_DebtInstrumentExtensionCircumstancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:to="lab_aort_DebtInstrumentExtensionCircumstancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_d375f197-59aa-42ad-8aa8-a23170756f39_negatedLabel_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated amortization</link:label>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_documentation_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from operating lease.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="aort-20230331.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_51831092-cb30-4d68-885b-f87de98846c9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2f3d1-d70b-4473-b880-f58692984916_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_0b748c25-1c5b-476e-9cf6-4c231d2bb085_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_0a463b50-b649-4d21-9042-3bff79c25cb9_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate: Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a02266a9-bead-4d43-b5ec-89c0347f10a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_6da7e9e8-9d0e-4eec-b524-a678ceb5cd73_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories_2c69e6e1-64e6-4c44-b520-84d43a52efbf_terseLabel_en-US" xlink:label="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down of inventories and deferred preservation costs</link:label>
    <link:label id="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories_label_en-US" xlink:label="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-Down of Deferred Preservation Costs and Inventories</link:label>
    <link:label id="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories_documentation_en-US" xlink:label="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of the current period expense charged to cost of products and preservation services for the purpose of reducing deferred preservation costs and inventory, respectively, to amounts that approximate their net realizable value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:href="aort-20230331.xsd#aort_WriteDownOfDeferredPreservationCostsAndInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:to="lab_aort_WriteDownOfDeferredPreservationCostsAndInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_366b2d43-b4df-49b2-a336-b99822e1aa82_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</link:label>
    <link:label id="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_label_en-US" xlink:label="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:to="lab_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_bb61207b-6c3d-4fba-bd54-2f39c2315b92_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_1765ec71-336d-4ab9-a46c-67dcd7bbc7e3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, Property and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtPeriodAxis_7e191794-00c5-4ba5-ace8-6bc134a15c48_terseLabel_en-US" xlink:label="lab_aort_DebtPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Axis]</link:label>
    <link:label id="lab_aort_DebtPeriodAxis_label_en-US" xlink:label="lab_aort_DebtPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period [Axis]</link:label>
    <link:label id="lab_aort_DebtPeriodAxis_documentation_en-US" xlink:label="lab_aort_DebtPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodAxis" xlink:href="aort-20230331.xsd#aort_DebtPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtPeriodAxis" xlink:to="lab_aort_DebtPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b350604a-5307-45fe-80d5-15ba122d5219_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_34254e08-9e14-4116-a3ec-25dd7cee5eba_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_f3e0a627-6992-49bb-ba8f-a813faa8bdb2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_970bfbb7-c78f-4697-85f5-bee4d564232d_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3a18f88b-52e0-4d96-868e-127ec64c6c81_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Authorized awards from approved stock incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_cfbaed40-35a2-4c29-b64b-17e14e3cc4dd_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_1b4f83e6-043f-45f3-86da-79ef26823d55_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_f7fd46d7-570d-4b15-86a7-313380907f05_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion consecutive trading day threshold</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_453b5e74-3fa8-4a83-9bcd-07132a3788eb_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c5cacc73-271f-438e-ba40-a10586a043c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f88a5571-4ef3-4e77-80b2-37f7f776cb7e_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_f596a403-df96-46f5-9f2a-00155a42baf1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt fair value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_b557e62c-41c9-45de-96f8-5bde868897e9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_3ec15cc7-cc8e-4f24-93f7-d533d7dff83d_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases:</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_aacfe267-89d0-4354-acda-96fa29b4ed3e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration, measurement input</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_f337005c-0f3f-4fab-a1a6-10b32bb2e86f_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_2ea81538-7099-4a73-819b-06a319a6445c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_ebf8a8d3-359e-4a83-aad6-f41fd81d65e8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized stock compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_77fa4de1-4e33-4cf5-a598-b5cff00bc01e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_21bba595-b7ee-4bbc-9606-41558ba8e18f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_bcb3a055-9b33-43e5-bbe6-a65dc35fd21e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_07f02d41-416f-4951-88f2-67e89261d92a_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share, basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3c8ebf1a-9c28-4231-8c31-9df7539ce19b_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic loss per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e3bbc0f7-02ec-4b7f-8a03-61a5de88b3d5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_77659bda-a85a-4874-ac35-564e27e174a2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_8c852faa-2ac7-422d-a36d-9ac7c8b6d6e4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_a275e35e-351e-4b1d-bd2e-39b70556c00f_negatedLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_550eba2e-4b2e-4704-9b22-21fa2d56f1fb_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b9aad109-ebd4-40d2-b313-5ca6c25aa30e_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_5c749768-055d-4bac-b8b5-9e3603e83c5c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductInformationTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable" xlink:to="lab_us-gaap_ScheduleOfProductInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_4839ff59-85a2-42bb-b1d3-960156d292da_terseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_cec03cff-b53e-4aaf-b6cd-8b6aa7715588_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_742c4bcb-f9e3-423d-b214-668761848427_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_0551cabb-e236-4f33-aeb0-0939f2143657_terseLabel_en-US" xlink:label="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion percentage of principal amount</link:label>
    <link:label id="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_label_en-US" xlink:label="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Redemption Percentage Of Principal Amount</link:label>
    <link:label id="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_documentation_en-US" xlink:label="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Redemption Percentage Of Principal Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:href="aort-20230331.xsd#aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:to="lab_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_7b6945d2-90d7-4524-ad69-2379b6040a58_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_c9a40584-9ee9-41e8-b1eb-a0c136c1dec7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_a92427e4-4e62-463d-b7a3-0e20d11ebfa7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_bcb5c60e-0007-4291-af9f-41288d75a92a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_6e6123e1-3b0c-4c08-91b7-baa65c07dd03_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured term loan facility</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_7ee7cebc-f7d5-4cd9-8708-7e4f77e9739b_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loan balance</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_aacdf5d4-7182-4b50-a8ef-24c2028e19c8_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_43cbd841-ebbe-43fd-b4a9-6817b12abbd8_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_1c55d3ae-5918-4213-99db-9f14bfe2ba47_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net borrowings</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_1c74055d-b6a1-4679-b7c5-7cb123f6b5bf_terseLabel_en-US" xlink:label="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:href="aort-20230331.xsd#aort_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_aort_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_852b0687-7725-4aa9-bad1-443de78349c7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b9497a4e-91d9-486b-891e-a38b7f9ac781_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d16f7cd-7051-4087-b933-0500123db846_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_2eb9da3e-5ee8-4dbf-a97d-04372cd981cd_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4192215f-a186-4fd4-86e4-a52362136463_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_e3a6e6ed-bd04-4169-9ca9-51c8017665df_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6065c9d7-94d6-4e29-ad69-9c70915b17da_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_8e247225-083d-471d-82f9-30bfe64303f4_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_8a12cffa-dd93-4c07-bfae-8483b673a7dc_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_6009950d-c347-43b6-b10a-812682b9e2a1_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_NoncashLeaseExpense_94df7c93-7d89-408f-8152-fc1a68bf4107_terseLabel_en-US" xlink:label="lab_aort_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_aort_NoncashLeaseExpense_label_en-US" xlink:label="lab_aort_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_aort_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_aort_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashLeaseExpense" xlink:href="aort-20230331.xsd#aort_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_NoncashLeaseExpense" xlink:to="lab_aort_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a3fdf858-1f66-479a-8a6a-8e45b544c88d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_2e391a99-4bdb-42cb-92e1-65d64d4d8133_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Per Common Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_e378dc24-e0db-4e2c-a5a5-2061af7dec07_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3a16751a-35cc-4a00-a327-2256cbfb15c0_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_6286fb29-f6cd-41f7-834b-fc0a27c7cb8f_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d3790eed-9f45-424b-b471-171076b3d6c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_8844e110-9fd9-4140-bbcd-7da6b83a07e8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7965a28b-2770-4ced-91a5-6438cf3d001f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_5ad21dbd-1265-45e7-8dd4-5cfb0ad70214_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (decrease) in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_77f864e0-89c3-45af-bbcf-dad0976db8a3_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_26440b00-d3fa-4595-9ba6-eca86906f27c_terseLabel_en-US" xlink:label="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="aort-20230331.xsd#aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_1d1ffcec-4b32-4407-87a1-6d6754ca86ae_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_11431c54-2c6a-4924-9150-66ac1c517eec_verboseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross margin</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_c99e4ff0-1e37-4282-b749-a26067fb075a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_69fe7923-146b-431d-857c-9ff9212bf192_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_eaf14756-421b-4020-adc1-0edaf78cfb67_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_1b53a1d0-6103-4912-b441-3032622e17fe_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial and Nonfinancial Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_2ea1fb60-7bbf-42a1-a09b-6fe0698523f9_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General, administrative, and marketing</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_58dcb92d-ee03-4d2e-9bd4-c085894c24e1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_ec6e4b32-912e-48c1-9b30-807798ffc130_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue_0f42fbfa-d199-4fa2-938c-ce1e43948136_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and repurchase of stock to cover tax withholdings</link:label>
    <link:label id="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Redeemed or Called During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:to="lab_us-gaap_StockRedeemedOrCalledDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_25076b58-2740-491e-ac44-d004e56f520c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_76289172-90b0-4ee7-a122-cfb423e8d830_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_e9a81fb1-5cd2-4458-b3d7-1c94feb4ffb8_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding equity acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_aabbd8b9-2ce5-4a7a-bdac-c32eb3c4f2a8_terseLabel_en-US" xlink:label="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility, percentage repaid for no covenants</link:label>
    <link:label id="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_label_en-US" xlink:label="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Percentage Repaid for No Covenants</link:label>
    <link:label id="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_documentation_en-US" xlink:label="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility, Percentage Repaid for No Covenants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:href="aort-20230331.xsd#aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:to="lab_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_8153207b-a494-4645-85d8-f5d6dcbad250_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_f0604aa4-aa40-4f42-9e59-f7e510737005_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_f51c1c82-fc86-4585-801c-bbf2deb8bbf8_totalLabel_en-US" xlink:label="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_label_en-US" xlink:label="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Estimate</link:label>
    <link:label id="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_documentation_en-US" xlink:label="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the first five fiscal years following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:href="aort-20230331.xsd#aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:to="lab_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_94b1cc90-fbee-4d27-a125-321bcb034cbe_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_025184a9-3884-4c10-969b-b8228ac03890_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_27444c33-2a81-4094-94e1-5f0fa0da4f0f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_60d49c1e-26c2-4a00-a016-54f70d066702_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net and Deferred Preservation Costs</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_da2bb5b8-aff1-4287-8bf6-97f7f5183142_negatedLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, Accumulated amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_32fcce71-aca1-4bc5-a0e6-0269d5eda807_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_3e0e4858-a4b0-4389-9d36-ed3c2d068f86_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products and preservation services:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_776e92d4-c78b-4604-bf02-5c3d0154ae8b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_724f72dd-a1bf-4d7c-8047-8154092b950b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of net minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_e2fa3b0a-64a7-4d6e-a037-0ff91e2a3cb8_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Net Revenues by Product and Service</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_19876ce5-764e-414c-8676-59035eb67bb5_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_4016b632-d8c4-42b0-973a-19c08f129b00_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_851facc7-4949-40b7-82f8-2d44df32704d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_00aec72f-9202-493b-8fc8-ea27d45e41a3_netLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate: Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_621159ac-834d-4e0c-9ef6-736cde2db269_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_2a397afe-1724-4e42-a8ea-cd4c3316392f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualRightsMember_b9333499-7339-4093-8a5b-a0c8d2f95c63_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Procurement contracts and agreements</link:label>
    <link:label id="lab_us-gaap_ContractualRightsMember_label_en-US" xlink:label="lab_us-gaap_ContractualRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualRightsMember" xlink:to="lab_us-gaap_ContractualRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_5e6d4aaf-a6fb-479b-9130-32d17fae89cc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_5b962543-234f-4c47-84a2-1a945d2fbaa4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_a3f9f53c-9718-4b33-8263-81796a1b3f9e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_24f98b81-1032-495a-a4ab-d70aa88ca29c_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Instruments Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DeferredPreservationCosts_8e62a023-039c-47fb-b67e-7541e07ab4ba_terseLabel_en-US" xlink:label="lab_aort_DeferredPreservationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred preservation costs, net</link:label>
    <link:label id="lab_aort_DeferredPreservationCosts_label_en-US" xlink:label="lab_aort_DeferredPreservationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Preservation Costs</link:label>
    <link:label id="lab_aort_DeferredPreservationCosts_documentation_en-US" xlink:label="lab_aort_DeferredPreservationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts" xlink:href="aort-20230331.xsd#aort_DeferredPreservationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DeferredPreservationCosts" xlink:to="lab_aort_DeferredPreservationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_a4eb0db7-c08c-4855-9647-5ebb55a6ed55_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a10a50a8-a7c2-4a82-9c7e-37968e9b1ebf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of property and equipment</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_FundedTranchePaymentPerAgreement_32e4f390-5261-43b0-a963-12a1c5fbf10a_terseLabel_en-US" xlink:label="lab_aort_FundedTranchePaymentPerAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded second tranche payment</link:label>
    <link:label id="lab_aort_FundedTranchePaymentPerAgreement_label_en-US" xlink:label="lab_aort_FundedTranchePaymentPerAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded Tranche Payment Per Agreement</link:label>
    <link:label id="lab_aort_FundedTranchePaymentPerAgreement_documentation_en-US" xlink:label="lab_aort_FundedTranchePaymentPerAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funded Tranche Payment Per Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FundedTranchePaymentPerAgreement" xlink:href="aort-20230331.xsd#aort_FundedTranchePaymentPerAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_FundedTranchePaymentPerAgreement" xlink:to="lab_aort_FundedTranchePaymentPerAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a2190440-926e-457c-a185-ec94d632b3b5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_7d1dd44b-c3b7-430e-94c1-9c009085cad2_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_f564b4d1-d0f7-48d9-9e87-808006997ad5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Weighted-Average Assumptions Used to Determine the Fair Value of Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_ff8bdcaa-4882-41d4-a830-7aa589590ed4_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f2adfa74-7acb-4021-b4ec-48990551ece4_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted loss per common share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_f7f736b0-0760-40a8-ba91-b2622c14b898_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_6ed614ed-6090-4933-8af7-6322c31d10d0_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CardiogenesisMember_0c6118d0-992a-4407-9fb5-2b55d205524f_terseLabel_en-US" xlink:label="lab_aort_CardiogenesisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CardioGenesis cardiac laser therapy</link:label>
    <link:label id="lab_aort_CardiogenesisMember_label_en-US" xlink:label="lab_aort_CardiogenesisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiogenesis [Member]</link:label>
    <link:label id="lab_aort_CardiogenesisMember_documentation_en-US" xlink:label="lab_aort_CardiogenesisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiogenesis [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CardiogenesisMember" xlink:href="aort-20230331.xsd#aort_CardiogenesisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CardiogenesisMember" xlink:to="lab_aort_CardiogenesisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_c1345390-5c52-4f0d-b047-3f59a5bc2234_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_e10cf002-f84a-4aeb-8ddd-4b2a260a3d47_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4463d47c-9dcc-40e6-846a-bc4f2d36a068_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f60b7842-65ae-4cda-9311-6854a0017479_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total sources of revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DebtInstrumentExtensionPeriod_c3cd9d7d-14a5-4222-b196-61b53e0c943f_terseLabel_en-US" xlink:label="lab_aort_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension period</link:label>
    <link:label id="lab_aort_DebtInstrumentExtensionPeriod_label_en-US" xlink:label="lab_aort_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension period</link:label>
    <link:label id="lab_aort_DebtInstrumentExtensionPeriod_documentation_en-US" xlink:label="lab_aort_DebtInstrumentExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt instrument, extension period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionPeriod" xlink:href="aort-20230331.xsd#aort_DebtInstrumentExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DebtInstrumentExtensionPeriod" xlink:to="lab_aort_DebtInstrumentExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_a2e77eee-b18d-4072-a6cc-4d1a91cc93aa_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less amount representing interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_c21f68ce-104a-4825-bc22-47a9ce5df3ac_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_e0767326-2250-4da4-8446-6d818ba4e3f2_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic loss per common share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_c8f1da28-7d3e-4f03-b72f-ca56275c4bfa_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4c61c17d-ac87-4b13-a516-392b3855c9b5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_7720f525-9742-4357-bea9-304cd7f1a6b0_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_ab7e8902-5be8-4094-8f81-8d72283dfdb1_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_18fe953b-e40f-4b6b-8465-211a93f73fba_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_10cf6d57-6f3f-4223-92b8-f0c0686e3af3_negatedLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_bd78d4df-2481-437d-b5fe-4130737ac04f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_866616fc-bebf-4462-a81a-fe7790939961_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other intangibles, net</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsNet" xlink:to="lab_us-gaap_OtherIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5c96c6f6-415b-4a7c-9c0a-0b3ea97d9b12_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term (in years): Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_f0e3b492-4955-43e4-a997-1571992a8bf3_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_007d784b-5b31-4447-b730-a85c48d70479_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating (loss) income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_8a970c8c-e418-4285-abb0-e6f138a5545f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_77a2d372-1c46-424d-8b07-299e3309d80f_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current maturities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_FinanceLeaseCost_317734c0-f702-45c8-a3e8-0b0e08c9e120_totalLabel_en-US" xlink:label="lab_aort_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease expense</link:label>
    <link:label id="lab_aort_FinanceLeaseCost_label_en-US" xlink:label="lab_aort_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Cost</link:label>
    <link:label id="lab_aort_FinanceLeaseCost_documentation_en-US" xlink:label="lab_aort_FinanceLeaseCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of finance lease cost recognized by lessee for lease contract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseCost" xlink:href="aort-20230331.xsd#aort_FinanceLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_FinanceLeaseCost" xlink:to="lab_aort_FinanceLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dc6708fc-71a2-4911-933f-44be74b917ca_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_499ff8b2-70c2-4f48-8191-d0127716439e_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock at cost, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_cd436a4a-d370-459f-ac86-1e9c7a2e3a23_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_b3e41dea-9fb1-4fcc-9de6-62eb42205da3_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8a5435b6-a297-4503-bb02-6eaeaf981545_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_22006048-7c42-4563-9c7d-3f10ed2856c6_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_0562c66b-f63b-4ab1-8c8e-c99026b2e620_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_e4c4f8b3-206a-4550-a2a1-1795dfb417a9_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_InternationalDistributorMember_410b239c-4b29-47da-966f-32632b978e94_terseLabel_en-US" xlink:label="lab_aort_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International distributors</link:label>
    <link:label id="lab_aort_InternationalDistributorMember_label_en-US" xlink:label="lab_aort_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor [Member]</link:label>
    <link:label id="lab_aort_InternationalDistributorMember_documentation_en-US" xlink:label="lab_aort_InternationalDistributorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Distributor [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalDistributorMember" xlink:href="aort-20230331.xsd#aort_InternationalDistributorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_InternationalDistributorMember" xlink:to="lab_aort_InternationalDistributorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_22f8b2ae-0755-4283-8117-f5879c9fc2f1_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8d4350ae-0bc0-41ee-9cd6-110ba9dd9a6a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_b4b93481-ff20-48f5-bd0e-8e031205efd4_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired technology</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b76d54d5-bd87-4b15-beb1-1d2c34917221_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_AscyrusMedicalLlcMember_5c9b4af9-6e22-4eb5-b23a-718fd214b54e_terseLabel_en-US" xlink:label="lab_aort_AscyrusMedicalLlcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascyrus Medical LLC</link:label>
    <link:label id="lab_aort_AscyrusMedicalLlcMember_label_en-US" xlink:label="lab_aort_AscyrusMedicalLlcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascyrus Medical Llc [Member]</link:label>
    <link:label id="lab_aort_AscyrusMedicalLlcMember_documentation_en-US" xlink:label="lab_aort_AscyrusMedicalLlcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ascyrus Medical LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AscyrusMedicalLlcMember" xlink:href="aort-20230331.xsd#aort_AscyrusMedicalLlcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_AscyrusMedicalLlcMember" xlink:to="lab_aort_AscyrusMedicalLlcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_788722e4-dd7c-41bb-9b65-d1e7ba24d7ba_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_ac8b8068-0f8d-4c03-8278-280e8e745ead_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liability</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_2ef80a01-0d1d-4320-b393-0726ec354e4f_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8137d356-f12c-472d-841d-ad7aca583f16_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_e257e487-9063-49fd-a530-91d87b33aadc_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients_825c9b9f-8ac9-489f-9721-9b5b1ef5089f_terseLabel_en-US" xlink:label="lab_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Required percentage of number of patients before third tranche of loan funding can be acquired</link:label>
    <link:label id="lab_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients_label_en-US" xlink:label="lab_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Tranche Of Funding For Secured Loan, Minimum Percentage Of Required Number Of Patients</link:label>
    <link:label id="lab_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients_documentation_en-US" xlink:label="lab_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Tranche Of Funding For Secured Loan, Minimum Percentage Of Required Number Of Patients</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" xlink:href="aort-20230331.xsd#aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" xlink:to="lab_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_bdf90799-68e9-46b7-9404-422a86616a54_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_35a382b8-202c-4e82-b1cd-d9c547c47f18_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ThirdTranchePayment_91483588-5e12-4280-927a-e1eb4d6d926f_terseLabel_en-US" xlink:label="lab_aort_ThirdTranchePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third tranche payment</link:label>
    <link:label id="lab_aort_ThirdTranchePayment_label_en-US" xlink:label="lab_aort_ThirdTranchePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Tranche Payment</link:label>
    <link:label id="lab_aort_ThirdTranchePayment_documentation_en-US" xlink:label="lab_aort_ThirdTranchePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Third Tranche Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThirdTranchePayment" xlink:href="aort-20230331.xsd#aort_ThirdTranchePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ThirdTranchePayment" xlink:to="lab_aort_ThirdTranchePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_9ab85ca8-fe50-4eb5-8481-b90c9fe649f8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_00e604ac-22bf-44e5-be0e-4b60f6701061_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_15a2198a-ccd3-48c9-b504-cbbd8a895a67_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_1355c86e-1e43-4055-a938-03da5672f3f2_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_dd7b2fd7-95f1-43ec-94ce-fe1bf77436a6_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_4d4bb91f-aacd-454f-a364-95bf2d9c158d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock compensation expense</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a8af3426-213b-44e5-b506-d9aa5103460b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_d9f70983-82be-4a94-a12b-f9b1fd090a53_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_92f71792-11ee-4930-a0d3-43f08b2b5333_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_191bd35e-84a1-4741-8f38-4f2d44a3885d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d4c895cd-b178-4eed-8d17-a2790a45010c_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_29987dbe-02bb-437c-8c80-aadc3ae569a3_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_da750205-9333-4c89-ac68-4c5b697a8202_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6889f290-53fc-40d9-9ac5-4cdf9b7ddf9c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_35c9ea02-b361-47b0-b6a9-7880e7b18cd2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses, and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_16d5e494-588e-48f1-9f24-d1ffe5f44dda_terseLabel_en-US" xlink:label="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option and ESPP expense</link:label>
    <link:label id="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_label_en-US" xlink:label="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Employee Stock Purchase Plan Option Expense [Member]</link:label>
    <link:label id="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_documentation_en-US" xlink:label="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option And Employee Stock Purchase Plan Option Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:href="aort-20230331.xsd#aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:to="lab_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e4e62442-b324-46ec-a0c1-39b846997b4d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_8f29ffc6-4320-407f-a6f2-300ec82aa95e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_4cb5b704-8243-4b68-ae80-944d4244a11c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consignment inventory</link:label>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_label_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:to="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CircumstanceIMember_221fe517-abc6-4dab-88ca-9893983a845b_terseLabel_en-US" xlink:label="lab_aort_CircumstanceIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance I</link:label>
    <link:label id="lab_aort_CircumstanceIMember_label_en-US" xlink:label="lab_aort_CircumstanceIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance I [Member]</link:label>
    <link:label id="lab_aort_CircumstanceIMember_documentation_en-US" xlink:label="lab_aort_CircumstanceIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance I [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIMember" xlink:href="aort-20230331.xsd#aort_CircumstanceIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CircumstanceIMember" xlink:to="lab_aort_CircumstanceIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_13628c3d-c703-4235-9a61-d226048e9262_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_0db915ab-c833-409a-8845-3b822a2939b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_e7ae9c36-e4c3-42d3-8e54-defe04b92e68_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current maturities of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_1fc6b389-d631-4a8c-a923-d2be6e9d4aeb_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current maturities of operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_7f448651-ff0e-42d0-a555-800f0342236c_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, less current maturities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d6ece1a4-9f89-4fe0-9b1f-3506252f7723_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_fadfefe0-1f20-4f0b-8943-bb9cd4e92181_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_07618ff3-1cef-41cc-85b6-ffab0d5d4186_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_c04faffd-57b0-4c87-aeb8-cdde4a9e6df6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_78dfe377-4039-4f01-bf60-2f31dfd8d27e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_d4052b88-5a84-4fd1-a5c7-b4b9bf000bba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_PreservationServicesMember_a77bea4d-cd78-4e6e-95e6-813cd43852d0_terseLabel_en-US" xlink:label="lab_aort_PreservationServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preservation services</link:label>
    <link:label id="lab_aort_PreservationServicesMember_label_en-US" xlink:label="lab_aort_PreservationServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preservation Services [Member]</link:label>
    <link:label id="lab_aort_PreservationServicesMember_documentation_en-US" xlink:label="lab_aort_PreservationServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preservation Services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember" xlink:href="aort-20230331.xsd#aort_PreservationServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_PreservationServicesMember" xlink:to="lab_aort_PreservationServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_bc50bea6-4c2d-46be-8e5a-c247afa79e4a_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_938bf949-2a86-48ef-a47d-b020b57d5195_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0823c199-1f2d-4677-ae9d-7628a5b738f1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_f017a1da-1b47-4af0-a918-9b8267076910_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_cd31c912-8ba0-4e1c-bbc5-0c81f5df8b32_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_cc58e9b4-b3ce-499e-8195-8841531623f6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of net minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3a7c7cc8-e63a-432c-946b-ce4bea4bbf5c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_cab917cf-313d-46b1-afa9-6553f79f2f6f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_530b3b21-bd7f-4e84-9449-79242aa1a088_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_6baa446d-6156-4a47-8d39-ee1c77ff0176_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_c1927239-5e33-403c-8897-c0310d0b18fe_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_cf9fcae3-3f14-43f5-8649-fdf488ccf231_terseLabel_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:label id="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_documentation_en-US" xlink:label="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount, before accumulated depreciation and amortization, of property, plant, and equipment and operating lease right-of-use asset.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="aort-20230331.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_712195b5-bda7-4b85-aaea-3061f2f570f5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Changes in Fair Value of Level 3 Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_c15c7784-82a6-4fc5-8ebf-6ee3969afff2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_50cb82b7-47a6-47aa-8e0a-0d620ceca995_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_45968e88-86e7-414f-a4a3-9e004ee4c0d3_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_810ea841-524b-4287-8d00-c05bfb39163d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_568348c2-ad8e-414d-870d-3524a810be96_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_32fbf247-60b2-4daf-9c16-256bac47a1ee_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a1b0c35d-a467-4c64-a7cb-6c838bd46b5a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade receivables, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_1c63098b-c857-44ab-87b9-d55880f0bcda_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_c6e63f58-5f4c-4f48-9630-1d433c451999_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_f6e38ebe-c82d-447f-93ab-ea257f68a293_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_aa929fc0-3dad-488b-9876-b253ebf20f4f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_130b3790-2ea7-4446-b93e-8a64fe1bf994_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_95c76c1e-185f-4308-a5f4-55e5f2af2281_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_035b17fe-88a5-4589-ae1e-787e1b83120e_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9efb8bba-3914-42bd-a4df-589184101821_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_NumberOfTranches_1a134842-93f0-4dba-a1fc-a86244a6d18a_terseLabel_en-US" xlink:label="lab_aort_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of tranches</link:label>
    <link:label id="lab_aort_NumberOfTranches_label_en-US" xlink:label="lab_aort_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Tranches</link:label>
    <link:label id="lab_aort_NumberOfTranches_documentation_en-US" xlink:label="lab_aort_NumberOfTranches" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Tranches</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NumberOfTranches" xlink:href="aort-20230331.xsd#aort_NumberOfTranches"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_NumberOfTranches" xlink:to="lab_aort_NumberOfTranches" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_55ca8145-d39e-49ca-a972-caffadb97802_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_c1173864-7e6d-4ee2-ba55-0d603f084e21_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2a788338-e279-431f-adf5-e13eda31f4a1_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues, Cost of Products and Services, and Gross Margins for Operating Segments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_22beac9e-d596-436c-a245-62b5b85b58cf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3dc12238-4cf2-48dc-872d-78a8cdc47603_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_63f6e6e0-008c-41ac-afe8-d90007138dac_negatedLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_53b11d5e-467e-4be2-9420-691387a55837_netLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_6f22902e-aadd-48fd-8c45-4e81c67c7ab5_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_9fb14b0c-96c3-4b5e-aa78-c334c09f75d3_negatedLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less short-term loan balance</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_75e308ec-7506-48b0-94ef-26dd77d20564_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_5036a1a9-df9c-4539-b5d5-7a63901bdd15_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccounting_68b7fafa-ef46-47df-9089-96791e15a503_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfAccounting_label_en-US" xlink:label="lab_us-gaap_BasisOfAccounting" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccounting" xlink:to="lab_us-gaap_BasisOfAccounting" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_InternationalHospitalsMember_7e08be9c-9ffd-4bfa-806a-7ce400f2cc09_terseLabel_en-US" xlink:label="lab_aort_InternationalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International hospitals</link:label>
    <link:label id="lab_aort_InternationalHospitalsMember_label_en-US" xlink:label="lab_aort_InternationalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Hospitals [Member]</link:label>
    <link:label id="lab_aort_InternationalHospitalsMember_documentation_en-US" xlink:label="lab_aort_InternationalHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International Hospitals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalHospitalsMember" xlink:href="aort-20230331.xsd#aort_InternationalHospitalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_InternationalHospitalsMember" xlink:to="lab_aort_InternationalHospitalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_188a1b4b-6d6c-4002-8143-42c9ad14803e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_3ef64e03-548a-470e-a546-f5e1386042c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e431f36f-453d-45d0-9926-882deec21be7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_795e393d-5c4e-4836-9141-598501c46cd3_netLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_d6f8b5b4-b813-4ce2-95a9-aa93d247df1b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_6dd008d0-c217-42d7-baf5-50c762e3d854_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_93c61138-6f09-4663-ab0d-e8508dd6983a_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases, property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_b0be4a12-e6dd-4df6-8b15-44d06ed7a25f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche_c886ed95-cb7a-4062-b080-8bf2757188d2_terseLabel_en-US" xlink:label="lab_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Per three tranches of funding</link:label>
    <link:label id="lab_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche_label_en-US" xlink:label="lab_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Tranches Of Funding For Secured Loan Per Tranche</link:label>
    <link:label id="lab_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche_documentation_en-US" xlink:label="lab_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Tranches Of Funding For Secured Loan Per Tranche</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche" xlink:href="aort-20230331.xsd#aort_ThreeTranchesOfFundingForSecuredLoanPerTranche"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche" xlink:to="lab_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_eda35960-4e3c-4d90-8cba-bc3680b7626b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_327060ba-d283-49b7-860e-7d652e760a61_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Total Stock Compensation Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_95b19915-df69-4c88-8517-d3cdc2ab2899_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum amount of future consideration payment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_2a5c038d-d893-4bab-9403-5c53c38ff44f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_6eca85b7-b857-4f50-8150-f29e2de2869f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_5674a7a0-b0e3-4087-bd6c-ea3917f14c0f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current maturities of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_8c082775-db7d-437d-ab80-350eab1411b9_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less current maturities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_c309cf6a-360c-491e-a457-19b597a1ab1c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP, percentage of market price for eligible employees</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c4449d3e-1228-47d7-8468-47c31202b9db_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_779ef3ae-41bb-4d58-b00c-8b9618a3d9da_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_1f7a2949-ff4b-4961-bcba-6956bef15846_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_a1a023d4-56fc-4cbc-a74b-729ec0ea7f14_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Carrying Values of Indefinite Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets and Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_a6a5c453-a433-45ca-8474-22bc241fea47_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances against deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_RestrictedStockUnitsAndPreferredStockUnitsMember_01875fd8-4698-4e60-82e9-a897a97905de_terseLabel_en-US" xlink:label="lab_aort_RestrictedStockUnitsAndPreferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs And PSUs</link:label>
    <link:label id="lab_aort_RestrictedStockUnitsAndPreferredStockUnitsMember_label_en-US" xlink:label="lab_aort_RestrictedStockUnitsAndPreferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units and Preferred Stock Units [Member]</link:label>
    <link:label id="lab_aort_RestrictedStockUnitsAndPreferredStockUnitsMember_documentation_en-US" xlink:label="lab_aort_RestrictedStockUnitsAndPreferredStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards, Restricted Stock Units, Preferred Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockUnitsAndPreferredStockUnitsMember" xlink:href="aort-20230331.xsd#aort_RestrictedStockUnitsAndPreferredStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_RestrictedStockUnitsAndPreferredStockUnitsMember" xlink:to="lab_aort_RestrictedStockUnitsAndPreferredStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_0dfbbff7-7c01-466d-a78e-c1d654a798ce_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_98a9e4f3-b080-435e-bac2-da694143535e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_DomesticHospitalsMember_9ce11f32-19af-4e2c-afa2-8292d4061209_terseLabel_en-US" xlink:label="lab_aort_DomesticHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic hospitals</link:label>
    <link:label id="lab_aort_DomesticHospitalsMember_label_en-US" xlink:label="lab_aort_DomesticHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Hospitals [Member]</link:label>
    <link:label id="lab_aort_DomesticHospitalsMember_documentation_en-US" xlink:label="lab_aort_DomesticHospitalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Hospitals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DomesticHospitalsMember" xlink:href="aort-20230331.xsd#aort_DomesticHospitalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_DomesticHospitalsMember" xlink:to="lab_aort_DomesticHospitalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_fe3ac920-158c-4da1-8ec8-bd8f77f90be6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Useful Life (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_a40ac7ce-faa2-4d3e-92df-6e15f11ec8c9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense on finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_14997715-1e99-4c84-8316-801789ac89bd_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1a57cc01-2f04-4b65-aabb-b5ec82ef5777_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted (Loss) Income Per Common Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_3008b350-7f5f-4f74-809f-f6674db5cb68_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion trading day threshold</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_3bbb83e3-a3cf-43f1-ab17-194983290aa9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_dea24dd7-b7a4-4968-b218-f69e25b23f10_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_007521aa-5d65-4ee6-a7a0-d74f6bed371d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_5f67259e-2334-46d2-b638-2316d46f200b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options and issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_abe8cd34-af06-43a6-aaab-13f4845629ee_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_d0a1545f-cfe9-4c5d-ad2f-0e53b0c3ef23_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_fa213a0a-3675-4914-a62a-2155210ea2ee_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss allocated to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_2093154c-fad8-4e1e-8ccc-1840ab4500cf_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_b2946bc5-3e7e-4d81-b8ba-a48eb9b735fc_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss allocated to common shareholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_39f8d3e5-0789-4097-ae68-876c4554d7df_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_ad44855f-947d-460d-909a-30a3b549d21b_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_fb473ce8-7ae8-4820-a0b1-9e4b621afe99_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_0aa04f82-46df-42fa-91c1-957a3ccb41e4_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_306aabbd-c76b-4976-9aef-589967e4997c_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products and Services [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_b2a74a2f-ee4e-4ca1-a8b7-b8ec37773df9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate on amounts borrowed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares_86e87444-4601-4f14-bd92-e104df597567_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and repurchase of stock to cover tax withholdings (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Redeemed or Called During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:to="lab_us-gaap_StockRedeemedOrCalledDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_6ae29a36-9289-4f5f-b116-550d1def89b3_terseLabel_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSA, RSU, and PSU expense</link:label>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_label_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards Restricted Stock Units Performance Stock Awards Performance Stock Units [Member]</link:label>
    <link:label id="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_documentation_en-US" xlink:label="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards Restricted Stock Units Performance Stock Awards Performance Stock Units [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:href="aort-20230331.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:to="lab_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5e309ec2-dc77-4c91-8e6d-cad900007743_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_8838a65c-23f2-4dfa-bc18-bb3cd176b1b4_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_0c129462-5165-45b0-80b3-cb2808340447_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6fb6c4fa-3d15-47c4-ab3f-2be92019bbcd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_00739762-6a9e-4e0e-80ef-922fe620c1fa_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Short-Term and Long-Term Balances of Term Loan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0b46a12e-b886-416a-8c9d-0b8fe3f70abe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_3ddcc731-4225-471a-9c45-e10a4fb982bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_493384a8-8f77-4ef2-b7a2-5ad63194f43c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Lease Costs</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_81477ffb-381b-450b-9b04-ad02ecc5ee81_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_ff658592-46b7-4c48-b566-3a038cc1dcd1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_e4624ed5-adad-461a-b6b4-1d189dc91b50_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_7bf55195-f0fe-4268-9934-b299eae25653_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d23087a8-2b68-42ce-b377-47a111722281_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e56f251c-e66f-4343-9cd0-d3c4f75a953f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share, diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_9aa783a5-df99-48a2-92a2-3c199377ca63_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted loss per common share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_4aa4644b-5a46-463a-b112-caa08328dcf4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_67346686-a47b-4d65-9339-e909c8b13856_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion percentage of stock price threshold</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_309c3595-ea80-4eb3-bda3-96212c1a92db_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_c8ccc93b-a0ee-4459-aeca-0bcd6b640fc7_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_e0d27b15-1f84-4444-a811-aaaae89606c9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_8ae7917f-d65e-469e-858a-019ebd8c6ce4_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_fcb68371-cd56-40ff-9a8f-1c0fce1fee29_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_3151e09a-ffc0-4c27-a6f9-4affb0e8e08a_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_28ac8722-f8a9-476f-8936-6f0c1fb1c68a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CircumstanceIiMember_008fe1c1-c17e-481e-b35b-b4143938a5e6_terseLabel_en-US" xlink:label="lab_aort_CircumstanceIiMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance II</link:label>
    <link:label id="lab_aort_CircumstanceIiMember_label_en-US" xlink:label="lab_aort_CircumstanceIiMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance Ii [Member]</link:label>
    <link:label id="lab_aort_CircumstanceIiMember_documentation_en-US" xlink:label="lab_aort_CircumstanceIiMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance II [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIiMember" xlink:href="aort-20230331.xsd#aort_CircumstanceIiMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CircumstanceIiMember" xlink:to="lab_aort_CircumstanceIiMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_bbe9cd54-0762-4806-9359-dbf11b8d3126_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableMember_e4a457ad-39d2-434b-9d16-97ec2f3f5fe0_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan balance</link:label>
    <link:label id="lab_us-gaap_LoansPayableMember_label_en-US" xlink:label="lab_us-gaap_LoansPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableMember" xlink:to="lab_us-gaap_LoansPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_05a3ebf0-936a-4af0-a00a-5a7d93a6d994_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_3170b944-aca0-4d39-94b4-af2b50242db3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_58bd7a4b-25f2-477e-86d4-6a0d7338dc1d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_650aab2f-cc6c-4280-bdf5-ce6ec839921b_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionRightsMember_55710301-ff0c-47a0-9990-eb1919762d5e_terseLabel_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution and manufacturing rights and know-how</link:label>
    <link:label id="lab_us-gaap_DistributionRightsMember_label_en-US" xlink:label="lab_us-gaap_DistributionRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionRightsMember" xlink:to="lab_us-gaap_DistributionRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_49e38319-9ce5-4036-96b8-d90017c1d43e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashExpense_90293e23-8ca8-4d90-a08e-d520560636be_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashExpense" xlink:to="lab_us-gaap_OtherNoncashExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_5df77363-44cf-4646-baf2-ede6241d55e6_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_RevolvingCreditFacilityAndTermLoanMember_67d94e8b-d01c-4981-9668-c210868bc29d_terseLabel_en-US" xlink:label="lab_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan</link:label>
    <link:label id="lab_aort_RevolvingCreditFacilityAndTermLoanMember_label_en-US" xlink:label="lab_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan [Member]</link:label>
    <link:label id="lab_aort_RevolvingCreditFacilityAndTermLoanMember_documentation_en-US" xlink:label="lab_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility And Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:href="aort-20230331.xsd#aort_RevolvingCreditFacilityAndTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:to="lab_aort_RevolvingCreditFacilityAndTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_81dc1f7c-9adc-4ae1-a080-fdec38ccbba0_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CircumstanceAfterJuly52023Member_232d421e-a1d0-42e9-b938-e1d104c9055d_terseLabel_en-US" xlink:label="lab_aort_CircumstanceAfterJuly52023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance After July 5, 2023</link:label>
    <link:label id="lab_aort_CircumstanceAfterJuly52023Member_label_en-US" xlink:label="lab_aort_CircumstanceAfterJuly52023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance After July52023 [Member]</link:label>
    <link:label id="lab_aort_CircumstanceAfterJuly52023Member_documentation_en-US" xlink:label="lab_aort_CircumstanceAfterJuly52023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Circumstance After July 5, 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceAfterJuly52023Member" xlink:href="aort-20230331.xsd#aort_CircumstanceAfterJuly52023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CircumstanceAfterJuly52023Member" xlink:to="lab_aort_CircumstanceAfterJuly52023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_2bcebcb1-f5e4-4527-bdbf-c8ee60d2de52_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of convertible debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_560323da-8933-43d9-ae3a-84a2baa1dc63_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_20c1909a-d97f-4d2f-8480-024354430889_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2899558d-149d-4ae0-b912-3acac3c45217_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_2234157e-9a69-4d37-807a-ed606621a62d_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_227fe889-8c44-40fa-ad3a-20ee03b7e630_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan2Member_1b3ce055-20a2-43bd-b84c-46eadd466a7a_terseLabel_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.40% Sparkasse Zollernalb (KFW Loan 2)</link:label>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan2Member_label_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Debt Kfw Loan2 [Member]</link:label>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan2Member_documentation_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Debt (KFW Loan 2) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:href="aort-20230331.xsd#aort_GovernmentSponsoredDebtKfwLoan2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:to="lab_aort_GovernmentSponsoredDebtKfwLoan2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_29b0d158-551a-492d-97f6-079737e91b3d_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cost of products and preservation services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_16a06cb8-ad4f-4a19-a9a4-de67ba153da9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_f8e6e667-55ad-434a-a47c-34fb3dbd051a_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_e07a0ed5-c0e1-4137-b89a-c45f14da9dc9_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ProductsMember_3b1841a6-6ad1-4052-80d5-d4d89c69fac3_terseLabel_en-US" xlink:label="lab_aort_ProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products</link:label>
    <link:label id="lab_aort_ProductsMember_label_en-US" xlink:label="lab_aort_ProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products [Member]</link:label>
    <link:label id="lab_aort_ProductsMember_documentation_en-US" xlink:label="lab_aort_ProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember" xlink:href="aort-20230331.xsd#aort_ProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ProductsMember" xlink:to="lab_aort_ProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_110c27a7-f6da-4e33-8172-cafec82defdd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_6e396b9b-2ed3-405a-a2a7-0b585291b6ca_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_ac48d84a-266d-48ce-9383-4cae35ff07af_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d518e293-ff2b-4818-8392-2b6bdbd99a58_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_c9e76361-cd23-4092-86a7-45bc8ad46ad3_negatedLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_69ea598a-2011-4936-bfaf-0b56efa13a47_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_820f04ec-ece7-49cc-98d0-7b7fec8393f6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_60f2084e-1e81-4cba-ad80-0de8f51fe400_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_AccruedProcurementFees_4fe2a58f-4236-4d89-8c36-63cbfb056c01_terseLabel_en-US" xlink:label="lab_aort_AccruedProcurementFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued procurement fees</link:label>
    <link:label id="lab_aort_AccruedProcurementFees_label_en-US" xlink:label="lab_aort_AccruedProcurementFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Procurement Fees</link:label>
    <link:label id="lab_aort_AccruedProcurementFees_documentation_en-US" xlink:label="lab_aort_AccruedProcurementFees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Donated tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. The Company accrues estimated procurement fees due at the time tissues are received based on contractual agreements between the Company and the tissue banks and organ procurement organizations.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AccruedProcurementFees" xlink:href="aort-20230331.xsd#aort_AccruedProcurementFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_AccruedProcurementFees" xlink:to="lab_aort_AccruedProcurementFees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_75e1c1a3-bcc4-455d-b6b3-cce65f1d2e37_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scheduled Amortization of Intangible Assets for Next Five Years</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_11bba322-6f9d-47eb-91d7-cd4df601f7ee_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_7349d1c2-c752-4df0-8550-5898271392c5_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_65f4bc3a-ed66-47be-b039-88b7ee897e8e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_45f79b10-b8b7-42bf-a217-0930d6db982e_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_de66a4b7-c2af-4085-b581-b392f08dd241_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_58699b7b-0f5a-448b-813e-63bce961f499_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost, 1,487 shares as of March 31, 2023 &#8206;and December 31, 2022</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_87933e88-64db-42fe-a825-85f405e707b5_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_e6056e24-f8cc-4359-969f-4fa473ffb4d8_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_ab5d366d-3d17-444c-ba59-255dbf9b1a85_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_bfdaa479-b384-4154-9f0b-d66da8b7d40e_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term loan balance</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_bf69b3e1-7587-42bc-8a36-e8c8a91d572e_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_5b975411-df93-4c9a-bd41-e510f203997b_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_365f70ba-3703-4e72-bc21-439b6f31c1bd_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_174fa099-7d0a-4604-81ef-9ec4593a27b7_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective income tax rate expense (benefit)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_37d8cde9-1b6c-4ed2-aa42-6b88f3e5fc88_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of the debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_9edf1904-f580-47c8-852e-a444b1c69d74_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserve</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e304ba0a-77b8-4b05-b1ef-21876d1cf755_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8ea84a36-5717-4399-850f-e62f21474a99_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductInformationLineItems_e6253f15-4983-41ab-a964-240a560fd533_terseLabel_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_ProductInformationLineItems_label_en-US" xlink:label="lab_us-gaap_ProductInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductInformationLineItems" xlink:to="lab_us-gaap_ProductInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_AorticStentGraftsMember_7967c50a-395f-4bea-9223-2da010502abe_terseLabel_en-US" xlink:label="lab_aort_AorticStentGraftsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic stent grafts</link:label>
    <link:label id="lab_aort_AorticStentGraftsMember_label_en-US" xlink:label="lab_aort_AorticStentGraftsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic Stent Grafts [Member]</link:label>
    <link:label id="lab_aort_AorticStentGraftsMember_documentation_en-US" xlink:label="lab_aort_AorticStentGraftsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aortic Stent Grafts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AorticStentGraftsMember" xlink:href="aort-20230331.xsd#aort_AorticStentGraftsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_AorticStentGraftsMember" xlink:to="lab_aort_AorticStentGraftsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_47f27008-7217-408e-bca9-ae6d69edbdaa_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_f3331e76-a281-42f1-87ad-286ed0cf6c45_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_SurgicalSealantsMember_73cd92c6-a768-4b7c-8f0a-8c7cc190e4bc_terseLabel_en-US" xlink:label="lab_aort_SurgicalSealantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical sealants</link:label>
    <link:label id="lab_aort_SurgicalSealantsMember_label_en-US" xlink:label="lab_aort_SurgicalSealantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Sealants [Member]</link:label>
    <link:label id="lab_aort_SurgicalSealantsMember_documentation_en-US" xlink:label="lab_aort_SurgicalSealantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgical Sealants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_SurgicalSealantsMember" xlink:href="aort-20230331.xsd#aort_SurgicalSealantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_SurgicalSealantsMember" xlink:to="lab_aort_SurgicalSealantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_ffbe7447-3805-43c4-b112-28b48f74ac08_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes payable</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_31813f0f-4d72-4c84-ba67-45d3d94f195e_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7320e05d-75f0-4fcc-a835-aeb3a1cae861_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_b4b54411-8069-4ef8-a1b1-9629294fe307_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_3b4a00be-45d8-468a-9cca-7430ac7dc0b1_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_OtherProductsMember_f87bf0ae-ba5d-4e9a-a29b-9570622c75e9_terseLabel_en-US" xlink:label="lab_aort_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_aort_OtherProductsMember_label_en-US" xlink:label="lab_aort_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:label id="lab_aort_OtherProductsMember_documentation_en-US" xlink:label="lab_aort_OtherProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Products [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OtherProductsMember" xlink:href="aort-20230331.xsd#aort_OtherProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_OtherProductsMember" xlink:to="lab_aort_OtherProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_4d0f1d5b-ffe7-4b9f-9d4f-74d97ce65c54_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_16bb07da-dada-4a00-b102-04bee615d3ec_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_0d6e6497-d534-48c0-9487-fd779544da49_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents:</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_3a5dcdaa-6360-467e-bb86-b6fd40e9aae3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8382a5f2-f540-4914-b5a8-eee081d50998_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6043f19c-a5c9-49da-9202-0422aa04f473_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4d4ec70a-a673-4b0e-a789-df440443cf4c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted-average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_1fcec0f8-b44f-4df1-a8cc-a8c727f1635e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_cd2408eb-ff2a-4453-bd53-a8dfcafc7a8a_negatedLabel_en-US" xlink:label="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories and deferred preservation costs</link:label>
    <link:label id="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_label_en-US" xlink:label="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Preservation Costs and Inventories</link:label>
    <link:label id="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_documentation_en-US" xlink:label="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The increase (decrease) during the reporting period in deferred preservation costs and inventories, associated with underlying transactions that are classified as operating activities. Preservation costs consists primarily of direct labor and materials and indirect costs which are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:href="aort-20230331.xsd#aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:to="lab_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_8fed8417-7e58-4de2-852c-71208cd8612e_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_e3b03b4e-d64a-45f7-bbc9-a3ce6846233c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_aa18e826-d838-4755-b48b-c6509d3ef589_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OfficerMember_e1931c5c-0314-430d-b1be-6d0e0563fd8c_terseLabel_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officers</link:label>
    <link:label id="lab_srt_OfficerMember_label_en-US" xlink:label="lab_srt_OfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficerMember" xlink:to="lab_srt_OfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan1Member_8938de44-0c72-4640-b9c4-7aa39ac2a379_terseLabel_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Sparkasse Zollernalb (KFW Loan 1)</link:label>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan1Member_label_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Debt Kfw Loan1 [Member]</link:label>
    <link:label id="lab_aort_GovernmentSponsoredDebtKfwLoan1Member_documentation_en-US" xlink:label="lab_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Sponsored Debt (KFW Loan 1) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:href="aort-20230331.xsd#aort_GovernmentSponsoredDebtKfwLoan1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:to="lab_aort_GovernmentSponsoredDebtKfwLoan1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_6ad67e05-1c45-49bc-824f-64236f95cfec_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_08702a6b-7a18-4443-ad0b-8de55da1b80e_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_086085e0-3601-4fa0-8e71-b15bc0ef6f85_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_846963d6-884f-4828-80e4-40db2e25bd27_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_6811959e-7951-4177-afb9-059ceb5292fb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bf9b0e3-b756-45b8-a98e-6f34e61d7cd4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3ed8384e-9924-4104-aa18-995fc0058c60_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_120a9965-ee8a-4077-a479-0311df71a5e3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_d20e79e3-05db-4a9a-b4d1-75bfdb30d335_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_2f7ec0bc-a5e4-45f0-9f49-e87bcbb6053f_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e89dcb60-cb3a-46a2-934f-c7d8ca5b009a_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_47c05791-c4ca-47af-9a8b-cb44f64b8a6f_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_c2642d22-958d-42e6-bea0-ee85b1967c2e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_15b95dd3-e9f0-4a93-b868-6443e2255f6a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption and repurchase of stock to cover tax withholdings</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_8a961eb8-addc-4a2c-a5cc-45834712e73a_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_8438f929-a6af-4a96-b281-f64a46ba3898_terseLabel_en-US" xlink:label="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate grant date market value</link:label>
    <link:label id="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_label_en-US" xlink:label="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Market Value Of Shares Granted</link:label>
    <link:label id="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_documentation_en-US" xlink:label="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market value of share based compensation arrangement by share based payment award other than options granted during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:href="aort-20230331.xsd#aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:to="lab_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_611a91cf-9aa0-407d-be6b-e5db74ccb881_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility aggregate commitments</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_d4e6bc81-f0de-41a9-9b6e-da76ac0750fb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows for finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_dda04312-0f88-43fe-b963-cce7fa706146_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Foreign Currency Translation Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:to="lab_us-gaap_GoodwillForeignCurrencyTranslationGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_17de4ad0-b64e-44d1-ab17-7b522aca4ead_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_18d67a90-1366-4053-8c12-29e7d4ab02a9_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_da5b4340-0094-4a2c-a18a-0071363f8de8_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_6cab827b-d209-4ae1-b312-0b31dfe7846b_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_2b861e70-b572-4070-9dde-f6c886969951_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_21680524-1ae2-45b8-a9f0-74695488dd4a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_9afde668-5164-43af-a710-1242a3b34403_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerListsMember_7d282f27-85c2-41a3-a49b-64df1dc28f05_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerListsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer lists and relationships</link:label>
    <link:label id="lab_us-gaap_CustomerListsMember_label_en-US" xlink:label="lab_us-gaap_CustomerListsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Lists [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerListsMember" xlink:to="lab_us-gaap_CustomerListsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_49ae0daf-0b3c-41c1-995e-33c49b3bbfc3_verboseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock_c2ee3cf3-7ecd-438d-86c0-4983f5bd6dcc_terseLabel_en-US" xlink:label="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Supplemental Balance Sheet Information Related to Leases</link:label>
    <link:label id="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Supplemental Balance Sheet Information Related To Leases [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="aort-20230331.xsd#aort_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_aort_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_706aef54-b8e8-4a50-80c1-3c71d8d2b743_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c1d56e48-a8a1-4548-ae89-33da3a002657_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_333f3be6-6ab4-47b4-b8a7-1a2b0bb13474_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current finance lease obligation</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_a30ba53e-2a18-478c-9161-2d75202d375e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current maturities of finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_f4c57cdf-9a56-4bea-8962-0f968264ab78_netLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities, less current maturities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_48929b37-629c-42f0-9c81-b3046a49cc70_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired technology, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_9073f7b2-dc44-4a27-b3d5-74ab34e49957_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d7493b56-ade4-4cc0-a9a3-69cf2aa51090_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_74a5fba1-d749-44b4-8177-5e4ea573282f_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_464abf6b-03f0-404d-ab53-2881cfbd5025_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_471ed8d7-3440-4f66-8242-f6e094199ab5_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment costs</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_0be114e8-1092-4dcc-be38-a6857a70e2b0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate202006Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2020-06 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate202006Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate202006Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_e3dff533-e60f-40a6-8e9e-c707a2026460_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill by Reportable Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ff592e2c-b650-4066-a89e-515f58f92601_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash from operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aort_CreditAgreementMember_0d3747e7-78da-431c-acb8-385399f1c6d1_terseLabel_en-US" xlink:label="lab_aort_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_aort_CreditAgreementMember_label_en-US" xlink:label="lab_aort_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_aort_CreditAgreementMember_documentation_en-US" xlink:label="lab_aort_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CreditAgreementMember" xlink:href="aort-20230331.xsd#aort_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aort_CreditAgreementMember" xlink:to="lab_aort_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_bee68160-e047-4a01-a357-7771573e5df6_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_d9dd2cb6-623f-412f-8c27-4a620e261baa_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_5dcd7a93-cbe5-4e02-bac7-a293131541b6_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less unamortized loan origination costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_cb4eced4-92ce-4d37-8814-24fa2cb4d054_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_26a8e906-4142-46b2-b5be-462750d03704_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>aort-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:b72a0741-f899-4d87-a80c-f9fdcb4bb4b4,g:8ab7fb08-5903-4a38-b428-03d2f07a3992-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.cryolife.com/role/Cover" xlink:type="simple" xlink:href="aort-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4c830479-eed1-4323-a407-8a14deeb6736" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_DocumentType_4c830479-eed1-4323-a407-8a14deeb6736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_b7bd8183-199c-42c2-9c4d-4209551c418d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_DocumentQuarterlyReport_b7bd8183-199c-42c2-9c4d-4209551c418d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_76a3da1c-030a-4f5b-9db8-7d8c05b3d9b9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_DocumentPeriodEndDate_76a3da1c-030a-4f5b-9db8-7d8c05b3d9b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_49e9f910-d610-4ca6-bb18-9594b0971a1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_DocumentTransitionReport_49e9f910-d610-4ca6-bb18-9594b0971a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0b5411f8-7b91-438f-8cfa-06c49cb7aa0b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityFileNumber_0b5411f8-7b91-438f-8cfa-06c49cb7aa0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d1886088-9872-4b52-adc5-7f9a1efa4cd3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityRegistrantName_d1886088-9872-4b52-adc5-7f9a1efa4cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_3642bf20-1a8f-4204-a6d1-eecd2c11c1cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityIncorporationStateCountryCode_3642bf20-1a8f-4204-a6d1-eecd2c11c1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2b5ac52e-6190-4058-8bc4-462d2f1dc9bd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityTaxIdentificationNumber_2b5ac52e-6190-4058-8bc4-462d2f1dc9bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_e21f5f5b-a87f-4f84-9e8a-2fb5a51a715a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityAddressAddressLine1_e21f5f5b-a87f-4f84-9e8a-2fb5a51a715a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_235bf077-1a85-4a06-8059-211a97cc377e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityAddressCityOrTown_235bf077-1a85-4a06-8059-211a97cc377e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_f26569e1-771c-46c2-b53c-961623e31d3e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityAddressStateOrProvince_f26569e1-771c-46c2-b53c-961623e31d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_92225dcf-0fc8-4eb6-96a6-137bb7efdc6d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityAddressPostalZipCode_92225dcf-0fc8-4eb6-96a6-137bb7efdc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_6c6949c3-3069-4362-a5db-98fefaecf61a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_CityAreaCode_6c6949c3-3069-4362-a5db-98fefaecf61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a8651483-cbda-486b-a59b-92ed265124e1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_LocalPhoneNumber_a8651483-cbda-486b-a59b-92ed265124e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_934bcb68-040b-4ef8-9d79-17da9726a53c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_Security12bTitle_934bcb68-040b-4ef8-9d79-17da9726a53c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_2669f478-8cfa-4efe-a634-5f56ef7539ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_TradingSymbol_2669f478-8cfa-4efe-a634-5f56ef7539ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_462e9197-c998-4f4f-a4e2-aa3a2919f01d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_SecurityExchangeName_462e9197-c998-4f4f-a4e2-aa3a2919f01d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_dd98c841-8a72-4d5b-8d16-4d71ca922833" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityCurrentReportingStatus_dd98c841-8a72-4d5b-8d16-4d71ca922833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_16f15d29-8029-42e5-bd15-dbf6d89a600b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityInteractiveDataCurrent_16f15d29-8029-42e5-bd15-dbf6d89a600b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_41eb1052-7ab6-4021-a6d3-3ff451748fd3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityFilerCategory_41eb1052-7ab6-4021-a6d3-3ff451748fd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_280a9d6e-61c7-40ea-aba7-d816d97cc857" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntitySmallBusiness_280a9d6e-61c7-40ea-aba7-d816d97cc857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_aa16720e-0b14-4b9a-82f5-c7a299d807f4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityEmergingGrowthCompany_aa16720e-0b14-4b9a-82f5-c7a299d807f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ebca91c6-f18c-4929-bdf6-505d0e4c81ed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityShellCompany_ebca91c6-f18c-4929-bdf6-505d0e4c81ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_d1e3cec5-16d2-495c-874f-c7e5ca3aca4a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_d1e3cec5-16d2-495c-874f-c7e5ca3aca4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_b249f5e7-1ccb-432b-973a-5e42debb6406" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_EntityCentralIndexKey_b249f5e7-1ccb-432b-973a-5e42debb6406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4cde24fb-54a9-4d60-bcce-748faf7caa58" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_CurrentFiscalYearEndDate_4cde24fb-54a9-4d60-bcce-748faf7caa58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_e14ab5f6-7fbb-4cb2-90c5-3aa585e6ab5e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_DocumentFiscalYearFocus_e14ab5f6-7fbb-4cb2-90c5-3aa585e6ab5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_d9efcd65-d3d2-460a-ac0d-3a05859e3aff" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_DocumentFiscalPeriodFocus_d9efcd65-d3d2-460a-ac0d-3a05859e3aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_112db383-5cc0-48b7-9b55-c651d35b0536" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b0a85a22-2b4c-4583-9984-0650abbff162" xlink:to="loc_dei_AmendmentFlag_112db383-5cc0-48b7-9b55-c651d35b0536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a85e898a-c3bb-4245-ad57-7895f93443c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_cc90635d-efad-4d3a-8627-019383fe1bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a85e898a-c3bb-4245-ad57-7895f93443c4" xlink:to="loc_us-gaap_StatementTable_cc90635d-efad-4d3a-8627-019383fe1bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d0293795-46be-4219-a4e6-614e7348d5ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cc90635d-efad-4d3a-8627-019383fe1bc5" xlink:to="loc_srt_ProductOrServiceAxis_d0293795-46be-4219-a4e6-614e7348d5ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_eab8891f-53bf-400a-b597-5a4d47f65d0f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d0293795-46be-4219-a4e6-614e7348d5ad" xlink:to="loc_srt_ProductsAndServicesDomain_eab8891f-53bf-400a-b597-5a4d47f65d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember_3b9a9dc0-98c6-42ba-b33f-db1d9967a023" xlink:href="aort-20230331.xsd#aort_ProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_eab8891f-53bf-400a-b597-5a4d47f65d0f" xlink:to="loc_aort_ProductsMember_3b9a9dc0-98c6-42ba-b33f-db1d9967a023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_fad714a8-452c-4a3c-ad71-8c8ecc45d131" xlink:href="aort-20230331.xsd#aort_PreservationServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_eab8891f-53bf-400a-b597-5a4d47f65d0f" xlink:to="loc_aort_PreservationServicesMember_fad714a8-452c-4a3c-ad71-8c8ecc45d131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_cc90635d-efad-4d3a-8627-019383fe1bc5" xlink:to="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_8b164a1f-b777-4272-a42b-749d235c322c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_RevenuesAbstract_8b164a1f-b777-4272-a42b-749d235c322c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d6fc25c-dcbd-43a5-bec1-6ac3b160ff31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_8b164a1f-b777-4272-a42b-749d235c322c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2d6fc25c-dcbd-43a5-bec1-6ac3b160ff31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_08dca7b8-0d0c-48f0-be93-ca2f51af358d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_CostOfRevenueAbstract_08dca7b8-0d0c-48f0-be93-ca2f51af358d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_7b816eb0-9b5b-44ec-b475-12764951c087" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_08dca7b8-0d0c-48f0-be93-ca2f51af358d" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_7b816eb0-9b5b-44ec-b475-12764951c087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_630b3c50-99b2-45ce-a6ce-6b44466f116c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_GrossProfit_630b3c50-99b2-45ce-a6ce-6b44466f116c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_61a5f251-e2f1-4ded-9853-bfa013567546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_61a5f251-e2f1-4ded-9853-bfa013567546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bf576a99-90bf-4bf9-82ba-643935db598b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bf576a99-90bf-4bf9-82ba-643935db598b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7b85ab3f-704e-42dc-afcc-03f9b9f379ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_7be79fc3-d2d9-41f3-951d-39a154f06213" xlink:to="loc_us-gaap_OperatingExpenses_7b85ab3f-704e-42dc-afcc-03f9b9f379ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6cbb4898-11ec-45bb-a96b-6b8d0dfcc7fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_OperatingIncomeLoss_6cbb4898-11ec-45bb-a96b-6b8d0dfcc7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_8f649705-c553-4ee7-ba71-2792faed0cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_InterestExpense_8f649705-c553-4ee7-ba71-2792faed0cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_4a6afb40-16a8-436e-8f16-b253553b6ecb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_InvestmentIncomeInterest_4a6afb40-16a8-436e-8f16-b253553b6ecb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_91dd02a9-dcb7-4697-89c3-737f0d215865" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_91dd02a9-dcb7-4697-89c3-737f0d215865" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a20e7c2c-0578-488a-9dc4-5706abb51042" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a20e7c2c-0578-488a-9dc4-5706abb51042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8ac29955-6da8-4803-82e9-af0e1bd0fbce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8ac29955-6da8-4803-82e9-af0e1bd0fbce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6eac5271-687c-4953-894d-dd253c5f16e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_NetIncomeLoss_6eac5271-687c-4953-894d-dd253c5f16e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fc50053d-144a-4b6d-905f-78ca38eeb0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fc50053d-144a-4b6d-905f-78ca38eeb0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_96a58170-7764-411d-9fb4-68ad9f841c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fc50053d-144a-4b6d-905f-78ca38eeb0fd" xlink:to="loc_us-gaap_EarningsPerShareBasic_96a58170-7764-411d-9fb4-68ad9f841c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0a99c740-93de-42d7-8c27-97f02e14b9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_fc50053d-144a-4b6d-905f-78ca38eeb0fd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0a99c740-93de-42d7-8c27-97f02e14b9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a664dd86-a762-48f5-83c3-379a1ac4f172" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a664dd86-a762-48f5-83c3-379a1ac4f172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cef32ee8-9787-4d4f-aafc-846fc065ffdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a664dd86-a762-48f5-83c3-379a1ac4f172" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cef32ee8-9787-4d4f-aafc-846fc065ffdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_43043ddb-69b8-498e-a316-c46c3c10ab8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_a664dd86-a762-48f5-83c3-379a1ac4f172" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_43043ddb-69b8-498e-a316-c46c3c10ab8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0587a409-d62c-4373-9078-d50dedd03321" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_NetIncomeLoss_0587a409-d62c-4373-9078-d50dedd03321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_5656a820-6bbc-4822-85cc-7e69a36f016c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfOtherComprehensiveIncomeAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_5656a820-6bbc-4822-85cc-7e69a36f016c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_91259192-4632-4664-9597-b6086bb87bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfOtherComprehensiveIncomeAbstract_5656a820-6bbc-4822-85cc-7e69a36f016c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_91259192-4632-4664-9597-b6086bb87bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_df562eee-4ae7-4d1a-9203-641631ad3458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4292b662-1d8e-418a-9231-df6f51354c8c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_df562eee-4ae7-4d1a-9203-641631ad3458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_f2d46335-c380-42ec-8b33-c8a247b39d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2d46335-c380-42ec-8b33-c8a247b39d5d" xlink:to="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f6378c0f-43be-4d29-b8dd-bb8448728e8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_f6378c0f-43be-4d29-b8dd-bb8448728e8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2228dea4-f60a-4244-818d-8d573bad684e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2228dea4-f60a-4244-818d-8d573bad684e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_86c9b509-6ce0-4ce5-9e78-8883e580e83c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_86c9b509-6ce0-4ce5-9e78-8883e580e83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e7e789fa-689f-4421-aebe-097a281c7f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:to="loc_us-gaap_InventoryNet_e7e789fa-689f-4421-aebe-097a281c7f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts_5c53cb0a-731c-4a5c-9a14-a72a6ed0cb88" xlink:href="aort-20230331.xsd#aort_DeferredPreservationCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:to="loc_aort_DeferredPreservationCosts_5c53cb0a-731c-4a5c-9a14-a72a6ed0cb88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d9bafc5e-2a39-4c93-8160-4e8f5dd94438" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_d9bafc5e-2a39-4c93-8160-4e8f5dd94438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_59783817-24e1-48af-afb5-ab72c0acee7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_17e48cd9-5b0f-44c6-879a-93f1ba2e940f" xlink:to="loc_us-gaap_AssetsCurrent_59783817-24e1-48af-afb5-ab72c0acee7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_463bc27b-f9ad-4135-a312-6585088d7935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_Goodwill_463bc27b-f9ad-4135-a312-6585088d7935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5fd8a35-0d63-4058-b900-2b425025b27f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f5fd8a35-0d63-4058-b900-2b425025b27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5b7dd170-5b6c-4557-b499-f73620fcefd7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5b7dd170-5b6c-4557-b499-f73620fcefd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d4e51775-897b-4e63-ab91-9f8a7c8e76ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d4e51775-897b-4e63-ab91-9f8a7c8e76ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsNet_198ebb45-968b-4558-944a-be14cddafe86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_OtherIntangibleAssetsNet_198ebb45-968b-4558-944a-be14cddafe86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7d84cac8-ad5f-41b0-8575-a2d19423ab15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7d84cac8-ad5f-41b0-8575-a2d19423ab15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_e3b79679-9ca3-48fd-8eb5-d25a848f4350" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_e3b79679-9ca3-48fd-8eb5-d25a848f4350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_08e99894-3e54-43ad-a7db-e786618143c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f1501937-8420-4fb2-942a-70936fbf32dd" xlink:to="loc_us-gaap_Assets_08e99894-3e54-43ad-a7db-e786618143c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_f2d46335-c380-42ec-8b33-c8a247b39d5d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_c5a886b5-1dfb-4d6f-98dc-a6cb06250e4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_us-gaap_AccountsPayableCurrent_c5a886b5-1dfb-4d6f-98dc-a6cb06250e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a52f4ed6-ba99-4ca5-ba26-a8c4e0e34e37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a52f4ed6-ba99-4ca5-ba26-a8c4e0e34e37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6977bf41-095b-4c18-bef3-b162829094a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_6977bf41-095b-4c18-bef3-b162829094a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_6e202cab-9524-4503-901f-b4134c84ec97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_us-gaap_TaxesPayableCurrent_6e202cab-9524-4503-901f-b4134c84ec97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_5d930e97-b74a-4dbd-a2dc-2ae8d1d987ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_5d930e97-b74a-4dbd-a2dc-2ae8d1d987ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AccruedProcurementFees_f2f77cd4-aab3-4280-9165-f5711ed23ff8" xlink:href="aort-20230331.xsd#aort_AccruedProcurementFees"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_aort_AccruedProcurementFees_f2f77cd4-aab3-4280-9165-f5711ed23ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_5f69e244-8c69-43b3-9b4d-a231b3f806ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_us-gaap_LongTermDebtCurrent_5f69e244-8c69-43b3-9b4d-a231b3f806ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_33e1a6e8-8f15-4957-84fe-3b438a2979b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_33e1a6e8-8f15-4957-84fe-3b438a2979b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_204379f7-46b4-482b-9d77-febbd7e43028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_552080ba-ae43-4b5c-b006-3abb36cac2fd" xlink:to="loc_us-gaap_LiabilitiesCurrent_204379f7-46b4-482b-9d77-febbd7e43028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_d1d5c6b0-9c41-4e93-89dc-794a74faf305" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_d1d5c6b0-9c41-4e93-89dc-794a74faf305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_52a907b1-494e-4400-859a-e21c8af0d742" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_52a907b1-494e-4400-859a-e21c8af0d742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f322f2d-1e34-499e-ba57-1143bb89f153" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_3f322f2d-1e34-499e-ba57-1143bb89f153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ef76505f-8340-467a-a9ab-f64fbe941c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_ef76505f-8340-467a-a9ab-f64fbe941c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_60bf706e-a262-4aa7-a9cb-3d81b429a8ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_60bf706e-a262-4aa7-a9cb-3d81b429a8ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_972d9959-8545-47cc-90b7-8df31022c244" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_972d9959-8545-47cc-90b7-8df31022c244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d045d66e-e8db-4626-9397-af3c79269cad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d045d66e-e8db-4626-9397-af3c79269cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_530e6667-fedd-4511-bc74-33c5502423e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_Liabilities_530e6667-fedd-4511-bc74-33c5502423e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_8711f27a-cc45-4aaf-a7ee-d7fba59af0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_CommitmentsAndContingencies_8711f27a-cc45-4aaf-a7ee-d7fba59af0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_6cdeefbb-3904-4c69-aab2-2ba31fa9321b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:to="loc_us-gaap_PreferredStockValue_6cdeefbb-3904-4c69-aab2-2ba31fa9321b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_acd2fed3-3244-48b3-9193-5ae4f91acb25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:to="loc_us-gaap_CommonStockValue_acd2fed3-3244-48b3-9193-5ae4f91acb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1ae42d68-5c56-4564-9c06-8c0b96f223ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_1ae42d68-5c56-4564-9c06-8c0b96f223ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a808acd5-7672-494c-a1e9-61b648ac99f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_a808acd5-7672-494c-a1e9-61b648ac99f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f6443f27-8969-49a4-bffd-ae903c51de43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f6443f27-8969-49a4-bffd-ae903c51de43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_a535932a-bc5b-4f46-8fa2-f485e82247b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:to="loc_us-gaap_TreasuryStockCommonValue_a535932a-bc5b-4f46-8fa2-f485e82247b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_cdf4a5e9-f774-4d85-86a9-12fd92456f0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_50c7aace-0754-4ed4-b6e4-5905f9b54977" xlink:to="loc_us-gaap_StockholdersEquity_cdf4a5e9-f774-4d85-86a9-12fd92456f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8e7ad25c-789a-4b6f-9925-f3d349008c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c598faba-2618-44b7-94f8-e17cd861e0e6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8e7ad25c-789a-4b6f-9925-f3d349008c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_19f432df-87f3-4d5e-89c8-afaf56b26711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_b497161f-cc95-4871-95ca-377ebcf92beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_19f432df-87f3-4d5e-89c8-afaf56b26711" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_b497161f-cc95-4871-95ca-377ebcf92beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a222f601-9ab2-4621-9d60-0cc527c983d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_19f432df-87f3-4d5e-89c8-afaf56b26711" xlink:to="loc_us-gaap_CommonStockSharesIssued_a222f601-9ab2-4621-9d60-0cc527c983d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_d7f5a3dc-746e-48b6-a18d-61e402c15435" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_19f432df-87f3-4d5e-89c8-afaf56b26711" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_d7f5a3dc-746e-48b6-a18d-61e402c15435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_d99dd698-c928-4ff4-9e87-9d7c78c42419" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_19f432df-87f3-4d5e-89c8-afaf56b26711" xlink:to="loc_us-gaap_TreasuryStockCommonShares_d99dd698-c928-4ff4-9e87-9d7c78c42419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_02cb7675-08d5-4e42-8389-b18cece0f547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b99c0ac8-59cf-4515-b8c1-2721f4e486ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02cb7675-08d5-4e42-8389-b18cece0f547" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b99c0ac8-59cf-4515-b8c1-2721f4e486ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_2793b079-d9ca-4b7a-bf93-b93d8899cc40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b99c0ac8-59cf-4515-b8c1-2721f4e486ae" xlink:to="loc_us-gaap_NetIncomeLoss_2793b079-d9ca-4b7a-bf93-b93d8899cc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b99c0ac8-59cf-4515-b8c1-2721f4e486ae" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_cc975499-56ab-4ef9-8f38-dc51d8a9ecd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_cc975499-56ab-4ef9-8f38-dc51d8a9ecd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_294f698b-2953-4030-b0be-90866f5a8752" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_294f698b-2953-4030-b0be-90866f5a8752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d645c0c4-6af4-4d77-b401-afe5631beae4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:to="loc_us-gaap_ShareBasedCompensation_d645c0c4-6af4-4d77-b401-afe5631beae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NoncashLeaseExpense_f974f16c-54e0-43f0-a7e9-b37a044f46e5" xlink:href="aort-20230331.xsd#aort_NoncashLeaseExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:to="loc_aort_NoncashLeaseExpense_f974f16c-54e0-43f0-a7e9-b37a044f46e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories_e1ffaf48-8a8a-4f30-bc9d-e5c5a5ea0214" xlink:href="aort-20230331.xsd#aort_WriteDownOfDeferredPreservationCostsAndInventories"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:to="loc_aort_WriteDownOfDeferredPreservationCostsAndInventories_e1ffaf48-8a8a-4f30-bc9d-e5c5a5ea0214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6906714b-fe90-4a22-9e1a-474744a65f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6906714b-fe90-4a22-9e1a-474744a65f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashExpense_41fcd4f5-2340-418c-8c99-2cefe45bb036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:to="loc_us-gaap_OtherNoncashExpense_41fcd4f5-2340-418c-8c99-2cefe45bb036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ed6b30-599d-4a0b-ba17-96118b562447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_4a098286-d70d-4bd5-9e5c-e8c0855cb2bf" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ed6b30-599d-4a0b-ba17-96118b562447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInReceivables_0a66455a-0588-497e-a273-5fce1187f1eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ed6b30-599d-4a0b-ba17-96118b562447" xlink:to="loc_us-gaap_IncreaseDecreaseInReceivables_0a66455a-0588-497e-a273-5fce1187f1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_578f448f-03aa-41db-b261-b741341c11b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ed6b30-599d-4a0b-ba17-96118b562447" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_578f448f-03aa-41db-b261-b741341c11b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_4ea5811e-cea7-4242-a1ab-185e963cfd6b" xlink:href="aort-20230331.xsd#aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ed6b30-599d-4a0b-ba17-96118b562447" xlink:to="loc_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories_4ea5811e-cea7-4242-a1ab-185e963cfd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7f1e8e5a-7762-4fc0-aa3c-88d9206b4767" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_18ed6b30-599d-4a0b-ba17-96118b562447" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7f1e8e5a-7762-4fc0-aa3c-88d9206b4767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07b306a3-28a0-470a-8912-8244416fdbe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b99c0ac8-59cf-4515-b8c1-2721f4e486ae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_07b306a3-28a0-470a-8912-8244416fdbe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d89a1121-b814-4dfe-8c4e-e337cde779e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02cb7675-08d5-4e42-8389-b18cece0f547" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d89a1121-b814-4dfe-8c4e-e337cde779e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49c6cc7a-f897-4b58-bf7d-dfaf380b3213" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d89a1121-b814-4dfe-8c4e-e337cde779e9" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_49c6cc7a-f897-4b58-bf7d-dfaf380b3213" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3c3d9e46-b362-451b-83ad-76693fcdd930" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d89a1121-b814-4dfe-8c4e-e337cde779e9" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3c3d9e46-b362-451b-83ad-76693fcdd930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90b11676-c03b-4cea-a5a1-77d5535d9618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d89a1121-b814-4dfe-8c4e-e337cde779e9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_90b11676-c03b-4cea-a5a1-77d5535d9618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cf7e90c-dd2d-44b5-a3e1-63411651679d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02cb7675-08d5-4e42-8389-b18cece0f547" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cf7e90c-dd2d-44b5-a3e1-63411651679d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6efae3b4-6b5a-46e0-9b4d-66d29016bde9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cf7e90c-dd2d-44b5-a3e1-63411651679d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_6efae3b4-6b5a-46e0-9b4d-66d29016bde9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e055090f-7b64-452d-b57b-f96895bbcabe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cf7e90c-dd2d-44b5-a3e1-63411651679d" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_e055090f-7b64-452d-b57b-f96895bbcabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_5939f2b7-71fa-4160-94c6-d307e74118e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cf7e90c-dd2d-44b5-a3e1-63411651679d" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_5939f2b7-71fa-4160-94c6-d307e74118e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c07a2046-2e6f-4dd0-a136-8c8158c56bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cf7e90c-dd2d-44b5-a3e1-63411651679d" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_c07a2046-2e6f-4dd0-a136-8c8158c56bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cfda7200-8d3f-4f31-b847-f65cb00678b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_7cf7e90c-dd2d-44b5-a3e1-63411651679d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cfda7200-8d3f-4f31-b847-f65cb00678b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7e8ab2d-8866-4326-bea2-d16353420511" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02cb7675-08d5-4e42-8389-b18cece0f547" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b7e8ab2d-8866-4326-bea2-d16353420511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_73dbc255-f7a9-4b8a-a5aa-3e3fb9b107c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02cb7675-08d5-4e42-8389-b18cece0f547" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_73dbc255-f7a9-4b8a-a5aa-3e3fb9b107c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e24ceda-abeb-43fa-8910-75d6ba03523c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02cb7675-08d5-4e42-8389-b18cece0f547" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3e24ceda-abeb-43fa-8910-75d6ba03523c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c502340c-231a-4bb9-9dc3-54ccf89b4e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_02cb7675-08d5-4e42-8389-b18cece0f547" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c502340c-231a-4bb9-9dc3-54ccf89b4e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="simple" xlink:href="aort-20230331.xsd#CondensedConsolidatedStatementsofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_126b49cb-8f60-42b0-ada1-b7cbdec0e7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f2607bf1-96af-4b95-b586-c705c87c4620" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_126b49cb-8f60-42b0-ada1-b7cbdec0e7ac" xlink:to="loc_us-gaap_StatementTable_f2607bf1-96af-4b95-b586-c705c87c4620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_264bf80f-e81b-485a-ba41-d7e199537f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f2607bf1-96af-4b95-b586-c705c87c4620" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_264bf80f-e81b-485a-ba41-d7e199537f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_264bf80f-e81b-485a-ba41-d7e199537f1a" xlink:to="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_29129159-e164-4f8a-b0f8-f8f882d4f4ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_CommonStockMember_29129159-e164-4f8a-b0f8-f8f882d4f4ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ef489590-dda5-4d0f-abc0-c1aaf0b4d9fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ef489590-dda5-4d0f-abc0-c1aaf0b4d9fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_40e4c968-56c9-4103-a30d-156cc0103289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_RetainedEarningsMember_40e4c968-56c9-4103-a30d-156cc0103289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df2763c5-49f8-4bc1-998b-cdf6ae3c7fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_df2763c5-49f8-4bc1-998b-cdf6ae3c7fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_c5709c74-d79a-4825-ac03-7c1770425f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_e32b0bc5-fa2b-4d33-acae-8462046d6184" xlink:to="loc_us-gaap_TreasuryStockCommonMember_c5709c74-d79a-4825-ac03-7c1770425f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8d9fd956-6ce1-455c-aca7-2ed5264b18d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f2607bf1-96af-4b95-b586-c705c87c4620" xlink:to="loc_us-gaap_StatementLineItems_8d9fd956-6ce1-455c-aca7-2ed5264b18d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d9fd956-6ce1-455c-aca7-2ed5264b18d9" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_5ea36b61-e46f-46da-874a-535ee0a36cf5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_5ea36b61-e46f-46da-874a-535ee0a36cf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4a184b55-7656-48fc-8c7c-3268b2fbc294" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockholdersEquity_4a184b55-7656-48fc-8c7c-3268b2fbc294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_7ca22b1f-cbb5-4fb4-a60f-68e8348ad18d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_TreasuryStockCommonShares_7ca22b1f-cbb5-4fb4-a60f-68e8348ad18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_0c167e0e-fc69-4338-a2e9-87824cffb7ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_TreasuryStockCommonValue_0c167e0e-fc69-4338-a2e9-87824cffb7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4f5c7976-e21e-4f04-882a-005e1625c314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_NetIncomeLoss_4f5c7976-e21e-4f04-882a-005e1625c314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_82a58568-c59b-42c1-906e-35bc37e533b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_82a58568-c59b-42c1-906e-35bc37e533b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_45ab28b7-6866-489f-9e4a-7d9e62169f3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_45ab28b7-6866-489f-9e4a-7d9e62169f3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_753fa3aa-fb75-4ea0-870c-cf5ac0f3c44b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_753fa3aa-fb75-4ea0-870c-cf5ac0f3c44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a87fa4c1-2e35-409b-9bfe-80d66b487a53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a87fa4c1-2e35-409b-9bfe-80d66b487a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_91d6d4c1-297f-46d8-8096-8dd6e596910e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_91d6d4c1-297f-46d8-8096-8dd6e596910e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_da7a03c0-1649-401e-86f2-7eadf8131858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_da7a03c0-1649-401e-86f2-7eadf8131858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c2c235f2-e929-4fbf-b32a-1c74c3e14265" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_c2c235f2-e929-4fbf-b32a-1c74c3e14265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_3349abd4-c346-4f78-9fc9-81ee3eddc047" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodShares"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodShares_3349abd4-c346-4f78-9fc9-81ee3eddc047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_b0b7d5fa-e508-41af-badf-da6e5554f7e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRedeemedOrCalledDuringPeriodValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockRedeemedOrCalledDuringPeriodValue_b0b7d5fa-e508-41af-badf-da6e5554f7e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_bded435c-1fdb-406c-93c7-f345df2cea52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_bded435c-1fdb-406c-93c7-f345df2cea52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c0bffc84-a3ee-4649-a431-d833a003371a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_StockholdersEquity_c0bffc84-a3ee-4649-a431-d833a003371a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_2b8a6d38-0c03-4d91-aa68-c4119926d2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_TreasuryStockCommonShares_2b8a6d38-0c03-4d91-aa68-c4119926d2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_54c26859-d0b9-434c-9507-f45bce111e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8e3c4cd6-9f04-4510-bede-1379cd501505" xlink:to="loc_us-gaap_TreasuryStockCommonValue_54c26859-d0b9-434c-9507-f45bce111e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="aort-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb071590-8e0e-4f21-a3c5-a8edbc910cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccounting_03f37534-2cff-4543-b12a-e215f312e34a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccounting"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_eb071590-8e0e-4f21-a3c5-a8edbc910cae" xlink:to="loc_us-gaap_BasisOfAccounting_03f37534-2cff-4543-b12a-e215f312e34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstruments" xlink:type="simple" xlink:href="aort-20230331.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2f277b3c-cdc5-4ecd-9a76-0f3a986b7ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_ed2dd988-9afa-417c-bb08-5ac7c33f0ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2f277b3c-cdc5-4ecd-9a76-0f3a986b7ab6" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_ed2dd988-9afa-417c-bb08-5ac7c33f0ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts" xlink:type="simple" xlink:href="aort-20230331.xsd#InventoriesnetandDeferredPreservationCosts"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_b1d1fdd8-f3b7-4d37-abea-2f1811b85a41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_f292f99c-3cbb-4442-8594-ec408451f177" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b1d1fdd8-f3b7-4d37-abea-2f1811b85a41" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_f292f99c-3cbb-4442-8594-ec408451f177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_053892c4-89bc-4cf7-ac6f-862ed27a0007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_84b9c7e6-0815-4835-a62e-98cebeab6d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_053892c4-89bc-4cf7-ac6f-862ed27a0007" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_84b9c7e6-0815-4835-a62e-98cebeab6d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/IncomeTaxes" xlink:type="simple" xlink:href="aort-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a13de8fd-633f-4d80-9865-e1d650d9405d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_9634a786-505c-4911-bdfc-35f58a5ca025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a13de8fd-633f-4d80-9865-e1d650d9405d" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_9634a786-505c-4911-bdfc-35f58a5ca025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/Leases" xlink:type="simple" xlink:href="aort-20230331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cdfc491c-8661-4bf4-80f6-2bb758393e29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_5bfe0e73-4b52-41b9-b3b6-497c02ad6430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cdfc491c-8661-4bf4-80f6-2bb758393e29" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_5bfe0e73-4b52-41b9-b3b6-497c02ad6430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/Debt" xlink:type="simple" xlink:href="aort-20230331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ed7b7605-49bb-4c5b-aedc-6fd3fd034531" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_450d6ac9-3968-43c1-8d87-78a1155076da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ed7b7605-49bb-4c5b-aedc-6fd3fd034531" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_450d6ac9-3968-43c1-8d87-78a1155076da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="aort-20230331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_46ba911b-0004-495e-8039-896bea6fcb7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e6e79864-44d4-49f9-ad98-fe1d2b75487d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_46ba911b-0004-495e-8039-896bea6fcb7e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_e6e79864-44d4-49f9-ad98-fe1d2b75487d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/RevenueRecognition" xlink:type="simple" xlink:href="aort-20230331.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2b15418c-ebb5-4924-bc00-affef8af0fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_64918d43-a3eb-4df4-99ea-154b2582fc4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2b15418c-ebb5-4924-bc00-affef8af0fa5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_64918d43-a3eb-4df4-99ea-154b2582fc4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensation" xlink:type="simple" xlink:href="aort-20230331.xsd#StockCompensation"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5fee8b86-0deb-43a0-a07f-96453edabb30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8917afd6-e89e-4cf0-9b74-3c1711789a51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5fee8b86-0deb-43a0-a07f-96453edabb30" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_8917afd6-e89e-4cf0-9b74-3c1711789a51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossPerCommonShare" xlink:type="simple" xlink:href="aort-20230331.xsd#LossPerCommonShare"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LossPerCommonShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7fc230a5-6936-40ba-9f9a-0c15d22f888c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d6dd16a2-61b3-46a0-b47d-3fbdce1666f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7fc230a5-6936-40ba-9f9a-0c15d22f888c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d6dd16a2-61b3-46a0-b47d-3fbdce1666f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformation" xlink:type="simple" xlink:href="aort-20230331.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_30c248d1-93d6-4e9f-89ea-649aa50717c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_27c716d9-c341-44e8-9a9f-2e87d0b6f740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_30c248d1-93d6-4e9f-89ea-649aa50717c9" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_27c716d9-c341-44e8-9a9f-2e87d0b6f740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SubsequentEvents" xlink:type="simple" xlink:href="aort-20230331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_bd8ca5ee-7fce-48c5-821c-1b7039b3c272" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_1c74305e-71bc-4570-9f46-9e4ff639b327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_bd8ca5ee-7fce-48c5-821c-1b7039b3c272" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_1c74305e-71bc-4570-9f46-9e4ff639b327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="aort-20230331.xsd#BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd293589-8599-4c0e-ad7f-c78f368dcf26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_af917798-2d14-46af-9df9-cde8911b4cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_fd293589-8599-4c0e-ad7f-c78f368dcf26" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_af917798-2d14-46af-9df9-cde8911b4cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="aort-20230331.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7d834900-6a41-4b2a-9b3f-76cc87c8cf91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_2175379b-4175-4285-b9ba-6ed70e6567f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7d834900-6a41-4b2a-9b3f-76cc87c8cf91" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_2175379b-4175-4285-b9ba-6ed70e6567f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0b755491-254f-41cf-9360-702686f5d079" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7d834900-6a41-4b2a-9b3f-76cc87c8cf91" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_0b755491-254f-41cf-9360-702686f5d079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables" xlink:type="simple" xlink:href="aort-20230331.xsd#InventoriesNetAndDeferredPreservationCostsTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_729288f3-60b6-43c0-bdd8-b70e20c7ba21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d187f9e9-c9dd-4913-8024-c171f4e1ae80" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_729288f3-60b6-43c0-bdd8-b70e20c7ba21" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d187f9e9-c9dd-4913-8024-c171f4e1ae80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29748228-78f6-41e5-b2a6-0b4e0f1b6b7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_c4633a29-50fb-4a14-82c3-b3ee0ccb98aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29748228-78f6-41e5-b2a6-0b4e0f1b6b7a" xlink:to="loc_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_c4633a29-50fb-4a14-82c3-b3ee0ccb98aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_bd9e6bba-d6d0-40ad-9432-ac19698d13e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29748228-78f6-41e5-b2a6-0b4e0f1b6b7a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_bd9e6bba-d6d0-40ad-9432-ac19698d13e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_5e9fbc8c-0d32-494d-b67c-bd2b3175e3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29748228-78f6-41e5-b2a6-0b4e0f1b6b7a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_5e9fbc8c-0d32-494d-b67c-bd2b3175e3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_43433160-d9b3-42b9-8ba2-6471d8150a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29748228-78f6-41e5-b2a6-0b4e0f1b6b7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_43433160-d9b3-42b9-8ba2-6471d8150a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d019b847-119d-4125-8eff-b55909506aad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_29748228-78f6-41e5-b2a6-0b4e0f1b6b7a" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_d019b847-119d-4125-8eff-b55909506aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesTables" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9be6b14e-743b-4879-b268-050508d4177f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AssetsAndLiabilitiesLesseeTableTextBlock_95a9db58-3a71-4328-b0cc-a82af934f1ab" xlink:href="aort-20230331.xsd#aort_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9be6b14e-743b-4879-b268-050508d4177f" xlink:to="loc_aort_AssetsAndLiabilitiesLesseeTableTextBlock_95a9db58-3a71-4328-b0cc-a82af934f1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_85cb623b-ac3b-4790-95d4-083de08146e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9be6b14e-743b-4879-b268-050508d4177f" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_85cb623b-ac3b-4790-95d4-083de08146e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c13bfe1c-8fa8-44a6-bd70-c177bd34882e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9be6b14e-743b-4879-b268-050508d4177f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_c13bfe1c-8fa8-44a6-bd70-c177bd34882e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0a03de5b-5487-46a4-b0f1-cc009f429e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9be6b14e-743b-4879-b268-050508d4177f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_0a03de5b-5487-46a4-b0f1-cc009f429e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtTables" xlink:type="simple" xlink:href="aort-20230331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_0b227d42-44e7-4f08-b248-76ab02a8a541" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_b8058150-729d-4b09-8eb9-0293b62821b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_0b227d42-44e7-4f08-b248-76ab02a8a541" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_b8058150-729d-4b09-8eb9-0293b62821b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="aort-20230331.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2ee12377-0aad-4742-a8bd-c9b8844a6003" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_b7e532c7-9628-4245-af26-c6d4bcb06484" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2ee12377-0aad-4742-a8bd-c9b8844a6003" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_b7e532c7-9628-4245-af26-c6d4bcb06484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationTables" xlink:type="simple" xlink:href="aort-20230331.xsd#StockCompensationTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5855dd56-83a9-4877-88b6-95670b77e57d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_10761fb3-b0fe-4f95-92aa-84a81452487a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5855dd56-83a9-4877-88b6-95670b77e57d" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_10761fb3-b0fe-4f95-92aa-84a81452487a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_c7c80ac3-d2aa-4c71-81bf-4c969bb54033" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5855dd56-83a9-4877-88b6-95670b77e57d" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_c7c80ac3-d2aa-4c71-81bf-4c969bb54033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossPerCommonShareTables" xlink:type="simple" xlink:href="aort-20230331.xsd#LossPerCommonShareTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LossPerCommonShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b3d69b28-30f1-40fc-949f-6051330cf6a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e3a77675-caa6-441b-bf57-7c06478d6151" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b3d69b28-30f1-40fc-949f-6051330cf6a5" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_e3a77675-caa6-441b-bf57-7c06478d6151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="aort-20230331.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_42dcc572-7e47-4883-a64f-4bd68fc2fa90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2a63d356-ddca-46bd-b3d2-96ad8362a145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_42dcc572-7e47-4883-a64f-4bd68fc2fa90" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_2a63d356-ddca-46bd-b3d2-96ad8362a145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_053b80dc-a697-46c6-8ef8-9ca66674cbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_42dcc572-7e47-4883-a64f-4bd68fc2fa90" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_053b80dc-a697-46c6-8ef8-9ca66674cbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_973ab134-5be0-485b-820e-5e895562e603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_973ab134-5be0-485b-820e-5e895562e603" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_df7a82f6-7270-47b3-951b-78bc71cc2192" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_df7a82f6-7270-47b3-951b-78bc71cc2192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_df7a82f6-7270-47b3-951b-78bc71cc2192" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1643bec1-b892-4eb8-89fa-dd78c6d063a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1643bec1-b892-4eb8-89fa-dd78c6d063a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_2dcf036a-d669-41ab-9223-a1e15d31ad1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_2dcf036a-d669-41ab-9223-a1e15d31ad1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_acd2428f-8b08-4005-a6b0-2b91948f4f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_4723f6ca-0cf2-4106-a416-3ac66b9ebf4b" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_acd2428f-8b08-4005-a6b0-2b91948f4f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_6cae1a10-27df-4d1c-acff-f12726ffd4fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_6cae1a10-27df-4d1c-acff-f12726ffd4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27306752-6d36-410f-92b9-7799cf540be8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_6cae1a10-27df-4d1c-acff-f12726ffd4fd" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27306752-6d36-410f-92b9-7799cf540be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_9133afed-578c-4048-ad9e-ff50ac16f76f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_27306752-6d36-410f-92b9-7799cf540be8" xlink:to="loc_us-gaap_MoneyMarketFundsMember_9133afed-578c-4048-ad9e-ff50ac16f76f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_27e10879-b83b-46df-a541-10e1c8012a87" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_000a0fe7-96e6-490e-9f6e-d1699864c28f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_000a0fe7-96e6-490e-9f6e-d1699864c28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_b4383615-ea74-4757-9552-1904368ee0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_b4383615-ea74-4757-9552-1904368ee0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ContingentConsiderationNoncurrentFairValue_ebc23606-e1ed-4480-bcf6-86bff2c1adba" xlink:href="aort-20230331.xsd#aort_ContingentConsiderationNoncurrentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_aort_ContingentConsiderationNoncurrentFairValue_ebc23606-e1ed-4480-bcf6-86bff2c1adba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_dd218dd5-501c-49e9-96bd-f35abfb4326a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_a8455446-1732-4d2f-ab29-6e6cd4560951" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_dd218dd5-501c-49e9-96bd-f35abfb4326a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#FinancialInstrumentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_640cbc84-106c-4247-a6c6-36172b95c8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_640cbc84-106c-4247-a6c6-36172b95c8bf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ba75e46e-bb93-43bf-a563-92f97fec3e26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ba75e46e-bb93-43bf-a563-92f97fec3e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93359c14-ae4c-45a1-bc3a-7913e53199c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ba75e46e-bb93-43bf-a563-92f97fec3e26" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93359c14-ae4c-45a1-bc3a-7913e53199c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AscyrusMedicalLlcMember_fa96d714-3686-4583-a43c-f2bbac201736" xlink:href="aort-20230331.xsd#aort_AscyrusMedicalLlcMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_93359c14-ae4c-45a1-bc3a-7913e53199c3" xlink:to="loc_aort_AscyrusMedicalLlcMember_fa96d714-3686-4583-a43c-f2bbac201736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_7ff75361-1197-4b39-999e-cacaddda89de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_7ff75361-1197-4b39-999e-cacaddda89de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_db32b499-3852-4753-b1a8-7210a33f59b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_7ff75361-1197-4b39-999e-cacaddda89de" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_db32b499-3852-4753-b1a8-7210a33f59b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_70b6a095-62cf-4363-bc70-dc0609a91c00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_db32b499-3852-4753-b1a8-7210a33f59b5" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_70b6a095-62cf-4363-bc70-dc0609a91c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a19612dc-d82f-48c8-b751-071ce46bb10f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f28d6cda-ba5d-45ef-a341-15de650fdf1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_f28d6cda-ba5d-45ef-a341-15de650fdf1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_fb8189aa-c6f6-4a8a-90a3-8c564c699696" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh_fb8189aa-c6f6-4a8a-90a3-8c564c699696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9b21279c-3c50-4110-adf7-a2a9544fbd54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput_9b21279c-3c50-4110-adf7-a2a9544fbd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_11bb54df-fefa-412c-ab24-b87456108a3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_2e5d850e-e6a1-441e-b2e4-70ad9501e590" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_11bb54df-fefa-412c-ab24-b87456108a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c50b343a-6dbe-48ca-bd1e-2bc74cb1fb6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_74f8dbf1-6d97-4929-a08f-c35f94984c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c50b343a-6dbe-48ca-bd1e-2bc74cb1fb6c" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_74f8dbf1-6d97-4929-a08f-c35f94984c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9c09a005-c548-475e-b819-66ef33be262b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_74f8dbf1-6d97-4929-a08f-c35f94984c48" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9c09a005-c548-475e-b819-66ef33be262b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_02ea4b4d-dc40-4206-abb7-c33178db749c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_74f8dbf1-6d97-4929-a08f-c35f94984c48" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_02ea4b4d-dc40-4206-abb7-c33178db749c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e1859d70-2d40-48e9-8da0-e639b578571f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward_74f8dbf1-6d97-4929-a08f-c35f94984c48" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e1859d70-2d40-48e9-8da0-e639b578571f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_d829b3ee-28d2-41dd-badd-24ba23931c42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_757c694e-e432-4c00-b8bd-45f5379a360d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d829b3ee-28d2-41dd-badd-24ba23931c42" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_757c694e-e432-4c00-b8bd-45f5379a360d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_08e34151-5200-419c-acc0-a3830fa982de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d829b3ee-28d2-41dd-badd-24ba23931c42" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_08e34151-5200-419c-acc0-a3830fa982de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0a773db1-188e-4036-94b0-b6d8ad12637c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d829b3ee-28d2-41dd-badd-24ba23931c42" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0a773db1-188e-4036-94b0-b6d8ad12637c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_68ef48b8-0fef-4c72-bf2d-e2f0885d723b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_d829b3ee-28d2-41dd-badd-24ba23931c42" xlink:to="loc_us-gaap_InventoryNet_68ef48b8-0fef-4c72-bf2d-e2f0885d723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#InventoriesnetandDeferredPreservationCostsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_080055a9-6646-4cd0-962b-64f126421ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_231ef3e2-a24b-48fd-8868-0c218571a157" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_080055a9-6646-4cd0-962b-64f126421ed7" xlink:to="loc_us-gaap_InventoryCurrentTable_231ef3e2-a24b-48fd-8868-0c218571a157" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_a5f3c583-07e7-49b5-b255-ecea5b2627c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_231ef3e2-a24b-48fd-8868-0c218571a157" xlink:to="loc_srt_StatementGeographicalAxis_a5f3c583-07e7-49b5-b255-ecea5b2627c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_61da4427-45b6-4c4e-8253-7120ef081029" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_a5f3c583-07e7-49b5-b255-ecea5b2627c9" xlink:to="loc_srt_SegmentGeographicalDomain_61da4427-45b6-4c4e-8253-7120ef081029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_16d99bd7-461a-4873-9015-ddcf3d172398" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_61da4427-45b6-4c4e-8253-7120ef081029" xlink:to="loc_country_US_16d99bd7-461a-4873-9015-ddcf3d172398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_deeb3243-4245-4545-a7e9-7805cb77d278" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_61da4427-45b6-4c4e-8253-7120ef081029" xlink:to="loc_us-gaap_NonUsMember_deeb3243-4245-4545-a7e9-7805cb77d278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_231ef3e2-a24b-48fd-8868-0c218571a157" xlink:to="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_3e24bda5-85b3-4553-9254-1e7468f7ea54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_3e24bda5-85b3-4553-9254-1e7468f7ea54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ConsignmentInventoryPercentage_335a200c-6a74-427f-872b-cf946fd59987" xlink:href="aort-20230331.xsd#aort_ConsignmentInventoryPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_aort_ConsignmentInventoryPercentage_335a200c-6a74-427f-872b-cf946fd59987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DeferredPreservationCosts_03837886-97c7-4f75-917d-8547488160d7" xlink:href="aort-20230331.xsd#aort_DeferredPreservationCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_aort_DeferredPreservationCosts_03837886-97c7-4f75-917d-8547488160d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_8ef9a22a-d9af-4973-8711-e0c02af58cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_e3b9f94b-ff26-4d7b-bf53-7f38c68a87d7" xlink:to="loc_us-gaap_InventoryValuationReserves_8ef9a22a-d9af-4973-8711-e0c02af58cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21971022-419e-4204-b111-79d4f4f872a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_47bf86f0-3e25-4576-b5ce-eefb880c4cec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21971022-419e-4204-b111-79d4f4f872a3" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_47bf86f0-3e25-4576-b5ce-eefb880c4cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a3257a2-27f7-4edf-8c66-7c13c5869761" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_47bf86f0-3e25-4576-b5ce-eefb880c4cec" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a3257a2-27f7-4edf-8c66-7c13c5869761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_91897bf3-aa74-4361-a337-6d263e86fa67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_4a3257a2-27f7-4edf-8c66-7c13c5869761" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_91897bf3-aa74-4361-a337-6d263e86fa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_b78d62c3-2cbd-4143-9c21-b259675c2b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_91897bf3-aa74-4361-a337-6d263e86fa67" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_b78d62c3-2cbd-4143-9c21-b259675c2b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualRightsMember_4238d241-472b-4f49-be52-1231964b0472" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractualRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_91897bf3-aa74-4361-a337-6d263e86fa67" xlink:to="loc_us-gaap_ContractualRightsMember_4238d241-472b-4f49-be52-1231964b0472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41585e46-9927-4ef0-9efb-bbe18580d12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_47bf86f0-3e25-4576-b5ce-eefb880c4cec" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41585e46-9927-4ef0-9efb-bbe18580d12f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_476fa714-3dd7-4b3c-84c7-a40bbfe2b623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41585e46-9927-4ef0-9efb-bbe18580d12f" xlink:to="loc_us-gaap_Goodwill_476fa714-3dd7-4b3c-84c7-a40bbfe2b623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ee784364-c624-421d-9476-5aa154ce449d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_41585e46-9927-4ef0-9efb-bbe18580d12f" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_ee784364-c624-421d-9476-5aa154ce449d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e301259a-be62-4095-b17e-1d7cc4d90293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_870f4890-30af-43bc-ba46-706dce5540d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e301259a-be62-4095-b17e-1d7cc4d90293" xlink:to="loc_us-gaap_GoodwillRollForward_870f4890-30af-43bc-ba46-706dce5540d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f07c657c-c5da-470f-848a-9e6cd9215955" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_870f4890-30af-43bc-ba46-706dce5540d8" xlink:to="loc_us-gaap_Goodwill_f07c657c-c5da-470f-848a-9e6cd9215955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2180642b-a267-4b0f-99a6-ffae622907a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillForeignCurrencyTranslationGainLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_870f4890-30af-43bc-ba46-706dce5540d8" xlink:to="loc_us-gaap_GoodwillForeignCurrencyTranslationGainLoss_2180642b-a267-4b0f-99a6-ffae622907a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_f951e666-6cd4-4c1e-b67a-ce541edabde8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_870f4890-30af-43bc-ba46-706dce5540d8" xlink:to="loc_us-gaap_Goodwill_f951e666-6cd4-4c1e-b67a-ce541edabde8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78c07654-c3a7-43f1-ae53-a66aaed8b575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d4f5253e-5d2a-4060-a030-faad52971554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_78c07654-c3a7-43f1-ae53-a66aaed8b575" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d4f5253e-5d2a-4060-a030-faad52971554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7d27b6db-d115-4f7e-a684-e5503a7534e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d4f5253e-5d2a-4060-a030-faad52971554" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7d27b6db-d115-4f7e-a684-e5503a7534e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d563f6a3-2739-4814-9298-b1ea49f8fb98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7d27b6db-d115-4f7e-a684-e5503a7534e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d563f6a3-2739-4814-9298-b1ea49f8fb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_44dfe529-b3e8-446d-bc4b-5d390079ad2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d563f6a3-2739-4814-9298-b1ea49f8fb98" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_44dfe529-b3e8-446d-bc4b-5d390079ad2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:href="aort-20230331.xsd#aort_IntangibleAssetsOtherThanAcquiredTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_d563f6a3-2739-4814-9298-b1ea49f8fb98" xlink:to="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerListsMember_b0ae2971-9b80-42c9-8119-f2a831033f48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerListsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:to="loc_us-gaap_CustomerListsMember_b0ae2971-9b80-42c9-8119-f2a831033f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionRightsMember_4999d58d-4800-4e88-8169-97d4b0b0d604" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DistributionRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:to="loc_us-gaap_DistributionRightsMember_4999d58d-4800-4e88-8169-97d4b0b0d604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_0c170eba-d8e7-42ef-bc44-8788dd359e24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:to="loc_us-gaap_PatentsMember_0c170eba-d8e7-42ef-bc44-8788dd359e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_cf4e074c-0ebc-4fed-b2ef-81dc00dcc488" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_IntangibleAssetsOtherThanAcquiredTechnologyMember_4544822c-10ae-423f-85fc-c70c8f5278c4" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_cf4e074c-0ebc-4fed-b2ef-81dc00dcc488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d4f5253e-5d2a-4060-a030-faad52971554" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_847e032c-40fe-4b70-8b71-f8bf950ad5cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_847e032c-40fe-4b70-8b71-f8bf950ad5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3c0f8588-33c8-48a2-b2a7-ecc22a4c8e35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_3c0f8588-33c8-48a2-b2a7-ecc22a4c8e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_64dce7b6-0269-496a-95cd-758bd19fd540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_64dce7b6-0269-496a-95cd-758bd19fd540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55eda0e4-3c43-42c7-b81b-d01eaaabb544" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_211c96d0-c01d-40d0-b35d-2e8a397150d0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_55eda0e4-3c43-42c7-b81b-d01eaaabb544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7701c68-53d9-4815-aa54-0103a045e768" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_bfb477cf-a808-4c89-8620-f33728bb7246" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f7701c68-53d9-4815-aa54-0103a045e768" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_bfb477cf-a808-4c89-8620-f33728bb7246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e09a5fd6-dffe-4e13-820c-0e8e7e489a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_aea50fc8-ba05-47ec-9440-d1fd0ff4a219" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e09a5fd6-dffe-4e13-820c-0e8e7e489a3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_aea50fc8-ba05-47ec-9440-d1fd0ff4a219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c922cbc0-0aad-48d2-b8ae-f9d2e4c13c54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e09a5fd6-dffe-4e13-820c-0e8e7e489a3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_c922cbc0-0aad-48d2-b8ae-f9d2e4c13c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8d7f0c23-3e2a-433a-ad71-c29732ea6639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e09a5fd6-dffe-4e13-820c-0e8e7e489a3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8d7f0c23-3e2a-433a-ad71-c29732ea6639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4b19a5fa-6bcf-4454-8075-cba952d3fe34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e09a5fd6-dffe-4e13-820c-0e8e7e489a3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_4b19a5fa-6bcf-4454-8075-cba952d3fe34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fd04bfb0-81ba-4d29-bb1c-15afb82d59e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e09a5fd6-dffe-4e13-820c-0e8e7e489a3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_fd04bfb0-81ba-4d29-bb1c-15afb82d59e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e1b2363c-dfb0-4d8d-8357-3c9dc0551041" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e09a5fd6-dffe-4e13-820c-0e8e7e489a3a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e1b2363c-dfb0-4d8d-8357-3c9dc0551041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_657330bf-962a-4141-a25b-27bee05b4b28" xlink:href="aort-20230331.xsd#aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e09a5fd6-dffe-4e13-820c-0e8e7e489a3a" xlink:to="loc_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate_657330bf-962a-4141-a25b-27bee05b4b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1a7a9458-d808-45aa-a6c4-4efb3e5245c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_261f3c49-eb78-4c34-ab48-4861411922ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1a7a9458-d808-45aa-a6c4-4efb3e5245c2" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_261f3c49-eb78-4c34-ab48-4861411922ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_689dfaa8-48c4-4091-912b-8ae53fdcf8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1a7a9458-d808-45aa-a6c4-4efb3e5245c2" xlink:to="loc_us-gaap_DeferredTaxLiabilities_689dfaa8-48c4-4091-912b-8ae53fdcf8ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7c120b55-f301-473f-987c-b50256d973c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1a7a9458-d808-45aa-a6c4-4efb3e5245c2" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7c120b55-f301-473f-987c-b50256d973c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5083c7e6-346b-43fe-8b8f-0dd0f35c50be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_36dfe385-2ac4-4cad-88a8-1148d90681f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5083c7e6-346b-43fe-8b8f-0dd0f35c50be" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_36dfe385-2ac4-4cad-88a8-1148d90681f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4da564dd-d3ce-4702-bcf3-9f195cd7d895" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_34a27214-2ff2-46bb-9c03-2107a386eec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4da564dd-d3ce-4702-bcf3-9f195cd7d895" xlink:to="loc_us-gaap_LeasesOperatingAbstract_34a27214-2ff2-46bb-9c03-2107a386eec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_c264bc74-f840-4670-9365-ba49d51a759f" xlink:href="aort-20230331.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_34a27214-2ff2-46bb-9c03-2107a386eec2" xlink:to="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_c264bc74-f840-4670-9365-ba49d51a759f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_3996e737-a1bc-4c28-9da9-6997c2bd4931" xlink:href="aort-20230331.xsd#aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_34a27214-2ff2-46bb-9c03-2107a386eec2" xlink:to="loc_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_3996e737-a1bc-4c28-9da9-6997c2bd4931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4a19a104-15ba-4430-b4dd-528a0c9dbd10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_34a27214-2ff2-46bb-9c03-2107a386eec2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4a19a104-15ba-4430-b4dd-528a0c9dbd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_abd6d2f5-7f9c-4a11-9a3c-2337af396571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_34a27214-2ff2-46bb-9c03-2107a386eec2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_abd6d2f5-7f9c-4a11-9a3c-2337af396571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e0817fdf-2486-48d9-bdfd-6ea95675d3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_34a27214-2ff2-46bb-9c03-2107a386eec2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e0817fdf-2486-48d9-bdfd-6ea95675d3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e39010b7-b1d6-44a7-a522-4454d97d2bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_34a27214-2ff2-46bb-9c03-2107a386eec2" xlink:to="loc_us-gaap_OperatingLeaseLiability_e39010b7-b1d6-44a7-a522-4454d97d2bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_8aded3af-0512-4351-8c9a-2ab4c5ecff39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4da564dd-d3ce-4702-bcf3-9f195cd7d895" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_8aded3af-0512-4351-8c9a-2ab4c5ecff39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_dd8847c2-0faa-48bb-90ca-69bd66a6efd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_8aded3af-0512-4351-8c9a-2ab4c5ecff39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_dd8847c2-0faa-48bb-90ca-69bd66a6efd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5137962f-7270-4450-a3af-5a95cd7204db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_8aded3af-0512-4351-8c9a-2ab4c5ecff39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_5137962f-7270-4450-a3af-5a95cd7204db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_9d9bfe74-7c95-43bd-b210-05f6811000fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_8aded3af-0512-4351-8c9a-2ab4c5ecff39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_9d9bfe74-7c95-43bd-b210-05f6811000fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_8668456c-3286-4b03-8b14-9a190223614d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_8aded3af-0512-4351-8c9a-2ab4c5ecff39" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_8668456c-3286-4b03-8b14-9a190223614d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_89261f76-beec-4421-8e01-ebde549466e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_8aded3af-0512-4351-8c9a-2ab4c5ecff39" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_89261f76-beec-4421-8e01-ebde549466e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_3d3e15c4-85ca-4a39-a72e-ba47b8481692" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_8aded3af-0512-4351-8c9a-2ab4c5ecff39" xlink:to="loc_us-gaap_FinanceLeaseLiability_3d3e15c4-85ca-4a39-a72e-ba47b8481692" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d1a33c11-2c0e-46da-8143-bc9d1bbbfe71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4da564dd-d3ce-4702-bcf3-9f195cd7d895" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_d1a33c11-2c0e-46da-8143-bc9d1bbbfe71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_e5e67c80-5cb7-4215-b3bb-622c3590a962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4da564dd-d3ce-4702-bcf3-9f195cd7d895" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_e5e67c80-5cb7-4215-b3bb-622c3590a962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2552005b-ecd6-4637-8d92-54685d83f480" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4da564dd-d3ce-4702-bcf3-9f195cd7d895" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_2552005b-ecd6-4637-8d92-54685d83f480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2f7559f9-c890-415b-b26c-c7ee4d82059b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4da564dd-d3ce-4702-bcf3-9f195cd7d895" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_2f7559f9-c890-415b-b26c-c7ee4d82059b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesSummaryOfLeaseCostsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_34235647-456f-49da-960a-95363076a261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_17ba2ae5-9cb9-48ad-a27f-fa2d5591e6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34235647-456f-49da-960a-95363076a261" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_17ba2ae5-9cb9-48ad-a27f-fa2d5591e6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_2c462f67-9a6f-4e81-9b14-b696095645ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34235647-456f-49da-960a-95363076a261" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_2c462f67-9a6f-4e81-9b14-b696095645ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseCost_0e62a133-33fa-40d1-9966-0247b4b8d1b4" xlink:href="aort-20230331.xsd#aort_FinanceLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34235647-456f-49da-960a-95363076a261" xlink:to="loc_aort_FinanceLeaseCost_0e62a133-33fa-40d1-9966-0247b4b8d1b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_01f04c9a-b015-4700-8417-196e2dc1562d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34235647-456f-49da-960a-95363076a261" xlink:to="loc_us-gaap_OperatingLeaseCost_01f04c9a-b015-4700-8417-196e2dc1562d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_cdf8a1d5-074c-42cb-9db1-c86e06960ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34235647-456f-49da-960a-95363076a261" xlink:to="loc_us-gaap_SubleaseIncome_cdf8a1d5-074c-42cb-9db1-c86e06960ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ddc18723-8564-4d5c-ab92-8c950abf9c3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_34235647-456f-49da-960a-95363076a261" xlink:to="loc_us-gaap_LeaseCost_ddc18723-8564-4d5c-ab92-8c950abf9c3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_12e8854d-4dcf-4450-95fe-e8091f3593de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_558a0d49-6d00-4f23-8635-26ba67c61b56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_12e8854d-4dcf-4450-95fe-e8091f3593de" xlink:to="loc_us-gaap_OperatingLeasePayments_558a0d49-6d00-4f23-8635-26ba67c61b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_347d88cc-e59d-409f-bd46-6d052038919b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_12e8854d-4dcf-4450-95fe-e8091f3593de" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_347d88cc-e59d-409f-bd46-6d052038919b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_bde44b39-8600-44c0-b617-b780ba719f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_12e8854d-4dcf-4450-95fe-e8091f3593de" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_bde44b39-8600-44c0-b617-b780ba719f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_707b3341-5ae7-46d5-bb29-982621274c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_707b3341-5ae7-46d5-bb29-982621274c9a" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_423f4d2a-ef7d-4f36-b297-4cca2d0db8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_423f4d2a-ef7d-4f36-b297-4cca2d0db8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0dd08235-01ee-43f0-8904-95ddd2666e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0dd08235-01ee-43f0-8904-95ddd2666e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_0972185d-ab5c-482c-9c02-bb1a9b3d8ed1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_0972185d-ab5c-482c-9c02-bb1a9b3d8ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e80177ca-c3a5-4152-a1db-4a5175221fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_e80177ca-c3a5-4152-a1db-4a5175221fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_f67449b4-21f6-41d3-a267-6addfdb8bbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_f67449b4-21f6-41d3-a267-6addfdb8bbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_4e8889ec-ed89-4fe9-aa2e-36ddcd6760c3" xlink:href="aort-20230331.xsd#aort_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_aort_FinanceLeaseLiabilityToBePaidAfterYearFour_4e8889ec-ed89-4fe9-aa2e-36ddcd6760c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_197ed23c-e250-4869-8abf-15673e1c5c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_197ed23c-e250-4869-8abf-15673e1c5c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e44541c5-f456-4c13-9491-2b89358c733d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_e44541c5-f456-4c13-9491-2b89358c733d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_9776e7a8-de29-46f0-88e3-3ea1bb4643a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiability_9776e7a8-de29-46f0-88e3-3ea1bb4643a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_03ade29c-17db-4478-9196-c081a6a8bbe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_03ade29c-17db-4478-9196-c081a6a8bbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_10bd8dd9-41e0-4633-aa1b-7bb5d1b77b36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_70bff8b9-ce53-408a-b51e-14c52eafaaac" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_10bd8dd9-41e0-4633-aa1b-7bb5d1b77b36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_707b3341-5ae7-46d5-bb29-982621274c9a" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_eebc7d51-bc3f-4b9d-9a80-f0b7b0d5e299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_eebc7d51-bc3f-4b9d-9a80-f0b7b0d5e299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ce3d753-4f87-4087-9b17-f376e772d97b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7ce3d753-4f87-4087-9b17-f376e772d97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d3030c59-b397-49c0-96de-490b560b8923" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d3030c59-b397-49c0-96de-490b560b8923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2db7568b-2dc4-46d6-b26d-0cb5d86fc978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2db7568b-2dc4-46d6-b26d-0cb5d86fc978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_68011efd-462a-4cd7-a934-c466c6ebd474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_68011efd-462a-4cd7-a934-c466c6ebd474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_79581ff4-863a-4a64-9078-7eca03575e16" xlink:href="aort-20230331.xsd#aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_79581ff4-863a-4a64-9078-7eca03575e16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1229b309-2e16-4a7b-9581-5f68168c03c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1229b309-2e16-4a7b-9581-5f68168c03c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6402428a-1356-474f-a7f7-58b1ffd1bb19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_6402428a-1356-474f-a7f7-58b1ffd1bb19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_68fb949e-e42c-48ec-8d9a-7335d179ab1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_OperatingLeaseLiability_68fb949e-e42c-48ec-8d9a-7335d179ab1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7a1e6a9d-75b0-4d6d-8020-076676e18bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7a1e6a9d-75b0-4d6d-8020-076676e18bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b50c3b09-d1ec-45bf-bb83-e471871cfa78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_a93bb8df-082c-4933-8dc2-ac7a14501106" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b50c3b09-d1ec-45bf-bb83-e471871cfa78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ec267c7e-3d86-496c-9d89-e53f7ae9665f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ec267c7e-3d86-496c-9d89-e53f7ae9665f" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1d5ae643-0590-4844-a9bb-8f33163aa7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1d5ae643-0590-4844-a9bb-8f33163aa7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_625a94df-79e4-4252-a1ff-eafbeea5382d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_1d5ae643-0590-4844-a9bb-8f33163aa7a5" xlink:to="loc_us-gaap_TypeOfAdoptionMember_625a94df-79e4-4252-a1ff-eafbeea5382d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate202006Member_5fa63281-fa13-4f5e-8266-d56c126b180e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate202006Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_625a94df-79e4-4252-a1ff-eafbeea5382d" xlink:to="loc_us-gaap_AccountingStandardsUpdate202006Member_5fa63281-fa13-4f5e-8266-d56c126b180e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c8201e-e4d0-4be5-9c23-0aaf2002a766" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c8201e-e4d0-4be5-9c23-0aaf2002a766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f1364133-71b7-47c9-9b6d-8abb201da925" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_d1c8201e-e4d0-4be5-9c23-0aaf2002a766" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f1364133-71b7-47c9-9b6d-8abb201da925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_74164846-dcdd-48cc-a6ef-b1d9f603a8e3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_f1364133-71b7-47c9-9b6d-8abb201da925" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_74164846-dcdd-48cc-a6ef-b1d9f603a8e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_393834b5-6066-4316-9565-c4fa2c1338ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_CreditFacilityAxis_393834b5-6066-4316-9565-c4fa2c1338ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_393834b5-6066-4316-9565-c4fa2c1338ce" xlink:to="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_4e001a66-586f-4b3c-b487-01ada3b34739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:to="loc_us-gaap_SecuredDebtMember_4e001a66-586f-4b3c-b487-01ada3b34739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_79d645bc-b1dd-44c7-a67b-e97105f0cbd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:to="loc_us-gaap_LoansPayableMember_79d645bc-b1dd-44c7-a67b-e97105f0cbd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_a6734807-e11a-4450-9827-462c54048e41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_a6734807-e11a-4450-9827-462c54048e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityAndTermLoanMember_40aa3514-c7e5-45f9-8ae7-42e4168fc336" xlink:href="aort-20230331.xsd#aort_RevolvingCreditFacilityAndTermLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_0cad2ea0-d7d4-4a2f-8016-d14e89032eea" xlink:to="loc_aort_RevolvingCreditFacilityAndTermLoanMember_40aa3514-c7e5-45f9-8ae7-42e4168fc336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_bf1d7476-77ea-4b2c-b67c-d8548b67dca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_VariableRateAxis_bf1d7476-77ea-4b2c-b67c-d8548b67dca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_bf1d7476-77ea-4b2c-b67c-d8548b67dca5" xlink:to="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_c11ee795-1806-424a-9de5-9acc1eb2eeba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:to="loc_us-gaap_BaseRateMember_c11ee795-1806-424a-9de5-9acc1eb2eeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d6a9b413-d00b-4c11-b609-d319a9884ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_d6a9b413-d00b-4c11-b609-d319a9884ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_17432936-2a02-4907-b258-91a35e2a33f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_713223f4-8f5f-40dc-a004-097bde39b61a" xlink:to="loc_us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember_17432936-2a02-4907-b258-91a35e2a33f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3dff6a30-ef5e-4804-ad54-a9b076e86c95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3dff6a30-ef5e-4804-ad54-a9b076e86c95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0d33c143-2fdf-414f-981a-3b63aae1200a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3dff6a30-ef5e-4804-ad54-a9b076e86c95" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0d33c143-2fdf-414f-981a-3b63aae1200a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_9fff956b-a923-4b58-9380-9e1e3bcb5a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0d33c143-2fdf-414f-981a-3b63aae1200a" xlink:to="loc_us-gaap_ConvertibleDebtMember_9fff956b-a923-4b58-9380-9e1e3bcb5a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e398deeb-edd2-4eff-a5c4-65fe6f046e89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_DebtInstrumentAxis_e398deeb-edd2-4eff-a5c4-65fe6f046e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_2a8a2481-67eb-478b-a936-d7ccc128bc51" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e398deeb-edd2-4eff-a5c4-65fe6f046e89" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_2a8a2481-67eb-478b-a936-d7ccc128bc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CreditAgreementMember_788ba425-4c4d-49cc-97ca-f643fb8e84d4" xlink:href="aort-20230331.xsd#aort_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_2a8a2481-67eb-478b-a936-d7ccc128bc51" xlink:to="loc_aort_CreditAgreementMember_788ba425-4c4d-49cc-97ca-f643fb8e84d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_16ff79c4-8099-4b0a-ba36-f28589138120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_16ff79c4-8099-4b0a-ba36-f28589138120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ab78b737-fd72-4a2b-a092-95a2449ab82e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_16ff79c4-8099-4b0a-ba36-f28589138120" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ab78b737-fd72-4a2b-a092-95a2449ab82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_66e8c4ba-82b1-49d2-8606-9a0f154603db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ab78b737-fd72-4a2b-a092-95a2449ab82e" xlink:to="loc_us-gaap_InterestExpenseMember_66e8c4ba-82b1-49d2-8606-9a0f154603db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodAxis_976b4eed-31be-4cd0-9282-7150ead03a38" xlink:href="aort-20230331.xsd#aort_DebtPeriodAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_aort_DebtPeriodAxis_976b4eed-31be-4cd0-9282-7150ead03a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:href="aort-20230331.xsd#aort_DebtPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_DebtPeriodAxis_976b4eed-31be-4cd0-9282-7150ead03a38" xlink:to="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIMember_1d971b7e-4204-4a1d-94ba-ab53a67c2ce0" xlink:href="aort-20230331.xsd#aort_CircumstanceIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:to="loc_aort_CircumstanceIMember_1d971b7e-4204-4a1d-94ba-ab53a67c2ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceIiMember_eb5f328d-d49d-480a-bd08-664689279998" xlink:href="aort-20230331.xsd#aort_CircumstanceIiMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:to="loc_aort_CircumstanceIiMember_eb5f328d-d49d-480a-bd08-664689279998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CircumstanceAfterJuly52023Member_0d5a8322-4165-4586-a41c-28d9978593c4" xlink:href="aort-20230331.xsd#aort_CircumstanceAfterJuly52023Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_DebtPeriodDomain_cd23cee7-bedf-43aa-9d24-51ec363a7342" xlink:to="loc_aort_CircumstanceAfterJuly52023Member_0d5a8322-4165-4586-a41c-28d9978593c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f40866b7-53c8-4d88-b8c6-1fa519497654" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_srt_RangeAxis_f40866b7-53c8-4d88-b8c6-1fa519497654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c397beec-5379-487f-8519-9871a946842b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f40866b7-53c8-4d88-b8c6-1fa519497654" xlink:to="loc_srt_RangeMember_c397beec-5379-487f-8519-9871a946842b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f353deda-6a8a-4148-956a-e4107eccd567" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c397beec-5379-487f-8519-9871a946842b" xlink:to="loc_srt_MinimumMember_f353deda-6a8a-4148-956a-e4107eccd567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9be4933c-8ff1-47f5-ae9d-772a26e1b680" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c397beec-5379-487f-8519-9871a946842b" xlink:to="loc_srt_MaximumMember_9be4933c-8ff1-47f5-ae9d-772a26e1b680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_97326b80-b550-4cbb-afa6-dd21fe40ab58" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_d44e7da0-586d-4206-a594-a6ab96b253f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_d44e7da0-586d-4206-a594-a6ab96b253f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e8988ecf-b4a5-4eb3-8155-6732b566f0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_e8988ecf-b4a5-4eb3-8155-6732b566f0ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionPeriod_b7828b92-b288-472e-be47-3e6ae4686966" xlink:href="aort-20230331.xsd#aort_DebtInstrumentExtensionPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_aort_DebtInstrumentExtensionPeriod_b7828b92-b288-472e-be47-3e6ae4686966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_96f1a066-819f-4521-8f07-469c56fcc04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_96f1a066-819f-4521-8f07-469c56fcc04b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentExtensionCircumstancePeriod_0ce29501-e577-42c4-82fc-d7f44c88a3c9" xlink:href="aort-20230331.xsd#aort_DebtInstrumentExtensionCircumstancePeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_aort_DebtInstrumentExtensionCircumstancePeriod_0ce29501-e577-42c4-82fc-d7f44c88a3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b0f08d59-3ccc-4104-a55f-4fee9aab2f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b0f08d59-3ccc-4104-a55f-4fee9aab2f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2ce8304b-6cf5-4043-a1c7-6d422098344d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_2ce8304b-6cf5-4043-a1c7-6d422098344d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_2544cbf2-ea52-466f-9067-0ddaf7c672cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_2544cbf2-ea52-466f-9067-0ddaf7c672cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_46ddc7fb-87d6-4f00-b2eb-a34759cad126" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_46ddc7fb-87d6-4f00-b2eb-a34759cad126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_dde4004d-f580-463f-986c-68d6735dc33f" xlink:href="aort-20230331.xsd#aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants_dde4004d-f580-463f-986c-68d6735dc33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9f1ed2bc-ddbc-4f9f-8996-5616d65cf68f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9f1ed2bc-ddbc-4f9f-8996-5616d65cf68f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_98ed4b62-31b8-4323-b7c0-362165200974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_98ed4b62-31b8-4323-b7c0-362165200974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_9a52c8c5-ed05-47d7-acd8-203eaa9e21d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_9a52c8c5-ed05-47d7-acd8-203eaa9e21d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_11bac857-10ad-46d5-90fc-1ee1ec5dd060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_LongTermDebt_11bac857-10ad-46d5-90fc-1ee1ec5dd060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_c4e45f6f-ba84-4217-98dc-2c9e28be43ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_c4e45f6f-ba84-4217-98dc-2c9e28be43ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_59b7a786-d991-456a-a63e-eaf1f77e97ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_59b7a786-d991-456a-a63e-eaf1f77e97ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_d1a877f6-9bb3-488c-ac51-4019f1fe36f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentFairValue_d1a877f6-9bb3-488c-ac51-4019f1fe36f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_fd5e9ee7-aeb7-4159-8300-85db21386adf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_InterestExpenseDebt_fd5e9ee7-aeb7-4159-8300-85db21386adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_b81bf0db-ceba-41d0-9755-c63f3ef27f2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_b81bf0db-ceba-41d0-9755-c63f3ef27f2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_9ecd1a2a-7e01-4b94-baaf-f71d108878d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdTradingDays"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdTradingDays_9ecd1a2a-7e01-4b94-baaf-f71d108878d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e4581129-5642-462f-9d1b-a7bc442d9b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_e4581129-5642-462f-9d1b-a7bc442d9b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_3e9debf0-6a76-4dbf-9df4-6aee36ced174" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_3e9debf0-6a76-4dbf-9df4-6aee36ced174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_7c92d1fb-efe2-48fe-b4c5-f408a0e7ee84" xlink:href="aort-20230331.xsd#aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e221aac0-2ead-4d8d-a055-b4f2497b3960" xlink:to="loc_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount_7c92d1fb-efe2-48fe-b4c5-f408a0e7ee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_bf876701-d6f0-4941-b5fc-ebdec2cc9c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_bf876701-d6f0-4941-b5fc-ebdec2cc9c0b" xlink:to="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d679334b-6948-4fa6-9d25-6a1a73bd1560" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:to="loc_us-gaap_CreditFacilityAxis_d679334b-6948-4fa6-9d25-6a1a73bd1560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a58dae09-162c-435e-a15b-67430d0c526f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d679334b-6948-4fa6-9d25-6a1a73bd1560" xlink:to="loc_us-gaap_CreditFacilityDomain_a58dae09-162c-435e-a15b-67430d0c526f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableMember_60678a02-c69d-43d7-bc8d-e402f9442401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a58dae09-162c-435e-a15b-67430d0c526f" xlink:to="loc_us-gaap_LoansPayableMember_60678a02-c69d-43d7-bc8d-e402f9442401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_c924145c-b8e7-4c61-9017-06bde1ea300a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_a58dae09-162c-435e-a15b-67430d0c526f" xlink:to="loc_us-gaap_ConvertibleDebtMember_c924145c-b8e7-4c61-9017-06bde1ea300a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b391d26d-ce9e-400a-87ed-add8c35e3257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_fa895bc8-4d70-4378-b7ee-aa25b6eaee0a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b391d26d-ce9e-400a-87ed-add8c35e3257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan1Member_adf9edb6-1019-47cd-9898-2a4ad18086ef" xlink:href="aort-20230331.xsd#aort_GovernmentSponsoredDebtKfwLoan1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b391d26d-ce9e-400a-87ed-add8c35e3257" xlink:to="loc_aort_GovernmentSponsoredDebtKfwLoan1Member_adf9edb6-1019-47cd-9898-2a4ad18086ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_GovernmentSponsoredDebtKfwLoan2Member_5bc296d8-bea8-4bce-8760-43ec137ad0f0" xlink:href="aort-20230331.xsd#aort_GovernmentSponsoredDebtKfwLoan2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_b391d26d-ce9e-400a-87ed-add8c35e3257" xlink:to="loc_aort_GovernmentSponsoredDebtKfwLoan2Member_5bc296d8-bea8-4bce-8760-43ec137ad0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_265f087e-6f69-486f-87ac-cecc2ac9da8d" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_71a5bf27-8f59-49a4-a074-e8b6ad8bde88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_71a5bf27-8f59-49a4-a074-e8b6ad8bde88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a0d6508a-27d7-4052-a976-dc3a8967a02d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_a0d6508a-27d7-4052-a976-dc3a8967a02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_9aa41e15-9595-4057-a408-39f2c2ba8e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_LongTermDebt_9aa41e15-9595-4057-a408-39f2c2ba8e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0a55af86-70a8-4c73-bdf3-cb61fbb217ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_LongTermDebtCurrent_0a55af86-70a8-4c73-bdf3-cb61fbb217ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cb8a7852-ad66-42f9-92b9-7f2b4c3f8889" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cb8a7852-ad66-42f9-92b9-7f2b4c3f8889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d5f1f3ff-6b9a-458a-826f-351e6890c1cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2212e3c7-95da-4bc2-bed0-5cb7fa212eaf" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d5f1f3ff-6b9a-458a-826f-351e6890c1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#RevenueRecognitionDisaggregationOfRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5b05bd9f-e6b1-41f6-a172-b9bf34f942c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_6d2113d6-f13b-4359-a740-24fdb22a1338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5b05bd9f-e6b1-41f6-a172-b9bf34f942c2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_6d2113d6-f13b-4359-a740-24fdb22a1338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_6ad67cd8-db2f-4031-b723-dab835cc7faa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6d2113d6-f13b-4359-a740-24fdb22a1338" xlink:to="loc_srt_ProductOrServiceAxis_6ad67cd8-db2f-4031-b723-dab835cc7faa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_6ad67cd8-db2f-4031-b723-dab835cc7faa" xlink:to="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_DomesticHospitalsMember_81769f05-4b85-4978-a941-f04437f51b22" xlink:href="aort-20230331.xsd#aort_DomesticHospitalsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:to="loc_aort_DomesticHospitalsMember_81769f05-4b85-4978-a941-f04437f51b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalHospitalsMember_33cb77c8-62cb-48e4-bed2-4b1782fd2697" xlink:href="aort-20230331.xsd#aort_InternationalHospitalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:to="loc_aort_InternationalHospitalsMember_33cb77c8-62cb-48e4-bed2-4b1782fd2697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_InternationalDistributorMember_6f2fa088-a650-43d6-a350-a7674939f2b5" xlink:href="aort-20230331.xsd#aort_InternationalDistributorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:to="loc_aort_InternationalDistributorMember_6f2fa088-a650-43d6-a350-a7674939f2b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_CardiogenesisMember_9f6163a3-5c90-47ad-92ef-4daeb7daa9bc" xlink:href="aort-20230331.xsd#aort_CardiogenesisMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_bfb77b84-fdfe-405e-9e63-81d7866452f0" xlink:to="loc_aort_CardiogenesisMember_9f6163a3-5c90-47ad-92ef-4daeb7daa9bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f2a1fe96-8b96-4e64-a697-97fdbf06c407" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_6d2113d6-f13b-4359-a740-24fdb22a1338" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f2a1fe96-8b96-4e64-a697-97fdbf06c407" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3fdadfcf-3b1d-4b69-93bd-d2ae2324fb26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f2a1fe96-8b96-4e64-a697-97fdbf06c407" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3fdadfcf-3b1d-4b69-93bd-d2ae2324fb26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#StockCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cc0a7adf-d235-4d77-9d58-a405588d10e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cc0a7adf-d235-4d77-9d58-a405588d10e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_272c677e-8e61-4b6f-98af-981f6eed8f3f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:to="loc_srt_TitleOfIndividualAxis_272c677e-8e61-4b6f-98af-981f6eed8f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1f825183-6a29-415a-9aae-f624ea9ca1d6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_272c677e-8e61-4b6f-98af-981f6eed8f3f" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1f825183-6a29-415a-9aae-f624ea9ca1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficerMember_84165e97-1cdf-41fb-8533-8dc7d09bf866" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_1f825183-6a29-415a-9aae-f624ea9ca1d6" xlink:to="loc_srt_OfficerMember_84165e97-1cdf-41fb-8533-8dc7d09bf866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_07c9137b-654a-4811-b1f7-385c793fc748" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:to="loc_us-gaap_AwardTypeAxis_07c9137b-654a-4811-b1f7-385c793fc748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd4077a7-0098-4a93-8c6f-b20ba147f641" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_07c9137b-654a-4811-b1f7-385c793fc748" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd4077a7-0098-4a93-8c6f-b20ba147f641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d8741da5-d2b8-4f85-8965-13cabd745104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd4077a7-0098-4a93-8c6f-b20ba147f641" xlink:to="loc_us-gaap_EmployeeStockMember_d8741da5-d2b8-4f85-8965-13cabd745104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockUnitsAndPreferredStockUnitsMember_233390fa-04de-436c-964b-7808d4b8640e" xlink:href="aort-20230331.xsd#aort_RestrictedStockUnitsAndPreferredStockUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bd4077a7-0098-4a93-8c6f-b20ba147f641" xlink:to="loc_aort_RestrictedStockUnitsAndPreferredStockUnitsMember_233390fa-04de-436c-964b-7808d4b8640e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_506a02e5-8db1-41b6-b9a7-e611ed989fa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a286363f-8ccb-4446-9a4b-278e17e125c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_a286363f-8ccb-4446-9a4b-278e17e125c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_64017897-0d6c-4585-9723-749827a6d667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_64017897-0d6c-4585-9723-749827a6d667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_1759a840-7cc0-4012-a63a-5e3b6c20bf94" xlink:href="aort-20230331.xsd#aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted_1759a840-7cc0-4012-a63a-5e3b6c20bf94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_079edb8b-ee43-4639-9720-fd4c514b02a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_079edb8b-ee43-4639-9720-fd4c514b02a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a63edfa2-3dd6-4ae1-9cd2-0142485eeb23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a63edfa2-3dd6-4ae1-9cd2-0142485eeb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_4d8ba9e9-11c1-4f99-8a4f-e0df1a08ce32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9335a7a-e372-457b-a404-c1416e60568c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_4d8ba9e9-11c1-4f99-8a4f-e0df1a08ce32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_825497fd-5c8a-4197-9c08-bd8e3c54b412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6389801-a7b8-4145-b9c0-217dbf48250c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_825497fd-5c8a-4197-9c08-bd8e3c54b412" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6389801-a7b8-4145-b9c0-217dbf48250c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6389801-a7b8-4145-b9c0-217dbf48250c" xlink:to="loc_us-gaap_AwardTypeAxis_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607457c4-d26c-4cc2-b49d-94dfc8bfd45f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_69c2a55f-a6ea-4cc0-83e3-122f6e1fa6cc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607457c4-d26c-4cc2-b49d-94dfc8bfd45f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_61daf558-98ae-4f63-aa7f-160dd6e0c036" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_607457c4-d26c-4cc2-b49d-94dfc8bfd45f" xlink:to="loc_us-gaap_EmployeeStockMember_61daf558-98ae-4f63-aa7f-160dd6e0c036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a6389801-a7b8-4145-b9c0-217dbf48250c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7e6ea9b1-f498-4ab8-9c0c-2b4d2f728aff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7e6ea9b1-f498-4ab8-9c0c-2b4d2f728aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1f6c738a-0ab4-4433-824f-ce9d59a7bddb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1f6c738a-0ab4-4433-824f-ce9d59a7bddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_81426b5e-a4e7-47da-b2a0-712c741fc699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9165f8e4-a60a-49b2-8667-3efb06319977" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_81426b5e-a4e7-47da-b2a0-712c741fc699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#StockCompensationSummaryOfTotalStockCompensationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_66100e65-a8ca-4d02-be73-cf836728b48c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de2e7c18-7318-4f68-9421-52ee3da9aaf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_66100e65-a8ca-4d02-be73-cf836728b48c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de2e7c18-7318-4f68-9421-52ee3da9aaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_87ea562f-2421-48b0-8944-152a96f0b224" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de2e7c18-7318-4f68-9421-52ee3da9aaf9" xlink:to="loc_us-gaap_AwardTypeAxis_87ea562f-2421-48b0-8944-152a96f0b224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0db5dea-8b94-4c04-a813-10610ad5a546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_87ea562f-2421-48b0-8944-152a96f0b224" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0db5dea-8b94-4c04-a813-10610ad5a546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_0d695ea3-fa34-41f0-a19a-243e71a9902e" xlink:href="aort-20230331.xsd#aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0db5dea-8b94-4c04-a813-10610ad5a546" xlink:to="loc_aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember_0d695ea3-fa34-41f0-a19a-243e71a9902e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_6d64d0c0-33ea-4408-82f3-b6821eb4885e" xlink:href="aort-20230331.xsd#aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f0db5dea-8b94-4c04-a813-10610ad5a546" xlink:to="loc_aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember_6d64d0c0-33ea-4408-82f3-b6821eb4885e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a9aadd3-411a-4000-abd7-397da39f7eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_de2e7c18-7318-4f68-9421-52ee3da9aaf9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a9aadd3-411a-4000-abd7-397da39f7eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_63a58ec1-aa98-4eca-891b-98a51d932111" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_4a9aadd3-411a-4000-abd7-397da39f7eb7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_63a58ec1-aa98-4eca-891b-98a51d932111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c7bf329b-3410-4a42-b965-ffc219b34967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_28c1ec6b-3f15-4dc8-a805-50225eac4e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c7bf329b-3410-4a42-b965-ffc219b34967" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_28c1ec6b-3f15-4dc8-a805-50225eac4e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d30cbebe-4e98-4816-9f9a-92724d8e6050" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_28c1ec6b-3f15-4dc8-a805-50225eac4e9e" xlink:to="loc_us-gaap_NetIncomeLoss_d30cbebe-4e98-4816-9f9a-92724d8e6050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_cc4b8bdf-c1f6-4dd3-88fa-6d703d04b37f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_28c1ec6b-3f15-4dc8-a805-50225eac4e9e" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_cc4b8bdf-c1f6-4dd3-88fa-6d703d04b37f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_02a608dc-c719-4415-bd75-577e78234687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_28c1ec6b-3f15-4dc8-a805-50225eac4e9e" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_02a608dc-c719-4415-bd75-577e78234687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_42afb8e3-e131-4d4b-a8d1-f69a225c3b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_28c1ec6b-3f15-4dc8-a805-50225eac4e9e" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_42afb8e3-e131-4d4b-a8d1-f69a225c3b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_7e68ba8b-0e87-4f86-9a3d-139d30e771c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract_28c1ec6b-3f15-4dc8-a805-50225eac4e9e" xlink:to="loc_us-gaap_EarningsPerShareBasic_7e68ba8b-0e87-4f86-9a3d-139d30e771c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f4a43892-0bcf-46ee-bb60-9925558c2a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c7bf329b-3410-4a42-b965-ffc219b34967" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f4a43892-0bcf-46ee-bb60-9925558c2a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9d259533-2338-4876-b502-cac5f74afe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f4a43892-0bcf-46ee-bb60-9925558c2a3c" xlink:to="loc_us-gaap_NetIncomeLoss_9d259533-2338-4876-b502-cac5f74afe0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_1a602d5f-de9d-43c3-8651-8752d10190cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f4a43892-0bcf-46ee-bb60-9925558c2a3c" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_1a602d5f-de9d-43c3-8651-8752d10190cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_6a3c3b2e-b550-40cc-86c8-187c167ad2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f4a43892-0bcf-46ee-bb60-9925558c2a3c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_6a3c3b2e-b550-40cc-86c8-187c167ad2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_34f484f2-536d-4f48-aee5-619f0ca91743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f4a43892-0bcf-46ee-bb60-9925558c2a3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_34f484f2-536d-4f48-aee5-619f0ca91743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a641a4c-bf3d-4890-894a-5fe13870e9fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f4a43892-0bcf-46ee-bb60-9925558c2a3c" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7a641a4c-bf3d-4890-894a-5fe13870e9fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_6c4a2505-01fb-410a-af73-ebb8131ee337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_f4a43892-0bcf-46ee-bb60-9925558c2a3c" xlink:to="loc_us-gaap_EarningsPerShareDiluted_6c4a2505-01fb-410a-af73-ebb8131ee337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0e8849f0-77c6-4fe2-b140-cf125acd6168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81e59873-c219-4ef1-a972-6a6e66eff1bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e8849f0-77c6-4fe2-b140-cf125acd6168" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81e59873-c219-4ef1-a972-6a6e66eff1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_8185348e-c5cb-454f-bfcb-5e856118029d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81e59873-c219-4ef1-a972-6a6e66eff1bb" xlink:to="loc_srt_ConsolidationItemsAxis_8185348e-c5cb-454f-bfcb-5e856118029d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_868130fe-e1ec-4737-9b86-58122c27d23c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_8185348e-c5cb-454f-bfcb-5e856118029d" xlink:to="loc_srt_ConsolidationItemsDomain_868130fe-e1ec-4737-9b86-58122c27d23c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_e26a61c0-eff9-497f-a9a1-692483f314a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_868130fe-e1ec-4737-9b86-58122c27d23c" xlink:to="loc_us-gaap_IntersegmentEliminationMember_e26a61c0-eff9-497f-a9a1-692483f314a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_9663c426-f665-4b3a-ae37-a68857bfd4c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_81e59873-c219-4ef1-a972-6a6e66eff1bb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_9663c426-f665-4b3a-ae37-a68857bfd4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_b1fe8f16-9075-418e-bce1-82f583c30e82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9663c426-f665-4b3a-ae37-a68857bfd4c9" xlink:to="loc_us-gaap_NumberOfReportableSegments_b1fe8f16-9075-418e-bce1-82f583c30e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b0f6c8d8-6024-4fd3-95c5-acc8cc8dfd3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_9663c426-f665-4b3a-ae37-a68857bfd4c9" xlink:to="loc_us-gaap_Revenues_b0f6c8d8-6024-4fd3-95c5-acc8cc8dfd3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_89070620-b1af-4009-8153-62c5bf317f70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d6a6072a-cbef-4334-a93a-b9f95a4f1c58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_89070620-b1af-4009-8153-62c5bf317f70" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d6a6072a-cbef-4334-a93a-b9f95a4f1c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_583820f4-bbb4-4221-86a5-f7a603813f32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d6a6072a-cbef-4334-a93a-b9f95a4f1c58" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_583820f4-bbb4-4221-86a5-f7a603813f32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3c4d3ffb-1b6a-4494-8466-0780c454359c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_583820f4-bbb4-4221-86a5-f7a603813f32" xlink:to="loc_us-gaap_SegmentDomain_3c4d3ffb-1b6a-4494-8466-0780c454359c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_MedicalDevicesMember_fe576c63-4ffd-421b-89e2-d772d533fd8e" xlink:href="aort-20230331.xsd#aort_MedicalDevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3c4d3ffb-1b6a-4494-8466-0780c454359c" xlink:to="loc_aort_MedicalDevicesMember_fe576c63-4ffd-421b-89e2-d772d533fd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_9251e69c-e2e7-4021-be89-4b18ade540bb" xlink:href="aort-20230331.xsd#aort_PreservationServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_3c4d3ffb-1b6a-4494-8466-0780c454359c" xlink:to="loc_aort_PreservationServicesMember_9251e69c-e2e7-4021-be89-4b18ade540bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d6a6072a-cbef-4334-a93a-b9f95a4f1c58" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83835836-e34d-4162-9e53-0ebc05404e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_83835836-e34d-4162-9e53-0ebc05404e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_9ff468e6-8107-47c9-b03b-aeb8e7015d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_9ff468e6-8107-47c9-b03b-aeb8e7015d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_6bac5bd3-0bc3-4bd9-8138-8619080e04df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d621a44-a751-4080-8417-a98b04beda70" xlink:to="loc_us-gaap_GrossProfit_6bac5bd3-0bc3-4bd9-8138-8619080e04df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bbd0cd3f-7c8c-4b28-9fbd-72e02010d7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductInformationTable_7c3f3d27-c175-469a-9613-9d1d748c7bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfProductInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bbd0cd3f-7c8c-4b28-9fbd-72e02010d7d0" xlink:to="loc_us-gaap_ScheduleOfProductInformationTable_7c3f3d27-c175-469a-9613-9d1d748c7bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_7c3f3d27-c175-469a-9613-9d1d748c7bc2" xlink:to="loc_srt_ProductOrServiceAxis_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2f04077d-a7aa-4d48-bf8e-e8f0be0e024c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_48b85fa0-ac97-48fd-9f06-a9c2c1a1e3fd" xlink:to="loc_srt_ProductsAndServicesDomain_2f04077d-a7aa-4d48-bf8e-e8f0be0e024c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:href="aort-20230331.xsd#aort_ProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2f04077d-a7aa-4d48-bf8e-e8f0be0e024c" xlink:to="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_AorticStentGraftsMember_b233aae7-96e5-4db8-8007-c3efe326988c" xlink:href="aort-20230331.xsd#aort_AorticStentGraftsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:to="loc_aort_AorticStentGraftsMember_b233aae7-96e5-4db8-8007-c3efe326988c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OnXMember_f43031e0-e8f1-4fa7-9215-850beb80f120" xlink:href="aort-20230331.xsd#aort_OnXMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:to="loc_aort_OnXMember_f43031e0-e8f1-4fa7-9215-850beb80f120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_SurgicalSealantsMember_469eceb0-d312-4497-b3e4-b06adb5b7a64" xlink:href="aort-20230331.xsd#aort_SurgicalSealantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:to="loc_aort_SurgicalSealantsMember_469eceb0-d312-4497-b3e4-b06adb5b7a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_OtherProductsMember_0ae285a5-6341-46f4-8913-fdccf2a59821" xlink:href="aort-20230331.xsd#aort_OtherProductsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aort_ProductsMember_18ed7b8c-83eb-41bd-b90f-66de0d43aeec" xlink:to="loc_aort_OtherProductsMember_0ae285a5-6341-46f4-8913-fdccf2a59821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_PreservationServicesMember_d0c18d69-9ac2-48ae-ac95-e8c3f96eb7b8" xlink:href="aort-20230331.xsd#aort_PreservationServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2f04077d-a7aa-4d48-bf8e-e8f0be0e024c" xlink:to="loc_aort_PreservationServicesMember_d0c18d69-9ac2-48ae-ac95-e8c3f96eb7b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductInformationLineItems_d6caf7f7-6dfc-40cf-b87d-7d4a4b4e78d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfProductInformationTable_7c3f3d27-c175-469a-9613-9d1d748c7bc2" xlink:to="loc_us-gaap_ProductInformationLineItems_d6caf7f7-6dfc-40cf-b87d-7d4a4b4e78d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c829865-dce7-405d-ace6-5894a36e148f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ProductInformationLineItems_d6caf7f7-6dfc-40cf-b87d-7d4a4b4e78d4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3c829865-dce7-405d-ace6-5894a36e148f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.cryolife.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="aort-20230331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.cryolife.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_777cf0fc-fced-42ab-9487-8732be43baad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_777cf0fc-fced-42ab-9487-8732be43baad" xlink:to="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_8432df2a-68b0-4926-992b-0ef6055fa65f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:to="loc_srt_ConsolidatedEntitiesAxis_8432df2a-68b0-4926-992b-0ef6055fa65f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5e14faab-733c-42cf-95d9-7c63ccc1ef69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_8432df2a-68b0-4926-992b-0ef6055fa65f" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5e14faab-733c-42cf-95d9-7c63ccc1ef69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b91c8968-d80f-488f-98b8-131d3665ff03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_5e14faab-733c-42cf-95d9-7c63ccc1ef69" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_b91c8968-d80f-488f-98b8-131d3665ff03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_17fcc989-3e76-4779-a3dd-4b2ccfc77cac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_17fcc989-3e76-4779-a3dd-4b2ccfc77cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a89ba6bc-78d4-4d5f-b77c-544e42d5e79d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_17fcc989-3e76-4779-a3dd-4b2ccfc77cac" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a89ba6bc-78d4-4d5f-b77c-544e42d5e79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_c00f0b9b-8321-4e2d-9060-2818dbdc6846" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a89ba6bc-78d4-4d5f-b77c-544e42d5e79d" xlink:to="loc_us-gaap_SecuredDebtMember_c00f0b9b-8321-4e2d-9060-2818dbdc6846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1139fb09-4e0f-459a-9929-f2f2bd05862e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1139fb09-4e0f-459a-9929-f2f2bd05862e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_968985bb-089f-4a5c-8fc8-f5bfaa647b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1139fb09-4e0f-459a-9929-f2f2bd05862e" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_968985bb-089f-4a5c-8fc8-f5bfaa647b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_5044c31c-3073-4b72-8881-cf0bfd619631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_968985bb-089f-4a5c-8fc8-f5bfaa647b9b" xlink:to="loc_us-gaap_SubsequentEventMember_5044c31c-3073-4b72-8881-cf0bfd619631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_9163361f-9017-4967-9298-9be1b188e209" xlink:to="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_8028a0cf-f5bc-452a-b7a6-eae668734d76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_8028a0cf-f5bc-452a-b7a6-eae668734d76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_NumberOfTranches_a688ec74-9fb0-4dbc-a31c-1aa5887c4097" xlink:href="aort-20230331.xsd#aort_NumberOfTranches"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_NumberOfTranches_a688ec74-9fb0-4dbc-a31c-1aa5887c4097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche_af52ef04-8336-4f82-ad7e-38311a5d9e31" xlink:href="aort-20230331.xsd#aort_ThreeTranchesOfFundingForSecuredLoanPerTranche"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche_af52ef04-8336-4f82-ad7e-38311a5d9e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_FundedTranchePaymentPerAgreement_6ae29838-5d72-4dfa-bbb3-8f620e00e752" xlink:href="aort-20230331.xsd#aort_FundedTranchePaymentPerAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_FundedTranchePaymentPerAgreement_6ae29838-5d72-4dfa-bbb3-8f620e00e752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients_b19a594a-d527-4c35-ab97-a27148ef09d3" xlink:href="aort-20230331.xsd#aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients_b19a594a-d527-4c35-ab97-a27148ef09d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aort_ThirdTranchePayment_84faf1bd-dfa0-4afd-94b8-3742c0b4ab48" xlink:href="aort-20230331.xsd#aort_ThirdTranchePayment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_d1ce8530-5305-4a17-9afe-d180f588f7e0" xlink:to="loc_aort_ThirdTranchePayment_84faf1bd-dfa0-4afd-94b8-3742c0b4ab48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970836160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Apr. 28, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-13165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ARTIVION, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">59-2417093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1655 Roberts Boulevard, NW<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Kennesaw<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">419-3355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AORT<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,875,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000784199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971330944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 83,229<span></span>
</td>
<td class="nump">$ 77,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of products and preservation services:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">29,502<span></span>
</td>
<td class="nump">26,494<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross margin</a></td>
<td class="nump">53,727<span></span>
</td>
<td class="nump">50,719<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">General, administrative, and marketing</a></td>
<td class="nump">50,365<span></span>
</td>
<td class="nump">38,955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">7,223<span></span>
</td>
<td class="nump">10,128<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">57,588<span></span>
</td>
<td class="nump">49,083<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating (loss) income</a></td>
<td class="num">(3,861)<span></span>
</td>
<td class="nump">1,636<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">6,096<span></span>
</td>
<td class="nump">3,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="num">(963)<span></span>
</td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(8,919)<span></span>
</td>
<td class="num">(2,429)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">4,613<span></span>
</td>
<td class="nump">960<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (13,532)<span></span>
</td>
<td class="num">$ (3,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Loss per share, basic (in usd per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Loss per share, diluted (in usd per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in shares)</a></td>
<td class="nump">40,432<span></span>
</td>
<td class="nump">39,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">40,432<span></span>
</td>
<td class="nump">39,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (13,532)<span></span>
</td>
<td class="num">$ (3,389)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfOtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustments</a></td>
<td class="nump">3,616<span></span>
</td>
<td class="num">(3,775)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">(9,916)<span></span>
</td>
<td class="num">(7,164)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_ProductsMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">62,291<span></span>
</td>
<td class="nump">57,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of products and preservation services:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">19,533<span></span>
</td>
<td class="nump">17,408<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_PreservationServicesMember', window );">Preservation services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">20,938<span></span>
</td>
<td class="nump">19,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Cost of products and preservation services:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">$ 9,969<span></span>
</td>
<td class="nump">$ 9,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_ProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_ProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_PreservationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_PreservationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971990672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 30,773<span></span>
</td>
<td class="nump">$ 39,351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Trade receivables, net</a></td>
<td class="nump">62,760<span></span>
</td>
<td class="nump">61,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="nump">3,952<span></span>
</td>
<td class="nump">7,764<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">76,273<span></span>
</td>
<td class="nump">74,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DeferredPreservationCosts', window );">Deferred preservation costs, net</a></td>
<td class="nump">47,415<span></span>
</td>
<td class="nump">46,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">19,508<span></span>
</td>
<td class="nump">17,550<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">240,681<span></span>
</td>
<td class="nump">247,334<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">245,648<span></span>
</td>
<td class="nump">243,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Acquired technology, net</a></td>
<td class="nump">149,833<span></span>
</td>
<td class="nump">151,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">41,473<span></span>
</td>
<td class="nump">41,859<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">38,716<span></span>
</td>
<td class="nump">38,674<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherIntangibleAssetsNet', window );">Other intangibles, net</a></td>
<td class="nump">30,807<span></span>
</td>
<td class="nump">31,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income taxes</a></td>
<td class="nump">2,373<span></span>
</td>
<td class="nump">1,314<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">7,542<span></span>
</td>
<td class="nump">7,339<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">757,073<span></span>
</td>
<td class="nump">762,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">9,473<span></span>
</td>
<td class="nump">12,004<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">9,678<span></span>
</td>
<td class="nump">12,374<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">9,028<span></span>
</td>
<td class="nump">13,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Taxes payable</a></td>
<td class="nump">6,911<span></span>
</td>
<td class="nump">2,635<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases</a></td>
<td class="nump">3,398<span></span>
</td>
<td class="nump">3,308<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_AccruedProcurementFees', window );">Accrued procurement fees</a></td>
<td class="nump">2,155<span></span>
</td>
<td class="nump">2,111<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">1,620<span></span>
</td>
<td class="nump">1,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities</a></td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">1,825<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">43,961<span></span>
</td>
<td class="nump">49,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt</a></td>
<td class="nump">306,279<span></span>
</td>
<td class="nump">306,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration</a></td>
<td class="nump">45,200<span></span>
</td>
<td class="nump">40,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current maturities of operating leases</a></td>
<td class="nump">40,774<span></span>
</td>
<td class="nump">41,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred income taxes</a></td>
<td class="nump">23,826<span></span>
</td>
<td class="nump">24,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liability</a></td>
<td class="nump">6,127<span></span>
</td>
<td class="nump">5,468<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Non-current finance lease obligation</a></td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">3,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">7,407<span></span>
</td>
<td class="nump">7,027<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">477,156<span></span>
</td>
<td class="nump">478,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, Value, Issued</a></td>
<td class="nump">424<span></span>
</td>
<td class="nump">418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">342,883<span></span>
</td>
<td class="nump">337,385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained deficit</a></td>
<td class="num">(30,749)<span></span>
</td>
<td class="num">(17,217)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(17,993)<span></span>
</td>
<td class="num">(21,609)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost, 1,487 shares as of March 31, 2023 &#8206;and December 31, 2022</a></td>
<td class="num">(14,648)<span></span>
</td>
<td class="num">(14,648)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders' equity</a></td>
<td class="nump">279,917<span></span>
</td>
<td class="nump">284,329<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 757,073<span></span>
</td>
<td class="nump">$ 762,798<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_AccruedProcurementFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Donated tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. The Company accrues estimated procurement fees due at the time tissues are received based on contractual agreements between the Company and the tissue banks and organ procurement organizations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_AccruedProcurementFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DeferredPreservationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DeferredPreservationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970925824">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">75,000,000<span></span>
</td>
<td class="nump">75,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">42,366,000<span></span>
</td>
<td class="nump">41,830,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">42,366,000<span></span>
</td>
<td class="nump">41,830,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock at cost, shares (in shares)</a></td>
<td class="nump">1,487,000<span></span>
</td>
<td class="nump">1,487,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971895488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Net cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (13,532)<span></span>
</td>
<td class="num">$ (3,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">5,734<span></span>
</td>
<td class="nump">5,881<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">4,800<span></span>
</td>
<td class="num">(1,800)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Non-cash compensation</a></td>
<td class="nump">3,341<span></span>
</td>
<td class="nump">3,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,802<span></span>
</td>
<td class="nump">1,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_WriteDownOfDeferredPreservationCostsAndInventories', window );">Write-down of inventories and deferred preservation costs</a></td>
<td class="nump">1,123<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred income taxes</a></td>
<td class="num">(2,167)<span></span>
</td>
<td class="num">(2,966)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashExpense', window );">Other</a></td>
<td class="nump">754<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInReceivables', window );">Receivables</a></td>
<td class="nump">3,540<span></span>
</td>
<td class="num">(1,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(2,014)<span></span>
</td>
<td class="nump">1,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories', window );">Inventories and deferred preservation costs</a></td>
<td class="num">(3,222)<span></span>
</td>
<td class="num">(1,359)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses, and other liabilities</a></td>
<td class="num">(6,313)<span></span>
</td>
<td class="num">(3,320)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash flows used in operating activities</a></td>
<td class="num">(6,154)<span></span>
</td>
<td class="num">(598)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Net cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(2,238)<span></span>
</td>
<td class="num">(2,239)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Acquisition of intangible assets</a></td>
<td class="num">(605)<span></span>
</td>
<td class="num">(469)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash flows used in investing activities</a></td>
<td class="num">(2,843)<span></span>
</td>
<td class="num">(2,708)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Net cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from exercise of stock options and issuance of common stock</a></td>
<td class="nump">2,581<span></span>
</td>
<td class="nump">2,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Redemption and repurchase of stock to cover tax withholdings</a></td>
<td class="num">(590)<span></span>
</td>
<td class="num">(1,730)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of term loan</a></td>
<td class="num">(690)<span></span>
</td>
<td class="num">(694)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(130)<span></span>
</td>
<td class="num">(129)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash flows provided by (used in) financing activities</a></td>
<td class="nump">1,171<span></span>
</td>
<td class="num">(235)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(752)<span></span>
</td>
<td class="num">(61)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash and cash equivalents</a></td>
<td class="num">(8,578)<span></span>
</td>
<td class="num">(3,602)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents beginning of period</a></td>
<td class="nump">39,351<span></span>
</td>
<td class="nump">55,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents end of period</a></td>
<td class="nump">$ 30,773<span></span>
</td>
<td class="nump">$ 51,408<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in deferred preservation costs and inventories, associated with underlying transactions that are classified as operating activities. Preservation costs consists primarily of direct labor and materials and indirect costs which are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_WriteDownOfDeferredPreservationCostsAndInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amounts of the current period expense charged to cost of products and preservation services for the purpose of reducing deferred preservation costs and inventory, respectively, to amounts that approximate their net realizable value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_WriteDownOfDeferredPreservationCostsAndInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense or loss included in net income that result in no cash flow, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971584464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Shareholders' Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings (Deficit)</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,397,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 300,728<span></span>
</td>
<td class="nump">$ 414<span></span>
</td>
<td class="nump">$ 322,874<span></span>
</td>
<td class="nump">$ 1,975<span></span>
</td>
<td class="num">$ (9,887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Beginning balance, treasury stock at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(3,389)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,389)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(3,775)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,775)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">205,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">3,340<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">3,338<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">1,680<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">1,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">638<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption and repurchase of stock to cover tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption and repurchase of stock to cover tax withholdings</a></td>
<td class="num">(1,730)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="num">(1,729)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,688,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 297,492<span></span>
</td>
<td class="nump">$ 417<span></span>
</td>
<td class="nump">326,799<span></span>
</td>
<td class="num">(1,414)<span></span>
</td>
<td class="num">(13,662)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Ending balance, treasury stock at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">41,830,000<span></span>
</td>
<td class="nump">41,830,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">$ 284,329<span></span>
</td>
<td class="nump">$ 418<span></span>
</td>
<td class="nump">337,385<span></span>
</td>
<td class="num">(17,217)<span></span>
</td>
<td class="num">(21,609)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Beginning balance, treasury stock (in shares) at Dec. 31, 2022</a></td>
<td class="num">(1,487,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Beginning balance, treasury stock at Dec. 31, 2022</a></td>
<td class="num">$ (14,648)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(13,532)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,532)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Other comprehensive loss</a></td>
<td class="nump">3,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Equity compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">326,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Equity compensation</a></td>
<td class="nump">3,513<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">3,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of options</a></td>
<td class="nump">2,006<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Employee stock purchase plan</a></td>
<td class="nump">575<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares', window );">Redemption and repurchase of stock to cover tax withholdings (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue', window );">Redemption and repurchase of stock to cover tax withholdings</a></td>
<td class="num">$ (590)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(590)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">42,366,000<span></span>
</td>
<td class="nump">42,366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="nump">$ 279,917<span></span>
</td>
<td class="nump">$ 424<span></span>
</td>
<td class="nump">$ 342,883<span></span>
</td>
<td class="num">$ (30,749)<span></span>
</td>
<td class="num">$ (17,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Ending balance, treasury stock (in shares) at Mar. 31, 2023</a></td>
<td class="num">(1,487,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,487,000)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Ending balance, treasury stock at Mar. 31, 2023</a></td>
<td class="num">$ (14,648)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (14,648)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRedeemedOrCalledDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRedeemedOrCalledDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387973571456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation and Summary of Significant Accounting Policies</a></td>
<td class="text">Basis of Presentation and Summary of Significant Accounting Policies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Condensed Consolidated Financial Statements include the accounts of Artivion, Inc. and its subsidiaries (&#8220;Artivion,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; or &#8220;us&#8221;). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Condensed Consolidated Balance Sheet as of December&#160;31, 2022 has been derived from audited financial statements. The accompanying unaudited Condensed Consolidated Financial Statements as of, and for the three months ended, March&#160;31, 2023 and 2022 have been prepared in accordance with (i) accounting principles generally accepted in the United States of America ("US GAAP") for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the US Securities and Exchange Commission (the &#8220;SEC&#8221;). Accordingly, such statements do not include all the information and disclosures that are required by US GAAP for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. These Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included in Artivion&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on February&#160;23, 2023. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our significant accounting policies is included in Note 1 of the &#8220;Notes to Consolidated Financial Statements&#8221; contained in our Form 10-K for the year ended December&#160;31, 2022. Management believes that the consistent application of these policies enables us to provide users of the financial statements with useful and reliable information about our operating results and financial condition. The Condensed Consolidated Financial Statements are prepared in accordance with US GAAP, which require us to make estimates and assumptions. We did not experience any significant changes during the three months ended March&#160;31, 2023 in any of our Significant Accounting Policies from those contained in our Form 10-K for the year ended December&#160;31, 2022.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020 the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 848&#8221;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. US GAAP requires entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December 31, 2022 and cannot be applied to contract modifications that occur after December 31, 2022.  In January 2021 the FASB issued ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The objective of the new reference rate reform standard is to clarify the scope of Topic 848 and provide explicit guidance to help companies applying optional expedients and exceptions. We adopted ASU 2020-04 and ASU 2021-01 on a prospective basis in fiscal year 2022. The adoption of ASU 2020-04 and ASU 2021-01 did not have a material impact on our financial condition or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387973696640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45,200)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45,200)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40,400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40,400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We used prices quoted from our investment advisors to determine the Level 1 valuation of our investments in money market funds. The estimated market value of all cash equivalents is equal to cost basis as there were no gross realized gains or losses on cash equivalents for the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;2, 2020 we entered into a Securities Purchase Agreement to acquire 100% of the outstanding equity interests of Ascyrus Medical LLC (&#8220;Ascyrus&#8221;). Ascyrus developed the AMDS, the world&#8217;s first aortic arch remodeling device for use in the treatment of acute Type A aortic dissections. As part of the acquisition, we may be required to pay additional consideration in cash of up to $100.0 million to the former shareholders of Ascyrus upon the achievement of certain milestones and the sales-based additional earn-out. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent consideration represents the estimated fair value of future potential payments. The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach. We applied a discount rate based on our unsecured credit spread and the term commensurate risk-free rate to the additional consideration to be paid, and then applied a risk-based estimate of the probability of achieving each scenario to calculate the fair value of the contingent consideration. This fair value measurement was based on unobservable inputs, including management estimates and assumptions about the future achievement of milestones and future estimate of revenues, and is, therefore, classified as Level 3 within the fair value hierarchy. We used a discount rate of approximately 13% and estimated future achievement of milestone dates between 2025 and 2026 to calculate the fair value of contingent consideration as of March&#160;31, 2023. We will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive Loss. Increases or decreases in the fair value of the contingent consideration liability can result from changes in passage of time, discount rates, the timing and amount of our revenue estimates, and the timing and expectation of regulatory approvals.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We performed an assessment of the fair value of the contingent consideration and recorded an expense of $4.8 million and income of $1.8 million for the three months ended March&#160;31, 2023 and 2022, respectively, in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive Loss, as a result of this assessment.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the contingent consideration component of the Ascyrus acquisition was updated using Level 3 inputs. Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,400)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45,200)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The determination of fair value and the assessment of a measurement&#8217;s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Although we believe that the recorded fair values of our financial instruments are appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387976138736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, net and Deferred Preservation Costs<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories, net and Deferred Preservation Costs</a></td>
<td class="text">Inventories, net and Deferred Preservation Costs  <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net at March&#160;31, 2023 and December&#160;31, 2022 were comprised of the following (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:71.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories, net </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76,273</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74,478</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To facilitate product usage, we maintain consignment inventory of our On-X heart valves at domestic hospital locations and On-X heart valves and aortic stent grafts at international hospital locations. We retain title and control over this consignment inventory until the device is implanted, at which time we invoice the hospital and recognize revenue. As of March&#160;31, 2023 we had $12.7 million in consignment inventory, with approximately 42% in domestic locations and 58% in international locations. As of December&#160;31, 2022 we had $12.7 million in consignment inventory, with approximately 41% in domestic locations and 59% in international locations.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred preservation costs were $47.4 million and $46.4 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory and deferred preservation costs obsolescence reserves were $2.1 million and $2.2 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970733504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill and Other Intangible Assets  <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indefinite Lived Intangible Assets </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 the carrying values of our indefinite lived intangible assets were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">245,648</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">243,631</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">In-process R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,120</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,080</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Procurement contracts and agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,013</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the phases of development of our acquired in-process research and development projects, including the risks associated with further development and the amount and timing of benefits expected to be derived from the completed projects. Incremental costs associated with development are charged to expense as incurred. Capitalized costs are amortized over the estimated useful life of the developed asset once completed. Our in-process research and development projects are reviewed for impairment annually, or more frequently, if events or changes in circumstances indicate that the asset might be impaired. We did not record any impairment of indefinite lived intangible assets during the three months ended March&#160;31, 2023. In-process research and development, procurement contracts and agreements are included in Other intangibles, net on the Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our experience with similar agreements, we believe that our acquired procurement contracts and agreements have indefinite useful lives, as we expect to continue to renew these contracts for the foreseeable future.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate our goodwill and non-amortizing intangible assets for impairment on an annual basis during the fourth quarter of the year, and, if necessary, during interim periods if factors indicate that an impairment review is warranted. As of March&#160;31, 2023 we concluded that our assessment of current factors did not indicate that goodwill or non-amortizing intangible assets are more likely than not to be impaired. We will continue to evaluate the recoverability of these non-amortizing intangible assets in future periods as necessary.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 the carrying value of goodwill, all of which is related to our Medical Devices segment, was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Medical Devices Segment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">243,631</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">245,648</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definite Lived Intangible Assets</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The definite lived intangible assets balance includes balances related to acquired technology, customer relationships, distribution and manufacturing rights and know-how, patents, and other definite lived intangible assets. As of March&#160;31, 2023 and December&#160;31, 2022 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">200,312</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">50,479</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">149,833</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31,068</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,489</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,579</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,455</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,353</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,102</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,286</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,192</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,094</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,822</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,923</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,899</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">50,631</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">23,957</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">26,674</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10.2</span></td></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">198,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">47,157</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">151,263</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31,030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,100</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,930</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,274</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,796</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,478</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,246</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,180</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,066</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,360</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,543</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,817</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">49,910</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">22,619</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">27,291</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10.3</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization Expense </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive Loss (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:71.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.143%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 scheduled amortization of intangible assets for the next five years is as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder<br/>of 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140388066450112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective income tax rate was an expense of 52% and 40% for the three months ended March&#160;31, 2023 and 2022, respectively. Our income tax rate for the three months ended March&#160;31, 2023 and 2022 was primarily impacted by changes in our valuation allowance against our net deferred tax assets, non-deductible executive compensation, the foreign derived intangible income deduction, the research and development tax credit, changes in our uncertain tax position liabilities, and tax shortfalls on stock compensation.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Income Taxes</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate deferred tax assets primarily as a result of finance and operating leases, net operating losses, excess interest carryforward, accrued compensation, and stock compensation. Our deferred tax liabilities are primarily comprised of intangible assets acquired in previous years, finance and operating leases, and unrealized gains and losses.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintained a net deferred tax liability of $21.5 million and $23.2 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. Our valuation allowance against our deferred tax assets was $19.6 million and $17.9 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively, primarily related to net operating loss carryforwards and disallowed excess interest carryforwards.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387977314992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases We have operating and finance lease obligations resulting from the lease of land and buildings that comprise our corporate headquarters and various manufacturing facilities; leases related to additional manufacturing, office, and warehouse space; leases on company vehicles; and leases on a variety of office and other equipment.<div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to leases included in the Condensed Consolidated Balance Sheets was as follows (in thousands, except lease term and discount rate):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating leases:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(15,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(14,202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating lease right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">41,473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">41,859</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of operating leases </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">41,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">44,172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">44,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Property and equipment, at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,498)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,854</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7.8</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.1%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current maturities of finance leases are included as a component of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_2e5b36fd-c488-467a-a7e5-80e362ee1e08"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_c3cbd70e-0a04-4d24-ab66-5fb27dcd22e3">Other current liabilities</span></span> on our Condensed Consolidated Balance Sheets. A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.737%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.104%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Amortization of property and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">131</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">137</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Interest expense on finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">152</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">162</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,920</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total lease expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">1,954</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">1,990</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,796</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,525</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">132</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">130</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24</span></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments and sublease rental income are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">442</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,246</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">606</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,819</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">585</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,620</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">566</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,008</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">561</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,867</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,670</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37,103</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,430</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">62,663</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(18,491)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Present value of net minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,108</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">44,172</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Lease liabilities, less current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,582</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,774</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387975395712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Credit Agreement</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December&#160;1, 2017 we entered into a credit and guaranty agreement for a $255.0 million senior secured credit facility, consisting of a $225.0 million secured term loan facility (the &#8220;Term Loan Facility&#8221;) and a $30.0 million secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221; and, together with the Term Loan Facility, the &#8220;Credit Agreement&#8221;). We and each of our existing domestic subsidiaries (subject to certain exceptions and exclusions) guarantee the obligations under the Credit Agreement (the &#8220;Guarantors&#8221;). The Credit Agreement is secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of us and the Guarantors.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;2, 2021 we entered into an amendment to our Credit Agreement to extend the maturity dates of both our Term Loan and Revolving Credit Facility. As part of the amendment, the maturity dates of both our Term Loan and Revolving Credit Facility were each extended by two and one-half years, until June 1, 2027 and June 1, 2025, respectively, subject to earlier springing maturities triggered if our 4.25% Convertible Senior Notes, described below, remain outstanding on April 1, 2025 and December 31, 2024, respectively. With respect to the Term Loan, if the Convertible Senior Notes remain outstanding on April 1, 2025, the Term Loan&#8217;s maturity date will be April 1, 2025, or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) 91 days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2027. In the case of the Revolving Credit Facility, if the Convertible Senior Notes are still outstanding on December 31, 2024, the Revolving Credit Facility&#8217;s maturity date will be either December 31, 2024 or, if the Convertible Senior Notes&#8217; own maturity date has been extended, the earlier of (i) 182 days prior to the Convertible Senior Notes&#8217; new maturity date and (ii) June 1, 2025. Under the amendment, the Term Loan Facility bears interest, at our option, at a floating annual rate equal to either the base rate, plus a margin of 2.50%, or LIBOR, plus a margin of 3.50%. Prior to the amendment, the optional floating annual rate was equal to either the base rate plus a margin of 2.25%, or LIBOR, plus a margin of 3.25%. We paid debt issuance costs of $2.1 million, of which $1.8 million will be amortized over the life of the Term Loan Facility and included in current and long-term debt on the Condensed Consolidated Balance Sheets. The remaining $361,000 of debt issuance costs and $474,000 of non-cash debt extinguishment costs were recorded in Interest expense on the Condensed Consolidated Statements of Operations and Comprehensive Loss. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 the Credit Agreement contains certain customary affirmative and negative covenants, including covenants that limit our ability and the ability of our subsidiaries to, among other things, grant liens, incur debt, dispose of assets, make loans and investments, make acquisitions, make certain restricted payments (including cash dividends), merge or consolidate, change business or accounting or reporting practices, in each case subject to customary exceptions for a credit facility of this size and type. Beginning in 2021 if we repay borrowings under our Revolving Credit Facility to 25% or less, no financial maintenance covenants, including the minimum liquidity covenant and the maximum first lien net leverage ratio covenant, are applicable. We are in compliance with our debt covenants as of March&#160;31, 2023.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 19, 2022 in accordance with adopting ASU 2020-04 and 2021-01, we entered into an amendment to our Credit Agreement to replace the LIBOR based benchmark interest rate with the Secured Overnight Financing Rate (&#8220;SOFR&#8221;) based benchmark interest rate for our Term Loan Facility and our Revolving Credit Facility. Based on historical analysis of the differences between the benchmark rates, SOFR is adjusted to arrive at a Term SOFR rate that serves as the replacement base rate for LIBOR under our amended credit facilities. Under this amendment, at the maturity of our existing LIBOR-based loan on December 30, 2022, the interest rate at the repricing of our Term Loan Facility was calculated as Term SOFR plus a fixed percentage credit spread of 3.50%. The loan under the Revolving Credit Facility bears interest at Term SOFR plus a margin of between 4.00% and 4.25%, depending on our consolidated leverage ratio. As of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023 </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the aggregate interest rate of the Credit Agreement was 8.66% per annum.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Convertible Senior Notes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;18, 2020 we issued $100.0 million aggregate principal amount of 4.25% Convertible Senior Notes with a maturity date of July&#160;1, 2025 (the &#8220;Convertible Senior Notes&#8221;). The net proceeds from this offering, after deducting initial purchasers&#8217; discounts and costs directly related to this offering, were approximately $96.5 million. On January 1, 2021 we adopted ASU 2020-06 and adjusted the carrying balance of the Convertible Senior Notes to notional. The Convertible Senior Notes balance was $100.0 million recorded in Long-term debt on the Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022. The Convertible Senior Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The initial conversion rate of the Convertible Senior Notes is 42.6203 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $23.46 per share, subject to adjustments. We use the if-converted method for assumed conversion of the Convertible Senior Notes for the diluted earnings per share calculation. The fair value and the effective interest rate of the Convertible Senior Notes as of March&#160;31, 2023 was approximately $90.7 million and 5.05%, respectively. The fair value was based on market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest expense recognized on the Convertible Senior Notes includes $1.2 million for the </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three months ended March&#160;31, 2023 and 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> related to the aggregate of the contractual coupon interest and the amortization of the debt issuance costs</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Interest on the Convertible Senior Notes began accruing upon issuance and is payable semi-annually. There were $1.7 million and $1.9 million of unamortized debt issuance costs related to Convertible Senior Notes as of March&#160;31, 2023 and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2022</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, respectively. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Convertible Senior Notes may convert their notes at their option at any time prior to January 1, 2025, but only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (iii) we give a notice of redemption with respect to any or all of the notes, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after January 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot redeem the Convertible Senior Notes before July 5, 2023. We can redeem them on or after July 5, 2023, in whole or in part, at our option, if the last reported sale price per share of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. We may redeem for cash all or part of the Convertible Senior Notes at a redemption price equal to 100% of the principal amount of the redeemable Convertible Senior Notes, plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the Convertible Senior Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the Convertible Senior Notes do not contain any financial covenants and do not restrict us from conducting significant restructuring transactions or issuing or repurchasing any of its other securities.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loan Balances</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term and long-term balances of our Term Loan and other long-term borrowings were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Term Loan balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">213,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">213,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Convertible Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.45% Sparkasse Zollernalb (KFW Loan 1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1.40% Sparkasse Zollernalb (KFW Loan 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total loan balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">314,109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">314,779</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less unamortized loan origination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(6,210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(6,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">307,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">308,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less short-term loan balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(1,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(1,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Long-term loan balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">306,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">306,499</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div>Interest expense was $6.1 million and $3.9 million for the three months ended March&#160;31, 2023 and 2022, respectively. Interest expense includes interest on debt and uncertain tax positions in both periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387973535744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liability Claims</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we are made aware of adverse events involving our products and tissues. Future adverse events could ultimately give rise to a lawsuit against us, and liability claims may be asserted against us in the future based on past events that we are not aware of at the present time. We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability claims. Claims-made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect. The amounts recorded in these Condensed Consolidated Financial Statements as of March&#160;31, 2023 and the Consolidated Financial Statements as of December&#160;31, 2022 represent our estimate of the probable losses and anticipated recoveries for incurred but not reported claims related to products sold and services performed prior to the balance sheet date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387973621088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Revenue</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified the following revenues disaggregated by revenue source:</span></div><div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Domestic hospitals &#8211; direct sales of products and preservation services.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International hospitals &#8211; direct sales of products and preservation services.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International distributors &#8211; generally these contracts specify a geographic area that the distributor will service, terms and conditions of the relationship, and purchase targets for the next calendar year.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CardioGenesis cardiac laser console trials and sales &#8211; CardioGenesis cardiac trialed laser consoles are delivered under separate agreements.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022 the sources of revenue were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Domestic hospitals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,883</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">36,993</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International hospitals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28,957</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28,414</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12,939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,064</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">CardioGenesis cardiac laser therapy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">450</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">742</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total sources of revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">83,229</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">77,213</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also see segment disaggregation information in Note 12 below.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may generate contract assets during the pre-delivery design and manufacturing stage of E-xtra Design Engineering product order fulfillment. We assess the balance related to any arrangements in process and determine if the enforceable right to payment creates a material contract asset requiring disclosure. No material arrangements in process existed as of March&#160;31, 2023 and 2022.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also incur contract obligations on general customer purchase orders that have been accepted but unfulfilled. Due to the short duration of time between order acceptance and delivery of the related product or service, we have determined that the balance related to these contract obligations is generally immaterial at any point in time. We monitor the value of orders accepted but unfulfilled at the close of each reporting period to determine if disclosure is appropriate. The value of orders accepted but unfulfilled as of March&#160;31, 2023 and 2022 was not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387977230512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock Compensation</a></td>
<td class="text">Stock Compensation <div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (&#8220;RSAs&#8221;), restricted stock units (&#8220;RSUs&#8221;), performance stock units (&#8220;PSUs&#8221;), and options to purchase shares of our common stock at exercise prices generally equal to the fair value of such stock at the dates of grant. We also maintain a shareholder-approved Employee Stock Purchase Plan (&#8220;ESPP&#8221;) for the benefit of our employees. The ESPP allows eligible employees to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Grants</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023 the</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compensation Committee of our Board of Directors (the &#8220;Committee&#8221;) authorized awards from approved stock incentive plans of RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together total</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed 376,000 shares and had an aggregate grant date fair value of $5.0 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2022 the Committee authorized awards from approved stock incentive plans of  RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled 452,000 shares and had an aggregate grant date fair value of $8.3 million. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee authorized, from approved stock incentive plans, grants of stock options to purchase a total of 314,000 shares to certain company officers during the three months ended </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The exercise prices of the options were equal to the closing stock prices on their respective grant dates. The Committee did not authorize any grants of stock options during the three months ended March&#160;31, 2023.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employees purchased common stock totaling 56,000 and 37,000 shares in the three months ended March&#160;31, 2023 and 2022, respectively, through the ESPP. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Compensation Expense </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.901%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.5 Years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.66</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.77%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:68.200%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.945%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.948%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">RSA, RSU, and PSU expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Stock option and ESPP expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total stock compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,340</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div>Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the ESPP. These amounts were recorded as stock compensation expense and were subject to our normal allocation of expenses to inventory costs and deferred preservation costs. We capitalized $172,000 and $174,000 in the three months ended March 31, 2023 and 2022, respectively, of the stock compensation expense into our inventory costs and deferred preservation costs.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971296096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Common Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Loss Per Common Share</a></td>
<td class="text">Loss Per Common Share <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted loss per common share (in thousands, except per share data): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"/><td style="width:73.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.116%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic loss per common share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(13,532)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,389)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net loss allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(3,371)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,432</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,850</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic loss per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.08)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:73.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted loss per common share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(13,532)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,389)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net loss allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(3,371)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,432</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39,850</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,432</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,850</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted loss per common share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.08)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares because the inclusion of these stock options would be antidilutive to loss per common share. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022 all stock options and awards were excluded from the calculation of diluted weighted-average common shares outstanding as these would be antidilutive due to the net loss.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387975227600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information  <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two reportable segments organized according to our products and services: Medical devices and Preservation services. The Medical Devices segment includes external revenues from product sales of aortic stent grafts, On-X, surgical sealants, and other product revenues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, and E-vita Thoracic 3G. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Surgical sealants include BioGlue Surgical Adhesive products. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are no intersegment revenues. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary measure of segment performance, as viewed by our management, is segment gross margin or net external revenues less cost of products and preservation services. We do not segregate assets by segment, therefore, asset information is excluded from the segment disclosures below. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">57,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">83,229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">77,213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Cost of products and preservation services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total cost of products and preservation services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">29,502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">26,494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">42,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total gross margin</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">53,727</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">50,719</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net revenues by product and service (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26,150</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25,506</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,656</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14,371</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,703</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15,681</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,782</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,984</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">62,291</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">57,542</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,938</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,671</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">83,229</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">77,213</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387977314992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events  <div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Endospan Loan</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 11, 2019 Artivion and Endospan Ltd. (&#8220;Endospan&#8221;), an Israeli corporation, entered into a loan agreement (&#8220;Endospan Loan&#8221;), in which Artivion agreed to provide Endospan a secured loan of up to $15.0&#160;million to be funded in three tranches of $5.0&#160;million each. The first tranche of the Endospan Loan was funded upon execution of the agreement in September 2019. In September 2020 we funded the second tranche payment of $5.0&#160;million upon the certification of the NEXUS IDE from the US Food and Drug Administration (the &#8220;FDA&#8221;).</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 16, 2023 Endospan completed an enrollment certification of 50% of the required number of patients in the primary arm of the FDA approved clinical trial for NEXUS, which, assuming compliance with other requirements under the Endospan Loan, may trigger a third tranche payment of $5.0&#160;million. We expect to fund the $5.0&#160;million payment during the second quarter of fiscal year 2023. </span></div>We elected the fair value option for recording the Endospan Loan and are evaluating the fair value impact of the anticipated funding of the third tranche payment.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971959408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation and Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">New Accounting Standards</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020 the Financial Accounting Standards Board (the &#8220;FASB&#8221;) issued Accounting Standard Update (&#8220;ASU&#8221;) 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform Topic 848</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 848&#8221;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. US GAAP requires entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December 31, 2022 and cannot be applied to contract modifications that occur after December 31, 2022.  In January 2021 the FASB issued ASU 2021-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The objective of the new reference rate reform standard is to clarify the scope of Topic 848 and provide explicit guidance to help companies applying optional expedients and exceptions. We adopted ASU 2020-04 and ASU 2021-01 on a prospective basis in fiscal year 2022. The adoption of ASU 2020-04 and ASU 2021-01 did not have a material impact on our financial condition or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387975197296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Summary of Financial Instruments Measured at Fair Value</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7,154</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,200)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45,200)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45,200)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:43.748%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.085%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market funds</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,098&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">10,098</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term liabilities: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40,400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(40,400)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Reconciliation of Changes in Fair Value of Level 3 Liabilities</a></td>
<td class="text">Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.809%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent Consideration</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,400)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,800)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(45,200)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970945616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories, Net And Deferred Preservation Costs (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventories</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventories, net at March&#160;31, 2023 and December&#160;31, 2022 were comprised of the following (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:71.088%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.881%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.124%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials and supplies</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,322&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,476&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,632&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,287&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total inventories, net </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">76,273</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">74,478</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970695584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of Carrying Values of Indefinite Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 the carrying values of our indefinite lived intangible assets were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Goodwill</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">245,648</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">243,631</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">In-process R&amp;D</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,120</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,080</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Procurement contracts and agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,013</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,013</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill by Reportable Segment</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022 the carrying value of goodwill, all of which is related to our Medical Devices segment, was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.718%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Medical Devices Segment</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">243,631</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Foreign currency translation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance as of March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">245,648</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets</a></td>
<td class="text">As of March&#160;31, 2023 and December&#160;31, 2022 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">200,312</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">50,479</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">149,833</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31,068</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,489</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,579</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,455</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,353</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,102</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,286</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,192</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,094</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,822</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,923</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,899</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">50,631</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">23,957</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">26,674</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10.2</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:44.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.006%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net Carrying <br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted Average<br/>Useful Life<br/>(Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Acquired technology</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">198,420</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">47,157</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">151,263</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18.2</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Other intangibles:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Customer lists and relationships</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">31,030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,100</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,930</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Distribution and manufacturing rights and know-how</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,274</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,796</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,478</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.0</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Patents</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,246</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,180</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,066</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17.0</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,360</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,543</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,817</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.4</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total other intangibles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">49,910</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">22,619</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">27,291</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">10.3</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Summary of Amortization Expense</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive Loss (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:71.807%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.142%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.143%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,882&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,084&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Scheduled Amortization of Intangible Assets for Next Five Years</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 scheduled amortization of intangible assets for the next five years is as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.960%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.965%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Remainder<br/>of 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2026</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2027</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2028</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,358&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,802&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,606&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,504&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387976302416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Schedule of Supplemental Balance Sheet Information Related to Leases</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to leases included in the Condensed Consolidated Balance Sheets was as follows (in thousands, except lease term and discount rate):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.172%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating leases:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,610&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">56,061&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(15,137)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(14,202)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating lease right-of-use assets, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">41,473</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">41,859</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of operating leases</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,398&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of operating leases </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,774&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">41,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">44,172</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">44,565</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance leases:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Property and equipment, at cost</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,533&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">6,408&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,679)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(2,498)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,854</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,910</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Current maturities of finance leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">526&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Non-current maturities of finance leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">3,644&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease liabilities</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,108</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,157</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average remaining lease term (in years):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11.9</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">7.8</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5.9%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.1%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Lease Costs</a></td>
<td class="text">A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows (in thousands): <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.737%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.101%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.558%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.104%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Amortization of property and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">131</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">137</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Interest expense on finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total finance lease expense</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">152</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">162</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating lease expense</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,802</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,920</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Sublease income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(92)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total lease expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">1,954</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">1,990</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for operating leases</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,796</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,525</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Financing cash flows for finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">132</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">130</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Operating cash flows for finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">21</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">24</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments and sublease rental income are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">442</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,246</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">606</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,819</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">585</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,620</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">566</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,008</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">561</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,867</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,670</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37,103</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,430</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">62,663</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(18,491)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Present value of net minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,108</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">44,172</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Lease liabilities, less current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,582</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,774</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease, Liability, Fiscal Year Maturity</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future minimum lease payments and sublease rental income are as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Finance<br/>Leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Operating<br/>Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">442</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,246</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">606</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,819</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">585</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,620</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">566</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">5,008</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2027</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">561</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,867</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,670</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">37,103</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total minimum lease payments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">4,430</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">62,663</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less amount representing interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(322)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(18,491)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Present value of net minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4,108</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">44,172</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less current maturities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(526)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Lease liabilities, less current maturities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,582</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,774</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Supplemental Balance Sheet Information Related To Leases [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387973555456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Short-Term and Long-Term Balances of Term Loan</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The short-term and long-term balances of our Term Loan and other long-term borrowings were as follows (in thousands):</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"/><td style="width:71.282%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.708%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.104%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Term Loan balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">213,188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">213,750&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Convertible Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2.45% Sparkasse Zollernalb (KFW Loan 1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">296&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1.40% Sparkasse Zollernalb (KFW Loan 2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">680&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">733&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total loan balance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">314,109</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">314,779</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less unamortized loan origination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(6,210)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(6,672)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net borrowings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">307,899&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">308,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Less short-term loan balance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(1,620)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(1,608)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Long-term loan balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">306,279</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">306,499</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387975338720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2023 and 2022 the sources of revenue were as follows (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Domestic hospitals</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,883</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">36,993</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International hospitals</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28,957</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">28,414</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">International distributors</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">12,939</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">11,064</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">CardioGenesis cardiac laser therapy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">450</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">742</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total sources of revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">83,229</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">77,213</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387975275664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Weighted-Average Assumptions Used to Determine the Fair Value of Options</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.293%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.900%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.901%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31, 2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stock Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESPP</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.5 Years</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected stock price volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">0.66</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">4.77%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Summary of Total Stock Compensation Expenses</a></td>
<td class="text"><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"><tr><td style="width:1.0%"/><td style="width:68.200%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.945%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.407%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.948%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">RSA, RSU, and PSU expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,641&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">2,768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Stock option and ESPP expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">872&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">572&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total stock compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,513</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">3,340</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387975338720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Common Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted (Loss) Income Per Common Share</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted loss per common share (in thousands, except per share data): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"><tr><td style="width:1.0%"/><td style="width:73.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.116%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic loss per common share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(13,532)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,389)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net loss allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(3,371)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,432</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,850</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Basic loss per common share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.08)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"><tr><td style="width:1.0%"/><td style="width:73.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.076%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted loss per common share</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(13,532)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">(3,389)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Net loss allocated to participating securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">60</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">18</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Net loss allocated to common shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(13,472)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(3,371)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Basic weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,432</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">39,850</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted weighted-average common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">40,432</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">39,850</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Diluted loss per common share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.33)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">(0.08)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387977179264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Revenues, Cost of Products and Services, and Gross Margins for Operating Segments</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">62,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">57,542&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">83,229</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">77,213</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Cost of products and preservation services:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">9,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total cost of products and preservation services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">29,502</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">26,494</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Gross margin:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Medical devices</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">42,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">40,134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,969&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">10,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total gross margin</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">53,727</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">50,719</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Summary of Net Revenues by Product and Service</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes net revenues by product and service (in thousands): </span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.930%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.083%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Three Months Ended<br/>March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Products:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Aortic stent grafts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">26,150</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">$</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">25,506</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">On-X</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">17,656</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">14,371</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Surgical sealants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">16,703</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">15,681</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,782</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">1,984</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total products</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">62,291</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">57,542</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">Preservation services </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">20,938</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%">19,671</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">83,229</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%">77,213</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971740448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">$ 7,154<span></span>
</td>
<td class="nump">$ 10,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ContingentConsiderationNoncurrentFairValue', window );">Contingent consideration</a></td>
<td class="num">(45,200)<span></span>
</td>
<td class="num">(40,400)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="num">(45,200)<span></span>
</td>
<td class="num">(40,400)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">7,154<span></span>
</td>
<td class="nump">10,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">7,154<span></span>
</td>
<td class="nump">10,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ContingentConsiderationNoncurrentFairValue', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">7,154<span></span>
</td>
<td class="nump">10,098<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ContingentConsiderationNoncurrentFairValue', window );">Contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ContingentConsiderationNoncurrentFairValue', window );">Contingent consideration</a></td>
<td class="num">(45,200)<span></span>
</td>
<td class="num">(40,400)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total liabilities</a></td>
<td class="num">(45,200)<span></span>
</td>
<td class="num">(40,400)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ContingentConsiderationNoncurrentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Consideration, Noncurrent, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ContingentConsiderationNoncurrentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971664032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Narrative) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 02, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase (decrease) in fair value of contingent consideration</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="num">$ (1,800)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=aort_AscyrusMedicalLlcMember', window );">Ascyrus Medical LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding equity acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh', window );">Maximum amount of future consideration payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Increase (decrease) in fair value of contingent consideration</a></td>
<td class="num">$ (4,800)<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=aort_AscyrusMedicalLlcMember', window );">Ascyrus Medical LLC | Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput', window );">Contingent consideration, measurement input</a></td>
<td class="nump">0.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure contingent consideration liability from business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=aort_AscyrusMedicalLlcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=aort_AscyrusMedicalLlcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970731616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward', window );"><strong>Contingent Consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="num">$ (40,400)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in valuation</a></td>
<td class="num">(4,800)<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="num">$ (45,200)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387976319072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and supplies</a></td>
<td class="nump">$ 36,322<span></span>
</td>
<td class="nump">$ 36,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">11,319<span></span>
</td>
<td class="nump">10,476<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">28,632<span></span>
</td>
<td class="nump">27,287<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories, net</a></td>
<td class="nump">$ 76,273<span></span>
</td>
<td class="nump">$ 74,478<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970839168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories, net and Deferred Preservation Costs (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment', window );">Consignment inventory</a></td>
<td class="nump">$ 12,700<span></span>
</td>
<td class="nump">$ 12,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DeferredPreservationCosts', window );">Deferred preservation costs, net</a></td>
<td class="nump">47,415<span></span>
</td>
<td class="nump">46,371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserve</a></td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">Domestic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ConsignmentInventoryPercentage', window );">Consignment inventory percentage</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ConsignmentInventoryPercentage', window );">Consignment inventory percentage</a></td>
<td class="nump">58.00%<span></span>
</td>
<td class="nump">59.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ConsignmentInventoryPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Consignment inventory percentage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ConsignmentInventoryPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DeferredPreservationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DeferredPreservationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387966917392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 245,648<span></span>
</td>
<td class="nump">$ 243,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process R&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Total indefinite-lived intangible assets</a></td>
<td class="nump">2,120<span></span>
</td>
<td class="nump">2,080<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember', window );">Procurement contracts and agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Total indefinite-lived intangible assets</a></td>
<td class="nump">$ 2,013<span></span>
</td>
<td class="nump">$ 2,013<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ContractualRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970819440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning balance</a></td>
<td class="nump">$ 243,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss', window );">Foreign currency translation</a></td>
<td class="nump">2,017<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending balance</a></td>
<td class="nump">$ 245,648<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillForeignCurrencyTranslationGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillForeignCurrencyTranslationGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970561424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 149,833<span></span>
</td>
<td class="nump">$ 151,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Acquired technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">200,312<span></span>
</td>
<td class="nump">198,420<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">50,479<span></span>
</td>
<td class="nump">47,157<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 149,833<span></span>
</td>
<td class="nump">$ 151,263<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">18 years 2 months 12 days<span></span>
</td>
<td class="text">18 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aort_IntangibleAssetsOtherThanAcquiredTechnologyMember', window );">Other intangibles:</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 50,631<span></span>
</td>
<td class="nump">$ 49,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">23,957<span></span>
</td>
<td class="nump">22,619<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 26,674<span></span>
</td>
<td class="nump">$ 27,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">10 years 2 months 12 days<span></span>
</td>
<td class="text">10 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember', window );">Customer lists and relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 31,068<span></span>
</td>
<td class="nump">$ 31,030<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">11,489<span></span>
</td>
<td class="nump">11,100<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 19,579<span></span>
</td>
<td class="nump">$ 19,930<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">20 years 6 months<span></span>
</td>
<td class="text">20 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember', window );">Distribution and manufacturing rights and know-how</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 9,455<span></span>
</td>
<td class="nump">$ 9,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">6,353<span></span>
</td>
<td class="nump">5,796<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 3,102<span></span>
</td>
<td class="nump">$ 3,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Patents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 4,286<span></span>
</td>
<td class="nump">$ 4,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,192<span></span>
</td>
<td class="nump">3,180<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 1,094<span></span>
</td>
<td class="nump">$ 1,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">17 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 5,822<span></span>
</td>
<td class="nump">$ 5,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,923<span></span>
</td>
<td class="nump">2,543<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Value</a></td>
<td class="nump">$ 2,899<span></span>
</td>
<td class="nump">$ 2,817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (Years)</a></td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
<td class="text">4 years 4 months 24 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aort_IntangibleAssetsOtherThanAcquiredTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=aort_IntangibleAssetsOtherThanAcquiredTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerListsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DistributionRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387973523232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 3,882<span></span>
</td>
<td class="nump">$ 4,084<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971897440">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 11,358<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2024</a></td>
<td class="nump">14,802<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2025</a></td>
<td class="nump">12,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2026</a></td>
<td class="nump">12,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2027</a></td>
<td class="nump">12,504<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2028</a></td>
<td class="nump">12,388<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate', window );">Total</a></td>
<td class="nump">$ 76,490<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the first five fiscal years following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971601232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate expense (benefit)</a></td>
<td class="nump">52.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax liability</a></td>
<td class="nump">$ 21.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowances against deferred tax assets</a></td>
<td class="nump">$ 19.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970751136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Narrative) (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other Liabilities, Current<span></span>
</td>
<td class="text">Other Liabilities, Current<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971701392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Operating leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 56,610<span></span>
</td>
<td class="nump">$ 56,061<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Accumulated amortization</a></td>
<td class="num">(15,137)<span></span>
</td>
<td class="num">(14,202)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">41,473<span></span>
</td>
<td class="nump">41,859<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current maturities of operating leases</a></td>
<td class="nump">3,398<span></span>
</td>
<td class="nump">3,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current maturities of operating leases</a></td>
<td class="nump">40,774<span></span>
</td>
<td class="nump">41,257<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">44,172<span></span>
</td>
<td class="nump">44,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Finance leases, Property and equipment, at cost</a></td>
<td class="nump">6,533<span></span>
</td>
<td class="nump">6,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Finance leases, Accumulated amortization</a></td>
<td class="num">(2,679)<span></span>
</td>
<td class="num">(2,498)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Finance leases, property and equipment, net</a></td>
<td class="nump">3,854<span></span>
</td>
<td class="nump">3,910<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Current maturities of finance leases</a></td>
<td class="nump">526<span></span>
</td>
<td class="nump">513<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Non-current maturities of finance leases</a></td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">3,644<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 4,108<span></span>
</td>
<td class="nump">$ 4,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years): Operating leases</a></td>
<td class="text">11 years 8 months 12 days<span></span>
</td>
<td class="text">11 years 10 months 24 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term (in years): Finance leases</a></td>
<td class="text">7 years 7 months 6 days<span></span>
</td>
<td class="text">7 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate: Operating leases</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">5.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate: Finance leases</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and operating lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387972320944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Summary Of Lease Costs) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of property and equipment</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest expense on finance leases</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_FinanceLeaseCost', window );">Total finance lease expense</a></td>
<td class="nump">152<span></span>
</td>
<td class="nump">162<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">1,802<span></span>
</td>
<td class="nump">1,920<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(92)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">$ 1,954<span></span>
</td>
<td class="nump">$ 1,990<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_FinanceLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of finance lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_FinanceLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971950528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 1,796<span></span>
</td>
<td class="nump">$ 1,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows for finance leases</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows for finance leases</a></td>
<td class="nump">$ 21<span></span>
</td>
<td class="nump">$ 24<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387966815888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_FinanceLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">1,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">4,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less amount representing interest</a></td>
<td class="num">(322)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of net minimum lease payments</a></td>
<td class="nump">4,108<span></span>
</td>
<td class="nump">$ 4,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less current maturities</a></td>
<td class="num">(526)<span></span>
</td>
<td class="num">(513)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Lease liabilities, less current maturities</a></td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">3,644<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">4,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">5,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">5,620<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">5,008<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">4,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">Thereafter</a></td>
<td class="nump">37,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total minimum lease payments</a></td>
<td class="nump">62,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less amount representing interest</a></td>
<td class="num">(18,491)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of net minimum lease payments</a></td>
<td class="nump">44,172<span></span>
</td>
<td class="nump">44,565<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less current maturities</a></td>
<td class="num">(3,398)<span></span>
</td>
<td class="num">(3,308)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities, less current maturities</a></td>
<td class="nump">$ 40,774<span></span>
</td>
<td class="nump">$ 41,257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_FinanceLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_FinanceLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387964989792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 19, 2022</div></th>
<th class="th">
<div>Jun. 02, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th">
<div>Jun. 18, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>day</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 01, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Secured term loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 314,109,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 314,779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,899,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">308,107,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,100,000<span></span>
</td>
<td class="nump">$ 3,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 361,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Debt extinguishment costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 474,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aort_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants', window );">Revolving credit facility, percentage repaid for no covenants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on amounts borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 96,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0426203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Debt fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Senior Notes | Circumstance I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Conversion consecutive trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion percentage of stock price threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Senior Notes | Circumstance II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Conversion consecutive trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion percentage of stock price threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Senior Notes | Circumstance After July 5, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays', window );">Conversion trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Conversion consecutive trading day threshold | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Conversion percentage of stock price threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount', window );">Conversion percentage of principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Secured term loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 213,188,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">213,750,000<span></span>
</td>
<td class="nump">$ 225,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance | Credit Agreement | Circumstance I</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DebtInstrumentExtensionCircumstancePeriod', window );">Debt instrument, extension circumstance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">91 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance | Credit Agreement | Circumstance II</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DebtInstrumentExtensionCircumstancePeriod', window );">Debt instrument, extension circumstance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">182 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance | Base Rate | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance | LIBOR | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility aggregate commitments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit facility margin</a></td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember', window );">Revolving Credit Facility And Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of the debt issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember', window );">Revolving Credit Facility And Term Loan | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Secured term loan facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 255,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_DebtInstrumentExtensionPeriod', window );">Debt instrument, extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.66%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember', window );">Revolving Credit Facility And Term Loan | Convertible Senior Notes | Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on amounts borrowed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member', window );">Accounting Standards Update 2020-06 | Cumulative Effect, Period of Adoption, Adjustment | Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Redemption Percentage Of Principal Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtInstrumentExtensionCircumstancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, extension circumstance period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtInstrumentExtensionCircumstancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtInstrumentExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt instrument, extension period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtInstrumentExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revolving Credit Facility, Percentage Repaid for No Covenants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031898-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69F<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495745-112612<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aort_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aort_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtPeriodAxis=aort_CircumstanceIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtPeriodAxis=aort_CircumstanceIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtPeriodAxis=aort_CircumstanceIiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtPeriodAxis=aort_CircumstanceIiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_DebtPeriodAxis=aort_CircumstanceAfterJuly52023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_DebtPeriodAxis=aort_CircumstanceAfterJuly52023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aort_RevolvingCreditFacilityAndTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate202006Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CumulativeEffectPeriodOfAdoptionAxis=srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387972314416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 01, 2017</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 314,109<span></span>
</td>
<td class="nump">$ 314,779<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Less unamortized loan origination costs</a></td>
<td class="num">(6,210)<span></span>
</td>
<td class="num">(6,672)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net borrowings</a></td>
<td class="nump">307,899<span></span>
</td>
<td class="nump">308,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less short-term loan balance</a></td>
<td class="num">(1,620)<span></span>
</td>
<td class="num">(1,608)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term loan balance</a></td>
<td class="nump">306,279<span></span>
</td>
<td class="nump">306,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan1Member', window );">2.45% Sparkasse Zollernalb (KFW Loan 1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on amounts borrowed</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan2Member', window );">1.40% Sparkasse Zollernalb (KFW Loan 2)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 680<span></span>
</td>
<td class="nump">733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on amounts borrowed</a></td>
<td class="nump">1.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember', window );">Term Loan balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 213,188<span></span>
</td>
<td class="nump">213,750<span></span>
</td>
<td class="nump">$ 225,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_ConvertibleDebtMember', window );">Convertible Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total loan balance</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=aort_GovernmentSponsoredDebtKfwLoan2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LoansPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970711280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Disaggregation Of Revenue) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">$ 83,229<span></span>
</td>
<td class="nump">$ 77,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_DomesticHospitalsMember', window );">Domestic hospitals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">40,883<span></span>
</td>
<td class="nump">36,993<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_InternationalHospitalsMember', window );">International hospitals</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">28,957<span></span>
</td>
<td class="nump">28,414<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_InternationalDistributorMember', window );">International distributors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">12,939<span></span>
</td>
<td class="nump">11,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_CardiogenesisMember', window );">CardioGenesis cardiac laser therapy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total sources of revenue</a></td>
<td class="nump">$ 450<span></span>
</td>
<td class="nump">$ 742<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_DomesticHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_DomesticHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_InternationalHospitalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_InternationalHospitalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_InternationalDistributorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_InternationalDistributorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_CardiogenesisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_CardiogenesisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387964901344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation (Narrative) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized stock compensation expense</a></td>
<td class="nump">$ 172<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">ESPP, percentage of market price for eligible employees</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Employee stock purchase plan (in shares)</a></td>
<td class="nump">56,000<span></span>
</td>
<td class="nump">37,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=aort_RestrictedStockUnitsAndPreferredStockUnitsMember', window );">RSUs And PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Authorized awards from approved stock incentive plans (in shares)</a></td>
<td class="nump">376,000<span></span>
</td>
<td class="nump">452,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted', window );">Aggregate grant date market value</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="nump">$ 8,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_OfficerMember', window );">Officers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Grants of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Market value of share based compensation arrangement by share based payment award other than options granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=aort_RestrictedStockUnitsAndPreferredStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=aort_RestrictedStockUnitsAndPreferredStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_OfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_OfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970742688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details) - ESPP<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility</a></td>
<td class="nump">66.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.77%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387971305600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock compensation expense</a></td>
<td class="nump">$ 3,513<span></span>
</td>
<td class="nump">$ 3,340<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember', window );">RSA, RSU, and PSU expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock compensation expense</a></td>
<td class="nump">2,641<span></span>
</td>
<td class="nump">2,768<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember', window );">Stock option and ESPP expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1', window );">Total stock compensation expense</a></td>
<td class="nump">$ 872<span></span>
</td>
<td class="nump">$ 572<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost expensed and capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387966903152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loss Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract', window );"><strong>Basic loss per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (13,532)<span></span>
</td>
<td class="num">$ (3,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Net loss allocated to participating securities</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss allocated to common shareholders</a></td>
<td class="num">$ (13,472)<span></span>
</td>
<td class="num">$ (3,371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">40,432<span></span>
</td>
<td class="nump">39,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic loss per common share (in usd per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Diluted loss per common share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (13,532)<span></span>
</td>
<td class="num">$ (3,389)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Net loss allocated to participating securities</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss allocated to common shareholders</a></td>
<td class="num">$ (13,472)<span></span>
</td>
<td class="num">$ (3,371)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">40,432<span></span>
</td>
<td class="nump">39,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted-average common shares outstanding (in shares)</a></td>
<td class="nump">40,432<span></span>
</td>
<td class="nump">39,850<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted loss per common share (in usd per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.08)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387970816704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Narrative) (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment Eliminations</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Intersegment revenues | $</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387966763552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 83,229<span></span>
</td>
<td class="nump">$ 77,213<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">29,502<span></span>
</td>
<td class="nump">26,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross margin</a></td>
<td class="nump">53,727<span></span>
</td>
<td class="nump">50,719<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aort_MedicalDevicesMember', window );">Medical devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">62,291<span></span>
</td>
<td class="nump">57,542<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">19,533<span></span>
</td>
<td class="nump">17,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross margin</a></td>
<td class="nump">42,758<span></span>
</td>
<td class="nump">40,134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=aort_PreservationServicesMember', window );">Preservation services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">20,938<span></span>
</td>
<td class="nump">19,671<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Total cost of products and preservation services</a></td>
<td class="nump">9,969<span></span>
</td>
<td class="nump">9,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Total gross margin</a></td>
<td class="nump">$ 10,969<span></span>
</td>
<td class="nump">$ 10,585<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=aort_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=aort_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=aort_PreservationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=aort_PreservationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387966696160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Summary Of Net Revenues By Product And Service) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 83,229<span></span>
</td>
<td class="nump">$ 77,213<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_ProductsMember', window );">Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">62,291<span></span>
</td>
<td class="nump">57,542<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_AorticStentGraftsMember', window );">Aortic stent grafts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">26,150<span></span>
</td>
<td class="nump">25,506<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_OnXMember', window );">On-X</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">17,656<span></span>
</td>
<td class="nump">14,371<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_SurgicalSealantsMember', window );">Surgical sealants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">16,703<span></span>
</td>
<td class="nump">15,681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_OtherProductsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">1,782<span></span>
</td>
<td class="nump">1,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aort_PreservationServicesMember', window );">Preservation services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductInformationLineItems', window );"><strong>Product Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenues</a></td>
<td class="nump">$ 20,938<span></span>
</td>
<td class="nump">$ 19,671<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_ProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_ProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_AorticStentGraftsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_AorticStentGraftsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_OnXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_OnXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_SurgicalSealantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_SurgicalSealantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_OtherProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_OtherProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aort_PreservationServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aort_PreservationServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140387972303360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Apr. 16, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 11, 2019 </div>
<div>USD ($) </div>
<div>tranche</div>
</th>
<th class="th">
<div>Sep. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_NumberOfTranches', window );">Number of tranches | tranche</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche', window );">Per three tranches of funding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_FundedTranchePaymentPerAgreement', window );">Funded second tranche payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients', window );">Required percentage of number of patients before third tranche of loan funding can be acquired</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aort_ThirdTranchePayment', window );">Third tranche payment</a></td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable Interest Entity, Primary Beneficiary | Secured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loan provided</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_FundedTranchePaymentPerAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Funded Tranche Payment Per Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_FundedTranchePaymentPerAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Third Tranche Of Funding For Secured Loan, Minimum Percentage Of Required Number Of Patients</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ThirdTranchePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Third Tranche Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ThirdTranchePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aort_ThreeTranchesOfFundingForSecuredLoanPerTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Three Tranches Of Funding For Secured Loan Per Tranche</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aort_ThreeTranchesOfFundingForSecuredLoanPerTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aort_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>aort-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aort="http://www.cryolife.com/20230331"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aort-20230331.xsd" xlink:type="simple"/>
    <context id="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i7835c64896c44c22ac5cc78e13028978_I20230428">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2023-04-28</instant>
        </period>
    </context>
    <context id="i1ae3a909430949bd90a175d270eb249f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i979c20305ec145afbd438a672f317ec1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:ProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic5cf4550d1e64e08a695b28c0c89be0e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="if1c72bde95b6478d85567313998b4435_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idc54f5a9f8964a9eac3519cb41b6887b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id34f77b2e87c4767bbb2e6a239ed82d3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i684ce4d481204a1aad79ec17a22ca9cc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8906191b80d94b2cb337250ebd00ffe4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0d4870864b08435ba93e18e414576db4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia20c6db1b736414388dabc9465f16d8e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i314c30b8aff54268bfed28a9c6beccd1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie7766a77cc4e4f6c80f140d23c8e7323_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie07dff7c65f54941b40235f8253ee52f_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id7529137f6374134ba29f2ac0fc74e1a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i261405fc086646eab594dad856c5d0ea_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia1f0e19f9d2846e8836488a6f5034a54_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic0611add9d054ed19bdf0000b33535f2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i371e868a09e8420ca81b51ae2ded7735_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i80ee1b53042f49daa8481c6a55b7f28d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="iba4345bc04bc4fd0b009820cbf10edda_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i6a9f88cb8b244d1f8d88193d41aee37f_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice4c3a2465c545898bd620a0413d3832_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib03cb376e30e462b9363c3c0bf7170c4_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="id19300d854664ca394ffabc2a495b2e5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iccd5df30d43d4a12952dc6138272e270_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib8256b73459843e0aaf032088b5f7f90_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i572ac13fae7e4dafbdaa8efdf37bea7f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ied76502fccf6460e89333e749c743f0e_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id42a947477504a9f9a4328bba9370244_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib659527ecee343bc87c222d16f27cd19_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i898f1ad5afdf4d8f9d86cd812ca5514c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iaf6b10a5a1ad4e50a4bc84b969e56728_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i99a5bc1a71c34a1b9e0b212e75b8f3c8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i7ffb145f12444931806dfef0dd45ec75_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0e538adb023b42dba22d620e4792eb34_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9897803022524b6b83398955223e2444_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i16e5777fa0694cc18917f184d3087f01_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ic6b549ee865943d6855f63e539a42cc5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia60a357239894830b1528f32f19aaf03_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icef1a873474b47e7b3ee0e7be4ef40b8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="icb10dd17357d43dfb35870e5456e7882_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i53c72e2891b643879b972b1f3ceb58fe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if63692cacc3a445dacf59c9a1047dd06_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if66fb22ae36440dab8fe8254cd95ffb1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5a5e9956c83a49c0b5cac54ad6a7f263_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4bd3bfffc6a2457bba90e050e14c2e58_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib98547abf55f42c59aefaa0f6d22fe1b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i71edbd22e4cf42339603deb7cbeac930_I20200902">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-02</instant>
        </period>
    </context>
    <context id="i77a16d00eb08404da8ae5de65c51f748_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9f174cecb39e48b9af65991c55af673a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie59b048c0d4b4b56a468429d5b300520_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">aort:AscyrusMedicalLlcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i08c0ea5c117b4dfeb0384a9e1247a5b9_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i26fcb04471584b5ea9d699972f9aa939_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i03f86365100d412b8f424f38d54c35d2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i330d4af7abf24d219bcf5d1880f8fc1e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2c6dba73291e448e8f57ab1bc8a6db08_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i79506f115b764903b5b77aff6438f481_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie93b31b47b134081a15dded0e238e7c8_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="idfdcdca476ee4794a47f75b9b0908a9f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ContractualRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4136c9e254424e49b35b6472a39e43cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i4a48d6cb9ff746b094b85d9a721d7be5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8dd274f665ea4e7683e9b456604be8cf_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7c38d20648d74b51a72771f63edb7c84_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i31c830db6dc5484fad7ab16e160c2aff_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if024f14950384826b773eb09bb2b089c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8a2765316f314fceb7d349c3f5a72808_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia4c9d1fe9fed440d85fc4a9e9e993bd5_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i66f8ed83f3d44b89bdc1f649e920bcad_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i52d7e0b1e38944d8b119d3830e7326b9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idf585199079741d2ad24baa4508e7b79_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i225c6055e6e34ecc8ff6267a3e5c52cb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3e7ccf2f59bf4c329c1dd9a597525246_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1a6a965e9f9b4929b0346378e7446b64_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ic3329eed5890493eaa1e7419306565e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id934e39711ff42389941ee999e64276a_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerListsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i261990d377b24cd39e6196259557695b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i34a04e6aff414a2493a8ecbef5858fb2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DistributionRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idcb5f46ffb5a46dba6a079186a59afa2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i78d3a75cb5e242e999b5d7a86b03fb8c_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie3b14dd7eb30490fab897cf536448da7_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9f4a2ffeb0704db5bbaba540ed9732b7_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i1555b8edf0a442659291ed6e92593f09_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idc88d943c8ff4e8d852e826c95138da2_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">aort:IntangibleAssetsOtherThanAcquiredTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i65f995e36b114f65a815c61bd66eb185_I20171201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-01</instant>
        </period>
    </context>
    <context id="i1f57c4f591b04b389e472914c7195492_I20171201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-01</instant>
        </period>
    </context>
    <context id="ic4c41e2ba6794170b867018c3fdc30de_I20171201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-01</instant>
        </period>
    </context>
    <context id="ia34bdcd0d6c84be4827773cf070dbfa6_I20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-02</instant>
        </period>
    </context>
    <context id="ideecae1179894ead84a8360473c0cd9d_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="ia668b5ef64df4c60b5d51cbb5b636f5d_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i45eb9ce0dbf4431780b0e06047ccab97_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i7c108b384b6c4ed9a50513917888bcb4_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="ied0df1c4e0394f72aa46bda78244dc54_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="i1e0b9fb023d14f00a03ee59906304080_D20210601-20210601">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="ieed7b0b097e2498496903c8c4c67c075_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i7bfa2fe6123047d79b18fc3d9809b3a6_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i5fd78494bf304f19b2f857c42b606fbc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i662e0658aa8247cd94c867b2227ab80a_D20221219-20221219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <context id="id234474f9a60494f90af8c621f315f96_D20221219-20221219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <context id="i19a8334307424620aa3c250d4ca58b1b_D20221219-20221219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-12-19</startDate>
            <endDate>2022-12-19</endDate>
        </period>
    </context>
    <context id="i782ff58a89804bf0b00b3bdac6676855_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia3124cad286644aab11fa66ae00f4ef1_I20200618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-18</instant>
        </period>
    </context>
    <context id="id7abca8345f249998cb27b9c944935cc_D20200618-20200618">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-18</startDate>
            <endDate>2020-06-18</endDate>
        </period>
    </context>
    <context id="i5fb16f084b93484db1e521afa59177ff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icb07d4b1080c4319a548201e2649918b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate202006Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia1abb3e2cea84ab7abd42b17a5446166_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i8df2957838504948bdf1f9a293198c26_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icdbd0ff6519a49e0a3512380762dc454_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i55c6d9dae4af45268902f43249c1803c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i936177e90cbd4e0b9837af78bc6af1ad_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i245d6adca68f4145ad5ff6862bb500d7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceIiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="aort:DebtPeriodAxis">aort:CircumstanceAfterJuly52023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i34b6700b45d349109d8e1e8318e1f9d0_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i330928a666a2457b8aec74cf41920829_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LoansPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4d1d1110dd9c4c4ea0509148da8595ea_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i65a4c670870a4d9f8805dd18a1e03eff_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ee531be8b494d88bc9356fd017a9774_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if6292b6052bc40909d1a2f96522bdb4f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9cadf7c14ba34a48bad3de79cb43a15f_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i17368e8c263742ae9eac5e48717b6911_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">aort:GovernmentSponsoredDebtKfwLoan2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ica3af079dd144cbfa68005cf48df464f_D20210602-20210602">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aort:RevolvingCreditFacilityAndTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aort:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-02</startDate>
            <endDate>2021-06-02</endDate>
        </period>
    </context>
    <context id="i6765ee8c4e514375bf2377f15526dbbc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5e02717d99e84bc08078c02ad4f2d3ab_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:DomesticHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i82de625935f54b34bbb5e4589a1fc149_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="idf63598993c849b9a81d477b9517fc7c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalHospitalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib9af7b4096844040ad375baefedff835_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ic8a7f94f926946f1b329419bb02b1cf7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:InternationalDistributorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9490fb1e6a364e808b33e4f022177191_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ide1a4c016001405a9f9e00487555dcea_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:CardiogenesisMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="id3cbd678f84346a6bd714e53648d0ce7_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockUnitsAndPreferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1e96a5da80644389a43614a81619129f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockUnitsAndPreferredStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib35623233c83476c8ae2823d953479ac_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:OfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie87171075e7c46b3a5e2f515abfa3038_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i46dae3eb2d6d4db5b3282cd30f4eb3b9_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i39bfa788f29c453e8e82fca1bd97483c_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if1fbc6109379459ab9d95037d44ee0bc_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i20695d53f4ce4fe6a0127135b2d1f023_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">aort:StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i24d764c46d944801885c59dde6cec14b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icb6dc10bc7ed4b5492b4ae7557ed2a02_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i350257931547498a908d5663ff901b70_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iaade080667b34ceaa2d4b4d14761568d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">aort:PreservationServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0d27f99bdef34490ab29648e4ece9919_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4e3f19c886f3413fb86666f3e6eb9394_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:AorticStentGraftsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i88ac222b2f944d15bd71802bc159841a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4cc9e6e0e71d487eaa136ec7431e6ce6_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OnXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icfa08b9642074e35bc71304309d137aa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib0b90e8de9b7458c9afe003e4bad474a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:SurgicalSealantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie2d424b22c484323a8479a4346ad4545_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i4337b65585504d8bbb937a66cdd29f5b_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aort:OtherProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icf3dcedf29fb4d59856021f6832683f4_I20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-11</instant>
        </period>
    </context>
    <context id="ie06473170a934a1f8ba18b66bd8feeb5_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="i2b7e03d58c2d4458be09a447fde2288f_D20190911-20190911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-11</startDate>
            <endDate>2019-09-11</endDate>
        </period>
    </context>
    <context id="i6093549b9fc14acc8ec2494386cd4ca5_D20200901-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i0ed7688ddb8243768813e25604041962_D20230416-20230416">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000784199</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-16</startDate>
            <endDate>2023-04-16</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="day">
        <measure>aort:day</measure>
    </unit>
    <unit id="segment">
        <measure>aort:segment</measure>
    </unit>
    <unit id="tranche">
        <measure>aort:tranche</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV8yLTEtMS0xLTU0OTkz_e1c6021e-bd51-469b-9f90-57f9717b5b2d">0000784199</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV8zLTEtMS0xLTU0OTkz_cad3afa7-714b-4aa9-8846-5ce7deb21874">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV80LTEtMS0xLTU0OTkz_0f19baec-a1c7-4049-bb37-524c2d1bc9f7">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV81LTEtMS0xLTU0OTkz_b035c50c-d137-4f97-948b-7fb550a92dd6">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180L2ZyYWc6MjVlNGU0ODRhYzRkNGNiODllMDY0MTBkMDgwNTBjN2UvdGFibGU6ODlmYmZiZjI5YWQyNDEzMGIwMDc2ODcyNTUxM2NmMTkvdGFibGVyYW5nZTo4OWZiZmJmMjlhZDI0MTMwYjAwNzY4NzI1NTEzY2YxOV82LTEtMS0xLTU0OTkz_ff09f6e2-d9b8-4e92-8e51-2e50ef553040">false</dei:AmendmentFlag>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_2e5b36fd-c488-467a-a7e5-80e362ee1e08">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_c3cbd70e-0a04-4d24-ab66-5fb27dcd22e3">http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <aort:DebtInstrumentExtensionPeriod
      contextRef="ica3af079dd144cbfa68005cf48df464f_D20210602-20210602"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181OC9mcmFnOjAxMjNlMjNkYmNkYzRjNTVhZjgyOTBjMjU5MTAxZWU2L3RhYmxlOmNmNDk5NDRlZWMyMjQwMGRiYjJlNDQ5MmYwNGYxMWIxL3RhYmxlcmFuZ2U6Y2Y0OTk0NGVlYzIyNDAwZGJiMmU0NDkyZjA0ZjExYjFfMi0xLTEtMS01NDk5Mw_071e48f5-8e91-4854-9d7b-dd43e689db4c">P2Y6M</aort:DebtInstrumentExtensionPeriod>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1
      contextRef="id7abca8345f249998cb27b9c944935cc_D20200618-20200618"
      decimals="7"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181OC9mcmFnOjAxMjNlMjNkYmNkYzRjNTVhZjgyOTBjMjU5MTAxZWU2L3RhYmxlOmNmNDk5NDRlZWMyMjQwMGRiYjJlNDQ5MmYwNGYxMWIxL3RhYmxlcmFuZ2U6Y2Y0OTk0NGVlYzIyNDAwZGJiMmU0NDkyZjA0ZjExYjFfMy0xLTEtMS01NDk5Mw_df6675bd-2a85-450c-a4c9-c9a4e28a79cc"
      unitRef="number">0.0426203</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <dei:DocumentType
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ1_b65f0aea-69b6-45fa-93b4-c062b5bedba6">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ2_4cb6f8ca-b8b5-44c9-a16e-c5fb979f2f28">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8xMDk5NTExNjI5OTYz_816c4c52-6978-4976-9069-f2e401ac399a">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ3_939f2a8a-638a-4968-8a69-3931c5dc0fc0">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQw_fab1693c-5d43-4840-a215-691365ac46ff">1-13165</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQx_4ce310d1-1a6e-4d4d-80b0-a8e560f12e82">ARTIVION, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18wLTAtMS0xLTU0OTkz_d5bd344e-46d1-40ff-8fb4-eb356bbc0a11">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18wLTItMS0xLTU0OTkz_e4188672-ef05-4c3c-adbb-7c996369e6cc">59-2417093</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18zLTAtMS0xLTU0OTkzL3RleHRyZWdpb246NmViMTNkNDg3NDMwNDk2Mjg2NzNmZjliOTljYjJhYTZfNA_31db9412-6bb3-430e-9ae0-b61bc7e8d04b">1655 Roberts Boulevard, NW</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18zLTAtMS0xLTU0OTkzL3RleHRyZWdpb246NmViMTNkNDg3NDMwNDk2Mjg2NzNmZjliOTljYjJhYTZfOA_0d057aab-fc61-4a34-9b47-adc499891e9d">Kennesaw</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18zLTAtMS0xLTU0OTkzL3RleHRyZWdpb246NmViMTNkNDg3NDMwNDk2Mjg2NzNmZjliOTljYjJhYTZfMTI_c9134897-77dd-4887-9305-3caf6c0b8cb1">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6MWZhM2ZmNGE2ZjY1NDFkYmJiN2IwMzFhZTBkYzRmZDcvdGFibGVyYW5nZToxZmEzZmY0YTZmNjU0MWRiYmI3YjAzMWFlMGRjNGZkN18zLTItMS0xLTU0OTkz_ba40943e-3ff5-4eda-a4ae-de7a4fcb3c63">30144</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQy_01879642-0e4d-426a-99dd-ddacb6f81efd">770</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ4_3db44940-28a3-4738-9ed9-c817d38c35e9">419-3355</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NmYxZDliYTFhZjIyNDI0M2IzMjRhODcwMzMxODlhMGYvdGFibGVyYW5nZTo2ZjFkOWJhMWFmMjI0MjQzYjMyNGE4NzAzMzE4OWEwZl8xLTAtMS0xLTU0OTkz_1963ec39-d913-43bd-b34f-551525fb92d6">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NmYxZDliYTFhZjIyNDI0M2IzMjRhODcwMzMxODlhMGYvdGFibGVyYW5nZTo2ZjFkOWJhMWFmMjI0MjQzYjMyNGE4NzAzMzE4OWEwZl8xLTEtMS0xLTU0OTkz_053d7063-364e-4f58-8f2d-f7341b4e311b">AORT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NmYxZDliYTFhZjIyNDI0M2IzMjRhODcwMzMxODlhMGYvdGFibGVyYW5nZTo2ZjFkOWJhMWFmMjI0MjQzYjMyNGE4NzAzMzE4OWEwZl8xLTItMS0xLTU0OTkz_d7f60acf-c8a1-4771-8077-cdfc99fc062a">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ5_21864cc1-557c-442c-b1fb-eb1330e79e52">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTUx_c0e13f3a-0342-4d00-acee-151419ebad31">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NDBkMTg2MjI3ZTk2NDc2ZDliYThlMGNiODg2OGM0NGUvdGFibGVyYW5nZTo0MGQxODYyMjdlOTY0NzZkOWJhOGUwY2I4ODY4YzQ0ZV8wLTEtMS0xLTU0OTkzL3RleHRyZWdpb246MmUyOGJhYTk3Mjk3NDAwZWFhNGY4MTU4Y2YwYjkzNWFfNA_9dfd1e87-67a0-4aaa-8a2c-5a24bc3f4130">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NDBkMTg2MjI3ZTk2NDc2ZDliYThlMGNiODg2OGM0NGUvdGFibGVyYW5nZTo0MGQxODYyMjdlOTY0NzZkOWJhOGUwY2I4ODY4YzQ0ZV8xLTQtMS0xLTU0OTkz_aed7032f-fde5-4bd3-bd28-d90430a5b286">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6NDBkMTg2MjI3ZTk2NDc2ZDliYThlMGNiODg2OGM0NGUvdGFibGVyYW5nZTo0MGQxODYyMjdlOTY0NzZkOWJhOGUwY2I4ODY4YzQ0ZV8yLTQtMS0xLTU0OTkz_feb0091e-89cd-4b36-a5eb-06701105ab1c">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGV4dHJlZ2lvbjo2ZGYzYmQ3MGM4MDE0OWY3OWFkZDFjMDA2ZjgzOTRiNF8yMTQ0_90167882-14b9-4a08-8924-d8f0d48ad0c7">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i7835c64896c44c22ac5cc78e13028978_I20230428"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xL2ZyYWc6NmRmM2JkNzBjODAxNDlmNzlhZGQxYzAwNmY4Mzk0YjQvdGFibGU6ODVhN2M1ODc2ZDFkNDBkNTg5MmY3NzdlODA0MTk5OTIvdGFibGVyYW5nZTo4NWE3YzU4NzZkMWQ0MGQ1ODkyZjc3N2U4MDQxOTk5Ml8xLTItMS0xLTU0OTkz_1ffc6311-2208-4fbb-ac94-7a7b73aa0bd6"
      unitRef="shares">40875444</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ae3a909430949bd90a175d270eb249f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMy0xLTEtMS01NDk5Mw_184c1d76-8ee1-44c1-8698-b612a4a0da6a"
      unitRef="usd">62291000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i979c20305ec145afbd438a672f317ec1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMy0zLTEtMS01NDk5Mw_adbf9203-2489-4a1c-9338-6e7db6abd4b6"
      unitRef="usd">57542000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5cf4550d1e64e08a695b28c0c89be0e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNC0xLTEtMS01NDk5Mw_c9e2171f-3e89-4195-abf5-f99d70ff4912"
      unitRef="usd">20938000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1c72bde95b6478d85567313998b4435_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNC0zLTEtMS01NDk5Mw_e0e3f455-59e0-4d4e-bd73-95a3017872c7"
      unitRef="usd">19671000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNS0xLTEtMS01NDk5Mw_cfe55018-018f-4756-b93f-a9971137cc9c"
      unitRef="usd">83229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNS0zLTEtMS01NDk5Mw_4f87c967-a16e-46dc-bd0e-935f7b5d7c00"
      unitRef="usd">77213000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1ae3a909430949bd90a175d270eb249f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfOC0xLTEtMS01NDk5Mw_1ebca0c2-e1c7-4214-951c-0c17858eaa36"
      unitRef="usd">19533000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i979c20305ec145afbd438a672f317ec1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfOC0zLTEtMS01NDk5Mw_56c89e94-f65d-4e90-bdb8-b64ba2ee1aa3"
      unitRef="usd">17408000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic5cf4550d1e64e08a695b28c0c89be0e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfOS0xLTEtMS01NDk5Mw_a500463a-c82d-4bc0-ab2e-6c25fcebe5a4"
      unitRef="usd">9969000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if1c72bde95b6478d85567313998b4435_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfOS0zLTEtMS01NDk5Mw_0b3a6c8f-4df6-4391-9116-9e1f732273c2"
      unitRef="usd">9086000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTAtMS0xLTEtNTQ5OTM_14bb03c4-19c2-4c14-8030-1f1f0f648d4b"
      unitRef="usd">29502000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTAtMy0xLTEtNTQ5OTM_9446488b-93f8-41ae-b759-31f971ea114d"
      unitRef="usd">26494000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTItMS0xLTEtNTQ5OTM_70b06b60-b242-4b41-b6dc-a0f23534c6e6"
      unitRef="usd">53727000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTItMy0xLTEtNTQ5OTM_dd63dc9f-b2ec-416e-8544-d2083ef39370"
      unitRef="usd">50719000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTUtMS0xLTEtNTQ5OTM_367eeb52-1c63-4247-895b-36bad5902c32"
      unitRef="usd">50365000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTUtMy0xLTEtNTQ5OTM_14c6ac6f-3590-4bf6-913c-c005b5e28922"
      unitRef="usd">38955000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTYtMS0xLTEtNTQ5OTM_407d123a-085d-4acc-9fdd-dd433bc4c786"
      unitRef="usd">7223000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTYtMy0xLTEtNTQ5OTM_927d3701-8dfb-4cbf-a21a-b204b78e0785"
      unitRef="usd">10128000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTctMS0xLTEtNTQ5OTM_7a6559a2-42dc-4648-bb4e-c3e16e44dc59"
      unitRef="usd">57588000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTctMy0xLTEtNTQ5OTM_85954b8c-4b29-4b49-996e-0f170ba35a7e"
      unitRef="usd">49083000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTktMS0xLTEtNTQ5OTM_0504444d-b9d5-4dd7-9bfc-c64a40bdf7d9"
      unitRef="usd">-3861000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMTktMy0xLTEtNTQ5OTM_e11424b3-ca0f-48f0-a81e-9cd38e9ff83a"
      unitRef="usd">1636000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpense
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjEtMS0xLTEtNTQ5OTM_338efd1f-325d-484f-9887-a02f8b8c685d"
      unitRef="usd">6096000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjEtMy0xLTEtNTQ5OTM_4f3f189d-68bb-4d09-9e01-29a138e3016e"
      unitRef="usd">3948000</us-gaap:InterestExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjItMS0xLTEtNTQ5OTM_da19086b-5a3c-471b-9883-4a3905c6ed0f"
      unitRef="usd">75000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjItMy0xLTEtNTQ5OTM_69a99a6b-1375-4699-beee-da0c5aff472d"
      unitRef="usd">16000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjMtMS0xLTEtNTQ5OTM_65168206-4493-439c-bf9c-64c60f2c1a92"
      unitRef="usd">963000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjMtMy0xLTEtNTQ5OTM_6fc4a77d-0772-4a7e-b15f-c68ed060387f"
      unitRef="usd">-133000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjUtMS0xLTEtNTQ5OTM_f6b4cb9d-6e6f-4a49-a9bb-3d04647c8036"
      unitRef="usd">-8919000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjUtMy0xLTEtNTQ5OTM_7d3ffeb7-dce7-4bd1-9034-948bb4bf0eb4"
      unitRef="usd">-2429000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjYtMS0xLTEtNTQ5OTM_d2ac711e-2728-4c11-9571-4ea61b0f8364"
      unitRef="usd">4613000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjYtMy0xLTEtNTQ5OTM_fa03f4d0-be62-4c41-96cf-3bc165406303"
      unitRef="usd">960000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjgtMS0xLTEtNTQ5OTM_40060c90-1151-458e-b526-eddece2daa58"
      unitRef="usd">-13532000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMjgtMy0xLTEtNTQ5OTM_301fd401-d117-4b65-a51c-f6eb3891d7c9"
      unitRef="usd">-3389000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzEtMS0xLTEtNTQ5OTM_37271a5a-9d8b-4d3b-a72b-755110195c96"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzEtMy0xLTEtNTQ5OTM_4b4bf364-0058-4508-b731-a87276d59d8d"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzItMS0xLTEtNTQ5OTM_24c178e9-e71f-4a35-a12e-656a6a1a1b5b"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzItMy0xLTEtNTQ5OTM_f1991c21-11ee-4ab5-af0b-ac75a8e1ab4b"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzUtMS0xLTEtNTQ5OTM_33178973-4f69-42c0-bc84-2299adcea1b3"
      unitRef="shares">40432000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzUtMy0xLTEtNTQ5OTM_3afd25f4-4e8b-42bf-b6c3-d7821634d9b6"
      unitRef="shares">39850000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzYtMS0xLTEtNTQ5OTM_34a9f06a-4efa-481d-a10b-609a6d934c86"
      unitRef="shares">40432000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzYtMy0xLTEtNTQ5OTM_cad59af5-ce3c-4692-835b-3ad4a554adf0"
      unitRef="shares">39850000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzgtMS0xLTEtNTQ5OTM_20ab3e06-6c7b-4c89-9170-22437425c997"
      unitRef="usd">-13532000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfMzgtMy0xLTEtNTQ5OTM_b7113e76-efc7-430a-969e-a36055f0dbb1"
      unitRef="usd">-3389000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNDAtMS0xLTEtNTQ5OTM_94170091-ec26-4fa3-87d0-4399695069a5"
      unitRef="usd">3616000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNDAtMy0xLTEtNTQ5OTM_66a112ef-b743-442f-92dd-a04cd81ca3d6"
      unitRef="usd">-3775000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNDEtMS0xLTEtNTQ5OTM_90d87f2e-ab36-46f9-b909-408c3d00474b"
      unitRef="usd">-9916000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xNi9mcmFnOmJmODI0YWE1ZTgwNTQ2MzhhMjQ3NDVhMTU3MmJiZjA3L3RhYmxlOjMxOTM2Mjk2MTFmMDQyNjNhODA4MjIwNjhhMGVjNTRlL3RhYmxlcmFuZ2U6MzE5MzYyOTYxMWYwNDI2M2E4MDgyMjA2OGEwZWM1NGVfNDEtMy0xLTEtNTQ5OTM_0792ad44-2268-46d3-acda-1cdbe332ad02"
      unitRef="usd">-7164000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNC0xLTEtMS01NDk5Mw_e05d1842-6cd9-4077-ba5a-905a2fc7ab53"
      unitRef="usd">30773000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNC0zLTEtMS01NDk5Mw_80acd703-d884-489e-bcbd-07aa46d1afae"
      unitRef="usd">39351000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNS0xLTEtMS01NDk5Mw_ff337c29-13c2-49fc-bbda-551c40fafffd"
      unitRef="usd">62760000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNS0zLTEtMS01NDk5Mw_080ed72b-39a5-49d7-932a-6a927d63a373"
      unitRef="usd">61820000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNi0xLTEtMS01NDk5Mw_7e055cf9-3b55-4cd8-9909-024332172413"
      unitRef="usd">3952000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNi0zLTEtMS01NDk5Mw_89258b18-d366-4794-a5d5-9231cbd6cbdf"
      unitRef="usd">7764000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNy0xLTEtMS01NDk5Mw_2808aa23-1fb5-4c69-a19c-0ece6fb204ff"
      unitRef="usd">76273000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNy0zLTEtMS01NDk5Mw_67b22c83-22f3-4500-8029-b061e7397a1b"
      unitRef="usd">74478000</us-gaap:InventoryNet>
    <aort:DeferredPreservationCosts
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfOC0xLTEtMS01NDk5Mw_6768f1a5-a96c-4527-b46d-9da0ed192808"
      unitRef="usd">47415000</aort:DeferredPreservationCosts>
    <aort:DeferredPreservationCosts
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfOC0zLTEtMS01NDk5Mw_c9ed2780-5eca-4fe1-a5c6-d1916f6196c6"
      unitRef="usd">46371000</aort:DeferredPreservationCosts>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfOS0xLTEtMS01NDk5Mw_6d0c6de3-f1d0-42c7-b9ea-1c59dc0beb64"
      unitRef="usd">19508000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfOS0zLTEtMS01NDk5Mw_378fbb7d-44a5-4195-ace5-bf0723b9070d"
      unitRef="usd">17550000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTAtMS0xLTEtNTQ5OTM_0abdab53-c1fe-4edc-9273-b45cd42060a5"
      unitRef="usd">240681000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTAtMy0xLTEtNTQ5OTM_a9b23c62-93ad-4e11-bf11-80a54eda018a"
      unitRef="usd">247334000</us-gaap:AssetsCurrent>
    <us-gaap:Goodwill
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTItMS0xLTEtNTQ5OTM_82a7da54-9eb0-4668-8276-cd95221f548a"
      unitRef="usd">245648000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTItMy0xLTEtNTQ5OTM_8c732447-319b-41a5-aaa7-4494bf2cdedf"
      unitRef="usd">243631000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTMtMS0xLTEtNTQ5OTM_6d671b5d-375f-4a9a-9d17-502d73000211"
      unitRef="usd">149833000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTMtMy0xLTEtNTQ5OTM_30dee6ce-5aa9-443b-91fe-63e9ef6bbdb8"
      unitRef="usd">151263000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTQtMS0xLTEtNTQ5OTM_3b06fe67-5e54-4386-965c-ebd88b3c7ed8"
      unitRef="usd">41473000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTQtMy0xLTEtNTQ5OTM_9fc58420-4038-4f44-8c3c-51a3cd827e49"
      unitRef="usd">41859000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTUtMS0xLTEtNTQ5OTM_dcefdef1-1f5a-405d-96c9-eb73703010ec"
      unitRef="usd">38716000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTUtMy0xLTEtNTQ5OTM_618a9eb5-ec92-4aa6-8623-c2c15de7cf56"
      unitRef="usd">38674000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTYtMS0xLTEtNTQ5OTM_565e55f7-3fc2-4f98-b8f1-09ab6fecd005"
      unitRef="usd">30807000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:OtherIntangibleAssetsNet
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTYtMy0xLTEtNTQ5OTM_bbb004bc-4cc6-480a-86b1-63855c4131bd"
      unitRef="usd">31384000</us-gaap:OtherIntangibleAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTctMS0xLTEtNTQ5OTM_df25f0b2-65d6-43d8-9927-23c507d9fbe9"
      unitRef="usd">2373000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTctMy0xLTEtNTQ5OTM_fa233739-6480-4cf2-b4a3-3e4482dcc30f"
      unitRef="usd">1314000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTgtMS0xLTEtNTQ5OTM_66e537dc-7d41-42f5-bc31-cd8eeafb4842"
      unitRef="usd">7542000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTgtMy0xLTEtNTQ5OTM_cb885ab3-0f78-4c41-bd7d-37d418513a28"
      unitRef="usd">7339000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTktMS0xLTEtNTQ5OTM_d58693ba-7d0a-48f7-8b56-f35128854951"
      unitRef="usd">757073000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMTktMy0xLTEtNTQ5OTM_710a79a6-607f-4454-a8e3-9d4e2eb7e467"
      unitRef="usd">762798000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjMtMS0xLTEtNTQ5OTM_95dd3fb2-1a46-45d1-939a-c231874ea843"
      unitRef="usd">9473000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjMtMy0xLTEtNTQ5OTM_beac3a4b-e925-46b1-bd5c-0baa2396958c"
      unitRef="usd">12004000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjQtMS0xLTEtNjI3NzA_7ba0591f-e925-4c3b-84f0-d2d3979ba1a7"
      unitRef="usd">9678000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjQtMy0xLTEtNjI3NzA_134a65bf-29d4-4d13-a1b0-d39394d17821"
      unitRef="usd">12374000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjQtMS0xLTEtNTQ5OTM_07b39162-c4ef-4aa1-ae07-973b9c303bb9"
      unitRef="usd">9028000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjQtMy0xLTEtNTQ5OTM_f4a7b208-98c7-4e09-834d-1b3dd94de328"
      unitRef="usd">13810000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjYtMS0xLTEtNTQ5OTM_bb9bb857-c6bb-4367-ad22-a2d7480787b0"
      unitRef="usd">6911000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjYtMy0xLTEtNTQ5OTM_126c6a38-1d79-4de2-9ccb-5f6793d2e9be"
      unitRef="usd">2635000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjctMS0xLTEtNjI3Nzg_f6b62a15-1025-4d15-8150-e2f3636e35d0"
      unitRef="usd">3398000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjctMy0xLTEtNjI3Nzg_fc259758-cb40-4b04-8413-1a66baf8d764"
      unitRef="usd">3308000</us-gaap:OperatingLeaseLiabilityCurrent>
    <aort:AccruedProcurementFees
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjctMS0xLTEtNTQ5OTM_e5ad15a0-eb71-4d9e-b593-fade769236d6"
      unitRef="usd">2155000</aort:AccruedProcurementFees>
    <aort:AccruedProcurementFees
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjctMy0xLTEtNTQ5OTM_f4f12bdd-1841-4ba8-b268-4de59a0ae8b2"
      unitRef="usd">2111000</aort:AccruedProcurementFees>
    <us-gaap:LongTermDebtCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjktMS0xLTEtNjI3ODY_71e8c484-451b-47fd-9329-83488f042a0e"
      unitRef="usd">1620000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMjktMy0xLTEtNjI3ODY_10e70bf6-3ff0-4e7e-bbd7-61a3ad57e77f"
      unitRef="usd">1608000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzAtMS0xLTEtNTQ5OTM_6ee5a45e-7c43-49c6-b430-172313ddf405"
      unitRef="usd">1698000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzAtMy0xLTEtNTQ5OTM_ee70d79e-350f-4d2f-a419-f4f8e125a813"
      unitRef="usd">1825000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzEtMS0xLTEtNTQ5OTM_a1a9dd8b-e224-430a-bb2e-789ee53a183a"
      unitRef="usd">43961000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzEtMy0xLTEtNTQ5OTM_365dd1e6-93b6-44bd-a283-4d634b41fcf7"
      unitRef="usd">49675000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzMtMS0xLTEtNTQ5OTM_20287866-abe0-47fb-8cda-fa633545a41c"
      unitRef="usd">306279000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzMtMy0xLTEtNTQ5OTM_f90613b4-b0ba-43b7-9e5a-ef1380e31693"
      unitRef="usd">306499000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzQtMS0xLTEtNTQ5OTM_1b1f5428-273d-4b08-be4f-d51a97240670"
      unitRef="usd">45200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzQtMy0xLTEtNTQ5OTM_3abc23fd-54df-4e91-bc29-70a2100ace9a"
      unitRef="usd">40400000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzUtMS0xLTEtNTQ5OTM_8264f4b5-a901-4647-8b6c-c8a4c83b986c"
      unitRef="usd">40774000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzUtMy0xLTEtNTQ5OTM_dbbf3ec5-bef2-4bcd-a62f-ece5f83fe1b9"
      unitRef="usd">41257000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzctMS0xLTEtNjI3OTQ_ff6ad13a-f2f1-4312-9080-96b4b237432e"
      unitRef="usd">23826000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzctMy0xLTEtNjI3OTQ_d458843b-14bc-4dd0-bd62-5987e8847bcf"
      unitRef="usd">24499000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzgtMS0xLTEtNjI3OTQ_ef7eed1d-055c-45ea-98ef-8fa26fcb92c5"
      unitRef="usd">6127000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzgtMy0xLTEtNjI3OTQ_2192ef2c-cda7-4b6a-83c3-3d344600354f"
      unitRef="usd">5468000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzYtMS0xLTEtNTQ5OTM_53cb82f3-3d6c-4e08-aeb8-55d105685e98"
      unitRef="usd">3582000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzYtMy0xLTEtNTQ5OTM_05711ce4-39ba-4c3c-a340-2784c7d1e7ec"
      unitRef="usd">3644000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzktMS0xLTEtNTQ5OTM_2250708b-c7d1-44ea-a31c-62fa3e2b33ff"
      unitRef="usd">7407000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfMzktMy0xLTEtNTQ5OTM_48b9ee41-2589-4f5d-9406-140f2c6a3d06"
      unitRef="usd">7027000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDAtMS0xLTEtNTQ5OTM_bd66891e-03fb-4d41-b591-09a795ef58bf"
      unitRef="usd">477156000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDAtMy0xLTEtNTQ5OTM_6091f4f3-f759-4495-a190-d7fe8aea26c5"
      unitRef="usd">478469000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDItMS0xLTEtNTQ5OTM_35b4a6be-f050-4a56-81ee-d9716d050684"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDItMy0xLTEtNTQ5OTM_530a4911-8438-4f89-b6b3-dfd409be1cad"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDUtMS0xLTEtNTQ5OTM_7f99a4e8-9255-4880-b37d-31576794bf50"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDUtMy0xLTEtNTQ5OTM_10626597-ded4-4c15-a312-af70b780888c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3OTA3_2061118f-540d-473a-a1bc-5016043a3f39"
      unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3OTA3_c1864409-b4f8-49ab-951f-957349a8673b"
      unitRef="shares">75000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3ODg5_342bb3a7-a21f-4167-92cf-59cb546917eb"
      unitRef="shares">42366000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3ODg5_c7e8d518-ebd8-40e9-88dc-137ef6628015"
      unitRef="shares">42366000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3ODk4_03041999-7c65-4044-9277-203998058722"
      unitRef="shares">41830000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjozZDg2YmE2N2Q1YWU0NWRhYjQzNzVhOTE4MzhlN2NlMl8xMDk5NTExNjI3ODk4_3915feb0-d07c-432a-8c01-8e99b77af709"
      unitRef="shares">41830000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMS0xLTEtNTQ5OTM_e85592d1-8a78-4627-80ca-5b1e073a3e5a"
      unitRef="usd">424000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDYtMy0xLTEtNTQ5OTM_422d2d4d-83fa-492e-b6e1-1cb8570e9f04"
      unitRef="usd">418000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDctMS0xLTEtNTQ5OTM_a61c2200-b098-4231-a15a-0db36cd23544"
      unitRef="usd">342883000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDctMy0xLTEtNTQ5OTM_be6282e8-480c-4574-9221-7f63f00831af"
      unitRef="usd">337385000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDgtMS0xLTEtNTQ5OTM_76dbba2b-1b25-4b72-9479-0e1bba42a8d4"
      unitRef="usd">-30749000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDgtMy0xLTEtNTQ5OTM_e329dbeb-9955-46f2-8d1d-4ac050ef4141"
      unitRef="usd">-17217000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDktMS0xLTEtNTQ5OTM_7225a011-26eb-40ce-99ce-cf91432427ae"
      unitRef="usd">-17993000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNDktMy0xLTEtNTQ5OTM_1dfe56d2-1773-4f27-81be-f3f8140cd063"
      unitRef="usd">-21609000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockCommonShares
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTAtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjpmMjg0NmY3MzBmOGQ0MTUxYTc5Y2FjZDEwMzY4YzgyMF8xMDk5NTExNjI3ODY2_51e3cf54-5066-40e4-9081-9d5770795a1b"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTAtMC0xLTEtNTQ5OTMvdGV4dHJlZ2lvbjpmMjg0NmY3MzBmOGQ0MTUxYTc5Y2FjZDEwMzY4YzgyMF8xMDk5NTExNjI3ODY2_e5025e94-8881-4a02-8349-707161e44731"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTAtMS0xLTEtNTQ5OTM_09447901-4edc-42ef-8170-73bf1575d63c"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTAtMy0xLTEtNTQ5OTM_31b09dbb-39c0-4d0b-be00-cc3d7b097f90"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTEtMS0xLTEtNTQ5OTM_174205b7-3892-4087-8f89-5a8cf77344e1"
      unitRef="usd">279917000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTEtMy0xLTEtNTQ5OTM_0f40ff60-1375-4d37-8f8d-bfde5685b82f"
      unitRef="usd">284329000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTMtMS0xLTEtNTQ5OTM_b7511d95-93d7-4cec-be59-4c2fe2e228c3"
      unitRef="usd">757073000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18xOS9mcmFnOmNjODE1ODA0ZmQyMzQwYjhiZGU5ZTFlOWZlMjNmNDE0L3RhYmxlOjVhZDRhYThlN2E2ODRmNmQ4MjVhNGZmYzQyNTk3OGU4L3RhYmxlcmFuZ2U6NWFkNGFhOGU3YTY4NGY2ZDgyNWE0ZmZjNDI1OTc4ZThfNTMtMy0xLTEtNTQ5OTM_00d0b6aa-a629-4aef-a3ca-19d31b9d6997"
      unitRef="usd">762798000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMy0xLTEtMS01NDk5Mw_9b3f296b-61ed-4a8b-a4bc-4bd0c39c8a6d"
      unitRef="usd">-13532000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMy0zLTEtMS01NDk5Mw_d6f995d7-8e1a-4af4-88b0-3c3aa6f5c785"
      unitRef="usd">-3389000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNi0xLTEtMS01NDk5Mw_96c03291-b28d-43b8-aeb2-c8ead5adcfab"
      unitRef="usd">5734000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNi0zLTEtMS01NDk5Mw_70234e54-dbcb-4112-9966-c41950dc17f8"
      unitRef="usd">5881000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNy0xLTEtMS02MTE0Mg_9cb2d1ab-55a0-4636-816c-12e2467b5071"
      unitRef="usd">4800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNy0zLTEtMS02MTE0Mg_6184d400-420e-4c9b-a6c3-9206bf83d3ea"
      unitRef="usd">-1800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ShareBasedCompensation
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNy0xLTEtMS01NDk5Mw_aef2f1cf-50cb-485b-9893-1bf4cbee1fc5"
      unitRef="usd">3341000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNy0zLTEtMS01NDk5Mw_1d86fc36-ec0a-43ab-8cd3-cc2e265d9873"
      unitRef="usd">3166000</us-gaap:ShareBasedCompensation>
    <aort:NoncashLeaseExpense
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfOC0xLTEtMS01NDk5Mw_be1983fe-a123-42b8-9c1d-5effe31a3fdb"
      unitRef="usd">1802000</aort:NoncashLeaseExpense>
    <aort:NoncashLeaseExpense
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfOC0zLTEtMS01NDk5Mw_b379b326-71a0-4d54-b0b3-0f55d5828d27"
      unitRef="usd">1920000</aort:NoncashLeaseExpense>
    <aort:WriteDownOfDeferredPreservationCostsAndInventories
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTAtMS0xLTEtNjExNTI_fec216b2-4d20-4f60-85fd-187b139355c2"
      unitRef="usd">1123000</aort:WriteDownOfDeferredPreservationCostsAndInventories>
    <aort:WriteDownOfDeferredPreservationCostsAndInventories
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTAtMy0xLTEtNjExNTI_0d4f6183-8200-495b-8f92-c39f208888f2"
      unitRef="usd">989000</aort:WriteDownOfDeferredPreservationCostsAndInventories>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfOS0xLTEtMS01NDk5Mw_90d7cd2c-fb31-4f0e-9724-8c70fcd289ab"
      unitRef="usd">2167000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfOS0zLTEtMS01NDk5Mw_fab7fb12-6a57-4ae2-9f39-24278f729f13"
      unitRef="usd">2966000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:OtherNoncashExpense
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTQtMS0xLTEtNTQ5OTM_945da9ef-7065-46af-9bc7-ea2005ea3cf0"
      unitRef="usd">754000</us-gaap:OtherNoncashExpense>
    <us-gaap:OtherNoncashExpense
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTQtMy0xLTEtNTQ5OTM_b0de9cca-57ce-4408-a9a6-f50ecfb28d5b"
      unitRef="usd">496000</us-gaap:OtherNoncashExpense>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTUtMS0xLTEtNjExNzI_918c1b24-6491-4fdb-b3c7-8780dd0a1847"
      unitRef="usd">-3540000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInReceivables
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTUtMy0xLTEtNjExNzI_5ae9bdd5-f7b7-4247-a6cf-6819854ac00a"
      unitRef="usd">1710000</us-gaap:IncreaseDecreaseInReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTYtMS0xLTEtNTQ5OTM_f25a604d-16fc-4385-ab7d-58231bc556de"
      unitRef="usd">2014000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTYtMy0xLTEtNTQ5OTM_008320bd-a117-4a50-8b34-4448792b6557"
      unitRef="usd">-1494000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTctMS0xLTEtNjExODQ_d3be2189-1a0f-480e-9139-d0f4ba53c874"
      unitRef="usd">3222000</aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories>
    <aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTctMy0xLTEtNjExODQ_a73bcb5e-31f7-49ad-9b6f-6d51231eb6c3"
      unitRef="usd">1359000</aort:IncreaseDecreaseInDeferredPreservationCostsAndInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTctMS0xLTEtNTQ5OTM_5f677919-c585-403e-8845-c3e7905662a4"
      unitRef="usd">-6313000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMTctMy0xLTEtNTQ5OTM_3c8e25f4-c15f-4cbe-ac81-ce1a03d98c0c"
      unitRef="usd">-3320000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjAtMS0xLTEtNTQ5OTM_d2aa810e-0837-4158-a300-cc081b5a5714"
      unitRef="usd">-6154000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjAtMy0xLTEtNTQ5OTM_958128df-a26b-45c3-bb54-bdc6ee1c7efa"
      unitRef="usd">-598000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjQtMS0xLTEtNTQ5OTM_0e1d765e-a55f-40a9-abfa-4485f2c32a9b"
      unitRef="usd">2238000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjQtMy0xLTEtNTQ5OTM_82486aab-1c36-4d56-b990-c68f0d6f2766"
      unitRef="usd">2239000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjYtMS0xLTEtNTQ5OTM_ada6f73c-470b-4559-86c0-aa6b4aaaaa4b"
      unitRef="usd">605000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjYtMy0xLTEtNTQ5OTM_c0ece91e-5a3d-4197-934f-14d26a4c912f"
      unitRef="usd">469000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjctMS0xLTEtNTQ5OTM_1ebe97cb-6181-4e2a-8753-3d0c0ebd6b8c"
      unitRef="usd">-2843000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMjctMy0xLTEtNTQ5OTM_45068e70-0ad8-4e49-ac6a-b37bfb2100bc"
      unitRef="usd">-2708000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzAtMS0xLTEtNTQ5OTM_bf4b244c-9438-407f-9de7-00c1803c2be7"
      unitRef="usd">2581000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzAtMy0xLTEtNTQ5OTM_b5df2166-3b18-4c65-80d4-8bcdeae4aa78"
      unitRef="usd">2318000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzEtMS0xLTEtNTQ5OTM_41831257-e05f-4f24-913c-4bb3078eddbb"
      unitRef="usd">590000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzEtMy0xLTEtNTQ5OTM_2f452591-ade8-4bd8-95eb-4f75164b8993"
      unitRef="usd">1730000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzItMS0xLTEtNTQ5OTM_b3f124ec-0ec0-4a65-9550-242cf1bce55e"
      unitRef="usd">690000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzItMy0xLTEtNTQ5OTM_f72ced52-95f6-4c29-bd95-ba7c5a8f854b"
      unitRef="usd">694000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzQtMS0xLTEtNTQ5OTM_aaa94be0-b945-4a26-ae2a-11055d6ee707"
      unitRef="usd">-130000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzQtMy0xLTEtNTQ5OTM_1f4f4330-a891-43e3-9b7c-6aa25095caed"
      unitRef="usd">-129000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzUtMS0xLTEtNTQ5OTM_15c23126-e69a-4d9b-8131-aecf24a589db"
      unitRef="usd">1171000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzUtMy0xLTEtNTQ5OTM_be717cf6-a7ee-46bb-acea-e314631698a7"
      unitRef="usd">-235000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzctMS0xLTEtNTQ5OTM_b53ed860-5545-49f6-b17d-b4217b3a4d7d"
      unitRef="usd">-752000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzctMy0xLTEtNTQ5OTM_b3e3fc7d-f00a-40f2-a341-0a7dc0f04231"
      unitRef="usd">-61000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzgtMS0xLTEtNTQ5OTM_76ba0001-3db2-476e-9428-a2b4a70ac7aa"
      unitRef="usd">-8578000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfMzgtMy0xLTEtNTQ5OTM_11156bbc-3767-44a6-b8eb-5222800e4952"
      unitRef="usd">-3602000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNDAtMS0xLTEtNTQ5OTM_d610b3a4-82c5-4299-bef6-6c363280b2b6"
      unitRef="usd">39351000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id34f77b2e87c4767bbb2e6a239ed82d3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNDAtMy0xLTEtNTQ5OTM_f614572d-bb02-47c7-b4f6-2254da35f4c6"
      unitRef="usd">55010000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNDEtMS0xLTEtNTQ5OTM_673fa443-5463-4fc4-b8d3-c2c0ebd50f73"
      unitRef="usd">30773000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i684ce4d481204a1aad79ec17a22ca9cc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yMi9mcmFnOmUxOWQxNDQzNjcxOTQyNjg4OGE4ZTk4YjcwZTNkODU2L3RhYmxlOjFhZDRlNzRhNjJiMjQwZTA4ZTRkZTNkOGE4NzQ1Y2JhL3RhYmxlcmFuZ2U6MWFkNGU3NGE2MmIyNDBlMDhlNGRlM2Q4YTg3NDVjYmFfNDEtMy0xLTEtNTQ5OTM_af75b3ce-e604-492f-acbb-041916dfd5a8"
      unitRef="usd">51408000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8906191b80d94b2cb337250ebd00ffe4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0xLTEtMS01NDk5Mw_a1ab71f1-661b-4047-8ed7-2c34ee38c69e"
      unitRef="shares">41830000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8906191b80d94b2cb337250ebd00ffe4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0zLTEtMS01NDk5Mw_f6f319ed-4ab2-44f9-8359-4282d31ae2ee"
      unitRef="usd">418000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0d4870864b08435ba93e18e414576db4_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi01LTEtMS01NDk5Mw_74f0aced-dc92-431a-ba3f-cbfc58274ba2"
      unitRef="usd">337385000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia20c6db1b736414388dabc9465f16d8e_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi03LTEtMS01NDk5Mw_aa3d8d78-4f18-47da-8e1c-1a67ef6010ce"
      unitRef="usd">-17217000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i314c30b8aff54268bfed28a9c6beccd1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi05LTEtMS01NDk5Mw_94ef9c16-e1f8-4b5d-bd56-ec3066aa8260"
      unitRef="usd">-21609000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="ie7766a77cc4e4f6c80f140d23c8e7323_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0xMS0xLTEtNTQ5OTM_7bb39f27-8b77-48a5-afdf-7020cfa731c4"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="ie7766a77cc4e4f6c80f140d23c8e7323_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0xMy0xLTEtNTQ5OTM_6dff7ebd-388d-4543-a7e7-7b4ccf124f2e"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMi0xNS0xLTEtNTQ5OTM_efcd615a-66f7-4f47-b101-2cbafdb5cb82"
      unitRef="usd">284329000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ie07dff7c65f54941b40235f8253ee52f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMy03LTEtMS01NDk5Mw_d7fe8154-9d97-4c75-9983-d571a21e9494"
      unitRef="usd">-13532000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfMy0xNS0xLTEtNTQ5OTM_467889da-5a86-43b0-8c49-2f65ff69d519"
      unitRef="usd">-13532000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="id7529137f6374134ba29f2ac0fc74e1a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNC05LTEtMS01NDk5Mw_b0885c15-0c85-4e3f-a5d1-3950a0e09a5d"
      unitRef="usd">3616000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNC0xNS0xLTEtNTQ5OTM_41e74777-0c0c-421f-8944-92aa52746e7a"
      unitRef="usd">3616000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNS0xLTEtMS01NDk5Mw_015cd668-196a-4725-8c7a-9651063e5211"
      unitRef="shares">326000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNS0zLTEtMS01NDk5Mw_9a4e6a43-ee59-4b9f-ad69-e2a876af9b49"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNS01LTEtMS01NDk5Mw_c14b65e3-c3ec-46b7-9951-c328875a30e4"
      unitRef="usd">3510000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNS0xNS0xLTEtNTQ5OTM_da55e18c-4797-4597-be6e-6aebdf2f2cc7"
      unitRef="usd">3513000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNi0xLTEtMS01NDk5Mw_b4a2004f-cf4d-45ca-a5e5-59cac891f793"
      unitRef="shares">196000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNi0zLTEtMS01NDk5Mw_0812dda2-c8b6-46b2-a8a8-3ad96b918fa3"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNi01LTEtMS01NDk5Mw_c8c9c78f-fe95-41d2-a75d-404e165b8a7e"
      unitRef="usd">2004000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNi0xNS0xLTEtNTQ5OTM_dc20f3ff-6216-47ee-afb7-d72091db3a2a"
      unitRef="usd">2006000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNy0xLTEtMS01NDk5Mw_c8059fc2-c15c-44ed-bee4-a1baca93d261"
      unitRef="shares">56000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNy0zLTEtMS01NDk5Mw_d5d7d972-8e72-4e2b-a12d-22045ee03f78"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNy01LTEtMS01NDk5Mw_e2c05d92-4a16-4b24-97c4-aa2a7fc90cd5"
      unitRef="usd">574000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfNy0xNS0xLTEtNTQ5OTM_c2022d1c-d727-449d-84a2-d4011d8930a9"
      unitRef="usd">575000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOC0xLTEtMS01NDk5Mw_ef0ba993-0d78-483c-a7de-4fbcb1411892"
      unitRef="shares">42000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i261405fc086646eab594dad856c5d0ea_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOC0zLTEtMS01NDk5Mw_53f3fe78-372d-4d31-a4aa-8f6d70171c5e"
      unitRef="usd">0</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i9c46386648044717a9ffc2a58789deb1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOC01LTEtMS01NDk5Mw_d9f161e4-8133-49db-bff2-b99edf687e13"
      unitRef="usd">590000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOC0xNS0xLTEtNTQ5OTM_ee468370-6d75-449d-9176-70d06de2651c"
      unitRef="usd">590000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ia1f0e19f9d2846e8836488a6f5034a54_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0xLTEtMS01NDk5Mw_c54bed82-c020-4ea3-b408-3756e0587368"
      unitRef="shares">42366000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ia1f0e19f9d2846e8836488a6f5034a54_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0zLTEtMS01NDk5Mw_e9c1a872-e3ac-43b1-8be6-7595fa6f366d"
      unitRef="usd">424000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic0611add9d054ed19bdf0000b33535f2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS01LTEtMS01NDk5Mw_04fcdd6d-1d04-49d2-964b-3fe0f21d5ed5"
      unitRef="usd">342883000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i371e868a09e8420ca81b51ae2ded7735_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS03LTEtMS01NDk5Mw_e38dcffb-cf7e-4a1b-854f-34caee3fd793"
      unitRef="usd">-30749000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i80ee1b53042f49daa8481c6a55b7f28d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS05LTEtMS01NDk5Mw_26b13643-6eeb-4bce-9849-b4cd98fd7f74"
      unitRef="usd">-17993000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iba4345bc04bc4fd0b009820cbf10edda_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0xMS0xLTEtNTQ5OTM_9e60e6a7-9b06-4fdb-aab7-6d9d64ec85d8"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="iba4345bc04bc4fd0b009820cbf10edda_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0xMy0xLTEtNTQ5OTM_e8615e6e-237f-4959-9896-5c6e333d5e17"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOjljOTVmNmNjY2VmNTQ4Nzk5NGQ5NWI2ZWUyZjFjM2M2L3RhYmxlcmFuZ2U6OWM5NWY2Y2NjZWY1NDg3OTk0ZDk1YjZlZTJmMWMzYzZfOS0xNS0xLTEtNTQ5OTM_b32142a5-756d-4320-8cf3-d3c5bc553032"
      unitRef="usd">279917000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6a9f88cb8b244d1f8d88193d41aee37f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0xLTEtMS01NDk5Mw_64bfc69a-ba31-49bf-a592-cc7906f3e5af"
      unitRef="shares">41397000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i6a9f88cb8b244d1f8d88193d41aee37f_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0zLTEtMS01NDk5Mw_bca1e45e-5214-4601-a763-c232fc12ebcc"
      unitRef="usd">414000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ice4c3a2465c545898bd620a0413d3832_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi01LTEtMS01NDk5Mw_8073311b-feb8-46ad-b0b8-88cdc4df52d8"
      unitRef="usd">322874000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib03cb376e30e462b9363c3c0bf7170c4_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi03LTEtMS01NDk5Mw_93c44098-b20c-41e0-80fc-6491536c10bf"
      unitRef="usd">1975000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id19300d854664ca394ffabc2a495b2e5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi05LTEtMS01NDk5Mw_0c53873f-7f1a-480d-9635-ca6454f7a7c9"
      unitRef="usd">-9887000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="iccd5df30d43d4a12952dc6138272e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0xMS0xLTEtNTQ5OTM_cd7669f4-7a77-49dd-b8bb-e890646ba381"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="iccd5df30d43d4a12952dc6138272e270_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0xMy0xLTEtNTQ5OTM_edab00e3-27dd-41e9-b34c-34c60c7e5b4c"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="id34f77b2e87c4767bbb2e6a239ed82d3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMi0xNS0xLTEtNTQ5OTM_9cacaa47-c1a0-441a-be1c-9ed8c82affd7"
      unitRef="usd">300728000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ib8256b73459843e0aaf032088b5f7f90_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMy03LTEtMS01NDk5Mw_968aaff6-c77d-4765-bb11-1c2e955547c5"
      unitRef="usd">-3389000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMy0xNS0xLTEtNTQ5OTM_4a1460b5-6ead-45d0-a3e8-c8d9e73e5e58"
      unitRef="usd">-3389000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i572ac13fae7e4dafbdaa8efdf37bea7f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNC05LTEtMS01NDk5Mw_7d4c9b6e-8ffb-47ef-a1cf-2f996b525b9f"
      unitRef="usd">-3775000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNC0xNS0xLTEtNTQ5OTM_55f752f9-ae83-4e35-9394-3cff813af16c"
      unitRef="usd">-3775000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNi0xLTEtMS01NDk5Mw_730f736e-8ecb-4330-9f41-118ea86dfb49"
      unitRef="shares">205000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNi0zLTEtMS01NDk5Mw_74028645-7065-41b1-93b5-d9c0dda3f775"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNi01LTEtMS01NDk5Mw_4a402f28-501a-4973-b49b-2cda47b3391a"
      unitRef="usd">3338000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNi0xNS0xLTEtNTQ5OTM_f6cf2a45-edec-4250-a1ef-b68981ce9526"
      unitRef="usd">3340000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNy0xLTEtMS01NDk5Mw_c0b6ead0-2427-4d03-9c93-0f0086b7635f"
      unitRef="shares">140000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNy0zLTEtMS01NDk5Mw_a5cdeb91-0c6c-4f24-b3c0-004584c10fa5"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNy01LTEtMS01NDk5Mw_89887166-e599-4667-9f24-7ab7233ff6cc"
      unitRef="usd">1678000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfNy0xNS0xLTEtNTQ5OTM_3bb5af69-398d-463f-8709-ed4aa3305ff1"
      unitRef="usd">1680000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOC0xLTEtMS01NDk5Mw_3a525907-8448-4ad5-8e26-1e881ef922b7"
      unitRef="shares">37000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOC0zLTEtMS01NDk5Mw_ca893b20-d7af-4791-9e32-2fd8bc6c15b5"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOC01LTEtMS01NDk5Mw_4488fcd8-1fa2-4485-955a-436e97397767"
      unitRef="usd">638000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOC0xNS0xLTEtNTQ5OTM_3b0f5f30-113b-4679-999b-986801737508"
      unitRef="usd">638000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOS0xLTEtMS01NDk5Mw_6421793c-d265-414e-9ccf-f926babf13a1"
      unitRef="shares">91000</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="ied76502fccf6460e89333e749c743f0e_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOS0zLTEtMS01NDk5Mw_e904dd3b-6539-45d6-aee1-3b03c2e47fac"
      unitRef="usd">1000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i7d518939597842538acf2e1eb0ad712f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOS01LTEtMS01NDk5Mw_cf2c954d-4273-452c-b10c-c180ba329521"
      unitRef="usd">1729000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfOS0xNS0xLTEtNTQ5OTM_ceb643fb-fbd1-4e51-beb3-b6710d61b414"
      unitRef="usd">1730000</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id42a947477504a9f9a4328bba9370244_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMS0xLTEtNTQ5OTM_599df7d8-8923-41ed-b3ab-484b57975131"
      unitRef="shares">41688000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="id42a947477504a9f9a4328bba9370244_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMy0xLTEtNTQ5OTM_073f28a5-ba54-461e-9ac0-520a7b8925b7"
      unitRef="usd">417000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib659527ecee343bc87c222d16f27cd19_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtNS0xLTEtNTQ5OTM_e471d6c8-9fd5-4f4f-98ac-c7be1b6791c3"
      unitRef="usd">326799000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i898f1ad5afdf4d8f9d86cd812ca5514c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtNy0xLTEtNTQ5OTM_33a1895f-e77a-4a95-a5e9-5d85157f5fe6"
      unitRef="usd">-1414000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iaf6b10a5a1ad4e50a4bc84b969e56728_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtOS0xLTEtNTQ5OTM_460adc53-bf05-4ac7-be4a-71eab663b39d"
      unitRef="usd">-13662000</us-gaap:StockholdersEquity>
    <us-gaap:TreasuryStockCommonShares
      contextRef="i99a5bc1a71c34a1b9e0b212e75b8f3c8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMTEtMS0xLTU0OTkz_c0bac6a1-f4a7-4485-9fc3-f3fb47953c77"
      unitRef="shares">1487000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue
      contextRef="i99a5bc1a71c34a1b9e0b212e75b8f3c8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMTMtMS0xLTU0OTkz_d050dd24-ae5a-4865-886d-0072ecc0d8a8"
      unitRef="usd">14648000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquity
      contextRef="i684ce4d481204a1aad79ec17a22ca9cc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18yNS9mcmFnOjNhOTBkNmRkNzRiYjRjZTliMjU3ZGRmMDEyNzkxMzAyL3RhYmxlOmYyZWQ0OGIyYmViNDQ5ZmI5NzJmZWM4YWQ0NWZjOWU1L3RhYmxlcmFuZ2U6ZjJlZDQ4YjJiZWI0NDlmYjk3MmZlYzhhZDQ1ZmM5ZTVfMTAtMTUtMS0xLTU0OTkz_64fc1439-511e-4923-b301-fb7dfd724f68"
      unitRef="usd">297492000</us-gaap:StockholdersEquity>
    <us-gaap:BasisOfAccounting
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zMS9mcmFnOjM4MmRkMjVhNGZjZjQ3Njk4N2ZmODNiYTg0YzY3NzlkL3RleHRyZWdpb246MzgyZGQyNWE0ZmNmNDc2OTg3ZmY4M2JhODRjNjc3OWRfNDE5Nw_70d32714-b857-45cf-b245-4dcd08ed83af">Basis of Presentation and Summary of Significant Accounting Policies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying Condensed Consolidated Financial Statements include the accounts of Artivion, Inc. and its subsidiaries (&#x201c;Artivion,&#x201d; the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; or &#x201c;us&#x201d;). All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying Condensed Consolidated Balance Sheet as of December&#160;31, 2022 has been derived from audited financial statements. The accompanying unaudited Condensed Consolidated Financial Statements as of, and for the three months ended, March&#160;31, 2023 and 2022 have been prepared in accordance with (i) accounting principles generally accepted in the United States of America ("US GAAP") for interim financial information and (ii) the instructions to Form 10-Q and Rule 10-01 of Regulation S-X of the US Securities and Exchange Commission (the &#x201c;SEC&#x201d;). Accordingly, such statements do not include all the information and disclosures that are required by US GAAP for a complete presentation of financial statements. In the opinion of management, all adjustments (including those of a normal, recurring nature) considered necessary for a fair presentation have been included. Operating results for the three months ended March&#160;31, 2023 are not necessarily indicative of the results that may be expected for the year ending December&#160;31, 2023. These Condensed Consolidated Financial Statements should be read in conjunction with the Consolidated Financial Statements and Notes included in Artivion&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022 filed with the SEC on February&#160;23, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our significant accounting policies is included in Note 1 of the &#x201c;Notes to Consolidated Financial Statements&#x201d; contained in our Form 10-K for the year ended December&#160;31, 2022. Management believes that the consistent application of these policies enables us to provide users of the financial statements with useful and reliable information about our operating results and financial condition. The Condensed Consolidated Financial Statements are prepared in accordance with US GAAP, which require us to make estimates and assumptions. We did not experience any significant changes during the three months ended March&#160;31, 2023 in any of our Significant Accounting Policies from those contained in our Form 10-K for the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020 the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standard Update (&#x201c;ASU&#x201d;) 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform Topic 848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 848&#x201d;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. US GAAP requires entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December 31, 2022 and cannot be applied to contract modifications that occur after December 31, 2022.  In January 2021 the FASB issued ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The objective of the new reference rate reform standard is to clarify the scope of Topic 848 and provide explicit guidance to help companies applying optional expedients and exceptions. We adopted ASU 2020-04 and ASU 2021-01 on a prospective basis in fiscal year 2022. The adoption of ASU 2020-04 and ASU 2021-01 did not have a material impact on our financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccounting>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zMS9mcmFnOjM4MmRkMjVhNGZjZjQ3Njk4N2ZmODNiYTg0YzY3NzlkL3RleHRyZWdpb246MzgyZGQyNWE0ZmNmNDc2OTg3ZmY4M2JhODRjNjc3OWRfNDE5OA_62f8409d-09e1-4750-a97a-df40cbc259e7">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020 the Financial Accounting Standards Board (the &#x201c;FASB&#x201d;) issued Accounting Standard Update (&#x201c;ASU&#x201d;) 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform Topic 848&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 848&#x201d;). The amendments in this ASU were put forth in response to the market transition from the LIBOR and other interbank offered rates to alternative reference rates. US GAAP requires entities to evaluate whether a contract modification, such as the replacement or change of a reference rate, results in the establishment of a new contract or continuation of an existing contract. ASC 848 allows an entity to elect not to apply certain modification accounting requirements to contracts affected by reference rate reform. The standard provides this temporary election through December 31, 2022 and cannot be applied to contract modifications that occur after December 31, 2022.  In January 2021 the FASB issued ASU 2021-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The objective of the new reference rate reform standard is to clarify the scope of Topic 848 and provide explicit guidance to help companies applying optional expedients and exceptions. We adopted ASU 2020-04 and ASU 2021-01 on a prospective basis in fiscal year 2022. The adoption of ASU 2020-04 and ASU 2021-01 did not have a material impact on our financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMjk0Mg_788a0a0a-3b65-434f-9ee9-d744efb1ce48">Financial Instruments&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We used prices quoted from our investment advisors to determine the Level 1 valuation of our investments in money market funds. The estimated market value of all cash equivalents is equal to cost basis as there were no gross realized gains or losses on cash equivalents for the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;2, 2020 we entered into a Securities Purchase Agreement to acquire 100% of the outstanding equity interests of Ascyrus Medical LLC (&#x201c;Ascyrus&#x201d;). Ascyrus developed the AMDS, the world&#x2019;s first aortic arch remodeling device for use in the treatment of acute Type A aortic dissections. As part of the acquisition, we may be required to pay additional consideration in cash of up to $100.0 million to the former shareholders of Ascyrus upon the achievement of certain milestones and the sales-based additional earn-out. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent consideration represents the estimated fair value of future potential payments. The fair value of the contingent consideration liability was estimated by discounting to present value the contingent payments expected to be made based on a probability-weighted scenario approach. We applied a discount rate based on our unsecured credit spread and the term commensurate risk-free rate to the additional consideration to be paid, and then applied a risk-based estimate of the probability of achieving each scenario to calculate the fair value of the contingent consideration. This fair value measurement was based on unobservable inputs, including management estimates and assumptions about the future achievement of milestones and future estimate of revenues, and is, therefore, classified as Level 3 within the fair value hierarchy. We used a discount rate of approximately 13% and estimated future achievement of milestone dates between 2025 and 2026 to calculate the fair value of contingent consideration as of March&#160;31, 2023. We will remeasure this liability at each reporting date and will record changes in the fair value of the contingent consideration in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive Loss. Increases or decreases in the fair value of the contingent consideration liability can result from changes in passage of time, discount rates, the timing and amount of our revenue estimates, and the timing and expectation of regulatory approvals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We performed an assessment of the fair value of the contingent consideration and recorded an expense of $4.8 million and income of $1.8 million for the three months ended March&#160;31, 2023 and 2022, respectively, in General, administrative, and marketing expenses on the Condensed Consolidated Statements of Operations and Comprehensive Loss, as a result of this assessment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the contingent consideration component of the Ascyrus acquisition was updated using Level 3 inputs. Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The determination of fair value and the assessment of a measurement&#x2019;s placement within the hierarchy requires judgment. Level 3 valuations often involve a higher degree of judgment and complexity. Although we believe that the recorded fair values of our financial instruments are appropriate, these fair values may not be indicative of net realizable value or reflective of future fair values.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMjk0Mw_7183ca8b-d9b8-40f8-8c86-8ff2950bdbb6">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of our financial instruments measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;7,154&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:43.748%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.085%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,098&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;10,098&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Long-term liabilities: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 28pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7ffb145f12444931806dfef0dd45ec75_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMi0yLTEtMS01NDk5Mw_e5eb3ff1-1365-439f-bdbf-f6c7ef3910b9"
      unitRef="usd">7154000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i0e538adb023b42dba22d620e4792eb34_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMi00LTEtMS01NDk5Mw_17faf652-fb11-4093-a5dd-ebab8ae7d1fc"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i9897803022524b6b83398955223e2444_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMi02LTEtMS01NDk5Mw_eba5a6b0-32c2-41ba-8d04-efae7f0ed7db"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i16e5777fa0694cc18917f184d3087f01_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMi04LTEtMS01NDk5Mw_b5dd53b4-37d7-4158-b0b3-4e8af693b66e"
      unitRef="usd">7154000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic6b549ee865943d6855f63e539a42cc5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMy0yLTEtMS01NDk5Mw_59f56131-38b2-45df-bd84-8197f7611744"
      unitRef="usd">7154000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ia60a357239894830b1528f32f19aaf03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMy00LTEtMS01NDk5Mw_be711114-c4b8-4ce4-b3ff-8b67a836a597"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="icef1a873474b47e7b3ee0e7be4ef40b8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMy02LTEtMS01NDk5Mw_7adce2b8-be8c-45a0-af39-802dac076345"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfMy04LTEtMS01NDk5Mw_ee2903ed-7a1f-4cd4-8c5c-a3a2a4cf9929"
      unitRef="usd">7154000</us-gaap:AssetsFairValueDisclosure>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="ic6b549ee865943d6855f63e539a42cc5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNi0yLTEtMS01NDk5Mw_2205e512-5044-4c1a-8acb-acab1aad892d"
      unitRef="usd">0</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="ia60a357239894830b1528f32f19aaf03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNi00LTEtMS01NDk5Mw_29d9dbef-3624-4495-ad19-461c948b068f"
      unitRef="usd">0</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="icef1a873474b47e7b3ee0e7be4ef40b8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNi02LTEtMS01NDk5Mw_c46cfe97-e72d-4923-b4a4-356cbcd8d5d5"
      unitRef="usd">45200000</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNi04LTEtMS01NDk5Mw_5220c395-b0ed-4b93-85c9-be879611b7ce"
      unitRef="usd">45200000</aort:ContingentConsiderationNoncurrentFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ic6b549ee865943d6855f63e539a42cc5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNy0yLTEtMS01NDk5Mw_bf9cd3a6-13c4-4bda-ae6e-9c33ae159f56"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ia60a357239894830b1528f32f19aaf03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNy00LTEtMS01NDk5Mw_3da101d2-52a1-455f-9e34-5539fc9bedd9"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="icef1a873474b47e7b3ee0e7be4ef40b8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNy02LTEtMS01NDk5Mw_c59993bd-b00c-451a-a13b-1149f9a96989"
      unitRef="usd">45200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmFhYzA0NjI5OGI0MzRmNmNiNDY3YmNlNmVjZDg2OWZkL3RhYmxlcmFuZ2U6YWFjMDQ2Mjk4YjQzNGY2Y2I0NjdiY2U2ZWNkODY5ZmRfNy04LTEtMS01NDk5Mw_5c38f2a4-24bf-4ff1-ac7b-8ea812e1b0e0"
      unitRef="usd">45200000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icb10dd17357d43dfb35870e5456e7882_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMi0yLTEtMS01NDk5Mw_9dc3e8b4-7f06-44f2-ac48-ff6aff23ea9f"
      unitRef="usd">10098000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i53c72e2891b643879b972b1f3ceb58fe_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMi00LTEtMS01NDk5Mw_8af14551-44ff-48de-a162-c3553af41f68"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if63692cacc3a445dacf59c9a1047dd06_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMi02LTEtMS01NDk5Mw_317d603c-9c1b-4527-9a03-fee5aa99496c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if66fb22ae36440dab8fe8254cd95ffb1_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMi04LTEtMS01NDk5Mw_db8bb7c4-48c0-48d8-8efc-06366a560685"
      unitRef="usd">10098000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i5a5e9956c83a49c0b5cac54ad6a7f263_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMy0yLTEtMS01NDk5Mw_af944278-901e-4056-98e6-b6fa2c8381d1"
      unitRef="usd">10098000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i4bd3bfffc6a2457bba90e050e14c2e58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMy00LTEtMS01NDk5Mw_b254ea70-bb34-4b0e-b782-e169ea4dfc40"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ib98547abf55f42c59aefaa0f6d22fe1b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMy02LTEtMS01NDk5Mw_b483f726-adce-4527-bb03-11f5935f5088"
      unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfMy04LTEtMS01NDk5Mw_300baecb-634b-4f95-8c9b-4070d75ad470"
      unitRef="usd">10098000</us-gaap:AssetsFairValueDisclosure>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="i5a5e9956c83a49c0b5cac54ad6a7f263_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNi0yLTEtMS01NDk5Mw_b1dd531f-9940-4b7c-a1ea-c46efc71b94a"
      unitRef="usd">0</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="i4bd3bfffc6a2457bba90e050e14c2e58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNi00LTEtMS01NDk5Mw_0b86de05-8326-4e28-863e-b6fa43920ca9"
      unitRef="usd">0</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="ib98547abf55f42c59aefaa0f6d22fe1b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNi02LTEtMS01NDk5Mw_3015cbf6-6e14-4364-866f-da8aa3b11acf"
      unitRef="usd">40400000</aort:ContingentConsiderationNoncurrentFairValue>
    <aort:ContingentConsiderationNoncurrentFairValue
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNi04LTEtMS01NDk5Mw_b7b85af3-5264-43ac-a0eb-38367d150204"
      unitRef="usd">40400000</aort:ContingentConsiderationNoncurrentFairValue>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i5a5e9956c83a49c0b5cac54ad6a7f263_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNy0yLTEtMS01NDk5Mw_f01fd494-b25b-4a6e-8ffc-d84374c993c3"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="i4bd3bfffc6a2457bba90e050e14c2e58_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNy00LTEtMS01NDk5Mw_674bf456-2d9b-4d17-9c2f-51623ae6c086"
      unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="ib98547abf55f42c59aefaa0f6d22fe1b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNy02LTEtMS01NDk5Mw_e72a7ea3-1f24-4b7f-a8b7-f6a173e1f92e"
      unitRef="usd">40400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOmYxODVhMzA3NTRjNTQxYmZhMDQzYjAzOTRkZDU2MjEwL3RhYmxlcmFuZ2U6ZjE4NWEzMDc1NGM1NDFiZmEwNDNiMDM5NGRkNTYyMTBfNy04LTEtMS01NDk5Mw_272246cc-c32e-46e3-886a-d5be9afeb929"
      unitRef="usd">40400000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i71edbd22e4cf42339603deb7cbeac930_I20200902"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMzQz_3e2f32ae-31d3-43f3-b500-3d14991ca445"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
      contextRef="i71edbd22e4cf42339603deb7cbeac930_I20200902"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfNjUx_787567e3-beb8-4538-a074-8beca02b9900"
      unitRef="usd">100000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh>
    <us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput
      contextRef="i77a16d00eb08404da8ae5de65c51f748_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMTY2NQ_a26f6199-4260-4d29-be56-7aad7bcae491"
      unitRef="number">0.13</us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i9f174cecb39e48b9af65991c55af673a_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMjQyMQ_0aa5e9c7-bdbe-47fa-9a6a-2331edeba50f"
      unitRef="usd">-4800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ie59b048c0d4b4b56a468429d5b300520_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfNTQ5NzU1ODE2ODYx_b02bf80d-c180-409f-bf6b-ef59c2335d4b"
      unitRef="usd">1800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RleHRyZWdpb246YzFjNDYyMjk5NjU2NDJhNWFiNGUwNWZmNjY3YjFjNjhfMjk0NA_86e60101-2b83-44f0-bd4f-12dbbe825356">Changes in fair value of Level 3 assets and liabilities are listed in the tables below (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Contingent Consideration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,800)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(45,200)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOjBjYmFlOTMyYjFkYTQwY2E4Y2EzMTRiNzdkOTUxOTFiL3RhYmxlcmFuZ2U6MGNiYWU5MzJiMWRhNDBjYThjYTMxNGI3N2Q5NTE5MWJfMS0xLTEtMS01NDk5Mw_969e11ab-6cd4-4af9-b2e0-777031ac5f77"
      unitRef="usd">40400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOjBjYmFlOTMyYjFkYTQwY2E4Y2EzMTRiNzdkOTUxOTFiL3RhYmxlcmFuZ2U6MGNiYWU5MzJiMWRhNDBjYThjYTMxNGI3N2Q5NTE5MWJfMi0xLTEtMS01NDk5Mw_0d70ac4e-9ce2-4c14-a457-3c8ea1511ed1"
      unitRef="usd">4800000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M18zNy9mcmFnOmMxYzQ2MjI5OTY1NjQyYTVhYjRlMDVmZjY2N2IxYzY4L3RhYmxlOjBjYmFlOTMyYjFkYTQwY2E4Y2EzMTRiNzdkOTUxOTFiL3RhYmxlcmFuZ2U6MGNiYWU5MzJiMWRhNDBjYThjYTMxNGI3N2Q5NTE5MWJfMy0xLTEtMS01NDk5Mw_19ed0282-635a-43ba-9011-2356a2d14763"
      unitRef="usd">45200000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfOTI1_e68971c7-7c08-40b9-8234-613777768634">Inventories, net and Deferred Preservation Costs  &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net at March&#160;31, 2023 and December&#160;31, 2022 were comprised of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total inventories, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76,273&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74,478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To facilitate product usage, we maintain consignment inventory of our On-X heart valves at domestic hospital locations and On-X heart valves and aortic stent grafts at international hospital locations. We retain title and control over this consignment inventory until the device is implanted, at which time we invoice the hospital and recognize revenue. As of March&#160;31, 2023 we had $12.7 million in consignment inventory, with approximately 42% in domestic locations and 58% in international locations. As of December&#160;31, 2022 we had $12.7 million in consignment inventory, with approximately 41% in domestic locations and 59% in international locations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred preservation costs were $47.4 million and $46.4 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory and deferred preservation costs obsolescence reserves were $2.1 million and $2.2 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfOTI2_5988a47a-efee-4504-b520-0639c9cd20f1">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventories, net at March&#160;31, 2023 and December&#160;31, 2022 were comprised of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.088%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.881%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.124%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total inventories, net &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;76,273&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;74,478&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMS0xLTEtMS01NDk5Mw_36f79126-c9ad-4d4c-84fc-c6036eea9754"
      unitRef="usd">36322000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMS0zLTEtMS01NDk5Mw_d3c75487-8f79-44a8-a190-9c72ebc0d34d"
      unitRef="usd">36715000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMi0xLTEtMS01NDk5Mw_cbcb9f0f-c474-4075-9792-0de769dcee17"
      unitRef="usd">11319000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMi0zLTEtMS01NDk5Mw_2822a314-0b5d-4401-9ac9-f83e44eef55f"
      unitRef="usd">10476000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMy0xLTEtMS01NDk5Mw_57223a97-dfa3-4af9-a965-a10438ddf7ae"
      unitRef="usd">28632000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfMy0zLTEtMS01NDk5Mw_78043e03-2b2c-4110-8e1c-daeab1522fe2"
      unitRef="usd">27287000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfNC0xLTEtMS01NDk5Mw_cfcee641-77f4-459b-9a7e-644ef0497143"
      unitRef="usd">76273000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RhYmxlOmI4MDBkZjdjNjIxZDQ5MGJhZTVlMzg4MjEyYmE3OGQ4L3RhYmxlcmFuZ2U6YjgwMGRmN2M2MjFkNDkwYmFlNWUzODgyMTJiYTc4ZDhfNC0zLTEtMS01NDk5Mw_7592564c-8219-40de-bf0c-08e4717719f0"
      unitRef="usd">74478000</us-gaap:InventoryNet>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNTA0_7902e7dc-4eb4-48f8-9d9a-ac9eb2c6c0dc"
      unitRef="usd">12700000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <aort:ConsignmentInventoryPercentage
      contextRef="i08c0ea5c117b4dfeb0384a9e1247a5b9_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNTUy_9d92f83d-c5cf-4d34-bd1f-1ccd30107665"
      unitRef="number">0.42</aort:ConsignmentInventoryPercentage>
    <aort:ConsignmentInventoryPercentage
      contextRef="i26fcb04471584b5ea9d699972f9aa939_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNTgx_e678c5cf-2da4-415d-ac95-b0fc89af824d"
      unitRef="number">0.58</aort:ConsignmentInventoryPercentage>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNjI4_71250245-cc31-4b42-8ba7-1a8e731da4e6"
      unitRef="usd">12700000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <aort:ConsignmentInventoryPercentage
      contextRef="i03f86365100d412b8f424f38d54c35d2_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNjc2_30cfebcb-ad54-484a-ac6f-01d5e7d7779d"
      unitRef="number">0.41</aort:ConsignmentInventoryPercentage>
    <aort:ConsignmentInventoryPercentage
      contextRef="i330d4af7abf24d219bcf5d1880f8fc1e_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNzA1_58275f9a-83eb-4041-9ae5-848c2f410c4f"
      unitRef="number">0.59</aort:ConsignmentInventoryPercentage>
    <aort:DeferredPreservationCosts
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNzc1_3ca630a2-9be5-493c-a197-46516dacb7dd"
      unitRef="usd">47400000</aort:DeferredPreservationCosts>
    <aort:DeferredPreservationCosts
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfNzgy_694a3c25-99e6-4d37-9a68-9d5f2c86ef16"
      unitRef="usd">46400000</aort:DeferredPreservationCosts>
    <us-gaap:InventoryValuationReserves
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfODg2_5a29b53c-083c-4b5b-8e5b-a956ddbc64ba"
      unitRef="usd">2100000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180My9mcmFnOmUzMDZlYzIxYjFiNzRiYjJhMWVkMDFkYWRhOGU3ODIzL3RleHRyZWdpb246ZTMwNmVjMjFiMWI3NGJiMmExZWQwMWRhZGE4ZTc4MjNfODkz_da26cc7f-d019-46a4-96c3-8080c6ddb37f"
      unitRef="usd">2200000</us-gaap:InventoryValuationReserves>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2NA_4c9c77e1-c7ce-45a2-ae53-615996a4c718">Goodwill and Other Intangible Assets  &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indefinite Lived Intangible Assets &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022 the carrying values of our indefinite lived intangible assets were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;245,648&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;243,631&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;In-process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,120&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,080&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Procurement contracts and agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,013&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We monitor the phases of development of our acquired in-process research and development projects, including the risks associated with further development and the amount and timing of benefits expected to be derived from the completed projects. Incremental costs associated with development are charged to expense as incurred. Capitalized costs are amortized over the estimated useful life of the developed asset once completed. Our in-process research and development projects are reviewed for impairment annually, or more frequently, if events or changes in circumstances indicate that the asset might be impaired. We did not record any impairment of indefinite lived intangible assets during the three months ended March&#160;31, 2023. In-process research and development, procurement contracts and agreements are included in Other intangibles, net on the Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Based on our experience with similar agreements, we believe that our acquired procurement contracts and agreements have indefinite useful lives, as we expect to continue to renew these contracts for the foreseeable future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate our goodwill and non-amortizing intangible assets for impairment on an annual basis during the fourth quarter of the year, and, if necessary, during interim periods if factors indicate that an impairment review is warranted. As of March&#160;31, 2023 we concluded that our assessment of current factors did not indicate that goodwill or non-amortizing intangible assets are more likely than not to be impaired. We will continue to evaluate the recoverability of these non-amortizing intangible assets in future periods as necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022 the carrying value of goodwill, all of which is related to our Medical Devices segment, was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Medical Devices Segment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;243,631&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;245,648&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Definite Lived Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The definite lived intangible assets balance includes balances related to acquired technology, customer relationships, distribution and manufacturing rights and know-how, patents, and other definite lived intangible assets. As of March&#160;31, 2023 and December&#160;31, 2022 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted Average&lt;br/&gt;Useful Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Acquired technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;200,312&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;50,479&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;149,833&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Other intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Customer lists and relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31,068&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,489&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,579&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Distribution and manufacturing rights and know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,455&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,353&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,102&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,286&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,192&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,094&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,822&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,923&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,899&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;50,631&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;23,957&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;26,674&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted Average&lt;br/&gt;Useful Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Acquired technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;198,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;47,157&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;151,263&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Other intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Customer lists and relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31,030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,930&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Distribution and manufacturing rights and know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,274&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,796&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,478&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,246&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,180&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,066&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,543&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,817&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;49,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;22,619&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;27,291&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Amortization Expense &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive Loss (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 scheduled amortization of intangible assets for the next five years is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remainder&lt;br/&gt;of 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2NQ_058719f7-9923-4481-9b06-288019125815">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022 the carrying values of our indefinite lived intangible assets were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;245,648&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;243,631&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;In-process R&amp;amp;D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,120&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,080&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Procurement contracts and agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,013&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,013&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
    <us-gaap:Goodwill
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMS0xLTEtMS01NDk5Mw_6f2015c7-c920-4a7b-b3f0-943cbce6fa54"
      unitRef="usd">245648000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMS0zLTEtMS01NDk5Mw_e23cddaf-e6ac-46a5-897a-f6fbbb864e9c"
      unitRef="usd">243631000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i2c6dba73291e448e8f57ab1bc8a6db08_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMi0xLTEtMS01NDk5Mw_803549c0-7850-46ae-9948-7883323402c9"
      unitRef="usd">2120000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i79506f115b764903b5b77aff6438f481_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMi0zLTEtMS01NDk5Mw_2f6541c5-535f-4f3c-9fa5-c56b2fe9053c"
      unitRef="usd">2080000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ie93b31b47b134081a15dded0e238e7c8_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMy0xLTEtMS01NDk5Mw_be84f597-8cbb-4a56-a64a-6ae12ff494e8"
      unitRef="usd">2013000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="idfdcdca476ee4794a47f75b9b0908a9f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmRmMGQyNmZiNjQ3ZDQ5MGE5OTQ0Mjg5ZjcwNzBmMjA5L3RhYmxlcmFuZ2U6ZGYwZDI2ZmI2NDdkNDkwYTk5NDQyODlmNzA3MGYyMDlfMy0zLTEtMS01NDk5Mw_5e4448c5-5af0-4f0f-b865-391f3e4b3374"
      unitRef="usd">2013000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2Ng_701c1361-47c8-4a96-8679-d7050f12d5fa">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022 the carrying value of goodwill, all of which is related to our Medical Devices segment, was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.718%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.082%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Medical Devices Segment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;243,631&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Foreign currency translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;245,648&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjQzYjIwYmY3OTU3NzRjZWU5ZjkyZGMxMDBkOWZlZGJjL3RhYmxlcmFuZ2U6NDNiMjBiZjc5NTc3NGNlZTlmOTJkYzEwMGQ5ZmVkYmNfMS0xLTEtMS01NDk5Mw_2a3c6549-ca08-4da5-8bd8-6ef91f3b8b64"
      unitRef="usd">243631000</us-gaap:Goodwill>
    <us-gaap:GoodwillForeignCurrencyTranslationGainLoss
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjQzYjIwYmY3OTU3NzRjZWU5ZjkyZGMxMDBkOWZlZGJjL3RhYmxlcmFuZ2U6NDNiMjBiZjc5NTc3NGNlZTlmOTJkYzEwMGQ5ZmVkYmNfMi0xLTEtMS01NDk5Mw_344bdc3b-60a4-4c4d-aa73-0de06297ecb7"
      unitRef="usd">2017000</us-gaap:GoodwillForeignCurrencyTranslationGainLoss>
    <us-gaap:Goodwill
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjQzYjIwYmY3OTU3NzRjZWU5ZjkyZGMxMDBkOWZlZGJjL3RhYmxlcmFuZ2U6NDNiMjBiZjc5NTc3NGNlZTlmOTJkYzEwMGQ5ZmVkYmNfMy0xLTEtMS01NDk5Mw_fc7e6999-94dd-41f0-87a4-59270f7cf3fe"
      unitRef="usd">245648000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2Nw_f3f7d13d-c237-4f62-9b4f-5c5cfa69d94c">As of March&#160;31, 2023 and December&#160;31, 2022 the gross carrying values, accumulated amortization, and approximate amortization period of our definite lived intangible assets were as follows (in thousands, except weighted average useful life): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted Average&lt;br/&gt;Useful Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Acquired technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;200,312&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;50,479&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;149,833&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Other intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Customer lists and relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31,068&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,489&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,579&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Distribution and manufacturing rights and know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,455&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,353&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,102&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,286&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,192&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,094&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,822&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,923&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,899&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;50,631&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;23,957&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;26,674&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.080%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.002%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.006%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net Carrying &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted Average&lt;br/&gt;Useful Life&lt;br/&gt;(Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Acquired technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;198,420&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;47,157&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;151,263&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Other intangibles:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Customer lists and relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;31,030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,930&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Distribution and manufacturing rights and know-how&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,274&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,796&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,478&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Patents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,246&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,180&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,066&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,360&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,543&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,817&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.4&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total other intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;49,910&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;22,619&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;27,291&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;10.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4136c9e254424e49b35b6472a39e43cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMS0yLTEtMS01NDk5Mw_e457ebb3-65e5-40c9-b43c-293c3679276f"
      unitRef="usd">200312000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4136c9e254424e49b35b6472a39e43cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMS00LTEtMS01NDk5Mw_8b1ca841-220c-4b04-9783-47cae8589c9a"
      unitRef="usd">50479000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i4136c9e254424e49b35b6472a39e43cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMS02LTEtMS01NDk5Mw_438a3bf2-9b5d-44ca-8049-ee3c65b57c54"
      unitRef="usd">149833000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4a48d6cb9ff746b094b85d9a721d7be5_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMS04LTEtMS01NDk5Mw_cf39e93e-ffc8-40f4-92fc-46a0e1b4f33d">P18Y2M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8dd274f665ea4e7683e9b456604be8cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMy0yLTEtMS01NDk5Mw_0504e9a1-49e8-4394-b23d-3be679843c19"
      unitRef="usd">31068000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8dd274f665ea4e7683e9b456604be8cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMy00LTEtMS01NDk5Mw_6ec375a5-1a24-44ef-9a4f-a271736257a7"
      unitRef="usd">11489000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8dd274f665ea4e7683e9b456604be8cf_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMy02LTEtMS01NDk5Mw_d8d1351c-b165-4cfa-b6e9-dc845db42a29"
      unitRef="usd">19579000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7c38d20648d74b51a72771f63edb7c84_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfMy04LTEtMS01NDk5Mw_b139d60e-18f1-431c-8c6d-fe2317a25cbe">P20Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i31c830db6dc5484fad7ab16e160c2aff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNC0yLTEtMS01NDk5Mw_012365be-bfdb-4330-8fe1-9efb732fee09"
      unitRef="usd">9455000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i31c830db6dc5484fad7ab16e160c2aff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNC00LTEtMS01NDk5Mw_ed942790-025b-4ff1-bd5f-13ee38a60b88"
      unitRef="usd">6353000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i31c830db6dc5484fad7ab16e160c2aff_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNC02LTEtMS01NDk5Mw_17829230-d042-4a68-9033-b0d0a2079ebf"
      unitRef="usd">3102000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if024f14950384826b773eb09bb2b089c_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNC04LTEtMS01NDk5Mw_43e7fe08-e4ed-4c04-9270-e99916b5e7c2">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8a2765316f314fceb7d349c3f5a72808_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNS0yLTEtMS01NDk5Mw_e3a24379-70e6-4fd2-aef7-8b8633a0d240"
      unitRef="usd">4286000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8a2765316f314fceb7d349c3f5a72808_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNS00LTEtMS01NDk5Mw_c8f4c6ca-b641-437e-8a7a-07dc99a5c4d0"
      unitRef="usd">3192000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8a2765316f314fceb7d349c3f5a72808_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNS02LTEtMS01NDk5Mw_1f82c086-9a2a-4c4e-b0fd-36fd9058e72b"
      unitRef="usd">1094000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia4c9d1fe9fed440d85fc4a9e9e993bd5_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNS04LTEtMS01NDk5Mw_be4b428b-a07f-4b9b-bb72-4e5c8e8a8116">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i66f8ed83f3d44b89bdc1f649e920bcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNi0yLTEtMS01NDk5Mw_5b263d49-3cd7-4e5a-b8af-58a41f2e73ee"
      unitRef="usd">5822000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i66f8ed83f3d44b89bdc1f649e920bcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNi00LTEtMS01NDk5Mw_0fdf294e-75ae-4a31-9e64-d1b37924b1b3"
      unitRef="usd">2923000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i66f8ed83f3d44b89bdc1f649e920bcad_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNi02LTEtMS01NDk5Mw_e934de77-7ebe-47e8-88c8-9da63d6c3e15"
      unitRef="usd">2899000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i52d7e0b1e38944d8b119d3830e7326b9_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNi04LTEtMS01NDk5Mw_63e35c8f-d37b-4497-804d-e0b7246e072c">P4Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idf585199079741d2ad24baa4508e7b79_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNy0yLTEtMS01NDk5Mw_903d109a-8b44-4f3e-99bf-d8b9118fa6eb"
      unitRef="usd">50631000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idf585199079741d2ad24baa4508e7b79_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNy00LTEtMS01NDk5Mw_113e9718-c8a9-42a2-a850-6ed312575ac9"
      unitRef="usd">23957000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idf585199079741d2ad24baa4508e7b79_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNy02LTEtMS01NDk5Mw_58f45cb6-7ac4-4632-9572-ce701c067345"
      unitRef="usd">26674000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i225c6055e6e34ecc8ff6267a3e5c52cb_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmQ2NTk2MDhmM2U1NTRjZGI5NDE0MDkzOWQ2MTU4NjhmL3RhYmxlcmFuZ2U6ZDY1OTYwOGYzZTU1NGNkYjk0MTQwOTM5ZDYxNTg2OGZfNy04LTEtMS01NDk5Mw_aa5fa6a1-57ee-4e04-ba79-ed9d50d3def6">P10Y2M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3e7ccf2f59bf4c329c1dd9a597525246_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMS0yLTEtMS01NDk5Mw_a0f801ec-1dc9-4776-9915-69d01468c83d"
      unitRef="usd">198420000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3e7ccf2f59bf4c329c1dd9a597525246_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMS00LTEtMS01NDk5Mw_427f6261-526b-437f-8b72-f05488a85f72"
      unitRef="usd">47157000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i3e7ccf2f59bf4c329c1dd9a597525246_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMS02LTEtMS01NDk5Mw_cd9421e4-18a8-41d3-b67a-a16be232667d"
      unitRef="usd">151263000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i1a6a965e9f9b4929b0346378e7446b64_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMS04LTEtMS01NDk5Mw_22ab8af6-0df4-4074-ac1a-355c88e0e547">P18Y2M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic3329eed5890493eaa1e7419306565e2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMy0yLTEtMS01NDk5Mw_6d1c9a96-952e-437b-af52-88f9337fed42"
      unitRef="usd">31030000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic3329eed5890493eaa1e7419306565e2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMy00LTEtMS01NDk5Mw_f4ab6133-c883-41d5-aee7-cacbd99917e1"
      unitRef="usd">11100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic3329eed5890493eaa1e7419306565e2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMy02LTEtMS01NDk5Mw_cfb22385-5b76-45f4-8908-3ec084163c6e"
      unitRef="usd">19930000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id934e39711ff42389941ee999e64276a_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfMy04LTEtMS01NDk5Mw_fe596c2f-823c-49ca-815f-f4218288bee4">P20Y6M</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i261990d377b24cd39e6196259557695b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNC0yLTEtMS01NDk5Mw_713e08f0-c508-4d75-a951-103c631a6f73"
      unitRef="usd">9274000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i261990d377b24cd39e6196259557695b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNC00LTEtMS01NDk5Mw_943611f6-cd46-4e77-ae7f-0188a0125501"
      unitRef="usd">5796000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i261990d377b24cd39e6196259557695b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNC02LTEtMS01NDk5Mw_332e9d36-e166-43ee-9872-01d6bdcc3f77"
      unitRef="usd">3478000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i34a04e6aff414a2493a8ecbef5858fb2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNC04LTEtMS01NDk5Mw_0b51a31d-456b-4cb1-9d45-5a327406cfdf">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="idcb5f46ffb5a46dba6a079186a59afa2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNS0yLTEtMS01NDk5Mw_50b08f2f-1eb6-40e2-bfba-287ba2aab9e4"
      unitRef="usd">4246000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="idcb5f46ffb5a46dba6a079186a59afa2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNS00LTEtMS01NDk5Mw_a08765ca-2a6a-4c3a-8f3d-f60d030bb088"
      unitRef="usd">3180000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="idcb5f46ffb5a46dba6a079186a59afa2_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNS02LTEtMS01NDk5Mw_a569e87a-406f-419e-8c12-9e556b112e44"
      unitRef="usd">1066000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i78d3a75cb5e242e999b5d7a86b03fb8c_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNS04LTEtMS01NDk5Mw_549cea5e-4ab7-431e-821d-feb7c26858c4">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie3b14dd7eb30490fab897cf536448da7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNi0yLTEtMS01NDk5Mw_a31cba17-8098-4d10-8187-b7e4ebc67814"
      unitRef="usd">5360000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie3b14dd7eb30490fab897cf536448da7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNi00LTEtMS01NDk5Mw_46dce217-e892-4bd4-af0b-54ba610069b2"
      unitRef="usd">2543000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie3b14dd7eb30490fab897cf536448da7_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNi02LTEtMS01NDk5Mw_61cb165e-8eba-4e55-aa5d-a83d41904943"
      unitRef="usd">2817000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9f4a2ffeb0704db5bbaba540ed9732b7_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNi04LTEtMS01NDk5Mw_1592ffb7-a584-46c6-8906-e7a43ed8c7cf">P4Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i1555b8edf0a442659291ed6e92593f09_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNy0yLTEtMS01NDk5Mw_f152e861-9107-4591-8be7-4b02b6636239"
      unitRef="usd">49910000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i1555b8edf0a442659291ed6e92593f09_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNy00LTEtMS01NDk5Mw_c5dccbaf-c9cb-4ee0-8b93-0ac55357fed4"
      unitRef="usd">22619000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i1555b8edf0a442659291ed6e92593f09_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNy02LTEtMS01NDk5Mw_a5caa0e6-2de7-4d26-9ba6-873716ef8de6"
      unitRef="usd">27291000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="idc88d943c8ff4e8d852e826c95138da2_D20220101-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjk3YjdkYjRlODY0YzQzYzZhNzQ4NWQyMzlkZGFjN2NkL3RhYmxlcmFuZ2U6OTdiN2RiNGU4NjRjNDNjNmE3NDg1ZDIzOWRkYWM3Y2RfNy04LTEtMS01NDk5Mw_1c360761-e200-462b-ac06-fb2d5526aa3d">P10Y3M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2OA_4e5b14f4-c1a6-42e9-a5fa-a1b81f8c345b">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of amortization expense as recorded in General, administrative, and marketing expenses on our Condensed Consolidated Statement of Operations and Comprehensive Loss (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.807%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.142%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.143%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,084&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmNkNTE4ZTNiODAyYzQxZDc4NTIyZmE0NjRmNTI0Yzc4L3RhYmxlcmFuZ2U6Y2Q1MThlM2I4MDJjNDFkNzg1MjJmYTQ2NGY1MjRjNzhfMi0xLTEtMS01NDk5Mw_8300bfd1-19ce-48f3-b3f2-5980cf2cbcb2"
      unitRef="usd">3882000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOmNkNTE4ZTNiODAyYzQxZDc4NTIyZmE0NjRmNTI0Yzc4L3RhYmxlcmFuZ2U6Y2Q1MThlM2I4MDJjNDFkNzg1MjJmYTQ2NGY1MjRjNzhfMi0zLTEtMS01NDk5Mw_463fd0dd-a33b-4cfc-a24a-86a65716fd77"
      unitRef="usd">4084000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RleHRyZWdpb246MGM1NjMwMzkyNzVhNGE1Yjg4OGNiMWYxMjc5YjE4ZDRfMjk2OQ_90dc86da-f788-4d1a-93cf-e23681e8a22f">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 scheduled amortization of intangible assets for the next five years is as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.960%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.965%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Remainder&lt;br/&gt;of 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,504&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS0xLTEtMS01NDk5Mw_9c22d8b5-3ffb-4ed8-a602-7604216f2427"
      unitRef="usd">11358000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS0zLTEtMS01NDk5Mw_2983d964-7f6f-4a7d-afde-c505a346bdf4"
      unitRef="usd">14802000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS01LTEtMS01NDk5Mw_3b833477-d273-4147-812b-7cafb7867def"
      unitRef="usd">12832000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS03LTEtMS01NDk5Mw_d7ddf1ad-f921-44f8-a323-3b9ab921b142"
      unitRef="usd">12606000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS05LTEtMS01NDk5Mw_ba7a6e0c-d352-4fe6-afc2-7a4f9f0bc9b2"
      unitRef="usd">12504000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS0xMS0xLTEtNTQ5OTM_a3be039b-04df-471b-8699-cff04b0666fb"
      unitRef="usd">12388000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <aort:FiniteLivedIntangibleAssetsAmortizationExpenseEstimate
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180Ni9mcmFnOjBjNTYzMDM5Mjc1YTRhNWI4ODhjYjFmMTI3OWIxOGQ0L3RhYmxlOjAxNWViY2JjNDA3ZTRkNzQ5ODM2MzZlN2EwNWQ2NWZiL3RhYmxlcmFuZ2U6MDE1ZWJjYmM0MDdlNGQ3NDk4MzYzNmU3YTA1ZDY1ZmJfMS0xMy0xLTEtNTQ5OTM_992da824-9248-4cb1-ae18-1cbdc981fff8"
      unitRef="usd">76490000</aort:FiniteLivedIntangibleAssetsAmortizationExpenseEstimate>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTU3NQ_8bfc6564-4b9a-4887-9f5e-7bdc150d1163">Income Taxes &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Tax Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective income tax rate was an expense of 52% and 40% for the three months ended March&#160;31, 2023 and 2022, respectively. Our income tax rate for the three months ended March&#160;31, 2023 and 2022 was primarily impacted by changes in our valuation allowance against our net deferred tax assets, non-deductible executive compensation, the foreign derived intangible income deduction, the research and development tax credit, changes in our uncertain tax position liabilities, and tax shortfalls on stock compensation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate deferred tax assets primarily as a result of finance and operating leases, net operating losses, excess interest carryforward, accrued compensation, and stock compensation. Our deferred tax liabilities are primarily comprised of intangible assets acquired in previous years, finance and operating leases, and unrealized gains and losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintained a net deferred tax liability of $21.5 million and $23.2 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively. Our valuation allowance against our deferred tax assets was $19.6 million and $17.9 million as of March&#160;31, 2023 and December&#160;31, 2022, respectively, primarily related to net operating loss carryforwards and disallowed excess interest carryforwards.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfODE_c138e332-c08f-41ab-a7ae-bb22e40d33ff"
      unitRef="number">0.52</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfNTQ5NzU1ODE1NDg4_efee29c4-988b-4552-b20f-331664008647"
      unitRef="number">0.40</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:DeferredTaxLiabilities
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTMzNQ_73dcc0b6-64ee-4fb0-b67c-d24251a569c0"
      unitRef="usd">21500000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTM0Mg_5b929c40-1cd3-4a58-8384-7e8a86bfb7c9"
      unitRef="usd">23200000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTQzNg_d2476be5-4e24-4876-9957-f63c7ad9bfda"
      unitRef="usd">19600000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M180OS9mcmFnOjE1MzczMTFkOTFmOTQ2ZTI5ZDJkMjA2NzU5YWYzYzFlL3RleHRyZWdpb246MTUzNzMxMWQ5MWY5NDZlMjlkMmQyMDY3NTlhZjNjMWVfMTQ0Mw_b6f0b9c7-d196-4bb3-a368-72011052e162"
      unitRef="usd">17900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYyMg_548aff42-6532-4a9b-a251-b311bd7a0ab0">Leases We have operating and finance lease obligations resulting from the lease of land and buildings that comprise our corporate headquarters and various manufacturing facilities; leases related to additional manufacturing, office, and warehouse space; leases on company vehicles; and leases on a variety of office and other equipment.&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to leases included in the Condensed Consolidated Balance Sheets was as follows (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;56,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;56,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(15,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(14,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating lease right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;41,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;41,859&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Current maturities of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Non-current maturities of operating leases &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;41,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;44,172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;44,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(2,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(2,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,854&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Current maturities of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Non-current maturities of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,157&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current maturities of finance leases are included as a component of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_2e5b36fd-c488-467a-a7e5-80e362ee1e08"&gt;&lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOA_c3cbd70e-0a04-4d24-ab66-5fb27dcd22e3"&gt;Other current liabilities&lt;/span&gt;&lt;/span&gt; on our Condensed Consolidated Balance Sheets. A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Amortization of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;131&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;137&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Interest expense on finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,920&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;1,954&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;1,990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our cash flow information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,796&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;132&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;130&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments and sublease rental income are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;442&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;606&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,819&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;585&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,620&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;566&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,008&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;561&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,867&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;37,103&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,430&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;62,663&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(18,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Present value of net minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;44,172&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Lease liabilities, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,582&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,774&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <aort:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxNw_dc4cefaf-b263-47fd-9480-58c1886a8288">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to leases included in the Condensed Consolidated Balance Sheets was as follows (in thousands, except lease term and discount rate):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.172%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;56,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;56,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(15,137)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(14,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating lease right-of-use assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;41,473&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;41,859&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Current maturities of operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Non-current maturities of operating leases &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;41,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;44,172&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;44,565&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Property and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;6,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(2,679)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(2,498)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,854&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,910&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Current maturities of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Non-current maturities of finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;3,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,108&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,157&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted average remaining lease term (in years):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;7.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;7.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.8%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</aort:AssetsAndLiabilitiesLesseeTableTextBlock>
    <aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMS0xLTEtMS01NDk5Mw_7b6b2c4f-acf6-42e4-8e2c-5db5ef6b475f"
      unitRef="usd">56610000</aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMS0zLTEtMS01NDk5Mw_695bf432-c80c-4c0f-a9ea-9a45c18716dc"
      unitRef="usd">56061000</aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMi0xLTEtMS01NDk5Mw_77965f69-b00b-46d6-9c9f-d2d0c966e39f"
      unitRef="usd">15137000</aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMi0zLTEtMS01NDk5Mw_9d0118b1-e7c9-4a54-8d08-ebf30b48fbce"
      unitRef="usd">14202000</aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMy0xLTEtMS01NDk5Mw_5b94509c-b4f4-419c-b7b3-de3c4d89cb4a"
      unitRef="usd">41473000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMy0zLTEtMS01NDk5Mw_ddc09698-c38b-4baf-beba-53917c5e166d"
      unitRef="usd">41859000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNS0xLTEtMS01NDk5Mw_abf3f993-7ed7-470e-8611-ffb0cff25d53"
      unitRef="usd">3398000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNS0zLTEtMS01NDk5Mw_3cf6ef69-a379-4fbd-912f-d684ed73eb3b"
      unitRef="usd">3308000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNi0xLTEtMS01NDk5Mw_aad84070-d64a-4de4-9704-341c2ab48945"
      unitRef="usd">40774000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNi0zLTEtMS01NDk5Mw_562ebd9a-7cb8-4524-a655-63cb8e238bb8"
      unitRef="usd">41257000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNy0xLTEtMS01NDk5Mw_6e833334-7fe1-4350-b3fa-bc27b9943b60"
      unitRef="usd">44172000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfNy0zLTEtMS01NDk5Mw_616e2c51-36da-4b34-9760-9c6e373a11c4"
      unitRef="usd">44565000</us-gaap:OperatingLeaseLiability>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTAtMS0xLTEtNTQ5OTM_c48b856c-d7c7-4eec-a47b-7507719b4181"
      unitRef="usd">6533000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTAtMy0xLTEtNTQ5OTM_0bcf181e-89d8-433b-b1c8-006b0b8dec1d"
      unitRef="usd">6408000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTEtMS0xLTEtNTQ5OTM_94499bbe-c61e-4d14-b343-0598e7e735b1"
      unitRef="usd">2679000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTEtMy0xLTEtNTQ5OTM_60903011-8f15-4b28-ab53-d5f03283855a"
      unitRef="usd">2498000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTItMS0xLTEtNTQ5OTM_a08104f6-fe6e-419b-b6d0-56f29cd36bc6"
      unitRef="usd">3854000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTItMy0xLTEtNTQ5OTM_76cf0d19-e382-456c-bd0c-1cbb0dff5616"
      unitRef="usd">3910000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTQtMS0xLTEtNTQ5OTM_87aee7c2-ae91-4a8d-8233-0c4f1362bc5b"
      unitRef="usd">526000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTQtMy0xLTEtNTQ5OTM_1d34443d-d448-4c0e-92a3-16e6139f3f13"
      unitRef="usd">513000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTUtMS0xLTEtNTQ5OTM_1b1512d5-a2f7-4c11-b06e-521cba9bb96e"
      unitRef="usd">3582000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTUtMy0xLTEtNTQ5OTM_f7406479-a928-41f8-b152-e70f595913e8"
      unitRef="usd">3644000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTYtMS0xLTEtNTQ5OTM_6009117e-a1d9-4568-b874-532861d4ff6b"
      unitRef="usd">4108000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTYtMy0xLTEtNTQ5OTM_08dbd30b-e168-431a-9823-1e2f7c1bb14d"
      unitRef="usd">4157000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTktMS0xLTEtNTQ5OTM_ec88a3ae-8f18-40a2-b993-d7182c7c4082">P11Y8M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMTktMy0xLTEtNTQ5OTM_8d3f1e63-17d7-4906-a5de-c324cb723d24">P11Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjAtMS0xLTEtNTQ5OTM_f509441f-18a2-467f-b21a-dbff2a19be46">P7Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjAtMy0xLTEtNTQ5OTM_1df7c112-1359-49dc-beff-1039e1128f48">P7Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjMtMS0xLTEtNTQ5OTM_bc534e98-9361-48dd-a4e6-23bfc3907909"
      unitRef="number">0.058</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjMtMy0xLTEtNTQ5OTM_8f1bf321-414e-414b-9c6e-2cef46cf1f01"
      unitRef="number">0.059</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjQtMS0xLTEtNTQ5OTM_ac29d664-6706-4c71-8cdf-70aef43f1877"
      unitRef="number">0.021</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjJlMmExNmEzYjEwYTQ4MGRiOGE1MzAzNjI1OWQ2OTdjL3RhYmxlcmFuZ2U6MmUyYTE2YTNiMTBhNDgwZGI4YTUzMDM2MjU5ZDY5N2NfMjQtMy0xLTEtNTQ5OTM_f08d61ed-83cc-410f-af10-e6abf792d9f8"
      unitRef="number">0.021</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYxOQ_9b7e55df-5ac2-44a8-9639-19d24806a577">A summary of lease expenses for our finance and operating leases included in General, administrative, and marketing expenses on our Condensed Consolidated Statements of Operations and Comprehensive Loss was as follows (in thousands): &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.737%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.101%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.558%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Amortization of property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;131&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;137&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Interest expense on finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total finance lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;162&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,802&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,920&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;1,954&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;1,990&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of our cash flow information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,796&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,525&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Financing cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;132&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;130&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Operating cash flows for finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;21&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;24&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfMi0xLTEtMS01NDk5Mw_2f1653cb-ba66-4fca-8f51-da0f5ccd4f32"
      unitRef="usd">131000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfMi0zLTEtMS01NDk5Mw_be9ff0ca-b4f9-4d15-a375-cf6b6165c31a"
      unitRef="usd">137000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfMy0xLTEtMS01NDk5Mw_1c3ef568-4c5e-4b97-89ee-2ab012227c3e"
      unitRef="usd">21000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfMy0zLTEtMS01NDk5Mw_11a356b2-5e44-40e6-ad7f-fa0ab1e865aa"
      unitRef="usd">25000</us-gaap:FinanceLeaseInterestExpense>
    <aort:FinanceLeaseCost
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNC0xLTEtMS01NDk5Mw_6d95a218-fc11-4de0-ab6e-5bab67dbde08"
      unitRef="usd">152000</aort:FinanceLeaseCost>
    <aort:FinanceLeaseCost
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNC0zLTEtMS01NDk5Mw_71af75b5-b3a4-4931-a45f-8e0923884093"
      unitRef="usd">162000</aort:FinanceLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNS0xLTEtMS01NDk5Mw_49684180-2ab9-4958-89fe-cd01e09a6447"
      unitRef="usd">1802000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNS0zLTEtMS01NDk5Mw_5323ef3a-c0ea-4951-ad48-d4963384178d"
      unitRef="usd">1920000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNi0xLTEtMS01NDk5Mw_da3e5bf3-b013-47b9-a26a-e7f7de3402ea"
      unitRef="usd">0</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNi0zLTEtMS01NDk5Mw_79f163a7-0538-47d5-a00e-f75645f6c503"
      unitRef="usd">92000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNy0xLTEtMS01NDk5Mw_aca15001-292d-4360-bca6-95f2cd50ac70"
      unitRef="usd">1954000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjg5NmFkZGFjZDdlZjQ4MmE4Mjg4ZGNiYWRiZGFjZDJlL3RhYmxlcmFuZ2U6ODk2YWRkYWNkN2VmNDgyYTgyODhkY2JhZGJkYWNkMmVfNy0zLTEtMS01NDk5Mw_d933db98-f669-49fe-8610-3914aaf08e41"
      unitRef="usd">1990000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfMi0xLTEtMS01NDk5Mw_3534bf5a-ef52-4345-8dfa-b21fadb0718c"
      unitRef="usd">1796000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfMi0zLTEtMS01NDk5Mw_61798fe1-02ad-4d90-846c-5812c5dccfe8"
      unitRef="usd">1525000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfMy0xLTEtMS01NDk5Mw_04f4f9a3-ef7f-46cb-9d4f-d4c3daf81b84"
      unitRef="usd">132000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfMy0zLTEtMS01NDk5Mw_27c02276-1f20-4bf3-a6e6-281c85c61e4a"
      unitRef="usd">130000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfNC0xLTEtMS01NDk5Mw_e36a8a00-c10f-4423-95c4-428ec3c94c84"
      unitRef="usd">21000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjlmYjA5ODI5MzI2OTQyN2M4ZjRlZmUwODdjYjY4YmRjL3RhYmxlcmFuZ2U6OWZiMDk4MjkzMjY5NDI3YzhmNGVmZTA4N2NiNjhiZGNfNC0zLTEtMS01NDk5Mw_8237461b-75b2-494f-991a-f1c72d05522d"
      unitRef="usd">24000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYyMQ_00ed2207-213a-4d0f-8e04-537b7b292ecf">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments and sublease rental income are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;442&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;606&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,819&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;585&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,620&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;566&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,008&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;561&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,867&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;37,103&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,430&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;62,663&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(18,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Present value of net minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;44,172&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Lease liabilities, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,582&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,774&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RleHRyZWdpb246MzcxODhmYmEyYWJmNDRkM2E4OWRiZGM3MTFiY2RkNmZfMTYyMQ_284b8fdc-d90b-4456-9f51-a078881d24a9">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future minimum lease payments and sublease rental income are as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Finance&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Operating&lt;br/&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;442&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;606&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,819&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;585&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,620&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;566&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;5,008&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;561&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,867&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,670&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;37,103&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;4,430&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;62,663&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less amount representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(322)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(18,491)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Present value of net minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4,108&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;44,172&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Lease liabilities, less current maturities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,582&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,774&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMS0xLTEtMS01NDk5Mw_a385393a-f5f7-46a7-9aac-f2cb9839151f"
      unitRef="usd">442000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMS0zLTEtMS01NDk5Mw_3f5fd458-72f2-450e-8be1-289d86eabba5"
      unitRef="usd">4246000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMi0xLTEtMS01NDk5Mw_ebf358e2-a3e1-4534-b29a-246490c6a037"
      unitRef="usd">606000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMi0zLTEtMS01NDk5Mw_25178329-3294-4ff7-be6e-841e2820c30a"
      unitRef="usd">5819000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMy0xLTEtMS01NDk5Mw_38c4c783-4896-4b07-b5be-6ff9c76dca74"
      unitRef="usd">585000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMy0zLTEtMS01NDk5Mw_3b62e269-516d-4610-9638-471c5c3f5b33"
      unitRef="usd">5620000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNC0xLTEtMS01NDk5Mw_fbad910d-c5e5-42ac-bcb7-7eb1068ca99f"
      unitRef="usd">566000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNC0zLTEtMS01NDk5Mw_9654d5ac-3519-4101-81cd-954f6fb1fcbb"
      unitRef="usd">5008000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNS0xLTEtMS01NDk5Mw_dca55fc1-04bf-43df-bae3-7d648269cb2e"
      unitRef="usd">561000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNS0zLTEtMS01NDk5Mw_9e844b72-19f0-46b8-a5eb-0b67f4f7090c"
      unitRef="usd">4867000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <aort:FinanceLeaseLiabilityToBePaidAfterYearFour
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNi0xLTEtMS01NDk5Mw_b2119f8d-2eda-4d7e-a706-ab4d7443cd60"
      unitRef="usd">1670000</aort:FinanceLeaseLiabilityToBePaidAfterYearFour>
    <aort:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNi0zLTEtMS01NDk5Mw_5ecda146-bfdd-471a-b0b4-e922c1d6153a"
      unitRef="usd">37103000</aort:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNy0xLTEtMS01NDk5Mw_ae27440f-7d0d-451e-971f-1f656adc3d5d"
      unitRef="usd">4430000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfNy0zLTEtMS01NDk5Mw_053733ed-8a67-47c4-abf5-4b4f7854b0e4"
      unitRef="usd">62663000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfOC0xLTEtMS01NDk5Mw_8081551d-389d-4e02-9ff8-9208b527fdc4"
      unitRef="usd">322000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfOC0zLTEtMS01NDk5Mw_4e5cf3a6-085c-4ff0-963e-45bbb0f110dd"
      unitRef="usd">18491000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiability
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfOS0xLTEtMS01NDk5Mw_3ac550c8-8a8c-4ca6-8051-ff5e167ebc09"
      unitRef="usd">4108000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfOS0zLTEtMS01NDk5Mw_171ed910-43da-43d2-9c21-2a65055aa124"
      unitRef="usd">44172000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMTAtMS0xLTEtNTQ5OTM_d789f3f9-32a4-4388-b7c5-2014419df757"
      unitRef="usd">526000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMTAtMy0xLTEtNTQ5OTM_6f7eed70-6c56-4a4d-b8d4-e86e4a630f62"
      unitRef="usd">3398000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMTEtMS0xLTEtNTQ5OTM_7c2decc5-39f7-4bef-b6bd-3438afacdee9"
      unitRef="usd">3582000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181Mi9mcmFnOjM3MTg4ZmJhMmFiZjQ0ZDNhODlkYmRjNzExYmNkZDZmL3RhYmxlOjFhOTRkNWNkNDcxYTQ0NDk4MjRjYzNhM2RmYzhiY2IyL3RhYmxlcmFuZ2U6MWE5NGQ1Y2Q0NzFhNDQ0OTgyNGNjM2EzZGZjOGJjYjJfMTEtMy0xLTEtNTQ5OTM_312934fe-8287-42f1-b4d0-2d822cc235d7"
      unitRef="usd">40774000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfODIyMw_982f9c74-7086-4beb-88b3-c7b4e484f1e0">Debt&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December&#160;1, 2017 we entered into a credit and guaranty agreement for a $255.0 million senior secured credit facility, consisting of a $225.0 million secured term loan facility (the &#x201c;Term Loan Facility&#x201d;) and a $30.0 million secured revolving credit facility (the &#x201c;Revolving Credit Facility&#x201d; and, together with the Term Loan Facility, the &#x201c;Credit Agreement&#x201d;). We and each of our existing domestic subsidiaries (subject to certain exceptions and exclusions) guarantee the obligations under the Credit Agreement (the &#x201c;Guarantors&#x201d;). The Credit Agreement is secured by a security interest in substantially all existing and after-acquired real and personal property (subject to certain exceptions and exclusions) of us and the Guarantors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;2, 2021 we entered into an amendment to our Credit Agreement to extend the maturity dates of both our Term Loan and Revolving Credit Facility. As part of the amendment, the maturity dates of both our Term Loan and Revolving Credit Facility were each extended by two and one-half years, until June 1, 2027 and June 1, 2025, respectively, subject to earlier springing maturities triggered if our 4.25% Convertible Senior Notes, described below, remain outstanding on April 1, 2025 and December 31, 2024, respectively. With respect to the Term Loan, if the Convertible Senior Notes remain outstanding on April 1, 2025, the Term Loan&#x2019;s maturity date will be April 1, 2025, or, if the Convertible Senior Notes&#x2019; own maturity date has been extended, the earlier of (i) 91 days prior to the Convertible Senior Notes&#x2019; new maturity date and (ii) June 1, 2027. In the case of the Revolving Credit Facility, if the Convertible Senior Notes are still outstanding on December 31, 2024, the Revolving Credit Facility&#x2019;s maturity date will be either December 31, 2024 or, if the Convertible Senior Notes&#x2019; own maturity date has been extended, the earlier of (i) 182 days prior to the Convertible Senior Notes&#x2019; new maturity date and (ii) June 1, 2025. Under the amendment, the Term Loan Facility bears interest, at our option, at a floating annual rate equal to either the base rate, plus a margin of 2.50%, or LIBOR, plus a margin of 3.50%. Prior to the amendment, the optional floating annual rate was equal to either the base rate plus a margin of 2.25%, or LIBOR, plus a margin of 3.25%. We paid debt issuance costs of $2.1 million, of which $1.8 million will be amortized over the life of the Term Loan Facility and included in current and long-term debt on the Condensed Consolidated Balance Sheets. The remaining $361,000 of debt issuance costs and $474,000 of non-cash debt extinguishment costs were recorded in Interest expense on the Condensed Consolidated Statements of Operations and Comprehensive Loss. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As discussed in our Annual Report on Form 10-K for the year ended December&#160;31, 2022 the Credit Agreement contains certain customary affirmative and negative covenants, including covenants that limit our ability and the ability of our subsidiaries to, among other things, grant liens, incur debt, dispose of assets, make loans and investments, make acquisitions, make certain restricted payments (including cash dividends), merge or consolidate, change business or accounting or reporting practices, in each case subject to customary exceptions for a credit facility of this size and type. Beginning in 2021 if we repay borrowings under our Revolving Credit Facility to 25% or less, no financial maintenance covenants, including the minimum liquidity covenant and the maximum first lien net leverage ratio covenant, are applicable. We are in compliance with our debt covenants as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 19, 2022 in accordance with adopting ASU 2020-04 and 2021-01, we entered into an amendment to our Credit Agreement to replace the LIBOR based benchmark interest rate with the Secured Overnight Financing Rate (&#x201c;SOFR&#x201d;) based benchmark interest rate for our Term Loan Facility and our Revolving Credit Facility. Based on historical analysis of the differences between the benchmark rates, SOFR is adjusted to arrive at a Term SOFR rate that serves as the replacement base rate for LIBOR under our amended credit facilities. Under this amendment, at the maturity of our existing LIBOR-based loan on December 30, 2022, the interest rate at the repricing of our Term Loan Facility was calculated as Term SOFR plus a fixed percentage credit spread of 3.50%. The loan under the Revolving Credit Facility bears interest at Term SOFR plus a margin of between 4.00% and 4.25%, depending on our consolidated leverage ratio. As of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2023 &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the aggregate interest rate of the Credit Agreement was 8.66% per annum.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June&#160;18, 2020 we issued $100.0 million aggregate principal amount of 4.25% Convertible Senior Notes with a maturity date of July&#160;1, 2025 (the &#x201c;Convertible Senior Notes&#x201d;). The net proceeds from this offering, after deducting initial purchasers&#x2019; discounts and costs directly related to this offering, were approximately $96.5 million. On January 1, 2021 we adopted ASU 2020-06 and adjusted the carrying balance of the Convertible Senior Notes to notional. The Convertible Senior Notes balance was $100.0 million recorded in Long-term debt on the Condensed Consolidated Balance Sheets as of March&#160;31, 2023 and December&#160;31, 2022. The Convertible Senior Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The initial conversion rate of the Convertible Senior Notes is 42.6203 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $23.46 per share, subject to adjustments. We use the if-converted method for assumed conversion of the Convertible Senior Notes for the diluted earnings per share calculation. The fair value and the effective interest rate of the Convertible Senior Notes as of March&#160;31, 2023 was approximately $90.7 million and 5.05%, respectively. The fair value was based on market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interest expense recognized on the Convertible Senior Notes includes $1.2 million for the &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three months ended March&#160;31, 2023 and 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; related to the aggregate of the contractual coupon interest and the amortization of the debt issuance costs&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Interest on the Convertible Senior Notes began accruing upon issuance and is payable semi-annually. There were $1.7 million and $1.9 million of unamortized debt issuance costs related to Convertible Senior Notes as of March&#160;31, 2023 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2022&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the Convertible Senior Notes may convert their notes at their option at any time prior to January 1, 2025, but only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period after any five consecutive trading day period in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on each such trading day; (iii) we give a notice of redemption with respect to any or all of the notes, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate events. On or after January 1, 2025 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time, regardless of the foregoing circumstances.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We cannot redeem the Convertible Senior Notes before July 5, 2023. We can redeem them on or after July 5, 2023, in whole or in part, at our option, if the last reported sale price per share of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption. We may redeem for cash all or part of the Convertible Senior Notes at a redemption price equal to 100% of the principal amount of the redeemable Convertible Senior Notes, plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the Convertible Senior Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the Convertible Senior Notes do not contain any financial covenants and do not restrict us from conducting significant restructuring transactions or issuing or repurchasing any of its other securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loan Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The short-term and long-term balances of our Term Loan and other long-term borrowings were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Term Loan balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;213,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;213,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.45% Sparkasse Zollernalb (KFW Loan 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1.40% Sparkasse Zollernalb (KFW Loan 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total loan balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;314,109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;314,779&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less unamortized loan origination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(6,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(6,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;307,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;308,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less short-term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(1,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Long-term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;306,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;306,499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Expense&lt;/span&gt;&lt;/div&gt;Interest expense was $6.1 million and $3.9 million for the three months ended March&#160;31, 2023 and 2022, respectively. Interest expense includes interest on debt and uncertain tax positions in both periods.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i65f995e36b114f65a815c61bd66eb185_I20171201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfOTA_284074ec-b029-4c8e-865e-9006755e6f43"
      unitRef="usd">255000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i1f57c4f591b04b389e472914c7195492_I20171201"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTQx_2d8a1c4f-5542-453b-9636-7250a1aaff2e"
      unitRef="usd">225000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ic4c41e2ba6794170b867018c3fdc30de_I20171201"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjA0_343f2990-c8db-4f11-8783-b9bd3e87d037"
      unitRef="usd">30000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia34bdcd0d6c84be4827773cf070dbfa6_I20210602"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTEwMw_479714b0-b7e4-4269-b6b4-7575cd676124"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aort:DebtInstrumentExtensionCircumstancePeriod
      contextRef="ideecae1179894ead84a8360473c0cd9d_D20210602-20210602"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTQ2OA_9e58db05-7d6c-4157-937b-a0bd9b3ee82e">P91D</aort:DebtInstrumentExtensionCircumstancePeriod>
    <aort:DebtInstrumentExtensionCircumstancePeriod
      contextRef="ia668b5ef64df4c60b5d51cbb5b636f5d_D20210602-20210602"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTg0NQ_c1b2689f-7768-45ba-a64c-698991411362">P182D</aort:DebtInstrumentExtensionCircumstancePeriod>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i45eb9ce0dbf4431780b0e06047ccab97_D20210602-20210602"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjA3Nw_3a19ee73-28f0-46e5-9e9d-cfc407175edb"
      unitRef="number">0.0250</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7c108b384b6c4ed9a50513917888bcb4_D20210602-20210602"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjEwOA_87332508-dcb9-4217-8bc7-89aa1a93a431"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="ied0df1c4e0394f72aa46bda78244dc54_D20210601-20210601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjIyMQ_d23a981d-4bdd-4fa1-b6e6-3256eee4db12"
      unitRef="number">0.0225</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i1e0b9fb023d14f00a03ee59906304080_D20210601-20210601"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjI1Mg_b00b135f-d9e3-4ac4-9a19-7f7b68db19f2"
      unitRef="number">0.0325</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ieed7b0b097e2498496903c8c4c67c075_D20210602-20210602"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjI4Nw_e5682639-cd98-4af9-85c7-f2abd9650dcf"
      unitRef="usd">2100000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ieed7b0b097e2498496903c8c4c67c075_D20210602-20210602"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjMwMA_f4991e5c-9686-424d-bced-9a7a592ac911"
      unitRef="usd">1800000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="i7bfa2fe6123047d79b18fc3d9809b3a6_D20210602-20210602"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjQ2NA_d9580384-a1f4-43ca-b4f2-0add8cfa0251"
      unitRef="usd">361000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i7bfa2fe6123047d79b18fc3d9809b3a6_D20210602-20210602"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMjQ5NA_479ec94a-2685-4d9f-9952-162dc0887857"
      unitRef="usd">474000</us-gaap:ExtinguishmentOfDebtAmount>
    <aort:RevolvingCreditFacilityPercentageRepaidForNoCovenants
      contextRef="i5fd78494bf304f19b2f857c42b606fbc_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMzMxMA_90705e52-e191-434a-b674-3a8fd4a660b0"
      unitRef="number">0.25</aort:RevolvingCreditFacilityPercentageRepaidForNoCovenants>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i662e0658aa8247cd94c867b2227ab80a_D20221219-20221219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTA5OTUxMTY0MDI5MA_56c8986f-feb0-4936-8c12-0523ee7d62f8"
      unitRef="number">0.0350</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="id234474f9a60494f90af8c621f315f96_D20221219-20221219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTA5OTUxMTY0MDI5Nw_a8acd739-37c9-40e7-af55-357a5ad5d06a"
      unitRef="number">0.0400</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i19a8334307424620aa3c250d4ca58b1b_D20221219-20221219"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMTA5OTUxMTY0MDMwNA_3a056c2f-142b-4367-a642-46636af49514"
      unitRef="number">0.0425</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i782ff58a89804bf0b00b3bdac6676855_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTQ5NzU1ODI1MTMw_928e8d3e-bff9-4ea4-bdb5-5814e8436922"
      unitRef="number">0.0866</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ia3124cad286644aab11fa66ae00f4ef1_I20200618"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMzU2OA_727087a4-58a7-4820-ae8e-49cb7b02c8d1"
      unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia3124cad286644aab11fa66ae00f4ef1_I20200618"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMzYwMQ_7d9a3b09-6686-4cb7-94b6-36299568aa7c"
      unitRef="number">0.0425</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromConvertibleDebt
      contextRef="id7abca8345f249998cb27b9c944935cc_D20200618-20200618"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfMzgzNw_37a3ae4f-3440-45ad-82c9-c813688670d0"
      unitRef="usd">96500000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:LongTermDebt
      contextRef="i5fb16f084b93484db1e521afa59177ff_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDAwMw_37b8380f-b555-4be7-8b0b-35ddb5c0d61c"
      unitRef="usd">100000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="icb07d4b1080c4319a548201e2649918b_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDAwMw_496a4140-c475-4a25-9c30-9169f43d127a"
      unitRef="usd">100000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="ia3124cad286644aab11fa66ae00f4ef1_I20200618"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDM1Nw_2b09bdaa-5bd4-467a-8d18-fd9cbee207c7"
      unitRef="usdPerShare">23.46</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ia1abb3e2cea84ab7abd42b17a5446166_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDYzNQ_86988564-e4bc-4b04-aada-900c98cedc14"
      unitRef="usd">90700000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="ia1abb3e2cea84ab7abd42b17a5446166_I20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDY0Mg_db3e21f2-9e6b-420d-81cc-8651a84e7889"
      unitRef="number">0.0505</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:InterestExpenseDebt
      contextRef="i8df2957838504948bdf1f9a293198c26_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDg2Ng_0eb57724-b33b-4a79-9ecb-b94124ac0d62"
      unitRef="usd">1200000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="icdbd0ff6519a49e0a3512380762dc454_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNDg2Ng_e759f220-4eb4-43d5-9e26-b07a834eaf9f"
      unitRef="usd">1200000</us-gaap:InterestExpenseDebt>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="ia1abb3e2cea84ab7abd42b17a5446166_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTIwNA_7d078b55-09d4-4b78-9ae6-d27eee256e30"
      unitRef="usd">1700000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense
      contextRef="i55c6d9dae4af45268902f43249c1803c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTQ5NzU1ODI4NjI5_48e7ff90-0855-402e-b4f2-df4f0933d04f"
      unitRef="usd">1900000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i936177e90cbd4e0b9837af78bc6af1ad_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTY0Nw_52767494-98d2-41e5-9cf8-f6c7481eebe2"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i936177e90cbd4e0b9837af78bc6af1ad_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTcxMQ_01c8c2e6-9634-416f-972a-36d84a1683b7"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i936177e90cbd4e0b9837af78bc6af1ad_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTg2MA_e507b111-b53c-4d23-8778-2a309f5d0dce"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i245d6adca68f4145ad5ff6862bb500d7_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTkzNQ_e748ae53-1673-47d6-9dad-94d77fef04dc"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i245d6adca68f4145ad5ff6862bb500d7_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTk2OA_d031105d-c85a-4e67-9f64-703a5cd68c75"
      unitRef="day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i245d6adca68f4145ad5ff6862bb500d7_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNjEyMw_a2fdd2cb-80b4-4078-9e4f-41aa923931eb"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNjk1MQ_5915e003-70a1-478e-826f-54332c6f9336"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdTradingDays
      contextRef="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNzAwNg_ccfaad2b-ef48-4dd6-8639-a14a574466be"
      unitRef="day">20</us-gaap:DebtInstrumentConvertibleThresholdTradingDays>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNzA2Mg_ba84cc8c-a54d-4002-ae01-a822df6c2861"
      unitRef="day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <aort:DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount
      contextRef="i15d4d32b71df4ee3b4c3dde56da2f917_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNzM1Nw_ddf7627b-ace5-48bb-b2f4-7c93156b9e23"
      unitRef="number">1</aort:DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfODIyMg_e97213a7-43ec-4eef-9217-86ecbb5613d0">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The short-term and long-term balances of our Term Loan and other long-term borrowings were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.282%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.708%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;March 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Term Loan balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;213,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;213,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Convertible Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2.45% Sparkasse Zollernalb (KFW Loan 1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1.40% Sparkasse Zollernalb (KFW Loan 2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total loan balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;314,109&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;314,779&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less unamortized loan origination costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(6,210)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(6,672)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net borrowings&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;307,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;308,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Less short-term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(1,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(1,608)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Long-term loan balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;306,279&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;306,499&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i34b6700b45d349109d8e1e8318e1f9d0_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMS0xLTEtMS01NDk5Mw_1b8cd54d-8cb7-4c2f-bc34-82c869e3e5e1"
      unitRef="usd">213188000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i330928a666a2457b8aec74cf41920829_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMS0zLTEtMS01NDk5Mw_dbeaf6bb-cc39-4c95-8c36-bd4ef72fbb9c"
      unitRef="usd">213750000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i4d1d1110dd9c4c4ea0509148da8595ea_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMi0xLTEtMS01NDk5Mw_5bb3ca97-19ca-41d7-bdc3-1e7dd5a5055a"
      unitRef="usd">100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i65a4c670870a4d9f8805dd18a1e03eff_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMi0zLTEtMS01NDk5Mw_ee9a5170-3403-4045-97c5-096d169aa626"
      unitRef="usd">100000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3ee531be8b494d88bc9356fd017a9774_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMy0wLTEtMS01NDk5My90ZXh0cmVnaW9uOmNlYWY4NzBiODA5ZTRhZmNiNGM0MzY1MzlmOGZhOTU5XzQ_0c5d7d6c-42db-490a-b6bf-4d9ced13ee45"
      unitRef="number">0.0245</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i3ee531be8b494d88bc9356fd017a9774_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMy0xLTEtMS01NDk5Mw_6d7b5cc3-d444-46b2-8c16-68d7c1a922d0"
      unitRef="usd">241000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="if6292b6052bc40909d1a2f96522bdb4f_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfMy0zLTEtMS01NDk5Mw_78e8cb80-c174-46d6-a6a5-3cdc28084410"
      unitRef="usd">296000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i9cadf7c14ba34a48bad3de79cb43a15f_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNC0wLTEtMS01NDk5My90ZXh0cmVnaW9uOmU5OWUxNDQwNDRlNTRlZjRhNjlhOTlmZTMwNTE5NzNkXzQ_0b983f49-9ec4-4689-a323-bc4683ed41c6"
      unitRef="number">0.0140</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9cadf7c14ba34a48bad3de79cb43a15f_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNC0xLTEtMS01NDk5Mw_a2292bf7-1d0a-43ce-9e5b-cae25e3e55cd"
      unitRef="usd">680000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i17368e8c263742ae9eac5e48717b6911_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNC0zLTEtMS01NDk5Mw_0b219f08-9d22-4f81-b500-97cf3082e3f6"
      unitRef="usd">733000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNS0xLTEtMS01NDk5Mw_7dbead79-6d63-4f9a-aedb-2fb6362f9ed5"
      unitRef="usd">314109000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNS0zLTEtMS01NDk5Mw_7b31fba1-37aa-497f-be4e-b628ad015b71"
      unitRef="usd">314779000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNi0xLTEtMS01NDk5Mw_be593a65-dce3-49cc-856f-0ab8f535d46d"
      unitRef="usd">6210000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNi0zLTEtMS01NDk5Mw_7f5d145b-4fb3-4325-b87e-60631f846377"
      unitRef="usd">6672000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNy0xLTEtMS01NDk5Mw_4ebcbb19-a88a-4df3-9dec-c5af1407ada3"
      unitRef="usd">307899000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfNy0zLTEtMS01NDk5Mw_56e4e9b0-4305-4329-aec3-b8a04b55bf8d"
      unitRef="usd">308107000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebtCurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfOC0xLTEtMS01NDk5Mw_22b9e864-63ce-4f2b-aa4a-928d1a5bfce4"
      unitRef="usd">1620000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfOC0zLTEtMS01NDk5Mw_362d4930-8ee7-4967-8644-56868e0e88cf"
      unitRef="usd">1608000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfOS0xLTEtMS01NDk5Mw_1cb8f584-2e7d-4dbb-b46a-5f8bd11b655f"
      unitRef="usd">306279000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="idc54f5a9f8964a9eac3519cb41b6887b_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RhYmxlOmIxYWJhNWFkYWU1ODQwYjI4NDQ4NjFjZjA4NTkxMGZlL3RhYmxlcmFuZ2U6YjFhYmE1YWRhZTU4NDBiMjg0NDg2MWNmMDg1OTEwZmVfOS0zLTEtMS01NDk5Mw_d4b5caab-330b-44d5-a3b1-fb0782b0f388"
      unitRef="usd">306499000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:InterestExpenseDebt
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfODEwNA_eb273645-adcf-402a-a757-34d3e5872590"
      unitRef="usd">6100000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NS9mcmFnOmFmZWFjNzA4NTk0YjQzMDc5MDc5N2ZhOGFjOWVkN2VhL3RleHRyZWdpb246YWZlYWM3MDg1OTRiNDMwNzkwNzk3ZmE4YWM5ZWQ3ZWFfNTQ5NzU1ODI2MjE3_052427eb-411b-4f30-ad2e-0ddf3c18d41b"
      unitRef="usd">3900000</us-gaap:InterestExpenseDebt>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182MS9mcmFnOjE4MDRkM2FkYTc1NjQyYmZiZWE4MTU3ODVjNzY5ZTYxL3RleHRyZWdpb246MTgwNGQzYWRhNzU2NDJiZmJlYTgxNTc4NWM3NjllNjFfMTg5NQ_0cd88ba7-0801-46d0-96b2-0f2b99afd336">Commitments and Contingencies&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liability Claims&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we are made aware of adverse events involving our products and tissues. Future adverse events could ultimately give rise to a lawsuit against us, and liability claims may be asserted against us in the future based on past events that we are not aware of at the present time. We maintain claims-made insurance policies to mitigate our financial exposure to product and tissue processing liability claims. Claims-made insurance policies generally cover only those asserted claims and incidents that are reported to the insurance carrier while the policy is in effect. The amounts recorded in these Condensed Consolidated Financial Statements as of March&#160;31, 2023 and the Consolidated Financial Statements as of December&#160;31, 2022 represent our estimate of the probable losses and anticipated recoveries for incurred but not reported claims related to products sold and services performed prior to the balance sheet date.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RleHRyZWdpb246NWFkOGEzZGQ5OGM5NDI3ZmJiNzU3NDFmZDk0OGNhZjVfMTcxNw_018d5a62-c45b-450a-88cf-96cc9ba1f194">Revenue Recognition&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sources of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have identified the following revenues disaggregated by revenue source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Domestic hospitals &#x2013; direct sales of products and preservation services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;International hospitals &#x2013; direct sales of products and preservation services.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;International distributors &#x2013; generally these contracts specify a geographic area that the distributor will service, terms and conditions of the relationship, and purchase targets for the next calendar year.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;CardioGenesis cardiac laser console trials and sales &#x2013; CardioGenesis cardiac trialed laser consoles are delivered under separate agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023 and 2022 the sources of revenue were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Domestic hospitals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,883&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;36,993&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;International hospitals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;28,957&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;28,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;International distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;12,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,064&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;CardioGenesis cardiac laser therapy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;450&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;742&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total sources of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;83,229&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;77,213&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Also see segment disaggregation information in Note 12 below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may generate contract assets during the pre-delivery design and manufacturing stage of E-xtra Design Engineering product order fulfillment. We assess the balance related to any arrangements in process and determine if the enforceable right to payment creates a material contract asset requiring disclosure. No material arrangements in process existed as of March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We also incur contract obligations on general customer purchase orders that have been accepted but unfulfilled. Due to the short duration of time between order acceptance and delivery of the related product or service, we have determined that the balance related to these contract obligations is generally immaterial at any point in time. We monitor the value of orders accepted but unfulfilled at the close of each reporting period to determine if disclosure is appropriate. The value of orders accepted but unfulfilled as of March&#160;31, 2023 and 2022 was not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RleHRyZWdpb246NWFkOGEzZGQ5OGM5NDI3ZmJiNzU3NDFmZDk0OGNhZjVfMTcxOA_b8c0a354-3691-45ac-abc5-7162c5714ded">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023 and 2022 the sources of revenue were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Domestic hospitals&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,883&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;36,993&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;International hospitals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;28,957&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;28,414&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;International distributors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;12,939&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;11,064&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;CardioGenesis cardiac laser therapy&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;450&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;742&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total sources of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;83,229&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;77,213&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6765ee8c4e514375bf2377f15526dbbc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfMi0xLTEtMS01NDk5Mw_447cd5a6-d38d-41b2-9e4b-27667639e285"
      unitRef="usd">40883000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e02717d99e84bc08078c02ad4f2d3ab_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfMi0zLTEtMS01NDk5Mw_3adcb103-c3de-44b3-9445-b82521292679"
      unitRef="usd">36993000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82de625935f54b34bbb5e4589a1fc149_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfMy0xLTEtMS01NDk5Mw_72d7bece-603d-42d9-8135-af86956921e4"
      unitRef="usd">28957000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf63598993c849b9a81d477b9517fc7c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfMy0zLTEtMS01NDk5Mw_dff3b7ba-bd35-4d31-afaf-754434660059"
      unitRef="usd">28414000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9af7b4096844040ad375baefedff835_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNC0xLTEtMS01NDk5Mw_17d1e054-f274-4aa2-8ad8-8bf1b85c835e"
      unitRef="usd">12939000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8a7f94f926946f1b329419bb02b1cf7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNC0zLTEtMS01NDk5Mw_2b9e817c-a818-4c99-8a8d-d7365a6cbd52"
      unitRef="usd">11064000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9490fb1e6a364e808b33e4f022177191_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNS0xLTEtMS01NDk5Mw_09aae98d-fba8-43b0-b75e-2bd10c5e4f82"
      unitRef="usd">450000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide1a4c016001405a9f9e00487555dcea_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNS0zLTEtMS01NDk5Mw_7a3c784a-80a1-4d2f-ad19-f41b486a3d1e"
      unitRef="usd">742000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNi0xLTEtMS01NDk5Mw_fa6f6d92-a0a5-4969-9877-164d50f4cfd9"
      unitRef="usd">83229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182NC9mcmFnOjVhZDhhM2RkOThjOTQyN2ZiYjc1NzQxZmQ5NDhjYWY1L3RhYmxlOjU3N2Q2YWZmZTU2MDRjNWY5NGFkZGFjZDRmNmM3MTUwL3RhYmxlcmFuZ2U6NTc3ZDZhZmZlNTYwNGM1Zjk0YWRkYWNkNGY2YzcxNTBfNi0zLTEtMS01NDk5Mw_03da3780-407f-4df4-8d60-ac1f4cc84b71"
      unitRef="usd">77213000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMjk0Ng_7cbbf71e-e598-4f3d-a2d6-95016a69df2a">Stock Compensation &lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have stock option and stock incentive plans for employees and non-employee Directors that provide for grants of restricted stock awards (&#x201c;RSAs&#x201d;), restricted stock units (&#x201c;RSUs&#x201d;), performance stock units (&#x201c;PSUs&#x201d;), and options to purchase shares of our common stock at exercise prices generally equal to the fair value of such stock at the dates of grant. We also maintain a shareholder-approved Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) for the benefit of our employees. The ESPP allows eligible employees to purchase common stock on a regular basis at the lower of 85% of the market price at the beginning or end of each offering period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Grants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023 the&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Compensation Committee of our Board of Directors (the &#x201c;Committee&#x201d;) authorized awards from approved stock incentive plans of RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together total&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ed 376,000 shares and had an aggregate grant date fair value of $5.0 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2022 the Committee authorized awards from approved stock incentive plans of  RSUs and PSUs to certain employees and company officers, which, assuming that performance under the PSUs were to be achieved at target levels, together totaled 452,000 shares and had an aggregate grant date fair value of $8.3 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Committee authorized, from approved stock incentive plans, grants of stock options to purchase a total of 314,000 shares to certain company officers during the three months ended &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The exercise prices of the options were equal to the closing stock prices on their respective grant dates. The Committee did not authorize any grants of stock options during the three months ended March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Employees purchased common stock totaling 56,000 and 37,000 shares in the three months ended March&#160;31, 2023 and 2022, respectively, through the ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Compensation Expense &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.77%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;RSA, RSU, and PSU expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Stock option and ESPP expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,513&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Included in the total stock compensation expense, as applicable in each period, were expenses related to RSAs, RSUs, PSUs, and stock options issued in each respective year, as well as those issued in prior periods that continue to vest during the period, and compensation related to the ESPP. These amounts were recorded as stock compensation expense and were subject to our normal allocation of expenses to inventory costs and deferred preservation costs. We capitalized $172,000 and $174,000 in the three months ended March 31, 2023 and 2022, respectively, of the stock compensation expense into our inventory costs and deferred preservation costs.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNjAy_a4ba81a0-fbff-4308-a1c2-353f29b128d9"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="id3cbd678f84346a6bd714e53648d0ce7_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMTA0MQ_865d387b-bd2f-4e63-9ff0-da42bcfd16b2"
      unitRef="shares">376000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted
      contextRef="id3cbd678f84346a6bd714e53648d0ce7_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMTA5Nw_fd79fc90-64da-430b-a3e2-81818af90ce3"
      unitRef="usd">5000000.0</aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i1e96a5da80644389a43614a81619129f_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2ODQ2_353eaeba-2aa1-486b-b40d-4e079270bafc"
      unitRef="shares">452000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted
      contextRef="i1e96a5da80644389a43614a81619129f_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2ODUw_171f6657-fee6-4917-99bd-7f2289e4ff38"
      unitRef="usd">8300000</aort:ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ib35623233c83476c8ae2823d953479ac_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2ODU4_814171de-d65b-4bc4-9661-113c647e3f31"
      unitRef="shares">314000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMTgyOQ_ffe9145f-9d51-4a3c-9768-86e0e4f43d4e"
      unitRef="shares">56000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ie87171075e7c46b3a5e2f515abfa3038_D20220101-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2OTM1_b5ce9e12-51ae-412e-b5d3-7524686ce8c3"
      unitRef="shares">37000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMjk0Nw_90d41a13-27d0-44a7-bb2b-802c87129989">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following weighted-average assumptions were used to determine the fair value of options and shares purchased under the ESPP: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.293%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.900%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.901%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Stock Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.5 Years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected stock price volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;0.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;N/A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;4.77%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmY5NTNhNjM2Njg4ZjQxNWY5ZjFkMDA1YWI4ZWVjYjEwL3RhYmxlcmFuZ2U6Zjk1M2E2MzY2ODhmNDE1ZjlmMWQwMDVhYjhlZWNiMTBfMi0zLTEtMS01NDk5Mw_8a441661-235b-4675-b8ba-28a11ce776bb">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmY5NTNhNjM2Njg4ZjQxNWY5ZjFkMDA1YWI4ZWVjYjEwL3RhYmxlcmFuZ2U6Zjk1M2E2MzY2ODhmNDE1ZjlmMWQwMDVhYjhlZWNiMTBfMy0zLTEtMS01NDk5Mw_a499ca96-54ca-4ae3-b70c-40fbc145be82"
      unitRef="number">0.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmY5NTNhNjM2Njg4ZjQxNWY5ZjFkMDA1YWI4ZWVjYjEwL3RhYmxlcmFuZ2U6Zjk1M2E2MzY2ODhmNDE1ZjlmMWQwMDVhYjhlZWNiMTBfNC0zLTEtMS01NDk5Mw_136bf017-ed0b-4a60-82ce-2506b64c7b3a"
      unitRef="number">0.0477</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMjk0OA_0cf5a423-e74d-4200-a1fd-679d93f4580e">&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes total stock compensation expenses prior to the capitalization of amounts into Deferred preservation and Inventory costs (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.696%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.200%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.945%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.407%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.948%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;RSA, RSU, and PSU expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;2,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Stock option and ESPP expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;872&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 4.13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total stock compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,513&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;3,340&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i46dae3eb2d6d4db5b3282cd30f4eb3b9_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfMi0xLTEtMS01NDk5Mw_2dc2fa94-9da2-48ec-9dd7-8d7366c22fc4"
      unitRef="usd">2641000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i39bfa788f29c453e8e82fca1bd97483c_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfMi0zLTEtMS01NDk5Mw_68ff03ba-129b-4667-9667-2769788ef868"
      unitRef="usd">2768000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="if1fbc6109379459ab9d95037d44ee0bc_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfMy0xLTEtMS01NDk5Mw_c2e39d52-4c5c-44d9-9337-33c54369d13f"
      unitRef="usd">872000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i20695d53f4ce4fe6a0127135b2d1f023_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfMy0zLTEtMS01NDk5Mw_b3dfd16b-844e-4cd7-876a-d67707da99ef"
      unitRef="usd">572000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfNC0xLTEtMS01NDk5Mw_cbeae9f5-a50a-4119-a37d-c1a752fa83fc"
      unitRef="usd">3513000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RhYmxlOmVjYTljNWIyNDg1ZTQxOTU4YWMzZDY0MTk2MjkxMmFlL3RhYmxlcmFuZ2U6ZWNhOWM1YjI0ODVlNDE5NThhYzNkNjQxOTYyOTEyYWVfNC0zLTEtMS01NDk5Mw_48cf8dc3-7524-416f-a3c4-e60823bd3c46"
      unitRef="usd">3340000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfMjc4MQ_c054322e-22c6-47fe-9e0b-5507d2a08432"
      unitRef="usd">172000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M182Ny9mcmFnOjRkM2I0NWQ1MGQ0YzRlZWViMTZhYTAyNmUyMDJkMTljL3RleHRyZWdpb246NGQzYjQ1ZDUwZDRjNGVlZWIxNmFhMDI2ZTIwMmQxOWNfNTQ5NzU1ODE2OTg0_760bded2-317c-4e81-8f7f-6cbb3329b58e"
      unitRef="usd">174000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RleHRyZWdpb246ZTJhMzYxN2RmZGM5NGU2YTk5NjFiNDgzNjU1MzMxODdfMTIxOQ_644db5b3-1cba-4ba1-b1b4-8ecbc00e4d4c">Loss Per Common Share &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted loss per common share (in thousands, except per share data): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(13,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(13,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(3,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,432&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,850&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(13,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(13,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(3,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,432&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;39,850&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,432&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,850&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We excluded stock options from the calculation of diluted weighted-average common shares outstanding if the per share value, including the sum of (i) the exercise price of the options and (ii) the amount of the compensation cost attributed to future services and not yet recognized, was greater than the average market price of the shares because the inclusion of these stock options would be antidilutive to loss per common share. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2023 and 2022 all stock options and awards were excluded from the calculation of diluted weighted-average common shares outstanding as these would be antidilutive due to the net loss.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RleHRyZWdpb246ZTJhMzYxN2RmZGM5NGU2YTk5NjFiNDgzNjU1MzMxODdfMTIxOA_89bfbd93-fb41-47ae-8f79-bed082b052e7">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted loss per common share (in thousands, except per share data): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.242%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.251%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.116%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(13,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(13,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(3,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,432&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,850&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Basic loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.545%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.076%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.408%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(13,532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;(3,389)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Net loss allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;60&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Net loss allocated to common shareholders&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(13,472)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(3,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Basic weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,432&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;39,850&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted weighted-average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;40,432&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;39,850&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 5.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Diluted loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;(0.08)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfMi0yLTEtMS01NDk5Mw_fd546f3a-5cdd-4753-885b-ce2fa6796993"
      unitRef="usd">-13532000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfMi00LTEtMS01NDk5Mw_631f15b1-d79c-4537-a3ca-a4a3ba2a382a"
      unitRef="usd">-3389000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfMy0yLTEtMS01NDk5Mw_92c28d72-3093-4f37-9b5e-9a008e4592dd"
      unitRef="usd">-60000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfMy00LTEtMS01NDk5Mw_c3fd1fe5-3e64-4074-883e-945af7a7e233"
      unitRef="usd">-18000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNC0yLTEtMS01NDk5Mw_4bf629ae-3a54-4d10-9a80-4db12b6fd448"
      unitRef="usd">-13472000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNC00LTEtMS01NDk5Mw_be8639e6-33ff-43ac-9768-be5a3bb5c551"
      unitRef="usd">-3371000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNi0yLTEtMS01NDk5Mw_c3295be5-ce16-4baf-af30-3bc12ea299c1"
      unitRef="shares">40432000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNi00LTEtMS01NDk5Mw_7e249359-6390-4313-9f8d-3044f9f2274e"
      unitRef="shares">39850000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNy0yLTEtMS01NDk5Mw_ccd9dd53-fc49-4f51-a7b0-a1d82055460b"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjdmODRjZWYyYzZjZjRjNmQ4NjEzYjRkMmY2ZTg2OWFhL3RhYmxlcmFuZ2U6N2Y4NGNlZjJjNmNmNGM2ZDg2MTNiNGQyZjZlODY5YWFfNy00LTEtMS01NDk5Mw_fdbcc176-8ff0-4507-b073-c13d60a78264"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLoss
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMi0yLTEtMS01NDk5Mw_92d6f28a-aa51-4a5a-a0ce-8295528e31cd"
      unitRef="usd">-13532000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMi00LTEtMS01NDk5Mw_d91ff517-3ef8-4b00-b53e-24c1bb9405f6"
      unitRef="usd">-3389000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMy0yLTEtMS01NDk5Mw_1a63786d-2dc5-4184-9401-63ddcda86f72"
      unitRef="usd">-60000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMy00LTEtMS01NDk5Mw_09415b62-6b81-49a9-bed8-242126e50b63"
      unitRef="usd">-18000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfNS0yLTEtMS01NDk5Mw_f9bc5d6f-5ca8-487c-ae65-b272a9af1903"
      unitRef="usd">-13472000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfNS00LTEtMS01NDk5Mw_b1e1a009-6eba-40f1-a628-5e52cde88cec"
      unitRef="usd">-3371000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfNy0yLTEtMS01NDk5Mw_104ad0f9-e6ed-4381-98c4-721a644fe821"
      unitRef="shares">40432000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfNy00LTEtMS01NDk5Mw_1cdc71cc-3dfd-4e34-a1b5-1beae35a7a62"
      unitRef="shares">39850000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMTAtMi0xLTEtNTQ5OTM_49552be8-d024-479f-81d6-9264f6fceb79"
      unitRef="shares">40432000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMTAtNC0xLTEtNTQ5OTM_b7f015f1-42d4-4d13-9ea3-2d175fddd647"
      unitRef="shares">39850000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMTEtMi0xLTEtNTQ5OTM_7ed2e90d-4df6-48ed-9e85-1437bc726401"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183MC9mcmFnOmUyYTM2MTdkZmRjOTRlNmE5OTYxYjQ4MzY1NTMzMTg3L3RhYmxlOjc4OWQ0YzI2MDk0ZTRhNDY5MmQzYjc3OGVlNWU5Mzk5L3RhYmxlcmFuZ2U6Nzg5ZDRjMjYwOTRlNGE0NjkyZDNiNzc4ZWU1ZTkzOTlfMTEtNC0xLTEtNTQ5OTM_518e44bb-5bd8-4cd5-a499-194abfc4347d"
      unitRef="usdPerShare">-0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfMTM4Mg_c1fe487b-3f1c-4b92-9523-d8af48f538a3">Segment Information  &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have two reportable segments organized according to our products and services: Medical devices and Preservation services. The Medical Devices segment includes external revenues from product sales of aortic stent grafts, On-X, surgical sealants, and other product revenues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Aortic arch stent grafts include our E-vita Open NEO, E-vita Open Plus, AMDS, NEXUS, and E-vita Thoracic 3G. Abdominal stent grafts include our E-xtra Design Engineering, E-nside, E-tegra, E-ventus BX, and E-liac products. Surgical sealants include BioGlue Surgical Adhesive products. The Preservation Services segment includes external services revenues from the preservation of cardiac and vascular tissues. There are no intersegment revenues. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary measure of segment performance, as viewed by our management, is segment gross margin or net external revenues less cost of products and preservation services. We do not segregate assets by segment, therefore, asset information is excluded from the segment disclosures below. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;57,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;83,229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;77,213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Cost of products and preservation services:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total cost of products and preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;29,502&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;26,494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross margin:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;42,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;53,727&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;50,719&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes net revenues by product and service (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Products:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Aortic stent grafts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;26,150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;25,506&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;On-X&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17,656&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;14,371&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Surgical sealants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;16,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;15,681&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,782&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,984&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;62,291&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;57,542&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20,938&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;83,229&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;77,213&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfMjI_f2599b81-cd0d-40b7-b2ce-1ce1f318ba3c"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="i24d764c46d944801885c59dde6cec14b_D20230101-20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfODM0_11c47906-682e-4063-b8e4-5135294c7069"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfMTM4Mw_6c0a5dea-cd60-411e-a197-58e2f82dc12f">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenues, cost of products and preservation services, and gross margins for our operating segments (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;62,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;57,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;83,229&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;77,213&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Cost of products and preservation services:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;9,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total cost of products and preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;29,502&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;26,494&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Gross margin:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Medical devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;42,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;40,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;10,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total gross margin&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;53,727&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;50,719&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMy0xLTEtMS01NDk5Mw_084fe88c-38df-436d-9309-7f19be32d997"
      unitRef="usd">62291000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb6dc10bc7ed4b5492b4ae7557ed2a02_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMy0zLTEtMS01NDk5Mw_ec3d5501-00db-4645-ba30-fe176cb24fc9"
      unitRef="usd">57542000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i350257931547498a908d5663ff901b70_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfNC0xLTEtMS01NDk5Mw_0fcb4917-95be-4065-886a-486b80dc14e1"
      unitRef="usd">20938000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaade080667b34ceaa2d4b4d14761568d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfNC0zLTEtMS01NDk5Mw_67de088e-f3df-46e6-873f-6a80f110892f"
      unitRef="usd">19671000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfNS0xLTEtMS01NDk5Mw_f409b8a2-e0cb-4a41-8405-55a6f6a38c30"
      unitRef="usd">83229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfNS0zLTEtMS01NDk5Mw_ecdcf572-7a8f-48bc-ada1-9c5ce01502da"
      unitRef="usd">77213000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfOC0xLTEtMS01NDk5Mw_84dc806b-adf1-419c-95e8-6ec3073878d6"
      unitRef="usd">19533000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icb6dc10bc7ed4b5492b4ae7557ed2a02_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfOC0zLTEtMS01NDk5Mw_add1f00a-5d83-405b-b5f6-3989c859a260"
      unitRef="usd">17408000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i350257931547498a908d5663ff901b70_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfOS0xLTEtMS01NDk5Mw_6b98f7eb-4115-46cf-9ec1-199a8887e4b2"
      unitRef="usd">9969000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iaade080667b34ceaa2d4b4d14761568d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfOS0zLTEtMS01NDk5Mw_558315d0-b354-4a40-b412-3f42f0e1f8ea"
      unitRef="usd">9086000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTAtMS0xLTEtNTQ5OTM_ec5bf81f-fb77-47b4-8eaa-b851611b2317"
      unitRef="usd">29502000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTAtMy0xLTEtNTQ5OTM_a1f2c88d-332a-4c1c-9038-69f2cbbc650a"
      unitRef="usd">26494000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit
      contextRef="i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTMtMS0xLTEtNTQ5OTM_93cb0c75-6178-4d60-bae5-3f7c87fda7ea"
      unitRef="usd">42758000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="icb6dc10bc7ed4b5492b4ae7557ed2a02_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTMtMy0xLTEtNTQ5OTM_cd80f257-88e9-46bf-be27-8d12641fda20"
      unitRef="usd">40134000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i350257931547498a908d5663ff901b70_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTQtMS0xLTEtNTQ5OTM_deeb5bae-fea1-48d0-a427-5edb8ab9781a"
      unitRef="usd">10969000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iaade080667b34ceaa2d4b4d14761568d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTQtMy0xLTEtNTQ5OTM_2c7cb9f7-bc2e-48ff-b901-d2eae5ae8fcc"
      unitRef="usd">10585000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTUtMS0xLTEtNTQ5OTM_6c604816-c719-42db-bb99-d9f240d93c96"
      unitRef="usd">53727000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjMwYmJiYThiMGZmMjQ3Yzk4YmFiNTk4OTYyZGQyOWY4L3RhYmxlcmFuZ2U6MzBiYmJhOGIwZmYyNDdjOThiYWI1OTg5NjJkZDI5ZjhfMTUtMy0xLTEtNTQ5OTM_39b5b2aa-ecf1-4d0c-bc9e-6d23fdf83cb7"
      unitRef="usd">50719000</us-gaap:GrossProfit>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RleHRyZWdpb246ODUxN2IwNTVjYmM3NDg1ZjhkZDNiOGVkZWI3NmY4MGJfMTM4NA_dc89e6a9-81d0-479b-b777-fd1997b064de">&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes net revenues by product and service (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.930%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Three Months Ended&lt;br/&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Products:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Aortic stent grafts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;26,150&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 1.97pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;25,506&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;On-X&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;17,656&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;14,371&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Surgical sealants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;16,703&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;15,681&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,782&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;1,984&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 23.5pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;62,291&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1.25pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;57,542&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;Preservation services &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;20,938&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1.97pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:108%"&gt;19,671&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;83,229&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1.25pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:108%"&gt;77,213&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0d27f99bdef34490ab29648e4ece9919_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfMy0xLTEtMS01NDk5Mw_1764a314-5998-4768-a7bc-e97494771c62"
      unitRef="usd">26150000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e3f19c886f3413fb86666f3e6eb9394_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfMy0zLTEtMS01NDk5Mw_d2e2a2fa-2898-499c-bb6d-ddbb2587eee8"
      unitRef="usd">25506000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i88ac222b2f944d15bd71802bc159841a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNC0xLTEtMS02MzM3MQ_7ee79148-2342-4763-88c7-0230df5f405b"
      unitRef="usd">17656000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cc9e6e0e71d487eaa136ec7431e6ce6_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNC0zLTEtMS02MzM3MQ_0287030f-272e-4bfa-b17a-f3a31a85d856"
      unitRef="usd">14371000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfa08b9642074e35bc71304309d137aa_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNC0xLTEtMS01NDk5Mw_669511b8-5d0e-40d7-bcfc-e8591818c057"
      unitRef="usd">16703000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0b90e8de9b7458c9afe003e4bad474a_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNC0zLTEtMS01NDk5Mw_aa372d22-59bc-4c63-a971-a22ddab1289a"
      unitRef="usd">15681000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie2d424b22c484323a8479a4346ad4545_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNi0xLTEtMS01NDk5Mw_1d11a5e3-248b-4cd6-a585-f3b3b05ae0e1"
      unitRef="usd">1782000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4337b65585504d8bbb937a66cdd29f5b_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNi0zLTEtMS01NDk5Mw_85385265-1c2b-4899-a364-9793141c2f38"
      unitRef="usd">1984000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ae3a909430949bd90a175d270eb249f_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNy0xLTEtMS01NDk5Mw_d412a3bc-fb34-42b9-a898-de8e82cffc34"
      unitRef="usd">62291000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i979c20305ec145afbd438a672f317ec1_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfNy0zLTEtMS01NDk5Mw_f7960b5c-9801-4c73-a398-2f7acd8b4610"
      unitRef="usd">57542000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5cf4550d1e64e08a695b28c0c89be0e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfOS0xLTEtMS01NDk5Mw_d8466d00-69b6-4b7f-9fb8-39699c11abd1"
      unitRef="usd">20938000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if1c72bde95b6478d85567313998b4435_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfOS0zLTEtMS01NDk5Mw_e54a354e-26b4-4d69-a806-db8f536ba7b3"
      unitRef="usd">19671000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfMTAtMS0xLTEtNTQ5OTM_1d3ef0ae-676f-4624-bfbf-672b30c538ba"
      unitRef="usd">83229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i506961bfca2948f68fe4bb81158c1af7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M183My9mcmFnOjg1MTdiMDU1Y2JjNzQ4NWY4ZGQzYjhlZGViNzZmODBiL3RhYmxlOjZlNjY0YjA5N2ZhYjRhNmU4YzBhZGUxYTk3YTVjN2QwL3RhYmxlcmFuZ2U6NmU2NjRiMDk3ZmFiNGE2ZThjMGFkZTFhOTdhNWM3ZDBfMTAtMy0xLTEtNTQ5OTM_4ea84304-bd8d-4b77-89e2-21a3b611de07"
      unitRef="usd">77213000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA2NzU_20141316-f12c-4682-adf6-6edc6e305b17">Subsequent Events  &lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Endospan Loan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 11, 2019 Artivion and Endospan Ltd. (&#x201c;Endospan&#x201d;), an Israeli corporation, entered into a loan agreement (&#x201c;Endospan Loan&#x201d;), in which Artivion agreed to provide Endospan a secured loan of up to $15.0&#160;million to be funded in three tranches of $5.0&#160;million each. The first tranche of the Endospan Loan was funded upon execution of the agreement in September 2019. In September 2020 we funded the second tranche payment of $5.0&#160;million upon the certification of the NEXUS IDE from the US Food and Drug Administration (the &#x201c;FDA&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 16, 2023 Endospan completed an enrollment certification of 50% of the required number of patients in the primary arm of the FDA approved clinical trial for NEXUS, which, assuming compliance with other requirements under the Endospan Loan, may trigger a third tranche payment of $5.0&#160;million. We expect to fund the $5.0&#160;million payment during the second quarter of fiscal year 2023. &lt;/span&gt;&lt;/div&gt;We elected the fair value option for recording the Endospan Loan and are evaluating the fair value impact of the anticipated funding of the third tranche payment.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="icf3dcedf29fb4d59856021f6832683f4_I20190911"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA2Nzc_f215a4cb-be1a-4651-b223-83e89a24cf2c"
      unitRef="usd">15000000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <aort:NumberOfTranches
      contextRef="ie06473170a934a1f8ba18b66bd8feeb5_D20190911-20190911"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3NTU_8330375e-34bb-44fe-8f19-76029ed701a1"
      unitRef="tranche">3</aort:NumberOfTranches>
    <aort:ThreeTranchesOfFundingForSecuredLoanPerTranche
      contextRef="i2b7e03d58c2d4458be09a447fde2288f_D20190911-20190911"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA2OTI_6bfe4580-e6dc-440d-bc7d-b49b345f379e"
      unitRef="usd">5000000</aort:ThreeTranchesOfFundingForSecuredLoanPerTranche>
    <aort:FundedTranchePaymentPerAgreement
      contextRef="i6093549b9fc14acc8ec2494386cd4ca5_D20200901-20200930"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3MDY_2ab60e70-4976-48cc-ae8a-8c8d36d0ab0d"
      unitRef="usd">5000000</aort:FundedTranchePaymentPerAgreement>
    <aort:ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients
      contextRef="i0ed7688ddb8243768813e25604041962_D20230416-20230416"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3MjA_2a79f70f-5766-4d98-b3b7-06539996ec3b"
      unitRef="number">0.50</aort:ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients>
    <aort:ThirdTranchePayment
      contextRef="i0ed7688ddb8243768813e25604041962_D20230416-20230416"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3Mjc_fefbf2a2-7ca6-47c0-9005-6f6543cb3abc"
      unitRef="usd">5000000</aort:ThirdTranchePayment>
    <aort:ThirdTranchePayment
      contextRef="i0ed7688ddb8243768813e25604041962_D20230416-20230416"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjVmYzNhYWIxODYzYTQ4YjI4OWU3ZmM2NzI2NjkyZDczL3NlYzo1ZmMzYWFiMTg2M2E0OGIyODllN2ZjNjcyNjY5MmQ3M181NDk3NTU4MTQ0NDEvZnJhZzpkMjU1ZjRkYTVmNWQ0ODgxYjUyMTMyNjVlNzExZDBmYi90ZXh0cmVnaW9uOmQyNTVmNGRhNWY1ZDQ4ODFiNTIxMzI2NWU3MTFkMGZiXzEwOTk1MTE2NDA3NTM_fefbf2a2-7ca6-47c0-9005-6f6543cb3abc"
      unitRef="usd">5000000</aort:ThirdTranchePayment>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>67
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M@*>*C=+B1,LDWVN<2ZUEE!^N!/>%,C? ]PLI]>[$_$"Y73WX%U!+ P04
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M+[T5ZE@DI"]VGDSSF,SDN49IFC!873*J2X+J/K2/9F"EJ@*=E[C/-;TW'V'
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M1PV_+QANM-SU1_0/4FO9])=;P8UL:V"^7TNI7V[LJ?_X*X_5_P!02P,$%
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MWDQZWDS1C2S-2J./@" [7C\!*VI3R(LI5V10X0U3'Q#%[Q$)"/7@6?S\<C(
MA]:>I4X?[='W!]1@:AVW=(Y;*ED@J#[%C"@?J_051G!]YG-=I3KTJ[:E?:;7
M+.47(ZA=S=66C^:__H+CX#>?W2=2=N2%L/9".*3=>2&7VIL?U<K8K;3M9CL?
M8QI1</[V$+Y'C-+IK)8ZPA75N*+!Z%QF_T!Q51EN)#2D5):IR#DJ]X#MT[(.
MX:N"%YTR>"=2=N2DN'92/!B\:PY*4\&JAEMFB!52&?&O>^"SO%(7'80J2FC8
MBJ=':#K%_G F-=)D$.EBQ<I';CO2D@F%MBS?<-NY(*HV8A!F>ZE%YD+H!Y]T
M<(73(&B![PJ-\:'4$?IIC7XZ7"2R'+L\2V4!_*Q[(4X[;Z<TQ"V('B$<QWZ$
MLQKA[.<0YAPX$_$G"Y/[(,XZ;P?_M$O:(S0C/4[$04-EP2#(KTH8/L[DKK2A
M%^46PBX55*G+7>!VKA1PV[Y0JJQ.I39^\@JZ&+'EE2-#/%*SOM:$#S@9_Z#N
M]E!%"1G!D6%/W \2=].1X#AIH_2)S?IR I,&)QG$^:=9<>7%13HO3*)V'_ (
MA;,^3 WKXF':K3J!MJW@H&%KS4V5!KE@#R+O;][XI-1[*FW'SFC(%P^S[QU/
MN=BRA[PG?<)NJXC"=LOS2(UQ@OO*M6%@/,A=\UO%UTQD+\VD"H^T*;6/EQ=R
MY$GE '=RJRN&PUG8 [GA0SQ,B)__9T_I4M^8$M+NCCXQ&(SZVDK#D7B8)"_3
M5&[LP+-FSS8GWL,@DZH-;T+P_B &!X7BM<7#A#'%G0;I$:.TM]<WC(E_0)G'
MT_5&NV[IG=&\Z+LD.8YQMT5YQ*+9M =\0Z9X]NJM@:4K_3/3)1YDZE<WJ!-I
M.]ZQ-91-ABE[P=;"L+Q*P$R8C?+'BW1Y=DP(G;;BU2/64SFD(60R3,B7Z?>-
MT,)5MQLM#)",@!(:Z%3$0[IQ$+41>Z3"N ]PP\QDF)E[RL.79%[L76H>DVG8
M+FZO6!+TU =I.)R\?NN\%"6#'=J/ZX.<E,!/I>W8$PV!DV$"OU4RY3S;^X _
M<94*[78VVLCT&_0[FY,5&0FM-^"B_;ZG*"!7G9#725U.)]&TO9/P25'<%]Z&
M^,DP\=_QC!?K>E,)8\!&I2MV:!=LOE.Y!1:"T1?MA%FM9)Y!\/W9ZID)HEE[
MC/%)X83V,!%I9@(R/!/<P13S;#\D6/2&JP+EDGEW;\3#ZW$7IU>J9W0A#?F3
M8?+OG=6);TM+.ZA\4J2O3S4T3EY%XVLEM[!'S]##,WJ[;UKOO*7OM:3+UA@&
MU;8E'DXG-.JQI.%T,KQ#_KA<\M3E ']*JZ\1,(EPE.[W(W8NM(;:C'<7'"AE
MRW+[!<IK3'>//$ZB]JCHDXI[OJ70AI7I,"M?\U2Y?;YX)6CJX=]IE+1IVB=&
MXX.O!,>X&YJFPS2]Z,.*'OBC*$N;0A @F!&%S+SXNVQ,9S1JIY!'+(J"OAT1
M;5B;#K-V/WYNQ_)!Y*3SE90&2=)F;(]8A,,.8T\.#A0*KA[=.8M&;OM0?9"O
MG]9G.9?N!*/U_ J?+:H3F49-=4!TPQ2$1*.<+T%E\"$!;ZKJS*6Z,7+MCBT>
MI#&R<)<KSC*NK #\?RFE>;FQ+ZA/ON;_ 5!+ P04    "  *=Z56T4K"_-((
M  #U3@  &    'AL+W=O<FMS:&5E=',O<VAE970V+GAM;+V<77/;N!6&_PI'
MW6F3F75$ !0_4MLS&XG$9J:[S=B[[46G%XP(6YQ0I):D[.3?%Z084?@01-AG
M>V-+-O  Q'L  2\/=?U<U5^:#6.M\W5;E,W-;-.VN_?S>;/>L&W:O*MVK.3_
M>:CJ;=KRM_7CO-G5+,WZ2MMBCEW7GV_3O)S=7O=_^U3?7E?[MLA+]JEVFOUV
MF];?/K"B>KZ9H=GW/]SECYNV^\/\]GJ7/K)[UOZ^^U3S=_,C)<NWK&SRJG1J
M]G S^PF]IR3J*O0E_I6SY^;DM=-=RN>J^M*]^9C=S-RN1ZQ@Z[9#I/S7$UNR
MHNA(O!]_#-#9L<VNXNGK[_2DOWA^,9_3ABVKXM]YUFYN9N',R=A#NB_:N^KY
M9S9<T*+CK:NBZ7\ZST-9=^:L]TU;;8?*O ?;O#S\3K\. W%2 9$S%?!0 4^M
M0(8*1*J @S,5O*&")U<(SU18#!464@5RK@5_J.#+U[ X4R$8*@2]6(?1[:59
MI6UZ>UU7ST[=E>:T[D6O;U^;*Y*772C>MS7_;\[KM;?+JLQX8+',X:^:JLBS
MM.5O[EO^BT=<VSC5@W._26NVJ8J,U<W?G/B/?=Y^<ZZ<W^]7SIL?WCH_.'GI
M_+:I]DU:9LWUO.7]ZNCS]="'#X<^X#-]^*UJTT)3;6FNMJRV6Q[,]VVU_J*I
MO3+7_BG+\FXRI(7S*<VSJX^ELTQWN;XGL9EUQUH^Z?FPQ6E=YN5CX[Q9L8=\
MG;=O-;#D0L?6Z_UV7_0R_+/=L)HKL^7+S*:;_T_,^4?5Z,:87AACODXU^_J;
M;KCF/&:.@8./@8-[H'<&^($]YF5WL7PE*-)RS9PW/ J:+E*:MT[:.BNV?N<0
M]*.#78QT06'D=TOP^V:7KMG-C%]\P^HG-KO]ZU^0[_Y=%RH'V**'=<OOTZV'
M2!2XKGL]?SJ-"LA68TA8 @FC0# A-,@Q-(AE:$P)AP/3/U&0N&Z 0U&_I5K,
M0YZDL0:%<1A(Q6*U&(J"A5@H40M=16$8B*6H<4!>.-S><;@]N^'^T6F_S_:F
MF^W6,]/8GNW,A(2M(&$Q)"R!A%%/6<VND!<*JYD0*HMCJ"Q>&2I3PL/8AFUX
M0,)6D+ 8$I9 PNA"79.0YWNA/CC\8W#X?3UR)C@^ENLN%EBW>3F\>MMM[/H-
M@[SY^\]=510./PP\IW7V7UV0^)!! @E;0<)B2%@"":- ,"&4@F,H!<9UYE=^
MAB[T^]0/@;JV$1)&TL>\D6^K."0LGM3_!+))"@03I R/4H9&*0]'D+5P!#DG
M;:@9FD#>42V-[=E*"PF+(6')I,&@0$T*TD9':2.CM,-:WFG+A4U[:^ADJZA3
MV BT7=4C982PNU!/;)!MQI"P!!)&@6!")"!WM(%<VUC0&CFNHADAGJ38<BAU
MND'!DJA:$)$.>[&YT[9R@=(H%$T4[,2W0V;!OK)ZG?/=6O7@5+M.K^;2Y#43
M;6?O0#M5$'FN.GU!6XU!:0DHC4+1Q(@8#3ED=N0T$:&- M4J0WZH3&%\>0KK
M0($RA4$],E :A:*)@HTV&3+[9/%V5U3?&!N.WKM]O=YTYZ\=/YI?G,M CM.@
M-E%78XUW"MIH#$I+0&D4BB9&QNCH(;.E9XH,;32HAI$O?Y@NAT*G4UH1> (G
M-O?=6C=0XPR*)NHVVFO([*_=L8QM=X=[K&7FU.RH'%^3#UJV%=]D/?$C59M^
M=9[S=M-9*X=[1A=F/*CM-M"$XTF$-%,>U%(#I26@- I%$T-G--^0T9!Y5>AH
MP\77>,@!43[G?8V7*,> %H4C>5T ]<) :12*)HH[VF'([(?%96:X4_I+6A\-
M=ZS5$M)-6B+5P?+X#C#43'Y0XPR4EH#2*!1-C(_18T-FDTV*CTDQ$:H;]"CP
M(BQ/<+6<AP)9:-6L(M@/(F6*:TPMI-Q_3;3%B.]+?:/F47GIJ(_V%[K@?PFC
M?NFNZ65%0,TQ4-H*E!:#TA)0&D6JJVB^=XI'CPQ?\,C,\3(E1LPM6">]0-)6
MH+08E): TBA6_4G3#50\FG+8;,I9)47I T1UU3P4$M576TXNN3)WVEI84 <.
ME$:A:*+\)REQMCEQDR376&VA1^3]]5)3C@LN:ZV:<H0$))3N.\6:<MV>7MX9
M)+IRF ^8U#EJ'IF7COQHI6'+E#.;'"B]*JHEIGR.#+I .D\K4%H,2DM :73*
M"(OA,/IG^+4I<9-"0#7,I(^)(0! 4]Q :3$H+0&ET<OC*\H_VG#XX-7\?S*9
M,*CQ!DI;@=)B4%H"2J-0-#&D1GL.F^TY4T83UOEC9$'DH[BY"6OI0?/8)EY#
M MHJA:*)HHZV'#;;<C:Y35AUS8B/?%EBT+PU4%H,2DLFC0>%:E,4>/35\ 5?
MS3[#R4RT7NVUQIKFB ::QP9*2T!I%(HF1L3H^6'KG#=M%*@N$ED@(L_V2-G
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M8AL<,+\TQN\_P@*'1]G\;U!+ P04    "  *=Z56DM]GKKD%   L#@  &0
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M/E>:L[7.E^K!:!]&<);*YJ(HR;]7O*QWXV($<X6-X0*:P_][!@*-W,+9  G
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MU^&[M]WOI<M<NK;PEY9P@<;W+D)]4'JQ)\WP@\>$5T-1FCBEO '+*>2AZM)
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M0&D$:'TAA&X^C(/VC\?T/U!+ P04    "  *=Z56.GI2/K,#  "&"   &0
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MM %7E/A8X$[(3@Y@/[<V;!;BH+]E3O\!4$L#!!0    (  IWI59GB^2C< ,
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M62)=,E,"?JTY$3CFB3MK^)WLH%_H^BIJPH1?X$.O/QI2^_[=..VG'P]Z82[
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M;"]W;W)K<VAE971S+W-H965T,C(N>&ULA51-;]LP#/TKA%<,+>#6L9VO94F
MI%VQ'CH$;;<>AAT4FXF%RI(GR4W[[T?)B9<.:7:Q*8I\?*1(CC=*/YD"T<)+
M*:29!(6UU2B*3%9@R<R%JE#2S4KIDEDZZG5D*HTL]TZEB)).IQ^5C,M@.O:Z
MA9Z.56T%E[C08.JR9/IUCD)M)D$<[!1W?%U8IXBFXXJM\1[M]VJAZ12U*#DO
M41JN)&A<38)9/)IWG;TW^,%Q8_9D<)DLE7IRAYM\$G0<(12868? Z/>,ERB$
M R(:O[>801O2.>[+._1KGSOELF0&+Y5XY+DM)L$P@!Q7K!;V3FV^XC:?GL/+
ME##^"YO&MD?&66VL*K?.Q*#DLOFSEVT=]AR&G7<<DJU#XGDW@3S+*V;9=*S5
M!K2S)C0G^%2]-Y'CTCW*O=5TR\G/3F_D,TJK-$<3PC=J@IG,X0I7J#7FL-!H
M4#\S7\!+9:R!TP>V%&C.QI&E\ XDRK:AYDVHY)U0*=PJ:0L#7V2.^5O_B&BW
MW),=]WER%/"6Z0M(XQ"23I(>P4O;6J0>+_U/+5[ABIM,*%-KA)^SI;&:FN?7
MH8P;P.YA0#=0(U.Q#"=!U502@^G'#W&_\_D(W6Y+MWL,?7I/ YK7 D&M8.\9
M#]$\"G28YIO&D-08S (5/"O:B@/SK9)AN42]TR:P0:I:ILI*<T,M1.1L@;!2
M@N:?RS6<<DD:51MR-V>C/= W6'=L0WUN47,FC ]EZJH21 =.(.V'*87RPB#N
MP2--_CF7YY56&1H#<1RF\2>(.V%WT(=K+CE-2 YKI7(#R3#LIPDD@S 9#N!!
M62: _YOM"0SZ83)(G= EE"$<>K%H;_!*U&N_7@QE7TO;S&"K;3?8K!G<O^;-
M^J,RK+DT('!%KIV+02\ W:R4YF!5Y<=XJ2PM!2\6M(51.P.Z7REE=P<7H-WK
MTS]02P,$%     @ "G>E5LTBQ>;E!0  ,1   !D   !X;"]W;W)K<VAE971S
M+W-H965T,C,N>&ULK5AM;]LV$/XKA%<4*\#&>G])$P-.TC=@78,D:S$,^T!+
MM$5$$E62BI/]^MU1LF([KI"N^R)+E'CW')^[YTB?K*6ZU07GAMQ79:U/)X4Q
MS?%TJK."5TP?R8;7\&8I5<4,/*K55#>*L]Q.JLJIYSC1M&*BGLQ.[-BEFIW(
MUI2BYI>*Z+:JF'HXXZ5<GT[<R6;@2JP*@P/3V4G#5OR:FS^:2P5/T\%*+BI>
M:R%KHOCR=#)WC\\2_-Y^\$7PM=ZZ)QC)0LI;?/B8GTX<!,1+GAFTP.#GCI_S
MLD1# .-;;W,RN,2)V_<;Z^]L[!#+@FE^+LNO(C?%Z229D)PO65N:*[G^P/MX
M0K27R5+;*UGWWSH3DK7:R*J?# @J47>_[+Y?A^=,\/H)GL7=.;(H+YAALQ,E
MUT3AUV -;VRH=C: $S62<FT4O!4PS\S>2YFO15D25N?DLRFX(A]KP^J56)2<
MS+7F1I-?;Q@\Z5<G4P,N<>(TZ\V?=>:][YCWR2=9FT*3MW7.\]WY4X ZX/4V
M>,^\48.?F#HBODN)YWC^B#U_B-^W]OSGQ/\T\@NALU+J5G'RUWRAC8(L^OO0
M,G1>@L->L+*.=<,R?CJ!TM%<W?')[.4O;N2\&8DA&&((QJS/KJ%2\Q9 RR4Y
M9TH]B'I%OK"RY1J'/L+2+T4M#">_004<"/-00.,NY]8RD)$5 QMV"2]XQJL%
M9%$_ZA'(*9)M4-T-J&2KB'A$5EIDXA$9ZPA8<X7W9"E+T ](15&#1=EJ<*9?
M'6]!V/$\T/J">$%(HR"Q=SZ-?!?B?]THF7&MR=5+5C5O+HA'7<^!JY,XY!+>
M >&@/(9DD+W(N;;!L97B=ESCIZ[?74<8# <&PV<S.$!?/) KWDAEL/C(-5^A
MYT-4C=O^*:IPZJH'1 D#5#"P+@38$AI$N60&:#/2TOF)YR)C)1B^$["Z1'>0
M*5D#@6,<[LWK0R5GK&1U9ND'KT_A/C(* @WR6X-@*L7K[($ :;4&<"C\2%*\
M9VQO.88L&>$R&KB,GL^EDI!D>S5)R3S+VJKMUFY> </B'PN56E[F#63GO8".
MPW?>DDNNA,R[M?CQ@AY'_8-9LK*![94UP-\*C#T)C&T%MOV6-$-@F$8_IPF4
M\/N,-P:^PH:,0.ZX@OT%:35?MB587?(=X;"A[C&US=#OL#4:7GS=6)WW5N?9
MMU8H+ *>%;4LY>H!T\EQJ.]BBH8.#>(4;MP@I8GO$S<Y\OI.^QB:/B;GMMG#
M:"ETKS>VOF"!="$:C5B=*"&N2X,D)6Y*0[#K.4<A=BFCQ*+M]CDPL6)UNP39
M:A5B5@BYLWA;R_7K A(ZI4$8DHCZH4]\ZCH>"8] ^B!@5+> >DF$XZE'P&L:
M$#>&UQWJD":0!1Y-/13 )$U)<!20&VF@A.5^7-T*8(W"HO@T#6.\B6@4@TT'
M5N)I?OW/5+AI0@,0]Q<DB*EK_;NA2[WH)ZGP':3"=1RD(H6G_TZ%!XL1TCC%
M)0_B9)^*P%(!G0D3(-JEPH^P;86!I0)D;IP*2,'4Q:7P/!JYF)5>3+W412K&
M^E@\:%\\KGW=UAXK>4>YWM[#(4+S0[(T:O#PQND&!*BK?5Q2Z$-L<Z9 QSO*
MPCO'J!:*9U+E5E#(>UY#RF!'RV%/C90Q/!S0GC%URPV:[F>#--96F<XE;%A@
M(,<[+4N1VZR\-O!C.Q:X_PQBUF6*-78N*P!>X"GF#N0:,WN__=T4L*O8V2=W
MDF2+87XHFA>0#TF"ZA+ CB4@(\PE W/)L[K6;D/JMH_[FV(X"D(EWAOR#F/Z
MDS-UL.&,.CS,[,$NI =H; _:T]: T+ _U0AOB? >$)Y-DN]O0*XX'E]S*!=P
M&. EQ$N$EQ@O25]3WV$#=, /09D#FH"0NE")OOV)G A_0B? 'S_!36@<T2!U
M#E(VW3K&@?JL[&$5NJQL:].=Z(;1X3P\[XZ!CY]WAVE8PI6 %"SY$J8Z1S'L
M$55W0.T>C&SLH7 A#4B=O2W@3,\5?@#OEU*:S0,Z&/XEF/T+4$L#!!0    (
M  IWI59%!#5ZU@4  %(1   9    >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM
M;.U8;6_;-A#^*P<W*6) C?4N.4T,).FR%4BW(.E6#,,^T!(="Y5$E:3RLE^_
M.U)6;,?6NL\;D$BDQ'MX+\_=43Y]%/*K6G*NX:DJ:W4V6FK=G$PF*EORBJEC
MT? :WRR$K)C&J;R?J$9REANAJISXKAM/*E;4H]FI>78C9Z>BU651\QL)JJTJ
M)I\O>"D>ST;>:/7@MKA?:GHPF9TV[)[?<?UK<R-Q-NE1\J+BM2I$#9(OSD;G
MWLE%0NO-@M\*_JC6QD"6S(7X2I./^=G()85XR3--" QO#_R2ER4!H1K?.LQ1
MOR4)KH]7Z%?&=K1ESA2_%.67(M?+LU$Z@IPO6%OJ6_'X$^_LB0@O$Z4R5WBT
M:^/I"+)6:5%UPJA!5=3VSIXZ/ZP)I.X> ;\3\(W>=B.CY0>FV>Q4BD>0M!K1
M:&!,-=*H7%%34.ZTQ+<%RNG9-4>3%!Q]9O.2J_'I1",HO9ID'<"%!?#W  3P
M2=1ZJ>"'.N?YIOP$E>DU\E<:7?B#@)^8/(; <\!W_6  +^@M# Q>,&SA'^=S
MI262X,]=-EJ(<#<$)<:):EC&ST;(?,7E Q_-WK[Q8O?]@()AKV XA#Z[PT3+
MVY*#6,!=VS0E1])K5L(%*UF=<;@SV?FQMBE(7+[E)=,\!RW FK?+IN%=U^'D
M"UQIO5746=EB/'$ >LGA4F!T:X4/<*1$6>1&8$-#!8], ?XM1(FYCJ0RPJ)5
MK,Z5 _PIXXVV.X#FL@)\#GFA,M'6&B0BCD_@EX;CJ*CO.U5.  F1+0TC/O",
M5W,NS61K(4C*OW=B\:[%"5.*%#J *'9BS[4#-_;@/,O:JK7FLDI(7?QE?7#D
M18X7)&,<A Y2;_P]&SA08V0.(/2<, GL((VF<-E*B3'$1-6M+'2!'L7@BBW3
M<'W@!-/4WMT4?A;UN^S[1$/729*0]O.C!#X+XLO6(B@+-B]*BX&JA8Z7^'80
MQ1%<%;6)W<K--Y+D];.)"O_6%@W1T &F(1.*K(R=* C,/41E]WO2=^)D.J9[
M.$W'>X&MZP)T6&CN4XS3;L<M-E2E8/HQ7;U@P&5;0H$3I3Y>XS#LW+6Q8-M9
MCN>F]H[N_6)J.]GY@!Z^1RIPZG<OGC9L)KH_<R;5#A:#YQTG=)EN^1V2XQC_
MT]=[;"3&#L3H.#W$R_1P&]$_]@[-9: V17UMBH9KD^W5Y$]3:##]E=Y9;89Q
MSE==GY"LS_A30Q6%RH4$T<H^'D235WQ?+T@_\AK?EDC-'#MB066=6KMC)'&3
MK]Q(]AL@)PE_3PV[TW@C1AK6=&[&!0;M4E18\9=T"'G@<"W4<)'#R']>2LXW
M>J)I9'3QX7P]3W"W9F=J(.^\P#/7!,L^DHMC_G7FD#5;U/8]\*.=I%[)>)$/
M7NR_*FG]>R=U<84S]5UL07/[$ETN*@YOWZ2^Y[^'HRG61+O)IO !"9H<QOO4
MA8U8D^,SII:P0&\AY%#3^?>>O23DAA6Y(1%6H9;"N-V\*H1OI8GQ"_W6\OUD
M+4(O'NJU[ACZNGA[3C*-S3WR5_5TA^16M+P /1VX^W?:$=UP()7C/I7CP12\
MYMBR^'K?-!GMP'7GB6<'6ZVIH,^[$GP8_:I%24XGU*)JJ\['#7NVB47T5BM>
M27NZZ>C%)!\*^JJVO6A]:VIOCJ< C*4)'+4TT]@</XSI40BQ&T/DI-Z4IA%$
M*?X[,;(;I_@FIK<N5GB<)CCU4#:-L8\N,=?8 C,.@QHG+@0)-H*@H_T>XVCC
M,* S1HR=+PZ /-V1$8TU)\;:J%ZL<ODH\'TZ::38(3WJD&8)/+"R-<= :HU[
M=K.=J6OF9J<=[>\(&R3BF]/%N*O<:X1W$'2WX$'7)P^Z \8 [Y*>=\DP,[H(
MOF;;%78X=.OOV#,'F?</^/\S[[_"O,G:=V[%Y;WYFD<TLM=^\O9/^Q\,SNUW
M\LMR^VL#?E3<%]CD2[Y 4?<XP?.+M%_P=J)%8[Z:YT+C-[@9+CG#X-,"?+\0
M0J\FM$'_,\KL;U!+ P04    "  *=Z56;E,34B(#  #2!@  &0   'AL+W=O
M<FMS:&5E=',O<VAE970R-2YX;6R%56UOVS80_BL'K1MBP+.H%[]EMH$X6;&A
M:1'4V0ILV =*.EM"*-(CJ;C=K]^14A05<[TO)H^\Y^5(ZKPZ*?UD2D0+GVLA
MS3HHK3U>AZ')2ZRYF:@C2MK9*UUS2Z$^A.:HD1<>5(LP9FP6UKR2P6;EUQ[T
M9J4:*RJ)#QI,4]=<?]FB4*=U$ 4O"Q^K0VG=0KA9'?D!=VA_.SYHBL*>I:AJ
ME*92$C3NU\%-=+U-7;Y/^+W"DQG,P562*?7D@E^+=<"<(1286\? :7C&6Q3"
M$9&-OSO.H)=TP.'\A?VMKYUJR;C!6R4^584MU\$B@ +WO!'VHSK]@ET]4\>7
M*V'\+YS:W.DR@+PQ5M4=F!S4E6Q'_KD[AP%@P;X!B#M ['VW0M[E';=\L]+J
M!-IE$YN;^%(]FLQ5TEW*SFK:K0AG-W>86;AZY)E ,UJ%EBC=1IAW\&T+C[\!
M3^"]DK8T\+,LL/@:'Y*5WD_\XF<;7R1\S_4$DF@,,8N3"WQ)7U_B^9)+]=U5
M)A?*-!KASYO,6$UOX:]SQ;9<Z7DN]WU<FR//<1W0!V!0/V.P^>&[:,9^NN T
M[9VFE]@W._K>BD8@J#WL2J7MCX^H:^"R@'LE#VVTY8++'(U+\@OWBLMSE5S4
M.E_)8XE@O+!]$19.V$?90%@U^E7<YRE;HAYF*TW55_)@X(1TZMS 7@EJ  :N
M*@FV5(TAG!E= UUX7OH;O\,<ZXQX7/#*WRG#&XBC9!PM%MUL/F5PJ^0S:EO1
MZX4=RDII^* LN8P8&S/&^C&>I-/O87?D^HD;@_ 'N4$MN<C@ZMW;3ZU2-((X
MC2!>SB":I.Q_\^,1S!8,YDD"C\IR00<P\)M$Z3AB2S_.YTNX1V.@D;RF$Z[^
MP:+-5KHZ5)+[#I4K8^F 9N,X8B,WSN8D\8$Z\^ \$S8?+Y9$RQ9$/V]I!]?V
ME8>K:#R+'1>-;#%J'])_T]X0&ZF2R7:6$O^Y%QT.^DR-^N"[J2'?C;1MR^E7
M^X9]T_:IU_2VV].U4]T&!.X)RB;S:0"Z[:!M8-71=ZU,6>J!?EK2GPYJET#[
M>T47W05.H/\;V_P+4$L#!!0    (  IWI58.#/ %R@(   (&   9    >&PO
M=V]R:W-H965T<R]S:&5E=#(V+GAM;(54VV[;, S]%<(KAA8PZFNN2P*TZ2Y]
M*%"DW?8P[$&Q&5NH+7F2W+1_/TI.O&Q(LX?$I$0>'E(D9UNIGG2):."EKH2>
M>Z4QS30(=%9BS?2E;%#0S4:JFAE251'H1B'+G5-=!7$8#H.:<>$M9N[L7BUF
MLC45%WBO0+=US=3K-59R._<B;W^PXD5I[$&PF#6LP <T7YM[15K0H^2\1J&Y
M%*!P,_>NHNEU:NV=P3>.6WT@@\UD+>6356[SN1=:0EAA9BP"H\\S+K&J+!#1
M^+7#]/J0UO%0WJ-_<KE3+FNF<2FK[SPWY=P;>Y#CAK656<GM%]SE,[!XF:RT
M^X=M9YN./,A:;62]<R8&-1?=E[WLZG#@, [?<(AW#K'CW05R+&^888N9DEM0
MUIK0K.!2==Y$C@O[* ]&T2TG/[-8X3.*%F&%F2P$=Y4Z?V3K"O7%+# 4P=H%
MV0[MND.+WT!+X$X*4VKX*'+,__8/B%E/+][3NXY/ MXQ=0E)Y$,<QLD)O*1/
M-W%XR7_2W2A9PY*X*FH+*KDI8>F*C0I^7*VU._]YK  =?GH<WX[05#<LP[E'
M,Z)1/:.W>/\N&H8?3K!/>_;I*?3%#=>L*!06S+V3W, NGV-$3T-12X,ID7X*
M$>KNU="^&E#-L[(O.C"16R%VYEJV*D-M0ZM=*;>H$)B&C:QHPC6<<T&FLM7D
MJ"^F\.@B'/9%A^LP;ZCBVO ,2JD;;EBEX0S2T!^/$Q*2H3^9)' K#"KA<F;5
M@64\]B>#D?VD4?J/5<[I#?FZ-5)IB&)_DDP@BOQPF,*2J9S+SRA0<PV9U5@&
M%8VV*XEBS2ND@Q!&:0R/DB(=R_H,QHD?QQ,21B,_CHXV9W PE]19A=L^%%*V
MPG0CVI_V"^ZJF^L_YMUVI$<IN-!0X89<P\O1P /5;9Q.,;)Q4[Z6AMK8B24M
M:536@.XW4IJ]8@/T:W_Q&U!+ P04    "  *=Z56R?C^(VT#  #O!P  &0
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MJ1P&\+#1HNV'WE9H&J']LJ!O%I3F #W?":&GC7$P?P6M_P%02P,$%     @
M"G>E5CYE_2&S!   GAT  !D   !X;"]W;W)K<VAE971S+W-H965T,S N>&UL
MQ5EK;Z,X%/TK%CM:M5*G@,FKW232-%5W*TTUU60>'U;[P4V<QBK@C&V2&6E_
M_-I ,1Z( 2VC?&D"N?=P[O'CW)KI@;(7OL58@.]1&/.9LQ5B=^VZ?+7%$>*7
M=(=C^<N&L@@)><F>7;YC&*W3I"ATH>>-W B1V)E/TWN/;#ZEB0A)C!\9X$D4
M(?;C!H?T,'-\Y_7&1_*\%>J&.Y_NT#->8O%Y]\CDE5N@K$F$8TYH#!C>S)QW
M_O4B@"HAC?A"\(&7O@-5RA.E+^KB?CUS/,4(AW@E% 22'WN\P&&HD"2/;SFH
M4SQ3)9:_OZ+?I<7+8IX0QPL:?B5KL9TY$P>L\08EH?A(#W_AO*"APEO1D*=_
MP2&/]1RP2KB@49XL&40DSC[1]UR(4H(_.)( \P38-B'($X*TT(Q96M8M$F@^
M9?0 F(J6:.I+JDV:+:LAL1K&I6#R5R+SQ/R.Q"A>$12"^Y@+EL@1$AR<+;-1
M!1\VH#[B 2.>,+P&[P2X0X2!+RA,\#DXN\4"D9"?@[?@\_(6G+TY!V\ B<&G
M+4TXBM=\Z@K)6SW=7>4<;S*.\ C'!\0N0>!? .C!H"9]84^_Q:LB'9KIKE2K
MD P6DL$4+S@F65'N!;A!H10'@V6ZY/YD--F1^/FB)-I2((&59F"!=FKF<O#W
M>XD([N5M_D^=&MGC!_6/5^OZFN_0"L\<N7 Y9GOLS'__S1]Y?]1ITQ.8H510
M*!78T.>?J) *(,ZQJ!WV+'N49JO]9C\?^\/!U-V7"Z@&^9YW-2FB#&:#@MG
MRFQ!8R$'2@W+2@X)66.&U.#4L<R0AB4";P=#N4W^Q+,NS!N4P@RBPX+HL(6$
M(4%/)"2"X%H=A^T8UH4=9S@J&(ZL#!]HC'_(+8F]R!6P28ZL<"M&USG=$YA1
M[K@H=WS:U3_N4ZF>P RE)H52$_L:0WP+\+>$[%&H/..ZKMI)94[6; '5(,L6
M<%70N[+2>X_W. 1^'2EK8M<AZ G,J-'WM+U[IYVN^?-[$JLO-%.M4C/D_R_#
MRM,;IFM-E&6^^KKO\*UFW<FT<J@RAY_MP!IB4M2&[[=Q_ :[RC&LW&PA)C=M
M^;[=\_,%#_X%[2S+#M=Y9O>$9A:OVPA_>.)]P-K'=%:K)S13+=W2^/:>II5U
MY1A-FT$URK89Z#;$MWIW/IMA+;%>6XB^T,PZ=1/A3TX\<:U=3&>U>D(SU=(]
MC6]O:AH-[*IYZ[6%F/\PZRX$6GV[DW/E4#:*UA"3HK9^V,;Z&YP+5IV]PLT6
M8G(K'3C8C3]?ZZV=RP[7^03A5QPA0-U2P.#$QRW6EJ:S6CVAF6KI)@<V'&RT
M<2Y8/:NH3&-;B,E-]R#0?I:13>.Z$[P;>V;G,?@5W0/4W0,<G7C&]GJ:TA>:
MJ99N9*"]D6FRK#S=.EEM(28MW7? AM.++I95/:"H/8"KC3M^ @>U[<,VMM]D
M7E5CKV=9%W><9:"[@,#>!>3KO[6-V>&Z3O.^T,SB=7\1^*?=% )K?]-9K9[0
M3+5TQQ,T''6TL;$<8V39&:PA&3>W]/),O;E\0.R92+U#O)$YWN58+@26O0S,
M+@3=I>_3GJ@0-$J_;C&2^X,*D+]O*!6O%^H57?%*=OX?4$L#!!0    (  IW
MI585BW[*[0,  (D1   9    >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;,U8
M;6_;-A#^*P>M&!(@LU[L.$YF&TBL%0V0%$&R=A^&?6"DLTU4(E62LA-@/WY'
M25;L6!'B0ACJ#Q9)\9X[/O="4N.U5-_T$M' 4YH(/7&6QF07KJNC):9,]V2&
M@M[,I4J9H:Y:N#I3R.)"*$W<P/.&;LJX<*;C8NQ.3<<R-PD7>*= YVG*U/,5
M)G(]<7QG,W#/%TMC!]SI.&,+?$#S);M3U'-KE)BG*#27 A3.)\ZE?Q'Z@14H
M9GSEN-9;;;!+>93RF^U<QQ/'LQ9A@I&Q$(P>*YQADE@DLN-[!>K4.JW@=GN#
M_K%8/"WFD6F<R>0O'IOEQ!DY$..<Y8FYE^M/6"WHU.)%,M'%/ZRKN9X#4:Z-
M3"MALB#EHGRRIXJ(+8$@>$,@J 2"]PKT*X'^>P4&E<"@8*9<2L%#R R;CI5<
M@[*S"<TV"C(+:5H^%];O#T;16TYR9OJ1"R8BSA*X%MJHG%QJ-!Q]9DHQZY%C
M. K1,)[H8_@ 7,"?2YEK)F(]=@WIMRAN5.FZ*G4%;^CJPZT49JGA#Q%CO"OO
MDMVU\<'&^*N@%?"6J1[T_1,(O* /7QY"./IPW&#7[/TP00M,V [S@%D/O*"
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MS,JO B\PY4<*NL<MN-"0X)P@O=X9'>U4>>\O.T9FQ4WX41JZ5Q?-)3)RA9U
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M_W[728C:$KH]["7QQSW'YUS;U^-*JB>] 3#D.>="3YR-,<6EZ^IT SG5%[(
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MEGB3R6NV^P*5H8'F2U@FS"_:5;&>@Y*-D"ROP$I!3FCYCQ^J1#0 ?O\ (*@
MP?\"P@H0&J.E,F-KAB6.(\YVB.MHQ:87)C<&K=P0JA_CC>3JE"B<C.=T"U0R
M3D"<(ZK*!M,4S6 )G$.*%AP$\"TV&9\R(04Z_8XYQSKW9^AT!A*33)RA#^CV
M9H9.3\[0"2(4_5BSC5!,(G*E$JEOY2:5H*M24'! T#?,>RCTSU'@!:$%/CT.
MGT%2PX,VW%6IJ?,3U/D)#%_X2GX>T>^OZ@C-)>3BC\U6R=.W\^ANO!0%3F#B
M%&52P8G?O_.'WD>;R8[(6I;#VG)XC#V>,M6D*ZIZ5:IG6=FW.2YIAH9&ORZV
ML1^,/"]RMTTKKT6U-/9KC?VC&NL*+9H5FN@*-65LDULR#AI"^J.^/]B3:XD:
MAB/?+G=0RQT<E?M<15N<;4JQU8.S*1V\2%G@O\BK)2@XE-9AK7-X/*TL!R%)
M8A-U%/G6^NZ(K&5R5)L<==32HRXM=T36LCRN+8_?WM*H )ZHI?I:V\R7C.-&
M?7F]?K!7A-:@ \UR48N]>*59)'!JF@1G-F5'X6]]+!V1M9SZWO/7U^NH%BNB
MCEQWQ=:VW1@Z_,[KL:)LU]I@O%>0]JB+O8IT&P.3GE;5T+$B5* ,E@KF]4;J
MY<K+ ;#<2%:8&>J.2361F>5:#<W =8 Z7S(FGS9Z+*O'\/@?4$L#!!0    (
M  IWI586_;KR]P(  ,\*   9    >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM
M;+5674_;,!3]*U:&$$@K^6I+"VTD:+6M$M,J"NQAVH.;W#86CIW93@O_?K83
M0@NA&U)Y:6WGGN-SCV^<.UAS<2]3 (4>,LKDT$F5RL]<5\8I9%B>\!R8?K+@
M(L-*3\72E;D G%A01MW \[INA@ESHH%=FXIHP M%"8.I0++(,BP>+X'R]=#Q
MG:>%:[),E5EPHT&.ES #=9M/A9ZY-4M",F"2<(8$+(;.A7\VZIMX&W!'8"TW
MQLAD,N?\WDPFR=#QC""@$"O#@/7?"D9 J2'2,OY4G$Z]I0%NCI_8O]C<=2YS
M+&'$Z4^2J'3H]!R4P (75%WS]3>H\ND8OIA3:7_1NHKU'!074O&L FL%&6'E
M/WZH?-@ ^.TW $$%"/X7$%: T"9:*K-IC;'"T4#P-1(F6K.9@?7&HG4VA)E3
MG"FAGQ*-4]%7SI,UH11AEJ ?*@6!)DQAMB1S"NA"2E 2'<UT\22%7N +-,)"
M/!*V1'>8%B#-TH1IXP@C"M"5/I3D-<4Q.AJ#PH3J40O=SL;HZ. 8'2#"T$W*
M"ZEWEP-7Z82,+#>NQ%^6XH,WQ'_'X@2%_F<4>$'8 !_MAH\AKN'!-MS5-M9>
M!K67@>4+W^![MJ%%FVU OZXT!DT49/)W4[[E!NWF#<P;?29S',/0T:^L!+$"
M)SK\Y'>]\Z;L]T2VY458>Q'N8J_KJBG)$MFU2'/+K**@W>FV>P-WM2F_*2SL
MAGX=MB6L70MK[Q0V8:U<\!BD1->'.,O/QTT2=W*\]QSV1+:5;J=.M_/1-=G9
MIQ=[(MORHEM[T=UY]#=<8:JOG!>.D&='L'6DR822N;-9C'[@O:C8AB"OYS77
MZVDM^G2GZ*DNUD* _G J%'.FA/[P27M;XZ4 N]XH>"?K>T]M3V1;!O1J WH?
M7<&]?7JQ)[(M+_JU%_T/J^#^Z^O4\\,7%?R/H%*TN]%NF%9/?X:7A$E$8:%A
MWLFI?@-$V3Z5$\5SVX',N=+]C!VFNN,$80+T\P7GZFEBFIJZAXW^ E!+ P04
M    "  *=Z56I7-X-8<"  #9!0  &0   'AL+W=O<FMS:&5E=',O<VAE970S
M-BYX;6R%5-]OFS 0_E=.K)I::2H$$EIU!*EI]Z,/U:IDW1ZF/3AP :O&9K8)
M[7^_,R0LFVCV C[[[KOOL^\N:95^,B6BA>=*2#/W2FOK*]\W68D5,^>J1DDG
M&Z4K9LG4A6]JC2SO@BKAAT$0^Q7CTDN3;N]!IXEJK. 2'S28IJJ8?EF@4.W<
MFWC[C24O2NLV_#2I68$KM(_U@R;+'U!R7J$T7$G0N)E[UY.K1>S\.X=O'%MS
ML :G9*W4DS/N\KD7.$(H,+,.@=%OBS<HA ,B&K]VF-Z0T@4>KO?H'SOMI&7-
M#-XH\9WGMIQ[EQ[DN&&-L$O5?L:=GIG#RY0PW1?:G6_@0=88JZI=,#&HN.S_
M['EW#P<!8?A*0+@+"#O>?:*.Y2VS+$VT:D$[;T)SBTYJ%TWDN'2/LK*:3CG%
MV?234GG+A0 F<_AB2]1P)RV3!5\+A&MCT!HX75$MY UMJ T,$>L76&*MM&7.
M=84%O94]@]-;M(P+<P8GP"5\+55C"-PDOB6^+JN?[;@M>F[A*]PBN%?2E@8^
MR!SSO^-]TCF(#?=B%^%1P'NFSR&:O(,P""-X7-W"Z<G9$=QHN,2HPXW^=XD_
MEHJ^5"XMT_G/,<4]T'0<R'7@E:E9AG./6LR@WJ*7OGTSB8/W1VA.!YK38^CI
M @LN)9<%U;%@,L,Q@CU$W$&XCMZFX32*HTGB;T=2SX;4LZ.IZ4JH/R15M-8H
MLQ>PFDDCF.O,,18]VNR013"Y&.<0#QSBHQRHBOZC/1[1/HNGE__D]0_:K4)=
M=$/%0*8::?O.&W:'N77=M^L?]W[H4472FQ@0N*'0X/R").M^D/2&5777O&ME
M:11TRY)F+VKG0.<;I>S>< F&:9[^!E!+ P04    "  *=Z56V44 -S4&  #;
M(P  &0   'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6RU6FUOVS80_BN$5PPI
MT-8B*<E2EAAPG;4+T&Y!L[88AGU0)-H6*HDN2<7-?OVHEXB61#%V)G])]'+W
M^.Y(/O>(TL6.LF]\0X@ /](DXY>3C1#;\^F4AQN2!OP-W9),WEE1E@9"GK+U
ME&\9":+2*4VFR++<:1K$V61^45Z[8?,+FHLDSL@- SQ/TX ]O"4)W5U.X.3Q
MPJ=XO1'%A>G\8ANLR2T1G[<W3)Y-&Y0H3DG&8YH!1E:7DP4\7]I6X5!:?(G)
MCN\=@R*5.TJ_%2?7T>7$*B(B"0E% 1'(?_=D29*D0))Q?*]!)\UO%H[[QX_H
M[\KD93)W 2=+FGR-([&YG'@3$)%5D"?B$]W]1NJ$G (OI DO_X)=;6M-0)AS
M0=/:64:0QEGU/_A1%V+/ ;D##JAV0(<ZX-H!EXE6D95I704BF%\PN@.LL)9H
MQ4%9F]);9A-GQ3#>"B;OQM)/S-]3&NWB) %!%H$_Q(8P<)V)(%O'=PD!"\Z)
MX.#L5LZ>*)<7Z J\9Y1SL P8>XBS-?@2)#GAK\ B#/,T3P)!(K!(*1/QOT$Q
M4*]*Y,5VR^B/6):=M.Z"&\)B&A6X5V059[&\_T&.:]2/XB4XNR(BB!-Y]!I\
MOKT"9R]>@A<@SL"?&YIS^3/\8BID38K,IF&=_]LJ?S20/P8?:28V'/R:1232
M^"_-_A 9 *9R,)H108\C\A89$3\&[ W \!5 %L*Z@,SN5R1LW)$A'-Q,$%SB
MX0&\=^6@O!X8%/#W!VD/K@5)^3^ZZE?@MAZ\X*ASO@U"<CF1),0)NR>3^<\_
M0=?Z19?Y2&"M.MA-'6P3^OQW2:GM2:]+M\)P2XR"0>_GT/8]+,?Q?C\1C9D#
MD:O,6B$Z38B.,<1%^#V/F1PF0<)-1A.Z?M#%: 0Y=DA& FOEZS;YNJ><FNZ8
M=1@)K%6'65.'F7'<=8RL2[A"<?9FG6SV&*+.Y.R;0=^SD:6?G%X3I/?$Y-3W
M!UV@7B\"Q[)G?B?.OI4]@\Y,'Z;?A.F/L,S]PY:YQLRPS*&E>K9E#/)K*4Z*
M0MX3)L46^,S)*D]DYUP1</87"1A_J6V%9ECH@8?"%R"05CU-=K<H>-"UU>4X
M6.T"[(D6:$2OA$K<+'E^KDW7"'+L"A\+K9TR4BFC4Y)=C3Y6+49":]="21)H
M[/0'$UX-X[:(Q,6PLTPU9K;OPP'"@THQ0+-D.(;R:J@6.6-_C\WJ4#5FR(7^
M0*A*.4"S=#B,]FJ0_4(AUYW9W2 U9C/DPX$@5;N'QB[Z?-HSPT+K&-H[$ LW
M6-Z3M*?Z/#0W^F7Y/"B9+XFY7//%@Q4C23FG^";>ZA]_C)!'+_R1T-H%4!H"
M>B<E0:-$.;H6(Z&U:Z&$"C0KE8-)L*]",+1<K[MHM69X@ 21TBK(+ 2.(<$:
MJB4]H>UUA9_6#%I#H2I5@<RJXC 2K$%:JDX2=2](G9D_6$^E Y"QMSZ;!)^
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M-3>W<OT16S\CRY=*KMT3UFULX$%::R/+%DP*RD(T;_;8YF$+0#S]@+ %A+N
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M*[1 0E9XE\F/;/\KJ0B-"[PERT3Y%^RK6&B!Y4Y(EE?)JH(\I8=/_*42HI6
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M*V7CEI'>+I\XNKRCT>6'?=.$CIUQX+K]T?4]C#%JG#'26^/S1M=X<'0AKR^
M(2-<*?4];#5J?#72&^MZJT+[7!BRP)5^)M%B4VA=_1I_C@*S,\J0LZZD-(D6
MFT+K2MG8?J3W_2?.J/#87B$7A6&_2\-CAX7<8 S[DVH SQE#V,1UZ32F&VG=
M:'3+Z#/A,EUD!,P)31D''Y@DP_M]1BVW4;38%%IW<[ QW0XTNSUHR#17^X,F
MT6)3:%TI&T/OZ W]:0U6@;0; D'8;HA*FM/B8GU1KR5MMS;SBU<O[S%?IU2
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MEX:FC%OF--9160.ZSZ0T^XUUT/Y1Q'\ 4$L#!!0    (  IWI5:%Q//%$P,
M + +   9    >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;,5676^;,!3]*Q:K
MIE9JRU="TBY!2M-.J[1J46BVAVD/#MP$5,"9[23MOY\_"(6(HE5"ZDMBFWN/
MSSF^F#O:$_K$8@".GK,T9V,CYGQS;9HLC"'#[))L(!=/5H1FF(LI79ML0P%'
M*BE+3<>R/#/#26[X([4VH_Z(;'F:Y#"CB&VS#-.7&TC)?FS8QF%AGJQC+A=,
M?[3!:PB +S8S*F9FB1(E&>0L(3FBL!H;$_MZ:ELR047\3&#/*F,DI2P)>9*3
M^VAL6)(1I!!R"8'%WPZFD*822?#X6X :Y9XRL3H^H']5XH68)68P)>FO).+Q
MV!@:*((5WJ9\3O;?H!#4EW@A29GZ1?LBUC)0N&6<9$6R8) EN?['SX41E02!
MTYS@% G.<4+OC02W2'"54,U,R;K%'/LC2O:(RFB!)@?*&Y4MU"2Y/,: 4_$T
M$7G<#S@)G]"49*(N&%;.G@;Z2-&/%7HD'*>H(>CN68Z!G:'36^ X2<7H BV"
M6W1Z<H9.4)*CQYAL&<XC-C*Y8"KW,\."U8UFY;S!RD4/).<Q0W=Y!%$]WQ0*
M2YG.0>:-TPKX@.DE<NUSY%B.V\!G^O_I3@L=MW3=57CN6Z['F,*%++^H;NN$
M4IRO0;PG'"U?4#5NAE_4\F2/:81^?Q>0Z)Y#QOXT^:OW[S7O+^^&:[;!(8P-
M\?(SH#LP_,^?;,_ZTF1.1V UJWJE5;TV=%]7(%,5&%:M EV!3>(UHJ<0Y3VV
M\]V^+8Y]5Q75$.3VK#*H1K9?DNVWDIT'DW,T#Q;G2-0]F@6+-I:M4.\]HH[
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M8:HF0N Z0)U?,B:W"WV!9L:,?@)02P,$%     @ "G>E5EGB)2%W @  J08
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M/?-B@NA $ETD.7^QF!=QOO?FCX5V'/6AY,/7K/EPU*(_%MJQ%(>R#W^T[K<
M1S71B=V3&WIJ!N,@A&=NZ*'TP]>O_?"TK,=Q,/QT,5DY47 F@$/QAV-4_Q:D
M_^$$'0-'DYD?^0.2=J]7J3!;Z1:.2Q4W1#1?ZMUJUR;>ZN9HL'ZGVD?= QU@
MFMYSWXN4>"DAG>M0ZL::=JZ9"%KKCNB9"ME?Z>%:ML"8*0/Y?$FIV$_4!EU3
MG?P'4$L#!!0    (  IWI5;W;SN* @0  !D5   9    >&PO=V]R:W-H965T
M<R]S:&5E=#4U+GAM;*U8:X_:.!3]*U:VJF:D[21V2( I( W,KG:DG1TTM+LK
M5?W@20Q$36S6-M#^^W4>Y '& M5?((][3\ZY]R2Y\6C/^#>Q)D2"[UE*Q=A9
M2[FY=UT1K4F&Q1W;$*K.+!G/L%2[?.6*#2<X+I*RU$6>%[H93J@S&17'YGPR
M8EN9)I3,.1#;+,/\QY2D;#]VH',X\)JLUC(_X$Y&&[PB"R(_;^9<[;DU2IQD
MA(J$4<#)<NP\P/L90GE"$?%W0O:BM0UR*6^,?<MWGN*QX^6,2$HBF4-@];<C
M,Y*F.9+B\5\%ZM37S!/;VP?TWPOQ2LP;%F3&TG^26*['SL !,5GB;2I?V?X/
M4@D*<KR(I:+X!?LJUG- M!62956R8I EM/S'WZM"M!(4CCX!50GH.*%W)L&O
M$OQ":,FLD/6()9Z,.-L#GD<KM'RCJ$V1K=0D-&_C0G)U-E%Y<K(@*]44"9YH
M:8F\M#>+LJ?@90G^4DYZ)3M"MT2 Z0\PYRS>1A(\T!@L"-\E$;D%-X]$XB05
MM^ #^+QX!#?O;L$[D%#P:<VV M-8C%RIR.:7=*.*V+0DALX0\\$SHW(MP&\T
M)G$WWU4B:Z7HH'2*C(#/F-\!'_X*D(=\#9_9Y>G(0,>O"^\7>/X9O$,AVX7_
M\J<* D^29.*KKF(E8D^/F-_P]V*#(S)VU!TM5'.(,WG_"PR]CSJYEL ZXGNU
M^)X)??*)29RJIT#I*YW4,C\L\O-'T6XR\!$:CMQ=6\-I5+^/H%]'=<@%-;G
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MGWKG<MJE?.WY7N/U_Y/J<CXW72]_67[O'-WC%YP#_&_Q^ 502P,$%     @
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MK779'/)9][G$Y!-02P$"% ,4    "  *=Z56!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    (  IWI58\
M,OQ9[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    (  IWI5:97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ "G>E5HQ[Q=7$!0
MNAX  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    (  IWI583SD/71P8  #T@   8              " @0@.
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    "  *=Z56D!5:
M 8L'  #Q(0  &               @(&%%   >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ "G>E5FT]F5&8 @  ; <  !@
M ("!1AP  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    (  IW
MI59DRUH.;08   4;   8              " @10?  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    "  *=Z56T4K"_-((  #U3@  &
M        @(&W)0  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ "G>E5CT$P@'+!P  7A0  !@              ("!ORX  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    (  IWI5;1[/,S] <  &X5   8
M              " @< V  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    "  *=Z56*\\>Z> #  "["0  &               @('J/@  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ "G>E5CV-857@!P
M&A4  !D              ("! $,  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    "  *=Z56?:?EE=P#  "@"0  &0              @($7
M2P  >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    (  IWI5:2
MWV>NN04  "P.   9              " @2I/  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ "G>E5HY]+Q+_#@  .BL  !D
M     ("!&E4  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    (  IWI5:CM&VO\@0  (0,   9              "
M@;5W  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ "G>E
M5CIZ4CZS P  A@@  !D              ("!WGP  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    "  *=Z56J%A+D;$$  !Q"@  &0
M        @('(@   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   (  IWI59GB^2C< ,  $D)   9              " @;"%  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ "G>E5N2.G0>Z @  XP4
M !D              ("!5XD  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    "  *=Z56S2+%YN4%   Q$   &0              @(%(C
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    (  IWI59%!#5Z
MU@4  %(1   9              " @622  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ "G>E5FY3$U(B P  T@8  !D
M ("!<9@  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    "  *
M=Z56#@SP!<H"   "!@  &0              @('*FP  >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    (  IWI5;)^/XC;0,  .\'   9
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M970S,2YX;6Q02P$"% ,4    "  *=Z56!'!:+;0"  !M!P  &0
M    @(%XL@  >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M  IWI5:0_6!JM (  !\'   9              " @6.U  !X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ "G>E5@?OJ,(! P  D@L  !D
M             ("!3K@  'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    "  *=Z56%OVZ\O<"  #/"@  &0              @(&&NP  >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (  IWI5:E<W@UAP(
M -D%   9              " @;2^  !X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ "G>E5ME% #<U!@  VR,  !D              ("!
M<L$  'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    "  *=Z56
M8,6EAW8"  #L!0  &0              @('>QP  >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    (  IWI58A-V)XHP(  !$'   9
M      " @8O*  !X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ "G>E5J1DW*WB @  OP@  !D              ("!9<T  'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    "  *=Z56M38B%S "  !M!0
M&0              @(%^T   >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    (  IWI58 K-<4<@0  +L1   9              " @>72  !X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ "G>E5OX.%>+]
M @  WP@  !D              ("!CM<  'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    "  *=Z56@HFJM[("  !#!P  &0
M@('"V@  >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    (  IW
MI5:]L_$:> 0  !(6   9              " @:O=  !X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ "G>E5K=F0/'Q$   F/0  !D
M         ("!6N(  'AL+W=O<FMS:&5E=',O<VAE970T-BYX;6Q02P$"% ,4
M    "  *=Z56CD;E@JD$  !?&@  &0              @(&"\P  >&PO=V]R
M:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    (  IWI59?B)3CCP,  &@0
M   9              " @6+X  !X;"]W;W)K<VAE971S+W-H965T-#@N>&UL
M4$L! A0#%     @ "G>E5L[+_</M P  -1   !D              ("!*/P
M 'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6Q02P$"% ,4    "  *=Z56&K99
MN*\"   T!@  &0              @(%,  $ >&PO=V]R:W-H965T<R]S:&5E
M=#4P+GAM;%!+ 0(4 Q0    (  IWI5:%Q//%$P,  + +   9
M  " @3(# 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @
M"G>E5LM"W#:P P  ;PX  !D              ("!? 8! 'AL+W=O<FMS:&5E
M=',O<VAE970U,BYX;6Q02P$"% ,4    "  *=Z566>(E(7<"  "I!@  &0
M            @(%C"@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4
M Q0    (  IWI58NNPG>N ,  & /   9              " @1$- 0!X;"]W
M;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ "G>E5O=O.XH"!
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M96QS+RYR96QS4$L! A0#%     @ "G>E5A'<_DM\!   ("4   \
M     ( !L!T! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    (  IWI58,/Y#\
MY0$  '\A   :              "  5DB 0!X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    (  IWI5:/X;=ITP$  #8A   3
M  "  78D 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !  $  =Q$  'HF
$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>161</ContextCount>
  <ElementCount>270</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>61</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss</Role>
      <ShortName>Condensed Consolidated Statements of Operations and Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity</Role>
      <ShortName>Condensed Consolidated Statements of Shareholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Inventories, net and Deferred Preservation Costs</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts</Role>
      <ShortName>Inventories, net and Deferred Preservation Costs</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Stock Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensation</Role>
      <ShortName>Stock Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Loss Per Common Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LossPerCommonShare</Role>
      <ShortName>Loss Per Common Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Presentation and Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/FinancialInstruments</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Inventories, Net And Deferred Preservation Costs (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables</Role>
      <ShortName>Inventories, Net And Deferred Preservation Costs (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/Leases</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/Debt</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/RevenueRecognition</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Stock Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensationTables</Role>
      <ShortName>Stock Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/StockCompensation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Loss Per Common Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LossPerCommonShareTables</Role>
      <ShortName>Loss Per Common Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LossPerCommonShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SegmentInformation</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails</Role>
      <ShortName>Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Financial Instruments (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails</Role>
      <ShortName>Financial Instruments (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails</Role>
      <ShortName>Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/FinancialInstrumentsTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails</Role>
      <ShortName>Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Inventories, net and Deferred Preservation Costs (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails</Role>
      <ShortName>Inventories, net and Deferred Preservation Costs (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/IncomeTaxes</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Leases (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails</Role>
      <ShortName>Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Leases (Summary Of Lease Costs) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails</Role>
      <ShortName>Leases (Summary Of Lease Costs) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails</Role>
      <ShortName>Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails</Role>
      <ShortName>Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LeasesTables</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Debt (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/DebtTables</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails</Role>
      <ShortName>Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/DebtTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Revenue Recognition (Disaggregation Of Revenue) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails</Role>
      <ShortName>Revenue Recognition (Disaggregation Of Revenue) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/RevenueRecognitionTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Stock Compensation (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensationNarrativeDetails</Role>
      <ShortName>Stock Compensation (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/StockCompensationTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails</Role>
      <ShortName>Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/StockCompensationTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails</Role>
      <ShortName>Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/StockCompensationTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Loss Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails</Role>
      <ShortName>Loss Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/LossPerCommonShareTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Segment Information (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SegmentInformationTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails</Role>
      <ShortName>Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SegmentInformationTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Segment Information (Summary Of Net Revenues By Product And Service) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails</Role>
      <ShortName>Segment Information (Summary Of Net Revenues By Product And Service) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SegmentInformationTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="aort-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.cryolife.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.cryolife.com/role/SubsequentEvents</ParentRole>
      <Position>56</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[dq-0542-Deprecated-Concept] Concept LondonInterbankOfferedRateLIBORMember in us-gaap/2021 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. aort-20230331.htm 4</Log>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: aort:DebtInstrumentExtensionPeriod, us-gaap:DebtInstrumentConvertibleConversionRatio1 -  aort-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="aort-20230331.htm">aort-20230331.htm</File>
    <File>aort-20230331.xsd</File>
    <File>aort-20230331_cal.xml</File>
    <File>aort-20230331_def.xml</File>
    <File>aort-20230331_lab.xml</File>
    <File>aort-20230331_pre.xml</File>
    <File>aort-20230331xex311.htm</File>
    <File>aort-20230331xex312.htm</File>
    <File>aort-20230331xex32.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="607">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>73
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "aort-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 23,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2021-01-31": 607,
    "http://xbrl.sec.gov/dei/2021q4": 29
   },
   "contextCount": 161,
   "dts": {
    "calculationLink": {
     "local": [
      "aort-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aort-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "aort-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "aort-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aort-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "aort-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 446,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 3,
    "http://www.cryolife.com/20230331": 1,
    "http://xbrl.sec.gov/dei/2021q4": 5,
    "total": 9
   },
   "keyCustom": 24,
   "keyStandard": 246,
   "memberCustom": 23,
   "memberStandard": 36,
   "nsprefix": "aort",
   "nsuri": "http://www.cryolife.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.cryolife.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Goodwill and Other Intangible Assets",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.cryolife.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.cryolife.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Debt",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.cryolife.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.cryolife.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Revenue Recognition",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.cryolife.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Stock Compensation",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.cryolife.com/role/StockCompensation",
     "shortName": "Stock Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Loss Per Common Share",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.cryolife.com/role/LossPerCommonShare",
     "shortName": "Loss Per Common Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Segment Information",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.cryolife.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.cryolife.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
     "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:SellingGeneralAndAdministrativeExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "20",
     "role": "http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Financial Instruments (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.cryolife.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Inventories, Net And Deferred Preservation Costs (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables",
     "shortName": "Inventories, Net And Deferred Preservation Costs (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aort:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.cryolife.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "aort:AssetsAndLiabilitiesLesseeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Debt (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.cryolife.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Revenue Recognition (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.cryolife.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Stock Compensation (Tables)",
     "menuCat": "Tables",
     "order": "27",
     "role": "http://www.cryolife.com/role/StockCompensationTables",
     "shortName": "Stock Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Loss Per Common Share (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.cryolife.com/role/LossPerCommonShareTables",
     "shortName": "Loss Per Common Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Segment Information (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.cryolife.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails",
     "shortName": "Financial Instruments (Summary Of Financial Instruments Measured At Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Financial Instruments (Narrative) (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails",
     "shortName": "Financial Instruments (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i71edbd22e4cf42339603deb7cbeac930_I20200902",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "idc54f5a9f8964a9eac3519cb41b6887b_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails",
     "shortName": "Financial Instruments (Reconciliation Of Changes In Fair Value Of Level 3 Liabilities) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "idc54f5a9f8964a9eac3519cb41b6887b_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails",
     "shortName": "Inventories, net and Deferred Preservation Costs (Schedule Of Inventories) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Inventories, net and Deferred Preservation Costs (Narrative) (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails",
     "shortName": "Inventories, net and Deferred Preservation Costs (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Carrying Values of Indefinite Lived Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i2c6dba73291e448e8f57ab1bc8a6db08_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "idc54f5a9f8964a9eac3519cb41b6887b_I20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Goodwill by Reportable Segment) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillForeignCurrencyTranslationGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i4136c9e254424e49b35b6472a39e43cf_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Intangible Assets (Summary of Amortization Expense) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails",
     "shortName": "Goodwill and Other Intangible Assets (Scheduled Amortization of Intangible Assets for Next Five Years) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockSharesAuthorized",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.cryolife.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Leases (Narrative) (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.cryolife.com/role/LeasesNarrativeDetails",
     "shortName": "Leases (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aort:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails",
     "shortName": "Leases (Schedule Of Supplemental Balance Sheet Information Related To Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aort:AssetsAndLiabilitiesLesseeTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "aort:PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Leases (Summary Of Lease Costs) (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails",
     "shortName": "Leases (Summary Of Lease Costs) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails",
     "shortName": "Leases (Schedule Of Supplemental Cash Flow Information Related To Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
     "shortName": "Leases (Schedule Of Minimum Lease Payments For Finance, Operating, And Sublease Income Leases) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Debt (Narrative) (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.cryolife.com/role/DebtNarrativeDetails",
     "shortName": "Debt (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails",
     "shortName": "Debt (Schedule Of Short-Term And Long-Term Balances Of Term Loan) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ifdfc0f0eb9c74eb0bb2a26d5225fdd03_I20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Revenue Recognition (Disaggregation Of Revenue) (Details)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
     "shortName": "Revenue Recognition (Disaggregation Of Revenue) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i6765ee8c4e514375bf2377f15526dbbc_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Stock Compensation (Narrative) (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
     "shortName": "Stock Compensation (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
     "shortName": "Stock Compensation (Schedule Of Weighted-Average Assumptions Used To Determine The Fair Value Of Options) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i1c644de6140d4e56b7fe6b124c7fad63_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails",
     "shortName": "Stock Compensation (Summary Of Total Stock Compensation Expenses) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Loss Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails",
     "shortName": "Loss Per Common Share (Computation Of Basic And Diluted (Loss) Income Per Common Share) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Segment Information (Narrative) (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.cryolife.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails",
     "shortName": "Segment Information (Revenues, Cost Of Products And Services, And Gross Margins For Operating Segments) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i56e7dd1126f2498d92e0aac01cfbc8da_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Segment Information (Summary Of Net Revenues By Product And Service) (Details)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails",
     "shortName": "Segment Information (Summary Of Net Revenues By Product And Service) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i0d27f99bdef34490ab29648e4ece9919_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ie06473170a934a1f8ba18b66bd8feeb5_D20190911-20190911",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "aort:NumberOfTranches",
      "reportCount": 1,
      "unique": true,
      "unitRef": "tranche",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Subsequent Events (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.cryolife.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "ie06473170a934a1f8ba18b66bd8feeb5_D20190911-20190911",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "aort:NumberOfTranches",
      "reportCount": 1,
      "unique": true,
      "unitRef": "tranche",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i6a9f88cb8b244d1f8d88193d41aee37f_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Shareholders' Equity",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
     "shortName": "Condensed Consolidated Statements of Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "i6a9f88cb8b244d1f8d88193d41aee37f_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies",
     "shortName": "Basis of Presentation and Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccounting",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Financial Instruments",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.cryolife.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Inventories, net and Deferred Preservation Costs",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts",
     "shortName": "Inventories, net and Deferred Preservation Costs",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "aort-20230331.htm",
      "contextRef": "iace09305debf49f1a8dd19b0c839ce29_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 61,
   "tag": {
    "aort_AccruedProcurementFees": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Donated tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. The Company accrues estimated procurement fees due at the time tissues are received based on contractual agreements between the Company and the tissue banks and organ procurement organizations.",
        "label": "Accrued Procurement Fees",
        "terseLabel": "Accrued procurement fees"
       }
      }
     },
     "localname": "AccruedProcurementFees",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_AorticStentGraftsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aortic Stent Grafts [Member]",
        "label": "Aortic Stent Grafts [Member]",
        "terseLabel": "Aortic stent grafts"
       }
      }
     },
     "localname": "AorticStentGraftsMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_AscyrusMedicalLlcMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ascyrus Medical LLC [Member]",
        "label": "Ascyrus Medical Llc [Member]",
        "terseLabel": "Ascyrus Medical LLC"
       }
      }
     },
     "localname": "AscyrusMedicalLlcMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Supplemental Balance Sheet Information Related To Leases [Table Text Block]",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Schedule of Supplemental Balance Sheet Information Related to Leases"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "aort_CardiogenesisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cardiogenesis [Member]",
        "label": "Cardiogenesis [Member]",
        "terseLabel": "CardioGenesis cardiac laser therapy"
       }
      }
     },
     "localname": "CardiogenesisMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_CircumstanceAfterJuly52023Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Circumstance After July 5, 2023 [Member]",
        "label": "Circumstance After July52023 [Member]",
        "terseLabel": "Circumstance After July 5, 2023"
       }
      }
     },
     "localname": "CircumstanceAfterJuly52023Member",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_CircumstanceIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Circumstance I [Member]",
        "label": "Circumstance I [Member]",
        "terseLabel": "Circumstance I"
       }
      }
     },
     "localname": "CircumstanceIMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_CircumstanceIiMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Circumstance II [Member]",
        "label": "Circumstance Ii [Member]",
        "terseLabel": "Circumstance II"
       }
      }
     },
     "localname": "CircumstanceIiMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_ConsignmentInventoryPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consignment inventory percentage.",
        "label": "Consignment Inventory Percentage",
        "terseLabel": "Consignment inventory percentage"
       }
      }
     },
     "localname": "ConsignmentInventoryPercentage",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aort_ContingentConsiderationNoncurrentFairValue": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration, Noncurrent, Fair Value",
        "label": "Contingent Consideration, Noncurrent, Fair Value",
        "negatedLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationNoncurrentFairValue",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit Agreement",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Convertible, Redemption Percentage Of Principal Amount",
        "label": "Debt Instrument, Convertible, Redemption Percentage Of Principal Amount",
        "terseLabel": "Conversion percentage of principal amount"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleRedemptionPercentageOfPrincipalAmount",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aort_DebtInstrumentExtensionCircumstancePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, extension circumstance period.",
        "label": "Debt instrument, extension circumstance period",
        "terseLabel": "Debt instrument, extension circumstance period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionCircumstancePeriod",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aort_DebtInstrumentExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt instrument, extension period",
        "label": "Debt instrument, extension period",
        "terseLabel": "Debt instrument, extension period"
       }
      }
     },
     "localname": "DebtInstrumentExtensionPeriod",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "aort_DebtPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Period",
        "label": "Debt Period [Axis]",
        "terseLabel": "Debt Period [Axis]"
       }
      }
     },
     "localname": "DebtPeriodAxis",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "aort_DebtPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Period [Domain]",
        "label": "Debt Period [Domain]",
        "terseLabel": "Debt Period [Domain]"
       }
      }
     },
     "localname": "DebtPeriodDomain",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_DeferredPreservationCosts": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.",
        "label": "Deferred Preservation Costs",
        "terseLabel": "Deferred preservation costs, net"
       }
      }
     },
     "localname": "DeferredPreservationCosts",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_DomesticHospitalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Domestic Hospitals [Member]",
        "label": "Domestic Hospitals [Member]",
        "terseLabel": "Domestic hospitals"
       }
      }
     },
     "localname": "DomesticHospitalsMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_FinanceLeaseCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of finance lease cost recognized by lessee for lease contract.",
        "label": "Finance Lease, Cost",
        "totalLabel": "Total finance lease expense"
       }
      }
     },
     "localname": "FinanceLeaseCost",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_FinanceLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Liability, to be Paid, after Year Four",
        "label": "Finance Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the first five fiscal years following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Estimate",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_FundedTranchePaymentPerAgreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Funded Tranche Payment Per Agreement",
        "label": "Funded Tranche Payment Per Agreement",
        "terseLabel": "Funded second tranche payment"
       }
      }
     },
     "localname": "FundedTranchePaymentPerAgreement",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_GovernmentSponsoredDebtKfwLoan1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Sponsored Debt (KFW Loan 1) [Member]",
        "label": "Government Sponsored Debt Kfw Loan1 [Member]",
        "terseLabel": "2.45% Sparkasse Zollernalb (KFW Loan 1)"
       }
      }
     },
     "localname": "GovernmentSponsoredDebtKfwLoan1Member",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_GovernmentSponsoredDebtKfwLoan2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Sponsored Debt (KFW Loan 2) [Member]",
        "label": "Government Sponsored Debt Kfw Loan2 [Member]",
        "terseLabel": "1.40% Sparkasse Zollernalb (KFW Loan 2)"
       }
      }
     },
     "localname": "GovernmentSponsoredDebtKfwLoan2Member",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_IncreaseDecreaseInDeferredPreservationCostsAndInventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in deferred preservation costs and inventories, associated with underlying transactions that are classified as operating activities. Preservation costs consists primarily of direct labor and materials and indirect costs which are deferred until revenue is recognized upon shipment of the tissue to an implanting facility.",
        "label": "Increase (Decrease) in Deferred Preservation Costs and Inventories",
        "negatedLabel": "Inventories and deferred preservation costs"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredPreservationCostsAndInventories",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_IntangibleAssetsOtherThanAcquiredTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible Assets Other Than Acquired Technology [Member]",
        "label": "Intangible Assets Other Than Acquired Technology [Member]",
        "terseLabel": "Other intangibles:"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanAcquiredTechnologyMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_InternationalDistributorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Distributor [Member]",
        "label": "International Distributor [Member]",
        "terseLabel": "International distributors"
       }
      }
     },
     "localname": "InternationalDistributorMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_InternationalHospitalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International Hospitals [Member]",
        "label": "International Hospitals [Member]",
        "terseLabel": "International hospitals"
       }
      }
     },
     "localname": "InternationalHospitalsMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_MedicalDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Devices [Member]",
        "label": "Medical Devices [Member]",
        "terseLabel": "Medical devices"
       }
      }
     },
     "localname": "MedicalDevicesMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_NumberOfTranches": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Tranches",
        "label": "Number Of Tranches",
        "terseLabel": "Number of tranches"
       }
      }
     },
     "localname": "NumberOfTranches",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "aort_OnXMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "On-X [Member]",
        "label": "On X [Member]",
        "terseLabel": "On-X"
       }
      }
     },
     "localname": "OnXMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_OtherProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Products [Member]",
        "label": "Other Products [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherProductsMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_PreservationServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Preservation Services [Member]",
        "label": "Preservation Services [Member]",
        "terseLabel": "Preservation services"
       }
      }
     },
     "localname": "PreservationServicesMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_ProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Products [Member]",
        "label": "Products [Member]",
        "terseLabel": "Products"
       }
      }
     },
     "localname": "ProductsMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from operating lease.",
        "label": "Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Accumulated amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseRightOfUseAsset",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and operating lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Operating Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndOperatingLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Awards Restricted Stock Units Performance Stock Awards Performance Stock Units [Member]",
        "label": "Restricted Stock Awards Restricted Stock Units Performance Stock Awards Performance Stock Units [Member]",
        "terseLabel": "RSA, RSU, and PSU expense"
       }
      }
     },
     "localname": "RestrictedStockAwardsRestrictedStockUnitsPerformanceStockAwardsPerformanceStockUnitsMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_RestrictedStockUnitsAndPreferredStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted Stock Awards, Restricted Stock Units, Preferred Stock Units",
        "label": "Restricted Stock Units and Preferred Stock Units [Member]",
        "terseLabel": "RSUs And PSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsAndPreferredStockUnitsMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_RevolvingCreditFacilityAndTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility And Term Loan [Member]",
        "label": "Revolving Credit Facility And Term Loan [Member]",
        "terseLabel": "Revolving Credit Facility And Term Loan"
       }
      }
     },
     "localname": "RevolvingCreditFacilityAndTermLoanMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_RevolvingCreditFacilityPercentageRepaidForNoCovenants": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolving Credit Facility, Percentage Repaid for No Covenants",
        "label": "Revolving Credit Facility, Percentage Repaid for No Covenants",
        "terseLabel": "Revolving credit facility, percentage repaid for no covenants"
       }
      }
     },
     "localname": "RevolvingCreditFacilityPercentageRepaidForNoCovenants",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aort_ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market value of share based compensation arrangement by share based payment award other than options granted during the period.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Other Than Options Market Value Of Shares Granted",
        "terseLabel": "Aggregate grant date market value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOtherThanOptionsMarketValueOfSharesGranted",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option And Employee Stock Purchase Plan Option Expense [Member]",
        "label": "Stock Option And Employee Stock Purchase Plan Option Expense [Member]",
        "terseLabel": "Stock option and ESPP expense"
       }
      }
     },
     "localname": "StockOptionAndEmployeeStockPurchasePlanOptionExpenseMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_SurgicalSealantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Surgical Sealants [Member]",
        "label": "Surgical Sealants [Member]",
        "terseLabel": "Surgical sealants"
       }
      }
     },
     "localname": "SurgicalSealantsMember",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "aort_ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Tranche Of Funding For Secured Loan, Minimum Percentage Of Required Number Of Patients",
        "label": "Third Tranche Of Funding For Secured Loan, Minimum Percentage Of Required Number Of Patients",
        "terseLabel": "Required percentage of number of patients before third tranche of loan funding can be acquired"
       }
      }
     },
     "localname": "ThirdTrancheOfFundingForSecuredLoanMinimumPercentageOfRequiredNumberOfPatients",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "aort_ThirdTranchePayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third Tranche Payment",
        "label": "Third Tranche Payment",
        "terseLabel": "Third tranche payment"
       }
      }
     },
     "localname": "ThirdTranchePayment",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_ThreeTranchesOfFundingForSecuredLoanPerTranche": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Tranches Of Funding For Secured Loan Per Tranche",
        "label": "Three Tranches Of Funding For Secured Loan Per Tranche",
        "terseLabel": "Per three tranches of funding"
       }
      }
     },
     "localname": "ThreeTranchesOfFundingForSecuredLoanPerTranche",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "aort_WriteDownOfDeferredPreservationCostsAndInventories": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amounts of the current period expense charged to cost of products and preservation services for the purpose of reducing deferred preservation costs and inventory, respectively, to amounts that approximate their net realizable value.",
        "label": "Write-Down of Deferred Preservation Costs and Inventories",
        "terseLabel": "Write-down of inventories and deferred preservation costs"
       }
      }
     },
     "localname": "WriteDownOfDeferredPreservationCostsAndInventories",
     "nsuri": "http://www.cryolife.com/20230331",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "Domestic"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.cryolife.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r200",
      "r395",
      "r396",
      "r397",
      "r398",
      "r454",
      "r502",
      "r567",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r200",
      "r395",
      "r396",
      "r397",
      "r398",
      "r454",
      "r502",
      "r567",
      "r570",
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r200",
      "r244",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r266",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r310",
      "r312",
      "r313",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r200",
      "r244",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r266",
      "r302",
      "r303",
      "r304",
      "r305",
      "r307",
      "r308",
      "r310",
      "r312",
      "r313",
      "r568",
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r176",
      "r204",
      "r211",
      "r217",
      "r283",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r402",
      "r405",
      "r407",
      "r408",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r176",
      "r204",
      "r211",
      "r217",
      "r283",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r402",
      "r405",
      "r407",
      "r408",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r176",
      "r204",
      "r211",
      "r217",
      "r283",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r402",
      "r405",
      "r407",
      "r408",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r366",
      "r462",
      "r478",
      "r503",
      "r504",
      "r519",
      "r532",
      "r537",
      "r572",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r366",
      "r462",
      "r478",
      "r503",
      "r504",
      "r519",
      "r532",
      "r537",
      "r572",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficerMember": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Officer [Member]",
        "terseLabel": "Officers"
       }
      }
     },
     "localname": "OfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r268",
      "r463",
      "r520",
      "r535",
      "r574",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r268",
      "r463",
      "r520",
      "r535",
      "r574",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Products and Services [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r359",
      "r366",
      "r461",
      "r462",
      "r478",
      "r503",
      "r504",
      "r519",
      "r532",
      "r537",
      "r572",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r359",
      "r366",
      "r461",
      "r462",
      "r478",
      "r503",
      "r504",
      "r519",
      "r532",
      "r537",
      "r572",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r269",
      "r270",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r521",
      "r536",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r269",
      "r270",
      "r491",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r521",
      "r536",
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r562",
      "r586"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingStandardsUpdate202006Member": {
     "auth_ref": [
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2020-06 Debt - Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity's Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity's Own Equity.",
        "label": "Accounting Standards Update 2020-06 [Member]",
        "terseLabel": "Accounting Standards Update 2020-06"
       }
      }
     },
     "localname": "AccountingStandardsUpdate202006Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r30",
      "r534"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r181",
      "r275",
      "r276",
      "r510"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Trade receivables, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r47",
      "r48",
      "r49",
      "r182",
      "r474",
      "r486",
      "r490"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r46",
      "r49",
      "r140",
      "r481",
      "r482",
      "r509",
      "r548",
      "r549",
      "r550",
      "r557",
      "r558",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r14"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r371",
      "r372",
      "r373",
      "r557",
      "r558",
      "r559",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r205",
      "r206",
      "r207",
      "r208",
      "r217",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r301",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r383",
      "r384",
      "r385",
      "r386",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r453",
      "r465",
      "r466",
      "r467",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Accounting Standards Update [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash from operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r53",
      "r337",
      "r435",
      "r554"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of the debt issuance costs"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r68",
      "r85",
      "r90"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsSummaryofAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r155",
      "r165",
      "r197",
      "r252",
      "r258",
      "r264",
      "r279",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r395",
      "r397",
      "r417",
      "r534",
      "r568",
      "r569",
      "r587"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r44",
      "r197",
      "r279",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r395",
      "r397",
      "r417",
      "r534",
      "r568",
      "r569",
      "r587"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r114",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccounting": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting [Text Block]",
        "terseLabel": "Basis of Presentation and Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfAccounting",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r131",
      "r132",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "verboseLabel": "Percentage of outstanding equity acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r394",
      "r553"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedLabel": "Change in valuation",
        "terseLabel": "Change in fair value of contingent consideration",
        "verboseLabel": "Increase (decrease) in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails",
      "http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh": {
     "auth_ref": [
      "r139"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.",
        "label": "Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High",
        "terseLabel": "Maximum amount of future consideration payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure contingent consideration liability from business combination.",
        "label": "Business Combination, Contingent Consideration, Liability, Measurement Input",
        "terseLabel": "Contingent consideration, measurement input"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent": {
     "auth_ref": [
      "r137",
      "r138"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.",
        "label": "Business Combination, Contingent Consideration, Liability, Noncurrent",
        "netLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r0",
      "r28",
      "r70"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents:"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r65",
      "r70",
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents end of period",
        "periodStartLabel": "Cash and cash equivalents beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r65",
      "r149"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r40",
      "r97",
      "r159",
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r96",
      "r98",
      "r299",
      "r300",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r557",
      "r558",
      "r578"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r13",
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "verboseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r13",
      "r534"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common Stock, Value, Issued"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r50",
      "r184",
      "r186",
      "r192",
      "r470",
      "r475"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractualRightsMember": {
     "auth_ref": [
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights that arise from a contractual arrangement with a third party (not including franchise rights and license agreements).",
        "label": "Contractual Rights [Member]",
        "terseLabel": "Procurement contracts and agreements"
       }
      }
     },
     "localname": "ContractualRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r100",
      "r315",
      "r316",
      "r327",
      "r328",
      "r329",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Senior Notes"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r55",
      "r463"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Total cost of products and preservation services"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "verboseLabel": "Cost of products and preservation services:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerListsMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.",
        "label": "Customer Lists [Member]",
        "terseLabel": "Customer lists and relationships"
       }
      }
     },
     "localname": "CustomerListsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r102",
      "r196",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r331",
      "r338",
      "r339",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r9",
      "r10",
      "r11",
      "r156",
      "r157",
      "r164",
      "r200",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r436",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Credit facility margin"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r11",
      "r157",
      "r164",
      "r342"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Secured term loan facility",
        "verboseLabel": "Total loan balance"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "auth_ref": [
      "r101",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The price per share of the conversion feature embedded in the debt instrument.",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "auth_ref": [
      "r37",
      "r104",
      "r105",
      "r107",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "terseLabel": "Conversion ratio"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "terseLabel": "Conversion consecutive trading day threshold"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "terseLabel": "Conversion percentage of stock price threshold"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.",
        "label": "Debt Instrument, Convertible, Threshold Trading Days",
        "terseLabel": "Conversion trading day threshold"
       }
      }
     },
     "localname": "DebtInstrumentConvertibleThresholdTradingDays",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r151",
      "r153",
      "r315",
      "r436",
      "r515",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Face value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r329",
      "r416",
      "r515",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Debt fair value"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r36",
      "r151",
      "r344",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r36",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate on amounts borrowed"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r38",
      "r200",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r436",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r38",
      "r104",
      "r106",
      "r107",
      "r108",
      "r150",
      "r151",
      "r153",
      "r163",
      "r200",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r321",
      "r327",
      "r328",
      "r329",
      "r330",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r340",
      "r436",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r150",
      "r153",
      "r573"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "negatedLabel": "Less unamortized loan origination costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liability"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r375",
      "r376"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r375",
      "r376"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "verboseLabel": "Valuation allowances against deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r129",
      "r576"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "terseLabel": "Net deferred tax liability"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r68",
      "r247"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r356",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r574"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DistributionRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels.",
        "label": "Distribution Rights [Member]",
        "terseLabel": "Distribution and manufacturing rights and know-how"
       }
      }
     },
     "localname": "DistributionRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r193",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r218",
      "r221",
      "r229",
      "r232",
      "r233",
      "r237",
      "r408",
      "r409",
      "r471",
      "r476",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Loss per share, basic (in usd per share)",
        "verboseLabel": "Basic loss per common share (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "verboseLabel": "Loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r193",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r221",
      "r229",
      "r232",
      "r233",
      "r237",
      "r408",
      "r409",
      "r471",
      "r476",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Loss per share, diluted (in usd per share)",
        "verboseLabel": "Diluted loss per common share (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Loss Per Common Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossPerCommonShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "verboseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Effective income tax rate expense (benefit)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r34"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r124"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized stock compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r103",
      "r176",
      "r187",
      "r188",
      "r189",
      "r201",
      "r202",
      "r203",
      "r206",
      "r214",
      "r216",
      "r239",
      "r283",
      "r346",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r407",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r481",
      "r482",
      "r483",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Debt extinguishment costs"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r144",
      "r410",
      "r411",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Fair Value by Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r143",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r143",
      "r147",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r143",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "verboseLabel": "Summary of Financial Instruments Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r329",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r411",
      "r458",
      "r459",
      "r460",
      "r515",
      "r516",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r329",
      "r360",
      "r365",
      "r411",
      "r458",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r329",
      "r360",
      "r365",
      "r411",
      "r459",
      "r515",
      "r516",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r329",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r411",
      "r460",
      "r515",
      "r516",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of Changes in Fair Value of Level 3 Liabilities"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r145"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r329",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r458",
      "r459",
      "r460",
      "r515",
      "r516",
      "r527",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]",
        "terseLabel": "Contingent Consideration"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsReconciliationOfChangesInFairValueOfLevel3LiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r440",
      "r444",
      "r533"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "aort_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest expense on finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r442",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r438",
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "terseLabel": "Present value of net minimum lease payments",
        "totalLabel": "Total finance lease liabilities"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease Liability [Abstract]",
        "terseLabel": "Finance leases:"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "negatedLabel": "Less current maturities",
        "terseLabel": "Current maturities of finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease, Liability, Fiscal Year Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "netLabel": "Lease liabilities, less current maturities",
        "terseLabel": "Non-current maturities of finance leases",
        "verboseLabel": "Non-current finance lease obligation"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r585"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less amount representing interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r441",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "terseLabel": "Financing cash flows for finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r440",
      "r444",
      "r533"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "aort_FinanceLeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization of property and equipment"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r449",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "netLabel": "Weighted average discount rate: Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r448",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted average remaining lease term (in years): Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Weighted Average Useful Life (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r291"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 5.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 3.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "verboseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "verboseLabel": "Summary of Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 1.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "verboseLabel": "2028"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 6.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "verboseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 4.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "verboseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r91"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails": {
       "order": 2.0,
       "parentTag": "aort_FiniteLivedIntangibleAssetsAmortizationExpenseEstimate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduledAmortizationofIntangibleAssetsforNextFiveYearsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r288",
      "r290",
      "r291",
      "r293",
      "r464",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r89",
      "r468"
     ],
     "calculation": {
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r86",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r89",
      "r464"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Acquired technology, net",
        "totalLabel": "Net Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r80",
      "r81",
      "r469",
      "r534"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails",
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r94"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": {
     "auth_ref": [
      "r82"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Foreign Currency Translation Gain (Loss)",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "GoodwillForeignCurrencyTranslationGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGoodwillbyReportableSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r54",
      "r197",
      "r252",
      "r257",
      "r263",
      "r266",
      "r279",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r417",
      "r513",
      "r568"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross margin",
        "verboseLabel": "Total gross margin"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process R&amp;D"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r51",
      "r154",
      "r160",
      "r172",
      "r252",
      "r257",
      "r263",
      "r266",
      "r472",
      "r513"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r294",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r198",
      "r379",
      "r380",
      "r382",
      "r387",
      "r389",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r199",
      "r215",
      "r216",
      "r250",
      "r377",
      "r388",
      "r390",
      "r477"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "verboseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses, and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInReceivables": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the total amount due within one year (or one operating cycle) from all parties, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Receivables",
        "negatedLabel": "Receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r289",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r92"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "verboseLabel": "Total indefinite-lived intangible assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r87",
      "r92"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r152",
      "r162",
      "r190",
      "r246",
      "r434"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r58",
      "r335",
      "r345",
      "r517",
      "r518"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing interest expense.",
        "label": "Interest Expense [Member]",
        "terseLabel": "Interest Expense"
       }
      }
     },
     "localname": "InterestExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r244",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment Eliminations"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventories, net and Deferred Preservation Costs"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCosts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r19",
      "r79"
     ],
     "calculation": {
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r1",
      "r43",
      "r534"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories, net",
        "totalLabel": "Total inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r21",
      "r22",
      "r79"
     ],
     "calculation": {
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "terseLabel": "Raw materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r43",
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserve"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r20",
      "r79"
     ],
     "calculation": {
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsScheduleOfInventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r57",
      "r245"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r450",
      "r533"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease expense"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r584"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Lease Costs"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeasesOperatingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases, Operating [Abstract]",
        "terseLabel": "Operating leases:"
       }
      }
     },
     "localname": "LeasesOperatingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r585"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r451"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r585"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r451"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less amount representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r33",
      "r197",
      "r279",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r396",
      "r397",
      "r398",
      "r417",
      "r512",
      "r568",
      "r587",
      "r588"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r18",
      "r158",
      "r168",
      "r534",
      "r556",
      "r563",
      "r580"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND SHAREHOLDERS' EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r35",
      "r197",
      "r279",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r396",
      "r397",
      "r398",
      "r417",
      "r534",
      "r568",
      "r587",
      "r588"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "auth_ref": [
      "r143"
     ],
     "calculation": {
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial and nonfinancial obligations.",
        "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure",
        "negatedTotalLabel": "Total liabilities"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r31"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility aggregate commitments"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r31",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Borrowing supported by a written promise to pay an obligation.",
        "label": "Loans Payable [Member]",
        "terseLabel": "Term Loan balance"
       }
      }
     },
     "localname": "LoansPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r11",
      "r157",
      "r166",
      "r328",
      "r343",
      "r515",
      "r516"
     ],
     "calculation": {
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Net borrowings",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedLabel": "Less short-term loan balance",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r38"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt",
        "verboseLabel": "Long-term loan balance"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails",
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r38",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/DebtScheduleOfShortTermAndLongTermBalancesOfTermLoanDetails",
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "auth_ref": [
      "r579"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate to determine present value of future cash flows.",
        "label": "Measurement Input, Discount Rate [Member]",
        "terseLabel": "Measurement Input, Discount Rate"
       }
      }
     },
     "localname": "MeasurementInputDiscountRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r575"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/FinancialInstrumentsSummaryOfFinancialInstrumentsMeasuredAtFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash flows provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Net cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash flows used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Net cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r65",
      "r66",
      "r69"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash flows used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Net cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r52",
      "r69",
      "r161",
      "r171",
      "r180",
      "r183",
      "r185",
      "r189",
      "r197",
      "r205",
      "r209",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r226",
      "r252",
      "r257",
      "r263",
      "r266",
      "r279",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r409",
      "r417",
      "r513",
      "r568"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r209",
      "r210",
      "r211",
      "r212",
      "r218",
      "r219",
      "r228",
      "r233",
      "r252",
      "r257",
      "r263",
      "r266",
      "r513"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss allocated to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Basic [Abstract]",
        "terseLabel": "Basic loss per common share"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r228",
      "r233"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net loss allocated to common shareholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Diluted loss per common share"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "verboseLabel": "New Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrent": {
     "auth_ref": [
      "r181"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Loan provided"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r252",
      "r257",
      "r263",
      "r266",
      "r513"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating (loss) income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r445",
      "r533"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of net minimum lease payments",
        "totalLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less current maturities",
        "terseLabel": "Current maturities of operating leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r438"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "netLabel": "Non-current maturities of operating leases",
        "terseLabel": "Non-current maturities of operating leases",
        "verboseLabel": "Lease liabilities, less current maturities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/LeasesScheduleOfMinimumLeasePaymentsForFinanceOperatingAndSubleaseIncomeLeasesDetails",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r443",
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalCashFlowInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r437"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "totalLabel": "Operating lease right-of-use assets, net",
        "verboseLabel": "Operating lease right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r449",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "netLabel": "Weighted average discount rate: Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r448",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "verboseLabel": "Weighted average remaining lease term (in years): Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "netLabel": "Foreign currency translation adjustments",
        "terseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsNet": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.",
        "label": "Other Intangible Assets, Net",
        "terseLabel": "Other intangibles, net"
       }
      }
     },
     "localname": "OtherIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": {
     "auth_ref": [
      "r546"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.",
        "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross",
        "terseLabel": "Consignment inventory"
       }
      }
     },
     "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesnetandDeferredPreservationCostsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r4",
      "r5",
      "r34",
      "r534"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.",
        "label": "Other Noncash Expense",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PatentsMember": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law.",
        "label": "Patents [Member]",
        "terseLabel": "Patents"
       }
      }
     },
     "localname": "PatentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "verboseLabel": "Debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r194"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedLabel": "Redemption and repurchase of stock to cover tax withholdings"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedLabel": "Acquisition of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r12",
      "r534"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r2",
      "r26",
      "r27"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "auth_ref": [
      "r62"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.",
        "label": "Proceeds from Convertible Debt",
        "terseLabel": "Proceeds from issuance of convertible debt"
       }
      }
     },
     "localname": "ProceedsFromConvertibleDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from exercise of stock options and issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r551",
      "r552"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Product Information [Line Items]",
        "terseLabel": "Product Information [Line Items]"
       }
      }
     },
     "localname": "ProductInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r565",
      "r582",
      "r583"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "negatedLabel": "Finance leases, Accumulated amortization"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r547",
      "r566",
      "r583"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "totalLabel": "Finance leases, property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "auth_ref": [
      "r545",
      "r564",
      "r581"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "terseLabel": "Finance leases, Property and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r7",
      "r8",
      "r95",
      "r169",
      "r473",
      "r534"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of term loan"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r128",
      "r173",
      "r595"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r15",
      "r109",
      "r167",
      "r374",
      "r485",
      "r490",
      "r534"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r176",
      "r201",
      "r202",
      "r203",
      "r206",
      "r214",
      "r216",
      "r283",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r407",
      "r481",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r243",
      "r244",
      "r256",
      "r261",
      "r262",
      "r268",
      "r269",
      "r272",
      "r355",
      "r356",
      "r463"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Total sources of revenue",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/RevenueRecognitionDisaggregationOfRevenueDetails",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails",
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r357",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r191",
      "r197",
      "r243",
      "r244",
      "r256",
      "r261",
      "r262",
      "r268",
      "r269",
      "r272",
      "r279",
      "r302",
      "r303",
      "r305",
      "r306",
      "r307",
      "r309",
      "r311",
      "r313",
      "r314",
      "r417",
      "r472",
      "r568"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Intersegment revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Summary of Total Stock Compensation Expenses"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "verboseLabel": "Schedule of Short-Term and Long-Term Balances of Term Loan"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Computation of Basic and Diluted (Loss) Income Per Common Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossPerCommonShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "verboseLabel": "Summary of Net Revenues by Product and Service"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r86",
      "r88",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r86",
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r83",
      "r84"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill by Reportable Segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r92",
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofCarryingValuesofIndefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": {
     "auth_ref": [
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.",
        "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Carrying Values of Indefinite Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r6",
      "r23",
      "r24",
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/InventoriesNetAndDeferredPreservationCostsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.",
        "label": "Schedule of Product Information [Table]",
        "terseLabel": "Schedule of Product Information [Table]"
       }
      }
     },
     "localname": "ScheduleOfProductInformationTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationSummaryOfNetRevenuesByProductAndServiceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r83"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Revenues, Cost of Products and Services, and Gross Margins for Operating Segments"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r114",
      "r125"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r119"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Weighted-Average Assumptions Used to Determine the Fair Value of Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "verboseLabel": "Scheduled Amortization of Intangible Assets for Next Five Years"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Debt"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails",
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember": {
     "auth_ref": [
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap that has its variable-rate leg referenced to Secured Overnight Financing Rate (SOFR) with no additional spread over SOFR on variable-rate leg.",
        "label": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate [Member]",
        "terseLabel": "Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate"
       }
      }
     },
     "localname": "SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r240",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r272",
      "r297",
      "r298",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segment [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r240",
      "r241",
      "r242",
      "r252",
      "r255",
      "r260",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r271",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationNarrativeDetails",
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "General, administrative, and marketing"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Non-cash compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r117"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "verboseLabel": "Authorized awards from approved stock incentive plans (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected stock price volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "verboseLabel": "Grants of stock options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r112",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails",
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails",
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1": {
     "auth_ref": [
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost expensed and capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount",
        "terseLabel": "Total stock compensation expense"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationSummaryOfTotalStockCompensationExpensesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r120",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationScheduleOfWeightedAverageAssumptionsUsedToDetermineTheFairValueOfOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "ESPP, percentage of market price for eligible employees"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r179",
      "r240",
      "r243",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r264",
      "r266",
      "r272",
      "r287",
      "r295",
      "r297",
      "r298",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SegmentInformationRevenuesCostOfProductsAndServicesAndGrossMarginsForOperatingSegmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r41",
      "r103",
      "r176",
      "r187",
      "r188",
      "r189",
      "r201",
      "r202",
      "r203",
      "r206",
      "r214",
      "r216",
      "r239",
      "r283",
      "r346",
      "r371",
      "r372",
      "r373",
      "r385",
      "r386",
      "r407",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432",
      "r481",
      "r482",
      "r483",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Other Comprehensive Income [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "StatementOfOtherComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r201",
      "r202",
      "r203",
      "r239",
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r12",
      "r13",
      "r103",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity",
      "http://www.cryolife.com/role/StockCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r12",
      "r13",
      "r103",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r12",
      "r13",
      "r103",
      "r109",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r12",
      "r13",
      "r103",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r12",
      "r13",
      "r109",
      "r113",
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Equity compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r41",
      "r103",
      "r109"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodShares": {
     "auth_ref": [
      "r103"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock Redeemed or Called During Period, Shares",
        "negatedTerseLabel": "Redemption and repurchase of stock to cover tax withholdings (in shares)"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRedeemedOrCalledDuringPeriodValue": {
     "auth_ref": [
      "r103"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.",
        "label": "Stock Redeemed or Called During Period, Value",
        "negatedTerseLabel": "Redemption and repurchase of stock to cover tax withholdings"
       }
      }
     },
     "localname": "StockRedeemedOrCalledDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r13",
      "r16",
      "r17",
      "r77",
      "r534",
      "r556",
      "r563",
      "r580"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r446",
      "r533"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LeasesSummaryOfLeaseCostsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r433",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r433",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r433",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r433",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r455",
      "r457"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Taxes payable"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights.",
        "label": "Technology-Based Intangible Assets [Member]",
        "terseLabel": "Acquired technology"
       }
      }
     },
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/GoodwillandOtherIntangibleAssetsScheduleofGrossCarryingValuesAccumulatedAmortizationandApproximateAmortizationPeriodofDefiniteLivedIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonMember": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockCommonMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockCommonShares": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Shares",
        "negatedPeriodEndLabel": "Ending balance, treasury stock (in shares)",
        "negatedPeriodStartLabel": "Beginning balance, treasury stock (in shares)",
        "verboseLabel": "Treasury stock at cost, shares (in shares)"
       }
      }
     },
     "localname": "TreasuryStockCommonShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockCommonValue": {
     "auth_ref": [
      "r42",
      "r110",
      "r111"
     ],
     "calculation": {
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.",
        "label": "Treasury Stock, Common, Value",
        "negatedLabel": "Treasury stock, at cost, 1,487 shares as of March 31, 2023 \u200eand December 31, 2022",
        "negatedPeriodEndLabel": "Ending balance, treasury stock",
        "negatedPeriodStartLabel": "Beginning balance, treasury stock"
       }
      }
     },
     "localname": "TreasuryStockCommonValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedBalanceSheets",
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r205",
      "r206",
      "r207",
      "r208",
      "r217",
      "r277",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r301",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r373",
      "r374",
      "r383",
      "r384",
      "r385",
      "r386",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r453",
      "r465",
      "r466",
      "r467",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "auth_ref": [
      "r29"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.",
        "label": "Unamortized Debt Issuance Expense",
        "terseLabel": "Unamortized debt issuance costs"
       }
      }
     },
     "localname": "UnamortizedDebtIssuanceExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r227",
      "r230",
      "r231"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "negatedLabel": "Net loss allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "auth_ref": [
      "r227",
      "r230",
      "r231",
      "r544"
     ],
     "calculation": {
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted",
        "negatedLabel": "Net loss allocated to participating securities"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "auth_ref": [
      "r141",
      "r395",
      "r396",
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r220",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted weighted-average common shares outstanding (in shares)",
        "verboseLabel": "Weighted-average common shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r218",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average common shares outstanding, basic (in shares)",
        "verboseLabel": "Basic weighted-average common shares outstanding (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.cryolife.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLoss",
      "http://www.cryolife.com/role/LossPerCommonShareComputationOfBasicAndDilutedLossIncomePerCommonShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466302&loc=d3e4852-112606",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5227-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "b",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(3)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r538": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r539": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r541": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r542": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r543": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=124256753&loc=SL5864739-113975",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>74
<FILENAME>0000784199-23-000088-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000784199-23-000088-xbrl.zip
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M=(ML@>_::3-YU^N;QFY^>/0<.]T\3^/_Z)UWADD14@TL@Y^B!#IMD4;*Z+C
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M@SC2./7<45SS8.;;0N8SIR&X206L2$EDF-=1*<2]Q\K@@&B8Y1F 69/)!-L
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MM!V:P0\T_-8$66D,#S"&NKG8'A95N,(@YIAIOK26;]_6\L"P4D*2+$3$,^:
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MX;MWTFJB,W#1970T8YI4K6]_=1I3IK3,I/0^8TK)+$D_H\Y$X9!5SD)PM16
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M9!K((1B^.O3[=/'5H8!II"9#E)&,>80R&.&088X9UL$:G]H;E^A7HM^SHA\
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M';A)N]\KX#SA^F@QP! :\FZW'SK_W1VL,PG%])<;E$9W!Z71ICLZM@$WZ/;
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M8[YG-_0%X$X_X)>8K?"9H5'?F1EK]TRCTAGFKG^)/PT'X&&3+#,'N/</RR,
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MA[J5=K_7[9E6\3KE9-&\Z>.\3!;=7VI?)-$J"[M^^Y'K"P8&^=SKA49PL#9
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MU,\6<UG$(;% D;QU+ABW-%=%P:D5XM3+&:IAB34A:(<BI;GK.[9@ZE!@'MH
M"6&6:&:WMCEK&CGK-BVUXQ[;?[*A:+,TSTI!F]6BS10K8E*$0*)$ACF).'<!
M6:K!Q F2<9!>\DD!VN1#ZK.TJ*#-'2I5ZAI4JKSE81^[NMV<(]R R-Q?)0SW
M6&&XTMYC%3O.;)TXD(Q66DID7<0Y$N>0]L'"DI*,"2[ */>Y5[!L4K5P@X\2
MBZNM#J\B%E=T>$4Z/)W98[ DS'$$T&O!1G4*F2@LBHDPC2,CTK"1#G-3)QW>
M@(#<"_@$##7[ST#=^JU09="#*I; W(K)Q._#/@RCWW_1/76M3C7IE\)X<546
M%P<9"EZM J]FRZ801Y+@5".J6,AG&31RD2<4!+%&48ZEPF#EBB;%"Z?_E/A=
M;35]692C:'I]-'W:GV6=IRP%)'A(B$=#$+Q@D,*6PGJQ/IKL/<=-7BM-WP#7
M!F@ \N6 =!V8RBW'*@M&K0*CWLVP$4TE3]P)9 TFB$N>.^U)C[RVW&OFC):^
MPBBU>$G)X@"IK3:O^)!TT>85:?,4XPC.)1:] (LB4; M?$!6TH2BCR)IEB+)
M)1DY:5*A:J3-&^ *V8TI@@*$1JOCNZ>Q,<B%BHH;9,7D8C+K>]6D']EO5T+Z
M![& T1+!Z'KYE<.CUQ]3DC809E&B":@%(Q09K#$RTG%'F>*,YM)0K D<I$;F
M3W%TU)-:%%U^2%T^OZ[+@0NM.7.( *E '# 8N2 I$D:K".\HYQ/H,E]&C*6X
M,NY%+*Z6GK](5SXO_HL'HA@OKDS_97&HMNWW6ZD50[& 5@%4GV9(1TPJQD "
MPD( 4(EHD=$Q(9U NLD[0[W(Y60)K9,!5-P9]>8<1;D?1[FG6 @EAL9$/?+!
M*L2=M$@SSQ +C'.),0.I;VV+)I?EY/6CQ5-2JV,[/H[B)XVN@\'=OQW.)AA(
MRV(B?XPFOGA>5P]-LV7L!?-.TY2Q2/K</T,C&YU&0@2"A=0B&ITK5 I-:V0?
M%5]'/7E'4>6'5.6I( H6BA ?.6(F)Y1ZYI%E'".J-/<JD*AB3@IO2EZ:[*UA
M?9=-L']65=^E0- J(.CS[+D4*K#"VJ&,-XCS: &"B$>2)LLB=8PE,'14D^/B
MQ7BZ6KRJ$B]%BU>DQ5-$@FMG8N0$4:$- E$&9#B6B'"<:.Z:$[#,6HQKY8M<
MDKMBK:J\_(!3+'YN^%9LJMM<_/>*GKTF>%S'*C8%@)<%P >[LY7R7)!2&Q(1
M9LDA'@"*G3 $86.5$3$)[8!&<:6:1,RFH*Q/18FYU/&1?44%3PN>KJY.3\'3
MI>+I%*&5V)#$$T-)"2"TW ADB<$HJ!2UC; 9YN Z5[K)Y6P:4,'3.U3H(62N
M$CUW-:7O<(TK3\O@D4)WZ-IQ"35Z'G&(3RKR>C/<ONB>GK8&N8=,OV$[H0+8
MZNRG_Y%_]![[]VIH\K=^ZWFGU?Y_M@:]89S&]2O/MM,)+ZX^68'RN:!\;X8:
M,^&XE2ZBA 5&W J)-(D1!:.(#/":U#RKT0R&/U)YKOLOQWE81EF.#[4<SZ?#
MY]AR0PC2G&G$05;(2<=02(%CXR+Q-MRZ'&_>2<UC;:2UOL8&;(EOCVTO'G?;
M0!7Z_].(_S=L#<Z?+W,KK-4U-B#N^ZHWR7'O#[K^<XGZKM@_>3'?;_-T_VW;
M>2^\:E>GUK<8T/?8ZY:-;ZZ-;_;\O4K&6!XU,E0(Q+7&R#$5$"-"266X2P)G
M^U4#0_FM1E&B$NNM9ZRWZ.X*=7>*M!(LJ11&H1 #1]P3D;,T*+))8:<TUEK[
M.NKN0W/ T/KR2.4'3T^[G1%I:/QRJS+V,U_L+T4?]P[^N,EJ['8J;:R(:7]G
M.#CN]N I0G%6+T\[WP_V7US3SB_AS[]Y^-__M#_0]A=WTOT.WZ7O3U_2 _J:
MO/_G'3[X!^YW\OK[P?>_CP^/7O+][WF,!^W]MOZVO_M9'!R]_#8Z>++#/E(L
M"2$Z(<%Q0%PQBRQQ'@D,2LR998F9'^#]C4OL?G2M++$GNL0\T9)S;)#C22-N
MK$-&D 0_%(._M%3,;6TKT<0W5(N;>:$Q6G(->[$4FHVZ+,_#X: _L)V\EY3U
MN1;K<_>3^,@X=8Y9A2R%5<F)5&"S>$!$V!4%EX:HZ.H#@7O]_K# WQHM+Z^B
M#H)H%%T ^,/1(*V#1X2IF*2D&I,<6Z9-)F]*U9F&OQP+JPOC*VMQG=;B9_X1
M,\R),08I+P6L1<X!ZI1"%#-C-!9:43HOU*UN>97M=!W7&#-$)-CR4,#*(\ZH
M1=IC@G0TQBF5?0BC4GV:S4'W6A745.C7O5P6C5:GD3?2ZO6\S)H-^/!9A.]^
MB>WS?UTX(2I+O9SJ7)%?_8KFCAUS12'G4\@IYWG40A@:0&FL LX@J4(:>XN$
M(Q&#C<ZBR 6V:9W.:98CU_5TG!?E7%0YIT\_41IHX %IEBSBAD;D9"2(>*>%
M GZ?,,\;7)V:U&] ,'T'1IIGV;8;9[85$% #;\]: ]LN<?45[_^74_\*9GZO
M\V(T[U>0I_#WY2&2G^UF+8FG%&/DL &Z %L"LD18A(-CT@?*! =$8IPVM68U
MBM>56'L]*4/1YP?6YRF&X:*DFD9096#]B N5W324()4D2QAK1FP"?6:JR?1L
MP^C-B;\_@C:^B0,++P;0G]3RK<&&=?R[/=E@F>RB#X\)OTW#TF3N7]I>!Z:M
MO^/]\'38MH,8=D?2*+"T/%CZ-)O2)X-SECI$'!6(.T61X<H@' F\SJG5(=,,
MW%1\]I#<OXI/X@GH]/T91M'I>NCT%-6(C)K@HD/&Y#1=F2C2N<HTMQX+'!,G
MG&QM$]6D9+:6RZ/H]":X,BZ5H-&M:L/E&OB]>!P[_=:7V&AW^_W[$8^UM8(>
ME7A<D4=5<NK%56F,VG;\!2(YB(/#=&2_%<1:'F+-EI!3($:+"4%4 FQQ["-@
M%_SPR1#.**?*Q@JQC)GU==P=L8J;H[X*OG064A3\,15\^O1!2%'(0!%1BB&>
M<O"3Y /=+&D"^AZP9%O;E#0E7L3,6&._QV.=.SCJ1=L?]LY')P^:#3N Q^T/
MYDW 75K&T&0\E4MR[)T<W[ HZ)(4]&CG)^E"9Z?[)Y_PP2G,W/??3P__?(WW
MC]Y]>W_DQ7OZQ\F'W9=?84;X^^^?SO?_F$X7>D\_"A*93X(C@:7,Z9$\-],C
MR 2A%%9&6/)XV;=E@:W_ HL"4Q$-1UK#LN(6@X7+>&Y6KX@DD7/%LH7;Y'K6
MP+W]]$'54WW?]OQQ@Y'F91+:;O3QU('%-GZ5;F(*VL,8:S]5U1L.B19-75!3
MIXPQ;$!_J@;K,7C$:6Y(1A1&BKE$A!)!,@_*Q9N2SZ;#%)?P4U#@906=BP(_
MB )/&5N,.&R"<X@9CQ$/V"$7,4;>LZ#@+94,KI<"+\G_NU9EO/LW5/Y9Q/^[
M0"W:=:[+NBRN44'46!PO*V$4D%H>2+V<81E$<8J%4XAI0\%&U KI7$E-6.V3
M4HSS"!2>*M,T-T2IUJ<\ZUS:N4;>Z V%FV4QHP(W*X:;Z3YIB>.4),Y'= 5P
M(E;!34 NA9@['N9^B  WFC<97>=JT \"-\NH8;G$4H,_?]C'+H8XYP@WD0Y?
MZ6I3.=WN0H_OJ 6CA[NU"O<3;-$P__,_E?UY!6UO=CJA[-:KW*WW9WOA*$%(
M, (9%A3B/GKD8N[BX&F*-%*J/<OEA503J]F$D'7=K>^@IX]L(!3 +8"[^KXX
M!7!7#[C3YA$.V$EKD9448-;&A"SS%A$3&'$F2&,4 *ZD365F?<8%<&\VD7X=
M6+CH)$X,/R8#.[6]3ZU.90_("F"7.G,$_VSJ:%5Z/L:&]3D+V7;.<^&5@^X
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M[$F0HJ.<>V0X [J 54(F1(4P]D1CYJF+*M,%H4O?WR>LULMW:Q:U?E"UGJY
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MG4-1&RRY=)9ILO@IX:?DGBIN_75WZ\]#7U8(;YMR)O<AT6WZ3&ZP#N/($%4
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MWN0)SNRGB!S0Q<_()GC Y[;]U9[WMWZ]-@^GK0ZZ.NG3\W7KK*2TLED9+6(
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MB1AK$V9+1M=BS-\76*>]C2XJ O]QY'E.Q/61HQP<0=I)93635AAUNS%?H+5
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M-RO/CYME*<)?$_ /1'H"D%3P]\$5:2.!<G I:Z3A +2#R@D(0/ @6! @Z((
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M]6LGF-*#37 D?83,J(O-?C.$$]?+5\&8[-J,I0(4")C]CZ9(GEGKB);,@CQ
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MG&J'+%8)<6<<<DY1Q*/P.FJK"9% 16K5&NBS]I86@>^E$>O!N;242<>@66*
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M:0ZJLQ,9PLA[ YMSR^"BDVZ_6<RJU;2NV8+?8W]48"Q_VV^ [I-@PD5QL?X
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MS0]"S;,BAY TNF L4MYIQ 7ER$HAD&3P=Z1,.Z<+BR,5\P$X3T?-K\L!7W0
MGY4TIJORE9[WTBWT5&)7"<\K@^=YG[N,FL'_<C?;2!!G B/'DD7.4^6,X<Q)
M#/#,JT3-AT:5#J'2YUZ"ZW/TN9?@^A#@.I=E0V2D7A#$9 !-UK&LR4J,C)>1
M*68)\;P 5R'GR[>6X%IZVTMO^\JA]\-TM;:E"FS<OXGE4S[C-1C-)SD916&@
MB^IRU4I11J^_?+CXLN:TM5N Y:6G15-<%QEI;>S^-^7XC'&CS&I>%WFKMO=V
M,-L^U7/MM) >!>45XC%Z9+ER2 FL%#$@-&NRL26K@LT'D#^FK?%^:N,MDD$)
M;R\4WE:E I;P]MS@;:8_*G8^P? CTB9HQ!ESR!&O$<82F)Z&928APQO_]?"-
M%<+;R](J'J$TP[*!<NOGW7W,T@R_B&HEGCTVGKV?$]<,Y\8X%Y&7 &H\$(X<
MXPQA871443'A0%RC5:GFDU&63\O^I4BT!^EF7Z+ NL@V)0H\ 0K,2#42&\PP
M(4@G(A!W5"/K!$-!),RH9EH(FU& +XB6?Q(46)%I[9G$AEQG9+M+/89Y>_0K
M<ES>;?+KHK6N353(?9$]=\4HX?VQX?WCG)!GL2:8)XE2E#%7=0"E50:,A$S4
M^,"D\S+G'&@Q'\W[C'R@=Z+R-;<4ECC]BG#ZJ27P$J>?"*=GQ' E?<*!&!29
MIHAG+XH+V"/BG<,A)2%)@=-F0?7L$J<?(%9EA1$"#Q6K\H1#? WQ#8LK0USI
M-[A\9'[I!7S>7L!5Z5/3O'@^^;IDHG=@HI_GE!VM;(S*4V2C(8A;'9"FC"'L
M>2),4N>%V]@2=+Z-=AE^4 +/>@+/JA2$$GA6"3PSTCL)C'/. @J<Z]S0(2)#
M+4-$1DF820S@!X"'K%/<TVL(#+B^KL/-8MP+=Q&NB]Q3)H$_!#Q]G9.+B"."
MT""0I4D!/!&"')81"4J\L\8Y(V,V+@@]GV7XF(5G2G?_\Q4E2EI^(%J>$362
MXEAR99 U%$0-DC0"ZJ8H*IR$$8:PJ#,M2_[+Y5E*I_TO%72X(F+<JYQ#Z1!Z
M?0ZA!Q6X2FA>'33OSXE9$F-#B(K(DF"R#P>@62N.!*-:DL!3DFYCBU?)@@#Q
MTH=3^MI+:'T>OO826A\>6F=S;W1P@6&'(I$Y]X989#1EB$30:#UQCO!00.N"
M,F8EM);N\=(]OG+@_5;\D3.N8%3V,%9ZL6V;G<L"=H/8:U?^U>Q4SJ+M]?]]
MOV(/M_#WM7C&:["D[][2$./>\]XT:HQCRYC:UL%K5Q^VX7Y_?[7MIM)0$ZIZ
M.R*J+Q.:*K[< XHB5P0-F(I_$X:]3&*E:+&$:'$\I[5%K[5E-N8$&! ML*7(
MY>X101%-O?(<:[JQ1<CFA60Q/@!;JZ"!57"VET1'=Y'12SIZ4CJ:$=%U8(E$
M"3*YRFU7#);(BA"19Y1[IR@+E!=T9&ZDHY<E.BTF@ _+.9_O.NL7 @'W9Z73
MBGD)  \* $?SY7^2P(9SDA#1P$.Y5 DY"HIZ<"E12XR+7&YLJ4VY$C[Z $+]
M2R*B^_/1DH@>E8CF(LFR/8M01)@PP$6#1PYD/40P,Q$^UXGK3$1Z&2:Z-B:>
MM7[&RY(XEC36A&;?PYP&%9"98VF:*4TS+T*EG/<"=89M%WLK\;'?4M1[AE=N
MCPGL"]#7G['GI\.L$2VYXQ+<L38G8CHO&(]&(\,D05R'@"R/$E'FDF<&*X/-
MQI;8G/>O_[,TUCP&9=W/Q5I2UN-3UJSU)A&7& 6B(CS7B>"NJ)./J(^)2Y](
MPB13UGPIL'^6YIO7:KYY7'9[@V):0L(O0\)\-J7UU 0I.9(*2\2](DC[D)#"
M%C"!):*5VMBBFV1%S+:TZ#P-LRWIZH'I:C:"'^L@20Q(,^^!U>*$;"(816E=
M4H8&V-!EZ*I@M?\96->*\&]H_MB:LPG!AY,CW+:]PV9G%%-$K]+!T; _:*:S
MQS_S%"]99J%B>['2[/C6,&0;!OP-E- ^Z7;RC7#UE8%G*R1J_D0-H.38>?/<
MSF<K_L^7LX-OX<11+FOG'L;6:.^WWY_M?_O4KF]_.8;WPAB_- ]V\G,_-/?I
ME^-Z^R#'S?W<??N=1N&83 ")7.MLAK?(JBB0QI%)&B.)6,]L]2M?,<^\"PI'
MA"WFB(?<)-5)B41R5 4?*(UL8VMWT(B]RB2;=%$Z1_%/!6"[.^Q5WG4[L)9]
M.*[P6Q'!5Y2G_MVVBG/]5R/&07^S<I,-W_J(#<,B1)>X2<2"ODN,PUXSXR,U
MW[<+N8E@@J[SB!6@_J[;'^QEF-B#1__>ZOKCYXG<O[;/G[\;!W0@0((1(-H@
MSJU&1C*#B($MUUA: 0)-L07-SA!X8'9J1">#LD)@@2E/VML8N!0"?M,B66PV
M*A'XX0DL^: W!+'A;:4_; /6GF58&L7!Q9\G^2#TLZ>D.!H3;,LE/>?ZRU^@
M7+-3V8D=^+95K=C0;G::_4&^]$>L%G?"2XYC<>?%"VX^>G\-X)]<$JP V+&*
M#1<43WL'<-J+#;@-7E#YH]OO5TXSSN91MUK=TWX1R3=H=(> ]:'_[S>5:QT0
M!2>ZGO.,I)SQ*A<C&!W&VU?ZZLX$ 5R4 <4Z3F$K02BE&*C$P=I)HK3/GHY\
MZ"^$Q5$,)["UECWIQS>37WX+S?Y)RYZ]:78*YE3<]-MXT*,LMC<YX6Q&3BSX
MY^CKWTZ;8=!X8\RFYH44-]9_QR\>?4LV,[.;#0$>?:?(IF+JVJ_Q)KGVNYL>
M2T"&P-??>M-C;_Y."/TP@^7+/G:!,C#91CB2MV21/-:5M]A";E5TS-RE"Y28
M+)/'WA.E)%^3_MCHQ5BIP76-?N4]8%'XK^O]9ZMF>[Y18:2ZA';XM L_I6$N
M&XE_^Y8\J?\ORP?+*.6W3O=UK1E]\*/Z!,=_54[/)RU[,%V9-(LS)POKI#]0
M>^,U2P=<LG[670IA+$G#EZ:UM<D2_.4J&??2NI9-%YPMOWNEONZ+R!$\%/7V
MA^.#G0]'!]NA!??P6OL]KQW!<W;JS?U".\O??6K-VM5VMX\I?'^\_ZU^7*=_
M@T9W>+:_=PCC;!SOTT^-@YU/Q7>U]M^IUAS9U*;:/=-$I !-'CD+NCM/WB*=
M!$'!XB2\#SRQ',?/YLUJ#^$:+I&F1)K;D$9@:21Q<%*IX3I)G2)W3A,BM"<V
MJ0)IZ 1I:(DT3X0TLXWE730I8< 7QY/)C;,$LDP)Y)-T$D#(,V(STER?BKP&
M0N(#BI/W<^D_J3CY,6L?L3^8V-*R*6W)$H$/ZXY\+K7%'E1JFNS.^]'FE/AU
M%_PZFY.4B&<QY>HTW(N(N#,*:1,CHM9A0BE5\#VHORL2E-;#K?]<Z.A!98*2
MCGZ)CF;E $(L$])1)"+GB.,HD0TJP1G"UI&HI;"Y=9YXI6+ #>4#ERKA][0V
M[ 4E_,:RP:^HB\MJ.U2L7\C2+]=?6IF,8$&7N0)LV<-=HMD=T*S^;DXJD,$(
M2XE&*=<'YB'B' 41D7#PCPHN%'$C1,R7"'[JT/I7350K$QA*HEH!4<V*""IO
M@7 ".69!1#",(,M%0AJ0D#*M.0 B$)6\%U&] !GA&9H*9M+M?DDJ>*GARH]@
M'[B:(C3"JI=?@?&1@.RO.>F &ZDYT3@;"7)>NM!(FQ21#YC SEK)N0(@JVJ\
M(OE@/<P&SX6\5FXV*,GK0<EK5DX0C+*8F$4>1YO)"^2$P#4*0'>, >4I'3)Y
M&7I]^\\UX/]EC,HT_?Z5JX1F$:'9\=WV]1+"@S4F>2[HM7+A8++R'XN%OXI<
MJ?DS!G0>>]T2M.X"6O,1%\&R*%QBR&'"$%<@&%@J+8HJJ1 9QS3:7 )94T)_
M>])F)/>K+?_DC86>E'[_]93BQRP!EX1Z%T*=LT( IDIF%<*":2#4W D,XXB2
M$I*+)+W ;&/+S$ON_UX?\GP!(LRO]C1: X?(C2:/VR8^MM..<VIF"ZD_SXBX
M)5MQ+,4K5KA,4\;NM8F76Q__T5QV9*G;KHS[S(>;6&^)P'E3# V(,XF1\U8B
M(Q+U06#K%2YT6S'?L>XA3$<E3)4P]2P\<B5,/21,S0K)P3 6G-$H29DMW"DB
M+0E&S!!N;<(Z<E+ E'E))KB+^B$S.=G3%46N?CZ5V3VF$)YEUY-NOYDO>-.+
MK2)+?9P537"1\SMUUQ@Q\.4MU@$^# ?7WS*7*/A$.C&A5[/<IW\V+LKMGMC#
MB%POVF-D$PSVC6V=VK/^QG^NIL4W.VAZ 6?G?NT,4WJP&8XP& "E.ZH-\ 9@
M/_;R53 FNS9CJ31Z&6G_T13),VL=T:#=<NVH-E$E+Q4%$J9!L>\*%)>B"$ W
MY6((@US]X+__L5N+MG%A50)*.<G%KFBVP@?";/ J:AP)E=XD9Z^K9K!$=8(;
M2R0\126>*[4K<B$);_N-2FIU3RO-SHCSY/D5!!Y#9="=U*RXN5+$'0I#/&[!
M!J"U33RBMWM4; !-Y"&*(&#]$!4;.)8/,UBVU&/+2@A+5$)8<I&>@V+Q+@/'
MB061/]>\L>U<0^YJ:9M!(U;:@![#7E&2YK):SE1AI:7*DJ^NV,"3GI1G6J#A
MJ=>,WH6"GFV(^FV!:!=\>EQCZI:"\&5N<IF;_,3Q>G_:LZ(2V6NP:+3:^T=O
MQ>[V1U&#<>SN?3ZKTQH_./K2.FA_/=W=#D?[1_L\WS]GT?AVT*QM'_/:T?%Y
M#<93W_[(]L\;[?K.W^V#O;>\3NO-^E&C>;!37U01@0G&71(6Q20HXHP+I$.R
MN2M3LL%A1;(>0JK*R+(F0HD[:X$[#QS(6.+. ^#.K"55$F5@WPC"U ;$@\%(
M<^F1T(1Z$;Q/,6<25<5MJ9$OU<-^4UN!!?+<6A0B>"X \J"%"/[L@0[;/+&M
M2QPIH6)YJ)CW#6.>>#*6@8BB$@*0<,@$GE#@G@6;-'$Z-XUE95+!2^#%)2FM
MD)1FN2Y5'C9!2402Q8CGN%PK<V\L3;P67I+(BZI$MW@O2QO*JGCNKS?^>BY%
M2QZE^,\8)W8[?XPMQ&<E8MP!,19D_$<FK;88(Y][D'!.&3+"<\2ICIYYPWUF
MOJNJ [0>O?2>"TD]2AV@DJ1^E:1FF;"F3''8-Z2$HX@;$&6-(18EXA4-6 A*
M Y#4+8&.UW3VN1J'\]"-0_K]&*\:3RY.26W4JN?LM3<5.:M]_HYQ#$!_"E'"
M+.(!%\4=.!),.>6HH=&GV28A#[QWTZ1>[MF"/:.:.YV"1\%@!XQ/2&1RJ6"+
ME=::!,KM7&.7]0O7^3"$'8V5W!FF/6R/W><G8VVJJ(/>GR2@YI9%MC7.0RV:
M:=W8V*6,URGC=5;40.-Y112,D;,(TOEC6<UO7:>X6 9=G';[C*:U>.<N))7K
M]NXU%!SX$MNVF:-D<SC5HHBB1_; /NEBK)L']KEHGO?KUGRSPGDAA4Z,O1<G
M=3=]:&:5<S_:W@M1/C\T=O= W,Q9*-O^)XP-UPN%\LM1'G.-?H&Q-T D_7@V
MUUGVVWM1W_E,]BG<<_ZA4=_^C'?W#L_J._4C&//YP<[!T>[.)U!>/Z7:?(TF
MR[1@!K20)))"7%J%C+4>)>J= ?6!")(VMCA_G J.)=:46/-86'.CM>(6S'GY
M@2"/!DBSUC &0!2XT$C11!$7."+M(D%4FZ!EM,Y9 8!4!2W^40)!UAI#X*3S
MLLG$TXLFV\-8AS?NG<;6CSA*W2AQX"XX,!^(&EUB0D>*+ /JYX)QY*BQ".B>
M&^REQ4QM;$F\HC#4]8CR>&U$M10/7DA<)0=>&>7-!84(HC2C!L%_'/$$>H&+
M$M@P)Y%JBCW#=F-+5#4QCQ(6LNX<6)21'FO!@;-HOG?Z4BHT/A+YSX=7,NVY
M!P! 7!N)N,- _L)%)%."#93!6\6!_/6]6M24(1[K04O+,MX+FBKY[<H(;D[C
M=9)&*@T21 ;$<_T8(XN:B\0+#_JP8RSS6WE;'>=7HO'*4N-='WZ;BQ64 ' '
M %@04YF<#89@.*HB"L2I]<AYIY"*CF"IO34F 0#(4M5]QM1T)XX[HJJ2YZZ,
MY&9YKI&"!P&$Q@0QB.?(.$U\0$;P)),CR3N7>2[&NM1QX8"K4L==&Y[[H3LL
MW=YWHO]YMS=HL4(D3Q#F+B'.0D+.1H94D%R#+.X=C9GEEGD,SYB8[L)R1T15
M<MR54=P<QXV:<Z<H(B9AT'*=1E9$A["3*O&DL,$^^W6U5*66N]>(O5C4 2UU
MW0>%BKD&IA?XL-?]/?YIF^%MWH42(5:.$/,>7T<)8(,.B,:0LV)41%9AB:R#
MW_G_9^]-F]I(MG7AOZ)@GWVC.X)DYSRXS^L(VMB^WG<CVC9N'_CBR!&$!>)(
MPAC_^G=E5@F-C&80IN*<]@94JLK*7,.S5JY\%F<^R,+Y+M6MR)2;0'@)5.U2
ME]RHW'VKW%P+P>B#)5PB!TN8$\X6P<)R% VEG@1)!+,K+YE:)9@]' 5 D=WE
M<,^7];59?(CJ>93/WV5OB-MV9%^:DM:?[O[P4-F#QI;>F2U=T+(F4D I."$5
M,-A202(RBB1$DA32!L^""#G X5>QJ32U](WA>6*&Y[J9EL8 W:$!F@5S6##%
M6 Q(6ZD S'D.H5,2B#N>E!;<X<A77DJZ*N5=@[DGF&+)(ENSS+?Z\;@?!_&H
MD#IU:J*3G^ES=;O6K8\Z'S=IW7JO>.734>@,?%Z7&%Y_][!,ZV65&O-P _.P
M-5]EH+$F0I" F#: 3R*FR*2DD:%8.T%5"A[, Z,_T]'U$B[5&SC->TGB-%K[
M(,[^8NUM//^=J?:LY^=1^,2L1%@+GROV2P5AA"#$.8<3(3A Z$'T*C?S&YJ/
MHMV_:+IHL9+^58&+UC?;/2E=Q8[B\)K9HYO,S8W/!"^]=5L62-(8KSLS7O.E
M&,QZ(;#7$+9H,%ZYRZ_&@J"41"121>>QR7D3<E4IUB,48S0J=P<J=P&2:)3N
M#I5N%C$016*N.<ZE3S;_ \& IP11*P46PEI">:;]6"7J"N:/N^RWL/2>O"0-
M_$D_<^.U#BMVQ,XEA%]-T'&O?OE5M1*-,;C) :3M]>&(!ZB]_5YL;6]^"4J;
MQ%(^\6LY6 .MD5->((H)Y\2$I(1:>2GH_ &$)C70:.G5KOQ<3QN/?H=*?#:M
MQ#*I&(/"2'HA$;<\(*<#1U'+R*UD.$FZ\I*M,C./HY]^#L L#7)8O"GWG]E&
MM:L0^5\+3%PS!JE)<1E,2.AE#M\J#FEV>>]PFIH]X)LBM';OR#?&_ZZ-_^LY
M!*<\A:D$R,9,IG%T,2$G74 ,P)Q-UH<833;^0B\5D6-CM!JCM8RYI\9LW9/9
MFL&LC%##>(I(4PUFBR:"' \8T: I]9XR$2#PY'A5J=NU/QEWS%C\^W1[E-RW
MH*RC2)Y9ZXB6S'+MJ#91)2\5E=+0H-@7(5:N;G8P4D.4C=(+HJ<MU<')8-A)
M9]6?,L?HT? %RA<]O/:5UA!JK:)YG__WGEN/;$0WW.@,?+<W..DO39N1]L=:
MI0[?'.Y^?@.JL\[;VU_QSL'['YL;7N3_X'O[6V_?'&Q]_OMKF_Z]/]MF9.?S
M;G?G,ZCDQAX!%>NT-S9/VS^^YO]@C*\Y?"9V/[]G</^TM?'N+!^3TS33+'&D
ML,[L2]$AK1U#7CD>N>:)1%S90A#;&-:S80HA2D\]R?7[/,!ZY$I4P;R2R9B(
MW6Q;DCSA\]I0*U.1Z1G-J%?BRL=,#XNZ*+GGC$#$R6'A-9>$46$\CS'*?+#@
M4?JCE#N^Z Q!"_TUU.)5/X;.L+6^UX\Q;]%>M]/) E5_I)XO6T>MC>CCH8O]
M2I_):HMBHEJGL56:,L20B]YZ+=ORU<OF/C![)[9OCX9G+3MZ\]+CT+;^ZP9N
M6@H0#1&9=(3P)(75)'>5=$'*"-959#=-% QSVDV+12;BW=$ Q#</Y)7M]\_
MKMZDLD0^-W.RO9Y;%F% 1QXY3 WB7H.?E2(B@[%40D29.%MY2858FZ](;X$@
M=O/J#N)1!]9]$ $0@:#4$@(A10%*JWF]!YU!J9SLI1N*!TE">9Z$(0YSQ\#+
M<D4-X5X1([BAC7C<EWAL;K___@50EB4P_T@(GJFVF<ME0Q(I*K EUJ:421
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M3L[^KE=)F0_QN-<OV.<-N(86P>C_E;K/;(/R9GVKVLN?+BBM-T3HXB*5/(4
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MBS?;BK.,4/"Y@6HI.<^I:)*LE#9BG'A,I!@'C"71-W*_ "!C<SCYLH32IWR
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M:T_KO>M151Z]VLR.].QU]0(-\K]8[_9H>^\+CDXH13ERC('>665  [U#SG
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MQU87?N_"78<]^&T_?R_O*C\>Z]O*2QC>A9ZD<MFSA2K,NR"53CJ?P+#2!47
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M9A(B6AM9@M_R5+)I^G\*(1BH$8J^:1WXE?RAR44C$=S7U2MX@R5T&K.1(^>
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M!K%?$Z9&!RJ_!2G=;7K#*"-8!^""+(,IQRC+B A03E1I*:4:5H5)F4$!'\,
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M",:0H*SB&&'YLN3/TFG\%)A+.!Y$E7A+96Q@E"*OOKQ0-4VVAOFGCE4C@.,
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MS5RF$.3*W*8X'IN5@,0_AXUK.;VH:N%:LN4&A[JI.6/:/2IS!@YS4I@;/R4
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MJ0#U]%K>#,JP:%K>/,Z6-X? /VIT\#I"4&B'_7M1QX-B2M*R+2)4JV^#R)C
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MS>V%\+T$?D:D7L3I"H.38208/\C6M!N0J.9S!!7^P[R"IYX$'L^%.5'804@
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M*)WM;LG&P=@X&!] ;=E;"C@^B?%C9!1.AY20[AA))Q$ #A&.45UEKDAFLEP
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M?#. (=^Q:P:G]%M"M7>KO/@=>ED%0@HQ;0I=O@=70ZZB<BV$;ZM=&J+;U2X
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M$DUFGB"Q[ 1H$5WH2W7OUI($S")1B QLE6((J28=]AY<,P8S6G7MV,B7*DJ
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M"[K_XHU"I^P*(<XS^;V(2/3S J0#F;)U](RI(HJZN1;KI'![*5D/>H67TMH
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MMS]O(;</X%GN''*[-7R?;_C^,9!:8ZB'@VT(&M>AMXP[00."$K#!6V_7\93
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M;8OW!=@DM(^:<B8=J2F:0*4PW2B-G+6AH-(JZ!I&B'[5.HYBYE"1Q*LT;<2
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MPVI5_H;*!B["_2?\0>E083(B$H[(2?S+&O2LH#S9A0BY;OEM/Q^:_70+S7X
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M.]M0J\ZP-NEAW)+/ &W0:Y# "Q%[<+:1*(S'N>/XD#O0(PA)*3E4G_I6-SF
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MP"-(]-;)$,DCIVNI)E#08Q'IOSWHA4JD2SX+,#IS"Y"1"VQ:4-NS@S2NRI0
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M-QX*A EBD#4-:E('YY,VA(;U(=T"QF>7@GG?!M?%1EC8X0-NJ.=66BPG\T)
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ME;1&G^ZO^A396N31,SZ;L5#F'K)\)S-"ZM?)=->),/K_8-7_&6EQ:2\CKT7
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MB9O0C"&FJO8]3%DA#$&N<6XHI6]"8[)NEL/'/R-O\6[0'^S7P*>8L0G-2_;
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MHIV#J&MUD1,*HA4TW$$PK<@)5X'WR7O<B&=("9 ]^;!IO\L>"FA&]=66TBM
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M*672F!Z-%=/PE+!E&$\QOPSS*?EM"XKR3HY.5FF=%UC&:;P<*<NED$;7=:T
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MK>#=LS2D^QGHAR!E>[TU/T6J^@[G;@-1&Z,F_6KM0FV 0^8^A !"D+EW.:7
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M%!QI'I*QV?D#DN0[L"'D9@[,DQVUTJX?]Z7CY=_5@7U3_EB<3LZCP+WC@IQ
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M-B<6WT.^#3+/7^8\%R(,WD,_OQV^@B_]*0R6X+!H'TS@+&<P-%1B.L3$61(
MA4=R$!I=B7$KK*= A.[DWN2NI"F-#_.J-]02E>:H4R!WT-A4;X A%Q$4STS0
MOQ.G?TK?IG!G/9ZG0(,.)-T@J?QE2K.SV0!6_;_69(8M@>8BG54T=AUHS=*Q
M9G@%'UG*Q0*JY$IJ$_W9&N)38$D;?1PFU7P)+!G':^-3,HT"U'9#AH9/M'9)
M.,>U-,4>+-?\Z1"C&WEOS"GOM)3WY_X0AJD/@[?#R70\FQ><?IR=G<'X^TE9
M]\-?YV/#_'+Z,_3'\QC9Z[I<#B97@6]7XMOEZSLH_6TFC6LEP5EJ$-HHP8/1
MUB"DY$OD-A+/I.>\UR60_1:/\\?]! -Z*W[\C#C]93R:?:&=\1S)N4-&%M,\
M;>4BX =>&Z.U9<+5_F%95JM)!F;1IJR-)1&T.<O:%_G>7AM,ZMV*]7]UC?D*
M@ZJH"_6<M^_L<<Z!%W0LD%!HD^#(0K'(LK"T3UB=I&^S#&\-\?#+\D%Y=\,A
M;**Z%H[B9(+K@46MO++", 3:;[0S!-$8R43@6EF/R+&1D[@)TC/C4#>JZ;JQ
MSN*^I=,Z6AII/R_O7*KW*<U+22ZVCQ[&))7EEJ' S+3VG,54+/,VEB+)Z<T1
M[MK?=WSG,Z%(2TTT<#S?]2'V!Z0(7$OGG*7P.1MFN*A7\F"@Q3!F5I2!6(CL
MTK8YM+H=US/A4@,E-7!!+T3S?9UP%@=\TJ'@W@46O8HUP9F&;[1@@J-(G@L)
MOLWA_S;H#G5D?E02=:ZFAW+L?FE@YU_^[SXMN>/T^?N[>OOYHHE><> EK:Q.
M.DX[<YS?IAV9\S$YD9(4H4W@;#M\QSJ([YX6FWG7E7H:!.#/H2V=[;,K3L$Y
MWE7GS"W -CV_WPGN<<[U6^A]$[6:*>WH3--.JF(3,)Z*K.<2EH$6EBE(UL:
ML32J5GT #+LC4>#!$6P77;4DUMOAE]ET,I> 6 :GA=4J8A*T@-=N_Q@]\Z$
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M:X\_SZ)/EHD"1@1-6XC9Z@1SJXK[\]<^#>/T_I+L\/J]<Q!+5FT#H_..+9<
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M &:W5S8Y7]ECU->.3ZQ-/!=>O Y6&Q6BUL58$S3$J$7@:XY/=GOYT4]'- 2
MG!79K@)JOW3.ZK$U4X$\<A6*P_BOTY%K""Y_O%97B9Y58#PF<@.@AKLQ ?-!
MQ+HT&)&#DD(\L(8N-\;P %?Y;MG;V>G'?NIO<=K1F3N;4:)+PC.G1$UFL;2[
M:2*>D8@J5V&71A'<9QC+VHN\1U'YPXQE>8=@K"Q,5MS:1_(G@M9,& G!%AZE
M;),D]\1B63LQX=98UBX:>2Q1@&W&]*]8UCUB63N1Y1#A@/MH^K&PN/ <34:H
M-SQH<H*Y9N"%8H);P2$;,+I1L?RC8>].L:P'1]Y=%-QU8[1K2:YSE)-UF:_O
M<5Q&XS,8)KSTR>O?O9P.R[,-!D&Q DK7JCFRE40 $KM")R $+N^5N-PAQ@?H
M0#4GT"TISL?2?M<Y]G,PBYQ6$M;&!D*+3RS#.ZL(8;8Z\\294C70K;EG7A;%
MHO528-3>F^U(>W\,SYV4!]+>@3+P%][3V^%\HM2G==))^^ZG=A&EW1'[M4"L
MB@*S,1RE1FV#  DY^6QB21:CY+TMGK^G.;9XP0?\0A+L#T\OO>G"I0_6JJ2E
M9<7:>@&& @:H' -+;''UC"$UBI]L@6Y?@_2W69T7M<%4?4EU&9=OG?2B*.B+
ML"QP1^,6'EE,*.J$,5XEQ=&WZ3*V&=,15KZN&7+=8.Q( 0TBD,L;P0@'+Y;F
MI6>62UJH2U8LF&08I.3I3Z9O8!,BK! \0;7?2[@M'-*+2-/F(=/FOOCA(J;D
M!9K@G6))UGN2L0@&P4EFP:*U6(J(C9+D=P=[L-!Q:\*T5M2QP\"UJ<JK>D?S
MH)_G8YF+;.&/"V^4IM4OF=HZW^C"R$2(S* W5@C/9<C;\&VKWC7K,3R 0' ;
MK8\ZE7['+8QN(EI%\[; U'FCM$UH#M\1K0M-W:KX/<1\, I8\A5Y088"$]..
MEM$0O67&"RF3=%FJK9*='Z#J;^EF=C#-[R#=!E;)O*ADN:&\&?3/^HN[S99.
M/$I:R@0Y\;26A7H98:$%#@2S06JOBA(:VIP-W@KKL'W.NM'<J)78#Y0;=R,^
ML#*K:PK'25ES.QM].6]5_RN,3_O#R<^C\0EMQU!WU)7?U6G8I4M 32(VS21V
M+=BCG4R0LZQ7D6OM-4#D)EM:MXQ&Z=2:8$^7T X0)Y+92@%:,W!&,,T]9UX+
MLNZ#CUQ'S."VND[X0<:)EKKXF18A6GJF8TC3VEGQU6PR'9WA^,VW-)AE>O?+
MR00GM9,$?.MYY97QRC)4.C,MK&0!C6(<8^)&<XVZ3>#L'F ?:(AA%TYM"#$T
M4UF#D--BIO\R&N7+T_SC:)![H11M/5KF!:^EI2FPR%4D!SIZ=%R8[+=R G<F
MTV9,3Y S'2F@@4DX7^AI#RC]:<]&2"9FHF5,BNF8 X%2GGDK @T7N<YMBG<N
M@7B"RK^OB-M6<F\=]\ADGG(G@:58K\95BH00%+ 82C"@BTBF3=_;QQZ6W(<S
MK15U[+#D^3BG,%VD ,\F)+C)9&5@SOUOVC*]Y$6S&&L7$$DT\18,*XY&JFCB
ME$87\MP*ZS$%+7?BQ(W;H;K238L#E@66I7>^#9BV":>7X1PG4[1#=5TGPMZR
M;DX E716I40FHJT)*$'36FLMX\[SI(U6)C1J+-)>\7<D61Y*[[N(N.MLR5\Q
M]Q,,7N/<;EX&S@H:9Y,E,ZH4<JJDB,P'E"P[)[-1JF2_7<K8NJ<?S0Z]C[1'
M78JJZZ3 ]V.<D,.SJ/A<>CY+6$$:@38D5JLIR$(B<D;T@>QBX2$C.<;73[PW
M:'#S.QZM'CL2V[&R[<YK>W_#Z2K@^-/W9;#QP@?N-"B\XSN;Q'WW&?>UT*XI
MSECEI%96:.O!HZ#5/$MO/%<FPIK0[HYOWV\'7CYVK>^3;8+BBF,VET04385%
M[S)S68..&IW/;<Z2;@%UC%BM2EX&;PW+:3Y536:0L!X;!0W*HM"^34CE4<1J
MNV)0%R':7335M"[YIE 6KIQ+9*MEZ5@2-6W1!F#!"L5"%MEIGUQ,C9SANZ =
M*NK2BB[=RO[8H97)W'B8C^-DO%SPYZZ ]M&; IQX'8CAGBS!4+AE$)), @22
M&=A9:L<Z!,</G'2BWU&'<NXXK6?-8>[2#MT&5.>I71OA'#ZW:W]-W51[1V(^
M& =DX?5*#MK8') ODK5GL7ADZ N/R)%+W5UNUX%U?TMRUX%4OXMTNXZ/K% M
M'43A,;OH4^T5%^L5>YG%P NS-B//6@%BNLN]6O/<PZ9B=23I43=BZCHJ\K)&
M[M-'<OBFOXRAG&.*4BD LD"#1=J)<O3,<TX;D\*"2MK@_7:JV_""P^EP;XF/
M.A97UY/N9/A?J_":)N$+Y)6!@ND"A$<*P[PA/D;/BY!\*Z6=/_*1JNE^(NGP
MH'M1R#H;G]88Z$>$ 0S/1T5F'2:,G&4E9 W%.185:A:YA1Q-=&#U5EI:__Q'
MJK(.A'53?VJ_B37]C.-KX^. TALPS"I-?+)%U[9ABI6<4I%@@I=BNREV\^&/
M5'/[BNFFVG2K0'_F2?AL PN0B$VU"2C97886!W*\:.F.)(!'$^AO9IQT(KX#
M!?QG<8+_G-6$]J_[)G=O>%07X?EM4%Z+NN=D=09M8XF@A;<^FBPQF"24\M':
MWJ:'[AG_N_K42X$MD= ;Q1G]1Q8."-I(H2#+@C91XWUQV"C]>0.BO4OC1]-Y
MBOF[$0PG'VB3Z7^M,9C?</K;:)AFXS&]K.>Y]%"#>,7$Q+21P.J6PQ#06N^4
MSJY-[Z5MT!WA3+$+=MPHD>]:$5W[2*L:_D]C&*;/..G5@EY,3I.K3I8)6?N)
M@1*)"0 :JTN:![?5-G+]R8]<H_M+JVO?Z!.)'U=(3LK/LV$];_EY-/Z(Q"R<
M<^X]CI>?Z$$Q$FGC)!M(V7HQL&20'3+EE1!@<D"UG76WVWN?@MH;2KIKOZQB
MP[Q$LNQF1-!>GM((ZM<]2]9K\,HSDQW9.;E 35M2S!<KR7+BZ(S<B@9WO>DI
M*+Y3:7;MPGWZW!^OL&T@Y:\D\[/9&4%.A!9.L39K^>>L3S]>+67OR1A>MFP)
M4#O)LVRD8SHIPR"22PK2">V)SR&K+=>'+G$]!1H=45-=.Z"7A[*<$#VO"Y3J
M4^<:[-=0X_PZ>J:<EHE'#5%OYWFN>?A34_]]9'93AV;O5(BK@UR<T 9A:<,2
MA05.8]/!UGAB\"Q$%%&0H2-YHVYA:] <K,RDA=F_MW@?0H+#19T^YC?#*4D?
MERT;M)*YD)=B:W]9':1E(<C(.!;+C2E@M[N :L?^%5=1'"W186_5KFUBL8>(
MF[4MN<"T:M"P!:J&O6NNXSEF]YI]]'4' ?80]N&H8%#0#@:1.:42HSV+N$^>
M#7/)JI22()!;[14/D@);=;%ISX!=9-R@^N?O,.[7U6UU3?(<W??WXWY-?_X)
MAR3LU*<O5\?$020?K&>9]D>F:8-DP9-%(Y3(RM+H"U=-K(?=<!ZKU\U^VAT=
M3#4-\F[?C8:GA//L-<;I>:=ZX4I*P0>FT%FFG0L,5,Y,1YE22<XE:%--M@[-
MHS<F.A-U@X+XZYB6_-\&5=-ZTO6XCE-8NK_>[B#"'D)OL+5L0 <^1+ QL9I)
MSG0VA46"Q(S6J&4VZ+;KEOF@J7!'J>FAF+"+K)N4%L]#7Q74<I-*G!<>0V1>
MU:M+4&9: "UGT@N?8T[6M[H*YCJ4P\><NM#1C<+B?03<HOKFVEYWSFVAZN%9
M;?=:C1-3ZP)HOV-%%ADS-]Y>OTJE4=3IJ=D"70B\PS.+6V"M-J<M@+7M,+$)
MVI&Z372AP+M)L8?T6VP,&P&2 Q.\B>12^T  P23F2_(U:X+\**L=K6U/@19W
M]:(X*"MV$7I[-BQW,L.U3C7-0G%7.WPYR;SW@B7:WTJV(MCKJ0QMF'"T]@?=
MJ.MV$MQ#UKNVSEU^N_Y5;S7^SW_[_U!+ P04    "  *=Z56_! KR9#/   D
M;0@ %0   &%O<G0M,C R,S S,S%?;&%B+GAM;-R]?9/;.'8O_'\^!>^FZF:F
MJC%#@B )[)/D5H_MV;C*8_O:WMVDIIY2X;6;6;742TJV>S_] _!%HEH2!4 D
MFWFJDMEV-XESS@_DCP? >?G7__/]81E\E469KU?_]H?HI_ /@5SQM<A7=__V
MAS]_^17@/_R??_^G?_K7_P7 ?_[RZ5WP>LVW#W*U"5X5DFZD"+[EF_O@KT*6
M?PM4L7X(_KHN_I9_I0#\>W73J_7C4Y'?W6\"&,+X^5^+/[(,TC!#$5"8$( $
MS@#%(0>**,$98OK_T,W='S%EF6(A!@D)8X!HC %#$(,P%E"%&8T)@=6@RWSU
MMS^:_S!:RD ;MRJK?_[;'^XWF\<__OSSMV_??OK.BN5/Z^+N9QB&\<_MU7]H
M+O]^=/VWN+HZ(H3\7/UU=VF9G[I0#QO]_)^_O?O,[^4#!?FJW- 5-P+*_(]E
M]<MW:TXW%>87]0K.7F'^!=K+@/D5B""(HY^^E^(/__Y/05##4:R7\I-4@?G?
M/W]Z>U8D^=E<\?-*WIF9_2B+?"T^;VBQ>4>97&KMJ]$V3X_RW_Y0Y@^/2]G^
M[KZ0ZO2PRZ(X&-5H28R646JT_.=SPGZ^0OV!]-T<ZSJ <I6Y[X?2L0_3]X.I
M^T7S@QQ?X8Z8JU6N'Z@W*S'5L[L3=;7JXVL\U&.QWM#E!(_%7DQ'Y:7YQ3O]
M4R/&#-1#II6<AKH[JLKO&[D2LF;+@Z&#7/S;'_1/"[HN-HM7Z]5&?Q+UAT__
M5.9"%A5[OU^O^+8H]*]_I7GQ%[K<RH4@$J4,9B!CE *490P0#!'0O\U(A"1)
M$%MT)V(A5^#/GUN]*N%>DO]@@\3%1ZV0Y7I;\/W7\&%YZA.GOV[F>XA_7M$'
M63[2Y@:MOG$<:HO^?:][P+O*_^O/>U.' WXY.9CM8S49B@=:WP1[O6\"HWE0
MJ3X.NJ)Q_*H+7@+E P7^!Z"]Y@<Z+HW#MRZ>8[;FOIC5O&IN!L:U#N/:[_MG
MU^%^/GI&;HM6=5KP"U/37/&S?K^Y?-R @W?!+ BNLG&SONJQJI'7*OXA6!?Z
M>KW .6'N[I78EN".TL?%^_5&EK?Z>[ZFJ_*3Y%*O6-A2:G]J+VN1QC&"-"(@
M([%>N%#) 64)!IKD.<&802K$8K/S:,Z^,2Y"75Z7S1F?;<AWQ>@:/!;KKWHR
MA!WM.&'<S^AC(3<RG?^:K_1B4#_(P5[7FX J/6'![7*Y_F:6BH%:%V:)+?)-
M\&Y=EEWVN9YQ?)#;NW&E-KJ"3=&2578WXVD,8?2S7&[*]C>&F2(01LV:])^=
M!$]"3#Y0M*SD=:\?)6G&^RJ+3:Z'?2W9YC?YP&2QX!FA&<PD$%Q @'@" 4VU
MTQG%89:2)$NRD+APT$DI<R.=CI+!9[G*]8M238 ;_YP&U(YPKH9I?(=QAY!1
M,/B]5O'_'8XY>B$8E"I.2YJ4&WJ-?4X&_1>[O?V5V_-A]9_-TZFDH%"%*4BQ
MC !2,0,LTF\_3&$LF<BP7G#:O.Z'P\[M_?ZP O_IL(39PV.Q_O,R>N2W]<,J
M^,_+;VB?X0Y+,R\ )EIYF8D?D*I.V]N[:MI?/=VBZ$C#@S7/\5_]_(?=TN@W
M2<MM(<UTEKM?_D>NUU(%OW]ZO7Z@^6HA($_3.$2 J3@!*-8N!=8N!9!Q&'&!
M4*K_[N)7.$F?&Q_ME_K!3M/@]UI7R_?5;Q;LG)'1L!U[&70*5KH2P?O;OUR&
MU]EA\8)I4$?&38-)'1PO<)X[/GZ#>.[0R,W;%5\_2+,V7D0LE#B#"F09DMHO
MDA0P2CA &8Q(@L.$A=HOVITB7-Y0Z([N1$=G#D2&?&^T<L%2Z^6XW7( 6)(*
M$1$-& F9 (@Q"(A@#% 109:*B"..%MJ+96OKW2M?R+I2Y@T:37&(:1H"E$ ,
M$*8$L(1(@$D69IQ2)0AVVO#S?LHF^.@- 9CE[ITO#"-_GPP"M6+!#T:U'X/;
MS:;(V79C]G:"S3KX2 ?>C3N%Q+#;;@<2IMU?.V7<T4;:R8O</A%E?5)0KI>Y
M,$><;U:;?)/+\O9[7B["F&<)S/270B32G,U& '.-4QA3C+*(Z*\&M'F'^X3,
M[57NZAFTB@:_&U4MW==>2/O?\J& &G_'S!TCZQ?<!H2^]US?WWG'RWKIVGV_
M>P5,\IK;F-B^[5;7^OF%'QZK0\'5W3OM@\I/)N[P@_IS*6_+4FX6@B<LS1(.
M)"+,?,930&G*011+$DJ1:E+ ;FY/K[SYN4$[=8.ET3>H C/!6H&M_@<U.I<W
MP4J>_Z9Y@$Y2%N+0H)PA[3:1* (,FIB8*,(L3 SLV,4Y'PSR*9SUEP#<SNT:
M#,:Q=T=W"%:*W@2?6@BULD&E[7 >F!4H@WID_1(G]="LC'_NL=G=Y$?F;QX>
ME^LG*3_)916KEE.6+ZLOQ:LF/D#$F"%(*$ A-H2.D29T" %-XD3II2SC:>BR
M)+LH<6Z^W2WGQ5:[+-IG?I2KTB&XSAYD.SX9%+J1.:75%12ULD%'VYO@U=!1
M%M;0#,HLEZ5.RB[6(#QG&/L;_5BF7G!^WNC!S8YEFY=1K6TP4FF"B5XN8HD
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MR^N3]L#?*"7Y9L%#LV[F"> H$J;1001(B!(00DXH0B(*J5,[C6G5=R+'"4H
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MK_=K/[8.T_D($Z%YX%E,)=/SD&K+2OV &Y_'K&R_Z%&:]BU)A.,H)!!P%H<
MB10#C!,&%,Z$)!BCE+ME4)Z3-+=%YE[1H-(T,*HZ=L2Y#*_E*<X0H(U]]N*'
ME_LQR24LACW<."MMVB.)2T8?'21<O,&S\$YQ1U<-YY@-L?4R%RT??=2/4_M5
M_Z!^S5=ZN933Y2ZEL]Q52X:"0Q6+"(@L9*9K3PP8QB%0"4X))!B1R"JU<E"M
MYD9 7:.J6O%[LRH7I&N8<7)VINV;CI?>=:^'F6<[=IM\]D9FPJDFSKUDT9!
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M<K<5G66*(B%-C%<< \15 FA",& )5RH,&0\CIRTZ)^FS8WCKX[3+V]P#S,V
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M1*8M5:-JNPH?,#S?"I)!::E?XJ0$9&7\<ZJQN\EST[+)3-0KW'9!G/.%*;8
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M7+/;B2='K'EU8_6FSV62#I3ZGSM9UE^P >&MOVMF0/.QBL.X^50-(6*2#]B
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MN&X@Z$;F,V_4/,I-7<1CX+)3Y^5-7'[JHN''9:@NW^)&'D+FBS>K3;YY^OQ
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MMS,BX)45@6K,N D>]Z]P45D2*+W*6=7;594Q#DGJ?O/53Z'3S,+(]+F?@-J
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M9U".'U?C23\2DX#__"LSC5"_S]3[K?&@/ZA/U3$694OY6=Y5R_!%#!7G,HL
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M[4Z;>+QE=^8Z[Y0#>G=7F# +S1:[O<!W^4J^W<B'<H&32%'.]7J/( )0R#*
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MJ/*SW5U^_-')+_VPN9>%J=!4R'NY*O.OLJY)_VY=FG+T']07^GU!8T54$G-
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MPD$_)#YZ3/J)N0*HYQ^?:X;RJFS(-OM"HTUTS7KU41;Y6BQXS 41F0 1H@E
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MQ "%! &L< 2PR"#$L5""12[>QGE1<WO9.YH&E:J!T=5Q]6&!L)U',0QN(Q.
M+V3.'L1E- ;U&GK$3>HI7#;[N7=@<8<?973V/YI\L0@K29*8 8E"I=<E*3/!
MKPF 441)K+)8V357/2MA;@31W0ET8X-C\.Q(X"I(1M^%V*,Q8'+=1=,'?=&/
MI4SZ?I\U\OEK??Y"_P/B<E.SA-GL?-N$;RQ,'DPJM&N?JEB9F,(8$,@P4"$/
M4YS*F*K8+>+EG*CY!;>TF@5YI:C[>?!)1.W>]*M0FN[DMU:Q.2ZY"=Y>BOKQ
M.NKMPV'P\]V3PB8_U.TS^=1);N_U?I3P%UKDYJCCDW[3JITO)C(LD%  (FSZ
MG64"L$1)@*(XS.*,\M"N[L Y 7/[O+?Z!49!KRW%(PCMWOUK@!GYG7?"Q/EE
M/V?XH"_YD9!)7^YS)CY_J<]>Y_<R5ZFSFACT7)IJG'42[7NY6> T3:-4<< D
MT]]WE$) <42!DEE&0A(3DCHM[\\)FMO+7>=_YSM%RYM@)1VC5<^":O>:#P'5
MR*][C=)>QUW"_/L>K)Q?^TM #/KZGQ4V*0U<,ODY'5R\_OKH][;G2--RI&Y)
MU=96^R*+AVB1<)+R5*7ZDY\P@*A)=.4A!2&+)269("QR;!OEIH#+FS%-9FNK
M<T";1BU%JW6P-&H'ID5+\$.^"IXD+<H?_QBT8=W5GQUC3!VGR_*H<K0I&/O(
M\C! ?C<5;<^<G?;U%8'1?YP >7O81HN0MU#AQ4+D[>'IBY%W&,6S^Y6\,XNH
M^D!%#_PZ+_ER;79/.RVM0ADS1"! )$GT&D@B0 G)0)1DD2G'AIF*G5I:798Y
M-\^I45E[!6I=//3W2??&V8ZZ!D9O9+YJ@=NI&^SU#7X?I[>3/4##-FRRD#MM
M%R9[((Y:*SG<ZKDX:\O8[@--%V&8B0PC!A(61WI=AC+ LCC4B[.$(RRRL"IA
M88HZ6*[+CF4X$<M.THB+C5TUYQ^65=BUS[;K*2PMEV/7(33V2FP'SD%H^H"+
ML//F#[O^.B%GVJ77>4./5ET]EU[YJI]LI;+ >A45<LR!1!$&".($4,9"(%,5
MQ9@F"4J<MEC[Q<W-LVC4"K13L2VJ2DXF?6R]>_)]EDP7 ,\R"D6<01!QI)>U
M$ F 69@!2(B,XY ('"JWXZT!()\^@YL?(3\HRHX$?/7#.AD7G^VP-0(O]Z(R
M#D6?%ODR;-UK_EGB[K_+HP)/=T5J6BXOXBC+8L1#H+)0+PL3C@&-)08A"V6(
M.9$1#&T<M9.CS\U%JZN(J>X65ELETJ%8S!&&_?QP-3+3[D,9[:X!PZ%8SC6@
M3%0?IRY?8+[CAT\-U^H&A>3KNU7^#RD"]J3_8'IZ!&I=[*ZI*VK]-% -G7-P
M]9;-.;IINDHYY_0]*(YS]B+O$X%\HQGSJQ3/CQOT5.H%\#]HW=BO>NG_2]+B
MR[?U0O T"['B((NHV1N+(D!B$R^$F,P0(U'&J?/!@+L>\SL?T,]3XKS'[S$!
MUEO]XX(Z/M-J_4%EP-&IY$U5WYM7)P =8VX"8T>@#1ET[]\?QZ&/ #PTF?HD
MP!^L$P<"5PSF1XE?BBJ&^JF*MFP"+TW5A7*!"#&-I2'0BW;3GP!A@",2 1%&
M,,NB%,5$NM'>65GSH[96U:"L(G[IIOJFW]05*<KJS+/^\?PFE2/<7* XI8@"
MO6(/M:M-E$F!34$D"=?K>!E3N(M%K8O#?=[08C,%\H=+]N?"QYN$7^1=OJK.
M.!E=&C_@)M@<SLL(\\!BB2(AJ6D[%.G'GIMZUS(%*90,01@F@CZ;AS<KR]V3
MX6>A%3W>'&@)$T^ W==^$"X9^8N^(Y%*R9NFN,I-4"LZW!?[(A:#?I7/2YOT
MRWO1Z.=?U\LW^&87<#.R?"WK_WU[4#?ES=^W^>;ITWJY_'5=?*.%6&":H#AA
M*:"09)KH3:$3%D*02BJI(CA*D%.% T?Y<]L7;]4/?F@-,&=C!Q6(_B6HK0A^
M-W8$C2&.X<JNTV1'0R."/S(YC8"[1_Z#%WH#IT6XZ3!QMH070,=)%'[#^)=3
M^#4O.5V:)<JO^C?E0CM.81KJ)43&33F%)(V!=FL%B%442@%QDO+4M9S",QES
M([9=O8!:SWJE7FGJ7D_A.9S]Y#002",3D <^7@45SB!P=4&%Y^-.7E#AC&&G
M"BJ<N]0SEM"X3;]H'A':C3)[$?5N?IBDD*<I RJ-30"U7CYACB7@A(0P95"F
MT*D]]&DQ<WO-WZ]7@-/RWM2LW"GI&#-X&D\[#^1ZE$9^SRL% 3,:!A_I4_7*
MWQ:%OD36304T@A6 ;RZ<M;D'"/9",VQ,X&E1TX8!]II[%/G7?_7U:95- 1")
M.%*8Q1JYE.HO?Q+JA0^-0)211"B&HHPZM:LZ%C$W1GB61NA54>4$D'9T<!T\
M(U.!(S)7I5B.6##EA)@72[/L+Y#2<Z5'>$B5>[VJ>((N7^?EILC95L](4^4#
M12&#,>&FCR@!*#.-Z=)4@1BF,60DPY(@ZPY-_;+F]LH?:!N(O;J6OKX-O/WO
M_\"@C;[YT,6KHZE/>_<+N#F$G R'WT0!*%?@Z!9=8H=,;ZS)A2&FBSRQL^4@
M#L7R%L]&S4+D]<@?:2[>KE[1QWQ#E\WC"Z$YA*42A)E)RH(X!CB*,J 2G!%.
M%(?**8>]5]K<>'6O;&"T!6]70:.O8]OF7HCM/*O!@!N96Y]CEN\P&Z%PE14H
MPW9R[I4X;3=G&^./.CI;W>19MDXOHV]7POR/V=3]2I?Z$U3>;E[1HGC*5W=5
M^=P%%BA.0L,HC(< 15("PD4*(NV_42($H:E;*3L;J7-C%J-M50*ZVGJ0>[T=
M:]U9(6Y',(/C.#+1[""L?NBH?&/B95JMZ[K; Y;*<T%IV/)Y5I*G+:GG L91
MF3VGFSW#RR2_7ZV7Z[NG:JOI>5A;\P%FB)'8U-U2"FI&PBH!3(028!G&$0P3
MJ835RM%)ZMP8Z9;K22BD"#8[[1U#:JRPMN.BP1$<F8OV^H)*X>.R/B,X/TX@
M#1N#8R5YVG@<%S".8G.<;O:CHG?KU9TI6&,:[G8*5+,L%0D2AG'JAB.)J186
M@4A 'B,291 ZK:].BYD;V1@M056^Q^AY<TWQ[S.XVO',]6B-3"Q^0#E323\.
M@W+'&5&3DD6_N<_9X<+5'CO9MR5_*K::5T3.Z?+=DC<?1]->"%%%0"I-<UC)
M-!G F((LPDK "+$$2>LM[#-"YD8%C9I!HV?P[MTKA\W7<TA:[%8/@,_86RG/
MH5ERGPWJ<Q@Y[$P/@-54.9''C]/0F]$7P.C=A3YW[W3;SQ>T/]AWOG3M4!'+
MKZ6216$<+U,*Y O]+LM%AK'V?20"0F0<H(@Q0%B: !')C%&(A/ZO:W%T"[E6
MC_2D121:)9N2/<'&J'EM\/$IQ.U<IN%0?-% XQVJ3<F?+[VH#A!:W(/2R '%
MIR2_<!AQ#QB7@X?[;O9CI';$;BC2OK#%DI9EKG(I3*184W6%<LQPF&(0*BP
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MTT6R/FTWWY=<\%>__JQKU#3-:9?K^UNV6WZO-VS[^Q3.2YI*7@*<RP3 3#"
M(1- BH3*LM2M_HSZG;BK,#>?2EG0U-J3J\V/*M)?G+9KLHY*(7O]_]V.8QW&
MQHQ7PR(>F$LUV'55ODY]W8+Z-VV!VKS]+=H;$3U;$>3.RQU$K_SIH,:DG.D.
MTS%/7O&F*WK!T.,V$KV[U%>_3N[/:K>W_[B^9DL6D$-*<2(!(8P#F$/U4U9
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MARB_[^'8KYSKS[LPQL:K4W%9ZJ2^A#$(QRZ$^0?=:*G)'5^HWR'&%>T0&1<
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MB[=2"K9KCJGNY"UOBA:UE]4Q2W1&4@KR1)=FRVD,4$PSP&B*8I3!&,+2- ;
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MNTWTB?B-9#> RRMAC<F;E(\,##^F&Y./>*T>I_B-K-EAO;(LR1.AV]%+R6(
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MFUR6.BFY&(-PS#7F'W0.<=+K:%V5LO-7?OU!=D];]=^C.)DL*6.*=1@D(S&
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MR'2GGN=U/3C>''C$?@O35&U\K09V2U;OUUS\_ _Q:Y$D,4M+4@)9< *@R#*
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M1T87&D@**3<Z$$R\&*E#UMAX:/_0Y$99.V2B[F]4'1EK.AYYYO$[X'8CH9Y
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M;4.'?_[C;YM_,3^$V7S]XV__#U!+ P04    "  *=Z56?L'([4-X  "E4P4
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M?&Z"ZE!8,9K2S-"K#*%855<NP>N4(.J,$8TMPP<K]7C;3M3 \QY/ J>^=-*
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M&]:/SG< T@$*:!!*)0 J ]L_N65:FV1-O'+$2E LX(KCZ #XH G$0!2QSM)
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M<MDY5VW@_8XT-N7$[8.074KQ>E!+8]OQC;F_YNOQR6D8O6<1F8.4->XYF2M
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M%?>)T+U%^,(PNDH;&4<,PY+I:"* 2MD",5A!4L8D@S$KJT:'Z/A)Y"X1NK<
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M\WEOG?8R[1C >.:;QDD,-\3#T>P<N:/R?9B=K]-013%G3+2@97*@LG,073+
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MHP3E7**W7M.!&"<_I: TI<U[^0A!NR'K!<;KAQ! !SBZUSB],@1*UNAKKT[
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M"2'8 MPP<KV1)2;;]$S]_U$]MA="=J@>VT=<'2!N )?;<Z-+'2T2#*-+[Z,
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M,@2_$UT)C G@K$6P!= IHIP2<2?($I2U7F&R@8-[-#5@+T)]TR*)2D, 0#1
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M-3AM0".5LFA;UG*Y-)>>R<7,"L>64N5;&><E-6,9-PZ[ZC_X24E\^$OWA6%
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M !$              ( !     &%O<G0M,C R,S S,S$N:'1M4$L! A0#%
M  @ "G>E5M+]W!OB#P  4:   !$              ( !J@$" &%O<G0M,C R
M,S S,S$N>'-D4$L! A0#%     @ "G>E5GCIR+IM(   /4$! !4
M     ( !NQ$" &%O<G0M,C R,S S,S%?8V%L+GAM;%!+ 0(4 Q0    (  IW
MI581=/TVY4   +:K @ 5              "  5LR @!A;W)T+3(P,C,P,S,Q
M7V1E9BYX;6Q02P$"% ,4    "  *=Z56_! KR9#/   D;0@ %0
M    @ %S<P( 86]R="TR,#(S,#,S,5]L86(N>&UL4$L! A0#%     @ "G>E
M5G[!R.U#>   I5,% !4              ( !-D,# &%O<G0M,C R,S S,S%?
M<')E+GAM;%!+ 0(4 Q0    (  IWI5:*CQY,WP<  "0D   7
M  "  :R[ P!A;W)T+3(P,C,P,S,Q>&5X,S$Q+FAT;5!+ 0(4 Q0    (  IW
MI59PZ(O<J <  %$C   7              "  <## P!A;W)T+3(P,C,P,S,Q
M>&5X,S$R+FAT;5!+ 0(4 Q0    (  IWI5:U]MLX/P4  $87   6
M      "  9W+ P!A;W)T+3(P,C,P,S,Q>&5X,S(N:'1M4$L%!@     )  D
*6 (  !#1 P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
